Cytidine, 2'-deoxy-, hydrate (1:1)
| Title | Journal |
|---|---|
| Licoricidin enhances gemcitabine-induced cytotoxicity in osteosarcoma cells by suppressing the Akt and NF-κB signal pathways. | Chemico-biological interactions 20180625 |
| Gemcitabine: Selective cytotoxicity, induction of inflammation and effects on urothelial function. | Toxicology and applied pharmacology 20170201 |
| Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts. | International journal of cancer 20170101 |
| Selective GPR55 antagonism reduces chemoresistance in cancer cells. | Pharmacological research 20160901 |
| Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs. | Molecular oncology 20160601 |
| 14-3-3σ regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression. | Oncotarget 20160405 |
| Comprehensive Assessment of Oxidatively Induced Modifications of DNA in a Rat Model of Human Wilson's Disease. | Molecular & cellular proteomics : MCP 20160301 |
| The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eµ-MYC driven B-cell lymphoma. | Oncotarget 20160119 |
| Using Whole-Exome Sequencing to Identify Genetic Markers for Carboplatin and Gemcitabine-Induced Toxicities. | Clinical cancer research : an official journal of the American Association for Cancer Research 20160115 |
| The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo. | Oncotarget 20151229 |
| Quercetin Enhances Chemosensitivity to Gemcitabine in Lung Cancer Cells by Inhibiting Heat Shock Protein 70 Expression. | Clinical lung cancer 20151101 |
| Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. | Cancer research 20150915 |
| A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20150901 |
| Combined effect of microRNA, nutraceuticals and drug on pancreatic cancer cell lines. | Chemico-biological interactions 20150525 |
| Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20150501 |
| Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R-GEM-P) is an effective regimen in relapsed diffuse large B-cell lymphoma. | European journal of haematology 20150301 |
| Reversible epigenetic regulation of 14-3-3σ expression in acquired gemcitabine resistance by uhrf1 and DNA methyltransferase 1. | Molecular pharmacology 20141101 |
| Triplex-forming oligonucleotides targeting c-MYC potentiate the anti-tumor activity of gemcitabine in a mouse model of human cancer. | Molecular carcinogenesis 20140901 |
| In vivo treatment with aflatoxin B1 increases DNA oxidation, base excision repair activity and 8-oxoguanine DNA glycosylase 1 levels in mouse lung. | Toxicology 20140703 |
| GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma. | Annals of hematology 20140501 |
| Intracellular effects of the Hepatitis C virus nucleoside polymerase inhibitor RO5855 (Mericitabine Parent) and Ribavirin in combination. | Antimicrobial agents and chemotherapy 20140501 |
| Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor. | Investigational new drugs 20140401 |
| Competitive fitness assays indicate that the E138A substitution in HIV-1 reverse transcriptase decreases in vitro susceptibility to emtricitabine. | Antimicrobial agents and chemotherapy 20140401 |
| Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development. | Journal of medicinal chemistry 20140227 |
| Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors. | Hepatology (Baltimore, Md.) 20140201 |
| Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1. | AIDS (London, England) 20140128 |
| Clinical outcome of paclitaxel and carboplatin as second-line chemotherapy for advanced urothelial carcinoma resistant to first-line therapy with gemcitabine and cisplatin. | Urologia internationalis 20140101 |
| Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine. | Anticancer research 20140101 |
| Rat N-ERC/mesothelin as a marker for in vivo screening of drugs against pancreas cancer. | PloS one 20140101 |
| GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways. | PloS one 20140101 |
| 5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors. | Bioorganic & medicinal chemistry 20131115 |
| Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer. | Toxicology letters 20130912 |
| Breast cancer drugs dampen vascular functions by interfering with nitric oxide signaling in endothelium. | Toxicology and applied pharmacology 20130601 |
| Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells. | Biochemical and biophysical research communications 20130426 |
| Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life. | Proceedings of the National Academy of Sciences of the United States of America 20130305 |
| Emtricitabine prodrugs with improved anti-HIV activity and cellular uptake. | Molecular pharmaceutics 20130204 |
| Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma. | International journal of cancer 20130101 |
| sVEGF R1 and Tie-2 levels during chemotherapy of lung cancer patients. | Advances in experimental medicine and biology 20130101 |
| Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer. | Current pharmaceutical design 20130101 |
| Enhancement of gene gun-induced vaccine-specific cytotoxic T-cell response by administration of chemotherapeutic drugs. | Methods in molecular biology (Clifton, N.J.) 20130101 |
| The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines. | Investigational new drugs 20121201 |
| Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapy. | Investigational new drugs 20121201 |
| Hepatic colorectal cancer metastases showing a distinctive pattern of pathological response after metronomic capecitabine and bevacizumab. | Medical oncology (Northwood, London, England) 20121201 |
| Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer. | Medical oncology (Northwood, London, England) 20121201 |
| Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib. | Medical oncology (Northwood, London, England) 20121201 |
| Rituximab, gemcitabine, cisplatin, and dexamethasone in patients with refractory or relapsed aggressive B-cell lymphoma. | Medical oncology (Northwood, London, England) 20121201 |
| Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer. | Investigational new drugs 20121201 |
| Effects of neo-adjuvant chemotherapy for oesophago-gastric cancer on neuro-muscular gastric function. | Molecular biology reports 20121201 |
| Adenocarcinoma of the lung with miliary brain and pulmonary metastases with echinoderm microtubule-associated protein like 4-anaplastic lymphoma kinase translocation treated with crizotinib: a case report. | Lung cancer (Amsterdam, Netherlands) 20121201 |
| Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor. | International journal of molecular medicine 20121201 |
| Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer. | Oncology reports 20121201 |
| Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition. | International journal of oncology 20121201 |
| Effects of 12-O-tetradecanoylphorbol-13-acetate in combination with gemcitabine on Panc-1 pancreatic cancer cells cultured in vitro or Panc-1 tumors grown in immunodeficient mice. | International journal of oncology 20121201 |
| Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes. | Molecular biology reports 20121201 |
| Structural flexibility of DNA-like conformers of canonical 2'-deoxyribonucleosides. | Physical chemistry chemical physics : PCCP 20121128 |
| Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial. | Cancer 20121115 |
| Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test case. | International journal of radiation oncology, biology, physics 20121115 |
| Effects of 5-fluorouracil and gemcitabine on a breast cancer cell line (MCF-7) via the JAK/STAT pathway. | Acta histochemica 20121101 |
| Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas. | Pediatric blood & cancer 20121101 |
| Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20121101 |
| Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin. | BJU international 20121101 |
| Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20121101 |
| Tumor macrophages as a target for Capsaicin mediated immunotherapy. | Cancer letters 20121101 |
| Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer. | European journal of cancer (Oxford, England : 1990) 20121101 |
| High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20121101 |
| Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma. | Surgery 20121101 |
| Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trial. | International journal of radiation oncology, biology, physics 20121101 |
| A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20121101 |
| Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO){dagger}. | Annals of oncology : official journal of the European Society for Medical Oncology 20121101 |
| Sustained local delivery of structurally diverse HIV-1 microbicides released from sublimation enthalpy controlled matrices. | Pharmaceutical research 20121101 |
| Salvage gemcitabine-vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy. | Oral oncology 20121101 |
| UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer. | Journal of cancer research and clinical oncology 20121101 |
| VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA. | Annals of oncology : official journal of the European Society for Medical Oncology 20121101 |
| BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20121101 |
| A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20121101 |
| Study on effectiveness of gemcitabine, dexamethasone, and cisplatin (GDP) for relapsed or refractory AIDS-related non-Hodgkin's lymphoma. | Annals of hematology 20121101 |
| Lamivudine or emtricitabine (XTC)/protease inhibitor dual therapy as a harm-reduction strategy in patients with tenofovir-related renal toxicity: a case-control study. | Scandinavian journal of infectious diseases 20121101 |
| Photochemical stability of 4'-azido-2'-deoxy-2'-methylcytidine hydrochloride: structural elucidation of major degradation products by LC-MS and NMR analysis. | Journal of pharmaceutical and biomedical analysis 20121101 |
| Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle attenuation in pancreatic carcinoma cells. | Human molecular genetics 20121101 |
| Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix. | Gynecologic oncology 20121101 |
| Role of chitosan nanoparticles in the oral absorption of Gemcitabine. | International journal of pharmaceutics 20121101 |
| A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02. | Cancer chemotherapy and pharmacology 20121101 |
| Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival. | The American journal of pathology 20121101 |
| Efficacy and safety of capecitabine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma. | Anti-cancer drugs 20121101 |
| The cellular level of histone H3 lysine 4 dimethylation correlates with response to adjuvant gemcitabine in Japanese pancreatic cancer patients treated with surgery. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20121101 |
| Oral antiretroviral chemoprophylaxis: current status. | Current opinion in HIV and AIDS 20121101 |
| The clinical pharmacology of antiretrovirals for HIV prevention. | Current opinion in HIV and AIDS 20121101 |
| Synergistic effects of photodynamic therapy with HPPH and gemcitabine in pancreatic cancer cell lines. | Lasers in surgery and medicine 20121101 |
| Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients. | Clinical pharmacology and therapeutics 20121101 |
| Safety and effectiveness of gemcitabine in 260 patients with biliary tract cancer in a Japanese clinical practice based on post-marketing surveillance in Japan. | Japanese journal of clinical oncology 20121101 |
| Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients. | Journal of viral hepatitis 20121101 |
| S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial. | The Lancet. Oncology 20121101 |
| Phase I-II study of radiopeptide 177Lu-octreotate in combination with capecitabine and temozolomide in advanced low-grade neuroendocrine tumors. | Cancer biotherapy & radiopharmaceuticals 20121101 |
| Trichoderma harzianum ETS 323-mediated resistance in Brassica oleracea var. capitata to Rhizoctonia solani involves the novel expression of a glutathione S-transferase and a deoxycytidine deaminase. | Journal of agricultural and food chemistry 20121031 |
| Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells. | British journal of cancer 20121023 |
| [Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer]. | Zhongguo fei ai za zhi = Chinese journal of lung cancer 20121020 |
| [A randomized, controlled, multicenter clinical trial comparing pemetrexed/cisplatin and gemcitabine/cisplatin as first-line treatment for advanced nonsquamous non-small cell lung cancer]. | Zhongguo fei ai za zhi = Chinese journal of lung cancer 20121020 |
| Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection. | The Journal of biological chemistry 20121012 |
| Clinical decisions. Preexposure prophylaxis for HIV prevention--polling results. | The New England journal of medicine 20121011 |
| Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II). | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20121010 |
| Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours. | British journal of cancer 20121009 |
| Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer. | American journal of clinical oncology 20121001 |
| Optimizing the administration of fixed-dose rate gemcitabine plus capecitabine using an alternating-week schedule: a dose finding and early efficacy study in advanced pancreatic and biliary carcinomas. | American journal of clinical oncology 20121001 |
| Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial. | American journal of clinical oncology 20121001 |
| Safety and efficacy of adjuvant chemoradiation therapy with capecitabine after resection of pancreatic ductal adenocarcinoma: a retrospective review. | American journal of clinical oncology 20121001 |
| Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704. | The pharmacogenomics journal 20121001 |
| Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab. | The European journal of health economics : HEPAC : health economics in prevention and care 20121001 |
| Long-term gemcitabine administration in heavily pretreated Japanese patients with metastatic breast cancer: additional safety analysis of a phase II study. | Breast cancer (Tokyo, Japan) 20121001 |
| Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies. | Investigational new drugs 20121001 |
| A phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable biliary tract cancer. | International journal of clinical oncology 20121001 |
| Use and costs of oral anticancer agents in the Netherlands in the period 2000-2008. | Pharmacoepidemiology and drug safety 20121001 |
| Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126. | Investigational new drugs 20121001 |
| A phase Ib study of preoperative lapatinib, paclitaxel, and gemcitabine combination therapy in women with HER2 positive early breast cancer. | Investigational new drugs 20121001 |
| Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum. | Investigational new drugs 20121001 |
| Isolated lung perfusion with gemcitabine combined with radiotherapy: no additional lung toxicity in an experimental model. | European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20121001 |
| Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy. | International journal of radiation oncology, biology, physics 20121001 |
| Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study. | International journal of colorectal disease 20121001 |
| Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before total mesorectal excision in patients with locally advanced rectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20121001 |
| Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. | Pancreas 20121001 |
| Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer. | Journal of cancer research and clinical oncology 20121001 |
| Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma. | Journal of cancer research and clinical oncology 20121001 |
| Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines. | Experimental hematology 20121001 |
| Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinoma. | Chinese journal of cancer 20121001 |
| Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB. | Journal of cancer research and clinical oncology 20121001 |
| Role of mitochondrial uncoupling protein 2 in cancer cell resistance to gemcitabine. | Biochimica et biophysica acta 20121001 |
| Enhanced anticancer activity of gemcitabine coupling with conjugated linoleic acid against human breast cancer in vitro and in vivo. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20121001 |
| Localized delivery of chemotherapy to the cervix for radiosensitization. | Gynecologic oncology 20121001 |
| [The efficacy and toxicity of gemcitabine and cisplatin chemotherapy in advanced/metastatic bladder urothelial carcinoma]. | Actas urologicas espanolas 20121001 |
| Radiotherapy for nasopharyngeal carcinoma and combined capecitabine and nimotuzumab treatment for lung metastases in a liver transplantation recipient: a case experience of sustained complete response. | Cancer biotherapy & radiopharmaceuticals 20121001 |
| Utility of inflammation-based prognostic scoring in patients given systemic chemotherapy first-line for advanced inoperable bladder cancer. | Japanese journal of clinical oncology 20121001 |
| Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses. | Molecular medicine reports 20121001 |
| Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors. | Cancer chemotherapy and pharmacology 20121001 |
| Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cells. | Cancer biology & therapy 20121001 |
| Two thymidine kinases and one multisubstrate deoxyribonucleoside kinase salvage DNA precursors in Arabidopsis thaliana. | The FEBS journal 20121001 |
| sMEK1 enhances gemcitabine anti-cancer activity through inhibition of phosphorylation of Akt/mTOR. | Apoptosis : an international journal on programmed cell death 20121001 |
| Emtricitabine/rilpivirine/tenofovir disoproxil fumarate single-tablet regimen: a guide to its use in HIV-1 infection. | Clinical drug investigation 20121001 |
| Emtricitabine/tenofovir in the treatment of HIV infection: current PK/PD evaluation. | Expert opinion on drug metabolism & toxicology 20121001 |
| Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation, with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20121001 |
| Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells. | Clinical cancer research : an official journal of the American Association for Cancer Research 20121001 |
| Letter to the editor: Hypersensitivity to lamivudine and emtricitabine. | Current HIV research 20121001 |
| Effect of pemetrexed on innate immune killer cells and adaptive immune T cells in subjects with adenocarcinoma of the pancreas. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20121001 |
| Gemcitabine, docetaxel, and bevacizumab in relapsed and refractory pediatric sarcomas. | Journal of pediatric hematology/oncology 20121001 |
| 5-Ethynyl-2'-deoxycytidine: a DNA building block with a 'clickable' side chain. | Acta crystallographica. Section C, Crystal structure communications 20121001 |
| Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells. | Nucleic acid therapeutics 20121001 |
| Phase II study of gemcitabine and bevacizumab as first-line treatment in taxane-pretreated, HER2-negative, locally recurrent or metastatic breast cancer. | Clinical breast cancer 20121001 |
| Effect analysis of chemoradiotherapy after operation in patients with stage III A non-small cell lung cancer. | Asian Pacific journal of tropical medicine 20121001 |
| Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy. | Anticancer research 20121001 |
| [A case of recurrent gastric cancer showing partial response to capecitabine/CDDP after treatment with S-1/CDDP]. | Gan to kagaku ryoho. Cancer & chemotherapy 20121001 |
| Curcumin-cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer. | British journal of cancer 20120925 |
| Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial. | British journal of cancer 20120925 |
| Successful use of eltrombopag without splenectomy in refractory HIV-related immune reconstitution thrombocytopenia. | AIDS (London, England) 20120924 |
| Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer? | World journal of gastroenterology 20120921 |
| [Gemcitabine combined with vinorelbine in the treatment of refractory patients with advanced non-small cell lung cancer: a multi-center retrospective study]. | Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120920 |
| Profiling cytosine oxidation in DNA by LC-MS/MS. | Chemical research in toxicology 20120917 |
| Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120915 |
| Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120915 |
| A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120910 |
| Role of taxanes in pancreatic cancer. | World journal of gastroenterology 20120907 |
| FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts. | World journal of gastroenterology 20120907 |
| Preexposure prophylaxis for HIV infection. | JAMA 20120905 |
| Ethical challenges of preexposure prophylaxis for HIV. | JAMA 20120905 |
| Reactions of an osmium-hexahydride complex with cytosine, deoxycytidine, and cytidine: the importance of the minor tautomers. | Inorganic chemistry 20120903 |
| Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma. | Journal of gastrointestinal cancer 20120901 |
| Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced esophegeal cancer. | Medical oncology (Northwood, London, England) 20120901 |
| GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma. | Medical oncology (Northwood, London, England) 20120901 |
| Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer. | Head & neck 20120901 |
| Langerhans/dendritic cell sarcoma arising from hairy cell leukemia: a rare phenomenon. | Annals of hematology 20120901 |
| Loss of control of HIV viremia associated with the fat malabsorption drug orlistat. | AIDS research and human retroviruses 20120901 |
| Capecitabine non-adherence: exploration of magnitude, nature and contributing factors. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120901 |
| Adjuvant chemotherapy with or without pelvic radiotherapy after simultaneous surgical resection of rectal cancer with liver metastases: analysis of prognosis and patterns of recurrence. | International journal of radiation oncology, biology, physics 20120901 |
| Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20120901 |
| Resumption or persistence of menstruation after cytotoxic chemotherapy is a prognostic factor for poor disease-free survival in premenopausal patients with early breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20120901 |
| Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma. | Acta oncologica (Stockholm, Sweden) 20120901 |
| Synthesis and biological evaluation of oral prodrugs based on the structure of gemcitabine. | Chemical biology & drug design 20120901 |
| Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20120901 |
| Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trial. | Gynecologic oncology 20120901 |
| Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma. | Gastroenterology 20120901 |
| Biweekly combination therapy with gemcitabine and carboplatin compared with gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer: a randomized, phase-II study. | Lung cancer (Amsterdam, Netherlands) 20120901 |
| Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120901 |
| Lentivirus-mediated expression of Drosophila melanogaster deoxyribonucleoside kinase driven by the hTERT promoter combined with gemcitabine: a potential strategy for cancer therapy. | International journal of molecular medicine 20120901 |
| A multi-centre randomized, open-label phase II trial of continuous erlotinib plus gemcitabine or gemcitabine as first-line therapy in ECOG PS2 patients with advanced non-small cell lung cancer. | Oncology reports 20120901 |
| Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells. | International journal of oncology 20120901 |
| Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway. | International journal of oncology 20120901 |
| Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivo. | Antimicrobial agents and chemotherapy 20120901 |
| The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models. | Molecular cancer therapeutics 20120901 |
| Chemotherapy effectiveness after first-line gefitinib treatment for advanced lepidic predominant adenocarcinoma (formerly advanced bronchioloalveolar carcinoma): exploratory analysis of the IFCT-0401 trial. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120901 |
| Targeting the MAGE A3 antigen in pancreatic cancer. | Surgery 20120901 |
| Gemcitabine-induced pleuropericardial effusion in a patient with pancreatic cancer. | Japanese journal of clinical oncology 20120901 |
| The antitumor activity of recombinant antitumor antiviral protein and the associated molecular mechanism in pancreatic tumor cells. | Cancer biotherapy & radiopharmaceuticals 20120901 |
| Outcome of first line systemic treatment in elderly compared to younger patients with metastatic colorectal cancer: a retrospective analysis of the CAIRO and CAIRO2 studies of the Dutch Colorectal Cancer Group (DCCG). | Acta oncologica (Stockholm, Sweden) 20120901 |
| Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer. | Cancer chemotherapy and pharmacology 20120901 |
| The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy. | Cancer biology & therapy 20120901 |
| A retrospective study of S-1 monotherapy as second-line treatment for patients with advanced biliary tract cancer. | Japanese journal of clinical oncology 20120901 |
| Colon carcinoma in a child treated with oxaliplatin and antiangiogenic treatment regimens. | Pediatric hematology and oncology 20120901 |
| Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF. | Expert opinion on pharmacotherapy 20120901 |
| Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120901 |
| Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120901 |
| Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis. | Cancer chemotherapy and pharmacology 20120901 |
| Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study). | The oncologist 20120901 |
| Acute myocardial infarction after capecitabine treatment: not always vasospasm is responsible. | Chinese medical journal 20120901 |
| Salvage chemotherapy using gemcitabine for taxane/platinum-resistant recurrent ovarian cancer: a single institutional experience. | Anticancer research 20120901 |
| Influcence of localization of primary tumor on effectiveness of 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) in patients with metastatic pancreatic adenocarcinoma: a retrospective study. | Anticancer research 20120901 |
| Gemcitabine-induced pulmonary toxicity. | Anticancer research 20120901 |
| Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study. | Anticancer research 20120901 |
| Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A. | The Journal of biological chemistry 20120831 |
| First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120820 |
| [Thermo-chemotherapy of GP or TP for advanced non-small cell lung cancer: a systematic review]. | Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120820 |
| High incidence of severe neutropenia after gemcitabine-based chemotherapy in Chinese cancer patients with CDA 79A>C mutation. | Clinica chimica acta; international journal of clinical chemistry 20120816 |
| Generic HIV drugs will widen US treatment net. | Nature 20120816 |
| MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma. | International journal of cancer 20120815 |
| Identification of novel germline polymorphisms governing capecitabine sensitivity. | Cancer 20120815 |
| A density functional theory study on the kinetics and thermodynamics of N-glycosidic bond cleavage in 5-substituted 2'-deoxycytidines. | Biochemistry 20120814 |
| Occupational exposure to antineoplastic drugs in four Italian health care settings. | Toxicology letters 20120813 |
| HIV pre-exposure prophylaxis. | BMJ (Clinical research ed.) 20120813 |
| Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. | MMWR. Morbidity and mortality weekly report 20120810 |
| A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications. | British journal of cancer 20120807 |
| In brief: Truvada for HIV prevention. | The Medical letter on drugs and therapeutics 20120806 |
| Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. | The New England journal of medicine 20120802 |
| Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. | The New England journal of medicine 20120802 |
| Preexposure prophylaxis for HIV infection among African women. | The New England journal of medicine 20120802 |
| Preexposure prophylaxis for HIV--where do we go from here? | The New England journal of medicine 20120802 |
| Clinical decisions. Preexposure prophylaxis for HIV prevention. | The New England journal of medicine 20120802 |
| Positive interaction between lapatinib and capecitabine in human breast cancer models: study of molecular determinants. | Fundamental & clinical pharmacology 20120801 |
| A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma. | Investigational new drugs 20120801 |
| Phase I study of axitinib (AG-013736) in combination with gemcitabine in patients with advanced pancreatic cancer. | Investigational new drugs 20120801 |
| The HIV reverse transcriptase inhibitor tenofovir induces cell cycle arrest in human cancer cells. | Investigational new drugs 20120801 |
| Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies. | Investigational new drugs 20120801 |
| Biologic therapies in the metastatic colorectal cancer treatment continuum--applying current evidence to clinical practice. | Cancer treatment reviews 20120801 |
| Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets. | International journal of cancer 20120801 |
| Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success. | International journal of cancer 20120801 |
| Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma. | Journal of cellular and molecular medicine 20120801 |
| Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer. | The Journal of surgical research 20120801 |
| Survivin-mediated therapeutic efficacy of gemcitabine through glucose-regulated protein 78 in hepatocellular carcinoma. | Annals of surgical oncology 20120801 |
| High-dose helical tomotherapy with concurrent full-dose chemotherapy for locally advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20120801 |
| Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor. | British journal of clinical pharmacology 20120801 |
| Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients. | Journal of surgical oncology 20120801 |
| Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma. | Journal of surgical oncology 20120801 |
| Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation. | Liver international : official journal of the International Association for the Study of the Liver 20120801 |
| Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era. | Biochemical pharmacology 20120801 |
| Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1. | Cancer science 20120801 |
| Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin. | Journal of magnetic resonance imaging : JMRI 20120801 |
| Analytical detection and method development of anticancer drug Gemcitabine HCl using gold nanoparticles. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120801 |
| Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer. | Cancer chemotherapy and pharmacology 20120801 |
| Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line. | The journal of obstetrics and gynaecology research 20120801 |
| Induction of pancreatic cancer cell apoptosis and enhancement of gemcitabine sensitivity by RAP80 siRNA. | Digestive diseases and sciences 20120801 |
| Human equilibrative nucleoside transporter 1 expression predicts survival of advanced cholangiocarcinoma patients treated with gemcitabine-based adjuvant chemotherapy after surgical resection. | Annals of surgery 20120801 |
| Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function. | European journal of cancer (Oxford, England : 1990) 20120801 |
| Case report of cytomegalovirus retinitis in an HIV-positive patient with a CD4-count nadir of 254 cells per μl. | Eye (London, England) 20120801 |
| Sorafenib in locally advanced or metastatic breast cancer. | Expert opinion on investigational drugs 20120801 |
| SL-01, an oral gemcitabine derivative, inhibited human cancer growth more potently than gemcitabine. | Toxicology and applied pharmacology 20120801 |
| Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells. | Molecular cancer therapeutics 20120801 |
| Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways. | Oncology reports 20120801 |
| Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma. | The British journal of surgery 20120801 |
| Nerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatment. | Neuromuscular disorders : NMD 20120801 |
| Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses. | European journal of immunology 20120801 |
| Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: a retrospective analysis of pooled data from 2 phase III randomized clinical trials. | Clinical breast cancer 20120801 |
| Intrahepatic and systemic therapy with oxaliplatin combined with capecitabine in patients with hepatic metastases from breast cancer. | Breast (Edinburgh, Scotland) 20120801 |
| The biochemistry of activation-induced deaminase and its physiological functions. | Seminars in immunology 20120801 |
| Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters. | Cancer chemotherapy and pharmacology 20120801 |
| Feasibility of gemcitabine and oxaliplatin in patients with advanced biliary tract carcinoma and a performance status of 2. | Anti-cancer drugs 20120801 |
| Sapacitabine, the prodrug of CNDAC, is a nucleoside analog with a unique action mechanism of inducing DNA strand breaks. | Chinese journal of cancer 20120801 |
| Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer. | Anti-cancer drugs 20120801 |
| hTERT-siRNA could potentiate the cytotoxic effect of gemcitabine to pancreatic cancer cells Bxpc-3. | Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20120801 |
| Silencing of ribonucleotide reductase subunit M1 potentiates the antitumor activity of gemcitabine in resistant cancer cells. | Cancer biology & therapy 20120801 |
| Synthesis and biological activity evaluation of cytidine-5'-deoxy-5-fluoro-N-[(alkoxy/aryloxy)] carbonyl-cyclic 2',3'-carbonates. | European journal of medicinal chemistry 20120801 |
| Targeting angiogenesis in metastatic breast cancer. | The oncologist 20120801 |
| Establishment and characterization of a new human gallbladder carcinoma cell line. | Anticancer research 20120801 |
| Effects of gemcitabine and gemcitabine in combination with carboplatin on five canine transitional cell carcinoma cell lines. | American journal of veterinary research 20120801 |
| Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II-III rectal cancer. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120801 |
| [Soft-tissue sarcoma: recent developments]. | Deutsche medizinische Wochenschrift (1946) 20120801 |
| [A single tablet against HIV: new combination preparation improves therapy]. | Deutsche medizinische Wochenschrift (1946) 20120801 |
| [A case of metastatic pancreatic cancer which trastuzumab+capecitabine combination therapy was effective]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120801 |
| [A case of unresectable hilar cholangiocarcinoma successfully treated by gemcitabine and S-1 combination chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120801 |
| Retrovolution: HIV-driven evolution of cellular genes and improvement of anticancer drug activation. | PLoS genetics 20120801 |
| Antiretroviral medications as prevention: will the new paradigm reverse the HIV epidemic? | Minnesota medicine 20120801 |
| Adjuvant treatments for triple-negative breast cancers. | Annals of oncology : official journal of the European Society for Medical Oncology 20120801 |
| [The effect of presurgical gemcitabine cisplatin chemotherapy for urothelial carcinoma]. | Hinyokika kiyo. Acta urologica Japonica 20120801 |
| [A case of renal salt wasting syndrome progressing to severe hyponatremia after gemcitabine-cisplatin chemotherapy]. | Hinyokika kiyo. Acta urologica Japonica 20120801 |
| Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge. | Cancer letters 20120728 |
| FDA paves the way for pre-exposure HIV prophylaxis. | Lancet (London, England) 20120728 |
| A nucleobase-discriminating pyrrolo-dC click adduct designed for DNA fluorescence mismatch sensing. | Chemistry (Weinheim an der Bergstrasse, Germany) 20120727 |
| Transactivation of the human NME5 gene by Sp1 in pancreatic cancer cells. | Gene 20120725 |
| Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group. | British journal of cancer 20120724 |
| Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas. | British journal of cancer 20120724 |
| Squalenoylation: a generic platform for nanoparticular drug delivery. | Journal of controlled release : official journal of the Controlled Release Society 20120720 |
| Regulation of transcription through light-activation and light-deactivation of triplex-forming oligonucleotides in mammalian cells. | ACS chemical biology 20120720 |
| Discontinuation of Atripla as first-line therapy in HIV-1 infected individuals. | AIDS (London, England) 20120717 |
| Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. | AIDS (London, England) 20120717 |
| Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir. | AIDS (London, England) 20120717 |
| FDA approves first drug to prevent HIV infection. | BMJ (Clinical research ed.) 20120717 |
| Dose-volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic adenocarcinoma. | International journal of radiation oncology, biology, physics 20120715 |
| A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. | International journal of radiation oncology, biology, physics 20120715 |
| Resected pancreatic neuroendocrine tumors: patterns of failure and disease-related outcomes with or without radiotherapy. | International journal of radiation oncology, biology, physics 20120715 |
| Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer. | International journal of radiation oncology, biology, physics 20120715 |
| Preparation of short cytosine-modified oligonucleotides by nicking enzyme amplification reaction. | Chemical communications (Cambridge, England) 20120714 |
| Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. | JAMA 20120711 |
| Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. | The Cochrane database of systematic reviews 20120711 |
| Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710 |
| Clinical and laboratory biomarkers in the management of pancreatic adenocarcinoma. | JOP : Journal of the pancreas 20120710 |
| Novel agents and new combination treatments on phase I studies on solid tumors and pancreatic cancer. | JOP : Journal of the pancreas 20120710 |
| Clinical studies in the second line setting of advanced pancreatic cancer: are we making any progress? | JOP : Journal of the pancreas 20120710 |
| Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo. | International journal of cancer 20120701 |
| Effects of capsid-modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancer. | International journal of cancer 20120701 |
| Immunohistochemical analysis of human equilibrative nucleoside transporter-1 (hENT1) predicts survival in resected pancreatic cancer patients treated with adjuvant gemcitabine monotherapy. | Annals of surgical oncology 20120701 |
| Combined analysis of dihydropyrimidine dehydrogenase and human equilibrative nucleoside transporter 1 expression predicts survival of pancreatic carcinoma patients treated with adjuvant gemcitabine plus S-1 chemotherapy after surgical resection. | Annals of surgical oncology 20120701 |
| Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study. | The British journal of nutrition 20120701 |
| Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo. | European journal of cancer (Oxford, England : 1990) 20120701 |
| Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study). | Annals of oncology : official journal of the European Society for Medical Oncology 20120701 |
| Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy. | International journal of radiation oncology, biology, physics 20120701 |
| Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer. | International journal of radiation oncology, biology, physics 20120701 |
| Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial. | Annals of surgical oncology 20120701 |
| Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction. | Journal of hepato-biliary-pancreatic sciences 20120701 |
| Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors. | Journal of hepato-biliary-pancreatic sciences 20120701 |
| Possibility of immunotherapy for biliary tract cancer: how do we prove efficacy? Introduction to a current ongoing phase I and randomized phase II study to evaluate the efficacy and safety of adding Wilms tumor 1 peptide vaccine to gemcitabine and cisplatin for the treatment of advanced biliary tract cancer (WT-BT trial). | Journal of hepato-biliary-pancreatic sciences 20120701 |
| Analysis of local control in patients receiving IMRT for resected pancreatic cancers. | International journal of radiation oncology, biology, physics 20120701 |
| A phase I/II study of carboplatin plus gemcitabine for elderly patients with advanced non-small cell lung cancer: West Japan Thoracic Oncology Group Trial (WJTOG) 2905. | Lung cancer (Amsterdam, Netherlands) 20120701 |
| The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice. | Journal of hepatology 20120701 |
| Treatment outcomes of recommended first-line antiretroviral regimens in resource-limited clinics. | Journal of acquired immune deficiency syndromes (1999) 20120701 |
| Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT. | Annals of surgical oncology 20120701 |
| A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study). | Lung cancer (Amsterdam, Netherlands) 20120701 |
| Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy. | International journal of radiation oncology, biology, physics 20120701 |
| Attenuation of phosphorylation by deoxycytidine kinase is key to acquired gemcitabine resistance in a pancreatic cancer cell line: targeted proteomic and metabolomic analyses in PK9 cells. | Pharmaceutical research 20120701 |
| Survival after chemoradiation in resected pancreatic cancer: the impact of adjuvant gemcitabine. | International journal of radiation oncology, biology, physics 20120701 |
| Pharmacogenetic assessment of clinical outcome in patients with metastatic breast cancer treated with docetaxel plus capecitabine. | Journal of cancer research and clinical oncology 20120701 |
| Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis. | Anti-cancer drugs 20120701 |
| Role of chemotherapy in treatments for biliary tract cancer. | Journal of hepato-biliary-pancreatic sciences 20120701 |
| Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment. | AIDS and behavior 20120701 |
| Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer. | Breast cancer research and treatment 20120701 |
| The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix. | European journal of obstetrics, gynecology, and reproductive biology 20120701 |
| ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines. | International journal of oncology 20120701 |
| Self-assembled drug delivery systems. Part 6: in vitro/in vivo studies of anticancer N-octadecanoyl gemcitabine nanoassemblies. | International journal of pharmaceutics 20120701 |
| Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells. | Biochemical pharmacology 20120701 |
| X-ACT: an important step on an unfinished journey. | Annals of oncology : official journal of the European Society for Medical Oncology 20120701 |
| Metabolism of deoxypyrimidines and deoxypyrimidine antiviral analogs in isolated brain mitochondria. | Journal of neurochemistry 20120701 |
| CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis. | Molecular cancer therapeutics 20120701 |
| Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumors. | Cancer investigation 20120701 |
| A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103). | Breast cancer research and treatment 20120701 |
| Involvement of the mitochondrial pathway in bruceine D-induced apoptosis in Capan-2 human pancreatic adenocarcinoma cells. | International journal of molecular medicine 20120701 |
| The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer. | International journal of oncology 20120701 |
| The elvitegravir Quad pill: the first once-daily dual-target anti-HIV tablet. | Expert opinion on investigational drugs 20120701 |
| Tenofovir: quo vadis anno 2012 (where is it going in the year 2012)? | Medicinal research reviews 20120701 |
| Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53. | Cancer chemotherapy and pharmacology 20120701 |
| Pharmacokinetic profiling of efavirenz-emtricitabine-tenofovir fixed dose combination in pregnant and non-pregnant rats. | Biopharmaceutics & drug disposition 20120701 |
| Gemcitabine-associated livedoid thrombotic microangiopathy with associated sclerema neonatorum-like microscopic changes. | Journal of cutaneous pathology 20120701 |
| Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases. | Cancer biology & therapy 20120701 |
| A feasibility study on gene therapy of pancreatic carcinoma with Ad-PUMA. | Cancer biology & therapy 20120701 |
| Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120701 |
| A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard). | The oncologist 20120701 |
| Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer. | Cancer chemotherapy and pharmacology 20120701 |
| A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer. | Cancer chemotherapy and pharmacology 20120701 |
| HIV-2 encephalitis: case report and literature review. | AIDS patient care and STDs 20120701 |
| Exploring protein kinase inhibitors: unveiling gemcitabine resistance in pancreatic cancer. | Pancreas 20120701 |
| Simultaneous analysis of multiple data types in pharmacogenomic studies using weighted sparse canonical correlation analysis. | Omics : a journal of integrative biology 20120701 |
| Efavirenz and psychosis: is there a link? | The Australian and New Zealand journal of psychiatry 20120701 |
| Efficacy of combination chemotherapy using oral fluoropyrimidine S-1 with oxaliplatin (SOX) against colorectal cancer in vivo. | Anticancer research 20120701 |
| Recurrent lower extremity pseudocellulitis. | American journal of therapeutics 20120701 |
| [A case of HER2-positive breast cancer receiving lapatinib+capecitabine chemotherapy with ventriculoperitoneal shunting for hydrocephalus associated with brain metastases]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120701 |
| Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors. | Pharmacogenomics 20120701 |
| Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine. | Pharmacogenomics 20120701 |
| Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape? | Pharmacogenomics 20120701 |
| New insights and emerging therapies for breast cancer brain metastases. | Oncology (Williston Park, N.Y.) 20120701 |
| Systemic therapy of advanced pancreatic cancer: has the landscape changed? | Clinical advances in hematology & oncology : H&O 20120701 |
| FDA treads carefully with PrEP. | The Lancet. Infectious diseases 20120701 |
| [Curative effect of 3D-CRT combined with gemcitabine concurrently with addition of Kanglaite Injection in treatment of locally advanced pancreatic]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20120701 |
| Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial. | Lancet (London, England) 20120630 |
| Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks. | Lancet (London, England) 20120630 |
| Label-free Raman spectroscopy for accessing intracellular anticancer drug release on gold nanoparticles. | The Analyst 20120621 |
| Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion. | World journal of gastroenterology 20120621 |
| Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer. | Cancer 20120615 |
| Synthesis and in vitro evaluation of novel lipophilic monophosphorylated gemcitabine derivatives and their nanoparticles. | International journal of pharmaceutics 20120615 |
| Safety and pharmacokinetics of ganitumab (AMG 479) combined with sorafenib, panitumumab, erlotinib, or gemcitabine in patients with advanced solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120615 |
| A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120615 |
| Discovery of checkpoint kinase inhibitor (S)-5-(3-fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by structure-based design and optimization of thiophenecarboxamide ureas. | Journal of medicinal chemistry 20120614 |
| Intervention of mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts. | World journal of gastroenterology 20120614 |
| A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study. | British journal of cancer 20120605 |
| Antiretroviral prophylaxis for HIV prevention reaches a key milestone. | Lancet (London, England) 20120602 |
| A randomized phase II study of recombinant human endostatin plus gemcitabine/cisplatin compared with gemcitabine/cisplatin alone as first-line therapy in advanced non-small-cell lung cancer. | Investigational new drugs 20120601 |
| Cost-effectiveness of gemcitabine + cisplatin vs. gemcitabine monotherapy in advanced biliary tract cancer. | Journal of gastrointestinal cancer 20120601 |
| Prospective phase I study of capecitabine and oxaliplatin concurrent with radiation therapy for the treatment of locally advanced pancreatic adenocarcinoma, and retrospective comparison to concurrent 5-fluorouracil/radiation and gemcitabine/radiation. | Journal of gastrointestinal cancer 20120601 |
| Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer. | Medical oncology (Northwood, London, England) 20120601 |
| A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802. | Medical oncology (Northwood, London, England) 20120601 |
| Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC. | Medical oncology (Northwood, London, England) 20120601 |
| A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinoma. | American journal of clinical oncology 20120601 |
| Phase II, multicenter, uncontrolled trial of single-agent capecitabine in patients with non-clear cell metastatic renal cell carcinoma. | American journal of clinical oncology 20120601 |
| Real-world impact of availability of adjuvant therapy on outcomes in patients with resected pancreatic adenocarcinoma: a Canadian Cancer Agency experience. | American journal of clinical oncology 20120601 |
| Activity of thalidomide and capecitabine in patients with advanced hepatocellular carcinoma. | American journal of clinical oncology 20120601 |
| Concurrent sulforaphane and eugenol induces differential effects on human cervical cancer cells. | Integrative cancer therapies 20120601 |
| Multidisciplinary treatment with chemotherapy, targeted drug, and high-intensity focused ultrasound in advanced pancreatic carcinoma. | Medical oncology (Northwood, London, England) 20120601 |
| Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer. | American journal of clinical oncology 20120601 |
| A phase I trial of vandetanib combined with capecitabine, oxaliplatin and bevacizumab for the first-line treatment of metastatic colorectal cancer. | Investigational new drugs 20120601 |
| A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research. | Investigational new drugs 20120601 |
| A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer. | Investigational new drugs 20120601 |
| 5-Fluorouracil or capecitabine in the treatment of advanced colorectal cancer: a pooled-analysis of randomized trials. | Medical oncology (Northwood, London, England) 20120601 |
| A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer. | Investigational new drugs 20120601 |
| A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy. | Investigational new drugs 20120601 |
| Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial. | Medical oncology (Northwood, London, England) 20120601 |
| Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20120601 |
| Capecitabine for the treatment for advanced gastric cancer: efficacy, safety and ethnicity. | Journal of clinical pharmacy and therapeutics 20120601 |
| The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20120601 |
| Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival. | International journal of radiation oncology, biology, physics 20120601 |
| Kounis syndrome is likely culprit of coronary vasospasm induced by capecitabine. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120601 |
| Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C. | Annals of oncology : official journal of the European Society for Medical Oncology 20120601 |
| Gemcitabine-induced posterior reversible encephalopathy syndrome: a case report. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120601 |
| Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial. | International journal of radiation oncology, biology, physics 20120601 |
| Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer. | European journal of cancer (Oxford, England : 1990) 20120601 |
| Acute myeloid leukemia secondary to oxaliplatin treatment for esophageal cancer. | Clinical colorectal cancer 20120601 |
| Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma. | International journal of radiation oncology, biology, physics 20120601 |
| Synergistic interaction between cisplatin and gemcitabine in neuroblastoma cell lines and multicellular tumor spheroids. | Cancer letters 20120601 |
| Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20120601 |
| Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma. | Cancer letters 20120601 |
| Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120601 |
| A observational study of the efficacy and safety of capecitabine versus bolus infusional 5-fluorouracil in pre-operative chemoradiotherapy for locally advanced rectal cancer. | International journal of colorectal disease 20120601 |
| Genistein potentiates the anti-cancer effects of gemcitabine in human osteosarcoma via the downregulation of Akt and nuclear factor-κB pathway. | Anti-cancer agents in medicinal chemistry 20120601 |
| Cytosine deoxyribonucleoside anti-HIV analogues: a small chemical substitution allows relevant activities. | International journal of antimicrobial agents 20120601 |
| Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines. | Anti-cancer drugs 20120601 |
| Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab. | Breast (Edinburgh, Scotland) 20120601 |
| The T393C polymorphism of GNAS1 as a predictor for chemotherapy sensitivity and survival in advanced non-small-cell lung cancer patients treated with gemcitabine plus platinum. | Cancer chemotherapy and pharmacology 20120601 |
| Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens. | The Journal of antimicrobial chemotherapy 20120601 |
| Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis. | International journal of oncology 20120601 |
| TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules. | Cancer chemotherapy and pharmacology 20120601 |
| The effect of monosialotetrahexosylganglioside (GM1) in prevention of oxaliplatin induced neurotoxicity: a retrospective study. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20120601 |
| CD147 silencing via RNA interference reduces tumor cell invasion, metastasis and increases chemosensitivity in pancreatic cancer cells. | Oncology reports 20120601 |
| A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine. | European journal of endocrinology 20120601 |
| A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin. | Clinical and experimental nephrology 20120601 |
| Neoadjuvant therapy for resectable and borderline resectable adenocarcinoma of the pancreas. | Current drug targets 20120601 |
| Conventional chemotherapy of advanced pancreatic cancer. | Current drug targets 20120601 |
| Prognostic significance of aquaporins in human biliary tract carcinoma. | Oncology reports 20120601 |
| Evaluations of biomarkers associated with sensitivity to 5-fluorouracil and taxanes for recurrent/advanced breast cancer patients treated with capecitabine-based first-line chemotherapy. | Anti-cancer drugs 20120601 |
| Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. | The Lancet. Oncology 20120601 |
| Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity. | Clinical breast cancer 20120601 |
| Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120601 |
| Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapy. | Nature structural & molecular biology 20120601 |
| Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20120601 |
| Patient-reported symptoms on the antiretroviral regimen efavirenz/emtricitabine/tenofovir. | AIDS patient care and STDs 20120601 |
| Unresectable pancreatic cancer: arterial embolization to achieve a single blood supply for intraarterial infusion of 5-fluorouracil and full-dose IV gemcitabine. | AJR. American journal of roentgenology 20120601 |
| Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1. | Cancer discovery 20120601 |
| Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients: results from the GEICAM/2002-01 phase II study. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120601 |
| Gemcitabine for advanced endometrial cancer: a retrospective study of the Memorial sloan-Kettering Cancer Center experience. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20120601 |
| Heat-shock protein 27 plays the key role in gemcitabine-resistance of pancreatic cancer cells. | Anticancer research 20120601 |
| Capecitabine-induced systemic lupus erythematosus and palmoplantar erythrodysesthesia. | Journal of drugs in dermatology : JDD 20120601 |
| Capecitabine in the treatment of rectal cancer. | The Lancet. Oncology 20120601 |
| Gemcitabine-induced severe peripheral edema in a patient with lung cancer. | Journal of pharmacy practice 20120601 |
| Gram-scale chemical synthesis of 2'-deoxynucleoside-5'-o-triphosphates. | Current protocols in nucleic acid chemistry 20120601 |
| [A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120601 |
| Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells. | Journal of gastrointestinal and liver diseases : JGLD 20120601 |
| A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model. | PLoS pathogens 20120601 |
| Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition. | Neoplasia (New York, N.Y.) 20120601 |
| Prevention. Using PrEP cost-effective in high-risk MSM groups. | AIDS policy & law 20120601 |
| [Breast cancer and the hand-foot syndrome]. | Soins; la revue de reference infirmiere 20120601 |
| Molecular changes in pancreatic cancer: implications for molecular targeting therapy. | Acta gastro-enterologica Belgica 20120601 |
| Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia. | Chinese medical journal 20120601 |
| [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group]. | Vnitrni lekarstvi 20120601 |
| The role of capecitabine in locally advanced rectal cancer treatment: an update. | Drugs 20120528 |
| Correlation of bevacizumab-induced hypertension and outcome in the BOXER study, a phase II study of capecitabine, oxaliplatin (CAPOX) plus bevacizumab as peri-operative treatment in 45 patients with poor-risk colorectal liver-only metastases unsuitable for upfront resection. | British journal of cancer 20120522 |
| Multilevel latent variable models for global health-related quality of life assessment. | Statistics in medicine 20120520 |
| [Efficacy of gemcitabine and vinorelbine in first-line treatment with advanced non-small cell lung cancer: a multicentre retrospective study]. | Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120520 |
| [Selected arterial infusion chemotherapy combined with target drugs for non-small cell lung cancer with multiple brain metastase]. | Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120520 |
| AIDS research. FDA panel recommends anti-HIV drug for prevention. | Science (New York, N.Y.) 20120518 |
| WITHDRAWN: Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV. | The Cochrane database of systematic reviews 20120516 |
| Mismatched pyrrolo-dC-modified duplex DNA as a novel probe for sensitive detection of silver ions. | Chemical communications (Cambridge, England) 20120514 |
| Gemcitabine-releasing polymeric films for covered self-expandable metallic stent in treatment of gastrointestinal cancer. | International journal of pharmaceutics 20120510 |
| Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C). | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120510 |
| Fluorocyclopentenyl-cytosine with broad spectrum and potent antitumor activity. | Journal of medicinal chemistry 20120510 |
| Incorporation and controlled release of silyl ether prodrugs from PRINT nanoparticles. | Journal of the American Chemical Society 20120509 |
| [Cerebral infarction after cisplatin-gemcitabine chemotherapy: probable cause-effect]. | Neurologia (Barcelona, Spain) 20120501 |
| A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management? | Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20120501 |
| Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy. | Annals of oncology : official journal of the European Society for Medical Oncology 20120501 |
| Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20120501 |
| Livedo reticularis as an initial clinical manifestation of gemcitabine-induced hemolytic uremic syndrome. | The Journal of dermatology 20120501 |
| Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5'-DFUR, the bioactive metabolite of Xeloda. | Breast cancer research and treatment 20120501 |
| A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20120501 |
| Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20120501 |
| Functions and regulation of the APOBEC family of proteins. | Seminars in cell & developmental biology 20120501 |
| Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies. | Annals of surgical oncology 20120501 |
| Factors predicting the appearance of neutropenia in patients with advanced pancreatic cancer undergoing gemcitabine therapy. | Hepato-gastroenterology 20120501 |
| Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study. | Cancer 20120501 |
| Pancreaticoduodenectomy with resection of the splenic artery and splenectomy for pancreatic double cancers after total gastrectomy. Preservation of the pancreatic function via the blood supply from the posterior epiploic artery: report of a case. | Surgery today 20120501 |
| Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): a combined analysis of three phase 3 trials. | Lung cancer (Amsterdam, Netherlands) 20120501 |
| Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy. | Cell death and differentiation 20120501 |
| Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. | Annals of surgical oncology 20120501 |
| Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma. | European journal of cancer (Oxford, England : 1990) 20120501 |
| Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious population of men who have sex with men. | HIV medicine 20120501 |
| Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma. | Cancer letters 20120501 |
| Age-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies. | Cancer chemotherapy and pharmacology 20120501 |
| A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures. | Cancer chemotherapy and pharmacology 20120501 |
| Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT. | Acta oncologica (Stockholm, Sweden) 20120501 |
| Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002). | Cancer chemotherapy and pharmacology 20120501 |
| Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study). | Cancer chemotherapy and pharmacology 20120501 |
| Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells. | International journal of oncology 20120501 |
| Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo. | Journal of cancer research and clinical oncology 20120501 |
| Cell fate control gene therapy based on engineered variants of human deoxycytidine kinase. | Molecular therapy : the journal of the American Society of Gene Therapy 20120501 |
| Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials. | Cancer chemotherapy and pharmacology 20120501 |
| RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer. | Cancer chemotherapy and pharmacology 20120501 |
| Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer. | Cancer chemotherapy and pharmacology 20120501 |
| Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine. | Cancer science 20120501 |
| Primary hepatocellular carcinoma of the pancreas: a case report and review of the heterogeneous group of pancreatic hepatoid carcinomas. | Histopathology 20120501 |
| A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer. | Cancer chemotherapy and pharmacology 20120501 |
| A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer. | Cancer chemotherapy and pharmacology 20120501 |
| Involvement of p53 in gemcitabine mediated cytotoxicity and radiosensitivity in breast cancer cell lines. | Gene 20120501 |
| Haemolytic uremic syndrome and gemcitabine: jaundice is not always progression in cholangiocarcinoma. | Acta oncologica (Stockholm, Sweden) 20120501 |
| Accelerated MVAC chemotherapy in patients with advanced bladder cancer previously treated with a platinum-gemcitabine regimen. | European journal of cancer (Oxford, England : 1990) 20120501 |
| Comparative active-site mutation study of human and Caenorhabditis elegans thymidine kinase 1. | The FEBS journal 20120501 |
| Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer. | Cancer gene therapy 20120501 |
| Simultaneous neoadjuvant radiochemotherapy with capecitabine and oxaliplatin for locally advanced rectal cancer. Treatment outcome outside clinical trials. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20120501 |
| Role of radiation therapy in the management of locally advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120501 |
| Radiotherapy improves survival in unresectable pancreatic cancer: small trial but big (and credible) results. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120501 |
| Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120501 |
| Gemcitabine is active against clinical multiresistant Staphylococcus aureus strains and is synergistic with gentamicin. | International journal of antimicrobial agents 20120501 |
| Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients. | Japanese journal of clinical oncology 20120501 |
| A Bayesian integrative genomic model for pathway analysis of complex traits. | Genetic epidemiology 20120501 |
| Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer. | Cancer investigation 20120501 |
| An analysis of a second-line S-1 monotherapy for gemcitabine-refractory biliary tract cancer. | Hepato-gastroenterology 20120501 |
| Discovery of 4'-azido-2'-deoxy-2'-C-methyl cytidine and prodrugs thereof: a potent inhibitor of Hepatitis C virus replication. | Bioorganic & medicinal chemistry letters 20120501 |
| Noxa enhances the cytotoxic effect of gemcitabine in human ovarian cancer cells. | Cancer biotherapy & radiopharmaceuticals 20120501 |
| Complete pathological response after chemotherapy alone in a patient with pancreatic adenocarcinoma. | Pancreas 20120501 |
| Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma. | Pancreas 20120501 |
| Perifosine , an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activity. | Expert opinion on drug metabolism & toxicology 20120501 |
| Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: two case reports. | Cancer biology & therapy 20120501 |
| Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. | Gastroenterology 20120501 |
| [Side effect analyses in consideration of renal functions for capecitabine-administered patients]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120501 |
| [Analysis of risk factors of drug-induced lung injury in patients receiving gemcitabine treatment]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120501 |
| [A case of primary adenocarcinoma of small intestine responding to XELOX chemotherapy and leading to a partial metabolic response]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120501 |
| The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2. | Anticancer research 20120501 |
| Combination therapy with gemcitabine (GEM) and erlotinib (E) in exocrine pancreatic cancer under special reference to RASH and the tumour marker CA19-9. | Anticancer research 20120501 |
| Variability of gemcitabine accumulation and its relationship to expression of nucleoside transporters in peripheral blood mononuclear cells. | Archives of pharmacal research 20120501 |
| Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients. | International journal of STD & AIDS 20120501 |
| [Emodin combined gemcitabine inhibited the growth of pancreatic cancer in vitro and in vivo and its mechanisms study]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20120501 |
| DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells. | Biochemical and biophysical research communications 20120427 |
| Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. | AIDS (London, England) 20120424 |
| What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples. | Journal of acquired immune deficiency syndromes (1999) 20120415 |
| First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120415 |
| A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120415 |
| A deficiency in nucleoside salvage impairs murine lymphocyte development, homeostasis, and survival. | Journal of immunology (Baltimore, Md. : 1950) 20120415 |
| BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway. | Nature communications 20120403 |
| Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine. | Investigational new drugs 20120401 |
| The expression of interferon receptor α/β in human pancreatic cancer in nude mice is essential for tumor response to interferon α treatment. | The Journal of surgical research 20120401 |
| Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer. | Investigational new drugs 20120401 |
| A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer. | Investigational new drugs 20120401 |
| A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy. | Investigational new drugs 20120401 |
| TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab. | Breast cancer research and treatment 20120401 |
| (18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts. | Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20120401 |
| Targeting of pancreatic and prostate cancer stem cell characteristics by Crambe crambe marine sponge extract. | International journal of cancer 20120401 |
| Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40). | Breast cancer research and treatment 20120401 |
| A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20120401 |
| Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II). | Breast cancer research and treatment 20120401 |
| Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20120401 |
| Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab. | Annals of oncology : official journal of the European Society for Medical Oncology 20120401 |
| Fanconi syndrome-like tubular acidosis associated with a tenofovir-containing antiretroviral regimen in a human immunodeficiency virus-1-infected Asian woman. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120401 |
| A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes. | Cancer chemotherapy and pharmacology 20120401 |
| Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: the Korean Cancer Study Group BR 07-01. | Breast cancer research and treatment 20120401 |
| Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128). | Hepatology (Baltimore, Md.) 20120401 |
| Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer. | Cancer chemotherapy and pharmacology 20120401 |
| Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients. | Cancer chemotherapy and pharmacology 20120401 |
| Effect of pregnancy on emtricitabine pharmacokinetics. | HIV medicine 20120401 |
| Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study. | HIV medicine 20120401 |
| Phase II multicenter trial of albumin-bound paclitaxel and capecitabine in first-line treatment of patients with metastatic breast cancer. | Clinical breast cancer 20120401 |
| Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro. | International journal of oncology 20120401 |
| Neo-adjuvant chemoradiation therapy using S-1 followed by surgical resection in patients with pancreatic cancer. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120401 |
| Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts. | Oncology reports 20120401 |
| Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer. | Molecular therapy : the journal of the American Society of Gene Therapy 20120401 |
| Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis C. | Gastroenterology 20120401 |
| Discovery of drugs that possess activity against feline leukemia virus. | The Journal of general virology 20120401 |
| Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy. | European journal of gastroenterology & hepatology 20120401 |
| Retrospective study on the use of different protocols for repeated transarterial chemoembolization in the treatment of patients with hepatocellular carcinoma. | Academic radiology 20120401 |
| Raltegravir, tenofovir DF, and emtricitabine for postexposure prophylaxis to prevent the sexual transmission of HIV: safety, tolerability, and adherence. | Journal of acquired immune deficiency syndromes (1999) 20120401 |
| Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1. | Antimicrobial agents and chemotherapy 20120401 |
| A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy. | Pharmacogenetics and genomics 20120401 |
| A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20120401 |
| Navitoclax (ABT-263) reduces Bcl-x(L)-mediated chemoresistance in ovarian cancer models. | Molecular cancer therapeutics 20120401 |
| MARVELD1 inhibited cell proliferation and enhance chemosensitivity via increasing expression of p53 and p16 in hepatocellular carcinoma. | Cancer science 20120401 |
| Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells. | The FEBS journal 20120401 |
| Chemotherapy-induced toxicity is highly heritable in Drosophila melanogaster. | Pharmacogenetics and genomics 20120401 |
| Phase I study of Rigosertib, an inhibitor of the phosphatidylinositol 3-kinase and Polo-like kinase 1 pathways, combined with gemcitabine in patients with solid tumors and pancreatic cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120401 |
| First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120401 |
| Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120401 |
| Functional polymorphisms of folate metabolism and response to chemotherapy for colorectal cancer, a systematic review and meta-analysis. | Pharmacogenetics and genomics 20120401 |
| First-line treatment with capecitabine combined with irinotecan in patients with advanced colorectal carcinoma: a phase II study. | Journal of clinical gastroenterology 20120401 |
| Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine, but also gemcitabine. | Expert opinion on investigational drugs 20120401 |
| Effect of biliary drainage on chemotherapy in patients with biliary tract cancer: an exploratory analysis of the BT22 study. | HPB : the official journal of the International Hepato Pancreato Biliary Association 20120401 |
| Meta-analysis of phase III randomized trials of molecular targeted therapies for advanced pancreatic cancer. | HPB : the official journal of the International Hepato Pancreato Biliary Association 20120401 |
| Exploring protein kinase inhibitors: potentiating gemcitabine efficacy in pancreatic cancer. | Pancreas 20120401 |
| Capecitabine monotherapy: review of studies in first-line HER-2-negative metastatic breast cancer. | The oncologist 20120401 |
| Synthesis and biological evaluation of (3'S)-3'-deoxy-3'-fluoro-3'-C-ethynylcytidine. | Nucleosides, nucleotides & nucleic acids 20120401 |
| Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trial. | Clinical breast cancer 20120401 |
| A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function. | Clinical nephrology 20120401 |
| Routine administration of a single dose of cisplatin ≥ 75 mg/m2 after short hydration in an outpatient lung-cancer clinic. | Bulletin du cancer 20120401 |
| Phase II study of bevacizumab in combination with trastuzumab and capecitabine as first-line treatment for HER-2-positive locally recurrent or metastatic breast cancer. | The oncologist 20120401 |
| A 2'-deoxycytidine long-linker click adduct forming two conformers in the asymmetric unit. | Acta crystallographica. Section C, Crystal structure communications 20120401 |
| Bilateral acute ptosis leading to the diagnosis of a presumed metastatic gastric adenocarcinoma. | Orbit (Amsterdam, Netherlands) 20120401 |
| Adjuvant chemoradiation with 5-fluorouracil or capecitabine in patients with gastric cancer after D2 nodal dissection. | Anticancer research 20120401 |
| Role of raltegravir in HIV-1 management. | The Annals of pharmacotherapy 20120401 |
| [The evaluation of chemotherapy for patients over eighty-years-old]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120401 |
| [Reduction of vascular pain due to drop-infusion of oxaliplatin (L-OHP) in peripheral vein with heated infusion route]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120401 |
| [A case of rectal hemorrhage during chemotherapy with bevacizumab for local recurrence of rectal cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120401 |
| [A case of locally advanced rectal cancer had a pathological complete response to XELOX Therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120401 |
| [New drugs of treatment of patients with chronic hepatitis B]. | Nihon rinsho. Japanese journal of clinical medicine 20120401 |
| Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer. | World journal of gastroenterology 20120328 |
| Mechanism of the alkali degradation of (6-4) photoproduct-containing DNA. | Organic & biomolecular chemistry 20120321 |
| Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120320 |
| Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. | Cancer cell 20120320 |
| Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. | International journal of radiation oncology, biology, physics 20120315 |
| Intensity-modulated radiotherapy for pancreatic adenocarcinoma. | International journal of radiation oncology, biology, physics 20120315 |
| Mutagen-mediated enhancement of HIV-1 replication in persistently infected cells. | Virology 20120315 |
| A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120315 |
| Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide. | British journal of cancer 20120313 |
| Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer. | British journal of cancer 20120313 |
| Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards. | AIDS (London, England) 20120313 |
| What options are available for refractory pancreatic cancer? | JOP : Journal of the pancreas 20120310 |
| Novel agents in early phase clinical studies on refractory pancreatic cancer. | JOP : Journal of the pancreas 20120310 |
| Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation. | Oncogene 20120308 |
| Thermodynamic signature of DNA damage: characterization of DNA with a 5-hydroxy-2'-deoxycytidine·2'-deoxyguanosine base pair. | Biochemistry 20120306 |
| Synthesis of 2'-deoxy-5-(methylselenyl)cytidine and Se-DNAs for structural and functional studies. | Chemistry, an Asian journal 20120305 |
| Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancer. | Medical oncology (Northwood, London, England) 20120301 |
| Long-term recurrence-free survival in a patient with pancreatic carcinosarcoma: a case report with a literature review. | Medical oncology (Northwood, London, England) 20120301 |
| Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients. | Medical oncology (Northwood, London, England) 20120301 |
| Capecitabine 'metronomic' chemotherapy for palliative treatment of elderly patients with advanced gastric cancer after fluoropyrimidine-based chemotherapy. | Medical oncology (Northwood, London, England) 20120301 |
| Fatal interstitial lung disease associated with gemcitabine and erlotinib therapy for lung cancer. | Medical oncology (Northwood, London, England) 20120301 |
| Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study. | Medical oncology (Northwood, London, England) 20120301 |
| Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120301 |
| Accelerated hyperfractionation field-involved re-irradiation combined with concurrent capecitabine chemotherapy for locally recurrent and irresectable rectal cancer. | The British journal of radiology 20120301 |
| Retinal vein thrombosis in a patient with metastatic colon cancer receiving XELOX chemotherapy combined with bevacizumab pre-hepatic resection. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120301 |
| PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients. | Journal of cellular physiology 20120301 |
| Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20120301 |
| Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir. | AIDS research and human retroviruses 20120301 |
| Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20120301 |
| Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces. | Analytical and bioanalytical chemistry 20120301 |
| Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma. | European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20120301 |
| Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen. | Annals of oncology : official journal of the European Society for Medical Oncology 20120301 |
| Unilateral hand-foot syndrome: does it take sides? Case report and literature review. | Clinical colorectal cancer 20120301 |
| Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinoma. | Pancreas 20120301 |
| Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR study. | Clinical colorectal cancer 20120301 |
| Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results. | Leukemia & lymphoma 20120301 |
| Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20120301 |
| RRM1 expression and clinical outcome of gemcitabine-containing chemotherapy for advanced non-small-cell lung cancer: a meta-analysis. | Lung cancer (Amsterdam, Netherlands) 20120301 |
| Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20120301 |
| MicroRNA miR-548d is a superior regulator in pancreatic cancer. | Pancreas 20120301 |
| Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay. | Annals of the rheumatic diseases 20120301 |
| Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma. | Cancer chemotherapy and pharmacology 20120301 |
| Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data. | Cancer chemotherapy and pharmacology 20120301 |
| [When should systemic chemotherapy be used for urinary bladder carcinoma?]. | Der Urologe. Ausg. A 20120301 |
| The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer. | Journal of cellular biochemistry 20120301 |
| PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells. | International journal of oncology 20120301 |
| Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX. | Cancer chemotherapy and pharmacology 20120301 |
| Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. | Journal of gastroenterology 20120301 |
| Metastatic clear cell adenocarcinoma of the urethra in a male patient: report of a case. | Clinical genitourinary cancer 20120301 |
| Pre-exposure chemoprophylaxis of HIV infection: quo vadis? | Biochemical pharmacology 20120301 |
| Combination of hedgehog signaling blockage and chemotherapy leads to tumor reduction in pancreatic adenocarcinomas. | Pancreas 20120301 |
| Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype. | International journal of oncology 20120301 |
| Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. | Cancer prevention research (Philadelphia, Pa.) 20120301 |
| Pharmacodynamic modeling of sequence-dependent antitumor activity of insulin-like growth factor blockade and gemcitabine. | The AAPS journal 20120301 |
| Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study. | Gynecologic oncology 20120301 |
| Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-κB and NF-κB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. | Molecular nutrition & food research 20120301 |
| Taxane-based mono- or combination therapy for managing metastatic breast cancer (MBC) in routine practice: a multinational prospective observational study. | Current medical research and opinion 20120301 |
| Reliability of tumor primary cultures as a model for drug response prediction: expression profiles comparison of tissues versus primary cultures from colorectal cancer patients. | Journal of cancer research and clinical oncology 20120301 |
| Low-dose metronomic oral dosing of a prodrug of gemcitabine (LY2334737) causes antitumor effects in the absence of inhibition of systemic vasculogenesis. | Molecular cancer therapeutics 20120301 |
| Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120301 |
| A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells. | Oncology reports 20120301 |
| Synergistic antitumor interactions between gemcitabine and clofarabine in human pancreatic cancer cell lines. | Molecular medicine reports 20120301 |
| A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. | Angiogenesis 20120301 |
| Gemcitabine with or without docetaxel and resection for recurrent osteosarcoma: the experience at Children's Memorial Hospital. | Journal of pediatric hematology/oncology 20120301 |
| A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer. | European journal of cancer (Oxford, England : 1990) 20120301 |
| Combining capecitabine and bevacizumab in metastatic breast cancer: a comprehensive review. | European journal of cancer (Oxford, England : 1990) 20120301 |
| Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. | The Lancet. Oncology 20120301 |
| Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trial. | European journal of cancer (Oxford, England : 1990) 20120301 |
| Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20120301 |
| First-line chemotherapy in epithelial ovarian cancer. | Clinical obstetrics and gynecology 20120301 |
| A rational approach to the management of recurrent or persistent ovarian carcinoma. | Clinical obstetrics and gynecology 20120301 |
| First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study. | The oncologist 20120301 |
| Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003. | The oncologist 20120301 |
| Capecitabine and weekly paclitaxel as first-line therapy in Thai patients with metastatic breast cancer. | Asia-Pacific journal of clinical oncology 20120301 |
| Pathological responses to gemcitabine/platinum-based neoadjuvant chemotherapy for muscle-invasive urothelial cancer. | Asia-Pacific journal of clinical oncology 20120301 |
| A retrospective observational study on the use of capecitabine in patients with severe renal impairment (GFR <30 mL/min) and end stage renal disease on hemodialysis. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120301 |
| [A case of malignant peritoneal mesothelioma successfully treated with systemic chemothrapy]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20120301 |
| Antiproliferative and antitumor effects of azacitidine against the human myelodysplastic syndrome cell line SKM-1. | Anticancer research 20120301 |
| Transforming growth factor beta receptor I inhibitor sensitizes drug-resistant pancreatic cancer cells to gemcitabine. | Anticancer research 20120301 |
| Cisplatin with capecitabine: tolerance and activity in a phase I/II study preferentially enrolling patients with gastric cancer. | Anticancer research 20120301 |
| Phase II study of panobinostat and bortezomib in patients with pancreatic cancer progressing on gemcitabine-based therapy. | Anticancer research 20120301 |
| [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report]. | Annales de dermatologie et de venereologie 20120301 |
| Severe hypertriglyceridaemia associated with the use of capecitabine. | The Netherlands journal of medicine 20120301 |
| [Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120301 |
| [A case of pancreatic cancer with liver metastasis controlled effectively by chemotherapy based on chemosensitivity test and stereotactic body radiotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120301 |
| A single nucleotide polymorphism in tetherin promotes retrovirus restriction in vivo. | PLoS pathogens 20120301 |
| [Successful gemcitabine-nedaplatin therapy in a hemodialysis patient with ureteral carcinoma after bilateral nephroureterectomy]. | Hinyokika kiyo. Acta urologica Japonica 20120301 |
| Weekly gemcitabine and docetaxel in refractory soft tissue sarcoma: a retrospective analysis. | Cancer research and treatment : official journal of Korean Cancer Association 20120301 |
| Drug interactions: the importance of looking inside cancer cells. | Cancer discovery 20120301 |
| nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer. | Cancer discovery 20120301 |
| Developments in metastatic pancreatic cancer: is gemcitabine still the standard? | World journal of gastroenterology 20120227 |
| Electron stimulated desorption of anions from native and brominated single stranded oligonucleotide trimers. | The Journal of chemical physics 20120221 |
| Direct analysis of 5-methylcytosine and 5-methyl-2'-deoxycytidine in human urine by isotope dilution LC-MS/MS: correlations with N-methylated purines and oxidized DNA lesions. | Chemical research in toxicology 20120220 |
| Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma. | Journal of proteomics 20120216 |
| Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer. | Cancer 20120215 |
| A method for generating high-yield enriched neuronal cultures from P19 embryonal carcinoma cells. | Journal of neuroscience methods 20120215 |
| WITHDRAWN. Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV. | The Cochrane database of systematic reviews 20120215 |
| Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST). | British journal of cancer 20120214 |
| Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine. | Blood 20120202 |
| Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors. | Investigational new drugs 20120201 |
| Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium. | Investigational new drugs 20120201 |
| Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer. | Investigational new drugs 20120201 |
| Phase I study of oral irinotecan as a single-agent and given sequentially with capecitabine. | Investigational new drugs 20120201 |
| Predictive factors of pathologic complete response and clinical tumor progression after preoperative chemotherapy in patients with stage II and III breast cancer. | Investigational new drugs 20120201 |
| Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report. | Investigational new drugs 20120201 |
| Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. | International journal of radiation oncology, biology, physics 20120201 |
| Phase II trial of pegylated liposomal doxorubicin in combination with gemcitabine in metastatic breast cancer patients. | American journal of clinical oncology 20120201 |
| Randomized phase II study of carboplatin-paclitaxel or gemcitabine-vinorelbine in patients with advanced nonsmall cell lung cancer and a performance status of 2: West Japan Thoracic Oncology Group 0004. | American journal of clinical oncology 20120201 |
| Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer. | International journal of radiation oncology, biology, physics 20120201 |
| Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network. | Annals of oncology : official journal of the European Society for Medical Oncology 20120201 |
| Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogs. | Breast cancer research and treatment 20120201 |
| Combining molecular dynamics and docking simulations of the cytidine deaminase from Mycobacterium tuberculosis H37Rv. | Journal of molecular modeling 20120201 |
| Phase I study of conformal radiotherapy and concurrent full-dose gemcitabine with erlotinib for unresected pancreatic cancer. | International journal of radiation oncology, biology, physics 20120201 |
| Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer. | International journal of radiation oncology, biology, physics 20120201 |
| Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors. | Cancer chemotherapy and pharmacology 20120201 |
| Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG). | Cancer chemotherapy and pharmacology 20120201 |
| A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. | Annals of surgical oncology 20120201 |
| The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine. | Lung cancer (Amsterdam, Netherlands) 20120201 |
| Evaluation of the safety and effectiveness of nevirapine plus coformulated tenofovir/emtricitabine as first-line therapy in routine clinical practice. | AIDS research and human retroviruses 20120201 |
| T3+ and T4 rectal cancer patients seem to benefit from the addition of oxaliplatin to the neoadjuvant chemoradiation regimen. | Annals of surgical oncology 20120201 |
| Safety evaluation of self-expanding metallic biliary stents eluting gemcitabine in a porcine model. | Journal of gastroenterology and hepatology 20120201 |
| A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma. | Cancer chemotherapy and pharmacology 20120201 |
| Dose adaptation of capecitabine based on individual prediction of limiting toxicity grade: evaluation by clinical trial simulation. | Cancer chemotherapy and pharmacology 20120201 |
| A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer. | Cancer chemotherapy and pharmacology 20120201 |
| Risk of thromboembolic events after perioperative chemotherapy versus surgery alone for esophageal adenocarcinoma. | Annals of surgical oncology 20120201 |
| The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis. | Cancer chemotherapy and pharmacology 20120201 |
| Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer. | Cancer chemotherapy and pharmacology 20120201 |
| Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study. | Cancer chemotherapy and pharmacology 20120201 |
| An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study. | Cancer chemotherapy and pharmacology 20120201 |
| Systemic chemotherapy in patients with advanced transitional cell carcinoma of the urothelium and impaired renal function. | Anti-cancer drugs 20120201 |
| Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer. | Acta oncologica (Stockholm, Sweden) 20120201 |
| Ixabepilone plus capecitabine in advanced breast cancer patients with early relapse after adjuvant anthracyclines and taxanes: a pooled subset analysis of two phase III studies. | Breast (Edinburgh, Scotland) 20120201 |
| Modulation of GemOx chemotherapy according to CIRS in elderly patients with advanced pancreatic cancer. | Oncology reports 20120201 |
| Impact of the histone deacetylase inhibitor 4-phenylbutyrate on the clearance of apoptotic pancreatic carcinoma cells by human macrophages. | International journal of oncology 20120201 |
| A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma. | Anti-cancer drugs 20120201 |
| HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines. | Cancer letters 20120201 |
| A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma. | Gynecologic oncology 20120201 |
| DNA glycosylases: in DNA repair and beyond. | Chromosoma 20120201 |
| Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms. | Oncology reports 20120201 |
| Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts. | Oncology reports 20120201 |
| Initial experience with repetitive transarterial chemoembolization (TACE) as a third line treatment of ovarian cancer metastasis to the liver: indications, outcomes and role in patient's management. | Gynecologic oncology 20120201 |
| Optimal functional levels of activation-induced deaminase specifically require the Hsp40 DnaJa1. | The EMBO journal 20120201 |
| Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial. | Breast cancer research and treatment 20120201 |
| Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303). | Journal of pain and symptom management 20120201 |
| Different baseline characteristics and different outcomes of HIV-infected patients receiving HAART through clinical trials compared with routine care in Mexico. | Journal of acquired immune deficiency syndromes (1999) 20120201 |
| Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study. | The Journal of antimicrobial chemotherapy 20120201 |
| Evaluation of oral chemotherapy with capecitabine and cyclophosphamide plus thalidomide and prednisone in prostate cancer patients. | Journal of cancer research and clinical oncology 20120201 |
| Light-regulated and cell-specific methylation of the maize PEPC promoter. | Journal of experimental botany 20120201 |
| Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials. | Clinical breast cancer 20120201 |
| Targeting quiescent tumor cells via oxygen and IGF-I supplementation. | Cancer research 20120201 |
| Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer. | Pharmacogenetics and genomics 20120201 |
| Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer. | Cancer research 20120201 |
| Sudden death related to toxicity in a patient on capecitabine and irinotecan plus bevacizumab intake: pharmacogenetic implications. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120201 |
| Biliary-tract cancer: improving therapy by adding molecularly targeted agents. | The Lancet. Oncology 20120201 |
| Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study. | The Lancet. Oncology 20120201 |
| Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder. | Urology 20120201 |
| Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites. | Molecular cancer therapeutics 20120201 |
| Simultaneous determination of deoxycytidine diphosphate and deoxycytidine triphosphate by capillary electrophoresis with transient isotachophoretic stacking: a sensitive monitoring method for ribonucleotide reductase activity. | Electrophoresis 20120201 |
| Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430. | The oncologist 20120201 |
| Effect of PI3K/Akt pathway inhibition-mediated G1 arrest on chemosensitization in ovarian cancer cells. | Anticancer research 20120201 |
| p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies. | Seminars in oncology 20120201 |
| Chemotherapy and fingerprint loss: beyond cosmetic. | The oncologist 20120201 |
| Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20120201 |
| Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review. | BJU international 20120201 |
| [A case of breast cancer with brain metastases responding to paclitaxel and capecitabine therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120201 |
| [A case of pancreatic cancer with celiac trunk and common hepatic artery invasion successfully resected after gemcitabine+S-1therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120201 |
| [A case of a patient with bladder cancer who received warfarin and showed a significantly prolonged PT-INR after gemcitabine and cisplatin combination therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120201 |
| Negative supercoiling creates single-stranded patches of DNA that are substrates for AID-mediated mutagenesis. | PLoS genetics 20120201 |
| Evaluation of 5-methyl-2'-deoxycytidine stability in hydrolyzed and nonhydrolyzed DNA by HPLC-UV. | Bioanalysis 20120201 |
| Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC). | British journal of cancer 20120131 |
| EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity. | Journal of controlled release : official journal of the Controlled Release Society 20120130 |
| Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. | Lancet (London, England) 20120128 |
| Bevacizumab added to neoadjuvant chemotherapy for breast cancer. | The New England journal of medicine 20120126 |
| [Acute coronary syndrome in patient treated with capecitabine]. | Medicina clinica 20120121 |
| Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120120 |
| [Phase II trial of improved regimen with gemcitabine in patients with advanced non-small cell lung cancer]. | Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120120 |
| Intravesical gemcitabine for non-muscle invasive bladder cancer. | The Cochrane database of systematic reviews 20120118 |
| Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases. | International journal of pharmaceutics 20120117 |
| Q-TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer. | Cancer 20120115 |
| A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120115 |
| Identification of 3,N(4)-etheno-5-methyl-2'-deoxycytidine in human DNA: a new modified nucleoside which may perturb genome methylation. | Chemical research in toxicology 20120113 |
| Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1. | Journal of controlled release : official journal of the Controlled Release Society 20120110 |
| Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120110 |
| Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120110 |
| More trials are cut short, but not the debate over their trajectory. | Nature medicine 20120106 |
| The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer. | British journal of cancer 20120103 |
| Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe. | The Journal of biological chemistry 20120102 |
| The role of S-adenosylmethionine in preventing oxaliplatin-induced liver toxicity: a retrospective analysis in metastatic colorectal cancer patients treated with bevacizumab plus oxaliplatin-based regimen. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120101 |
| Masitinib as a chemosensitizer of canine tumor cell lines: a proof of concept study. | Veterinary journal (London, England : 1997) 20120101 |
| First-line bevacizumab-containing therapy for breast cancer: results in patients aged≥70 years treated in the ATHENA study. | Annals of oncology : official journal of the European Society for Medical Oncology 20120101 |
| Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression. | Annals of oncology : official journal of the European Society for Medical Oncology 20120101 |
| A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20120101 |
| Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST). | Investigative radiology 20120101 |
| Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine. | Cancer chemotherapy and pharmacology 20120101 |
| A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer. | Cancer chemotherapy and pharmacology 20120101 |
| Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial. | Cancer chemotherapy and pharmacology 20120101 |
| A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen). | Cancer chemotherapy and pharmacology 20120101 |
| A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabine. | Cancer chemotherapy and pharmacology 20120101 |
| Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells. | Cancer chemotherapy and pharmacology 20120101 |
| Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial. | European journal of cancer (Oxford, England : 1990) 20120101 |
| Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy. | Lung cancer (Amsterdam, Netherlands) 20120101 |
| Different combination schedules of gemcitabine with endostar affect antitumor efficacy. | Cancer chemotherapy and pharmacology 20120101 |
| Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder. | Cancer 20120101 |
| Preoperative chemotherapy for bladder cancer: a standard waits to be optimally deployed. | Cancer 20120101 |
| Preoperative treatment with capecitabine, bevacizumab and radiotherapy for primary locally advanced rectal cancer--a two stage phase II clinical trial. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20120101 |
| Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer. | European journal of cancer (Oxford, England : 1990) 20120101 |
| Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation. | Lung cancer (Amsterdam, Netherlands) 20120101 |
| Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen. | AIDS care 20120101 |
| Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review. | Journal of neuro-oncology 20120101 |
| Brain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancer. | Clinical lung cancer 20120101 |
| Resolving actinic keratoses: an expected side-effect of capecitabine therapy. | Clinical and experimental dermatology 20120101 |
| Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer. | Breast cancer research and treatment 20120101 |
| A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120101 |
| Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20120101 |
| Hydroxyurea decreases gemcitabine resistance in pancreatic carcinoma cells with highly expressed ribonucleotide reductase. | Pancreas 20120101 |
| A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer. | Breast cancer research and treatment 20120101 |
| Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer. | Cancer science 20120101 |
| Surviving cells after treatment with gemcitabine or 5-fluorouracil for the study of de novo resistance of pancreatic cancer. | Cancer letters 20120101 |
| A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz. | Journal of acquired immune deficiency syndromes (1999) 20120101 |
| ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine. | Oncology reports 20120101 |
| A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists. | Molecular cancer therapeutics 20120101 |
| Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120101 |
| Bevacizumab-induced laryngeal necrosis. | Annals of oncology : official journal of the European Society for Medical Oncology 20120101 |
| Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120101 |
| Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with chemotherapy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120101 |
| [Population pharmacokinetics of gemcitabine applied to personalize the dosage used in cancer patients]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20120101 |
| Potentially increased sensitivity of pregnant and lactating female rats to immunotoxic agents. | Toxicologic pathology 20120101 |
| Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G. | Liver international : official journal of the International Association for the Study of the Liver 20120101 |
| Gemcitabine and cisplatin combination chemotherapy in triple negative metastatic breast cancer previously treated with a taxane/anthracycline chemotherapy; multicenter experience. | Neoplasma 20120101 |
| Reporting of adjuvant breast cancer trials: when is the right time? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120101 |
| Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120101 |
| Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands. | Acta oncologica (Stockholm, Sweden) 20120101 |
| Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer. | Annals of surgery 20120101 |
| The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma. | Pharmacogenetics and genomics 20120101 |
| Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir. | AIDS patient care and STDs 20120101 |
| Oxaliplatin: a review of approved uses. | Expert opinion on pharmacotherapy 20120101 |
| Elvitegravir: a once-daily, boosted, HIV-1 integrase inhibitor. | Expert review of anti-infective therapy 20120101 |
| Role of myeloid-derived suppressor cells in tumor immunotherapy. | Immunotherapy 20120101 |
| Local control of experimental malignant pancreatic tumors by treatment with a combination of chemotherapy and intratumoral 224radium-loaded wires releasing alpha-emitting atoms. | Translational research : the journal of laboratory and clinical medicine 20120101 |
| Prediction of a side effect and efficacy of adjuvant chemotherapy with gemcitabine for post operative patient of pancreatic cancer by a genetic polymorphism analysis. | Hepato-gastroenterology 20120101 |
| The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. | The Journal of infectious diseases 20120101 |
| Recent HIV-1 infection: to treat or not to treat, that is the question. | The Journal of infectious diseases 20120101 |
| Cutaneous presentation of a distant metastasis of malignant phyllodes tumor. | International journal of dermatology 20120101 |
| Capecitabine induced cardiotoxicity: a case report and review of literature. | Pakistan journal of pharmaceutical sciences 20120101 |
| Inoperable pancreatic adenocarcinoma rendered complete remission by high-intensity focused ultrasound concurrent with gemcitabine-capecitabine chemotherapy: case report and topic review. | Journal of digestive diseases 20120101 |
| Long term cultured HL-60 cells are intrinsically resistant to Ara-C through high CDA activity. | Frontiers in bioscience (Landmark edition) 20120101 |
| Adverse event profiles of 5-fluorouracil and capecitabine: data mining of the public version of the FDA Adverse Event Reporting System, AERS, and reproducibility of clinical observations. | International journal of medical sciences 20120101 |
| Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway. | International journal of biological sciences 20120101 |
| A CDD polymorphism as predictor of capecitabine-induced hand-foot syndrome--letter. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120101 |
| In vitro and in vivo double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for PC-3 cell line. | World journal of surgical oncology 20120101 |
| First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study. | The oncologist 20120101 |
| CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab. | Cancer investigation 20120101 |
| [A case of adenosquamous carcinoma of lower extrahepatic bile duct]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120101 |
| [A case of curatively resected locally advanced cancer of the pancreatic body treated by distal pancreatectomy with en bloc celiac axis resection after neoadjuvant chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120101 |
| Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer. | BMC cancer 20120101 |
| Gemcitabine: a critical nucleoside for cancer therapy. | Current medicinal chemistry 20120101 |
| Isolation and characterization of a murine P388 leukemia line resistant to thiarabine. | Nucleosides, nucleotides & nucleic acids 20120101 |
| Treatment of high-risk gastric cancer postoperatively using intensity-modulated radiotherapy: a single-institution experience. | Hepato-gastroenterology 20120101 |
| Comparing cystatin C changes as a measure of renal function before and after radiotherapy in patients with stomach cancer. | Acta medica Iranica 20120101 |
| Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. | PloS one 20120101 |
| Evolution of the primate APOBEC3A cytidine deaminase gene and identification of related coding regions. | PloS one 20120101 |
| Two genetic determinants acquired late in Mus evolution regulate the inclusion of exon 5, which alters mouse APOBEC3 translation efficiency. | PLoS pathogens 20120101 |
| In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells. | Radiation oncology (London, England) 20120101 |
| Intravenously administered 2'-deoxycytidine suppresses mouse myeloma tumor growth. | Biological & pharmaceutical bulletin 20120101 |
| Autologous cytokine-induced killer cell transfusion in combination with gemcitabine plus cisplatin regimen chemotherapy for metastatic nasopharyngeal carcinoma. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20120101 |
| High-pressure intrapleural chemotherapy: feasibility in the pig model. | World journal of surgical oncology 20120101 |
| A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer. | Chemotherapy 20120101 |
| Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma. | International journal of molecular sciences 20120101 |
| A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients. | Oncology 20120101 |
| Gemcitabine alone versus combination of gemcitabine and cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a retrospective analysis of multicenter study. | Neoplasma 20120101 |
| Highly parallel genome-wide expression analysis of single mammalian cells. | PloS one 20120101 |
| EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer. | PloS one 20120101 |
| Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine. | Nucleosides, nucleotides & nucleic acids 20120101 |
| The British HIV Association/British Association for Sexual Health and HIV Position Statement on pre-exposure prophylaxis in the UK. | International journal of STD & AIDS 20120101 |
| DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. | PloS one 20120101 |
| Changes in body composition and mitochondrial DNA in HIV-1-infected patients switching to fixed-dose abacavir/lamivudine or tenofovir/emtricitabine: a substudy of the BICOMBO trial. | Antiviral therapy 20120101 |
| A phase II study of first-line chemotherapy with weekly carboplatin plus gemcitabine in advanced non-small cell lung cancer. | Chemotherapy 20120101 |
| Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. | Radiation oncology (London, England) 20120101 |
| Molecular targets of gemcitabine action: rationale for development of novel drugs and drug combinations. | Current pharmaceutical design 20120101 |
| First efficacy results of capecitabine with anthracycline- and taxane-based adjuvant therapy in high-risk early breast cancer: a meta-analysis. | PloS one 20120101 |
| The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer. | BMC cancer 20120101 |
| Combination of gemcitabine and carboplatin in urothelial cancer patients unfit for cisplatin due to impaired renal or cardiac function. | International braz j urol : official journal of the Brazilian Society of Urology 20120101 |
| Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC. | Cancer genomics & proteomics 20120101 |
| Resistance to mericitabine, a nucleoside analogue inhibitor of HCV RNA-dependent RNA polymerase. | Antiviral therapy 20120101 |
| Methylation of Wnt7a is modulated by DNMT1 and cigarette smoke condensate in non-small cell lung cancer. | PloS one 20120101 |
| Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy. | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101 |
| Glucose metabolite glyoxal induces senescence in telomerase-immortalized human mesenchymal stem cells. | Chemistry Central journal 20120101 |
| DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells. | PloS one 20120101 |
| Current approaches to the management of Her2-negative metastatic breast cancer. | Breast cancer research : BCR 20120101 |
| Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells. | Molecular cancer 20120101 |
| Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma? | BMC cancer 20120101 |
| Reversal of cocaine-conditioned place preference through methyl supplementation in mice: altering global DNA methylation in the prefrontal cortex. | PloS one 20120101 |
| A phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines with/without taxanes. | Hematology/oncology and stem cell therapy 20120101 |
| Antiviral activity of FNC, 2'-deoxy-2'-β-fluoro-4'-azidocytidine, against human and duck HBV replication. | Antiviral therapy 20120101 |
| Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review. | Radiation oncology (London, England) 20120101 |
| Endostatin inhibits angiogenesis in hepatocellular carcinoma after transarterial chemoembolization. | Hepato-gastroenterology 20120101 |
| Poorly differentiated neuroendocrine carcinoma of the pancreas responsive to combination therapy with gemcitabine and S-1. | Internal medicine (Tokyo, Japan) 20120101 |
| Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial. | PloS one 20120101 |
| Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats. | PloS one 20120101 |
| [Efficacy evaluation of high intensity focused ultrasound combined with intra-arterial infusion of gemcitabine in the treatment of pancreatic cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20120101 |
| Genetic association studies of copy-number variation: should assignment of copy number states precede testing? | PloS one 20120101 |
| Lapatinib-based therapy in heavily pretreated HER2-positive metastatic breast cancer: a single institution experience. | Tumori 20120101 |
| High lapatinib plasma levels in breast cancer patients: risk or benefit? | Tumori 20120101 |
| A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer. | Swiss medical weekly 20120101 |
| Reporter gene imaging of immune responses to cancer: progress and challenges. | Theranostics 20120101 |
| Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications. | Theranostics 20120101 |
| Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis. | PloS one 20120101 |
| Epigenetic factors in cancer risk: effect of chemical carcinogens on global DNA methylation pattern in human TK6 cells. | PloS one 20120101 |
| Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. | PloS one 20120101 |
| Crucial role of heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to chemotherapeutic agents. | PloS one 20120101 |
| Soft-tissue metastasis revealing a pancreatic adenocarcinoma: one case report and a review of literature. | The Pan African medical journal 20120101 |
| Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20120101 |
| Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for patients with advanced stage soft tissue sarcoma. | Asian Pacific journal of cancer prevention : APJCP 20120101 |
| Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma. | Asian Pacific journal of cancer prevention : APJCP 20120101 |
| [Late-onset leukoencephalopathy induced by long-term chemotherapy with capecitabine and cyclophosphamide for liver metastasis from breast cancer]. | Rinsho shinkeigaku = Clinical neurology 20120101 |
| Prognostic value of expression of Kit67, p53, TopoIIa and GSTP1 for curatively resected advanced gastric cancer patients receiving adjuvant paclitaxel plus capecitabine chemotherapy. | Hepato-gastroenterology 20120101 |
| Polysaccharides from the Medicinal Mushroom Cordyceps taii Show Antioxidant and Immunoenhancing Activities in a D-Galactose-Induced Aging Mouse Model. | Evidence-based complementary and alternative medicine : eCAM 20120101 |
| DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma. | PloS one 20120101 |
| Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study. | Journal of translational medicine 20120101 |
| Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment. | Retrovirology 20120101 |
| Oocytes selected using BCB staining enhance nuclear reprogramming and the in vivo development of SCNT embryos in cattle. | PloS one 20120101 |
| The cyclobutane dimers of 2'-deoxyuridine, 2'-deoxycytidine, 5-methyl-2'-deoxycytidine and 5-bromo-2'-deoxyuridine. | Photochemistry and photobiology 20120101 |
| Recent advances in thymidine kinase 2 (TK2) inhibitors and new perspectives for potential applications. | Current pharmaceutical design 20120101 |
| Limited SHIV env diversification in macaques failing oral antiretroviral pre-exposure prophylaxis. | Retrovirology 20120101 |
| Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years. | Chemotherapy 20120101 |
| FKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment of pancreatic cancer. | PloS one 20120101 |
| Comparative profiling of Pseudomonas aeruginosa strains reveals differential expression of novel unique and conserved small RNAs. | PloS one 20120101 |
| Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. | International journal of nanomedicine 20120101 |
| Malignant fibrous histiocytoma of the ovary: a case report. | European journal of gynaecological oncology 20120101 |
| Tetrahydrouridine inhibits cell proliferation through cell cycle regulation regardless of cytidine deaminase expression levels. | PloS one 20120101 |
| Chemotherapy-related thrombocytosis: does it increase the risk of thromboembolism? | Oncology 20120101 |
| Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis. | PloS one 20120101 |
| Prognostic factors for overall survival in patients with metastatic colorectal carcinoma treated with vascular endothelial growth factor-targeting agents. | Asian Pacific journal of cancer prevention : APJCP 20120101 |
| How good is 'good enough'? The case for varying standards of evidence according to need for new interventions in HIV prevention. | The American journal of bioethics : AJOB 20120101 |
| Loss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage. | PloS one 20120101 |
| Metal Ion Chelates as Surrogates of Nucleobases for the Recognition of Nucleic Acid Sequences: The Pd(2+) Complex of 2,6-Bis(3,5-dimethylpyrazol-1-yl)purine Riboside. | Journal of nucleic acids 20120101 |
| Current knowledge on pancreatic cancer. | Frontiers in oncology 20120101 |
| Preparation and evaluation of polymeric microparticulates for improving cellular uptake of gemcitabine. | International journal of nanomedicine 20120101 |
| Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism. | PloS one 20120101 |
| Versatility of RNA-Binding Proteins in Cancer. | Comparative and functional genomics 20120101 |
| Ribonucleotide reductase M2 does not predict survival in patients with resectable pancreatic adenocarcinoma. | International journal of clinical and experimental pathology 20120101 |
| Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases. | International journal of nanomedicine 20120101 |
| Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer. | BMC cancer 20120101 |
| Concurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I study. | Radiation oncology (London, England) 20120101 |
| Significant association between hand-foot syndrome and efficacy of capecitabine in patients with metastatic breast cancer. | Biological & pharmaceutical bulletin 20120101 |
| [Basic investigation for classification of anticancer drugs by pharmacological effects]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101 |
| Antiretroviral drugs: critical issues and recent advances. | Indian journal of pharmacology 20120101 |
| [HIV preexposure prophylaxis]. | Przeglad epidemiologiczny 20120101 |
| Intermittent chemotherapy is a treatment choice for advanced urothelial cancer. | Oncology 20120101 |
| Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer. | PloS one 20120101 |
| Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy. | BMC cancer 20120101 |
| XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis. | BMC cancer 20120101 |
| [Increased INR from concomitant use of acenocoumarol and capecitabine]. | Nederlands tijdschrift voor geneeskunde 20120101 |
| Surface-modified gemcitabine with mucoadhesive polymer for oral delivery. | Journal of microencapsulation 20120101 |
| Everolimus enhances gemcitabine-induced cytotoxicity in bladder-cancer cell lines. | Journal of toxicology and environmental health. Part A 20120101 |
| Efficacy and safety of gemcitabine monotherapy for patients with advanced biliary tract cancer. | Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20120101 |
| Capecitabine may induce coronary artery vasospasm. | Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20120101 |
| Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans. | Asian Pacific journal of cancer prevention : APJCP 20120101 |
| Relationship between antimetabolite toxicity and pharmacogenetics in Turkish cancer patients. | Asian Pacific journal of cancer prevention : APJCP 20120101 |
| Antiemetic control with palonosetron in patients with gastrointestinal cancer receiving a fluoropyrimidine-based regimen in addition to either irinotecan or oxaliplatin: a retrospective study. | Oncology 20120101 |
| Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trial. | PloS one 20120101 |
| A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II). | BMC cancer 20120101 |
| Capecitabine in elderly patients with metastatic breast cancer. | Tumori 20120101 |
| Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study. | Chemotherapy 20120101 |
| Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment. | AIDS reviews 20120101 |
| Trends in HIV-1 reverse transcriptase resistance-associated mutations and antiretroviral prescription data from 2003-2010. | Antiviral therapy 20120101 |
| Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer. | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20120101 |
| Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea. | BMC cancer 20120101 |
| Correlation of HER2, p95HER2 and HER3 expression and treatment outcome of lapatinib plus capecitabine in her2-positive metastatic breast cancer. | PloS one 20120101 |
| Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK. | HIV clinical trials 20120101 |
| Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers. | Journal of translational medicine 20120101 |
| [Combined effect of gemcitabine and lomustine in mice with intracranial transplanted lymphosarcoma LIO-1]. | Voprosy onkologii 20120101 |
| Effective use of gemcitabine in the treatment of undifferentiated carcinoma with osteoclast-like giant cells of the pancreas with portal vein tumor thrombus. | Internal medicine (Tokyo, Japan) 20120101 |
| Cisplatin-based therapy for the treatment of elderly patients with non-small-cell lung cancer: a retrospective analysis of a single institution. | Asian Pacific journal of cancer prevention : APJCP 20120101 |
| Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an Anatolian Society of Medical Oncology multicenter study. | Asian Pacific journal of cancer prevention : APJCP 20120101 |
| Triplet platinum-based combination sequential chemotherapy improves survival outcome and quality of life of advanced non-small cell lung cancer patients. | Asian Pacific journal of cancer prevention : APJCP 20120101 |
| Gemcitabine-based concurrent chemoradiotherapy versus chemotherapy alone in patients with locally advanced pancreatic cancer. | Asian Pacific journal of cancer prevention : APJCP 20120101 |
| Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population. | Asian Pacific journal of cancer prevention : APJCP 20120101 |
| Antiviral activity of nucleoside analogues against norovirus. | Antiviral therapy 20120101 |
| Switching to tenofovir/emtricitabine from abacavir/lamivudine in HIV-infected adults with raised cholesterol: effect on lipid profiles. | Antiviral therapy 20120101 |
| [Hand-foot syndrome induced by chemotherapy: a case study]. | Revista brasileira de enfermagem 20120101 |
| [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients]. | Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20120101 |
| Synergistic effects of nanosecond pulsed electric fields combined with low concentration of gemcitabine on human oral squamous cell carcinoma in vitro. | PloS one 20120101 |
| Continuous transarterial infusion chemotherapy with gemcitabine and 5-Fluorouracil for advanced pancreatic carcinoma. | Asian Pacific journal of cancer prevention : APJCP 20120101 |
| Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy: a pooled analysis of three trials. | Oncology 20120101 |
| Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells. | PloS one 20120101 |
| Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. | Journal of experimental & clinical cancer research : CR 20120101 |
| Optimize administration protocol of capecitabine plus docetaxel combination in metastatic breast cancer patients. | Current topics in medicinal chemistry 20120101 |
| Preclinical combination therapy of clofarabine plus radiation. | Nucleosides, nucleotides & nucleic acids 20120101 |
| Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma. | Radiation oncology (London, England) 20120101 |
| Lack of association of genetic variations of deoxycytidine kinase with toxicity or survival of non-small-cell lung cancer patients treated with gemcitabine plus cisplatin. | Oncology research 20120101 |
| Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy. | Onkologie 20120101 |
| Capecitabine-induced hypertriglyceridemia and hyperglycemia: two cases. | Pharmacology 20120101 |
| Intralesional cidofovir for the treatment of multiple and recalcitrant cutaneous viral warts. | Dermatologic therapy 20120101 |
| Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma. | PloS one 20120101 |
| Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas. | PloS one 20120101 |
| Modelling non-homogeneous stochastic reaction-diffusion systems: the case study of gemcitabine-treated non-small cell lung cancer growth. | BMC bioinformatics 20120101 |
| Knockdown of Ezrin by RNA interference reverses malignant behavior of human pancreatic cancer cells in vitro. | Asian Pacific journal of cancer prevention : APJCP 20120101 |
| Retrospective study of gemcitabine based chemotherapy for unresectable or recurrent esophagus squamous cell carcinoma refractory to first line chemotherapy. | Asian Pacific journal of cancer prevention : APJCP 20120101 |
| Involvement of phosphatidylinositol 3-kinase/Akt pathway in gemcitabine-induced apoptosis-like cell death in insulinoma cell line INS-1. | Biological & pharmaceutical bulletin 20120101 |
| Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells. | Cancer letters 20111227 |
| Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells. | Cancer letters 20111227 |
| Taxane doublets for metastatic breast cancer: do we need another cytotoxic pair or another approach? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111220 |
| Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111220 |
| Antiretroviral prophylaxis: a defining moment in HIV control. | Lancet (London, England) 20111217 |
| Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity. | Journal of neuroimmunology 20111215 |
| SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent manner. | Cancer research 20111215 |
| Mammalian DNA δ15N exhibits 40‰ intramolecular variation and is unresponsive to dietary protein level. | Rapid communications in mass spectrometry : RCM 20111215 |
| Importance of the C2, N7, and C8 positions to the mutagenic potential of 8-Oxo-2'-deoxyguanosine with two A family polymerases. | Biochemistry 20111213 |
| Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111210 |
| Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity. | Biochemical and biophysical research communications 20111209 |
| Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma. | Blood 20111208 |
| Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. | Science translational medicine 20111207 |
| Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor. | Pituitary 20111201 |
| Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin. | Medical oncology (Northwood, London, England) 20111201 |
| A phase I study of topotecan and gemcitabine in advanced solid tumors. | Investigational new drugs 20111201 |
| Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer. | Investigational new drugs 20111201 |
| Comparison of cisplatin- and carboplatin-based third-generation chemotherapy in 1,014 Chinese patients with advanced non-small-cell lung cancer. | Medical oncology (Northwood, London, England) 20111201 |
| Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapy. | Medical oncology (Northwood, London, England) 20111201 |
| Chemoradiation for unresectable gall bladder cancer: time to review historic nihilism? | Journal of gastrointestinal cancer 20111201 |
| Conditions causing gemcitabine crystallization. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20111201 |
| Phase 1 trial of gemcitabine with bortezomib in elderly patients with advanced solid tumors. | American journal of clinical oncology 20111201 |
| CA 19-9 level as indicator of early distant metastasis and therapeutic selection in resected pancreatic cancer. | International journal of radiation oncology, biology, physics 20111201 |
| A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer. | Medical oncology (Northwood, London, England) 20111201 |
| Gemcitabine and cisplatin salvage regimen in heavily pretreated metastatic breast cancer: a Brazilian experience. | Medical oncology (Northwood, London, England) 20111201 |
| Safety and pharmacokinetics of sorafenib combined with capecitabine in patients with advanced solid tumors: results of a phase 1 trial. | Journal of clinical pharmacology 20111201 |
| Capecitabine-induced, nonneutropenic enterocolitis. | Journal of gastrointestinal cancer 20111201 |
| Metachronous multiple adenocarcinomas of the pancreas. | International journal of clinical oncology 20111201 |
| Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20111201 |
| Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer. | Nanomedicine : nanotechnology, biology, and medicine 20111201 |
| Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: a Taiwan cooperative oncology group phase II study. | International journal of radiation oncology, biology, physics 20111201 |
| Tumor growth modeling from clinical trials reveals synergistic anticancer effect of the capecitabine and docetaxel combination in metastatic breast cancer. | Cancer chemotherapy and pharmacology 20111201 |
| Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial. | Cancer chemotherapy and pharmacology 20111201 |
| A 4-week versus a 3-week schedule of gemcitabine monotherapy for advanced pancreatic cancer: a randomized phase II study to evaluate toxicity and dose intensity. | International journal of clinical oncology 20111201 |
| Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials. | Cancer chemotherapy and pharmacology 20111201 |
| Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors. | Cancer chemotherapy and pharmacology 20111201 |
| Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy. | Nanomedicine : nanotechnology, biology, and medicine 20111201 |
| A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202. | Cancer chemotherapy and pharmacology 20111201 |
| Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells. | International journal of clinical oncology 20111201 |
| Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational 'SUN' (Survey on the lUng cancer maNagement) study. | Lung cancer (Amsterdam, Netherlands) 20111201 |
| Empirical Bayes estimation of random effects of a mixed-effects proportional odds Markov model for ordinal data. | Computer methods and programs in biomedicine 20111201 |
| In vitro screening of synergistic ascorbate-drug combinations for the treatment of malignant mesothelioma. | Toxicology in vitro : an international journal published in association with BIBRA 20111201 |
| Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases. | Journal of neuro-oncology 20111201 |
| DNA copy number profiles correlate with outcome in colorectal cancer patients treated with fluoropyrimidine/antifolate-based regimens. | Current drug metabolism 20111201 |
| Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study. | Journal of aerosol medicine and pulmonary drug delivery 20111201 |
| Prognostic value of lymph-node dissection in patients undergoing radical cystectomy following previous oncological treatment for bladder cancer. | Scandinavian journal of urology and nephrology 20111201 |
| Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer. | Clinical breast cancer 20111201 |
| c-Met is a marker of pancreatic cancer stem cells and therapeutic target. | Gastroenterology 20111201 |
| A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman Radiation Oncology Study TROG 03.07. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111201 |
| Chemotherapy in elderly patients with advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20111201 |
| Hypoxia-inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer. | Oncology reports 20111201 |
| The combined treatment of CT-guided percutaneous 125I seed implantation and chemotherapy for non-small-cell lung cancer. | Journal of cancer research and clinical oncology 20111201 |
| Gemcitabine or gemcitabine plus oxaliplatin in the first-line treatment of patients with advanced transitional cell carcinoma of the urothelium unfit for cisplatin-based chemotherapy: a randomized phase 2 study of the French Genitourinary Tumor Group (GETUG V01). | European urology 20111201 |
| Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgery. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20111201 |
| Differential expression of uridine phosphorylase in tumors contributes to an improved fluoropyrimidine therapeutic activity. | Molecular cancer therapeutics 20111201 |
| Pharmacokinetic evaluation of gemcitabine hydrochloride for the treatment of cervical cancer. | Expert opinion on drug metabolism & toxicology 20111201 |
| Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111201 |
| Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in pancreatic cancer. | Molecular cancer therapeutics 20111201 |
| Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer. | Gynecologic oncology 20111201 |
| A randomised comparison of safety and efficacy of nevirapine vs. atazanavir/ritonavir combined with tenofovir/emtricitabine in treatment-naïve patients. | International journal of clinical practice 20111201 |
| Synchronous bilateral urothelial cancer in a kidney recipient. | International journal of urology : official journal of the Japanese Urological Association 20111201 |
| High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy. | International journal of urology : official journal of the Japanese Urological Association 20111201 |
| Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111201 |
| Elacytarabine--lipid vector technology overcoming drug resistance in acute myeloid leukemia. | Expert opinion on investigational drugs 20111201 |
| Association of cytidine deaminase and xeroderma pigmentosum group D polymorphisms with response, toxicity, and survival in cisplatin/gemcitabine-treated advanced non-small cell lung cancer patients. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111201 |
| Single-agent gemcitabine chemotherapy in dogs with hepatocellular carcinomas. | Veterinary and comparative oncology 20111201 |
| Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity. | Expert opinion on drug delivery 20111201 |
| Gemcitabine-associated sweet syndrome-like eruption. | Journal of the American Academy of Dermatology 20111201 |
| Development of thrombotic microangiopathy in a patient with granulomatosis with polyangiitis. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20111201 |
| Phase 2 study of capecitabine and irinotecan combination chemotherapy (modified XELIRI regimen) in patients with advanced gastric cancer. | American journal of clinical oncology 20111201 |
| Capecitabine in gastric cancer. | Expert review of anticancer therapy 20111201 |
| Pharmacogenomics of cytarabine in childhood leukemia. | Pharmacogenomics 20111201 |
| Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells. | Nucleosides, nucleotides & nucleic acids 20111201 |
| Determination of the phosphorylated metabolites of gemcitabine and of difluorodeoxyuridine by LCMSMS. | Nucleosides, nucleotides & nucleic acids 20111201 |
| Regulation of deoxycytidine kinase expression and sensitivity to gemcitabine by micro-RNA 330 and promoter methylation in cancer cells. | Nucleosides, nucleotides & nucleic acids 20111201 |
| [Chemotherapy of metastatic pancreatic adenocarcinoma: challenges and encouraging results]. | Bulletin du cancer 20111201 |
| [Gemcitabine plus S-1 combination therapy (GS therapy) for pancreatic cancer patients with high-grade hepatic metastasis]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111201 |
| Preparation of DNA containing 5-hydroxymethyl-2'-deoxycytidine modification through phosphoramidites with TBDMS as 5-hydroxymethyl protecting group. | Current protocols in nucleic acid chemistry 20111201 |
| Randomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancer. | Asia-Pacific journal of clinical oncology 20111201 |
| [First line therapy for local advanced or metastasized urothelial carcinoma: randomized double-blind phase II study to compare gemcitabin and cisplatin in combination with OGX-427 or placebo for advanced transitional cell carcinoma of the bladder (OGX-427 - AB 39/11 of the Working Group Urological Oncology)]. | Der Urologe. Ausg. A 20111201 |
| Capecitabine-induced hand-foot syndrome complicated by pseudomonal superinfection resulting in bacterial sepsis and death: case report and review of the literature. | Archives of dermatology 20111201 |
| [Safety profiles of gemcitabine hydrochloride(GEMZAR®)in Japanese clinical studies]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111201 |
| [A case of local-recurring breast cancer under long term-treatment by capecitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111201 |
| DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death. | Oncotarget 20111201 |
| Effect of maintenance chemotherapy with gemcitabine and paclitaxel on recurrent squamous cell carcinoma of the bladder: a case report. | Anticancer research 20111201 |
| [Effect of gemcitabine in enhancing the radiosensitivity of HepG2 hepatoma cells and the possible mechanism]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111201 |
| Metabolic variation during development in culture of Leishmania donovani promastigotes. | PLoS neglected tropical diseases 20111201 |
| Requirement of nuclear factor κB for Smac mimetic-mediated sensitization of pancreatic carcinoma cells for gemcitabine-induced apoptosis. | Neoplasia (New York, N.Y.) 20111201 |
| HIV preexposure prophylaxis: new data and potential use. | Topics in antiviral medicine 20111201 |
| Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial. | Chinese medical journal 20111201 |
| Radiotherapy: the importance of local control in pancreatic cancer. | Nature reviews. Clinical oncology 20111129 |
| A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer. | Cancer letters 20111128 |
| Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patient. | AIDS (London, England) 20111128 |
| The price of tenofovir-emtricitabine undermines the cost-effectiveness and advancement of pre-exposure prophylaxis. | AIDS (London, England) 20111128 |
| Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer. | Oncogene 20111124 |
| Randomized placebo-controlled phase II trial of perifosine plus capecitabine as second- or third-line therapy in patients with metastatic colorectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111120 |
| KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancer. | International journal of radiation oncology, biology, physics 20111115 |
| Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105. | International journal of radiation oncology, biology, physics 20111115 |
| Weekly gemcitabine and cisplatin in combination with radiotherapy in patients with locally advanced head-and-neck cancer: Phase I study. | International journal of radiation oncology, biology, physics 20111115 |
| Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. | International journal of radiation oncology, biology, physics 20111115 |
| DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter. | Human molecular genetics 20111115 |
| Systemic management strategies for metastatic soft tissue sarcoma. | Drugs 20111112 |
| Bevacizumab: a review of its use in combination with paclitaxel or capecitabine as first-line therapy for HER2-negative metastatic breast cancer. | Drugs 20111112 |
| HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. | Nature 20111106 |
| Hand-foot hyperpigmentation skin lesions associated with combination gemcitabine-carboplatin (GemCarbo) therapy. | American journal of therapeutics 20111101 |
| Reversible neuropathy after chemotherapy for metastatic adenocarcinoma from an unknown primary tumor to the sural nerve. | American journal of therapeutics 20111101 |
| Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter Phase II study. | International journal of radiation oncology, biology, physics 20111101 |
| Prognosis of esophageal cancer patients with pathologic complete response after preoperative concurrent chemoradiotherapy. | International journal of radiation oncology, biology, physics 20111101 |
| Nutritional status of patients with locally advanced pancreatic cancer: a pilot study. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20111101 |
| Congenital retroperitoneal vascular anomalies: impact on pelvic surgery. | Archives of gynecology and obstetrics 20111101 |
| Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck. | Annals of oncology : official journal of the European Society for Medical Oncology 20111101 |
| Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group. | Annals of oncology : official journal of the European Society for Medical Oncology 20111101 |
| First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group. | Cancer chemotherapy and pharmacology 20111101 |
| A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer. | Cancer chemotherapy and pharmacology 20111101 |
| A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopy. | Cancer chemotherapy and pharmacology 20111101 |
| Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia. | Annals of hematology 20111101 |
| Tubulin, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum-gemcitabine chemotherapy. | Lung cancer (Amsterdam, Netherlands) 20111101 |
| Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines. | Lung cancer (Amsterdam, Netherlands) 20111101 |
| Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. | Annals of surgical oncology 20111101 |
| p53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia. | Leukemia 20111101 |
| Treatment of advanced HIV disease in antiretroviral-naïve HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in combination with tenofovir disoproxil fumarate and emtricitabine. | AIDS care 20111101 |
| Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo. | International journal of oncology 20111101 |
| Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20111101 |
| Histology as a treatment effect modifier in advanced non-small cell lung cancer: a systematic review of the evidence. | Respirology (Carlton, Vic.) 20111101 |
| Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy. | European journal of cancer (Oxford, England : 1990) 20111101 |
| Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: a special reference to gene-expression microarray analysis. | Oncology reports 20111101 |
| Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients. | HIV medicine 20111101 |
| The deaminated metabolite of gemcitabine, 2',2'-difluorodeoxyuridine, modulates the rate of gemcitabine transport and intracellular phosphorylation via deoxycytidine kinase. | Drug metabolism and disposition: the biological fate of chemicals 20111101 |
| Prognostic factors in second-line treatment of urothelial cancers with gemcitabine and paclitaxel (German Association of Urological Oncology trial AB20/99). | European urology 20111101 |
| HIV-HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistance. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20111101 |
| Ethnic difference in hematological toxicity in patients with non-small cell lung cancer treated with chemotherapy: a pooled analysis on Asian versus non-Asian in phase II and III clinical trials. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111101 |
| Gene set analysis of purine and pyrimidine antimetabolites cancer therapies. | Pharmacogenetics and genomics 20111101 |
| Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells. | Molecular cancer therapeutics 20111101 |
| Acute digital ischemia complicating gemcitabine and carboplatin combination chemotherapy for ovarian cancer. | Acta obstetricia et gynecologica Scandinavica 20111101 |
| Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells. | Molecular bioSystems 20111101 |
| Capecitabine-phenytoin interaction is dose dependent with an unexpected time course. | Anti-cancer drugs 20111101 |
| In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections. | Antiviral research 20111101 |
| Induction of caspase mediated apoptosis and down-regulation of nuclear factor-κB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells. | The Journal of urology 20111101 |
| Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111101 |
| Serum vascular endothelial growth factor and COX-2/5-LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111101 |
| Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111101 |
| Locally advanced pancreatic cancer: where should we go from here? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111101 |
| Liver metastases of pancreatic cancer: role of repetitive transarterial chemoembolization (TACE) on tumor response and survival. | Pancreas 20111101 |
| [Strategies for preoperative downsizing in patients with local nonresectable pancreatic cancer]. | Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20111101 |
| A phase I multicenter study of continuous oral administration of lonafarnib (SCH 66336) and intravenous gemcitabine in patients with advanced cancer. | Cancer investigation 20111101 |
| Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial. | The Lancet. Oncology 20111101 |
| Securin identifies a subgroup of patients with poor outcome in rectal cancer treated with long-course (chemo)radiotherapy. | Acta oncologica (Stockholm, Sweden) 20111101 |
| [Effectiveness of systemic chemotherapy of GEM+CBDCA+5-FU/LV and hepatic arterial infusion of CDDP in a case of advanced, combined hepatocellular-cholangiocarcinoma with multiple lung metastases]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111101 |
| Isolation and characterization of a murine P388 leukemia line resistant to clofarabine. | Nucleosides, nucleotides & nucleic acids 20111101 |
| Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20111101 |
| Mechanisms underlying gemcitabine resistance in pancreatic cancer and sensitisation by the iMiD™ lenalidomide. | Anticancer research 20111101 |
| Intra-arterial chemoinfusion prior to chemoradiotherapy with full-dose systemic gemcitabine for management of locally advanced pancreatic cancer. | Anticancer research 20111101 |
| Herpesviruses that infect fish. | Viruses 20111101 |
| FDA notifications. Complera approved. | AIDS alert 20111101 |
| [Our experience of the treatment with XELOX±Bevacizumab for unresectable advanced colorectal cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111101 |
| [Preoperative chemoradiation (XELOX/RT) therapy for anal canal adenocarcinoma with the metastasis to inguinal lymph node]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111101 |
| [A pilot study of intraperitoneal gemcitabine for reduction of peritoneal dissemination in advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111101 |
| [A case of locally advanced pancreas cancer effectively treated by multidisciplinary strategy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111101 |
| [An example case that chemoradiotherapy was succeeded for unresectable pancreas cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111101 |
| [A case of peritoneal recurrence of invasive carcinoma derived from IPMN after distal pancreatectomy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111101 |
| [A case of breast cancer liver metastases responding to lapatinib and capecitabine therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111101 |
| [An operated case of metastasis to the small intestine from lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111101 |
| [Curative resection of gallbladder cancer with simultaneous liver metastasis]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111101 |
| [A novel gemcitabine delivery system]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111101 |
| [Re-resection for local recurrence in the remnant pancreas after pancreaticoduodenectomy for pancreatic cancer- a case report]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111101 |
| [A case of intrahepatic cholangiocarcinoma with invasion to right adrenal gland]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111101 |
| [A case of intrahepatic recurrence of intrahepatic cholangiocarcinoma treated with repeated hepatectomy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20111101 |
| [Efficacy and safety of regimens of capecitabine-based chemotherapy in the treatment of advanced breast cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20111101 |
| [A randomized controlled trial of the efficacy of combination of gemcitabine and carboplatin or paclitaxel and combination of paclitaxel and carboplatin in the treatment for advanced non-small cell lung cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20111101 |
| Aberrant DNA methylation and prostate cancer. | Current genomics 20111101 |
| [MicroRNA expression pattern in intraductal papillary mucinous neoplasm]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20111025 |
| CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. | Life sciences 20111024 |
| Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111020 |
| Checkpoint kinase inhibitor synergizes with DNA-damaging agents in G1 checkpoint-defective neuroblastoma. | International journal of cancer 20111015 |
| Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy. | Cancer 20111015 |
| Selective derivatization of cytosine and methylcytosine moieties with 2-bromoacetophenone for submicrogram DNA methylation analysis by reversed phase HPLC with spectrofluorimetric detection. | Analytical chemistry 20111015 |
| Optimizing initial therapy for HIV infection. | The Journal of infectious diseases 20111015 |
| Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results. | The Journal of infectious diseases 20111015 |
| Electrogenerated chemiluminescence of triazole-modified deoxycytidine analogues in N,N-dimethylformamide. | Physical chemistry chemical physics : PCCP 20111014 |
| Ultraviolet enhances the sensitivity of pancreatic cancer cells to gemcitabine by activation of 5' AMP-activated protein kinase. | Biochemical and biophysical research communications 20111014 |
| HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma. | Blood 20111013 |
| A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study). | British journal of cancer 20111011 |
| Epidermal growth factor receptor blockers for the treatment of ovarian cancer. | The Cochrane database of systematic reviews 20111005 |
| High-throughput and cost-effective global DNA methylation assay by liquid chromatography-mass spectrometry. | Analytica chimica acta 20111003 |
| A Phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimens. | Investigational new drugs 20111001 |
| Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer. | Investigational new drugs 20111001 |
| Phase I trial of oblimersen (Genasense®) and gemcitabine in refractory and advanced malignancies. | Investigational new drugs 20111001 |
| Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness. | Investigational new drugs 20111001 |
| Patterns of response after preoperative intensity-modulated radiation therapy and capecitabine/oxaliplatin in rectal cancer: is there still a place for ecoendoscopic ultrasound? | International journal of radiation oncology, biology, physics 20111001 |
| A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group study. | American journal of clinical oncology 20111001 |
| A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981. | American journal of clinical oncology 20111001 |
| Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer. | Critical reviews in oncology/hematology 20111001 |
| A phase I study of the oral platinum agent satraplatin in sequential combination with capecitabine in the treatment of patients with advanced solid malignancies. | Acta oncologica (Stockholm, Sweden) 20111001 |
| Addition of gemcitabine at the time of sunitinib resistance in metastatic renal cell cancer. | BJU international 20111001 |
| Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial. | Cancer chemotherapy and pharmacology 20111001 |
| Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting. | Cancer chemotherapy and pharmacology 20111001 |
| Investigation of emtricitabine-associated skin pigmentation and safety in HIV-1-infected Japanese patients. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20111001 |
| Combination therapy consisting of gemcitabine, carboplatin, and docetaxel as an active treatment for advanced urothelial carcinoma. | International journal of clinical oncology 20111001 |
| Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study. | International journal of clinical oncology 20111001 |
| MRI-based indications for neoadjuvant radiochemotherapy in rectal carcinoma: interim results of a prospective multicenter observational study. | Annals of surgical oncology 20111001 |
| Treatment of borderline cases for curative resection of biliary tract cancer. | Journal of surgical oncology 20111001 |
| Evaluation of cutaneous angioimmunoblastic T-cell lymphoma. | Journal of the American Academy of Dermatology 20111001 |
| Change in the growth rate of localized pancreatic adenocarcinoma in response to gemcitabine, bevacizumab, and radiation therapy on MDCT. | International journal of radiation oncology, biology, physics 20111001 |
| Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation. | Biomedical microdevices 20111001 |
| Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review. | The Lancet. Oncology 20111001 |
| Epidermal growth factor receptor mutations are associated with docetaxel sensitivity in lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111001 |
| 5-Ethynyl-2'-deoxycytidine as a new agent for DNA labeling: detection of proliferating cells. | Analytical biochemistry 20111001 |
| Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors. | European urology 20111001 |
| Membranous nephropathy in an HIV-positive patient complicated with hepatitis B virus infection. | Clinical and experimental nephrology 20111001 |
| Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial. | International journal of oncology 20111001 |
| SCOTCERV: a phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer. | Gynecologic oncology 20111001 |
| Metabolic activation of furfuryl alcohol: formation of 2-methylfuranyl DNA adducts in Salmonella typhimurium strains expressing human sulfotransferase 1A1 and in FVB/N mice. | Carcinogenesis 20111001 |
| Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer: a randomised double blinded, placebo controlled pilot study. | Clinical nutrition (Edinburgh, Scotland) 20111001 |
| Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer. | European journal of cancer (Oxford, England : 1990) 20111001 |
| Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL. | Cancer chemotherapy and pharmacology 20111001 |
| The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors. | Experimental hematology 20111001 |
| Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study. | Antiviral research 20111001 |
| Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models. | Cancer biology & therapy 20111001 |
| Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. | Cancer biology & therapy 20111001 |
| Preoperative radiotherapy combined with capecitabine chemotherapy in Chinese patients with locally advanced rectal cancer. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20111001 |
| [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20111001 |
| Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer. | Journal of cancer research and clinical oncology 20111001 |
| Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy. | The Journal of antimicrobial chemotherapy 20111001 |
| An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine. | Cancer gene therapy 20111001 |
| Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapy. | Molecular cancer therapeutics 20111001 |
| [Chemotherapy and rectal cancer]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20111001 |
| Electrochemotherapy: a new technological approach in treatment of metastases in the liver. | Technology in cancer research & treatment 20111001 |
| FOLFIRINOX: a small step or a great leap forward? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111001 |
| Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy. | Japanese journal of clinical oncology 20111001 |
| Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111001 |
| Metastatic adenocarcinoma of the epididymis from pancreatic cancer successfully treated by chemotherapy and high-intensity focused ultrasound therapy: a case report and review of the literature. | Pancreas 20111001 |
| Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells. | Cancer biotherapy & radiopharmaceuticals 20111001 |
| Enhanced efficacy of gemcitabine by indole-3-carbinol in pancreatic cell lines: the role of human equilibrative nucleoside transporter 1. | Anticancer research 20111001 |
| Polo-like kinase 1 inhibition as a new therapeutic modality in therapy of cholangiocarcinoma. | Anticancer research 20111001 |
| [Adjuvant gemcitabine plus S-1 chemotherapy for pancreatic cancer after surgical resection - outcomes and future perspectives]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111001 |
| [Evidences for adjuvant therapy of resected pancreatic cancer]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111001 |
| [Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111001 |
| Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. | PLoS pathogens 20111001 |
| OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer. | Cell death & disease 20111001 |
| Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy. | Neoplasia (New York, N.Y.) 20111001 |
| Inappropriate continuation of medication when patients are admitted acutely: the example of capecitabine. | Clinical medicine (London, England) 20111001 |
| Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection. | AIDS (London, England) 20110924 |
| Modulation of the ribonucleotide reductase M1-gemcitabine interaction in vivo by N-ethylmaleimide. | Biochemical and biophysical research communications 20110923 |
| Intracellular detection of cytosine incorporation in genomic DNA by using 5-ethynyl-2'-deoxycytidine. | Chembiochem : a European journal of chemical biology 20110919 |
| Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. | Lancet (London, England) 20110917 |
| Combination chemotherapy for older adults with advanced non-small-cell lung cancer. | Lancet (London, England) 20110917 |
| Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer. | Cancer 20110915 |
| Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110915 |
| Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110915 |
| Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection. | Journal of pharmaceutical and biomedical analysis 20110910 |
| Direct evidence that RNA inhibits APOBEC3G ssDNA cytidine deaminase activity. | Biochemical and biophysical research communications 20110909 |
| PrEP trial successes prompt cost-effectiveness questions. | Nature medicine 20110907 |
| Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro. | World journal of gastroenterology 20110907 |
| Deaminase activity on single-stranded DNA (ssDNA) occurs in vitro when APOBEC3G cytidine deaminase forms homotetramers and higher-order complexes. | The Journal of biological chemistry 20110902 |
| Steroids, cancer and vertebral fractures: a dreaded combination. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20110901 |
| Sensitization of SiHa cell to gemcitabine by CD40 activation and its overexpression in cervical carcinoma. | Medical oncology (Northwood, London, England) 20110901 |
| A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma. | Journal of gastrointestinal cancer 20110901 |
| Toxic encephalopathy in elderly patients during treatment with capecitabine: literature review and a case report. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20110901 |
| Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresectable pancreatic cancer. | Cancer chemotherapy and pharmacology 20110901 |
| Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer. | Cancer chemotherapy and pharmacology 20110901 |
| Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma. | Cancer chemotherapy and pharmacology 20110901 |
| ERK phosphorylation predicts synergism between gemcitabine and the epidermal growth factor receptor inhibitor AG1478. | Lung cancer (Amsterdam, Netherlands) 20110901 |
| A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection. | Annals of oncology : official journal of the European Society for Medical Oncology 20110901 |
| Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience. | Lung cancer (Amsterdam, Netherlands) 20110901 |
| Differential expression of ERCC1 in pancreas adenocarcinoma: high tumor expression is associated with earlier recurrence and shortened survival after resection. | Annals of surgical oncology 20110901 |
| Gemcitabine-induced acute myositis in a patient with duodenal cancer. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20110901 |
| Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma. | Journal of hepato-biliary-pancreatic sciences 20110901 |
| Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20110901 |
| Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response. | Cancer immunology, immunotherapy : CII 20110901 |
| Chemotherapy and targeted therapies for unresectable malignant mesothelioma. | Lung cancer (Amsterdam, Netherlands) 20110901 |
| Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: cytoplasmic sequestration of CDK2 by p27. | Gynecologic oncology 20110901 |
| Triphendiol (NV-196), development of a novel therapy for pancreatic cancer. | Anti-cancer drugs 20110901 |
| Chemotherapy only for localized Hodgkin lymphoma. | Journal of internal medicine 20110901 |
| Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of l-3'-azido-2',3'-dideoxypurine nucleosides. | European journal of medicinal chemistry 20110901 |
| Subamolide A, a component isolated from Cinnamomum subavenium, induces apoptosis mediated by mitochondria-dependent, p53 and ERK1/2 pathways in human urothelial carcinoma cell line NTUB1. | Journal of ethnopharmacology 20110901 |
| Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy. | Journal of acquired immune deficiency syndromes (1999) 20110901 |
| A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110901 |
| Circulating tumor cells count and characterization in a male breast cancer patient. | Cancer biology & therapy 20110901 |
| Tumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110901 |
| Renal excretion of apricitabine in rats: ex vivo and in vivo studies. | European journal of drug metabolism and pharmacokinetics 20110901 |
| IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques. | Blood 20110901 |
| Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110901 |
| Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer. | HPB : the official journal of the International Hepato Pancreato Biliary Association 20110901 |
| Nonsurgical management of esophageal adenocarcinoma. | Clinical colorectal cancer 20110901 |
| A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancer. | Clinical colorectal cancer 20110901 |
| The efficacy of gemcitabine as salvage treatment in patients with refractory advanced colorectal cancer (CRC): a single institution experience. | Anticancer research 20110901 |
| SNPs and Haplotypes in DPYD and Outcome of Capecitabine-Letter. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110901 |
| SNPs and haplotypes in DPYD and outcome of capecitabine--Letter. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110901 |
| [Recurrent liver sigmoid cancer responding remarkably to neoadjuvant chemotherapy using bevacizumab/XELOX: report of a case]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110901 |
| [A resected case of locally invasive rectal cancer successfully treated with neoadjuvant capecitabine, oxaliplatin, bevacizumab and radiation therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110901 |
| Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity. | Pharmacogenomics 20110901 |
| Genital erythrodysesthesia as a severe manifestation of capecitabine therapy: a report of 3 cases. | Archives of dermatology 20110901 |
| Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines. | Lasers in surgery and medicine 20110901 |
| [Meta-analysis of the efficacy between gemcitabine-alone and gemcitabine-based chemotherapy applied in advanced pancreatic cancer]. | Zhonghua wai ke za zhi [Chinese journal of surgery] 20110901 |
| [Experience with gemcitabine monotherapy in three patients with metastatic urothelial carcinoma]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20110901 |
| [HER-2 expression in advanced gastric cancer and its correlation with clinical features, outcome and prognosis]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110901 |
| [Efficacy of late accelerated hyperfractionated conformal radiotherapy combined with capecitabine for esophageal carcinoma]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110901 |
| β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction. | European journal of pharmacology 20110831 |
| Chemotherapy for older patients with colorectal cancer. | Lancet (London, England) 20110827 |
| In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemia. | Blood 20110825 |
| FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. | The New England journal of medicine 20110825 |
| Antiretroviral therapy alone resulted in successful resolution of large idiopathic esophageal ulcers in a patient with acute retroviral syndrome. | AIDS (London, England) 20110824 |
| HIV drug-prevention strategy carries risks. | Nature 20110816 |
| Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. | Cancer 20110815 |
| Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer. | Cancer 20110815 |
| Delayed maturation of antibody avidity but not seroconversion in rhesus macaques infected with simian HIV during oral pre-exposure prophylaxis. | Journal of acquired immune deficiency syndromes (1999) 20110815 |
| Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells. | International journal of cancer 20110815 |
| Gemcitabine in elderly patients with advanced pancreatic cancer. | World journal of gastroenterology 20110814 |
| Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohorts. | British journal of cancer 20110809 |
| Duplex and triplex formation of mixed pyrimidine oligonucleotides with stacking of phenyl-triazole moieties in the major groove. | The Journal of organic chemistry 20110805 |
| Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. | Journal of the National Cancer Institute 20110803 |
| A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer. | Investigational new drugs 20110801 |
| Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma. | International journal of radiation oncology, biology, physics 20110801 |
| Preoperative chemoradiation for rectal cancer using capecitabine and celecoxib correlated with posttreatment assessment of thymidylate synthase and thymidine phosphorylase expression. | International journal of radiation oncology, biology, physics 20110801 |
| Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors. | Cancer chemotherapy and pharmacology 20110801 |
| Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer. | Cancer chemotherapy and pharmacology 20110801 |
| Cytotoxicity and genotoxicity of capecitabine in head and neck cancer and normal cells. | Molecular biology reports 20110801 |
| Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs. | Lung cancer (Amsterdam, Netherlands) 20110801 |
| The safety and efficacy of EGFR TKIs monotherapy versus single-agent chemotherapy using third-generation cytotoxics as the first-line treatment for patients with advanced non-small cell lung cancer and poor performance status. | Lung cancer (Amsterdam, Netherlands) 20110801 |
| The promise of a personalized genomic approach to pancreatic cancer and why targeted therapies have missed the mark. | World journal of surgery 20110801 |
| Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial. | Cancer 20110801 |
| Progressive multifocal leukoencephalopathy following chemotherapy for lung cancer. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20110801 |
| ATP assay-guided chemosensitivity testing for gemcitabine with biopsy specimens obtained from unresectable pancreatic cancer using endoscopic ultrasonography-guided fine-needle aspiration. | International journal of clinical oncology 20110801 |
| The efficacy and safety of gemcitabine plus cisplatin regimen for patients with advanced urothelial carcinoma after failure of M-VAC regimen. | International journal of clinical oncology 20110801 |
| Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis. | Annals of surgical oncology 20110801 |
| Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. | Annals of surgical oncology 20110801 |
| MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer. | Annals of surgical oncology 20110801 |
| Lopinavir/ritonavir-based antiretroviral therapy in human immunodeficiency virus type 1-infected naive children: rare protease inhibitor resistance mutations but high lamivudine/emtricitabine resistance at the time of virologic failure. | The Pediatric infectious disease journal 20110801 |
| Angiotensin-converting enzyme 2 acts as a potential molecular target for pancreatic cancer therapy. | Cancer letters 20110801 |
| A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells. | Cancer letters 20110801 |
| Effects and mechanisms of the combination of suberoylanilide hydroxamic acid and bortezomib on the anticancer property of gemcitabine in pancreatic cancer. | Pancreas 20110801 |
| Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment. | European journal of cancer (Oxford, England : 1990) 20110801 |
| Novel approaches to treatment of leiomyosarcomas. | Current oncology reports 20110801 |
| Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer. | Journal of surgical oncology 20110801 |
| The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20110801 |
| Systemic gemcitabine and capecitabine plus intra-arterial epirubicin and cisplatin as second-line chemotherapy in gemcitabine-failure pancreatic cancer. | Pancreas 20110801 |
| Identification of genes associated to 2',2'-difluorodeoxycytidine resistance in HeLa cells with a lentiviral short-hairpin RNA library. | Biochemical pharmacology 20110801 |
| Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs. | Expert opinion on drug metabolism & toxicology 20110801 |
| Emerging pharmacotherapeutic strategies for cholangiocarcinoma. | Expert opinion on pharmacotherapy 20110801 |
| Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy. | Cancer biology & therapy 20110801 |
| A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells. | Cancer biology & therapy 20110801 |
| Predicting the chemosensitivity of pancreatic cancer cells by quantifying the expression levels of genes associated with the metabolism of gemcitabine and 5-fluorouracil. | International journal of oncology 20110801 |
| Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines. | Oncology reports 20110801 |
| Differential effect of polymorphisms of CMPK1 and RRM1 on survival in advanced non-small cell lung cancer patients treated with gemcitabine or taxane/cisplatinum. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110801 |
| [New perspectives for radiosensitization in pancreatic carcinoma: a review of mechanisms involved in pancreatic tumorigenesis]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20110801 |
| Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. | Cancer research 20110801 |
| Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group. | Clinical breast cancer 20110801 |
| Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801 |
| Multicenter phase II study of gemcitabine and S-1 combination therapy (GS Therapy) in patients with metastatic pancreatic cancer. | Japanese journal of clinical oncology 20110801 |
| A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer. | Clinical breast cancer 20110801 |
| Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents. | Cancer biology & therapy 20110801 |
| Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. | Journal of the American Academy of Dermatology 20110801 |
| [First line therapy for local advanced or metastatic urothelial cell carcinoma: randomized phase II study to investigate the combination of vinflunine with gemcitabine and vinflunine with carboplatin in patients unfit for cisplatin therapy with advanced or metastatic urothelial cell carcinoma (JASINT-1 - AB 38/11) of AUO]. | Der Urologe. Ausg. A 20110801 |
| Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. | The Lancet. Oncology 20110801 |
| Carboplatin and gemcitabine in first-line treatment of elderly patients with advanced non-small cell lung cancer: data from a retrospective study. | Journal of chemotherapy (Florence, Italy) 20110801 |
| Phase II trial of neoadjuvant chemotherapy with XELOX plus bevacizumab for locally advanced rectal cancer. | Japanese journal of clinical oncology 20110801 |
| Comparison of in vitro metabolic conversion of capecitabine to 5-FU in rats, mice, monkeys and humans--toxicological implications. | The Journal of toxicological sciences 20110801 |
| New approaches to the treatment of pancreatic cancer: from tumor-directed therapy to immunotherapy. | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20110801 |
| Enzyme kinetics of the mitochondrial deoxyribonucleoside salvage pathway are not sufficient to support rapid mtDNA replication. | PLoS computational biology 20110801 |
| Complete response of metastatic malignant hidradenocarcinoma to capecitabine treatment. | Archives of dermatology 20110801 |
| Clinical efficacy of capecitabine and cyclophosphamide (XC) in patients with metastatic breast cancer. | Acta medica Okayama 20110801 |
| The HCV NS5B nucleoside and non-nucleoside inhibitors. | Clinics in liver disease 20110801 |
| 3rd congress of the International Academy of Oral Oncology. | The Lancet. Oncology 20110801 |
| Application of the continual reassessment method to a phase I dose-finding trial in Japanese patients: East meets West. | Statistics in medicine 20110730 |
| AIDS research. Complexity surrounds HIV prevention advances. | Science (New York, N.Y.) 20110722 |
| [A randomized study of gemcitabine plus oxaliplatin versus gemcitabine plus cisplatin as the 1st line chemotherapy for advanced non-small cell lung cancer in elderly patients]. | Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110720 |
| Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage. | AIDS (London, England) 20110717 |
| Rilpivirine: a step forward in tailored HIV treatment. | Lancet (London, England) 20110716 |
| Antiretrovirals for HIV prevention: translating promise into praxis. | Lancet (London, England) 20110716 |
| Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial. | Lancet (London, England) 20110716 |
| Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. | Lancet (London, England) 20110716 |
| Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women. | Lancet (London, England) 20110716 |
| Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer. | Cancer 20110715 |
| Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma. | Cancer 20110715 |
| SSC: a tool for constructing libraries for systematic screening of conformers. | Journal of computational chemistry 20110715 |
| Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer. | Cancer research 20110715 |
| Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trial. | British journal of cancer 20110712 |
| Updates on treatment of gemcitabine-refractory pancreatic adenocarcinoma. Highlights from the '2011 ASCO Annual Meeting'. Chicago, IL, USA; June 3-7, 2011. | JOP : Journal of the pancreas 20110708 |
| Raman imaging of single living cells: probing effects of non-cytotoxic doses of an anti-cancer drug. | The Analyst 20110707 |
| Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110701 |
| Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologists. | European journal of cancer care 20110701 |
| A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. | Cancer chemotherapy and pharmacology 20110701 |
| Difluorodeoxyuridine plasma concentrations after low-dose gemcitabine during chemoradiation in head and neck cancer patients. | Cancer chemotherapy and pharmacology 20110701 |
| Antiviral activity of apricitabine in treatment-experienced HIV-1-infected patients with M184V who are failing combination therapy. | HIV medicine 20110701 |
| Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA). | Lung cancer (Amsterdam, Netherlands) 20110701 |
| The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine-cisplatin-based combination chemotherapy. | BJU international 20110701 |
| Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994-1998 and 2003-2006. | Breast cancer research and treatment 20110701 |
| Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20110701 |
| Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study. | Annals of oncology : official journal of the European Society for Medical Oncology 20110701 |
| A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancer. | Breast cancer (Tokyo, Japan) 20110701 |
| Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma. | Gynecologic oncology 20110701 |
| Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial. | Breast cancer (Tokyo, Japan) 20110701 |
| UBE2M-mediated p27(Kip1) degradation in gemcitabine cytotoxicity. | Biochemical pharmacology 20110701 |
| Lamellar crystalline self-assembly behaviour and solid lipid nanoparticles of a palmityl prodrug analogue of Capecitabine--a chemotherapy agent. | Colloids and surfaces. B, Biointerfaces 20110701 |
| Gemcitabine combined with cisplatin as neoadjuvant chemotherapy in stage IB-IIIA non-small cell lung cancer. | Anti-cancer drugs 20110701 |
| Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinoma; a Gynecologic Oncology Group study. | Gynecologic oncology 20110701 |
| Metastatic pancreatic cancer: old drugs, new paradigms. | Current opinion in oncology 20110701 |
| Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study). | HIV medicine 20110701 |
| NeoGemTax: gemcitabine and docetaxel as neoadjuvant treatment for locally advanced nonmetastasized pancreatic cancer. | World journal of surgery 20110701 |
| Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer. | Cancer chemotherapy and pharmacology 20110701 |
| Urothelial cancer cell response to combination therapy of gemcitabine and TRAIL. | International journal of oncology 20110701 |
| Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group. | European journal of cancer (Oxford, England : 1990) 20110701 |
| Synergistic antitumor activity of gemcitabine and ABT-737 in vitro and in vivo through disrupting the interaction of USP9X and Mcl-1. | Molecular cancer therapeutics 20110701 |
| Oxaliplatin, irinotecan, and gemcitabine: a novel combination in the therapy of progressed, relapsed, or refractory tumors in children. | Journal of pediatric hematology/oncology 20110701 |
| Phase I and pharmacokinetic study of IV vinflunine in combination with gemcitabine for treatment of advanced non-small cell lung cancer in Chemonaive patients. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110701 |
| Increased expression of DNA repair genes in invasive human pancreatic cancer cells. | Pancreas 20110701 |
| A man with a testicular mass and a colon stenosis. Diagnosis: Metastatic pancreatic adenocarcinoma to the gonads. | Gastroenterology 20110701 |
| Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110701 |
| Syntheses of 5-formyl- and 5-carboxyl-dC containing DNA oligos as potential oxidation products of 5-hydroxymethylcytosine in DNA. | Organic letters 20110701 |
| Neoadjuvant gemcitabine plus cisplatin for muscle-invasive bladder cancer. | Japanese journal of clinical oncology 20110701 |
| Intravenous fluid therapy successfully prevents renal injury by gemcitabine in patients with pancreatic cancer. | Pancreas 20110701 |
| Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma. | BJU international 20110701 |
| [Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110701 |
| [Eighty-five-year-old patient with recurrent rectal cancer effectively treated with CapeOX chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110701 |
| [A case of advanced rectal cancer resected successfully after preoperative XELOX chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110701 |
| Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110701 |
| Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. | PLoS pathogens 20110701 |
| [Granulocyte colony stimulating factor-producing spindle cell renal cell carcinoma successfully treated by chemotherapy consisting of gemcitabine and doxorubicin]. | Hinyokika kiyo. Acta urologica Japonica 20110701 |
| Combinatorial cytotoxicity of gemcitabine and cytokine-activated killer cells in hepatocellular carcinoma via the NKG2D-MICA/B system. | Anticancer research 20110701 |
| XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results. | British journal of cancer 20110628 |
| Cardiotoxicity in patients treated with bevacizumab is potentially reversible. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110620 |
| Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110620 |
| [Gemcitabine in RRM1-negative advanced refractory non-small cell lung cancer (NSCLC): a case report]. | Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110620 |
| Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. | Lancet (London, England) 20110618 |
| First-line treatment of advanced colorectal cancer. | Lancet (London, England) 20110618 |
| Comment on 'Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer,' i.e., all we are saying is, give C a chance. | Free radical biology & medicine 20110615 |
| Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202. | The Journal of infectious diseases 20110615 |
| A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003. | Cancer 20110615 |
| Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models. | Investigational new drugs 20110601 |
| Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors. | Investigational new drugs 20110601 |
| Gemcitabine and cisplatin in patients with carcinoma of unknown primary site. | Medical oncology (Northwood, London, England) 20110601 |
| Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy. | Critical reviews in oncology/hematology 20110601 |
| Bevacizumab, capecitabine, amifostine, and preoperative hypofractionated accelerated radiotherapy (HypoArc) for rectal cancer: a Phase II study. | International journal of radiation oncology, biology, physics 20110601 |
| Phase II trial of full-dose gemcitabine and bevacizumab in combination with attenuated three-dimensional conformal radiotherapy in patients with localized pancreatic cancer. | International journal of radiation oncology, biology, physics 20110601 |
| Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer. | Cancer chemotherapy and pharmacology 20110601 |
| Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer. | Cancer chemotherapy and pharmacology 20110601 |
| A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer. | Cancer chemotherapy and pharmacology 20110601 |
| Capecitabine-based chemotherapy for metastatic colorectal cancer. | Journal of cancer research and clinical oncology 20110601 |
| Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells. | Cancer epidemiology 20110601 |
| Global DNA methylation in the mouse liver is affected by methyl deficiency and arsenic in a sex-dependent manner. | Archives of toxicology 20110601 |
| Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT. | Annals of hematology 20110601 |
| Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer. | International journal of radiation oncology, biology, physics 20110601 |
| The effect of COX-2 inhibitor on capecitabine-induced hand-foot syndrome in patients with stage II/III colorectal cancer: a phase II randomized prospective study. | Journal of cancer research and clinical oncology 20110601 |
| Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes. | Annals of oncology : official journal of the European Society for Medical Oncology 20110601 |
| The efficacy of HER2-targeted agents in metastatic breast cancer: a meta-analysis. | Annals of oncology : official journal of the European Society for Medical Oncology 20110601 |
| Traditional Chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined targeted therapy and chemotherapy. | Integrative cancer therapies 20110601 |
| Laparoscopic proctectomy after neoadjuvant therapy: safety and long-term follow-up. | Surgical endoscopy 20110601 |
| [Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20110601 |
| Histone deacetylase inhibitor MGCD0103 synergizes with gemcitabine in human pancreatic cells. | Cancer science 20110601 |
| Retention of the in vitro radiosensitizing potential of gemcitabine under anoxic conditions, in p53 wild-type and p53-deficient non-small-cell lung carcinoma cells. | International journal of radiation oncology, biology, physics 20110601 |
| Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation. | Haematologica 20110601 |
| Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. | Free radical biology & medicine 20110601 |
| Genetically modified tumour vaccines producing IL-12 augment chemotherapy of HPV16-associated tumours with gemcitabine. | Oncology reports 20110601 |
| [Collecting duct renal cell carcinoma]. | Actas urologicas espanolas 20110601 |
| Mechanism of action of pentostatin and cladribine in hairy cell leukemia. | Leukemia & lymphoma 20110601 |
| Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis. | Laboratory investigation; a journal of technical methods and pathology 20110601 |
| Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz. | AIDS care 20110601 |
| A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis. | Japanese journal of clinical oncology 20110601 |
| Treatment of metastatic renal cell carcinoma and renal pelvic cancer. | Clinical and experimental nephrology 20110601 |
| Assessment of chk1 phosphorylation as a pharmacodynamic biomarker of chk1 inhibition. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110601 |
| Current treatment options for pancreatic carcinoma. | Current oncology reports 20110601 |
| Ultra-performance liquid chromatography/tandem mass spectrometry for accurate quantification of global DNA methylation in human sperms. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110601 |
| High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells. | Molecular cancer research : MCR 20110601 |
| Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20110601 |
| Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: a substudy of the Avastin in Lung trial. | Asia-Pacific journal of clinical oncology 20110601 |
| An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia. | Asia-Pacific journal of clinical oncology 20110601 |
| Early end for FEM-PrEP HIV prevention trial. | AIDS patient care and STDs 20110601 |
| Global gene disruption in human cells to assign genes to phenotypes by deep sequencing. | Nature biotechnology 20110601 |
| Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110601 |
| [Main treatment and preventive measures for hand-foot syndrome, a dermatologic side effect of cancer therapy]. | Magyar onkologia 20110601 |
| Biomarker-based selection of therapy for colorectal cancer. | Biomarkers in medicine 20110601 |
| A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma. | Future oncology (London, England) 20110601 |
| [A case of effective neoadjuvant chemoradiotherapy with capecitabine for locally advanced sigmoid colon cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110601 |
| Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors. | Drugs in R&D 20110601 |
| Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04). | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110601 |
| [Adjuvant chemotherapy for gastric cancer: more drugs do not mean better efficacy]. | Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20110601 |
| Transmission. Company halts Truvada PrEP for women study. | AIDS policy & law 20110601 |
| Response of recurrent urachal cancer to gemcitabine and cisplatin therapy: a case report and literature review. | Anticancer research 20110601 |
| Feasibility of intravenous gemcitabine and an intraperitoneal platinum agent in the treatment of ovarian cancer. | Journal of chemotherapy (Florence, Italy) 20110601 |
| Combined chemotherapy with cisplatin, docetaxel and capecitabine for metastatic nasopharyngeal carcinoma: a retrospective analysis. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20110601 |
| Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study. | Clinical advances in hematology & oncology : H&O 20110601 |
| A novel effective therapy for refractory angiosarcoma of the face and scalp. | Clinical advances in hematology & oncology : H&O 20110601 |
| A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer. | Clinical colorectal cancer 20110601 |
| [Therapeutic adherence to oral cancer therapy and interdisciplinary management]. | Revue medicale suisse 20110525 |
| Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial. | Lancet (London, England) 20110521 |
| Do we need oncology trials tailored for the elderly or frail? | Lancet (London, England) 20110521 |
| [Advances of drug resistance marker of gemcitabine for non-small cell lung cancer]. | Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110520 |
| Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET. | Blood 20110519 |
| AACR highlights: promise for treating pancreatic cancer. | Journal of the National Cancer Institute 20110518 |
| Study halted: no benefit seen from antiretroviral pill in preventing HIV in women. | JAMA 20110518 |
| In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles. | International journal of pharmaceutics 20110516 |
| Managing hepatitis B/HIV co-infected: adding entecavir to truvada (tenofovir disoproxil/emtricitabine) experienced patients. | AIDS (London, England) 20110515 |
| Fluorescent detection of single nucleotide polymorphism utilizing a hairpin DNA containing a nucleotide base analog pyrrolo-deoxycytidine as a fluorescent probe. | Talanta 20110515 |
| Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110515 |
| FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. | The New England journal of medicine 20110512 |
| Novel approach to Gorlin syndrome: a patient treated with oral capecitabine. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110510 |
| Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma. | World journal of gastroenterology 20110507 |
| [Efavirenz in fixed combination with tenofovir and emtricitabine. Long-term effectiveness verified in new studies]. | MMW Fortschritte der Medizin 20110505 |
| A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer. | Critical reviews in oncology/hematology 20110501 |
| Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20110501 |
| The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype. | Cancer chemotherapy and pharmacology 20110501 |
| Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study. | Cancer chemotherapy and pharmacology 20110501 |
| Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20110501 |
| Ischemic colitis after capecitabine plus cisplatin treatment in advanced gastric cancer. | Journal of thrombosis and thrombolysis 20110501 |
| Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20110501 |
| A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma. | Acta oncologica (Stockholm, Sweden) 20110501 |
| Analysis of tumor burden versus progression-free survival for Phase II decision making. | Contemporary clinical trials 20110501 |
| Crystal structure determination and dynamic studies of Mycobacterium tuberculosis Cytidine deaminase in complex with products. | Archives of biochemistry and biophysics 20110501 |
| Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis. | Oncology reports 20110501 |
| Differentiation of nestin-positive cells derived from bone marrow into pancreatic endocrine and ductal cells in vitro. | The Journal of endocrinology 20110501 |
| An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosis. | Biomaterials 20110501 |
| A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study. | European journal of cancer (Oxford, England : 1990) 20110501 |
| Synergistic antitumor effect of interferon-ß with gemcitabine in interferon-α-non-responsive pancreatic cancer cells. | International journal of oncology 20110501 |
| Water soluble heptakis(6-deoxy-6-thio)cyclomaltoheptaose capped gold nanoparticles via metal vapour synthesis: NMR structural characterization and complexation properties. | Carbohydrate research 20110501 |
| MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110501 |
| Chronic thrombotic microangiopathy secondary to chemotherapy for urothelial carcinoma in a patient with a history of Wegener granulomatosis. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20110501 |
| Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110501 |
| Nonsurgical therapy of biliary tract cancer. | Current opinion in gastroenterology 20110501 |
| Medical treatment of pancreatic cancer: new hopes after 10 years of gemcitabine. | Clinics and research in hepatology and gastroenterology 20110501 |
| Are we making progress in curing advanced cervical cancer? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110501 |
| Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110501 |
| Lyotropic liquid crystalline self-assembly material behavior and nanoparticulate dispersions of a phytanyl pro-drug analogue of capecitabine-a chemotherapy agent. | ACS applied materials & interfaces 20110501 |
| Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study. | The oncologist 20110501 |
| Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility. | The oncologist 20110501 |
| Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. | Annals of surgical oncology 20110501 |
| Multicystic mesothelioma of the pericardium. | Pathology international 20110501 |
| Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients. | Chinese journal of cancer 20110501 |
| Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment. | Neoplasia (New York, N.Y.) 20110501 |
| [Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110501 |
| [A case of toxicity caused by drug interaction between capecitabine and phenytoin in patient with colorectal cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110501 |
| [A case of advanced pancreatic cancer responding well to S-1/gemcitabine combination therapy after gemcitabine therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110501 |
| Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110501 |
| Determination of genomic 5-hydroxymethyl-2'-deoxycytidine in human DNA by capillary electrophoresis with laser induced fluorescence. | Epigenetics 20110501 |
| Response to low-dose oral capecitabine monotherapy in an elderly frail patient with metastatic breast carcinoma and impaired renal function: documentation by fluorodeoxyglucose positron emission tomography. | Japanese journal of radiology 20110501 |
| Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer. | Health technology assessment (Winchester, England) 20110501 |
| Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction. | Health technology assessment (Winchester, England) 20110501 |
| Experimental study of the anticancer effect of gemcitabine combined with sirolimus on chemically induced urothelial lesions. | Anticancer research 20110501 |
| Off-label use of oxaliplatin in patients with metastatic breast cancer. | Anticancer research 20110501 |
| Bevacizumab in first-line therapy of metastatic colorectal cancer: a retrospective comparison of FOLFIRI and XELIRI. | Anticancer research 20110501 |
| Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110501 |
| Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110501 |
| Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110501 |
| [Postoperative adjuvant treatment for pancreatic cancer]. | Nihon Geka Gakkai zasshi 20110501 |
| [Therapeutic perspectives of cutaneous T-cell lymphoma]. | Annales de dermatologie et de venereologie 20110501 |
| [Improved sensitivity of gastric carcinoma cells to fluorouracil-related drugs by transfection of thymidine phosphorylase gene]. | Zhonghua bing li xue za zhi = Chinese journal of pathology 20110501 |
| [Evaluation of the efficacy and safety of intravesical instillation with gemcitabine after first-line intravesical chemotherapy failure in the treatment of non-muscle-invasive bladder cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110501 |
| [Short-term intermittent prophylactic administration of recombinant human thrombopoietin attenuates chemotherapy-induced thrombocytopenia in lung cancer patients]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110501 |
| [New drugs of treatment of patients with chronic hepatitis B]. | Nihon rinsho. Japanese journal of clinical medicine 20110501 |
| Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection. | AIDS (London, England) 20110424 |
| Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110420 |
| [Relations between RRM1 protein expression levels and effects of gemcitabine and cisplatin chemotherapy in advanced non-small cell lung cancer patients]. | Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110420 |
| HIV prevention trial in women is abandoned after drugs show no impact on infection rates. | BMJ (Clinical research ed.) 20110420 |
| Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid-cholesterol monolayers mimicking a biomembrane. | Langmuir : the ACS journal of surfaces and colloids 20110419 |
| Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives. | Free radical biology & medicine 20110415 |
| Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110415 |
| Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder. | Journal of the American Veterinary Medical Association 20110415 |
| A randomized crossover study to determine relative bioequivalence of tenofovir, emtricitabine, and efavirenz (Atripla) fixed-dose combination tablet compared with a compounded oral liquid formulation derived from the tablet. | Journal of acquired immune deficiency syndromes (1999) 20110415 |
| Gemcitabine for unresectable, locally advanced or metastatic bladder cancer. | The Cochrane database of systematic reviews 20110413 |
| Post-translational phosphorylation of serine 74 of human deoxycytidine kinase favors the enzyme adopting the open conformation making it competent for nucleoside binding and release. | Biochemistry 20110412 |
| Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques. | Virology 20110410 |
| Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110410 |
| Preexposure chemoprophylaxis for HIV prevention. | The New England journal of medicine 20110407 |
| Preexposure chemoprophylaxis for HIV prevention. | The New England journal of medicine 20110407 |
| Preexposure chemoprophylaxis for HIV prevention. | The New England journal of medicine 20110407 |
| Preexposure chemoprophylaxis for HIV prevention. | The New England journal of medicine 20110407 |
| Preexposure chemoprophylaxis for HIV prevention. | The New England journal of medicine 20110407 |
| Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine. | Investigational new drugs 20110401 |
| A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer. | Investigational new drugs 20110401 |
| Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer. | American journal of clinical oncology 20110401 |
| Deoxyuridine analog nucleotides in deoxycytidine analog treatment: secondary active metabolites? | Fundamental & clinical pharmacology 20110401 |
| Clinical outcomes of sorafenib treatment in patients with metastatic hepatocellular carcinoma who had been previously treated with fluoropyrimidine plus platinum-based chemotherapy. | American journal of clinical oncology 20110401 |
| A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma. | American journal of clinical oncology 20110401 |
| The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. | Journal of cellular and molecular medicine 20110401 |
| Phase II trial of oxaliplatin and capecitabine after progression to first-line chemotherapy in androgen-independent prostate cancer patients. | American journal of clinical oncology 20110401 |
| Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy. | Cancer chemotherapy and pharmacology 20110401 |
| A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer. | Cancer chemotherapy and pharmacology 20110401 |
| PharmGKB summary: fluoropyrimidine pathways. | Pharmacogenetics and genomics 20110401 |
| Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma. | Journal of neuro-oncology 20110401 |
| A Phase I-II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas. | Acta oncologica (Stockholm, Sweden) 20110401 |
| Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma. | Acta oncologica (Stockholm, Sweden) 20110401 |
| Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies. | Annals of oncology : official journal of the European Society for Medical Oncology 20110401 |
| Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG). | Annals of oncology : official journal of the European Society for Medical Oncology 20110401 |
| Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma. | Leukemia research 20110401 |
| Perioperative intra-arterial and systemic chemotherapy for pancreatic cancer. | Annals of surgical oncology 20110401 |
| Further evidences for pharmacogenetic assessment of nucleoside analogue-treated patients. | Leukemia research 20110401 |
| Outcomes from chemoradiotherapy for patients with esophageal cancer. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20110401 |
| Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy. | Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 20110401 |
| Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer. | Annals of surgical oncology 20110401 |
| Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway. | European journal of nuclear medicine and molecular imaging 20110401 |
| A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: a gynecologic oncology group study. | Gynecologic oncology 20110401 |
| Improvement of capecitabine antitumoral activity by melatonin in pancreatic cancer. | Pancreas 20110401 |
| Weekly paclitaxel combining with gemcitabine is an effective and safe treatment for advanced breast cancer patients. | Japanese journal of clinical oncology 20110401 |
| FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cells. | Biochemical pharmacology 20110401 |
| Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy. | European journal of cancer (Oxford, England : 1990) 20110401 |
| Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression. | Oncology reports 20110401 |
| The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110401 |
| Construction and validation of a prognostic index for patients with metastatic pancreatic adenocarcinoma. | Pancreas 20110401 |
| Context dependence of checkpoint kinase 1 as a therapeutic target for pancreatic cancers deficient in the BRCA2 tumor suppressor. | Molecular cancer therapeutics 20110401 |
| Unity is strength: one, two, or more drugs against advanced pancreatic cancer? | Annals of oncology : official journal of the European Society for Medical Oncology 20110401 |
| Characterization of cytarabine-resistant leukemic cell lines established from five different blood cell lineages using gene expression and proteomic analyses. | International journal of oncology 20110401 |
| Effect of its deaminated metabolite, 2',2'-difluorodeoxyuridine, on the transport and toxicity of gemcitabine in HeLa cells. | Biochemical pharmacology 20110401 |
| Deoxyribonucleotide metabolism in cycling and resting human fibroblasts with a missense mutation in p53R2, a subunit of ribonucleotide reductase. | The Journal of biological chemistry 20110401 |
| Intensity of deoxycytidine deamination of HIV-1 proviral DNA by the retroviral restriction factor APOBEC3G is mediated by the noncatalytic domain. | The Journal of biological chemistry 20110401 |
| Evolution of 5-fluorouracil-based chemoradiation in the management of rectal cancer. | Anti-cancer drugs 20110401 |
| Interstitial lung disease during chemotherapy combined with oxaliplatin and/or bevacizumab in advanced colorectal cancer patients. | Japanese journal of clinical oncology 20110401 |
| Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells. | Biochemical and biophysical research communications 20110401 |
| Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening. | Molecular cancer therapeutics 20110401 |
| A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110401 |
| Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cells. | Clinical & experimental metastasis 20110401 |
| [HIV infected women with intense bone and muscular pain and general weakness]. | Enfermedades infecciosas y microbiologia clinica 20110401 |
| Optimizing pemetrexed-gemcitabine combination in patients with advanced non-small cell lung cancer: a pharmacogenetic approach. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110401 |
| [Metastatic non-small cell lung cancer: Systemic treatment of patients aged 70 and over]. | Presse medicale (Paris, France : 1983) 20110401 |
| Chimeric Trop2 virus-like particles: a potential immunotherapeutic approach against pancreatic cancer. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20110401 |
| Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy. | Journal of surgical oncology 20110401 |
| The use of genomic information to optimize cancer chemotherapy. | Seminars in oncology 20110401 |
| Pegylated liposomal doxorubicin and gemcitabine in a fixed dose rate infusion for the treatment of patients with poor prognosis of recurrent ovarian cancer: a phase Ib study. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20110401 |
| A pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer. | Oncology 20110401 |
| Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. | Nature medicine 20110401 |
| Trial success spurs planning for rollout of HIV prevention pills. | Nature medicine 20110401 |
| Acute transverse myelopathy probably related to intravenous gemcitabine plus cisplatin. | The Annals of pharmacotherapy 20110401 |
| Bevacizumab in the treatment of metastatic breast cancer: three case reports. | Current opinion in oncology 20110401 |
| [Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer(JO19380)]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110401 |
| Adenoviral therapy is more effective in gemcitabine-resistant pancreatic cancer than in gemcitabine-sensitive cells. | Anticancer research 20110401 |
| Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancer. | Anticancer research 20110401 |
| Roles of BCL-2 and MDR1 expression in the efficacy of paclitaxel-based lung cancer chemoradiation. | Anticancer research 20110401 |
| Clinical experience with nevirapine combined with tenofovir plus emtricitabine or lamivudine-containing regimens in HIV-infected subjects. | International journal of STD & AIDS 20110401 |
| [Second line chemotherapy for pancreatic cancer]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20110401 |
| Full-dose capecitabine with local radiotherapy: one of the treatment options for inoperable T4 breast cancer. | Japanese journal of radiology 20110401 |
| Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. | Cell death & disease 20110401 |
| Silencing of high mobility group A1 enhances gemcitabine chemosensitivity of lung adenocarcinoma cells. | Chinese medical journal 20110401 |
| E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma. | Chinese medical journal 20110401 |
| Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer. | Journal of chemotherapy (Florence, Italy) 20110401 |
| [Comparison between the effects of irinotecan or oxaliplatin combined with capecitabine in the treatment of advanced gastric cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110401 |
| [Effect of emodin combined gemcitabine on the growth and apoptosis of pancreatic cancer cell line BxPC-3 in vitro]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20110401 |
| Interim guidance for PrEP in MSM. CDC: Do not expand to other risk groups yet. | AIDS alert 20110401 |
| In vitro and in vivo anti-tumor effects of gemcitabine loaded with a new drug delivery system. | Journal of nanoscience and nanotechnology 20110401 |
| [Development of oral drugs in the standard therapy for metastatic colorectal cancer patients]. | Nihon rinsho. Japanese journal of clinical medicine 20110401 |
| Phase II study of single agent capecitabine in the treatment of metastatic non-pancreatic neuroendocrine tumours. | British journal of cancer 20110329 |
| Severe hypertriglyceridaemia during treatment with capecitabine. | British journal of cancer 20110329 |
| Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer. | British journal of cancer 20110329 |
| Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection. | AIDS (London, England) 20110327 |
| CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. | Science (New York, N.Y.) 20110325 |
| DNA adducts formed from p-benzoquinone, an electrophilic metabolite of benzene, are extensively metabolized in vivo. | Chemical research in toxicology 20110321 |
| Fourier transform infrared spectroscopy of 2'-deoxycytidine aggregates in CDCl3 solutions. | The Journal of chemical physics 20110321 |
| [Randomize trial of cisplatin plus gemcitabine with either sorafenib or placebo as first-line therapy for non-small cell lung cancer]. | Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110320 |
| Preoperative chemoradiation with irinotecan and capecitabine in patients with locally advanced resectable rectal cancer: long-term results of a Phase II study. | International journal of radiation oncology, biology, physics 20110315 |
| The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies. | International journal of cancer 20110315 |
| Gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer: Long-term cumulative results of 2 prospective single-institution studies. | Cancer 20110315 |
| Durable remission of metastatic renal cell carcinoma with gemcitabine and capecitabine after failure of targeted therapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110310 |
| Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110310 |
| Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110310 |
| Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110310 |
| First-line treatment for advanced pancreatic cancer. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011. | JOP : Journal of the pancreas 20110309 |
| Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011. | JOP : Journal of the pancreas 20110309 |
| Adjuvant therapy of pancreatic cancer: beyond gemcitabine. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011. | JOP : Journal of the pancreas 20110309 |
| Treatment for refractory pancreatic cancer. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011. | JOP : Journal of the pancreas 20110309 |
| Novel agents in the management of pancreatic adenocarcinoma: phase I studies. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011. | JOP : Journal of the pancreas 20110309 |
| Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. Highlights from the '2011 ASCO Gastrointestinal Cancers Symposium'. San Francisco, CA, USA. January 20-22, 2011. | JOP : Journal of the pancreas 20110309 |
| Overall survival of patients with advanced pancreatic cancer improved with an increase in second-line chemotherapy after gemcitabine-based therapy. | JOP : Journal of the pancreas 20110309 |
| Combinatorial pharmacologic effects of gemcitabine and its metabolite dFdU. | ChemMedChem 20110307 |
| Trapping a labile adduct formed between an ortho-quinone methide and 2'-deoxycytidine. | Organic letters 20110304 |
| High response of second-line chemotherapy with pemetrexed or gemcitabine combined with carboplatin in patients with non-small-cell lung cancer experiencing progression following 6 months after concluding platinum-based chemotherapy. | Medical oncology (Northwood, London, England) 20110301 |
| A patient of situs ambiguus with pancreatic head cancer successfully treated with gemcitabine and erlotinib. | Medical oncology (Northwood, London, England) 20110301 |
| Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. | Cancer chemotherapy and pharmacology 20110301 |
| A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas. | Cancer chemotherapy and pharmacology 20110301 |
| A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination. | Cancer chemotherapy and pharmacology 20110301 |
| Targeting IL-13Rα2 in human pancreatic ductal adenocarcinoma with combination therapy of IL-13-PE and gemcitabine. | International journal of cancer 20110301 |
| In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents. | Cancer chemotherapy and pharmacology 20110301 |
| Plasma disposition of capecitabine and its metabolites 5'DFCR and 5'DFUR in a standard and dose-intensified monotherapy regimen. | Cancer chemotherapy and pharmacology 20110301 |
| Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines. | Cancer chemotherapy and pharmacology 20110301 |
| Pancreatic cancer cells resistant to chemoradiotherapy rich in 'stem-cell-like' tumor cells. | Digestive diseases and sciences 20110301 |
| Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20110301 |
| Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine. | Annals of oncology : official journal of the European Society for Medical Oncology 20110301 |
| NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer. | Surgery 20110301 |
| Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo. | International journal of cancer 20110301 |
| Induction chemotherapy for unresectable urothelial carcinoma of the bladder. | BJU international 20110301 |
| Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. | Annals of surgical oncology 20110301 |
| Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20110301 |
| Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective study. | Basic & clinical pharmacology & toxicology 20110301 |
| Treatment trends in metastatic pancreatic cancer patients: Is it time to change? | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20110301 |
| Bayesian hierarchical changepoint methods in modeling the tumor growth profiles in xenograft experiments. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110301 |
| Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine. | Biochemical pharmacology 20110301 |
| Capecitabine and hand-foot syndrome. | Expert opinion on drug safety 20110301 |
| Adenovirus-mediated Drosophila melanogaster deoxyribonucleoside kinase mutants combined with gemcitabine harbor a safe cancer treatment profile. | International journal of oncology 20110301 |
| Disrupted plasma membrane localization of equilibrative nucleoside transporter 2 in the chemoresistance of human pancreatic cells to gemcitabine (dFdCyd). | Cancer science 20110301 |
| Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer. | Annals of surgical oncology 20110301 |
| Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells. | Cellular & molecular biology letters 20110301 |
| High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. | International journal of oncology 20110301 |
| Deoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity. | Cancer research 20110301 |
| Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer. | The British journal of surgery 20110301 |
| Pulmonary cryptococcus infection after mono-chemotherapy with gemcitabine. | Respiratory care 20110301 |
| Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours. | British journal of clinical pharmacology 20110301 |
| Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110301 |
| Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer. | British journal of cancer 20110301 |
| Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study. | The Lancet. Oncology 20110301 |
| Genexol inhibits primary tumour growth and metastases in gemcitabine-resistant pancreatic ductal adenocarcinoma. | HPB : the official journal of the International Hepato Pancreato Biliary Association 20110301 |
| How fast can pancreatic cancer grow? A case of pancreatic carcinoma developed within 5 months after a negative examination to the advanced stage with multiple liver and bone metastases. | Pancreas 20110301 |
| A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172). | Leukemia & lymphoma 20110301 |
| The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C. | Asia-Pacific journal of clinical oncology 20110301 |
| Capecitabine monotherapy as salvage treatment after failure of chemotherapy containing oxaliplatin and irinotecan in patients with metastatic colorectal cancer. | Asia-Pacific journal of clinical oncology 20110301 |
| Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre. | BJU international 20110301 |
| Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre. | BJU international 20110301 |
| Novel roles for hypoxia and prostaglandin E2 in the regulation of IL-8 during endometrial repair. | The American journal of pathology 20110301 |
| RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum. | Journal of Zhejiang University. Science. B 20110301 |
| No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus. | Hepatology (Baltimore, Md.) 20110301 |
| [Signet ring cell carcinoma of the ampulla of Vater]. | Gastroenterologia y hepatologia 20110301 |
| Connexin-26 is a key factor mediating gemcitabine bystander effect. | Molecular cancer therapeutics 20110301 |
| [Prominent efficacy from capecitabine mono-therapy for a case with lymphangiosis carcinomatosa derived from recurrent breast cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110301 |
| [A resected case of gastric regional lymph node metastasis from ascending colon cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110301 |
| [Combination chemotherapy of paclitaxel, carboplatin and gemcitabine in patients who have received prior cisplatin-based chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110301 |
| A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumors. | Clinical advances in hematology & oncology : H&O 20110301 |
| Limited dCTP availability accounts for mitochondrial DNA depletion in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). | PLoS genetics 20110301 |
| [Inhibitory effect of 5-aza-2'-deoxycytidine combined with docetaxel on prostate cancer PC3 cells in vitro]. | Zhonghua nan ke xue = National journal of andrology 20110301 |
| A mathematical model of human thymidine kinase 2 activity. | Nucleosides, nucleotides & nucleic acids 20110301 |
| Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors. | Anticancer research 20110301 |
| Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study. | Clinical lung cancer 20110301 |
| Modulation in concentrative nucleoside transporters-mediated intestinal absorption of mizoribine, an immunosuppressive agent, in lipopolysaccharide-treated rats. | Die Pharmazie 20110301 |
| [Relationship between the protein expression of ERCC1, BRCA, β-tubulin and K-ras and the efficacy and prognosis in advanced non-small cell lung cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110301 |
| [The prognostic significance of human equilibrative nucleoside transporter1 (hENT1) expression in metastatic bladder cancer patients treated with gemcitabine-cisplatin based combination chemotherapy]. | Hinyokika kiyo. Acta urologica Japonica 20110301 |
| Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group. | Clinical colorectal cancer 20110301 |
| A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumors. | Clinical colorectal cancer 20110301 |
| Brief commentary: largest randomized trial of biliary tract cancer treatment with cisplatin plus gemcitabine versus gemcitabine alone: an excellent opportunity to evaluate the prognostic value of tumor marker CA 19-9. | Clinical colorectal cancer 20110301 |
| Solution structure of a DNA duplex containing the potent anti-poxvirus agent cidofovir. | Journal of the American Chemical Society 20110223 |
| Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics. | ACS nano 20110222 |
| Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110220 |
| [Randomized clinical case-control trial for the comparison of docetaxel plus thiotepa versus docetaxel plus capecitabine in patients with metastatic breast cancer]. | Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20110218 |
| A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer. | Cancer 20110215 |
| Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial. | Cancer 20110215 |
| Improved synthesis of 5-hydroxymethyl-2'-deoxycytidine phosphoramidite using a 2'-deoxyuridine to 2'-deoxycytidine conversion without temporary protecting groups. | Bioorganic & medicinal chemistry letters 20110215 |
| Anthraquinone-sensitized photooxidation of 5-methylcytosine in DNA leading to piperidine-induced efficient strand cleavage. | Chemistry (Weinheim an der Bergstrasse, Germany) 20110211 |
| Integrating pharmacogenetics into gemcitabine dosing--time for a change? | Nature reviews. Clinical oncology 20110208 |
| Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance. | The Journal of biological chemistry 20110204 |
| Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: results of a phase II, randomized, noncomparative study. | Investigational new drugs 20110201 |
| Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trial. | Investigational new drugs 20110201 |
| Age has no significant impact on overall survival and on treatment tolerability in relapsed stage IV cutaneous malignant melanoma patients receiving Cisplatin, Gemcitabine, and Treosulfan. | American journal of clinical oncology 20110201 |
| The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer. | The pharmacogenomics journal 20110201 |
| Phase II study of gemcitabine plus docetaxel as second-line treatment in malignant pleural mesothelioma: a single institution study. | American journal of clinical oncology 20110201 |
| Phase I/II study of hepatic arterial infusion chemotherapy with gemcitabine in patients with unresectable intrahepatic cholangiocarcinoma (JIVROSG-0301). | American journal of clinical oncology 20110201 |
| Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer. | Cancer chemotherapy and pharmacology 20110201 |
| In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects. | Cancer chemotherapy and pharmacology 20110201 |
| Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer. | Journal of cancer research and clinical oncology 20110201 |
| Irradiation, cisplatin, and 5-azacytidine upregulate cytomegalovirus promoter in tumors and muscles: implementation of non-invasive fluorescence imaging. | Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20110201 |
| Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer. | Cancer chemotherapy and pharmacology 20110201 |
| Second-line chemotherapy with capecitabine (Xeloda) and docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial. | Cancer chemotherapy and pharmacology 20110201 |
| Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in mice. | Cancer chemotherapy and pharmacology 20110201 |
| Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinoma. | American journal of clinical oncology 20110201 |
| Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer. | International journal of cancer 20110201 |
| A case of metastatic breast cancer successfully treated with lapatinib plus capecitabine therapy. | Archives of gynecology and obstetrics 20110201 |
| Randomized phase II study of gemcitabine and carboplatin +/- sequential docetaxel in non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20110201 |
| Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20110201 |
| Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99]. | Annals of oncology : official journal of the European Society for Medical Oncology 20110201 |
| A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck. | Annals of oncology : official journal of the European Society for Medical Oncology 20110201 |
| Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy. | Annals of surgical oncology 20110201 |
| Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54). | European journal of haematology 20110201 |
| Fused-core silica column ultra-performance liquid chromatography-ion trap tandem mass spectrometry for determination of global DNA methylation status. | Analytical biochemistry 20110201 |
| Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours. | European journal of nuclear medicine and molecular imaging 20110201 |
| Phase II study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer. | Anti-cancer drugs 20110201 |
| A phase II study of outpatient biweekly gemcitabine-oxaliplatin in advanced biliary tract carcinomas. | Japanese journal of clinical oncology 20110201 |
| The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients. | European journal of cancer (Oxford, England : 1990) 20110201 |
| Chemotherapy for thymic tumors: induction, consolidation, palliation. | Thoracic surgery clinics 20110201 |
| A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110201 |
| Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. | The Journal of antimicrobial chemotherapy 20110201 |
| Cytotoxic effects of new trans-2,4-diaryl-r-3-methyl-1,2,3,4-tetrahydroquinolines and their interaction with antitumoral drugs gemcitabine and paclitaxel on cellular lines of human breast cancer. | Chemico-biological interactions 20110201 |
| Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2. | Cancer research 20110201 |
| Isolation and characterization of gemcitabine-resistant human non-small cell lung cancer A549 cells. | International journal of oncology 20110201 |
| Epigenetic regulation of gene expression as an anticancer drug target. | Current cancer drug targets 20110201 |
| Targeted combined aerosol chemotherapy in dogs and radiologic toxicity grading. | Journal of aerosol medicine and pulmonary drug delivery 20110201 |
| How do carbon nanotubes serve as carriers for gemcitabine transport in a drug delivery system? | Journal of molecular graphics & modelling 20110201 |
| Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer. | Cancer science 20110201 |
| Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765). | Breast cancer research and treatment 20110201 |
| Correlation of basal EGFR expression with pancreatic cancer grading but not with clinical outcome after gemcitabine-based treatment. | Annals of oncology : official journal of the European Society for Medical Oncology 20110201 |
| A phase III randomized trial of gemcitabine-oxaliplatin versus carboplatin-paclitaxel as first-line therapy in patients with advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110201 |
| Silencing of tubulin binding cofactor C modifies microtubule dynamics and cell cycle distribution and enhances sensitivity to gemcitabine in breast cancer cells. | Molecular cancer therapeutics 20110201 |
| Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer. | Anti-cancer drugs 20110201 |
| Changing management and survival in patients with stage IV colorectal cancer. | Diseases of the colon and rectum 20110201 |
| Microcystic/reticular schwannoma of the pancreas: a potential diagnostic pitfall. | Pathology international 20110201 |
| Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110201 |
| Response to combined molecular targeting: defining the role of P-STAT3. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110201 |
| Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20110201 |
| Phase II trial of capecitabine and cisplatin in advanced, persistent, or recurrent carcinoma of the cervix. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20110201 |
| Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities. | Hepatology (Baltimore, Md.) 20110201 |
| Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings. | AIDS patient care and STDs 20110201 |
| [Pharmacogenomic research for avoiding adverse reactions by anti-cancer drugs]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110201 |
| Peritoneal fibrosis leading to small bowel obstruction two years after first-line intraperitoneal chemotherapy for optimally debulked ovarian cancer. | The Australian & New Zealand journal of obstetrics & gynaecology 20110201 |
| XELOX in colorectal cancer: a convenient option for the future? | Expert review of gastroenterology & hepatology 20110201 |
| [AUO-study AB34/09: an open-label, randomised, multicentre, phase II study to evaluate the efficacy of chemotherapy with gemcitabine and cisplatin in combination with the EGF receptor antibody panitumumab (GemCisP) versus GemCis in the first-line therapy of locally advanced/metastatic urothelial carcinoma in patients with wild-type HRAS - PURO]. | Der Urologe. Ausg. A 20110201 |
| Cetuximab concomitant with gemcitabine and radiotherapy in advanced squamous cell carcinomas of upper aerodigestive tract: a pilot study. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110201 |
| Relationship between single nucleotide polymorphisms in the deoxycytidine kinase gene and chemosensitivity of gemcitabine in six pancreatic cancer cell lines. | Chinese medical journal 20110201 |
| [A case of coexisting malignant mesothelioma and squamous cell carcinoma of the lung]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110201 |
| [Two cases of curatively resected intrahepatic cholangiocellular carcinomas through effective response to neoadjuvant chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110201 |
| [A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110201 |
| Deoxycytidine production by metabolically engineered Corynebacterium ammoniagenes. | Journal of microbiology (Seoul, Korea) 20110201 |
| Initial results reported on raltegravir once-daily dosing. | AIDS patient care and STDs 20110201 |
| [Contribution of microCT structural imaging to preclinical evaluation of hepatocellular carcinoma chemotherapeutics on orthotopic graft in ACI rats]. | Bulletin du cancer 20110201 |
| [A case of interstitial pneumonia during gemcitabine and cisplatin chemotherapy for locally advanced bladder cancer]. | Hinyokika kiyo. Acta urologica Japonica 20110201 |
| Treatment of early-stage pancreatic cancer. | Oncology (Williston Park, N.Y.) 20110201 |
| Concomitant chemoradiotherapy with low-dose weekly gemcitabine for nonmetastatic unresectable pancreatic cancer. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20110201 |
| Carboplatin and gemcitabine combination in metastatic triple-negative anthracycline- and taxane-pretreated breast cancer patients: a phase II study. | Journal of chemotherapy (Florence, Italy) 20110201 |
| EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer. | Journal of biomedical nanotechnology 20110201 |
| [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine]. | Yao xue xue bao = Acta pharmaceutica Sinica 20110201 |
| Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy. | AIDS (London, England) 20110128 |
| Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. | MMWR. Morbidity and mortality weekly report 20110128 |
| Iniparib plus chemotherapy in metastatic triple-negative breast cancer. | The New England journal of medicine 20110120 |
| [A meta-analysis of pemetrexed plus platinum chemotherapy versus gemcitabine plus platinum chemotherapy for advanced non-small cell lung cancer]. | Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110120 |
| AIDS: Drugs that prevent HIV infection. | Nature 20110120 |
| First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas. | Cancer 20110115 |
| Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110115 |
| Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system. | Biomacromolecules 20110110 |
| Sequence-specific ultrasonic cleavage of DNA. | Biophysical journal 20110105 |
| A rare case of thyroid metastasis from pancreatic adenocarcinoma. | JOP : Journal of the pancreas 20110105 |
| Medical therapy for advanced pancreatic cancer: work in progress. | JOP : Journal of the pancreas 20110105 |
| Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction. | British journal of cancer 20110104 |
| Comment on 'capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'. | British journal of cancer 20110104 |
| Bypass of N²-ethylguanine by human DNA polymerase κ. | DNA repair 20110102 |
| The effects of Gemcitabine and Vinorelbine on inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) distribution of MCF-7 breast cancer cells. | Acta histochemica 20110101 |
| Successful use of biweekly gemcitabine plus nab-paclitaxel in two male patients with stage iv breast cancer: case reports and review of the literature. | American journal of therapeutics 20110101 |
| Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancer. | Cancer chemotherapy and pharmacology 20110101 |
| Capecitabine-induced, rapid decrease of renal function due to drug dispensing error in a hospital pharmacy. | Journal of clinical pharmacology 20110101 |
| Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase. | Cancer chemotherapy and pharmacology 20110101 |
| Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach. | Breast cancer (Tokyo, Japan) 20110101 |
| Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers. | International journal of radiation oncology, biology, physics 20110101 |
| Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head. | International journal of radiation oncology, biology, physics 20110101 |
| Anal cancer with cerebral metastasis: a case report. | Journal of neuro-oncology 20110101 |
| 3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase. | Leukemia research 20110101 |
| Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC). | Current cancer drug targets 20110101 |
| Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity. | Annals of oncology : official journal of the European Society for Medical Oncology 20110101 |
| Heat shock protein 70 (Hsp70)-stimulated deoxycytidine deaminases from a human lymphoma cell but not the activation-induced cytidine deaminase (AID) from Ramos 6.4 human Burkitt's lymphoma cells. | Cell stress & chaperones 20110101 |
| Selective fluorescence sensing of deoxycytidine 5'-monophosphate (dCMP) employing a bis(diphenylphosphate)diimine ligand. | Journal of fluorescence 20110101 |
| Multicentre phase II study of XELOX with bevacizumab in late-stage elderly patients with unresectable advanced/recurrent colorectal cancer: an ASCA study. | Japanese journal of clinical oncology 20110101 |
| New recommendation of doses in an ongoing phase II study of docetaxel, oxaliplatin and capecitabine as first line therapy in advanced gastro-oesophageal cancer. | Acta oncologica (Stockholm, Sweden) 20110101 |
| Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1. | Biochemical pharmacology 20110101 |
| The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II study. | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20110101 |
| Human SMG-1 is involved in gemcitabine-induced primary microRNA-155/BIC up-regulation in human pancreatic cancer PANC-1 cells. | Pancreas 20110101 |
| Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo. | Anti-cancer drugs 20110101 |
| Outcomes and tolerability of systemic chemotherapy for pancreatic or biliary cancer patients aged 75 years or older. | Japanese journal of clinical oncology 20110101 |
| Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer. | Cancer chemotherapy and pharmacology 20110101 |
| High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer. | Breast cancer research and treatment 20110101 |
| Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study. | European journal of cancer (Oxford, England : 1990) 20110101 |
| Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model. | Cancer immunology, immunotherapy : CII 20110101 |
| Implications of HIV PrEP trials results. | AIDS research and human retroviruses 20110101 |
| Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial). | The Journal of antimicrobial chemotherapy 20110101 |
| Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials. | Breast cancer research and treatment 20110101 |
| Capecitabine for skin cancer prevention in solid organ transplant recipients. | Clinical transplantation 20110101 |
| [Immune reconstitution inflammatory syndrome associated with eosinophilic pustular folliculitis in an HIV-infected patient]. | Medecine et maladies infectieuses 20110101 |
| A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancer. | European journal of cancer (Oxford, England : 1990) 20110101 |
| Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma: results of a phase 2 study. | Cancer 20110101 |
| Erlotinib resistance is altered after gemcitabine chemotherapy for recurrent non-small-cell lung cancer. | Clinical drug investigation 20110101 |
| Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II study. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110101 |
| Utility of the novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen), for elderly patients with invasive bladder cancer. | International journal of oncology 20110101 |
| Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110101 |
| KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine. | Chemotherapy 20110101 |
| Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer. | Molecular cancer therapeutics 20110101 |
| Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A1*6 and UGT1A1*27 with severe neutropenia. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110101 |
| Phase 1 trial of Wilms tumor 1 (WT1) peptide vaccine and gemcitabine combination therapy in patients with advanced pancreatic or biliary tract cancer. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20110101 |
| Interstitial lung disease under erlotinib plus gemcitabine for pancreatic carcinoma: a therapeutic dilemma. | Pancreas 20110101 |
| Synthesis of a covalent gemcitabine-(carbamate)-[anti-HER2/neu] immunochemotherapeutic and its cytotoxic anti-neoplastic activity against chemotherapeutic-resistant SKBr-3 mammary carcinoma. | Bioorganic & medicinal chemistry 20110101 |
| Capecitabine combined with oxaliplatin (CAPOX) in clinical practice: how significant is peripheral neuropathy? | Annals of oncology : official journal of the European Society for Medical Oncology 20110101 |
| Repeated chemoembolization followed by laser-induced thermotherapy for liver metastasis of breast cancer. | AJR. American journal of roentgenology 20110101 |
| Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20110101 |
| Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies? | Journal of biomedicine & biotechnology 20110101 |
| The impact of human immunodeficiency virus on viral hepatitis. | Liver international : official journal of the International Association for the Study of the Liver 20110101 |
| The ART of preventing HIV. | Nature medicine 20110101 |
| Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer. | BMC cancer 20110101 |
| Angiosarcoma of the scalp with complete response to a biweekly gemcitabine and docetaxel (GEMDOC) chemotherapy regimen. | Ear, nose, & throat journal 20110101 |
| Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110101 |
| Exudative, nonhealing scalp: a complication of systemic chemotherapy with capecitabine and bevacizumab. | Archives of dermatology 20110101 |
| Cladribine: mode of action and implications for treatment of multiple sclerosis. | Clinical neuropharmacology 20110101 |
| Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease. | Hepatology (Baltimore, Md.) 20110101 |
| A Leu to Ile but not Leu to Val change at HIV-1 reverse transcriptase codon 74 in the background of K65R mutation leads to an increased processivity of K65R+L74I enzyme and a replication competent virus. | Virology journal 20110101 |
| Mutation of HIV-1 genomes in a clinical population treated with the mutagenic nucleoside KP1461. | PloS one 20110101 |
| Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabine. | PloS one 20110101 |
| A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer. | Anticancer research 20110101 |
| 5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine. | Anticancer research 20110101 |
| Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer. | Neoplasma 20110101 |
| A novel modular antigen delivery system for immuno targeting of human 6-sulfo LacNAc-positive blood dendritic cells (SlanDCs). | PloS one 20110101 |
| Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States. | Journal of medical economics 20110101 |
| Second-line combination chemotherapy with vinorelbine and capecitabine in patients with advanced breast cancer previously treated with anthracyclines and/or taxanes. | Chemotherapy 20110101 |
| Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. | Journal of clinical biochemistry and nutrition 20110101 |
| Nucleotides function as endogenous chemical sensors for oxidative stress signaling. | Journal of clinical biochemistry and nutrition 20110101 |
| An insertion mutation that distorts antibody binding site architecture enhances function of a human antibody. | mBio 20110101 |
| Analysis of drug resistance during HIV RNA viraemia in the MONET trial of darunavir/ritonavir monotherapy. | Antiviral therapy 20110101 |
| Virological characterization of patients failing darunavir/ritonavir or lopinavir/ritonavir treatment in the ARTEMIS study: 96-week analysis. | Antiviral therapy 20110101 |
| Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial. | BMC cancer 20110101 |
| Multidisciplinary approach and multimodal therapy in resected pancreatic cancer. Observational study. | Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20110101 |
| Mestastatic gastric cancer from malignant fibrous histiocytoma. | Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20110101 |
| [Effectiveness of adjuvant chemotherapy using gemcitabine for resected pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110101 |
| [A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20110101 |
| Newly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compounds. | PloS one 20110101 |
| Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells. | Archives of medical research 20110101 |
| Changes in gene expression and cellular architecture in an ovarian cancer progression model. | PloS one 20110101 |
| Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. | PloS one 20110101 |
| Modeling antibiotic and cytotoxic effects of the dimeric isoquinoline IQ-143 on metabolism and its regulation in Staphylococcus aureus, Staphylococcus epidermidis and human cells. | Genome biology 20110101 |
| Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences. | Korean journal of radiology 20110101 |
| Copy Number Alterations and Methylation in Ewing's Sarcoma. | Sarcoma 20110101 |
| A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma. | Journal of hematology & oncology 20110101 |
| Salvage therapy with mitomycin and ifosfamide in patients with gemcitabine-resistant metastatic pancreatic cancer: a phase II trial. | Chemotherapy 20110101 |
| [Nephropathy following administration of angiogenesis inhibitors]. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20110101 |
| Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB. | Molecular medicine reports 20110101 |
| Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report. | BMC gastroenterology 20110101 |
| An effective personalized approach to a rare tumor: prolonged survival in metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line development. | Journal of Cancer 20110101 |
| Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis. | BMC cancer 20110101 |
| [Ileitis following capecitabine use]. | Nederlands tijdschrift voor geneeskunde 20110101 |
| Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma. | Journal of veterinary internal medicine 20110101 |
| Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer. | BMC cancer 20110101 |
| Reduced emergence of the M184V/I resistance mutation when antiretroviral-naïve subjects use emtricitabine versus lamivudine in regimens composed of two NRTIs plus the NNRTI efavirenz. | HIV clinical trials 20110101 |
| Single-agent gemcitabine in elderly patients with unresectable biliary tract cancer. | Hepato-gastroenterology 20110101 |
| Opened-ring adducts of 5-methylcytosine and 1,5-dimethylcytosine with amines and water and evidence for an opened-ring hydrate of 2'-deoxycytidine. | Photochemistry and photobiology 20110101 |
| Capecitabine in combination with oxaliplatin as first-line therapy for advanced gastric cancer: a case report. | Tumori 20110101 |
| T cell chemo-vaccination effects after repeated mucosal SHIV exposures and oral pre-exposure prophylaxis. | PloS one 20110101 |
| Toxicity profile and adherence to the pharmacotherapeutic regimen of gemcitabine-carboplatin in non-small cell lung cancer. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101 |
| Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial. | Antiviral therapy 20110101 |
| UMP/CMPK is not the critical enzyme in the metabolism of pyrimidine ribonucleotide and activation of deoxycytidine analogs in human RKO cells. | PloS one 20110101 |
| Identification of a novel TGFβ/PKA signaling transduceome in mediating control of cell survival and metastasis in colon cancer. | PloS one 20110101 |
| [Concurrent versus sequential systemic chemotherapy and whole brain radiation therapy for brain matastases in non-small-cell lung cancer patients]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110101 |
| Combination therapy of lapatinib and Capecitabine for ErbB2-positive metastatic or locally advanced breast cancer: results from the Lapatinib Expanded Access Program (LEAP) in Central and Eastern Europe. | Onkologie 20110101 |
| Ixabepilone for the treatment of breast cancer. | Annals of medicine 20110101 |
| Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel. | BMC cancer 20110101 |
| Regional chemotherapy in locally advanced pancreatic cancer: RECLAP trial. | Trials 20110101 |
| Prospective phase II trial of gemcitabine in combination with irinotecan as first-line chemotherapy in patients with advanced biliary tract cancer. | Chemotherapy 20110101 |
| Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression. | BMC cancer 20110101 |
| Self-reported compliance with capecitabine: findings from a prospective cohort analysis. | Oncology 20110101 |
| PrEP trial in women halted due to doubts that it could show efficacy. | IAVI report : newsletter on international AIDS vaccine research 20110101 |
| Clusterin confers gemcitabine resistance in pancreatic cancer. | World journal of surgical oncology 20110101 |
| Successful treatment with GEMOX in patient with metastatic pancreatic adenosquamous carcinoma. | Tumori 20110101 |
| Development of oral immunomodulatory agents in the management of multiple sclerosis. | Drug design, development and therapy 20110101 |
| Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751. | Asian Pacific journal of cancer prevention : APJCP 20110101 |
| Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells. | PloS one 20110101 |
| Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines. | Swiss medical weekly 20110101 |
| Single-agent gemcitabine in elderly patients with unresectable biliary tract cancer. | Hepato-gastroenterology 20110101 |
| GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancer. | Hepato-gastroenterology 20110101 |
| Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and hyperglycaemia on a high-fat diet. | Diabetologia 20110101 |
| Cancer stem-like cells enriched in Panc-1 spheres possess increased migration ability and resistance to gemcitabine. | International journal of molecular sciences 20110101 |
| HPLC-UV, MALDI-TOF-MS and ESI-MS/MS analysis of the mechlorethamine DNA crosslink at a cytosine-cytosine mismatch pair. | PloS one 20110101 |
| Changes in global gene expression in response to chemical and genetic perturbation of chromatin structure. | PloS one 20110101 |
| PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib. | BMC cancer 20110101 |
| Gemcitabine and oxaliplatin combination chemotherapy for patients with refractory pancreatic cancer. | Oncology 20110101 |
| Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma. | BMC cancer 20110101 |
| Low-density lipoprotein size and lipoprotein-associated phospholipase A2 in HIV-infected patients switching to abacavir or tenofovir. | Antiviral therapy 20110101 |
| Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients. | Antiviral therapy 20110101 |
| Global proteomic analysis of two tick-borne emerging zoonotic agents: anaplasma phagocytophilum and ehrlichia chaffeensis. | Frontiers in microbiology 20110101 |
| Dramatic response of recalcitrant warts as a side effect of colorectal cancer treatment with oral capecitabine. | European journal of dermatology : EJD 20110101 |
| A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic cancer. | Oncology 20110101 |
| Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial. | BMC cancer 20110101 |
| The HIV-1 Rev/RRE system is required for HIV-1 5' UTR cis elements to augment encapsidation of heterologous RNA into HIV-1 viral particles. | Retrovirology 20110101 |
| Successful management of metastatic urothelial carcinoma with gemcitabine and Paclitaxel chemotherapy in a hemodialysis patient. | Urologia internationalis 20110101 |
| Use of specific chemical reagents for detection of modified nucleotides in RNA. | Journal of nucleic acids 20110101 |
| Combination of gemcitabine and doxorubicin in rapidly progressive metastatic renal cell carcinoma and/or sarcomatoid renal cell carcinoma. | Oncology 20110101 |
| Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. | PloS one 20110101 |
| Capecitabine (and 5 fluorouracil) cardiotoxicity. Metabolic considerations. | The breast journal 20110101 |
| Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma. | Hematology/oncology and stem cell therapy 20110101 |
| Control of centrin stability by Aurora A. | PloS one 20110101 |
| Second-line treatment with intravenous gemcitabine and oral etoposide in platinum-resistant advanced ovarian cancer patients: results of a phase II study. | Oncology 20110101 |
| Final results of ERASME-4: a randomized trial of first-line docetaxel plus either capecitabine or epirubicin for metastatic breast cancer. | Oncology 20110101 |
| Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer. | Oncology 20110101 |
| Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. | PloS one 20110101 |
| Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement. | BMC cancer 20110101 |
| Expression of CD147 in advanced non-small cell lung cancer correlated with cisplatin-based chemotherapy resistance. | Neoplasma 20110101 |
| Common side effects and interactions of colorectal cancer therapeutic agents. | The Journal of practical nursing 20110101 |
| Urothelial bladder cancer with cavitary lung metastases. | Canadian respiratory journal 20110101 |
| How addition of capecitabine might be more beneficial in the neoadjuvant treatment of breast cancer. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101 |
| Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells. | BMC pharmacology 20110101 |
| A conjugate of gemcitabine with bisphosphonate (Gem/BP) shows potential as a targeted bone-specific therapeutic agent in an animal model of human breast cancer bone metastases. | Oncology research 20110101 |
| 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma. | Oncology 20110101 |
| Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer. | Tumori 20110101 |
| Generation of germline-competent rat induced pluripotent stem cells. | PloS one 20110101 |
| Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study. | BMC cancer 20110101 |
| Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients. | Radiation oncology (London, England) 20110101 |
| Primary leiomyosarcoma of the seminal vesicle: case report and review of the literature. | BMC cancer 20110101 |
| [Role of gemcitabine in treatment of metastatic breast cancer]. | Voprosy onkologii 20110101 |
| [Results of adjuvant chemotherapy (XELOX) of advanced colorectal cancer]. | Voprosy onkologii 20110101 |
| [Investigation of gemcitabine plus lomustine treatment in mice with transplantable lymphosarcoma LIO-1]. | Voprosy onkologii 20110101 |
| [End results of combined treatment in metastatic colorectal cancer]. | Voprosy onkologii 20110101 |
| Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS). | BMC cancer 20110101 |
| Docetaxel plus oxaliplatin in combination with capecitabine as first-line treatment for advanced gastric cancer. | Oncology 20110101 |
| Intravesical therapy for urothelial carcinoma of the bladder. | Indian journal of urology : IJU : journal of the Urological Society of India 20110101 |
| Use of nucleic Acid analogs for the study of nucleic Acid interactions. | Journal of nucleic acids 20110101 |
| Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study). | BMC cancer 20110101 |
| Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20110101 |
| Cost-effectiveness of nucleoside reverse transcriptase inhibitor pairs in efavirenz-based regimens for treatment-naïve adults with HIV infection in the United States. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20110101 |
| The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1. | Molecular cancer 20110101 |
| Molecular basis for chiral selection in RNA aminoacylation. | International journal of molecular sciences 20110101 |
| Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01). | BMC cancer 20110101 |
| Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. | BMC cancer 20110101 |
| Mechanisms of resistance to decitabine in the myelodysplastic syndrome. | PloS one 20110101 |
| Effect of low-dose gemcitabine on unresectable pancreatic cancer in elderly patients. | Digestion 20110101 |
| A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial. | BMC cancer 20110101 |
| Evaluation of fluorescent analogs of deoxycytidine for monitoring DNA transitions from duplex to functional structures. | Journal of nucleic acids 20110101 |
| Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study. | Radiation oncology (London, England) 20110101 |
| [Effectiveness of neoadjuvant chemoradiotherapy of locally advanced rectal cancer in conjunction with local hyperthermia and metronidazole]. | Voprosy onkologii 20110101 |
| Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma. | BMC cancer 20110101 |
| KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line therapy. | Oncology 20110101 |
| Dermal fibrosis related to combination chemotherapy with carboplatin and gemcitabine. | European journal of dermatology : EJD 20110101 |
| Randomized phase II study of two schedules of carboplatin and gemcitabine for stage IIIB and IV advanced non-small cell lung cancer (JACCRO LC-01 study). | Chemotherapy 20110101 |
| Oxamflatin significantly improves nuclear reprogramming, blastocyst quality, and in vitro development of bovine SCNT embryos. | PloS one 20110101 |
| Sarcomatoid peritoneal malignant mesothelioma. | Internal medicine (Tokyo, Japan) 20110101 |
| Phase I dose-finding study of vandetanib in combination with gemcitabine in locally advanced unresectable or metastatic pancreatic adenocarcinoma. | Oncology 20110101 |
| Pulmonary toxicity with oxaliplatin and capecitabine/5-Fluorouracil chemotherapy: a case report and review of the literature. | Onkologie 20110101 |
| Replication protein A (RPA) hampers the processive action of APOBEC3G cytosine deaminase on single-stranded DNA. | PloS one 20110101 |
| Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patients. | Hepato-gastroenterology 20110101 |
| High resolution analysis of the chromatin landscape of the IgE switch region in human B cells. | PloS one 20110101 |
| An integrated PCR colony hybridization approach to screen cDNA libraries for full-length coding sequences. | PloS one 20110101 |
| [Peculiarities of urinary bladder cancer tumor cells apoptosis response on neoadjuvant chemotherapy]. | TSitologiia i genetika 20110101 |
| The past, present, and future of biomarkers: a need for molecular beacons for the clinical management of pancreatic cancer. | Advances in surgery 20110101 |
| Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma? | World journal of surgical oncology 20110101 |
| HuR's role in gemcitabine efficacy: an exception or opportunity? | Wiley interdisciplinary reviews. RNA 20110101 |
| Controlled adhesion and growth of long term glial and neuronal cultures on Parylene-C. | PloS one 20110101 |
| Evaluation of cardiovascular biomarkers in HIV-infected patients switching to abacavir or tenofovir based therapy. | BMC infectious diseases 20110101 |
| Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients. | Cancer genomics & proteomics 20110101 |
| Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. | PloS one 20110101 |
| TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence. | PloS one 20110101 |
| Chemoresistance of glioblastoma cancer stem cells--much more complex than expected. | Molecular cancer 20110101 |
| Doses of capecitabine and oral vinorelbine are not relevant for efficacy in breast cancer patients: an analysis of dose intensity. | Tumori 20110101 |
| Use of metronomic chemotherapy in oncology: results from a national Italian survey. | Tumori 20110101 |
| Phase II trial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer. | Tumori 20110101 |
| Some aspects of purinergic signaling in the ventricular system of porcine brain. | Acta veterinaria Scandinavica 20110101 |
| Clinical and electrocardiography changes in patients treated with capecitabine. | Chemotherapy 20110101 |
| Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention. | PloS one 20110101 |
| Aurora-A inactivation causes mitotic spindle pole fragmentation by unbalancing microtubule-generated forces. | Molecular cancer 20110101 |
| Looking to the future: biomarkers in the management of pancreatic adenocarcinoma. | International journal of molecular sciences 20110101 |
| Resistance data in the ARTEN trial. | Antiviral therapy 20110101 |
| Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials. | Oncology 20110101 |
| The relationship between treatment time of gemcitabine and development of hematologic toxicity in cancer patients. | Biological & pharmaceutical bulletin 20110101 |
| Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or abacavir-lamivudine. | PloS one 20110101 |
| Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets. | PloS one 20110101 |
| An autoimmune disease prevented by anti-retroviral drugs. | Retrovirology 20110101 |
| Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy. | BMC gastroenterology 20110101 |
| Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging. | Journal of computer assisted tomography 20110101 |
| Re: gemcitabine versus bacille Calmette-Guérin after initial bacille Calmette-Guérin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trial. | The Journal of urology 20110101 |
| [A woman with palmar and plantar hyperpigmentation]. | Nederlands tijdschrift voor geneeskunde 20110101 |
| Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck. | Head & neck oncology 20110101 |
| Can gemcitabine instillation ablate solitary low-risk non-muscle-invasive bladder cancer? Results of a phase II marker lesion study. | Urologia internationalis 20110101 |
| Successful neoadjuvant treatment with radiochemotherapy and systemic chemotherapy for the locally advanced pancreatic head cancer: report of a case. | Hepato-gastroenterology 20110101 |
| Novel strategy with gemcitabine for advanced pancreatic cancer. | ISRN oncology 20110101 |
| A multicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/capecitabine as first-line treatment for advanced breast cancer: a Gruppo Oncologico Italia Meridionale study. | Oncology 20110101 |
| Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer. | PloS one 20110101 |
| Fast track multi-discipline treatment (FTMDT trial) versus conventional treatment in colorectal cancer--the design of a prospective randomized controlled study. | BMC cancer 20110101 |
| Silencing of X-linked inhibitor of apoptosis decreases resistance to cisplatin and paclitaxel but not gemcitabine in non-small cell lung cancer. | The Journal of international medical research 20110101 |
| Human native lipoprotein-induced de novo DNA methylation is associated with repression of inflammatory genes in THP-1 macrophages. | BMC genomics 20110101 |
| Evaluation of the efficacy and safety of the combination of gemcitabine and nedaplatin for elderly patients with advanced non-small-cell lung cancer. | Oncology 20110101 |
| The association of DNA damage response and nucleotide level modulation with the antibacterial mechanism of the anti-folate drug trimethoprim. | BMC genomics 20110101 |
| Update on chemotherapy in the treatment of urothelial carcinoma. | TheScientificWorldJournal 20110101 |
| Nephrotoxicity of anticancer drugs--an underestimated problem? | Acta clinica Belgica 20110101 |
| A case of thyroid metastasis of nasopharyngeal cancer. | Tumori 20110101 |
| Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects: the progress study, 48-week results. | HIV clinical trials 20110101 |
| Video-assisted thoracoscopic surgery is more favorable than thoracotomy for administration of adjuvant chemotherapy after lobectomy for non-small cell lung cancer. | World journal of surgical oncology 20110101 |
| DNA lesion bypass polymerases and 4'-thio-β-Darabinofuranosylcytosine (T-araC). | International journal of biochemistry and molecular biology 20110101 |
| [Results of chemotherapy for gynecologic cancer patients in ambulatory care]. | Voprosy onkologii 20110101 |
| Neo-adjuvant chemo/immunotherapy in the treatment of stage III (N2) non-small cell lung cancer: a phase I/II pilot study. | International journal of immunopathology and pharmacology 20110101 |
| Phase I trial of neoadjuvant chemoradiation with gemcitabine and surgical resection for cholangiocarcinoma patients (NACRAC study). | Hepato-gastroenterology 20110101 |
| Mobile health for drug dose optimisation. | Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20110101 |
| Gemcitabine adsorbed onto carbon particles increases drug concentrations at the injection site and in the regional lymph nodes in an animal experiment and a clinical study. | The Journal of international medical research 20110101 |
| DNA methylation: a timeline of methods and applications. | Frontiers in genetics 20110101 |
| Murine leukemia viruses: objects and organisms. | Advances in virology 20110101 |
| XMRV Discovery and Prostate Cancer-Related Research. | Advances in virology 20110101 |
| Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: rationale and report of early data. | International journal of surgical oncology 20110101 |
| Mechanisms of TRAIL and gemcitabine induction of pancreatic cancer cell apoptosis. | Asian Pacific journal of cancer prevention : APJCP 20110101 |
| Increased mean corpuscular volume of erythrocytes during capecitabine treatment: a simple surrogate marker for clinical response. | Tumori 20110101 |
| Survival benefit during zoledronic acid and docetaxel-based chemotherapy in metastatic hormone-refractory prostate cancer patients: an institutional report. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101 |
| Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer: experience at Sindh Institute of Urology & Transplantation (SIUT). | JPMA. The Journal of the Pakistan Medical Association 20110101 |
| [Synergism of antitumor activity of gemcitabine and dioxadet in mice with ascitic Ehrlich's tumor]. | Voprosy onkologii 20110101 |
| HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer. | Asian Pacific journal of cancer prevention : APJCP 20110101 |
| Pancreatic cancer: chemotherapy and radiotherapy. | North American journal of medical sciences 20110101 |
| Another blue pill for sex: Preventing HIV with Truvada PrEP--already at a pharmacy near you. | Positively aware : the monthly journal of the Test Positive Aware Network 20110101 |
| Rilpivirine and complera: new first-line treatment options. | BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation 20110101 |
| Molecular targets for radiation oncology in prostate cancer. | Frontiers in oncology 20110101 |
| BOOP as a rare complication of gemcitabine therapy. | BMJ case reports 20110101 |
| Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. | The New England journal of medicine 20101230 |
| Oral preexposure prophylaxis for HIV--another arrow in the quiver? | The New England journal of medicine 20101230 |
| Structural basis for proficient incorporation of dTTP opposite O6-methylguanine by human DNA polymerase iota. | The Journal of biological chemistry 20101224 |
| [Clinical efficacy and adverse effects of taxol plus carboplatin or gemcitabine plus carboplatin in patients with advanced non-small-cell lung carcinoma]. | Zhonghua yi xue za zhi 20101221 |
| Modular polymer-caged nanobins as a theranostic platform with enhanced magnetic resonance relaxivity and pH-responsive drug release. | Angewandte Chemie (International ed. in English) 20101217 |
| Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3. | Cancer 20101215 |
| Pancreatic cancer: will incremental advances begin to make a difference? | Journal of the National Cancer Institute 20101215 |
| Activation of guanine-β-D-arabinofuranoside and deoxyguanosine to triphosphates by a common pathway blocks T lymphoblasts at different checkpoints. | Experimental cell research 20101210 |
| Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101210 |
| Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma. | Cancer letters 20101208 |
| Standard-dose tegafur combined with uracil is not safe treatment after severe toxicity from 5-fluorouracil or capecitabine. | Annals of internal medicine 20101207 |
| Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Atripla®): a review of its use in the management of HIV infection. | Drugs 20101203 |
| HIV/AIDS clinical trials. A powerful and perplexing new HIV prevention tool. | Science (New York, N.Y.) 20101203 |
| Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes. | Investigational new drugs 20101201 |
| Capecitabine-induced cerebellar toxicity in a patient with metastatic colorectal cancer. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20101201 |
| The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater. | Medical oncology (Northwood, London, England) 20101201 |
| Pharmacogenetics and pharmacoepigenetics of gemcitabine. | Medical oncology (Northwood, London, England) 20101201 |
| The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer. | Medical oncology (Northwood, London, England) 20101201 |
| Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer. | Medical oncology (Northwood, London, England) 20101201 |
| Atypical presentation of acute neurotoxicity secondary to oxaliplatin. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20101201 |
| Cost comparison of capecitabine in patients with breast cancer. | American journal of clinical oncology 20101201 |
| Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma. | Journal of cancer research and clinical oncology 20101201 |
| A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20101201 |
| Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study). | Lung cancer (Amsterdam, Netherlands) 20101201 |
| Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20101201 |
| Modular therapy approach in metastatic castration-refractory prostate cancer. | World journal of urology 20101201 |
| High-level mRNA of excision repair cross-complementation group 1 gene is associated with poor outcome of platinum-based doublet chemotherapy of advanced nonsmall cell lung cancer patients. | Cancer investigation 20101201 |
| Synthesis and transdermal permeation of novel N4-methoxypoly(ethylene glycol) carbamates of cytarabine. | Drug development and industrial pharmacy 20101201 |
| Pharmacokinetic study to optimize the intravesical administration of gemcitabine. | BJU international 20101201 |
| Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. | Biochimica et biophysica acta 20101201 |
| Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial. | Annals of surgical oncology 20101201 |
| Successful salvage chemotherapy with gemcitabine and vinorelbine in a malignant pleural mesothelioma patient previously treated with pemetrexed. | Japanese journal of clinical oncology 20101201 |
| A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. | Gastroenterology 20101201 |
| Randomized phase II study of gemcitabine plus S-1 combination therapy vs. S-1 in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG0805). | Japanese journal of clinical oncology 20101201 |
| Long-term administration of Wilms tumor-1 peptide vaccine in combination with gemcitabine causes severe local skin inflammation at injection sites. | Japanese journal of clinical oncology 20101201 |
| Weekly Paclitaxel after failure of gemcitabine in pancreatic cancer patients with malignant ascites: a retrospective study. | Japanese journal of clinical oncology 20101201 |
| Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial. | International journal of clinical oncology 20101201 |
| The addition of pravastatin to chemotherapy in advanced gastric carcinoma: a randomised phase II trial. | European journal of cancer (Oxford, England : 1990) 20101201 |
| Chemoresistance testing of human ovarian cancer cells and its in vitro model. | Toxicology in vitro : an international journal published in association with BIBRA 20101201 |
| First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial. | European journal of cancer (Oxford, England : 1990) 20101201 |
| Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101201 |
| Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study. | Gynecologic oncology 20101201 |
| The risk of HIV drug resistance following implementation of pre-exposure prophylaxis. | Current opinion in infectious diseases 20101201 |
| [Digital necrosis related to gemcitabine]. | Presse medicale (Paris, France : 1983) 20101201 |
| Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer. | Biomaterials 20101201 |
| Down-regulation of Rad51 expression overcomes drug resistance to gemcitabine in human non-small-cell lung cancer cells. | The Journal of pharmacology and experimental therapeutics 20101201 |
| A bioluminescent microbial biosensor for in vitro pretreatment assessment of cytarabine efficacy in leukemia. | Clinical chemistry 20101201 |
| Antiviral activity of 5'-O-carbonate-2',3'-dideoxy-3'-thiacytidine prodrugs against hepatitis B virus in HepG2 2.2.15 cells. | International journal of antimicrobial agents 20101201 |
| CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. | Cancer biology & therapy 20101201 |
| Optimization and evaluation of electroporation delivery of siRNA in the human leukemic CEM cell line. | Cytotechnology 20101201 |
| Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice. | Clinical and experimental immunology 20101201 |
| Efficacy and safety of bevacizumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase III BO17704 study (AVAiL). | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20101201 |
| Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma. | Pediatric blood & cancer 20101201 |
| E phage gene transfection enhances sensitivity of lung and colon cancer cells to chemotherapeutic agents. | International journal of oncology 20101201 |
| Evaluation of the effectiveness of a chemoprevention model of pancreatic adenocarcinoma using protein chip technology. | International journal of oncology 20101201 |
| Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study. | The Lancet. Oncology 20101201 |
| [Chemotherapy in gallbladder carcinoma]. | Presse medicale (Paris, France : 1983) 20101201 |
| Myelinoid bodies in a patient with membranoproliferative glomerulonephritis. | Pathology 20101201 |
| Bevacizumab-based therapy and complication risk after colonic stent placement: is it time for a warning? | Gastrointestinal endoscopy 20101201 |
| Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy. | Asia-Pacific journal of clinical oncology 20101201 |
| Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection. | Asia-Pacific journal of clinical oncology 20101201 |
| A phase II study of gemcitabine plus paclitaxel in patients with metastatic breast cancer and prior anthracycline treatment. | Asia-Pacific journal of clinical oncology 20101201 |
| One patient with metastastic colorectal cancer successfully treated by combination of targeted agents after failure of chemotherapy. | Chinese journal of cancer 20101201 |
| Comparison of the 5-fluorouracil-warfarin and capecitabine-warfarin drug interactions. | Pharmacotherapy 20101201 |
| [HER2 and gastric cancer: a novel therapeutic target for trastuzumab]. | Bulletin du cancer 20101201 |
| [Case of intrahepatic cholangiocarcinoma drained through a fistula of the duodenal bulb]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20101201 |
| ABCB1 gene polymorphisms are associated with adverse reactions in fluoropyrimidine-treated colorectal cancer patients. | Pharmacogenomics 20101201 |
| Cutaneous metastasis of pancreatic adenocarcinoma after kidney transplant: a case report and review of the literature. | Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20101201 |
| A Phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapse. | Clinical lymphoma, myeloma & leukemia 20101201 |
| [A case of capecitabine-resistant recurrent breast cancer found to be responsive to S-1]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101201 |
| Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy. | The Canadian journal of urology 20101201 |
| Efficacy of initial treatment with clevudine in naive patients with chronic hepatitis B. | The Korean journal of internal medicine 20101201 |
| Gender differences in gemcitabine (Gemzar) efficacy in cancer cells: effect of indole-3-carbinol. | Anticancer research 20101201 |
| A rapid and simple HPLC assay for quantification of capecitabine for drug monitoring purposes. | Anticancer research 20101201 |
| Avascular necrosis of the talus in a HIV-infected patient. | Foot & ankle international 20101201 |
| [Emodin enhances antitumor effect of gemcitabine in model of SW1990 cell xenograft on athymic mouse]. | Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20101201 |
| Cytosine methyltransferases as tumor markers. | Current genomics 20101201 |
| A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people. | AIDS (London, England) 20101127 |
| Trastuzumab for gastric cancer treatment. | Lancet (London, England) 20101120 |
| Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer. | Cancer 20101115 |
| Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma. | Cancer 20101115 |
| RG7128 alone or in combination with pegylated interferon-α2a and ribavirin prevents hepatitis C virus (HCV) Replication and selection of resistant variants in HCV-infected patients. | The Journal of infectious diseases 20101115 |
| Gemcitabine causes minimal modulation of carboplatin-DNA monoadduct formation and repair in bladder cancer cells. | Chemical research in toxicology 20101115 |
| Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients. | British journal of cancer 20101109 |
| Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer. | British journal of cancer 20101109 |
| Isolation and identification of ester impurities in RG7128, an HCV polymerase inhibitor. | Journal of pharmaceutical and biomedical analysis 20101102 |
| The impact of new treatment options for advanced colorectal cancer on routine care: results of a retrospective analysis of 206 consecutive patients treated in a community-based oncology group practice in Germany. | European journal of cancer care 20101101 |
| Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer. | Cancer chemotherapy and pharmacology 20101101 |
| A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer. | Cancer chemotherapy and pharmacology 20101101 |
| Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20101101 |
| Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: a phase I dose-escalation study. | Lung cancer (Amsterdam, Netherlands) 20101101 |
| Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinations. | Lung cancer (Amsterdam, Netherlands) 20101101 |
| Optimising the dose of capecitabine in metastatic breast cancer: confused, clarified or confirmed? | Annals of oncology : official journal of the European Society for Medical Oncology 20101101 |
| A ribonucleotide reductase inhibitor reverses burn-induced inflammatory defects. | Shock (Augusta, Ga.) 20101101 |
| Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism. | Annals of oncology : official journal of the European Society for Medical Oncology 20101101 |
| Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer. | Acta oncologica (Stockholm, Sweden) 20101101 |
| Trastuzumab beyond progression: a cost-utility analysis. | Annals of oncology : official journal of the European Society for Medical Oncology 20101101 |
| Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20101101 |
| Capecitabine dosing is not yet optimized for breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20101101 |
| The efficacy of the frontline platinum-based combination chemotherapy in malignant peritoneal mesothelioma. | Japanese journal of clinical oncology 20101101 |
| Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma. | Journal of gastroenterology 20101101 |
| A phase II trial evaluating weekly docetaxel and capecitabine in patients with metastatic or advanced, locally recurrent head and neck cancers. | Cancer investigation 20101101 |
| Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial. | Cancer 20101101 |
| Pharmacokinetics and bioavailability of an integrase and novel pharmacoenhancer-containing single-tablet fixed-dose combination regimen for the treatment of HIV. | Journal of acquired immune deficiency syndromes (1999) 20101101 |
| Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms. | Molecular therapy : the journal of the American Society of Gene Therapy 20101101 |
| Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study. | Breast cancer research and treatment 20101101 |
| Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer. | Cancer science 20101101 |
| Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens. | Journal of acquired immune deficiency syndromes (1999) 20101101 |
| The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions. | Journal of hepatology 20101101 |
| Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy. | Breast cancer research and treatment 20101101 |
| Overcoming platinum resistance in ovarian carcinoma. | Expert opinion on investigational drugs 20101101 |
| Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine. | Cancer biology & therapy 20101101 |
| Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group report. | Pediatric hematology and oncology 20101101 |
| {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment. | Cancer research 20101101 |
| Generation of AcGFP fusion with single-chain Fv selected from a phage display library constructed from mice hyperimmunized against 5-methyl 2'-deoxycytidine. | Protein engineering, design & selection : PEDS 20101101 |
| Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101101 |
| A phase II first-line study of gemcitabine, carboplatin, and bevacizumab in advanced stage nonsquamous non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20101101 |
| Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer. | Cancer chemotherapy and pharmacology 20101101 |
| Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101101 |
| Contribution of thymidylate synthase to gemcitabine therapy for advanced pancreatic cancer. | Pancreas 20101101 |
| Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301). | Gut 20101101 |
| Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results. | Cancer science 20101101 |
| Management of untreated and nonresponder patients with chronic hepatitis C. | Seminars in liver disease 20101101 |
| Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine. | British journal of cancer 20101101 |
| Current status of adjuvant therapy for pancreatic cancer. | The oncologist 20101101 |
| Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase. | British journal of cancer 20101101 |
| CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy. | British journal of cancer 20101101 |
| Microemulsions for intravesical delivery of gemcitabine. | Chemical & pharmaceutical bulletin 20101101 |
| Chronic anemia resistant to erythropoietin in a patient treated with gemcitabine showing a hemolytic uremic syndrome (HUS). | Gastroenterologie clinique et biologique 20101101 |
| Enhanced antitumor effect of coincident intravesical gemcitabine plus BCG therapy in an orthotopic bladder cancer model. | Urology 20101101 |
| [Prediction of gemcitabine treatment discontinuation based on platelet count before first administration]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101101 |
| [Two cases of HER2-positive advanced or metastatic breast cancer, responding to lapatinib and capecitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101101 |
| [Weekly irinotecan plus capecitabine as a second-line chemotherapy for advanced gastric cancer: an analysis of 21 cases]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20101101 |
| Granulomatous mycosis fungoides with large cell transformation misdiagnosed as leprosy. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20101101 |
| Sorafenib modulates the gene expression of multi-drug resistance mediating ATP-binding cassette proteins in experimental hepatocellular carcinoma. | Anticancer research 20101101 |
| Analysis of the cytotoxic activity of carboplatin and gemcitabine combination. | Anticancer research 20101101 |
| Additive growth inhibition after combined treatment of 2-methoxyestradiol and conventional chemotherapeutic agents in human pancreatic cancer cells. | Anticancer research 20101101 |
| A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer. | Anticancer research 20101101 |
| A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancer. | Anticancer research 20101101 |
| XELIRI or FOLFIRI as salvage therapy in advanced pancreatic cancer. | Anticancer research 20101101 |
| Semisynthesis of 6-chloropurine-2'-deoxyriboside 5'-dimethoxytrityl 3'-(2-cyanoethyl-N,N-diisopropylamino)phosphoramidite and its use in the synthesis of fluorescently labeled oligonucleotides. | Nucleosides, nucleotides & nucleic acids 20101101 |
| Update on capecitabine alone and in combination regimens in colorectal cancer patients. | Cancer treatment reviews 20101101 |
| Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer. | Chinese medical journal 20101101 |
| [Successful long-term management of hepatic and lymph nodes metastases of ureteral cancer by multimodal treatment including radiofrequency ablation]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20101101 |
| [Gemcitabine based combination chemotherapy, a new salvage regimen for recurrent platinum resistant epithelial ovarian cancer]. | Zhonghua fu chan ke za zhi 20101101 |
| [Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20101101 |
| [Application of ATP-tumor chemosensitivity assay in recurrent epithelial ovarian cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20101101 |
| [Locally advanced pancreatic cancer successfully treated by arterial infusion chemotherapy combined with stereotactic radiotherapy--a case report]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101101 |
| [Two cases of pancreatic cancer with fairly good prognosis]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101101 |
| [A 6-year survival case of locally advanced unresectable pancreatic tail cancer treated with chemo-radiation therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101101 |
| [The case of a person who let to umbilicus metastasis at a year after PD]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101101 |
| [A case of liver metastasis of pancreatic cancer that was resistant to S-1 and gemcitabine successfully treated by 5-FU and cisplatin hepatic arterial infusion]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101101 |
| [Our experiences of XELOX + bevacizumab for two cases of metastatic sigmoid colon cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101101 |
| [Evaluation of systemic chemotherapy for unresectable gallbladder carcinoma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101101 |
| [A case of unresectable advanced gallbladder cancer successfully treated by a combined administration of gemcitabine + CDDP]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101101 |
| [A long-term survival case of unresectable intrahepatic cholangiocarcinoma treated with chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101101 |
| Curing hepatitis C with pills: a step toward global control. | Lancet (London, England) 20101030 |
| Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial. | Lancet (London, England) 20101030 |
| A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients. | British journal of cancer 20101026 |
| Combination of sapacitabine and HDAC inhibitors stimulates cell death in AML and other tumour types. | British journal of cancer 20101026 |
| Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance. | AIDS (London, England) 20101023 |
| Hypoxia inducible BHLHB2 is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. | Biochemical and biophysical research communications 20101022 |
| Microwave-mediated synthesis of labeled nucleotides with utility in the synthesis of DNA probes. | Bioconjugate chemistry 20101020 |
| Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101020 |
| Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101020 |
| Phase I studies of drug combinations. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101020 |
| Phase IB study of the mTOR inhibitor ridaforolimus with capecitabine. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101020 |
| Analysis of multi-arm tumor growth trials in xenograft animals using phase change adaptive piecewise quadratic models. | Statistics in medicine 20101015 |
| Dose escalation of gemcitabine concomitant with radiation and cisplatin for nonsmall cell lung cancer: a phase 1-2 study. | Cancer 20101015 |
| Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway. | Journal of controlled release : official journal of the Controlled Release Society 20101015 |
| Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin. | Cancer research 20101015 |
| Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20101015 |
| A novel arylethynyltriazole acyclonucleoside inhibits proliferation of drug-resistant pancreatic cancer cells. | Bioorganic & medicinal chemistry letters 20101015 |
| Simultaneous determination of 8-hydroxy-2'-deoxyguanosine and 5-methyl-2'-deoxycytidine in DNA sample by high performance liquid chromatography/positive electrospray ionization tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20101015 |
| Antiretroviral therapies in women after single-dose nevirapine exposure. | The New England journal of medicine 20101014 |
| Radiosensitizing drugs: lessons to be learned from the oxaliplatin story. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010 |
| Are we ready to use an early alternative end point as the primary end point of a phase III study in rectal cancer? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010 |
| A phase I study of sunitinib plus capecitabine in patients with advanced solid tumors. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010 |
| Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010 |
| Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals. | The Cochrane database of systematic reviews 20101006 |
| Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer. | Investigational new drugs 20101001 |
| Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer. | Breast cancer (Tokyo, Japan) 20101001 |
| Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy? | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20101001 |
| Impact of prophylactic pyridoxine on occurrence of hand-foot syndrome in patients receiving capecitabine for advanced or metastatic breast cancer. | Breast cancer (Tokyo, Japan) 20101001 |
| Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer. | Journal of surgical oncology 20101001 |
| Impact of comorbidities on clinical outcomes in non-small cell lung cancer patients who are elderly and/or have poor performance status. | Critical reviews in oncology/hematology 20101001 |
| PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a central Italy population. | Molecular biology reports 20101001 |
| Is it possible to increase pCR in the neoadjuvant treatment with a dose-dense/sequential combination?: results from a phase II Trial combining epirubicin and cyclophosphamide followed by paclitaxel and gemcitabine ± trastuzumab in stage II and III breast cancer patients. | American journal of clinical oncology 20101001 |
| Ixabepilone, a new treatment option for metastatic breast cancer. | American journal of clinical oncology 20101001 |
| Increased anticoagulant activity of warfarin used in combination with doxifluridine. | Cancer chemotherapy and pharmacology 20101001 |
| Renal atrophy secondary to chemoradiotherapy of abdominal malignancies. | International journal of radiation oncology, biology, physics 20101001 |
| Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials. | International journal of radiation oncology, biology, physics 20101001 |
| Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient. | International journal of clinical oncology 20101001 |
| Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO). | Critical reviews in oncology/hematology 20101001 |
| Silencing of Tousled-like kinase 1 sensitizes cholangiocarcinoma cells to cisplatin-induced apoptosis. | Cancer letters 20101001 |
| Moderate dose capecitabine in older patients with metastatic breast cancer: a standard option for first line treatment? | Breast (Edinburgh, Scotland) 20101001 |
| 177Lu-octreotate, alone or with radiosensitising chemotherapy, is safe in neuroendocrine tumour patients previously treated with high-activity 111In-octreotide. | European journal of nuclear medicine and molecular imaging 20101001 |
| Phase I/II study of capecitabine plus oxaliplatin (XELOX) plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer. | Japanese journal of clinical oncology 20101001 |
| Impact of S-1 on the survival of patients with advanced pancreatic cancer. | Pancreas 20101001 |
| A phase I study of gemcitabine plus irinotecan for advanced NSCLC: Japan Clinical Oncology Group Trial (JCOG9904). | Japanese journal of clinical oncology 20101001 |
| Influence of cytidine deaminase on antitumor activity of 2'-deoxycytidine analogs in vitro and in vivo. | Drug metabolism and disposition: the biological fate of chemicals 20101001 |
| Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection. | Gastroenterology 20101001 |
| Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs. | Biomaterials 20101001 |
| Casein kinase 1delta activates human recombinant deoxycytidine kinase by Ser-74 phosphorylation, but is not involved in the in vivo regulation of its activity. | Archives of biochemistry and biophysics 20101001 |
| A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin. | Gynecologic oncology 20101001 |
| A phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced breast cancer. | Clinical breast cancer 20101001 |
| Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling. | International journal of radiation oncology, biology, physics 20101001 |
| Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine). | Breast cancer research and treatment 20101001 |
| Stacking interaction in the middle and at the end of a DNA helix studied with non-natural nucleotides. | Molecular bioSystems 20101001 |
| Gemcitabine plus paclitaxel versus carboplatin plus either gemcitabine or paclitaxel in advanced non-small-cell lung cancer: a literature-based meta-analysis. | Lung 20101001 |
| Inhibition of carboplatin-induced DNA interstrand cross-link repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20101001 |
| A fluorescein-containing, small-molecule, water-soluble receptor for cytosine free bases. | Bioorganic & medicinal chemistry 20101001 |
| Safety and resource utilization by non-small cell lung cancer histology: results from the randomized phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaïve patients with advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20101001 |
| Novel bladder preservation therapy for locally invasive bladder cancer: combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation. | International journal of oncology 20101001 |
| The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation. | International journal of oncology 20101001 |
| Ribonucleotide reductase subunit M1 assessed by quantitative double-fluorescence immunohistochemistry predicts the efficacy of gemcitabine in biliary tract carcinoma. | International journal of oncology 20101001 |
| A phase I study of docetaxel, oxaliplatin, & capecitabine (DOC) as first-line therapy of patients with locally advanced or metastatic adenocarcinoma of stomach and GE junction. | Cancer investigation 20101001 |
| The impact of gender and anchor drugs on TDF renal toxicity. | Journal of acquired immune deficiency syndromes (1999) 20101001 |
| Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomised phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20101001 |
| Systemic preexposure prophylaxis for human immunodeficiency virus infection. | Pharmacotherapy 20101001 |
| Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects. | Journal of chromatographic science 20101001 |
| Sonographic features of pectoralis muscle necrosis secondary to gemcitabine-induced radiation recall: case report and review of current literature. | Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 20101001 |
| Chemotherapy: Gemcitabine alone or plus cisplatin for biliary tract cancer? | Nature reviews. Clinical oncology 20101001 |
| Medical oncology: A novel low-toxicity regimen for advanced colorectal cancer? | Nature reviews. Clinical oncology 20101001 |
| Intertriginous lymphomatoid drug eruption. | International journal of dermatology 20101001 |
| Ixabepilone plus capecitabine for breast cancer patients with an early metastatic relapse after adjuvant chemotherapy: two clinical trials. | Clinical breast cancer 20101001 |
| Patients with locally advanced and metastatic colorectal cancer treated with capecitabine versus 5-fluorouracil as monotherapy or combination therapy with oxaliplatin: a cost comparison. | Clinical colorectal cancer 20101001 |
| Differences in efficacy and safety between capecitabine and infusional 5-fluorouracil when combined with irinotecan for the treatment of metastatic colorectal cancer. | Clinical colorectal cancer 20101001 |
| Specific targeting of tumor endothelial cells by a shiga-like toxin-vascular endothelial growth factor fusion protein as a novel treatment strategy for pancreatic cancer. | Neoplasia (New York, N.Y.) 20101001 |
| Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. | Neoplasia (New York, N.Y.) 20101001 |
| Tolerability, efficacy, and safety of pegylated liposomal Doxorubicin in combination with Carboplatin versus gemcitabine-Carboplatin for the treatment of platinum-sensitive recurrent ovarian cancer: a systematic review. | The oncologist 20101001 |
| [A case of hemolytic uremic syndrome after adjuvant chemotherapy with gemcitabine in a patient with pancreatic cancer]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20101001 |
| Challenges of drug resistance in the management of pancreatic cancer. | Expert review of anticancer therapy 20101001 |
| Simultaneous breast and ovarian metastasis from gallbladder carcinoma. | Hepatobiliary & pancreatic diseases international : HBPD INT 20101001 |
| [A case of malignant peritoneal mesothelioma treated effectively with cisplatin and gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101001 |
| [A long-term survivor treated with S-1 and gemcitabine for recurrence following an operation for advanced gall bladder cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20101001 |
| Methylation-mediated silencing of TMS1 in pancreatic cancer and its potential contribution to chemosensitivity. | Anticancer research 20101001 |
| Inhibition of GST-pi nuclear transfer increases mantle cell lymphoma sensitivity to cisplatin, cytarabine, gemcitabine, bortezomib and doxorubicin. | Anticancer research 20101001 |
| A retrospective analysis of non-platinum-based first- and second-line chemotherapy in patients with advanced non-small cell lung cancer. | Anticancer research 20101001 |
| Regulatory roles of tankyrase 1 at telomeres and in DNA repair: suppression of T-SCE and stabilization of DNA-PKcs. | Aging 20101001 |
| Capecitabine for the treatment of advanced gastric cancer. | Health technology assessment (Winchester, England) 20101001 |
| Gemox: a widely useful therapy against solid tumors-review and personal experience. | Journal of chemotherapy (Florence, Italy) 20101001 |
| [Effect of gemcitabine on granulocyte colony-stimulating factor receptor and bcr/abl mRNA in patients with chronic myeloid leukemia]. | Zhongguo shi yan xue ye xue za zhi 20101001 |
| Tolerability of HIV postexposure prophylaxis with tenofovir/emtricitabine and lopinavir/ritonavir tablet formulation. | AIDS (London, England) 20100924 |
| High-dose-rate intraluminal brachytherapy during preoperative chemoradiation for locally advanced rectal cancers. | World journal of gastroenterology 20100921 |
| Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100920 |
| Aberrant repair of etheno-DNA adducts in leukocytes and colon tissue of colon cancer patients. | Free radical biology & medicine 20100915 |
| Accumulation of miscoding etheno-DNA adducts and highly expressed DNA repair during liver fluke-induced cholangiocarcinogenesis in hamsters. | Mutation research 20100910 |
| Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. | JAMA 20100908 |
| Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma. | British journal of cancer 20100907 |
| Still a long wait for approved HIV-protective gel. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20100907 |
| Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer. | Medical oncology (Northwood, London, England) 20100901 |
| Role of low dose capecitabine combined to irinotecan in advanced and metastatic gastric cancer. | Medical oncology (Northwood, London, England) 20100901 |
| Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway. | Medical oncology (Northwood, London, England) 20100901 |
| Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report. | Medical oncology (Northwood, London, England) 20100901 |
| Capecitabine cardiac toxicity presenting as effort angina: a case report. | Journal of cardiovascular medicine (Hagerstown, Md.) 20100901 |
| Complications after sphincter-saving resection in rectal cancer patients according to whether chemoradiotherapy is performed before or after surgery. | International journal of radiation oncology, biology, physics 20100901 |
| Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL). | Annals of oncology : official journal of the European Society for Medical Oncology 20100901 |
| MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. | Cancer letters 20100901 |
| ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20100901 |
| Outcome of patients receiving chemotherapy for advanced biliary tract or gallbladder carcinoma. | European journal of gastroenterology & hepatology 20100901 |
| Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study. | Journal of acquired immune deficiency syndromes (1999) 20100901 |
| Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents. | Laboratory investigation; a journal of technical methods and pathology 20100901 |
| Synthesis, spectroscopic and DNA alkylating properties of malondialdehyde (MDA) bis-imine fluorescent adducts. | Molecular bioSystems 20100901 |
| Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism. | European journal of clinical pharmacology 20100901 |
| Radiation myelopathy after 36 Gy in 12 fractions palliative chest radiotherapy for squamous cell cancer of the lung: case report and review of published studies. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20100901 |
| Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma. | Human pathology 20100901 |
| Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer. | Breast cancer research and treatment 20100901 |
| Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. | Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 20100901 |
| Chemoradiotherapy with or without induction chemotherapy for locally advanced pancreatic cancer: a UK multi-institutional experience. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20100901 |
| Exploiting drug repositioning for discovery of a novel HIV combination therapy. | Journal of virology 20100901 |
| Ecotoxicity and genotoxicity assessment of cytotoxic antineoplastic drugs and their metabolites. | Chemosphere 20100901 |
| Modest reductions in dose intensity and drug-induced neutropenia have no major impact on survival of patients with non-small cell lung cancer treated with platinum-doublet chemotherapy. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100901 |
| Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20100901 |
| Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100901 |
| A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model. | Molecular cancer therapeutics 20100901 |
| Dose-finding trial of a combined regimen with bevacizumab, immunotherapy, and chemotherapy in patients with metastatic renal cell cancer: An Italian Oncology Group for Clinical Research (GOIRC) study. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20100901 |
| One year survival with poorly differentiated metastatic pancreatic carcinoma following chemoembolization with gemcitabine and cisplatin. | Oncology reports 20100901 |
| A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients. | Oncology reports 20100901 |
| Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100901 |
| Safety of capecitabine: a review. | Expert opinion on drug safety 20100901 |
| Lapatinib plus capecitabine in women with HER-2-positive advanced breast cancer: final survival analysis of a phase III randomized trial. | The oncologist 20100901 |
| HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients. | Annals of surgery 20100901 |
| A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20100901 |
| Finding the tumor copycat: approximating a human cancer. | Nature medicine 20100901 |
| Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells. | Neoplasia (New York, N.Y.) 20100901 |
| [Adverse events in patients treated with capecitabine as adjuvant chemotherapy after surgery for colorectal cancer--countermeasures against hand-foot syndrome]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100901 |
| [A case of gallbladder cancer which completely responded to gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100901 |
| [S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100901 |
| [Acute liver injury with hepatic encephalopathy associated with gemcitabine administration for adjuvant chemotherapy in an HBV carrier with pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100901 |
| [A phase II study of gemcitabine and carboplatin bi-weekly combination chemotherapy for complete resected non-small-cell lung cancer patients]. | Kyobu geka. The Japanese journal of thoracic surgery 20100901 |
| Lapatinib: clinical benefit in patients with HER 2-positive advanced breast cancer. | The Netherlands journal of medicine 20100901 |
| Sister Mary Joseph's nodule as a metastasis of ovarian adenocarcinoma. | International journal of dermatology 20100901 |
| Is pyridoxine helpful in preventing palmar-plantar erythrodysesthesia associated with capecitabine? | Asia-Pacific journal of clinical oncology 20100901 |
| Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia. | Asia-Pacific journal of clinical oncology 20100901 |
| [Second-line therapy in patients with malignant pleural mesothelioma. A French retrospective study (2005-2006)]. | Revue de pneumologie clinique 20100901 |
| [Granulocyte-colony stimulating factor producing squamous cell carcinoma of the renal pelvis: a case report]. | Hinyokika kiyo. Acta urologica Japonica 20100901 |
| [A case of leiomyosarcoma of prostate: multimodality therapy suppressed disease progression for long term]. | Hinyokika kiyo. Acta urologica Japonica 20100901 |
| Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry. | Anticancer research 20100901 |
| Modulation of gemcitabine accumulation by DNA-damaging agents: mechanisms and specificity in an in vitro model. | Anticancer research 20100901 |
| Phase II study of neoadjuvant gemcitabine, pegylated liposomal doxorubicin, and docetaxel in locally advanced breast cancer. | Anticancer research 20100901 |
| Efficacy of S-1 in patients with capecitabine-resistant breast cancer-Japan Breast Cancer Research Network (JBCRN) 04-1 trial. | Anticancer research 20100901 |
| Combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas in patients 80 years of age and over. | Anticancer research 20100901 |
| [Long-term therapy for chronic hepatitis B in HIV co-infected patients]. | Gastroenterologie clinique et biologique 20100901 |
| Combination with low-dose gemcitabine and hTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancer. | Cancer letters 20100828 |
| Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. | Lancet (London, England) 20100828 |
| Improved syntheses of 5'-S-(2-aminoethyl)-6-N-(4-nitrobenzyl)-5'-thioadenosine (SAENTA), analogues, and fluorescent probe conjugates: analysis of cell-surface human equilibrative nucleoside transporter 1 (hENT1) levels for prediction of the antitumor efficacy of gemcitabine. | Journal of medicinal chemistry 20100826 |
| Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo models. | Journal of medicinal chemistry 20100826 |
| The frequency and severity of capecitabine-induced hypertriglyceridaemia in routine clinical practice: a prospective study. | British journal of cancer 20100824 |
| Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy. | British journal of cancer 20100824 |
| Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100820 |
| Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs. | International journal of pharmaceutics 20100816 |
| Up-regulation of connexin 32 gene by 5-aza-2'-deoxycytidine enhances vinblastine-induced cytotoxicity in human renal carcinoma cells via the activation of JNK signalling. | Biochemical pharmacology 20100815 |
| Poorly differentiated endocrine carcinoma of the pancreas responded to gemcitabine: Case report. | World journal of gastroenterology 20100814 |
| The sugar ring of the nucleoside is required for productive substrate positioning in the active site of human deoxycytidine kinase (dCK): implications for the development of dCK-activated acyclic guanine analogues. | Journal of medicinal chemistry 20100812 |
| Structural and kinetic characterization of human deoxycytidine kinase variants able to phosphorylate 5-substituted deoxycytidine and thymidine analogues . | Biochemistry 20100810 |
| Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. | British journal of cancer 20100810 |
| Capecitabine with radiation is an effective adjuvant therapy in gastric cancers. | World journal of gastroenterology 20100807 |
| Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs. | Journal of aerosol medicine and pulmonary drug delivery 20100801 |
| A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer. | American journal of clinical oncology 20100801 |
| Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy. | Cancer chemotherapy and pharmacology 20100801 |
| A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer. | Cancer chemotherapy and pharmacology 20100801 |
| 18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy. | International journal of radiation oncology, biology, physics 20100801 |
| Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial. | International journal of radiation oncology, biology, physics 20100801 |
| Complete response of hepatocellular carcinoma with systemic combination chemotherapy: not to get out the chemotherapy? | European journal of gastroenterology & hepatology 20100801 |
| Capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy? | Annals of oncology : official journal of the European Society for Medical Oncology 20100801 |
| MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy. | Journal of cancer research and clinical oncology 20100801 |
| Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer? | Cancer treatment reviews 20100801 |
| Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502. | Lung cancer (Amsterdam, Netherlands) 20100801 |
| Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX. | Annals of surgical oncology 20100801 |
| Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100801 |
| Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature. | International journal of clinical oncology 20100801 |
| Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration. | Annals of surgical oncology 20100801 |
| Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer. | International journal of clinical oncology 20100801 |
| Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas. | International journal of clinical oncology 20100801 |
| Gemcitabine synergistically enhances the effect of adenovirus gene therapy through activation of the CMV promoter in pancreatic cancer cells. | Cancer gene therapy 20100801 |
| Disruption of p73-MDM2 binding synergizes with gemcitabine to induce apoptosis in HuCCT1 cholangiocarcinoma cell line with p53 mutation. | Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 20100801 |
| Radiological response in an incidental meningioma in a patient treated with chemotherapy combined with CP-751,871, an IGF-1R inhibitor. | Acta oncologica (Stockholm, Sweden) 20100801 |
| Interaction of a new anticancer prodrug, gemcitabine-squalene, with a model membrane: coupled DSC and XRD study. | Biochimica et biophysica acta 20100801 |
| A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study. | Gynecologic oncology 20100801 |
| Impact of S-1 in patients with gemcitabine-refractory pancreatic cancer in Japan. | Japanese journal of clinical oncology 20100801 |
| Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. | European journal of cancer (Oxford, England : 1990) 20100801 |
| Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment. | Cancer chemotherapy and pharmacology 20100801 |
| Deoxycytidine kinase is downregulated in Ara-C-resistant acute myeloid leukemia murine cell lines. | Leukemia 20100801 |
| Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine. | Journal of aerosol medicine and pulmonary drug delivery 20100801 |
| Therapy with azanucleosides for myelodysplastic syndromes. | Nature reviews. Clinical oncology 20100801 |
| Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium. | Leukemia & lymphoma 20100801 |
| Synthesis and anti-HCV activity of 3',4'-oxetane nucleosides. | Bioorganic & medicinal chemistry letters 20100801 |
| Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100801 |
| Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100801 |
| Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100801 |
| Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms. | Clinical pharmacokinetics 20100801 |
| Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5-fluorouracil and oral capecitabine. | Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20100801 |
| Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses. | Journal of immunology (Baltimore, Md. : 1950) 20100801 |
| Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. | Molecular cancer therapeutics 20100801 |
| No changes in efavirenz plasma concentrations in HIV-infected patients who switch from Stocrin to Atripla. | Journal of acquired immune deficiency syndromes (1999) 20100801 |
| Small interfering RNA against the apurinic or apyrimidinic endonuclease enhances the sensitivity of human pancreatic cancer cells to gemcitabine in vitro. | Journal of digestive diseases 20100801 |
| Survival analysis of pancreatic and periampullary collision cancers. | Journal of digestive diseases 20100801 |
| Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimens. | The Journal of thoracic and cardiovascular surgery 20100801 |
| Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- mice. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20100801 |
| A phase I study of Vandetanib in combination with vinorelbine/cisplatin or gemcitabine/cisplatin as first-line treatment for advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100801 |
| Gemcitabine-induced acute eosinophilic pneumonia. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100801 |
| Effects of chloride, bromide, and iodide upon decomposition of nucleosides induced by ultrasound in neutral solution. | Nucleosides, nucleotides & nucleic acids 20100801 |
| Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study. | HPB : the official journal of the International Hepato Pancreato Biliary Association 20100801 |
| Short communication: Comparable safety and efficacy with once-daily versus twice-daily dosing of lopinavir/ritonavir tablets with emtricitabine + tenofovir DF in antiretroviral-naïve, HIV type 1-infected subjects: 96 week final results of the randomized trial M05-730. | AIDS research and human retroviruses 20100801 |
| Investigation of adaptive responses in bystander cells in 3D cultures containing tritium-labeled and unlabeled normal human fibroblasts. | Radiation research 20100801 |
| Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer. | Molecular cancer therapeutics 20100801 |
| Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20100801 |
| Low dose fractionated cisplatin plus gemcitabine for elderly patients with advanced non small cell lung cancer: a retrospective analysis. | Journal of chemotherapy (Florence, Italy) 20100801 |
| Quantification of gemcitabine incorporation into human DNA by LC/MS/MS as a surrogate measure for target engagement. | Analytical chemistry 20100801 |
| Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system. | Cell cycle (Georgetown, Tex.) 20100801 |
| [A dialysis patient with advanced lung adenocarcinoma who was safely given biweekly gemcitabine therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100801 |
| [Response in a case of inoperable bile duct cancer treated by combined chemotherapy of S-1 and gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100801 |
| [An effective case of gemcitabine therapy with post-operative peritoneal recurrence of intrahepatic cholangiocarcinoma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100801 |
| [Rituximab-mediated sensitization of B-NHL cell lines to apoptosis induced by gemcitabine and Navelbine in vitro]. | Zhongguo shi yan xue ye xue za zhi 20100801 |
| Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy. | Lung cancer (Amsterdam, Netherlands) 20100801 |
| Costs of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and Germany. | Lung cancer (Amsterdam, Netherlands) 20100801 |
| Societal cost savings through bevacizumab-based treatment in non-small cell lung cancer (NSCLC). | Lung cancer (Amsterdam, Netherlands) 20100801 |
| Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20100801 |
| Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation. | Nanoscale 20100801 |
| Polar alkaloids from the Caribbean marine sponge Niphates digitalis. | Natural product communications 20100801 |
| [Oxaliplatin plus capecitabine for advanced gastric cancer: report of 38 cases]. | Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20100801 |
| [Efficacy and safety of bevacizumab plus capecitabine for metastatic colorectal cancer]. | Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20100801 |
| [Efficacy of gemcitabine combined with erlotinib in patients with advanced pancreatic cancer]. | Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20100801 |
| [Efficacy and safety of chemotherapy combined with interstitial (125)I seed implantation brachytherapy in unresectable stage IIIa/IIIb non-small cell lung cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100801 |
| Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era. | International journal of radiation oncology, biology, physics 20100715 |
| Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. | International journal of cancer 20100715 |
| [A pilot study of weekly versus 3-week docetaxel in combination with capecitabine in patients with anthracycline-pretreated metastatic breast cancer]. | Zhonghua yi xue za zhi 20100713 |
| Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100710 |
| Cisplatin plus gemcitabine for biliary tract cancer. | The New England journal of medicine 20100708 |
| Cisplatin plus gemcitabine for biliary tract cancer. | The New England journal of medicine 20100708 |
| Kinetic basis of nucleotide selection employed by a protein template-dependent DNA polymerase. | Biochemistry 20100706 |
| Combinatorial drug conjugation enables nanoparticle dual-drug delivery. | Small (Weinheim an der Bergstrasse, Germany) 20100705 |
| Capecitabine/oxaliplatin as first-line treatment for metastatic colorectal cancer: a meta-analysis. | Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20100701 |
| Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer. | Breast cancer (Tokyo, Japan) 20100701 |
| Clinical features of oral chemotherapy: results of a longitudinal prospective study of breast and colorectal cancer patients receiving capecitabine in the UK. | European journal of cancer care 20100701 |
| Effects of taxane-based chemotherapy on inhibin B and gonadotropins as biomarkers of spermatogenesis. | Fertility and sterility 20100701 |
| A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer. | Cancer chemotherapy and pharmacology 20100701 |
| Evidence linking CD44-positive cells and gemcitabine resistance in pancreatic cancer cells: need for further substantiation. | International journal of cancer 20100701 |
| Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial. | Lung cancer (Amsterdam, Netherlands) 20100701 |
| Patterns of radiotherapy practice for pancreatic cancer in Japan: results of the Japanese Radiation Oncology Study Group (JROSG) survey. | International journal of radiation oncology, biology, physics 20100701 |
| Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer. | Cancer chemotherapy and pharmacology 20100701 |
| Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer. | Cancer chemotherapy and pharmacology 20100701 |
| Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial). | Annals of oncology : official journal of the European Society for Medical Oncology 20100701 |
| Combined environmental risk assessment for 5-fluorouracil and capecitabine in Europe. | Integrated environmental assessment and management 20100701 |
| Economic evaluation of docetaxel-gemcitabine versus vinorelbine-cisplatin combination as front-line treatment of patients with advanced/metastatic non-small-cell lung cancer in Greece: a cost-minimization analysis. | Annals of oncology : official journal of the European Society for Medical Oncology 20100701 |
| Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials. | Breast cancer research and treatment 20100701 |
| Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. | Cancer letters 20100701 |
| Failure of bacille Calmette-Guérin in patients with high risk non-muscle-invasive bladder cancer unsuitable for radical cystectomy: an update of available treatment options. | BJU international 20100701 |
| Disseminated bartonellosis presenting as neuroretinitis in a young adult with human immunodeficiency virus infection. | The Pediatric infectious disease journal 20100701 |
| Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer. | Cancer chemotherapy and pharmacology 20100701 |
| First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series. | European journal of cancer (Oxford, England : 1990) 20100701 |
| Carboplatin/gemcitabine alternating with carboplatin/pegylated liposomal doxorubicin and carboplatin/cyclophosphamide in platinum-refractory/resistant paclitaxel - pretreated ovarian carcinoma. | Gynecologic oncology 20100701 |
| Staurosporine increases toxicity of gemcitabine in non-small cell lung cancer cells: role of protein kinase C, deoxycytidine kinase and ribonucleotide reductase. | Anti-cancer drugs 20100701 |
| Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy? | Current hematologic malignancy reports 20100701 |
| Bladder cancer: can we move beyond chemotherapy? | Current oncology reports 20100701 |
| Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trial. | Anti-cancer drugs 20100701 |
| Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes. | Breast cancer research and treatment 20100701 |
| CD38 expression, function, and gene resequencing in a human lymphoblastoid cell line-based model system. | Leukemia & lymphoma 20100701 |
| New drugs in neuroendocrine tumors: rising of new therapeutic philosophies? | Current opinion in oncology 20100701 |
| Adenocarcinoma of the small bowel: changes in the landscape? | Current opinion in oncology 20100701 |
| Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer. | Cancer biology & therapy 20100701 |
| Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100701 |
| Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas. | Current opinion in oncology 20100701 |
| [Adjuvant chemotherapy in older women with breast cancer. CALGB Study (The Cancer and Leukemia Group B Study)]. | Der Internist 20100701 |
| Novel PET probes specific for deoxycytidine kinase. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20100701 |
| Neoadjuvant treatment of adenocarcinomas of the gastroesophageal junction and stomach - a feasibility trial combining cisplatin and docetaxel with either 5-fluorouracil or capecitabine. | International journal of clinical pharmacology and therapeutics 20100701 |
| Plasma disposition of capecitabine (CCB) and its metabolites 5'-deoxy-5-fluorocytidine (5'-DFCR) and 5'-deoxy-5-fluorouracil (5'-DFUR) with two different capecitabine/oxaliplatin dosage regimens. | International journal of clinical pharmacology and therapeutics 20100701 |
| Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine. | Experimental biology and medicine (Maywood, N.J.) 20100701 |
| 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models. | Cancer 20100701 |
| Adjuvant chemoradiation therapy in gallbladder cancer. | Journal of surgical oncology 20100701 |
| Leveraging combinatorial chemotherapy to improve outcomes in patients with pancreatic cancer. | Cancer biology & therapy 20100701 |
| Volumetric modulated arc therapy for advanced pancreatic cancer. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20100701 |
| A Comparison of white and African American outcomes from a three-arm, randomized, phase III multicenter trial of advanced or metastatic non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100701 |
| Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro. | American journal of veterinary research 20100701 |
| Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer. | Molecular cancer therapeutics 20100701 |
| Novel therapies for pancreatic cancer: setbacks and progress. | Future oncology (London, England) 20100701 |
| Proton-pump inhibitor as palliative care for chemotherapy-induced gastroesophageal reflux disease in pancreatic cancer patients. | Journal of palliative medicine 20100701 |
| A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancer. | Clinical colorectal cancer 20100701 |
| Development of bronchiolitis obliterans organizing pneumonia with platinum-based chemotherapy for metastatic rectal cancer. | Clinical colorectal cancer 20100701 |
| Phase II study of capecitabine (Ro 09-1978) in patients who have failed first line treatment for locally advanced and/or metastatic cervical cancer. | Gan to kagaku ryoho. Cancer & chemotherapy 20100701 |
| [A case of pancreatic cancer treated by gemcitabine with sequential radiotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100701 |
| [Renal medullary carcinoma: remission with gemcitabine-cisplatin and review of therapeutic perspectives]. | Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20100701 |
| Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells. | Anticancer research 20100701 |
| Docetaxel second-line therapy in patients with advanced pancreatic cancer: a retrospective study. | Anticancer research 20100701 |
| Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy. | Anticancer research 20100701 |
| Trastuzumab plus capecitabine and docetaxel as first-line therapy for HER2-positive metastatic breast cancer: phase II results. | Anticancer research 20100701 |
| [Vertigo as a symptom of psychosocial pain]. | Wiener medizinische Wochenschrift (1946) 20100701 |
| [Primary urothelial carcinoma with sarcomatous transformation of the prostate]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20100701 |
| Assessment of pancreatic carcinoma cell chemosensitivity using a three-dimensional culture system. | Chinese medical journal 20100701 |
| Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II Consortium. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20100701 |
| [Establish a gemcitabine-resistant pancreatic cancer cell line SW1990/GZ and research the relationship between SW1990/GZ and pancreatic cancer stem cell]. | Zhonghua wai ke za zhi [Chinese journal of surgery] 20100701 |
| New trends in nucleoside biotechnology. | Acta naturae 20100701 |
| Characterization of emtricitabine related substances by liquid chromatography coupled to an ion trap mass spectrometer. | Talanta 20100630 |
| Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma. | British journal of cancer 20100629 |
| Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy. | The Cochrane database of systematic reviews 20100616 |
| Incorporation of gemcitabine and cytarabine into DNA by DNA polymerase beta and ligase III/XRCC1. | Biochemistry 20100615 |
| Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair. | Cancer research 20100615 |
| NICE rejects drug for metastatic breast cancer because of cost and poor efficacy. | BMJ (Clinical research ed.) 20100611 |
| Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment. | British journal of cancer 20100608 |
| Regarding: 'Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array'. | British journal of cancer 20100608 |
| Gemcitabine and lenalidomide combination in a patient with metastatic pancreatic cancer: a case study. | Medical oncology (Northwood, London, England) 20100601 |
| Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer. | Investigational new drugs 20100601 |
| The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20100601 |
| Capecitabine-induced pancreatitis. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20100601 |
| Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients. | Lung cancer (Amsterdam, Netherlands) 20100601 |
| A multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non-small-cell lung cancer patients with N2 nodal disease. | International journal of radiation oncology, biology, physics 20100601 |
| A phase I study of capecitabine, irinotecan, celecoxib, and radiation as neoadjuvant therapy of patients with locally advanced rectal cancer. | American journal of clinical oncology 20100601 |
| A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer. | American journal of clinical oncology 20100601 |
| A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20100601 |
| Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs). | Annals of oncology : official journal of the European Society for Medical Oncology 20100601 |
| Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer. | The pharmacogenomics journal 20100601 |
| [Digital ischemia in two patients treated with gemcitabine]. | Journal des maladies vasculaires 20100601 |
| Intravenous versus oral vinorelbine plus capecitabine as second-line treatment in advanced breast cancer patients. A retrospective comparison of two consecutive phase II studies. | Breast (Edinburgh, Scotland) 20100601 |
| Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity. | Journal of controlled release : official journal of the Controlled Release Society 20100601 |
| Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506. | Japanese journal of clinical oncology 20100601 |
| S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failure. | Japanese journal of clinical oncology 20100601 |
| Out-of-pocket payment and cost-effectiveness of XELOX and XELOX plus bevacizumab therapy: from the perspective of metastatic colorectal cancer patients in Japan. | International journal of clinical oncology 20100601 |
| Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism. | European journal of clinical pharmacology 20100601 |
| Cisplatin-gemcitabine therapy in metastatic breast cancer: Improved outcome in triple negative breast cancer patients compared to non-triple negative patients. | Breast (Edinburgh, Scotland) 20100601 |
| Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine. | Cutaneous and ocular toxicology 20100601 |
| The antiretroviral potency of emtricitabine is approximately 3-fold higher compared to lamivudine in dual human immunodeficiency virus type 1 infection/competition experiments in vitro. | Antiviral research 20100601 |
| New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals. | The Journal of antimicrobial chemotherapy 20100601 |
| Gemcitabine and epirubicin plasma concentration-related excretion in saliva in patients with non-small cell lung cancer. | Therapeutic drug monitoring 20100601 |
| Chemotherapy followed by chemoradiotherapy for locally advanced non-metastatic pancreatic cancer - a new paradigm? | Clinical oncology (Royal College of Radiologists (Great Britain)) 20100601 |
| Improved survival of left-sided pancreas cancer after surgery. | Japanese journal of clinical oncology 20100601 |
| Silencing and re-expression of retinoic acid receptor beta2 in human melanoma. | Pigment cell & melanoma research 20100601 |
| Dosing considerations for capecitabine-irinotecan regimens in the treatment of metastatic and/or locally advanced colorectal cancer. | American journal of clinical oncology 20100601 |
| ERCC1, toxicity and quality of life in advanced NSCLC patients randomized in a large multicentre phase III trial. | European journal of cancer (Oxford, England : 1990) 20100601 |
| Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC). | European journal of cancer (Oxford, England : 1990) 20100601 |
| Gemcitabine-associated large vessel vasculitis presenting as fever of unknown origin. | Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20100601 |
| Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study. | Endocrine-related cancer 20100601 |
| Phase II study of biweekly pemetrexed and gemcitabine in patients with previously untreated advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100601 |
| Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer. | Pharmaceutical research 20100601 |
| Potentiation of gemcitabine by Turmeric Force in pancreatic cancer cell lines. | Oncology reports 20100601 |
| Chemoprevention strategies for pancreatic cancer. | Nature reviews. Gastroenterology & hepatology 20100601 |
| Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20100601 |
| Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancer. | Current molecular medicine 20100601 |
| MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. | Cancer research 20100601 |
| Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma. | Journal of surgical oncology 20100601 |
| Gastrointestinal tolerability and quality of life in antiretroviral-naive HIV-1-infected patients: data from the CASTLE study. | AIDS care 20100601 |
| [Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines]. | Bulletin du cancer 20100601 |
| PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice. | The Journal of clinical investigation 20100601 |
| Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models. | Nature biotechnology 20100601 |
| A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer. | Clinical breast cancer 20100601 |
| Novel targeted therapies in inflammatory breast cancer. | Cancer 20100601 |
| Overcoming radiation resistance in inflammatory breast cancer. | Cancer 20100601 |
| Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response. | Pharmacogenomics 20100601 |
| [HIV-therapy-associated immune reconstitution syndrome presenting as immunogenic hyperthyroidism]. | Deutsche medizinische Wochenschrift (1946) 20100601 |
| Gemcitabine combined with gum mastic causes potent growth inhibition and apoptosis of pancreatic cancer cells. | Acta pharmacologica Sinica 20100601 |
| Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer. | Acta pharmacologica Sinica 20100601 |
| Two lung masses with different responses to pemetrexed. | The Korean journal of internal medicine 20100601 |
| An APCI LC-MS/MS method for routine determination of capecitabine and its metabolites in human plasma. | Journal of mass spectrometry : JMS 20100601 |
| Salirasib in the treatment of pancreatic cancer. | Future oncology (London, England) 20100601 |
| Pasteurella multocida thymidine kinase 1 efficiently activates pyrimidine nucleoside analogs. | Nucleosides, nucleotides & nucleic acids 20100601 |
| Identification and characterization of mitochondrial factors modulating thymidine kinase 2 activity. | Nucleosides, nucleotides & nucleic acids 20100601 |
| The activity of the lipophilic nucleoside derivatives elacytarabine and CP-4126 in a panel of tumor cell lines resistant to nucleoside analogues. | Nucleosides, nucleotides & nucleic acids 20100601 |
| Induction of resistance to the lipophilic cytarabine prodrug elacytarabine (CP-4055) in CEM leukemic cells. | Nucleosides, nucleotides & nucleic acids 20100601 |
| Tissue specific distribution of pyrimidine deoxynucleoside salvage enzymes shed light on the mechanism of mitochondrial DNA depletion. | Nucleosides, nucleotides & nucleic acids 20100601 |
| Influence of phosphorylation of THR-3, SER-11, and SER-15 on deoxycytidine kinase activity and stability. | Nucleosides, nucleotides & nucleic acids 20100601 |
| Methylation specific PCR to characterize methylation of the promoter of deoxycytidine kinase. | Nucleosides, nucleotides & nucleic acids 20100601 |
| Study of apoptosis induction and deoxycytidine kinase/cytidine deaminase modulation in the synergistic interaction of a novel ceramide analog and gemcitabine in pancreatic cancer cells. | Nucleosides, nucleotides & nucleic acids 20100601 |
| Localizing putative markers in genetic association studies by incorporating linkage disequilibrium into bayesian hierarchical models. | Human heredity 20100601 |
| CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy. | Asia-Pacific journal of clinical oncology 20100601 |
| Five-year survival of stage IIIA-IIIB (non-N3) non-small cell lung cancer patients after platinum/gemcitabine induction chemotherapy and surgery. | Journal of chemotherapy (Florence, Italy) 20100601 |
| [A case of Complete Response(CR)to combination therapy of S-1 and Gemcitabine(GEM)for unresectable pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100601 |
| [A case of abdominal wall metastasis from pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100601 |
| Bioequivalent formulation for the fixed-dose regimen of Truvada and TMC278 finalized. | AIDS patient care and STDs 20100601 |
| Constraint-based model of Shewanella oneidensis MR-1 metabolism: a tool for data analysis and hypothesis generation. | PLoS computational biology 20100601 |
| Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer. | British journal of pharmacology 20100601 |
| Suppression of renin-angiotensin system and cancer therapy (discussion). | Nihon rinsho. Japanese journal of clinical medicine 20100601 |
| High frequency of hand foot syndrome with capecitabine. | Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20100601 |
| Inhibition of heme oxygenase-1 enhances the cytotoxic effect of gemcitabine in urothelial cancer cells. | Anticancer research 20100601 |
| Phase I study of oral vinorelbine and capecitabine in patients with metastatic breast cancer. | Anticancer research 20100601 |
| Historical perspectives in the development of antiviral agents against poxviruses. | Viruses 20100601 |
| Metabolic Fingerprinting in Toxicological Assessment Using FT-ICR MS. | Journal of toxicologic pathology 20100601 |
| Improved plasma stability and sustained release profile of gemcitabine via polypeptide conjugation. | International journal of pharmaceutics 20100531 |
| Interaction between DNA Polymerase lambda and anticancer nucleoside analogs. | The Journal of biological chemistry 20100528 |
| Structural model for deoxycytidine deamination mechanisms of the HIV-1 inactivation enzyme APOBEC3G. | The Journal of biological chemistry 20100521 |
| Pyrrolo-dC based fluorescent aptasensors for the molecular recognition of targets. | Chemical communications (Cambridge, England) 20100521 |
| Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells. | World journal of gastroenterology 20100521 |
| Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium. | Cancer 20100515 |
| Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcome. | Clinical cancer research : an official journal of the American Association for Cancer Research 20100515 |
| Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer. | British journal of cancer 20100511 |
| Impact of cytidine deaminase polymorphisms on toxicity after gemcitabine: the question is still ongoing. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100510 |
| Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100510 |
| Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100510 |
| First case report associating gemcitabine with hypersensitivity reaction in a patient with pancreatic cancer. | JOP : Journal of the pancreas 20100505 |
| Options for the treatment of gemcitabine-resistant advanced pancreatic cancer: are we there yet? | JOP : Journal of the pancreas 20100505 |
| Electron attachment to hydrated oligonucleotide dimers: guanylyl-3',5'-cytidine and cytidylyl-3',5'-guanosine. | Chemistry (Weinheim an der Bergstrasse, Germany) 20100503 |
| [Oncological treatment of patients with pancreatic cancer]. | Ugeskrift for laeger 20100503 |
| Gemcitabine induced digital ischaemia and necrosis. | European journal of cancer care 20100501 |
| Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20100501 |
| Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: why pneumonectomy should be avoided. | Lung cancer (Amsterdam, Netherlands) 20100501 |
| Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. | International journal of radiation oncology, biology, physics 20100501 |
| Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer. | Cancer chemotherapy and pharmacology 20100501 |
| A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer. | Cancer chemotherapy and pharmacology 20100501 |
| Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancer. | Cancer chemotherapy and pharmacology 20100501 |
| Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20100501 |
| Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells. | Cancer investigation 20100501 |
| Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. | Annals of oncology : official journal of the European Society for Medical Oncology 20100501 |
| Downregulation of nuclear factor-kappaB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer. | Cancer letters 20100501 |
| Gemcitabine and carboplatin in the treatment of transitional cell carcinoma of the urothelium: a single centre experience and review of the literature. | European journal of cancer care 20100501 |
| ABC transporter gene expression in benign and malignant ovarian tissue. | Gynecologic oncology 20100501 |
| The effect of endostatin and gemcitabine combined with HIFU on the animal xenograft model of human pancreatic cancer. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20100501 |
| Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of interferon-stimulated gene 15 kd is associated with intrinsic chemoresistance. | Pancreas 20100501 |
| EMAP II-based antiangiogenic-antiendothelial in vivo combination therapy of pancreatic cancer. | Annals of surgical oncology 20100501 |
| Pancreatic cancer: progress made. | Acta oncologica (Stockholm, Sweden) 20100501 |
| An association between transient hypokalemia and severe acute oxaliplatin-related toxicity predominantly in women. | Acta oncologica (Stockholm, Sweden) 20100501 |
| Long-term AZT exposure alters the metabolic capacity of cultured human lymphoblastoid cells. | Toxicological sciences : an official journal of the Society of Toxicology 20100501 |
| Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer. | Cancer chemotherapy and pharmacology 20100501 |
| Gemcitabine-based cytotoxic doublets chemotherapy for advanced pancreatic cancer: updated subgroup meta-analyses of overall survival. | Japanese journal of clinical oncology 20100501 |
| Randomized phase II study of two different schedules of gemcitabine and oral S-1 in chemo-naïve patients with advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100501 |
| Efficacy and safety of cisplatin/pemetrexed versus cisplatin/gemcitabine as first-line treatment in East Asian patients with advanced non-small cell lung cancer: results of an exploratory subgroup analysis of a phase III trial. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100501 |
| The cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG) regimen in advanced biliary tract adenocarcinoma. | Cancer 20100501 |
| Can CDA deficiency explain tumour lysis syndrome in a child with neuroblastoma receiving gemcitabine? | Pediatric blood & cancer 20100501 |
| Phase II study of capecitabine in combination with thalidomide in patients with metastatic breast cancer. | Cancer investigation 20100501 |
| Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer. | Journal of cellular biochemistry 20100501 |
| Capecitabine and oxaliplatin as second-line treatment in patients with carcinoma of unknown primary site. | Acta oncologica (Stockholm, Sweden) 20100501 |
| Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer. | Breast cancer research and treatment 20100501 |
| Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100501 |
| Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100501 |
| Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma. | Leukemia & lymphoma 20100501 |
| Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy. | Current cancer drug targets 20100501 |
| Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? (Review). | Oncology reports 20100501 |
| Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells. | Oncology reports 20100501 |
| Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20100501 |
| Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. | Cancer research 20100501 |
| Any progress in pancreatic cancer? Well, but progress for Acta Oncologica. | Acta oncologica (Stockholm, Sweden) 20100501 |
| Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. | Acta oncologica (Stockholm, Sweden) 20100501 |
| Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study. | Acta oncologica (Stockholm, Sweden) 20100501 |
| Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. | Clinical cancer research : an official journal of the American Association for Cancer Research 20100501 |
| Clinical benefit of lapatinib-based therapy in patients with human epidermal growth factor receptor 2-positive breast tumors coexpressing the truncated p95HER2 receptor. | Clinical cancer research : an official journal of the American Association for Cancer Research 20100501 |
| Phase II study of cetuximab, docetaxel, and gemcitabine in patients with previously untreated advanced non-small-cell lung cancer. | Clinical lung cancer 20100501 |
| Haemolytic uraemic syndrome associated with gemcitabine. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20100501 |
| [A case of drug-induced interstitial pneumonitis after adjuvant chemotherapy with gemcitabine for bile duct cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100501 |
| Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer. | Health technology assessment (Winchester, England) 20100501 |
| Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix. | Health technology assessment (Winchester, England) 20100501 |
| [Difference of colon cancer and rectal cancer-from the view of an oncological physician]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100501 |
| Pancreatic cancer. | The New England journal of medicine 20100429 |
| [Protease inhibitor or non-nucleoside reverse transcriptase inhibitor. ACTG study 5202 in focus]. | MMW Fortschritte der Medizin 20100429 |
| Emerging mutations at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine. | AIDS (London, England) 20100424 |
| Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420 |
| Conventional and complementary therapies: a tale of two research standards? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420 |
| Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420 |
| Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420 |
| Gemcitabine versus bacille Calmette-Guérin after initial bacille Calmette-Guérin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trial. | Cancer 20100415 |
| Efficacy of tenofovir-emtricitabine versus abacavir-lamivudine. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100415 |
| 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. | Cancer research 20100415 |
| [Efficacy observation of accelerated hyperfractionation recourse radiotherapy plus concurrent capecitabine in the treatment of locoregional recurrent rectal cancer]. | Zhonghua yi xue za zhi 20100413 |
| Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. | The New England journal of medicine 20100408 |
| A step forward in the treatment of advanced biliary tract cancer. | The New England journal of medicine 20100408 |
| Stromal depletion goes on trial in pancreatic cancer. | Journal of the National Cancer Institute 20100407 |
| Phase II study of gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial. | Investigational new drugs 20100401 |
| Gemcitabine combined with either pemetrexed or paclitaxel in the treatment of advanced non-small cell lung cancer: a randomized phase II SICOG trial. | Lung cancer (Amsterdam, Netherlands) 20100401 |
| Feasibility study of adjuvant chemotherapy with gemcitabine and split-dose cisplatin for completely resected non-small-cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20100401 |
| Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2'-deoxyadenosine (2-CdA) and Rituximab. | Leukemia research 20100401 |
| A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma. | Biomedical chromatography : BMC 20100401 |
| A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignancies. | Cancer chemotherapy and pharmacology 20100401 |
| A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinoma. | American journal of clinical oncology 20100401 |
| A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer. | Cancer chemotherapy and pharmacology 20100401 |
| Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20100401 |
| Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer. | Journal of cancer research and clinical oncology 20100401 |
| Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. | Cancer letters 20100401 |
| Preclinical studies of apogossypolone, a novel pan inhibitor of bcl-2 and mcl-1, synergistically potentiates cytotoxic effect of gemcitabine in pancreatic cancer cells. | Pancreas 20100401 |
| Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. | Annals of oncology : official journal of the European Society for Medical Oncology 20100401 |
| Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer. | Annals of surgical oncology 20100401 |
| Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer. | Acta oncologica (Stockholm, Sweden) 20100401 |
| Survival prediction for pancreatic cancer patients receiving gemcitabine treatment. | Molecular & cellular proteomics : MCP 20100401 |
| Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study. | Anti-cancer drugs 20100401 |
| Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer. | Anti-cancer drugs 20100401 |
| Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment. | Cancer science 20100401 |
| MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil. | Cancer biology & therapy 20100401 |
| An Italian study on treatment trends and outcomes of patients with stage III pancreatic adenocarcinoma in the gemcitabine era: is it time to change? | Anti-cancer drugs 20100401 |
| Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab. | Cancer chemotherapy and pharmacology 20100401 |
| Management of borderline resectable pancreatic cancer. | Surgical oncology clinics of North America 20100401 |
| Update on adjuvant trials for pancreatic cancer. | Surgical oncology clinics of North America 20100401 |
| Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06). | The Lancet. Oncology 20100401 |
| Cetuximab and chemoradiation for rectal cancer--is the water getting muddy? | Acta oncologica (Stockholm, Sweden) 20100401 |
| Update on the hyper immunoglobulin M syndromes. | British journal of haematology 20100401 |
| Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401 |
| Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401 |
| PARP inhibition: PARP1 and beyond. | Nature reviews. Cancer 20100401 |
| Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancer. | Journal of clinical gastroenterology 20100401 |
| Phase I evaluation of telatinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20100401 |
| Toxicities of gemcitabine in patients with severe hepatic dysfunction. | The Annals of pharmacotherapy 20100401 |
| A phase II trial of pemetrexed and gemcitabine in patients with metastatic breast cancer who have received prior taxane therapy. | Clinical breast cancer 20100401 |
| Evolution of capecitabine dosing in breast cancer. | Clinical breast cancer 20100401 |
| Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer. | Cancer research 20100401 |
| Preoperative capecitabine and pelvic radiation in locally advanced rectal cancer--is it equivalent to 5-FU infusion plus leucovorin and radiotherapy? | International journal of radiation oncology, biology, physics 20100401 |
| Metronomic chemotherapy for renal cancer in the landscape of targeted therapy. | The Lancet. Oncology 20100401 |
| Adjuvant and neoadjuvant therapy in curable pancreatic cancer. | The Surgical clinics of North America 20100401 |
| Curative radiation therapy for pancreatic malignancies. | The Surgical clinics of North America 20100401 |
| Palliative chemotherapy for pancreatic malignancies. | The Surgical clinics of North America 20100401 |
| Impact of low abundance HIV variants on response to ritonavir-boosted atazanavir or fosamprenavir given once daily with tenofovir/emtricitabine in antiretroviral-naive HIV-infected patients. | AIDS research and human retroviruses 20100401 |
| Economic evaluation of capecitabine as adjuvant or metastatic therapy in colorectal cancer. | Expert review of pharmacoeconomics & outcomes research 20100401 |
| Evolution of systemic therapy for advanced pancreatic cancer. | Expert review of anticancer therapy 20100401 |
| Role of capecitabine and irinotecan combination therapy in advanced or metastatic gastric cancer. | Expert review of anticancer therapy 20100401 |
| Tenofovir/emtricitabine combination results in lower bone-mineral density. | AIDS patient care and STDs 20100401 |
| Recent advances in combined modality therapy. | The oncologist 20100401 |
| [More effective positioning of capecitabine for advanced and metastatic breast cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100401 |
| [Cost-effectiveness analysis of chemotherapy with GEM or S-1 for patients with non-resectable pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100401 |
| [An effective case of liver metastasis of breast cancer treated with capecitabine + docetaxel combination therapy using vitamin B6]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100401 |
| [Influence of gemcitabine on expression of C-myc gene and its apoptosis-inducing effect on HL-60 cells]. | Zhongguo shi yan xue ye xue za zhi 20100401 |
| [Short-term therapeutic effect and safety of endostar combined with XELIRI regimen in the treatment of advanced colorectal cancer]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20100401 |
| Cost analysis of capecitabine vs 5-fluorouracil-based treatment for metastatic colorectal cancer patients. | Journal of chemotherapy (Florence, Italy) 20100401 |
| Erlotinib in combination with capecitabine (5'dFUR) in resistant pancreatic cancer cell lines. | Journal of chemotherapy (Florence, Italy) 20100401 |
| [Gemcitabine combined with cisplatin and methylprednisolone sodium succinate in chemotherapy for relapsed or refractory T cell non-Hodgkin lymphoma]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100401 |
| Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina. | Internal medicine journal 20100401 |
| A phase I dose-escalation study of imatinib mesylate (Gleevec/STI571) plus capecitabine (Xeloda) in advanced solid tumors. | Anticancer research 20100401 |
| A neoadjuvant strategy for pancreatic adenocarcinoma increases the likelihood of receiving all components of care: lessons from a single-institution database. | HPB : the official journal of the International Hepato Pancreato Biliary Association 20100401 |
| [Experimental study of the function and mechanism combining dihydroartemisinin and gemcitabine in treating pancreatic cancer]. | Zhonghua wai ke za zhi [Chinese journal of surgery] 20100401 |
| Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication. | Virology 20100330 |
| [A meta analysis of gemcitabine plus platinum chemotherapy compared with single-agent chemotherapy in the treatment of non-small cell lung cancer]. | Zhongguo fei ai za zhi = Chinese journal of lung cancer 20100320 |
| Structural characterization of formaldehyde-induced cross-links between amino acids and deoxynucleosides and their oligomers. | Journal of the American Chemical Society 20100317 |
| Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma. | British journal of cancer 20100316 |
| Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the UK experience. | British journal of cancer 20100316 |
| Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis. | British journal of cancer 20100316 |
| DNA modifications by the omega-3 lipid peroxidation-derived mutagen 4-oxo-2-hexenal in vitro and their analysis in mouse and human DNA. | Chemical research in toxicology 20100315 |
| Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer. In regard to MG Zampino et al. (Int J Radiat Oncol Biol Phys 2009;75:421-427). | International journal of radiation oncology, biology, physics 20100315 |
| Cutaneous metastasis as first clinical manifestation of signet ring cell gastric carcinoma. | Dermatology online journal 20100315 |
| Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients. | AIDS (London, England) 20100313 |
| Electronic signatures of all four DNA nucleosides in a tunneling gap. | Nano letters 20100310 |
| Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100310 |
| Mutagenic potential of DNA glycation: miscoding by (R)- and (S)-N2-(1-carboxyethyl)-2'-deoxyguanosine. | Biochemistry 20100309 |
| Hepatic arterial infusion of gemcitabine-oxaliplatin in a large metastasis from colon cancer. | World journal of gastroenterology 20100307 |
| Deficiency in APOBEC2 leads to a shift in muscle fiber type, diminished body mass, and myopathy. | The Journal of biological chemistry 20100305 |
| Options for the treatment of gemcitabine-resistant advanced pancreatic cancer. | JOP : Journal of the pancreas 20100305 |
| Updates in adjuvant therapy in pancreatic cancer: gemcitabine and beyond. Highlights from the '2010 ASCO Gastrointestinal Cancers Symposium'. Orlando, FL, USA. January 22-24, 2010. | JOP : Journal of the pancreas 20100305 |
| Gemcitabine-induced pulmonary toxicity in a patient with pancreatic cancer. | JOP : Journal of the pancreas 20100305 |
| Pulmonary toxicity associated with gemcitabine. | JOP : Journal of the pancreas 20100305 |
| A controlled trial of initial antiviral regimens for HIV-1 infection. | The New England journal of medicine 20100304 |
| Capecitabine and oxaliplatin for advanced esophagogastric cancer. | The New England journal of medicine 20100304 |
| Coexistence Hodgkin's lymphoma and colonic adenocarcinoma: a case report. | Medical oncology (Northwood, London, England) 20100301 |
| External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a phase II study. | International journal of radiation oncology, biology, physics 20100301 |
| Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. | International journal of radiation oncology, biology, physics 20100301 |
| Structural lung damage after chemotherapy fact or fiction? | Lung cancer (Amsterdam, Netherlands) 20100301 |
| A phase II trial of induction gemcitabine and vinorelbine followed by concurrent vinorelbine and radiotherapy in locally advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20100301 |
| Carboplatin-gemcitabine in the therapy of advanced ovarian cancer: dose reduction consideration. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20100301 |
| Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer. | Cancer chemotherapy and pharmacology 20100301 |
| Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial. | Cancer chemotherapy and pharmacology 20100301 |
| Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes. | Cancer chemotherapy and pharmacology 20100301 |
| Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20100301 |
| Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer. | International journal of cancer 20100301 |
| An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20100301 |
| Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20100301 |
| A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20100301 |
| EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20100301 |
| Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20100301 |
| Evaluation of the role of three candidate human kinases in the conversion of the hepatitis C virus inhibitor 2'-C-methyl-cytidine to its 5'-monophosphate metabolite. | Antiviral research 20100301 |
| Capecitabine monotherapy is efficient and safe in all line settings in patients with metastatic and advanced breast cancer. | Japanese journal of clinical oncology 20100301 |
| Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100301 |
| The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma. | European journal of haematology 20100301 |
| A case report of gemcitabine treatment for duodenal cancer: the good (a sustained response) and the bad (life threatening refractory thrombotic thrombocytopenic purpura). | Journal of gastrointestinal cancer 20100301 |
| Functional analysis of LOXL2 in pancreatic carcinoma. | International journal of colorectal disease 20100301 |
| Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells. | Carcinogenesis 20100301 |
| Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin. | Anti-cancer drugs 20100301 |
| Defective repair of 5-hydroxy-2'-deoxycytidine in Cockayne syndrome cells and its complementation by Escherichia coli formamidopyrimidine DNA glycosylase and endonuclease III. | Free radical biology & medicine 20100301 |
| Lapatinib and metronomic capecitabine combination in an HER2-positive inflammatory breast cancer patient: a case report. | Annals of oncology : official journal of the European Society for Medical Oncology 20100301 |
| Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study. | Journal of acquired immune deficiency syndromes (1999) 20100301 |
| Structural and functional analyses of Mycobacterium tuberculosis Rv3315c-encoded metal-dependent homotetrameric cytidine deaminase. | Journal of structural biology 20100301 |
| Enhanced anticancer effect of gemcitabine by genistein in osteosarcoma: the role of Akt and nuclear factor-kappaB. | Anti-cancer drugs 20100301 |
| A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20100301 |
| Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients. | The Journal of antimicrobial chemotherapy 20100301 |
| Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trial. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20100301 |
| A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer. | European journal of cancer (Oxford, England : 1990) 20100301 |
| Transgenic cardiac-targeted overexpression of human thymidylate kinase. | Laboratory investigation; a journal of technical methods and pathology 20100301 |
| Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion. | Neuromuscular disorders : NMD 20100301 |
| Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies. | Phytomedicine : international journal of phytotherapy and phytopharmacology 20100301 |
| Safety and efficacy of single-day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience. | Expert opinion on drug safety 20100301 |
| Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. | The Lancet. Oncology 20100301 |
| Simultaneous quantification of emtricitabine and tenofovir nucleotides in peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100301 |
| DNA methylation profiles of organic anion transporting polypeptide 1B3 in cancer cell lines. | Pharmaceutical research 20100301 |
| Serum CA19-9 alterations during preoperative gemcitabine-based chemoradiation therapy for resectable invasive ductal carcinoma of the pancreas as an indicator for therapeutic selection and survival. | Annals of surgery 20100301 |
| Stability of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in combination. | AAPS PharmSciTech 20100301 |
| Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase. | Cell cycle (Georgetown, Tex.) 20100301 |
| Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20100301 |
| Meta-analysis of randomized trials: evaluation of benefit of gemcitabine-based molecular targeted therapy for inoperable pancreatic cancer. | Pancreas 20100301 |
| Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV). | Medical science monitor : international medical journal of experimental and clinical research 20100301 |
| Chemotherapy: Gemcitabine remains the standard of care for pancreatic cancer. | Nature reviews. Clinical oncology 20100301 |
| Neoadjuvant chemotherapy in MRI-staged rectal cancer. | The Lancet. Oncology 20100301 |
| [Gemcitabine therapy for unresectable pancreatic cancer in elderly patients]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20100301 |
| Chemotherapy-associated peripheral sensory neuropathy assessed using in vivo corneal confocal microscopy. | Archives of neurology 20100301 |
| Single-tablet Quad regimen achieves high rate of virologic suppression. | AIDS patient care and STDs 20100301 |
| [Severe toxicity following capecitabine administration because of dihydropyrimidine deshydrogenase (DPD) deficiency]. | Gastroenterologie clinique et biologique 20100301 |
| Increased mast cell density in capecitabine-induced hand-foot syndrome: a new pathologic finding. | Journal of drugs in dermatology : JDD 20100301 |
| Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment. | AAPS PharmSciTech 20100301 |
| [Current status of adjuvant chemotherapy for resected lung cancer at our institute--focus on clinical trial enrollment]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100301 |
| [A case of metastatic pancreatic cancer with a remarkable response to combination therapy of gemcitabine and adoptive immune cell therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100301 |
| [Preliminary study of XELOX regimen as the first-line chemotherapy in advanced or recurrent gastric cancer]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20100301 |
| [Efficacy and safety evaluation of docetaxel plus oxaliplatin and capecitabine in the treatment of advanced gastric adenocarcinoma: a single center non-controlled phase II clinical trial]. | Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20100301 |
| [Treatment possibilities in breast cancer progressing after anthracyclines and/or taxanes]. | Magyar onkologia 20100301 |
| Molecular therapy of pancreatic cancer. | Minerva endocrinologica 20100301 |
| [A case of a pulmonary pleomorphic carcinoma with fever which responded well to chemotherapy]. | Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20100301 |
| Establishment and characterization of multidrug-resistant gastric cancer cell lines. | Anticancer research 20100301 |
| Findings in humanized-mouse model suggest benefit of further studies in HIV pre-exposure prophylaxis. | Expert review of clinical immunology 20100301 |
| [Chemotherapy of colonic cancer]. | Soins; la revue de reference infirmiere 20100301 |
| Impact of biomarkers on non-small cell lung cancer treatment. | Targeted oncology 20100301 |
| FDA notifications. Updated Atripla label approved. | AIDS alert 20100301 |
| More research needed to find new HIV-suppressive functions of cytotoxic T cells. | Immunotherapy 20100301 |
| Preparation, physicochemical characterization and cytotoxicity in vitro of gemcitabine-loaded PEG-PDLLA nanovesicles. | World journal of gastroenterology 20100227 |
| Randomized phase II trial of first-line trastuzumab plus docetaxel and capecitabine compared with trastuzumab plus docetaxel in HER2-positive metastatic breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100220 |
| Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3'-deoxy-3'-fluorothymidine. | Biochemical pharmacology 20100215 |
| Pancreatic cancer presenting with paraneoplastic thrombophlebitis--case report. | Journal of medicine and life 20100215 |
| Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer. | World journal of gastroenterology 20100214 |
| Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100210 |
| Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100210 |
| Blue fluorescent deoxycytidine analogues: convergent synthesis, solid-state and electronic structure, and solvatochromism. | Organic & biomolecular chemistry 20100207 |
| Effect of N2-guanyl modifications on early steps in catalysis of polymerization by Sulfolobus solfataricus P2 DNA polymerase Dpo4 T239W. | Journal of molecular biology 20100205 |
| Specific amino acid residues are involved in substrate discrimination and template binding of human REV1 protein. | Biochemical and biophysical research communications 20100205 |
| Use of Drosophila deoxynucleoside kinase to study mechanism of toxicity and mutagenicity of deoxycytidine analogs in Escherichia coli. | DNA repair 20100204 |
| Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial. | British journal of cancer 20100202 |
| INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model. | Investigational new drugs 20100201 |
| Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: a phase II trial. | Investigational new drugs 20100201 |
| A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503. | Investigational new drugs 20100201 |
| Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer. | Cancer chemotherapy and pharmacology 20100201 |
| Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? | International journal of radiation oncology, biology, physics 20100201 |
| A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer. | Cancer chemotherapy and pharmacology 20100201 |
| A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer. | Cancer chemotherapy and pharmacology 20100201 |
| A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer. | Cancer chemotherapy and pharmacology 20100201 |
| A prospective monitoring of fatal serious adverse events (SAEs) in a Dutch Colorectal Cancer Group (DCCG) phase III trial (CAIRO) in patients with advanced colorectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20100201 |
| Feasibility and efficacy of capecitabine and FOLFIRI in patients aged 65 years and older with advanced colorectal cancer: a retrospective analysis. | Journal of cancer research and clinical oncology 20100201 |
| Modulation of human UMP/CMP kinase affects activation and cellular sensitivity of deoxycytidine analogs. | Biochemical pharmacology 20100201 |
| Advanced phase I/II studies of targeted gene delivery in vivo: intravenous Rexin-G for gemcitabine-resistant metastatic pancreatic cancer. | Molecular therapy : the journal of the American Society of Gene Therapy 20100201 |
| Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100201 |
| Induction chemotherapy followed by chemoradiation in locally advanced pancreatic cancer: an effective and well-tolerated treatment. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20100201 |
| Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging. | Molecular pharmaceutics 20100201 |
| North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20100201 |
| Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model. | International journal of colorectal disease 20100201 |
| Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma. | European journal of endocrinology 20100201 |
| Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma. | Cancer chemotherapy and pharmacology 20100201 |
| Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer. | Cancer science 20100201 |
| In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy. | Cancer investigation 20100201 |
| A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer. | European journal of cancer (Oxford, England : 1990) 20100201 |
| Resistance profile of the new nucleoside reverse transcriptase inhibitor apricitabine. | The Journal of antimicrobial chemotherapy 20100201 |
| High-resolution melting analysis of sequence variations in the cytidine deaminase gene (CDA) in patients with cancer treated with gemcitabine. | Therapeutic drug monitoring 20100201 |
| Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer. | Breast cancer research and treatment 20100201 |
| Sickle cell crisis in a patient receiving capecitabine chemotherapy. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20100201 |
| Antitumour activity of NK012, SN-38-incorporating polymeric micelles, in hypovascular orthotopic pancreatic tumour. | European journal of cancer (Oxford, England : 1990) 20100201 |
| Tranilast strongly sensitizes pancreatic cancer cells to gemcitabine via decreasing protein expression of ribonucleotide reductase 1. | International journal of oncology 20100201 |
| Is the resistance of gemcitabine for pancreatic cancer settled only by overexpression of deoxycytidine kinase? | Oncology reports 20100201 |
| Synthesis of fluorescent nucleoside analogs as probes for 2'-deoxyribonucleoside kinases. | Bioorganic & medicinal chemistry letters 20100201 |
| Fixed-dose every-other-week capecitabine and oxaliplatin for refractory squamous cell carcinoma of the head and neck. | The American journal of the medical sciences 20100201 |
| Expanded postexposure prophylaxis for simultaneous multiple source HIV exposure in a health-care worker. | International journal of STD & AIDS 20100201 |
| A fine-needle aspirate-based vulnerability assay identifies polo-like kinase 1 as a mediator of gemcitabine resistance in pancreatic cancer. | Molecular cancer therapeutics 20100201 |
| Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers. | Cancer research 20100201 |
| Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20100201 |
| Ixabepilone. | Clinical journal of oncology nursing 20100201 |
| Metastatic prostatic adenocarcinoma mimicking inflammatory breast carcinoma: a case report. | Clinical breast cancer 20100201 |
| [Correlation of deoxycytidine kinase gene expression with fludarabine resistance in patients with chronic lymphocytic leukemia]. | Zhongguo shi yan xue ye xue za zhi 20100201 |
| Ixabepilone plus capecitabine with capecitabine alone for metastatic breast cancer. | Future oncology (London, England) 20100201 |
| Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF. | AIDS patient care and STDs 20100201 |
| Recent FDA approvals and changes. | AIDS patient care and STDs 20100201 |
| Transverse leukonychia (Mees' lines) associated with docetaxel. | The Journal of dermatology 20100201 |
| Fixed-dose-rate gemcitabine: a viable first-line treatment option for advanced pancreatic and biliary tract cancer. | The oncologist 20100201 |
| [Cerebral vasculitis associated with gemcitabine]. | Der Urologe. Ausg. A 20100201 |
| Efficient syntheses of clofarabine and gemcitabine from 2-deoxyribonolactone. | Nucleosides, nucleotides & nucleic acids 20100201 |
| [Efficacy and toxicity analysis of XELOX and FOLFOX4 regimens as adjuvant chemotherapy for stage III colorectal cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100201 |
| Chemotherapy-induced reversible posterior leucoencephalopathy syndrome. | Internal medicine journal 20100201 |
| Clofarabine in leukemia. | Expert review of hematology 20100201 |
| Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction. | AIDS (London, England) 20100128 |
| Chelation-controlled regioselective alkylation of pyrimidine 2'-deoxynucleosides. | Carbohydrate research 20100126 |
| Modeling the dissociative hydrolysis of the natural DNA nucleosides. | The journal of physical chemistry. B 20100121 |
| Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status. | British journal of cancer 20100119 |
| Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID. | The Journal of experimental medicine 20100118 |
| Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. | Biochemical pharmacology 20100115 |
| A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC Clinical Trials Group. | Cancer 20100115 |
| An epigenetic mechanism for capecitabine resistance in mesothelioma. | Biochemical and biophysical research communications 20100115 |
| [An experimental study of gemcitabine inducing pancreatic cancer cell apoptosis potentiated by nuclear factor-kappa B P65 siRNA]. | Zhonghua wai ke za zhi [Chinese journal of surgery] 20100115 |
| Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance. | World journal of gastroenterology 20100114 |
| Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection. | Science translational medicine 20100113 |
| [Efficacy study of single-agent gemcitabine versus gemcitabine plus carboplatin in untreated elderly patients with stage IIIb/IV non-small-cell lung cancer]. | Zhonghua yi xue za zhi 20100112 |
| Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. | Archives of internal medicine 20100111 |
| DAART for human immunodeficiency virus-infected patients: Studying subjects not at risk for nonadherence and use of untested interventions. | Archives of internal medicine 20100111 |
| Phase I clinical and pharmacokinetic study of oral sapacitabine in patients with acute leukemia and myelodysplastic syndrome. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100110 |
| Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer. | British journal of cancer 20100105 |
| Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses. | British journal of cancer 20100105 |
| [Cardiotoxicity induced by 5-fluorouracil or capecitabine]. | Ugeskrift for laeger 20100104 |
| Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer. | Urologic oncology 20100101 |
| Capecitabine plus oxaliplatin vs fluorouracil plus oxaliplatin as first line treatment for metastatic colorectal caner - meta-analysis of six randomized trials. | Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20100101 |
| Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials. | Lung cancer (Amsterdam, Netherlands) 20100101 |
| Promising overall survival of patients with recurrent/metastatic squamous cell carcinoma of head and neck receiving gemcitabine plus cisplatin treatment: report of a multi-center phase II study. | Cancer chemotherapy and pharmacology 20100101 |
| Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials. | Cancer chemotherapy and pharmacology 20100101 |
| A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction. | Annals of oncology : official journal of the European Society for Medical Oncology 20100101 |
| Severe palmar-plantar erytrodysesthesia after treatment with capecitabine. | Journal of the European Academy of Dermatology and Venereology : JEADV 20100101 |
| A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20100101 |
| Metastatic pancreatic adenocarcinoma: current standards, future directions. | American journal of therapeutics 20100101 |
| Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer. | European radiology 20100101 |
| Cytotoxic activity of gemcitabine in cultured cell lines derived from histologically different types of bladder cancer: role of thymidine kinase 2. | Biochemical pharmacology 20100101 |
| A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines. | Journal of cancer research and clinical oncology 20100101 |
| Oral treatment of metastatic breast cancer with capecitabine: what influences the decision-making process? | European journal of cancer care 20100101 |
| Chemotherapy with paclitaxel and gemcitabine in progressive medullary and thyroid carcinoma of the follicular epithelium. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20100101 |
| Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG). | Breast cancer research and treatment 20100101 |
| Phase II trial of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) chemotherapy in patients with advanced biliary tree cancers. | Japanese journal of clinical oncology 20100101 |
| Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'. | Anti-cancer drugs 20100101 |
| A phase II study of irinotecan and capecitabine for patients with unresectable liver-only metastases from colorectal cancer. | Japanese journal of clinical oncology 20100101 |
| Prognostic Impact of [18F] FDG-PET in operable breast cancer treated with neoadjuvant chemotherapy. | Annals of surgical oncology 20100101 |
| The contribution of deleterious DPYD gene sequence variants to fluoropyrimidine toxicity in British cancer patients. | Cancer chemotherapy and pharmacology 20100101 |
| Generation of a recombinant single-chain variable fragment (scFv) targeting 5-methyl-2'-deoxycytidine. | Journal of biochemistry 20100101 |
| Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer. | Anti-cancer drugs 20100101 |
| A dose escalation study of docetaxel plus capecitabine in combination with oxaliplatin in patients with advanced solid tumors. | Acta oncologica (Stockholm, Sweden) 20100101 |
| Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study. | Acta oncologica (Stockholm, Sweden) 20100101 |
| The role of pemetrexed combined with gemcitabine for non-small-cell lung cancer. | Current drug targets 20100101 |
| Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme. | Cancer chemotherapy and pharmacology 20100101 |
| Acute aortic dissection during sorafenib-containing therapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20100101 |
| Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial. | Anti-cancer drugs 20100101 |
| Chemotherapy-associated toxicity in a large cohort of elderly patients with non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100101 |
| Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts. | Annals of oncology : official journal of the European Society for Medical Oncology 20100101 |
| Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20100101 |
| Capecitabine after gastrectomy for advanced gastric cancer: have we got the patient right? | Annals of oncology : official journal of the European Society for Medical Oncology 20100101 |
| Estimation of gas-phase acidities of deoxyribonucleosides: an experimental and theoretical study. | Journal of the American Society for Mass Spectrometry 20100101 |
| Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20100101 |
| Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20100101 |
| Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study. | The Lancet. Oncology 20100101 |
| Cytidine deaminase residual activity in serum is a predictive marker of early severe toxicities in adults after gemcitabine-based chemotherapies. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100101 |
| Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel. | International journal of oncology 20100101 |
| Novel potent inhibitors of deoxycytidine kinase identified and compared by multiple assays. | Journal of biomolecular screening 20100101 |
| Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicity. | Acta pharmacologica Sinica 20100101 |
| Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity. | Clinical cancer research : an official journal of the American Association for Cancer Research 20100101 |
| Interaction between capecitabine and brivudin in a patient with breast cancer. | Nature reviews. Clinical oncology 20100101 |
| Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabine-containing regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100101 |
| Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data. | Applied health economics and health policy 20100101 |
| [Clinical features of hypersensitivity reactions to oxaliplatin among Chinese colorectal cancer patients]. | Chinese journal of cancer 20100101 |
| The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106. | Molecular cancer therapeutics 20100101 |
| Vesicular phospholipid gels. | Methods in molecular biology (Clifton, N.J.) 20100101 |
| Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma. | Zeitschrift fur Gastroenterologie 20100101 |
| Therapeutic usefulness of postoperative adjuvant chemotherapy with Tegafur-Uracil (UFT) in patients with breast cancer: focus on the results of clinical studies in Japan. | The oncologist 20100101 |
| Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. | PloS one 20100101 |
| Memoirs of differential radiation doses: Gemcitabine induced radiation recall. | Acta oncologica (Stockholm, Sweden) 20100101 |
| Hypertriglyceridemia: An underdiagnosed side effect of Capecitabine chemotherapy. | Acta oncologica (Stockholm, Sweden) 20100101 |
| Evolution of capecitabine dosing in colorectal cancer. | Clinical colorectal cancer 20100101 |
| [Combination chemotherapy with gemcitabine and paclitaxel in a hemodialysis patient with metastatic urothelial carcinoma]. | Hinyokika kiyo. Acta urologica Japonica 20100101 |
| Two forms of activation-induced cytidine deaminase differing in their ability to bind agarose. | PloS one 20100101 |
| [Effects of gemcitabine and pemetrexed on the proliferation of pancreatic cancer cell lines BXPC-3 and PANC-1 in vitro]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20100101 |
| Z-360, a novel cholecystokinin-2/gastrin receptor antagonist, inhibits gemcitabine-induced expression of the vascular endothelial growth factor gene in human pancreatic cancer cells. | Biological & pharmaceutical bulletin 20100101 |
| A randomized controlled pilot trial of 'Feiji Recipe' on quality of life of non-small cell lung cancer patients. | The American journal of Chinese medicine 20100101 |
| Targeted therapy for biliary-tract cancer. | The Lancet. Oncology 20100101 |
| Effects of alphavbeta6 gene silencing by RNA interference in PANC-1 pancreatic carcinoma cells. | Anticancer research 20100101 |
| Phase I trial of fixed-dose rate gemcitabine in combination with bortezomib in advanced solid tumors. | Anticancer research 20100101 |
| Mechanisms of chromosomal rearrangement in the human genome. | BMC genomics 20100101 |
| On the general theory of the origins of retroviruses. | Theoretical biology & medical modelling 20100101 |
| [A case of refractory pulmonary peripheral T cell lymphoma successfully treated with Cisplatin Plus Gemcitabine Plus Solumedrol]. | Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20100101 |
| Preliminary experience of cetuximab in the treatment of advanced-stage biliary tract cancer. | Onkologie 20100101 |
| Long-lasting control of triple-negative metastatic breast cancer with the novel drug combination ixabepilone and capecitabine--case report. | Onkologie 20100101 |
| Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium Trial. | Cancer journal (Sudbury, Mass.) 20100101 |
| [Prinzmetal's angina in a patient treated with capecitabine: a case study]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20100101 |
| Neo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience. | Radiation oncology (London, England) 20100101 |
| Bacillus Calmette-Guérin versus gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study. | Urologia internationalis 20100101 |
| Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer. | Journal of experimental & clinical cancer research : CR 20100101 |
| Targeted HER2 treatment in advanced gastric cancer. | Oncology 20100101 |
| [Long-term response of liver metastases of breast cancer to capecitabine--case report]. | Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20100101 |
| Selective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468. | BMC cancer 20100101 |
| What else in gemcitabine-pretreated advanced pancreatic cancer? An update of second line therapies. | Reviews on recent clinical trials 20100101 |
| Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model. | PloS one 20100101 |
| [Expression of Gemcitabine-resistance-related gene and polymorphism of ribonucleotide reductase M1 gene promoter in Gemcitabine-resistant A549/Gem and NCI-H460/Gem cell lines]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100101 |
| Retrospective analysis of the efficacy of gemcitabine for previously treated AIDS-associated Kaposi's sarcoma in western Kenya. | Oncology 20100101 |
| Gefitinib in combination with capecitabine as second-line therapy in patients with advanced colorectal cancer (aCRC): a phase I/II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). | Onkologie 20100101 |
| RRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy. | Journal of hematology & oncology 20100101 |
| A phase II study of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer. | Hematology/oncology and stem cell therapy 20100101 |
| Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy. | Retrovirology 20100101 |
| Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract. | Urologia internationalis 20100101 |
| Abacavir/lamivudine combination in the treatment of HIV: a review. | Therapeutics and clinical risk management 20100101 |
| Gemcitabine induces the VMP1-mediated autophagy pathway to promote apoptotic death in human pancreatic cancer cells. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20100101 |
| Phase I trial of gemcitabine dose escalation with concurrent radiotherapy for patients with locally advanced pancreatic cancer. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20100101 |
| The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. | International journal of cell biology 20100101 |
| Phase II trial of XELOX as first-line treatment for patients with advanced gastric cancer. | Chemotherapy 20100101 |
| The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer. | BMC cancer 20100101 |
| Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells. | BMC cancer 20100101 |
| The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetics of ritonavir-boosted darunavir in HIV type-1-infected patients. | Antiviral therapy 20100101 |
| A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas. | Oncology 20100101 |
| [New generation chemotherapy in the treatment of operated gastric cancer--an alternative to traditional chemotherapy]. | Chirurgia (Bucharest, Romania : 1990) 20100101 |
| Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032. | Journal of translational medicine 20100101 |
| A dose escalation trial of biweekly docetaxel and gemcitabine with filgrastim or pegfilgrastim for the treatment of patients with advanced solid tumors. | Chemotherapy 20100101 |
| Study of low-dose capecitabine monotherapy for metastatic breast cancer. | Chemotherapy 20100101 |
| [Use of a fixed-dose combination of Efavirenz-Emtricitabine-Tenofovir in a tertiary hospital]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20100101 |
| Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis. | Therapeutics and clinical risk management 20100101 |
| A phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) as first-line chemotherapy in advanced gastric cancer: a Chinese single-center experience. | Chemotherapy 20100101 |
| Cancer chemotherapy and cardiovascular risks: is capecitabine-induced hypertriglyceridemia a rare adverse effect? | Cardiology 20100101 |
| [Adjuvant therapy in colon cancer]. | Onkologie 20100101 |
| [New data on pancreatic cancer]. | Onkologie 20100101 |
| Raltegravir, tenofovir, and emtricitabine in an HIV-infected patient with HCV chronic hepatitis, NNRTI intolerance and protease inhibitors-induced severe liver toxicity. | European journal of medical research 20100101 |
| Immunoglobulin E-mediated severe anaphylaxis to paclitaxel. | Journal of investigational allergology & clinical immunology 20100101 |
| Gemcitabine and treatment of diffuse large B-cell lymphoma in relapsed or refractory elderly patients: a prospective randomized trial in Algeria. | Journal of cancer research and therapeutics 20100101 |
| Capecitabine and sixth cranial nerve palsy. | Journal of cancer research and therapeutics 20100101 |
| Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia. | Molecular cancer 20100101 |
| Nucleoside drugs induce cellular differentiation by caspase-dependent degradation of stem cell factors. | PloS one 20100101 |
| Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine. | Head & neck oncology 20100101 |
| Analysis of chemiotherapeutic protocols efficiency in therapy of advanced non small cell lung cancer. | Medicinski arhiv 20100101 |
| Phase II study of pre-operative radiotherapy with capecitabine and oxaliplatin for rectal cancer and carcinoembryonic antigen as a predictor of pathological tumour response. | The Journal of international medical research 20100101 |
| Evaluation of the in vitro anti-HBV activity of clevudine in combination with other nucleoside/nucleotide inhibitors. | Antiviral therapy 20100101 |
| Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling. | Breast disease 20100101 |
| 2'-Deoxycytidine decreases the anti-tumor effects of 5-fluorouracil on mouse myeloma cells. | Biological & pharmaceutical bulletin 20100101 |
| A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer. | Oncology 20100101 |
| Strategic options on behalf of patients with metastatic colorectal cancer: mass tumor murder versus serial tumor killing. | Onkologie 20100101 |
| Oxaliplatin, irinotecan and capecitabine (OCX) for first-line treatment of advanced/metastatic colorectal cancer: a phase I trial (SAKK 41/03). | Onkologie 20100101 |
| Copy number variation and cytidine analogue cytotoxicity: a genome-wide association approach. | BMC genomics 20100101 |
| Ovarian metastasis following gallbladder carcinoma: a case report. | European journal of gynaecological oncology 20100101 |
| Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy. | Molecular cancer 20100101 |
| Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies. | Journal of translational medicine 20100101 |
| Rapid improvement in fasting lipids and hepatic toxicity after switching from didanosine/lamivudine to tenofovir/emtricitabine in patients with toxicity attributable to didanosine. | HIV clinical trials 20100101 |
| Feasibility study of docetaxel, oxaliplatin and capecitabine combination regimen in advanced gastric or gastroesophageal adenocarcinoma. | Hematology/oncology and stem cell therapy 20100101 |
| Case report of acute aortic dissection during treatment with capecitabine for a late recurrence of breast cancer. | Chemotherapy 20100101 |
| Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma. | Chemotherapy 20100101 |
| Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications. | BMC cancer 20100101 |
| Treatment of metachronous and simultaneous liver metastases of pancreatic cancer. | European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20100101 |
| Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer. | Radiation oncology (London, England) 20100101 |
| Pyrimidine deoxynucleoside and nucleoside reverse transcriptase inhibitor metabolism in the perfused heart and isolated mitochondria. | Antiviral therapy 20100101 |
| An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes. | OncoTargets and therapy 20100101 |
| Use of clofarabine for acute childhood leukemia. | Biologics : targets & therapy 20100101 |
| Rationalisation of the differences between APOBEC3G structures from crystallography and NMR studies by molecular dynamics simulations. | PloS one 20100101 |
| The interaction between AID and CIB1 is nonessential for antibody gene diversification by gene conversion or class switch recombination. | PloS one 20100101 |
| The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer. | Medicina (Kaunas, Lithuania) 20100101 |
| Gemcitabine resistance induced by interaction between alternatively spliced segment of tenascin-C and annexin A2 in pancreatic cancer cells. | Biological & pharmaceutical bulletin 20100101 |
| Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine. | Drug design, development and therapy 20100101 |
| Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation. | European journal of medical research 20100101 |
| Pharmacokinetics of once-daily etravirine without and with once-daily darunavir/ritonavir in antiretroviral-naive HIV type-1-infected adults. | Antiviral therapy 20100101 |
| Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer. | BMC cancer 20100101 |
| Synergistic cytotoxicity and molecular interaction on drug targets of sorafenib and gemcitabine in human pancreas cancer cells. | Chemotherapy 20100101 |
| Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells. | BMC cancer 20100101 |
| Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes. | Chemotherapy 20100101 |
| In vitro study on the schedule-dependency of the interaction between pemetrexed, gemcitabine and irradiation in non-small cell lung cancer and head and neck cancer cells. | BMC cancer 20100101 |
| Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins. | BMC cancer 20100101 |
| Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability. | BMC cancer 20100101 |
| [Specific features of toxicological profile of gemcitabine, an antitumour agent from the group of anti-metabolites]. | Sudebno-meditsinskaia ekspertiza 20100101 |
| The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy. | Journal of experimental therapeutics & oncology 20100101 |
| Unique DNA repair gene variations and potential associations with the primary antibody deficiency syndromes IgAD and CVID. | PloS one 20100101 |
| Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine. | PloS one 20100101 |
| Herpesvirus vectors for therapy of brain tumors. | The open virology journal 20100101 |
| Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand. | Antiviral therapy 20100101 |
| Clinical study of adjuvant capecitabine monotherapy in Chinese elderly patients (aged 55-70) with stage IIa breast cancer. | Onkologie 20100101 |
| Clinical observations on safety of fixed dose rate gemcitabine chemotherapy by intravenous infusion. | Asian Pacific journal of cancer prevention : APJCP 20100101 |
| Use of trastuzumab in HER2-positive metastatic breast cancer beyond disease progression: a systematic review of published studies. | Tumori 20100101 |
| Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma. | Tumori 20100101 |
| Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tablets. | Therapeutics and clinical risk management 20100101 |
| Epigenetic drugs can stimulate metastasis through enhanced expression of the pro-metastatic Ezrin gene. | PloS one 20100101 |
| Effect of genetic alterations of cytarabine- metabolizing enzymes in childhood acute lymphoblastic leukemia. | Hematology/oncology and stem cell therapy 20100101 |
| Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer. | Radiation oncology (London, England) 20100101 |
| Biweekly vinorelbine and gemcitabine as second-line treatment and beyond in non-small cell lung cancer. | Chemotherapy 20100101 |
| Equitoxic doses of 5-azacytidine and 5-aza-2'deoxycytidine induce diverse immediate and overlapping heritable changes in the transcriptome. | PloS one 20100101 |
| A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment. | BMC cancer 20100101 |
| Gemcitabine plus infusional 5-fluorouracil and high dose leucovorin in advanced stage pancreatic cancer. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20100101 |
| Interferon-alpha induces high expression of APOBEC3G and STAT-1 in vitro and in vivo. | International journal of molecular sciences 20100101 |
| Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis. | Neuropsychiatric disease and treatment 20100101 |
| Safety and efficacy of azacitidine in myelodysplastic syndromes. | Drug design, development and therapy 20100101 |
| Complete response in gallbladder cancer to erlotinib plus gemcitabine does not require mutation of the epidermal growth factor receptor gene: a case report. | BMC cancer 20100101 |
| Postoperative gemcitabine alone and concurrent with radiation therapy in locally advanced pancreatic carcinoma. | Tumori 20100101 |
| Treatment effect or secret nature: long-term remissions in metastatic pancreatic cancer. | Onkologie 20100101 |
| Sustained partial remission of metastatic pancreatic cancer following systemic chemotherapy with gemcitabine and oxaliplatin plus adjunctive treatment with mistletoe extract. | Onkologie 20100101 |
| The effects of forodesine in murine and human multiple myeloma cells. | Advances in hematology 20100101 |
| Gemcitabine in arterial injection chemotherapy for pancreatic cancer does not cause catheter obstruction or any other complication. | Hepato-gastroenterology 20100101 |
| Occult HBV infection in untreated HIV-infected adults in Côte d'Ivoire. | Antiviral therapy 20100101 |
| Capecitabine in breast cancer: the issue of cardiotoxicity during fluoropyrimidine treatment. | The breast journal 20100101 |
| Effects of capecitabine and celecoxib in experimental pancreatic cancer. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20100101 |
| Curcumin and gemcitabine in patients with advanced pancreatic cancer. | Nutrition and cancer 20100101 |
| [The role of membrane transporters in cellular resistance of pancreatic carcinoma to gemcitabine]. | Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20100101 |
| Treatment efficacy/safety and prognostic factors in patients with advanced biliary tract cancer receiving gemcitabine monotherapy: an analysis of 100 cases. | Oncology 20100101 |
| Complete response of brain metastases from breast cancer overexpressing Her-2/neu to radiation and concurrent Lapatinib and Capecitabine. | The breast journal 20100101 |
| Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas. | BMC cancer 20100101 |
| The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine. | Molecular cancer 20100101 |
| The Glasgow Prognostic Score is a good predictor of treatment outcome in patients with unresectable pancreatic cancer. | Chemotherapy 20100101 |
| Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy. | BMC medical genetics 20100101 |
| Gemcitabine functions epigenetically by inhibiting repair mediated DNA demethylation. | PloS one 20100101 |
| Efficacy and safety of endostar combined with chemotherapy in patients with advanced solid tumors. | Asian Pacific journal of cancer prevention : APJCP 20100101 |
| Combination of oral vinorelbine and capecitabine in the treatment of metastatic breast cancer patients previously exposed to anthracyclines: a pilot study. | Hematology/oncology and stem cell therapy 20100101 |
| Nelarabine in the treatment of refractory T-cell malignancies. | Clinical Medicine Insights. Oncology 20100101 |
| pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs. | PloS one 20100101 |
| Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma. | PloS one 20100101 |
| Epigenomics in cancer management. | Cancer management and research 20100101 |
| Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20100101 |
| Metastatic pancreatic cancer response to treatment with cetuximab and gemcitabine plus capecitabine: a case report and review of the literature. | Tumori 20100101 |
| Long-lasting response with metronomic capecitabine in advanced hepatocellular carcinoma. | Tumori 20100101 |
| Pharmacological therapy of neuroendocrine tumors. | Tumori 20100101 |
| [Neuroendocrine small-cell bladder cancer: our experience]. | Urologia 20100101 |
| Capecitabine-related intracranial hypotension syndrome mimicking dural metastasis in a breast cancer patient: case report and review of the literature. | Journal of cancer research and therapeutics 20100101 |
| Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6. | Oncology 20100101 |
| Vaccine briefs. | IAVI report : newsletter on international AIDS vaccine research 20100101 |
| Characterization of a cancer stem cell-like side population derived from human pancreatic adenocarcinoma cells. | Tumori 20100101 |
| Durable complete response of hepatocellular carcinoma after metronomic capecitabine. | Tumori 20100101 |
| An unusually large pleural mesothelioma with an outstanding clinical response and long lasting survival: a case report and literature review. | Tumori 20100101 |
| Is capecitabine efficacious in triple negative metastatic breast cancer? | Oncology 20100101 |
| The iPrEx results: lifting hopes, raising questions. | BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation 20100101 |
| Emerging therapies for treatment of multiple sclerosis. | Journal of inflammation research 20100101 |
| Towards Inhibition of Vif-APOBEC3G Interaction: Which Protein to Target? | Advances in virology 20100101 |
| Acute liver failure secondary to gemcitabine. | BMJ case reports 20100101 |
| Compliance and effective management of the hand-foot syndrome in colon cancer patients receiving capecitabine as adjuvant chemotherapy. | Yonsei medical journal 20091231 |
| Ultrashort fluorescence lifetimes of hydrogen-bonded base pairs of guanosine and cytidine in solution. | The journal of physical chemistry. B 20091224 |
| Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091220 |
| Direct binding of glyceraldehyde 3-phosphate dehydrogenase to telomeric DNA protects telomeres against chemotherapy-induced rapid degradation. | Journal of molecular biology 20091211 |
| Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy. | The New England journal of medicine 20091203 |
| Drug compendia in oncology: are they flawed? | Journal of the National Cancer Institute 20091202 |
| The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study. | Medical oncology (Northwood, London, England) 20091201 |
| Encephalopathy secondary to capecitabine chemotherapy: a case report and discussion. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20091201 |
| Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20091201 |
| Blepharoptosis following oxaliplatin administration. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20091201 |
| Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancer. | International journal of radiation oncology, biology, physics 20091201 |
| A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors. | Cancer chemotherapy and pharmacology 20091201 |
| Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies. | Cancer chemotherapy and pharmacology 20091201 |
| Neoadjuvant chemoradiation and pancreaticoduodenectomy for initially locally advanced head pancreatic adenocarcinoma. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20091201 |
| Triweekly oxaliplatin plus oral capecitabine as first-line chemotherapy in elderly patients with advanced gastric cancer. | American journal of clinical oncology 20091201 |
| Phase I study of fixed dose gemcitabine plus epirubicin in patients with advanced solid malignancies. | American journal of clinical oncology 20091201 |
| Ceramide metabolism determines glioma cell resistance to chemotherapy. | Journal of cellular physiology 20091201 |
| Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20091201 |
| Is pneumonectomy after induction chemotherapy for non-small cell lung cancer a reasonable procedure? A multicenter retrospective study of 228 cases. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20091201 |
| [Virchow's node as the form of onset of squamous cell carcinoma of the pancreas]. | Gastroenterologia y hepatologia 20091201 |
| Second-line therapy for advanced pancreatic cancer: a review of the literature and future directions. | Cancer treatment reviews 20091201 |
| Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: a French multicenter phase II study. | Gynecologic oncology 20091201 |
| Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patients. | The Journal of antimicrobial chemotherapy 20091201 |
| Phase II trial of weekly gemcitabine and split-dose cisplatin for advanced non-small-cell lung cancer. | Japanese journal of clinical oncology 20091201 |
| Irinotecan plus capecitabine as a second-line treatment after failure of 5-fluorouracil and platinum in patients with advanced gastric cancer. | Japanese journal of clinical oncology 20091201 |
| Regular dose of gemcitabine induces an increase in CD14+ monocytes and CD11c+ dendritic cells in patients with advanced pancreatic cancer. | Japanese journal of clinical oncology 20091201 |
| IR spectroscopy reveals effect of non-cytotoxic doses of anti-tumour drug on cancer cells. | Analytical and bioanalytical chemistry 20091201 |
| Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian cancer patients: results of a three-arm Phase I study. | Gynecologic oncology 20091201 |
| 5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinase. | Bioorganic & medicinal chemistry letters 20091201 |
| Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitors. | Bioorganic & medicinal chemistry letters 20091201 |
| Dynamics and energetics of the base flipping conformation studied with base pair-mimic nucleosides. | Biochemistry 20091201 |
| Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20091201 |
| Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091201 |
| Third-line chemotherapy in advanced non-small cell lung cancer: identifying the candidates for routine practice. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20091201 |
| Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials. | British journal of cancer 20091201 |
| Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer--a multi-centre randomised phase II study. | British journal of cancer 20091201 |
| Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial. | The Lancet. Oncology 20091201 |
| Current combination chemotherapy regimens for metastatic breast cancer. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20091201 |
| A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate. | Expert opinion on pharmacotherapy 20091201 |
| Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabine. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20091201 |
| Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. | Annals of surgery 20091201 |
| ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer. | Expert review of anticancer therapy 20091201 |
| Gemcitabine and vinorelbine combination in platinum-sensitive recurrent ovarian cancer. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20091201 |
| Capecitabine-induced severe hypertriglyceridaemia and diabetes: a case report and review of the literature. | Diabetic medicine : a journal of the British Diabetic Association 20091201 |
| [Analysis of factors associated with quality of life for older adult patients with non-small cell lung cancer receiving outpatient gemcitabine therapy as an alternative inpatient therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091201 |
| [Clinical evaluation of calculating carboplatin doses using modification of diet in renal disease (MDRD) estimate and adverse events]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091201 |
| The role of histology with common first-line regimens for advanced non-small cell lung cancer: a brief report of the retrospective analysis of a three-arm randomized trial. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20091201 |
| Second and third line treatment in advanced non-small cell lung cancer. | Discovery medicine 20091201 |
| Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumors. | Anticancer research 20091201 |
| Biweekly gemcitabine (GEM) in combination with erlotinib (ERL): an active and convenient regimen for advanced pancreatic cancer. | Anticancer research 20091201 |
| Weekly epirubicin as salvage therapy in patients with gemcitabine-resistant advanced pancreatic cancer. | Journal of chemotherapy (Florence, Italy) 20091201 |
| [Validation study of KRAS mutation in colorectal cancer]. | Magyar onkologia 20091201 |
| [Lapatinib treatment-option in trastuzumab-resistant breast cancer]. | Magyar onkologia 20091201 |
| [The effect of thalidomide in preventing delayed nausea and vomiting induced by GP regimen of chemotherapy for non-small cell lung cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20091201 |
| Efficiency and tolerance of aranose combinations with cisplatin and gemcitabine in experimental lung cancer. | Bulletin of experimental biology and medicine 20091201 |
| Adaptive group sequential design for phase II clinical trials: a Bayesian decision theoretic approach. | Statistics in medicine 20091130 |
| Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabine. | Journal of medicinal chemistry 20091126 |
| Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer 'unfit' for cisplatin-based chemotherapy: phase II--results of EORTC study 30986. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120 |
| Call for clarity in the reporting of benefit associated with anticancer therapies. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120 |
| Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120 |
| What does similarity mean in clinical trials? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120 |
| Changing the paradigm in conducting randomized clinical studies in advanced pancreatic cancer: an opportunity for better clinical development. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120 |
| Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120 |
| Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120 |
| Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment. | Cancer letters 20091118 |
| Characterization of covalent adducts of nucleosides and DNA formed by reaction with levuglandin. | Biochemistry 20091117 |
| A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer. | British journal of cancer 20091117 |
| Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice. | Journal of controlled release : official journal of the Controlled Release Society 20091116 |
| Differential base stacking interactions induced by trimethylene interstrand DNA cross-links in the 5'-CpG-3' and 5'-GpC-3' sequence contexts. | Chemical research in toxicology 20091116 |
| Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer. | International journal of radiation oncology, biology, physics 20091115 |
| CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells. | International journal of cancer 20091115 |
| Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20091115 |
| The art of managing human immunodeficiency virus infection: a balancing act. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20091115 |
| A case of advanced intrahepatic cholangiocarcinoma successfully treated with chemosensitivity test-guided systemic chemotherapy. | World journal of gastroenterology 20091107 |
| Freeze-drying of squalenoylated nucleoside analogue nanoparticles. | International journal of pharmaceutics 20091103 |
| Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. | International journal of radiation oncology, biology, physics 20091101 |
| Patient attitudes towards chemotherapy and survival: a prospective observational study in advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20091101 |
| Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer. | Cancer chemotherapy and pharmacology 20091101 |
| Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study. | Cancer chemotherapy and pharmacology 20091101 |
| Experimental study of combination therapy with S-1 against pancreatic cancer. | Cancer chemotherapy and pharmacology 20091101 |
| Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma. | Cancer chemotherapy and pharmacology 20091101 |
| Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. | Annals of oncology : official journal of the European Society for Medical Oncology 20091101 |
| Intermediate dose gemcitabine-cisplatin combination chemotherapy without treatment delay for cytopenia followed by autografting--a new standard of care in relapsed or refractory Hodgkin lymphoma? | Annals of hematology 20091101 |
| Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO). | Thrombosis research 20091101 |
| Combination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer. | Cancer gene therapy 20091101 |
| [Sudden blindness following combination chemotherapy with Cisplatin and Gemcitabine]. | Presse medicale (Paris, France : 1983) 20091101 |
| Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells. | Biochemical pharmacology 20091101 |
| Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma--correlation with excision repair cross-complementing-1 polymorphisms. | Annals of oncology : official journal of the European Society for Medical Oncology 20091101 |
| Pemetrexed in the treatment of advanced non-squamous lung cancer. | Lung cancer (Amsterdam, Netherlands) 20091101 |
| Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. | International journal of cancer 20091101 |
| Does stent placement for advanced colon cancer increase the risk of perforation during bevacizumab-based therapy? | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20091101 |
| Contemporary issues and the potential uses of capecitabine in metastatic breast cancer. | Cancer treatment reviews 20091101 |
| Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma. | Cancer 20091101 |
| Four cases of pancreatic acinar cell carcinoma treated with gemcitabine or S-1 as a single agent. | Japanese journal of clinical oncology 20091101 |
| Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer. | European journal of cancer (Oxford, England : 1990) 20091101 |
| Enterocolitis related to chemotherapy with gemcitabine and cisplatin in patient with transitional cell carcinoma of ureter. | European journal of cancer care 20091101 |
| OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. | Cardiovascular and interventional radiology 20091101 |
| Lysosomal ceramide mediates gemcitabine-induced death of glioma cells. | Journal of molecular medicine (Berlin, Germany) 20091101 |
| Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and Carboplatin in advanced non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091101 |
| Systemic absorption and pharmacokinetics of single-dose intravesical gemcitabine after transurethral resection of the bladder in non-muscle-invasive bladder cancer. | Urology 20091101 |
| Phase II study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic breast cancer patients after anthracycline and taxane treatment. | Japanese journal of clinical oncology 20091101 |
| On-line coupling of anion exchange and ion-pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitors. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091101 |
| Phase II trial of thalidomide, irinotecan and gemcitabine in chemonaive patients with advanced non-small cell lung cancer. | Cancer investigation 20091101 |
| Modified directly observed therapy to improve HIV treatment outcomes: little impact with potent, once-daily therapy in unselected antiretroviral-naïve patients. | Current HIV/AIDS reports 20091101 |
| Altered tissue 3'-deoxy-3'-[18F]fluorothymidine pharmacokinetics in human breast cancer following capecitabine treatment detected by positron emission tomography. | Clinical cancer research : an official journal of the American Association for Cancer Research 20091101 |
| Refractory neuroendocrine tumor-response to liposomal doxorubicin and capecitabine. | Nature reviews. Clinical oncology 20091101 |
| Lapatinib in metastatic breast cancer. | Women's health (London, England) 20091101 |
| Editorial comment. | Urology 20091101 |
| Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention. | AIDS research and human retroviruses 20091101 |
| Capecitabine in the routine treatment of advanced breast cancer: results from a non-interventional observational study in 876 [corrected] patients. | Onkologie 20091101 |
| Weekly cetuximab and gemcitabine plus cisplatin as salvage therapy for unresectable non-small cell lung cancer. | Onkologie 20091101 |
| Pharmacogenomics in acute myeloid leukemia. | Pharmacogenomics 20091101 |
| Lapatinib plus letrozole for postmenopausal patients with advanced HER2(+)/HR(+) breast cancer. | Expert review of anticancer therapy 20091101 |
| Sources of extracellular, oxidatively-modified DNA lesions: implications for their measurement in urine. | Journal of clinical biochemistry and nutrition 20091101 |
| [Efficacy of Shenyi Capsule combined with gemcitabine plus cisplatin in treatment of advanced esophageal cancer: a randomized controlled trial]. | Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20091101 |
| [A case of adenocarcinoma of the lung with a long-term therapeutic effect due to S-1 administered as the sixth regimen]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091101 |
| [Two cases of inoperable advanced bileduct cancer treated effectively with a gemcitabine/cisplatin combination]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091101 |
| Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer. | Clinical breast cancer 20091101 |
| Phase 2 trial of docetaxel, gemcitabine, and oxaliplatin combination chemotherapy in platinum- and paclitaxel-pretreated epithelial ovarian cancer. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20091101 |
| [The possibility of local control of cancer by neoadjuvant chemoradiation therapy with gemcitabine and surgical resection for advanced cholangiocarcinoma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091101 |
| [A case of postoperative multiple liver metastases of pancreatic cancer successfully treated by combination chemotherapy with weekly high-dose 5-FU hepatic arterial infusion plus systemic infusion of gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091101 |
| [A case of long-term survival for advanced gallbladder cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091101 |
| [The effectiveness of reduction surgery and gemcitabine for multiple bowel obstructions due to peritoneal dissemination of pancreatic carcinoma with liver metastasis--a case report]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091101 |
| [A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091101 |
| [A partial response to S-1 as second-line chemotherapy in a patient with unresectable pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091101 |
| [A case report of un-resectable pancreas body carcinoma successfully treated by chemoradiotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091101 |
| [A case of locally advanced pancreatic cancer with superior membrane artery invasion successfully resected after gemcitabine-based chemoradiotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091101 |
| [A case report-neoadjuvant chemoradiotherapy with combination of S-1 and gemcitabine in a patient with locally advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091101 |
| [A case of postoperative brain metastasis originated from pancreatic cancer which was successfully treated by resection and postoperative irradiation]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091101 |
| Bacterial deoxyribonucleoside kinases are poor suicide genes in mammalian cells. | Nucleosides, nucleotides & nucleic acids 20091101 |
| Lapatinib: a review of its use in the treatment of HER2-overexpressing, trastuzumab-refractory, advanced or metastatic breast cancer. | Drugs 20091022 |
| Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091020 |
| Cap-dependent translation blockade and fixed dose-rate gemcitabine: interaction in an in vitro bioreactor system. | Cancer letters 20091018 |
| [Acute renal failure and hypercalcemia in an AIDS patient on tenofovir and low-dose vitamin D therapy with immune reconstitution inflammatory syndrome]. | Medizinische Klinik (Munich, Germany : 1983) 20091015 |
| Longitudinal melanonychia induced by capecitabine. | Dermatology online journal 20091015 |
| WITHDRAWN: Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. | The Cochrane database of systematic reviews 20091007 |
| CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone. | British journal of cancer 20091006 |
| Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group. | British journal of cancer 20091006 |
| Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin. | British journal of cancer 20091006 |
| Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells. | Investigational new drugs 20091001 |
| Results of a Phase II trial of gemcitabine, mitoxantrone, and rituximab in relapsed or refractory mantle cell lymphoma. | Investigational new drugs 20091001 |
| A phase I study of an oral simulated FOLFOX with high dose capecitabine. | Investigational new drugs 20091001 |
| Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment. | Breast cancer research and treatment 20091001 |
| A phase II trial of pemetrexed and gemcitabine as first line therapy for poor performance status and/or elderly patients with stage IIIB/IV non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20091001 |
| Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer. | International journal of radiation oncology, biology, physics 20091001 |
| Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin. | Cancer chemotherapy and pharmacology 20091001 |
| Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma. | Cancer chemotherapy and pharmacology 20091001 |
| A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies. | Cancer chemotherapy and pharmacology 20091001 |
| Surgery after neoadjuvant chemotherapy for colorectal liver metastases is safe and feasible in elderly patients. | Journal of surgical oncology 20091001 |
| Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot study. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20091001 |
| In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer. | Cancer chemotherapy and pharmacology 20091001 |
| A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial. | Cancer chemotherapy and pharmacology 20091001 |
| Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer. | Breast cancer research and treatment 20091001 |
| A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20091001 |
| Treatment of disseminated paraganglioma with gemcitabine and docetaxel. | Pediatric blood & cancer 20091001 |
| Sonochemically prepared BSA microspheres containing Gemcitabine, and their potential application in renal cancer therapeutics. | Acta biomaterialia 20091001 |
| Subacute cutaneous lupus erythematosus induced by capecitabine. | Clinical and experimental dermatology 20091001 |
| SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival. | Leukemia 20091001 |
| A phase ii study of gemcitabine and capecitabine in patients with advanced renal cell cancer: Southwest Oncology Group Study S0312. | American journal of clinical oncology 20091001 |
| Characterizing DNA methylation patterns in pancreatic cancer genome. | Molecular oncology 20091001 |
| Enhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer. | Pancreas 20091001 |
| Capecitabine-induced stomatitis: a likely pathogenetic mechanism of oral lichenoid mucositis. | European journal of clinical pharmacology 20091001 |
| Serum REG4 level is a predictive biomarker for the response to preoperative chemoradiotherapy in patients with pancreatic cancer. | Pancreas 20091001 |
| Health utility scores of colorectal cancer based on societal preference in Japan. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20091001 |
| Development of HIV-1 drug resistance through 144 weeks in antiretroviral-naïve subjects on emtricitabine, tenofovir disoproxil fumarate, and efavirenz compared with lamivudine/zidovudine and efavirenz in study GS-01-934. | Journal of acquired immune deficiency syndromes (1999) 20091001 |
| Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension. | Anti-cancer drugs 20091001 |
| Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine. | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20091001 |
| Gemcitabine and pemetrexed combination: the key role of the sequence of drugs administration. | Annals of oncology : official journal of the European Society for Medical Oncology 20091001 |
| Simultaneous quantification of 2',2'-difluorodeoxycytidine and 2',2'-difluorodeoxyuridine nucleosides and nucleotides in white blood cells using porous graphitic carbon chromatography coupled with tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20091001 |
| Delta-di-carboxybutyl phosphoramidate of 2'-deoxycytidine-5'-monophosphate as substrate for DNA polymerization by HIV-1 reverse transcriptase. | Bioorganic & medicinal chemistry 20091001 |
| Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091001 |
| Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel. | Journal of pediatric hematology/oncology 20091001 |
| Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. | Pancreas 20091001 |
| Artificial neural networks for prediction of response to chemoradiation in HT29 xenografts. | International journal of radiation oncology, biology, physics 20091001 |
| Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection. | The Annals of pharmacotherapy 20091001 |
| Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols. | AJR. American journal of roentgenology 20091001 |
| Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients. | HIV medicine 20091001 |
| Chemotherapy: Adjuvant chemotherapy in older patients with breast cancer. | Nature reviews. Clinical oncology 20091001 |
| [Progress in chemotherapy for advanced gastric cancer]. | Ai zheng = Aizheng = Chinese journal of cancer 20091001 |
| Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy. | Histopathology 20091001 |
| Toxicity and efficacy of 5-fluorouracil and capecitabine in a patient with TYMS gene polymorphism: A challenge or a dilemma? | Clinical colorectal cancer 20091001 |
| HuR modulates gemcitabine efficacy: new perspectives in pancreatic cancer treatment. | Expert review of anticancer therapy 20091001 |
| Novel agents for the treatment of adenocarcinoma of the pancreas. | Expert review of anticancer therapy 20091001 |
| [Gemcitabine in combination with S-1 or UFT in patients with advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091001 |
| [A case of recurrent pancreatic cancer with lung metastasis responding to S-1 combined gemcitabine chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091001 |
| [A case of unresectable hilar bile duct cancer responding to chemo-radiotherapy by gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091001 |
| [A case of interstitial pneumonia induced by gemcitabine hydrochloride for unresectable bile duct cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091001 |
| Genetic factors influencing cytarabine therapy. | Pharmacogenomics 20091001 |
| Lapatinib for the treatment of HER2-overexpressing breast cancer. | Health technology assessment (Winchester, England) 20091001 |
| Phase I/II study of PHY906/capecitabine in advanced hepatocellular carcinoma. | Anticancer research 20091001 |
| Downsizing to resectability of a large solid and cystic papillary tumor of the pancreas by single-agent chemotherapy. | Journal of pediatric surgery 20091001 |
| Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors. | International journal of clinical oncology 20091001 |
| Successful treatment of metastatic pancreatic adenocarcinoma with combination chemotherapy regimens. | International journal of clinical oncology 20091001 |
| Low-dose gemcitabine efficacious in three patients with tumor-stage mycosis fungoides. | Clinical lymphoma & myeloma 20091001 |
| [Complementary treatment for pancreas cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091001 |
| Features of gemcitabine-related severe pulmonary toxicity: patients with pancreatic or biliary tract cancer. | Pancreas 20091001 |
| A case of unresectable gallbladder cancer responding to gemcitabine after metallic biliary stent implantation. | Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20091001 |
| FDA notifications. Generic efavirenz/emtricitabine/fenofovir has tentative approval. | AIDS alert 20091001 |
| Thymidine kinase and deoxycytidine kinase in HIV-infected children. | The new microbiologica 20091001 |
| Repetitive response to gemcitabine that led to curative resection in cholangiocarcinoma. | World journal of gastroenterology 20090928 |
| Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme. | The Journal of biological chemistry 20090925 |
| Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States. | World journal of gastroenterology 20090921 |
| A Bayesian hierarchical nonlinear model for assessing the association between genetic variation and drug cytotoxicity. | Statistics in medicine 20090920 |
| A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. | British journal of cancer 20090915 |
| Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2). | British journal of cancer 20090915 |
| [Effect of human telomerase reverse transcriptase gene antisense oligonucleotide on sensitivity of gemcitabine in pancreatic cancer cell]. | Zhonghua yi xue za zhi 20090915 |
| Acute cytotoxicity of arabinofuranosyl nucleoside analogs is not dependent on mitochondrial DNA. | Experimental cell research 20090910 |
| Different impact of excision repair cross-complementation group 1 on survival in male and female patients with inoperable non-small-cell lung cancer treated with carboplatin and gemcitabine. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090910 |
| Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial. | Lancet (London, England) 20090905 |
| An efficient and diastereoselective synthesis of PSI-6130: a clinically efficacious inhibitor of HCV NS5B polymerase. | The Journal of organic chemistry 20090904 |
| Metastatic pancreatic adenocarcinoma and renal cell carcinoma treated with gemcitabine and sunitinib malate. A case report. | JOP : Journal of the pancreas 20090904 |
| Gemcitabine-induced hepatitis in a pancreatic cancer patient receiving adjuvant therapy following metastasectomy. | JOP : Journal of the pancreas 20090904 |
| Chemotherapy in older women with breast cancer. | The New England journal of medicine 20090903 |
| Chemotherapy in older women with breast cancer. | The New England journal of medicine 20090903 |
| International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy. | Journal of the National Cancer Institute 20090902 |
| A phase II study of first-line biweekly capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer. | Critical reviews in oncology/hematology 20090901 |
| A meta-analysis of platinum plus gemcitabine or vinorelbine in the treatment of advanced non-small-cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20090901 |
| Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy. | Lung cancer (Amsterdam, Netherlands) 20090901 |
| Phase II trial of S-1 in combination with gemcitabine for chemo-naïve patients with locally advanced or metastatic pancreatic cancer. | Cancer chemotherapy and pharmacology 20090901 |
| A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancer. | Cancer chemotherapy and pharmacology 20090901 |
| Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer. | Cancer chemotherapy and pharmacology 20090901 |
| Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy. | International journal of radiation oncology, biology, physics 20090901 |
| A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03. | Hematological oncology 20090901 |
| (188)Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study. | European journal of nuclear medicine and molecular imaging 20090901 |
| Bortezomib in combination with IGEV chemotherapy regimen for a primary refractory Hodgkin's lymphoma of bone. | Leukemia research 20090901 |
| Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases. | The British journal of dermatology 20090901 |
| Capecitabine and vinorelbine in metastatic breast cancer. | European journal of cancer (Oxford, England : 1990) 20090901 |
| Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study. | European journal of cancer (Oxford, England : 1990) 20090901 |
| Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20090901 |
| Quantitative DNA-methylation in Daphnia magna and effects of multigeneration Zn exposure. | Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20090901 |
| Preliminary validation of an optimally weighted patient-based utility index by application to randomized trials in breast cancer. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090901 |
| Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. | Gastroenterology 20090901 |
| A phase I study of gemcitabine and carboplatin in patients with advanced non-small cell lung cancer and a performance status of 2. | Japanese journal of clinical oncology 20090901 |
| Gemcitabine in brief versus prolonged low-dose infusion, both combined with cisplatin, for advanced non-small cell lung cancer: a randomized phase II clinical trial. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090901 |
| DNA deaminases: AIDing hormones in immunity and cancer. | Journal of molecular medicine (Berlin, Germany) 20090901 |
| A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion. | European journal of cancer (Oxford, England : 1990) 20090901 |
| Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study. | European urology 20090901 |
| Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20090901 |
| Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report. | Journal of cardiovascular medicine (Hagerstown, Md.) 20090901 |
| Subdural collections arising from calvarial metastases following discontinuation of anti-angiogenic therapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20090901 |
| Severe drug-induced thrombocytopenia after treatment with trastuzumab but not with lapatinib. | Annals of oncology : official journal of the European Society for Medical Oncology 20090901 |
| Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090901 |
| Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090901 |
| Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090901 |
| Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival. | Expert opinion on drug safety 20090901 |
| Is there a palliative benefit of gemcitabine plus fluoropyrimidines in patients with refractory colorectal cancer? A review of the literature previously presented: poster at the 2008 Gastrointestinal Cancer Symposium (Abstract No. 512). | Expert opinion on investigational drugs 20090901 |
| Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090901 |
| Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine. | Journal of drug targeting 20090901 |
| Adjuvant chemotherapy for older adults with breast cancer: making the standard a standard. | Women's health (London, England) 20090901 |
| Brief report of biweekly pemetrexed and gemcitabine in elderly patients with non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090901 |
| Capecitabine as salvage treatment for lymphoepithelioma-like carcinoma of lung. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090901 |
| Medullary thyroid carcinoma with poor differentiation and atypical radiographic pattern of metastasis. | Pathology international 20090901 |
| The necessity of chemotherapy in T3N0M0 colon cancer without risk factors. | American journal of surgery 20090901 |
| Pharmacokinetics of gemcitabine and metabolites in a patient with double-sided nephrectomy: a case report and review of the literature. | The oncologist 20090901 |
| [Prognostic analysis of 443 cases of stage II colorectal cancer and the value of adjuvant chemotherapy]. | Ai zheng = Aizheng = Chinese journal of cancer 20090901 |
| [Clinical significance of a transient increase in carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with metastatic colorectal cancer receiving chemotherapy]. | Ai zheng = Aizheng = Chinese journal of cancer 20090901 |
| Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro. | Acta pharmacologica Sinica 20090901 |
| Cost impact of oral capecitabine compared to intravenous taxane-based chemotherapy in first-line metastatic breast cancer. | Journal of medical economics 20090901 |
| The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients. | Expert review of anti-infective therapy 20090901 |
| Approval summary: pemetrexed in the initial treatment of advanced/metastatic non-small cell lung cancer. | The oncologist 20090901 |
| [A case of stage IV breast cancer with large cancer ulcer responding to combination therapy of capecitabine and medroxyprogesterone acetate and cyclophosphamide]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090901 |
| Gemcitabine, paclitaxel, and cisplatin as combined adjuvant approach in transitional cell carcinoma of the urothelium. | Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20090901 |
| Chemotherapy, which drugs and when. | European journal of cancer (Oxford, England : 1990) 20090901 |
| Optimisation of replication-selective oncolytic adenoviral mutants in combination with chemotherapeutics. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20090901 |
| [The development of the first line treatment of metastatic colorectal cancer (mCRC)]. | Magyar onkologia 20090901 |
| Gemcitabine for the treatment of metastatic breast cancer. | Health technology assessment (Winchester, England) 20090901 |
| [The inhibition of the Sonic Hedgehog (SHh) pathway improves the effects of chemotherapy in a model of ductal carcinoma of the pancreas in mice]. | Bulletin du cancer 20090901 |
| [Efficacy and safety of TAM-sparing antiretroviral regimens in naïve HIV-positive patients]. | Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20090901 |
| [Bemusement and strategy on the efficacy of clinical application of targeted anticancer drugs]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20090901 |
| [Relationship between the level of RRM1 expression and the sensitivity to gemcitabine in the esophageal squamous cell carcinoma cell lines]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20090901 |
| Lapatinib for treatment of advanced or metastasized breast cancer: systematic review. | Sao Paulo medical journal = Revista paulista de medicina 20090901 |
| Origin of pyrimidine deoxyribonucleotide pools in perfused rat heart: implications for 3'-azido-3'-deoxythymidine-dependent cardiotoxicity. | The Biochemical journal 20090827 |
| Fishing in the (deoxyribonucleotide) pool. | The Biochemical journal 20090827 |
| Cancer and chemotherapy. | BMJ (Clinical research ed.) 20090824 |
| Metastatic colorectal cancer: is surgery necessary? | Journal of the National Cancer Institute 20090819 |
| Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. | British journal of cancer 20090818 |
| The role of apoptotic cell death in the radiosensitising effect of gemcitabine. | British journal of cancer 20090818 |
| Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2alpha overexpression. | British journal of cancer 20090818 |
| Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma. | International journal of cancer 20090815 |
| Quantification of regional DNA methylation by liquid chromatography/tandem mass spectrometry. | Analytical biochemistry 20090815 |
| Accumulation of lipid peroxidation-derived DNA lesions in iron-overloaded thalassemic mouse livers: comparison with levels in the lymphocytes of thalassemia patients. | International journal of cancer 20090815 |
| A randomized comparative trial of continued zidovudine/lamivudine or replacement with tenofovir disoproxil fumarate/emtricitabine in efavirenz-treated HIV-1-infected individuals. | Journal of acquired immune deficiency syndromes (1999) 20090815 |
| Synthesis and properties of nucleoside derivatives acylated by chemically stable 2-(trimethylsilyl)benzoyl group. | Bioorganic & medicinal chemistry 20090815 |
| Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. | Cancer research 20090815 |
| Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma. | Oncogene 20090813 |
| Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090810 |
| Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090810 |
| Hydrophilic multi-walled carbon nanotubes decorated with magnetite nanoparticles as lymphatic targeted drug delivery vehicles. | Chemical communications (Cambridge, England) 20090807 |
| Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy. | Cancer immunology, immunotherapy : CII 20090801 |
| Selective pulmonary artery perfusion for the treatment of primary lung cancer: Improved drug exposure of the lung. | Lung cancer (Amsterdam, Netherlands) 20090801 |
| A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20090801 |
| Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens. | Cancer chemotherapy and pharmacology 20090801 |
| Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial. | International journal of radiation oncology, biology, physics 20090801 |
| Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20090801 |
| Long-term results of a combination of paclitaxel, cisplatin and gemcitabine for salvage therapy in male germ-cell tumours. | BJU international 20090801 |
| Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation. | Biochimica et biophysica acta 20090801 |
| Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancer. | American journal of clinical oncology 20090801 |
| Generating genome-scale candidate gene lists for pharmacogenomics. | Clinical pharmacology and therapeutics 20090801 |
| Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenografts. | The Prostate 20090801 |
| Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20090801 |
| Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I-II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20090801 |
| A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia. | Annals of oncology : official journal of the European Society for Medical Oncology 20090801 |
| Quantification of mouse pulmonary cancer models by microcomputed tomography imaging. | Cancer science 20090801 |
| Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas: a single-center experience. | Cancer 20090801 |
| Acute rhabdomyolysis as a complication of paclitaxel-gemcitabine chemotherapy for ovarian cancer. | European journal of obstetrics, gynecology, and reproductive biology 20090801 |
| Successful antiangiogenic combination therapy for pseudomyxoma peritonei with bevacizumab and capecitabine. | Cancer biology & therapy 20090801 |
| Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20090801 |
| Chemoradioimmunotherapy in locally advanced pancreatic and biliary tree adenocarcinoma: a multicenter phase II study. | Pancreas 20090801 |
| Gefitinib in combination with gemcitabine and carboplatin in never smokers with non-small cell lung carcinoma: a retrospective analysis. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090801 |
| The usefulness of perfusion-weighted magnetic resonance imaging in advanced pancreatic cancer. | Pancreas 20090801 |
| A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer. | Cell cycle (Georgetown, Tex.) 20090801 |
| Antitumor activity of bevacizumab in combination with capecitabine and oxaliplatin in human colorectal cancer xenograft models. | Oncology reports 20090801 |
| Synergistic inhibitory effect of gemcitabine and angiotensin type-1 receptor blocker, losartan, on murine pancreatic tumor growth via anti-angiogenic activities. | Oncology reports 20090801 |
| Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics. | Pharmacogenetics and genomics 20090801 |
| An antiendothelial combination therapy strategy to increase survival in experimental pancreatic cancer. | Surgery 20090801 |
| Phase II trial of neoadjuvant therapy with carboplatin, gemcitabine plus thalidomide for stages IIB and III non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090801 |
| Is capecitabine a new choice of treatment for lung adenocarcinoma? A case report involving partial response in second line of treatment and hypothesis of the biological basis. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20090801 |
| Weekly gemcitabine and trastuzumab in the treatment of patients with HER2-overexpressing metastatic breast cancer. | Clinical breast cancer 20090801 |
| Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results. | The oncologist 20090801 |
| Preclinical and clinical aspects of carboplatin and gemcitabine combined with whole-body hyperthermia for pancreatic adenocarcinoma. | Anticancer research 20090801 |
| Combination chemotherapy of nafamostat mesilate with gemcitabine for pancreatic cancer targeting NF-kappaB activation. | Anticancer research 20090801 |
| Placement of an expandable metallic stent improves the efficacy of chemoradiotherapy for pancreatic cancer with malignant portal vein stenosis or obstruction. | Anticancer research 20090801 |
| Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: a single institution phase II study. | Anticancer research 20090801 |
| [A case of unresectable advanced pancreatic cancer treated by gemcitabine-based chemotherapy following cancer pain alleviation by low-dose matrix-type transdermal fentanyl]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090801 |
| Second complete once-daily single tablet therapy in development. | AIDS patient care and STDs 20090801 |
| Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer. | Journal of the National Medical Association 20090801 |
| Gemcitabine: new indication. Relapsed ovarian cancer: simply more toxic. Increases haematologic toxicity but not overall survival. | Prescrire international 20090801 |
| Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment. | AIDS (London, England) 20090731 |
| Ixabepilone: in locally advanced or metastatic breast cancer. | Drugs 20090730 |
| Structure of the human Rev1-DNA-dNTP ternary complex. | Journal of molecular biology 20090724 |
| Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array. | British journal of cancer 20090721 |
| All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial. | British journal of cancer 20090721 |
| Curative surgical treatment after preoperative chemotherapy for primarily inoperable locally advanced pancreatic carcinoma: report of a case. | The Tokai journal of experimental and clinical medicine 20090720 |
| Development of a sensitive and selective LC-MS/MS method for simultaneous determination of gemcitabine and 2,2-difluoro-2-deoxyuridine in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090715 |
| Mice heterozygous for germ-line mutations in methylthioadenosine phosphorylase (MTAP) die prematurely of T-cell lymphoma. | Cancer research 20090715 |
| Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. | Cancer research 20090715 |
| Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. | Cancer research 20090715 |
| Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial. | Archives of internal medicine 20090713 |
| Cost-effectiveness analysis of XELOX for metastatic colorectal cancer based on the NO16966 and NO16967 trials. | British journal of cancer 20090707 |
| Pharmacogenetics in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009. | JOP : Journal of the pancreas 20090706 |
| Any progress in the management of advanced pancreatic cancer? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009. | JOP : Journal of the pancreas 20090706 |
| Adjuvant treatment of pancreatic cancer in 2009: where are we? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009. | JOP : Journal of the pancreas 20090706 |
| Sirolimus can reverse resistance to gemcitabine, capecitabine and docetaxel combination therapy in pancreatic cancer. | JOP : Journal of the pancreas 20090706 |
| Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial. | Breast cancer research and treatment 20090701 |
| Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study. | Cancer chemotherapy and pharmacology 20090701 |
| Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes. | Cancer chemotherapy and pharmacology 20090701 |
| Fixed-dose rate infusion of gemcitabine and weekly cisplatin in elderly or poor performance status patients with unresectable non-small cell lung cancer. | Cancer chemotherapy and pharmacology 20090701 |
| A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma. | Cancer chemotherapy and pharmacology 20090701 |
| A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer. | Cancer chemotherapy and pharmacology 20090701 |
| Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients. | Journal of neuro-oncology 20090701 |
| Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers. | Biomaterials 20090701 |
| Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. | International immunopharmacology 20090701 |
| Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues. | Cancer gene therapy 20090701 |
| Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1. | Molecular pharmacology 20090701 |
| Impact of rhenium-188, gemcitabine, and 5-fluorouracil on cholangiocellular carcinoma cells: an in vitro study. | Cardiovascular and interventional radiology 20090701 |
| A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression. | Journal of acquired immune deficiency syndromes (1999) 20090701 |
| Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer. | Cancer biology & therapy 20090701 |
| Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090701 |
| Epigenetic modulation and attacking the hedgehog pathway: potentially synergistic therapeutic targets for pancreatic cancer. | Cancer biology & therapy 20090701 |
| Phase II trial of capecitabine and weekly docetaxel for metastatic castrate resistant prostate cancer. | The Journal of urology 20090701 |
| Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer. | Cancer chemotherapy and pharmacology 20090701 |
| Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study. | European journal of cancer (Oxford, England : 1990) 20090701 |
| Travel warning with capecitabine. | Annals of oncology : official journal of the European Society for Medical Oncology 20090701 |
| Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090701 |
| Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma. | American journal of hematology 20090701 |
| Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: prognostic factors and treatment selection based on two large randomized clinical trials. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090701 |
| High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090701 |
| The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090701 |
| Determination of 5-methyl-2'-deoxycytidine in genomic DNA using high performance liquid chromatography-ultraviolet detection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090701 |
| Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine. | Molecular cancer therapeutics 20090701 |
| Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy. | Oncology reports 20090701 |
| 3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer. | Cancer research 20090701 |
| Genetic prognostic and predictive markers in colorectal cancer. | Nature reviews. Cancer 20090701 |
| Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. | Cancer research 20090701 |
| 'The best-laid plans ... often go awry ...'. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090701 |
| Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer. | Annals of surgery 20090701 |
| Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies. | Neoplasia (New York, N.Y.) 20090701 |
| Radiation metabolomics. 2. Dose- and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice. | Radiation research 20090701 |
| Acquired Fanconi syndrome after treatment with capecitabine, irinotecan, and bevacizumab. | The Annals of pharmacotherapy 20090701 |
| Expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in human breast carcinoma cells and tissues. | Anticancer research 20090701 |
| Cisplatin-Ifosfamide-gemcitabine as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and Paclitaxel. | Anticancer research 20090701 |
| Salvage chemotherapy with oxaliplatin and capecitabine for breast cancer patients pretreated with anthracyclines and taxanes. | Anticancer research 20090701 |
| Phase I study of capecitabine, carboplatin and intensity-modulated radiation therapy for head and neck cancer. | Anticancer research 20090701 |
| [A squamous cell lung cancer patient who developed immune hemolytic anemia after gemcitabine and docetaxel administration]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090701 |
| [A resected case of effective treatment with S-1/gemcitabine and Paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090701 |
| [Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection]. | Ai zheng = Aizheng = Chinese journal of cancer 20090701 |
| Mass flows of X-ray contrast media and cytostatics in hospital wastewater. | Environmental science & technology 20090701 |
| Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism. | British journal of cancer 20090616 |
| Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study. | British journal of cancer 20090616 |
| Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer: findings from the bolus, infusional, or capecitabine with camptostar-celecoxib study. | Cancer 20090615 |
| Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma. | Cancer 20090615 |
| Effects of bromide upon reaction of nucleosides with hydrogen peroxide induced by ultraviolet light. | Bioorganic & medicinal chemistry letters 20090615 |
| Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells. | Biochemical pharmacology 20090615 |
| Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. | Science (New York, N.Y.) 20090612 |
| Cancer. Breaching the cancer fortress. | Science (New York, N.Y.) 20090612 |
| Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090610 |
| A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer. | British journal of cancer 20090602 |
| A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma. | British journal of cancer 20090602 |
| Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies. | Cancer chemotherapy and pharmacology 20090601 |
| Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients. | Investigational new drugs 20090601 |
| Dose finding study of erlotinib combined to capecitabine and irinotecan in pretreated advanced colorectal cancer patients. | Cancer chemotherapy and pharmacology 20090601 |
| A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer. | Cancer chemotherapy and pharmacology 20090601 |
| Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial. | International journal of radiation oncology, biology, physics 20090601 |
| Costs of first-line doublet chemotherapy and lifetime medical care in advanced non-small-cell lung cancer in the United States. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090601 |
| Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia. | Lung cancer (Amsterdam, Netherlands) 20090601 |
| Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20090601 |
| Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report. | Cancer chemotherapy and pharmacology 20090601 |
| Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy. | Cancer treatment reviews 20090601 |
| DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20090601 |
| To widen the setting of cancer patients who could benefit from metronomic capecitabine. | Cancer chemotherapy and pharmacology 20090601 |
| Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090601 |
| A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102. | Annals of oncology : official journal of the European Society for Medical Oncology 20090601 |
| The optimal therapeutic use of ixabepilone in patients with locally advanced or metastatic breast cancer. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20090601 |
| A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine. | European journal of cancer (Oxford, England : 1990) 20090601 |
| Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer. | Chest 20090601 |
| Re: Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20090601 |
| Methods to monitor gene therapy with molecular imaging. | Methods (San Diego, Calif.) 20090601 |
| A landmark point analysis with cytotoxic agents for advanced NSCLC. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090601 |
| Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients. | Journal of acquired immune deficiency syndromes (1999) 20090601 |
| A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219). | The Journal of urology 20090601 |
| Final overall results of a study with a novel triplet induction chemotherapy regimen (PACCAGE) followed by consolidation radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC). | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090601 |
| Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy. | International journal of oncology 20090601 |
| Development and validation of an LC method for the determination of emtricitabine and related compounds in the drug substance. | Journal of separation science 20090601 |
| Potentiation of the effect of gemcitabine by emodin in pancreatic cancer is associated with survivin inhibition. | Biochemical pharmacology 20090601 |
| Gemcitabine, vinorelbine, and Cisplatin in the treatment of advanced nonsmall cell lung cancer. | American journal of clinical oncology 20090601 |
| Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxel-gemcitabine regimen. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090601 |
| Gemcitabine and capecitabine chemotherapy in Japanese patients with immunotherapy-resistant renal cell carcinoma. | International journal of urology : official journal of the Japanese Urological Association 20090601 |
| Tapping into combination pills for HIV. | Nature reviews. Drug discovery 20090601 |
| The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase. | Cancer research 20090601 |
| Rationale for an intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer. | Recent patents on anti-cancer drug discovery 20090601 |
| DNA methylation at the C-5 position of cytosine by methyl radicals: a possible role for epigenetic change during carcinogenesis by environmental agents. | Chemical research in toxicology 20090601 |
| Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment. | Pharmacogenomics 20090601 |
| Sarcoidosis as a diagnostic pitfall of pancreatic cancer. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20090601 |
| Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines. | Molecular cancer research : MCR 20090601 |
| Malignant solitary fibrous tumor with superior vena cava syndrome. | General thoracic and cardiovascular surgery 20090601 |
| [Local recurrence after surgical resection of pancreatic cancer effectively treated with combined chemoradiotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090601 |
| A case of advanced mucinous cystadenocarcinoma of the pancreas with peritoneal dissemination responding to gemcitabine. | Gan to kagaku ryoho. Cancer & chemotherapy 20090601 |
| [A case of advanced ampullary carcinoma successfully resected after primary chemotherapy with s-1 and gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090601 |
| Cell cycle effects and increased adduct formation by temozolomide enhance the effect of cytotoxic and targeted agents in lung cancer cell lines. | Journal of chemotherapy (Florence, Italy) 20090601 |
| [Chemotherapy of elderly patients with colorectal cancer]. | Magyar onkologia 20090601 |
| Combination chemotherapy with cisplatin and gemcitabine in malignant peritoneal mesothelioma. | International journal of clinical oncology 20090601 |
| Current role of bevacizumab in colorectal cancer. | Clinical advances in hematology & oncology : H&O 20090601 |
| Effects of the anti-VEGF monoclonal antibody bevacizumab in a preclinical model and in patients with refractory and multiple relapsed Hodgkin lymphoma. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20090601 |
| [Efficacy and safety of combination of irinotecan and capecitabine in patients with metastatic colorectal cancer after failure of chemotherapy with oxaliplatin]. | Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20090601 |
| Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify ongoing therapy just to use one less tablet. Better adherence than with separate dosing has not been demonstrated, while reduced efficacy is plausible. | Prescrire international 20090601 |
| Gemcitabine: cutaneous, hepatic and vascular disorders. | Prescrire international 20090601 |
| Quantitative phosphorus metabolomics using nanoflow liquid chromatography-tandem mass spectrometry and culture-derived comprehensive global internal standards. | Analytical chemistry 20090515 |
| The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. | Science (New York, N.Y.) 20090515 |
| 2'-deoxy-1-methylpseudocytidine, a stable analog of 2'-deoxy-5-methylisocytidine. | Bioorganic & medicinal chemistry 20090515 |
| The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4'-azidocytidine against hepatitis C virus replication: the discovery of 4'-azido-2'-deoxy-2'-fluorocytidine and 4'-azido-2'-dideoxy-2',2'-difluorocytidine. | Journal of medicinal chemistry 20090514 |
| Adjuvant chemotherapy in older women with early-stage breast cancer. | The New England journal of medicine 20090514 |
| Chemotherapy and immunotherapy in metastatic colorectal cancer. | The New England journal of medicine 20090514 |
| Chemotherapy and immunotherapy in metastatic colorectal cancer. | The New England journal of medicine 20090514 |
| Chemotherapy and immunotherapy in metastatic colorectal cancer. | The New England journal of medicine 20090514 |
| Capecitabine-induced acute myeloid leukaemia. | The New Zealand medical journal 20090508 |
| A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study. | Breast cancer research and treatment 20090501 |
| Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer. | Breast cancer research and treatment 20090501 |
| Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer. | Breast cancer research and treatment 20090501 |
| A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20090501 |
| Third generation triplet cytotoxic chemotherapy in advanced non-small cell lung cancer: a systematic overview. | Lung cancer (Amsterdam, Netherlands) 20090501 |
| Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. | International journal of radiation oncology, biology, physics 20090501 |
| Early severe toxicities after capecitabine intake: possible implication of a cytidine deaminase extensive metabolizer profile. | Cancer chemotherapy and pharmacology 20090501 |
| Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study. | Critical reviews in oncology/hematology 20090501 |
| The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells. | Pancreas 20090501 |
| Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20090501 |
| Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20090501 |
| The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials. | Annals of oncology : official journal of the European Society for Medical Oncology 20090501 |
| Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104). | Annals of oncology : official journal of the European Society for Medical Oncology 20090501 |
| Gemicitabine resistence and mesenchymal phenotype. | Annals of surgical oncology 20090501 |
| Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20090501 |
| Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort. | HIV medicine 20090501 |
| Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells. | Liver international : official journal of the International Association for the Study of the Liver 20090501 |
| Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. | Cancer 20090501 |
| MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy. | Gynecologic oncology 20090501 |
| Drosophila melanogaster deoxyribonucleoside kinase activates gemcitabine. | Biochemical and biophysical research communications 20090501 |
| Identification of a predictive biomarker for hematologic toxicities of gemcitabine. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090501 |
| Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090501 |
| Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090501 |
| Efficacy does not necessarily translate to cost effectiveness: a case study in the challenges associated with 21st-century cancer drug pricing. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090501 |
| Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090501 |
| AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells. | Molecular cancer therapeutics 20090501 |
| Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in cisplatin-refractory germ cell tumor. | Southern medical journal 20090501 |
| Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and blood mononuclear cells. | Molecular cancer therapeutics 20090501 |
| Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma. | Annals of surgery 20090501 |
| Medical Oncology: Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer. | Nature reviews. Clinical oncology 20090501 |
| Complete and durable response of choroid metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapy. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090501 |
| Mechanisms of APOBEC3G-catalyzed processive deamination of deoxycytidine on single-stranded DNA. | Nature structural & molecular biology 20090501 |
| Generic Truvada approved. | AIDS patient care and STDs 20090501 |
| XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer. | Acta biochimica et biophysica Sinica 20090501 |
| Spindle epithelial tumor with thymus-like elements of the thyroid: a multi-institutional case series and review of the literature. | Journal of pediatric surgery 20090501 |
| First-line simplified GEMOX (S-GemOx) versus classical GEMOX in metastatic pancreatic cancer (MPA): results of a GERCOR randomized phase II study. | Bulletin du cancer 20090501 |
| MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. | Molecular cancer therapeutics 20090501 |
| Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer. | Molecular cancer therapeutics 20090501 |
| Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines. | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20090501 |
| Rhabdomyolysis in an HIV-infected patient on anti-retroviral therapy precipitated by high-dose pravastatin. | Current drug safety 20090501 |
| A phase I/II study of docetaxel and gemcitabine combination for chemotherapy-resistant ovarian cancer. | Anticancer research 20090501 |
| Gemcitabine-capecitabine plus intra-arterial epirubicin-cisplatin in pretreated pancreatic cancer patients: a phase I study. | Anticancer research 20090501 |
| Single nucleotide polymorphisms and clinical outcome in patients with biliary tract carcinoma treated with epirubicin, cisplatin and capecitabine. | Anticancer research 20090501 |
| Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines. | Anticancer research 20090501 |
| Metastatic acinar cell carcinoma of the pancreas responding to gemcitabine, 5-fluorouracil and leucovorin therapy: a case report. | European journal of cancer care 20090501 |
| [Palliative chemotherapy for metastatic breast cancer with capecitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090501 |
| [Seven cases of gemcitabine-induced lung injury during treatment for pancreatic or biliary tract cancers]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090501 |
| [A case of triple negative chest wall recurrent breast cancer treated with capecitabine and docetaxel combination therapy (XT therapy)]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090501 |
| Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase. | PLoS pathogens 20090501 |
| [Toxic dermatitis due to capecitabine: presentation of 2 cases and literature review]. | Actas dermo-sifiliograficas 20090501 |
| HIV and anal cancer outcomes: a single institution's experience. | Diseases of the colon and rectum 20090501 |
| Thrombotic microangiopathy associated with gemcitabine: rare but real. | Expert opinion on drug safety 20090501 |
| [Case of malignant pleural mesothelioma with long-term disease control after 4 different lines of systemic chemotherapy and pleurodesis]. | Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20090501 |
| The 'Corey's reagent,' 3,5-di-tert-butyl-1,2-benzoquinone, as a modifying agent in the synthesis of fluorescent and double-headed nucleosides. | Nucleosides, nucleotides & nucleic acids 20090501 |
| [Medication change due to side effects or possible long-term complications. Side effect management with vision]. | MMW Fortschritte der Medizin 20090430 |
| [One year with Atripla. Changeover to complete HIV therapy in a single tablet has proven successful]. | MMW Fortschritte der Medizin 20090430 |
| Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1. | AIDS (London, England) 20090427 |
| DFT study of the interaction of cytidine and 2'-deoxycytidine with Li+, Na+, and K+: effects of metal cationization on sugar puckering and stability of the N-glycosidic bond. | Carbohydrate research 20090421 |
| Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090420 |
| Development of a sensitive and selective LC-MS/MS method for the determination of alpha-fluoro-beta-alanine, 5-fluorouracil and capecitabine in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090415 |
| Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090415 |
| FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090415 |
| Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090415 |
| A phase I study of a combination of yttrium-90-labeled anti-carcinoembryonic antigen (CEA) antibody and gemcitabine in patients with CEA-producing advanced malignancies. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090415 |
| Gemcitabine impacts histological structure of mice testis and embryonic organs. | Pakistan journal of biological sciences : PJBS 20090415 |
| Retention studies of 2'-2'-difluorodeoxycytidine and 2'-2'-difluorodeoxyuridine nucleosides and nucleotides on porous graphitic carbon: development of a liquid chromatography-tandem mass spectrometry method. | Journal of chromatography. A 20090410 |
| Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090410 |
| Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib. | British journal of cancer 20090407 |
| Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study. | British journal of cancer 20090407 |
| Analysis of dermatologic events in patients with cancer treated with lapatinib. | Breast cancer research and treatment 20090401 |
| Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature. | Cancer chemotherapy and pharmacology 20090401 |
| A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma. | Cancer chemotherapy and pharmacology 20090401 |
| Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer. | Cancer chemotherapy and pharmacology 20090401 |
| Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies. | Investigational new drugs 20090401 |
| A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer. | Cancer chemotherapy and pharmacology 20090401 |
| Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada) in virologically suppressed HIV-infected patients on HAART. | European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090401 |
| Simultaneous quantification of a non-nucleoside reverse transcriptase inhibitor efavirenz, a nucleoside reverse transcriptase inhibitor emtricitabine and a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry. | Biomedical chromatography : BMC 20090401 |
| Adult onset Still's disease after first cycle of pemetrexed and gemcitabine for non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20090401 |
| A dynamic model of hand-and-foot syndrome in patients receiving capecitabine. | Clinical pharmacology and therapeutics 20090401 |
| Preoperative concomitant radiotherapy with oral capecitabine in advanced rectal cancer within 6 cm from anal verge. | International journal of colorectal disease 20090401 |
| Fragmentation of isomeric intrastrand crosslink lesions of DNA in an ion-trap mass spectrometer. | Journal of the American Society for Mass Spectrometry 20090401 |
| Rana grylio virus thymidine kinase gene: an early gene of iridovirus encoding for a cytoplasmic protein. | Virus genes 20090401 |
| Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer. | Pancreas 20090401 |
| Antimetastatic effects of liposomal gemcitabine and empty liposomes in an orthotopic mouse model of pancreatic cancer. | Pancreas 20090401 |
| Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20090401 |
| High-performance capillary electrophoretic method for the quantification of global DNA methylation: application to methotrexate-resistant cells. | Analytical biochemistry 20090401 |
| The integration of chemoradiation in the care of patient with localized pancreatic cancer. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20090401 |
| Gemcitabine, irinotecan and celecoxib in patients with biliary cancer. | Anti-cancer drugs 20090401 |
| Y-Family DNA polymerases may use two different dNTP shapes for insertion: a hypothesis and its implications. | Journal of molecular graphics & modelling 20090401 |
| Costs associated with complications are lower with capecitabine than with 5-fluorouracil in patients with colorectal cancer. | Cancer 20090401 |
| Combination of gemcitabine and paclitaxel as second-line chemotherapy for advanced urothelial carcinoma. | Japanese journal of clinical oncology 20090401 |
| Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer. | Anti-cancer drugs 20090401 |
| A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer. | Pancreas 20090401 |
| Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells. | International journal of oncology 20090401 |
| Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma. | Neoplasia (New York, N.Y.) 20090401 |
| Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug. | Molecular cancer therapeutics 20090401 |
| Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer. | Molecular cancer therapeutics 20090401 |
| Phase II trial of capecitabine and oxaliplatin in patients with adeno- and undifferentiated carcinoma of unknown primary. | Onkologie 20090401 |
| First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype. | Expert review of anticancer therapy 20090401 |
| Role of liver transplantation in the treatment of cholangiocarcinoma. | Expert review of anticancer therapy 20090401 |
| Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab. | Expert review of anticancer therapy 20090401 |
| Novel therapeutic agents for osteosarcoma. | Expert review of anticancer therapy 20090401 |
| [A case of drug induced interstitial pneumonitis after gemcitabine treatment for pancreatic carcinoma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090401 |
| Are viruses inhibited by APOBEC3 molecules from their host species? | PLoS pathogens 20090401 |
| Nursing considerations for capecitabine-based combination therapy. | ONS connect 20090401 |
| Gallbladder carcinoma presenting as a pelvic mass with elevated serum testosterone: a case report. | The Journal of reproductive medicine 20090401 |
| [Phalanges necrosis--a rare manifestation of 'hand-foot' syndrome induced by gemcitabine used in the second--line therapy for progressive ovarian cancer. A case report]. | Ginekologia polska 20090401 |
| [Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20090401 |
| [Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer]. | Ai zheng = Aizheng = Chinese journal of cancer 20090401 |
| A convenient synthesis of N,N'-dibenzyl-2,4-diaminopyrimidine-2'-deoxyribonucleoside and 1-methyl-2'-deoxypseudoisocytidine. | Nucleosides, nucleotides & nucleic acids 20090401 |
| Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients. | British journal of cancer 20090324 |
| Escherichia coli expressing single-chain Fv on the cell surface as a potential prophylactic of porcine epidemic diarrhea virus. | Vaccine 20090323 |
| Triple cytotoxic therapy for advanced ovarian cancer: a failed application, not a failed strategy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090320 |
| Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090320 |
| Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090320 |
| Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090320 |
| Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model. | Brain research 20090319 |
| Timing is everything: order of administration of 5-aza 2' deoxycytidine, trichostatin A and tamoxifen changes estrogen receptor mRNA expression and cell sensitivity. | Cancer letters 20090318 |
| The reopening rate of the fingers domain is a determinant of base selectivity for RB69 DNA polymerase. | Biochemistry 20090317 |
| HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090315 |
| Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine. | Cancer biology & therapy 20090315 |
| Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. | Cancer research 20090315 |
| Unilateral taxane-induced onychopathy in a patient with a brain metastasis. | Dermatology online journal 20090315 |
| Non-homologous end joining in class switch recombination: the beginning of the end. | Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20090312 |
| Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090310 |
| Pancreatic cancer: translating lessons from mouse models. | JOP : Journal of the pancreas 20090309 |
| Advancements in the management of pancreatic cancer. | JOP : Journal of the pancreas 20090309 |
| Therapeutic tools in pancreatic cancer. | JOP : Journal of the pancreas 20090309 |
| Cardiotoxicity of 5-fluorouracil and capecitabine in a pancreatic cancer patient with a novel mutation in the dihydropyrimidine dehydrogenase gene. | JOP : Journal of the pancreas 20090309 |
| Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity. | Blood 20090305 |
| DNA hairpins containing the cytidine analog pyrrolo-dC: structural, thermodynamic, and spectroscopic studies. | Biophysical journal 20090304 |
| Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer. | Breast cancer research and treatment 20090301 |
| Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: effect on chemotherapy toxicity and efficacy. | Cancer chemotherapy and pharmacology 20090301 |
| Inhibition of activation of dsRNA-dependent protein kinase and tumour growth inhibition. | Cancer chemotherapy and pharmacology 20090301 |
| Development of selective agonists and antagonists of P2Y receptors. | Purinergic signalling 20090301 |
| Selective pulmonary artery perfusion followed by blood flow occlusion: new challenge for the treatment of pulmonary malignancies. | Lung cancer (Amsterdam, Netherlands) 20090301 |
| Liver perfusion chemotherapy with 5-Fluorouracil followed by systemic gemcitabine administration for resected pancreatic cancer: preliminary results of a prospective phase 2 study. | Pancreas 20090301 |
| Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients. | European journal of cancer (Oxford, England : 1990) 20090301 |
| Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531). | Annals of oncology : official journal of the European Society for Medical Oncology 20090301 |
| A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group. | European journal of cancer (Oxford, England : 1990) 20090301 |
| Genetic transfer of PNAS-4 induces apoptosis and enhances sensitivity to gemcitabine in lung cancer. | Cell biology international 20090301 |
| Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: the CORGI-L Study. | European journal of cancer (Oxford, England : 1990) 20090301 |
| Caveolin-1 as a prognostic marker for local control after preoperative chemoradiation therapy in rectal cancer. | International journal of radiation oncology, biology, physics 20090301 |
| Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study. | Gynecologic oncology 20090301 |
| A randomized phase II trial assessing in advanced non-small cell lung cancer patients with stable disease after two courses of cisplatin-gemcitabine an early modification of chemotherapy doublet with paclitaxel-gemcitabine versus continuation of cisplatin-gemcitabine chemotherapy (GFPC 03-01 Study). | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090301 |
| Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results. | Anti-cancer drugs 20090301 |
| Cyclopentenyl cytosine has biological and anti-tumour activity, but does not enhance the efficacy of gemcitabine and radiation in two animal tumour models. | International journal of oncology 20090301 |
| XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis. | Current medical research and opinion 20090301 |
| Mouse RS21-C6 is a mammalian 2'-deoxycytidine 5'-triphosphate pyrophosphohydrolase that prefers 5-iodocytosine. | The FEBS journal 20090301 |
| The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies. | The oncologist 20090301 |
| Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090301 |
| Interferon-gamma down-regulates heat shock protein 27 of pancreatic cancer cells and helps in the cytotoxic effect of gemcitabine. | Pancreas 20090301 |
| Emerging role of capecitabine in gastric cancer. | Pharmacotherapy 20090301 |
| Chemotherapy-related posterior reversible leukoencephalopathy syndrome. | Nature clinical practice. Neurology 20090301 |
| Gemcitabine, etoposide, cisplatin, and dexamethasone in patients with refractory or relapsed non-Hodgkin's lymphoma. | The Korean journal of internal medicine 20090301 |
| Unanticipated toxicity to capecitabine. | Oncology nursing forum 20090301 |
| [Thrombotic microangiopathy under an effective treatment with gemcitabine]. | Zeitschrift fur Gastroenterologie 20090301 |
| Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy. | Archives of dermatology 20090301 |
| A human protein interaction network shows conservation of aging processes between human and invertebrate species. | PLoS genetics 20090301 |
| Second-line therapy in refractory pancreatic cancer. results of a phase II study. | Onkologie 20090301 |
| [A patient with axillary node metastasis from breast cancer who responded to trastuzumab/capecitabine combination therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090301 |
| [Biological basis of chemo-radiotherapy associations]. | Bulletin du cancer 20090301 |
| Induction chemotherapy and chemoradiation therapy for inoperable locally advanced non-small-cell lung cancer: a single-institution review of two different regimens. | Clinical lung cancer 20090301 |
| Phase II study of capecitabine plus cisplatin in patients with gastric cancer. | Anti-cancer drugs 20090301 |
| Palliative chemotherapy with gemcitabine, paclitaxel, and cisplatin as first-line treatment following gemcitabine monotherapy for patients with transitional cell carcinoma of the urothelium. | Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20090301 |
| Truvada and Epivir are similar at suppressing HIV. | Project Inform perspective 20090301 |
| Prognostic value of serum CA19-9 in patients with advanced pancreatic cancer receiving gemcitabine based chemotherapy. | Ai zheng = Aizheng = Chinese journal of cancer 20090301 |
| Hepatitis B in HIV patients: what is the current treatment and what are the challenges? | Journal of HIV therapy 20090301 |
| Data demonstrate pharmacokinetic boosting activity of GS 9350. | AIDS patient care and STDs 20090301 |
| Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group. | British journal of cancer 20090224 |
| New thermolytic carbamoyl groups for the protection of nucleobases. | Organic & biomolecular chemistry 20090221 |
| Combined treatment of oxaliplatin and capecitabine in patients with metastatic esophageal squamous cell cancer. | World journal of gastroenterology 20090221 |
| Extending thymidine kinase activity to the catalytic repertoire of human deoxycytidine kinase. | Biochemistry 20090217 |
| Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series. | Cancer 20090215 |
| Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090215 |
| Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo. | World journal of gastroenterology 20090214 |
| Challenge of high polarity and low concentrations in analysis of cytostatics and metabolites in wastewater by hydrophilic interaction chromatography/tandem mass spectrometry. | Journal of chromatography. A 20090213 |
| Down-regulation of stathmin is required for TGF-beta inducible early gene 1 induced growth inhibition of pancreatic cancer cells. | Cancer letters 20090208 |
| Versatility of Y-family Sulfolobus solfataricus DNA polymerase Dpo4 in translesion synthesis past bulky N2-alkylguanine adducts. | The Journal of biological chemistry 20090206 |
| Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. | The New England journal of medicine 20090205 |
| Targeted therapy for advanced colorectal cancer--more is not always better. | The New England journal of medicine 20090205 |
| Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma. | Chinese medical journal 20090205 |
| Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine. | Cancer chemotherapy and pharmacology 20090201 |
| Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma. | Cancer chemotherapy and pharmacology 20090201 |
| Gemcitabine-induced retinopathy in a diabetic patient. | Acta ophthalmologica 20090201 |
| Inhibition of protein synthesis by imexon reduces HIF-1alpha expression in normoxic and hypoxic pancreatic cancer cells. | Investigational new drugs 20090201 |
| An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients. | Lung cancer (Amsterdam, Netherlands) 20090201 |
| Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401. | Journal of cancer research and clinical oncology 20090201 |
| Patient-reported outcomes as a component of the primary endpoint in a double-blind, placebo-controlled trial in advanced pancreatic cancer. | Journal of pain and symptom management 20090201 |
| Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20090201 |
| Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer. | Cancer chemotherapy and pharmacology 20090201 |
| Effective, homogeneous and transient interference with cytosine methylation in plant genomic DNA by zebularine. | The Plant journal : for cell and molecular biology 20090201 |
| A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20090201 |
| Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20090201 |
| Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin. | BJU international 20090201 |
| Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience. | World journal of urology 20090201 |
| Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. | Annals of surgical oncology 20090201 |
| Regression of rectal cancer with radiotherapy with or without concurrent capecitabine--optimising the timing of surgical resection. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20090201 |
| Inactivation of different strains of Escherichia coli O157:H7 in various apple ciders treated with dimethyl dicarbonate (DMDC) and sulfur dioxide (SO2) as an alternative method. | Food microbiology 20090201 |
| Typical signature of DNA damage in white blood cells: a pilot study on etheno adducts in Danish mother-newborn child pairs. | Carcinogenesis 20090201 |
| [Medical-oncological aspects in the treatment of pancreatic cancer]. | Der Radiologe 20090201 |
| Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201 |
| Cost-effectiveness analysis of lapatinib in HER-2-positive advanced breast cancer. | Cancer 20090201 |
| Pharmacologic aspects of new antiretroviral drugs. | Current HIV/AIDS reports 20090201 |
| Unchanged thymidine triphosphate pools and thymidine metabolism in two lines of thymidine kinase 2-mutated fibroblasts. | The FEBS journal 20090201 |
| Role of combination therapy in chronic hepatitis B. | Current gastroenterology reports 20090201 |
| A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. | Molecular cancer therapeutics 20090201 |
| Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors. | American journal of clinical oncology 20090201 |
| Gemcitabine nephrotoxicity and hemolytic uremic syndrome: report of 29 cases from a single institution. | Clinical nephrology 20090201 |
| Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma. | Molecular cancer therapeutics 20090201 |
| Schedule-dependent synergistic interaction between gemcitabine and oxaliplatin in human gallbladder adenocarcinoma cell lines. | Anti-cancer drugs 20090201 |
| FDA notifications. Generic emtricitabine is approved by the FDA. | AIDS alert 20090201 |
| [Retrospective analysis of uracil/tegafur, cyclophosphamide and gemcitabine compared with gemcitabine monotherapy in unresectable pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090201 |
| [Effective gemcitabine plus S-1 treatment in elderly non-small cell lung cancer patients with multiple bone metastases]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090201 |
| [A case of metastatic pancreatic cancer after combination chemotherapy with uracil-tegafur and gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090201 |
| [A case of metastatic breast cancer with liver metastasis effectively treated with capecitabine and vinorelbine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090201 |
| [Chemotherapy, chemoradiotherapy or observation after complete resection of pancreatic adenocarcinoma?]. | Gastroenterologia y hepatologia 20090201 |
| Synthesis and hybridization properties of modified oligodeoxynucleotides carrying non-natural bases. | Chemistry & biodiversity 20090201 |
| Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis. | Cancer investigation 20090201 |
| Apricitabine--a novel nucleoside reverse transcriptase inhibitor for the treatment of HIV infection that is refractory to existing drugs. | Expert opinion on investigational drugs 20090201 |
| Molecular evolution of a viral non-coding sequence under the selective pressure of amiRNA-mediated silencing. | PLoS pathogens 20090201 |
| Definitive chemoradiotherapy with capecitabine and cisplatin in patients with esophageal cancer: a pilot study. | Journal of Korean medical science 20090201 |
| Intra-arterial chemotherapy with gemcitabine and cisplatin for patients with recurrence of transitional cell carcinoma confined to the pelvis. | Journal of chemotherapy (Florence, Italy) 20090201 |
| A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer. | Anticancer research 20090201 |
| Lapatinib: new drug. For some women with metastatic breast cancer. | Prescrire international 20090201 |
| Clinical utility of CA-125 for maintenance therapy in the treatment of advanced stage ovarian carcinoma. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20090201 |
| [Effects of magnetic gemcitabine stealth nano-liposomes on the characteristics of breast cancer cell line MCF-7]. | Yao xue xue bao = Acta pharmaceutica Sinica 20090201 |
| Evaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay. | Oncogene 20090129 |
| Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients. | World journal of gastroenterology 20090128 |
| Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience. | British journal of cancer 20090127 |
| Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. | British journal of cancer 20090127 |
| A highly sensitive enzyme immunoassay for evaluation of 2'-deoxycytidine plasma level as a prognostic marker for breast cancer chemotherapy. | Analytica chimica acta 20090126 |
| Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090120 |
| Translesion DNA synthesis by human DNA polymerase eta on templates containing a pyrimidopurinone deoxyguanosine adduct, 3-(2'-deoxy-beta-d-erythro-pentofuranosyl)pyrimido-[1,2-a]purin-10(3H)-one. | Biochemistry 20090120 |
| Synergistic effects of acyclic retinoid and gemcitabine on growth inhibition in pancreatic cancer cells. | Cancer letters 20090118 |
| Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090115 |
| Structure of the nucleotide radical formed during reaction of CDP/TTP with the E441Q-alpha2beta2 of E. coli ribonucleotide reductase. | Journal of the American Chemical Society 20090114 |
| Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial. | British journal of cancer 20090113 |
| A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer. | British journal of cancer 20090113 |
| Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090110 |
| Cisplatin and gemcitabine in the management of metastatic penile cancer. | Urologic oncology 20090101 |
| A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer. | Cancer chemotherapy and pharmacology 20090101 |
| Ten years of HER2-directed therapy: still questions after all these years. | Breast cancer research and treatment 20090101 |
| Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report. | Breast cancer (Tokyo, Japan) 20090101 |
| Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: a multicenter phase II study. | Lung cancer (Amsterdam, Netherlands) 20090101 |
| Efficacy and factors affecting outcome of gemcitabine concurrent chemoradiotherapy in patients with locally advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20090101 |
| Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients. | Lung cancer (Amsterdam, Netherlands) 20090101 |
| Oxaliplatin and capecitabine-based chemoradiotherapy for gastric cancer--an extended phase I MARGIT and AIO trial. | International journal of radiation oncology, biology, physics 20090101 |
| XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy. | Urologic oncology 20090101 |
| Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer. | International journal of radiation oncology, biology, physics 20090101 |
| A phase I pharmacokinetic study of hypoxic abdominal stop-flow perfusion with gemcitabine in patients with advanced pancreatic cancer and refractory malignant ascites. | Cancer chemotherapy and pharmacology 20090101 |
| siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity. | Digestive diseases and sciences 20090101 |
| Management of colorectal liver metastases after complete response to neoadjuvant chemotherapy. A case of computertomography-guided wire marking of the liver tumor. | International journal of colorectal disease 20090101 |
| Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer. | Annals of oncology : official journal of the European Society for Medical Oncology 20090101 |
| Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20090101 |
| Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer. | Thorax 20090101 |
| Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine. | Breast cancer (Tokyo, Japan) 20090101 |
| Capecitabine: have we got the dose right? | Nature clinical practice. Oncology 20090101 |
| Lung cancer and renal insufficiency: prevalence and anticancer drug issues. | Lung 20090101 |
| Excision of the oxidatively formed 5-hydroxyhydantoin and 5-hydroxy-5-methylhydantoin pyrimidine lesions by Escherichia coli and Saccharomyces cerevisiae DNA N-glycosylases. | Biochimica et biophysica acta 20090101 |
| Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy. | Radiology 20090101 |
| Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. | Annals of surgical oncology 20090101 |
| Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer. | Gastroenterology 20090101 |
| Oral fluoropyrimidines (capecitabine or S-1) and cisplatin as first line treatment in elderly patients with advanced gastric cancer: a retrospective study. | Japanese journal of clinical oncology 20090101 |
| CP-4055 and CP-4126 are active in ara-C and gemcitabine-resistant lymphoma cell lines. | British journal of haematology 20090101 |
| Personalized medicine for pancreatic cancer: a step in the right direction. | Gastroenterology 20090101 |
| S-1 and gemcitabine as an outpatient-based regimen in patients with advanced or metastatic pancreatic cancer. | Japanese journal of clinical oncology 20090101 |
| Gemcitabine-induced acute coronary syndrome: a case report. | Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20090101 |
| Cutaneous vasculitis associated with gemcitabine therapy. | Clinical and experimental dermatology 20090101 |
| Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study. | Radiology 20090101 |
| Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy. | The British journal of radiology 20090101 |
| RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ('ping-pong trial') followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090101 |
| Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339). | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090101 |
| Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors. | Pharmacogenomics 20090101 |
| Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition. | Journal of immunology (Baltimore, Md. : 1950) 20090101 |
| Metastatic non-small-cell lung cancer and the use of gemcitabine during pregnancy. | Journal of perinatology : official journal of the California Perinatal Association 20090101 |
| The predictive and therapeutic value of thymidine phosphorylase and dihydropyrimidine dehydrogenase in capecitabine (Xeloda)-based chemotherapy for head and neck cancer. | The Laryngoscope 20090101 |
| Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B. | Cancer research 20090101 |
| A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer. | BMC surgery 20090101 |
| Capecitabine-based combination therapy for breast cancer: implications for nurses. | Oncology nursing forum 20090101 |
| Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells. | Molecular cancer therapeutics 20090101 |
| In vivo activity of novel capecitabine regimens alone and with bevacizumab and oxaliplatin in colorectal cancer xenograft models. | Molecular cancer therapeutics 20090101 |
| Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68. | Molecular cancer therapeutics 20090101 |
| The role of capecitabine in the management of tumors of the digestive system. | Reviews on recent clinical trials 20090101 |
| [Feasibility and response of gemcitabine and carboplatin biweekly combination chemotherapy for patients with postoperative recurrence non-small cell lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20090101 |
| Management of platinum-resistant ovarian cancer with the combination of pemetrexed and gemcitabine. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20090101 |
| Fatal drug-drug interaction of brivudine and capecitabine. | Acta oncologica (Stockholm, Sweden) 20090101 |
| Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G. | PloS one 20090101 |
| Combined gemcitabine and carboplatin therapy for carcinomas in dogs. | Journal of veterinary internal medicine 20090101 |
| Genetic evidence for single-strand lesions initiating Nbs1-dependent homologous recombination in diversification of Ig v in chicken B lymphocytes. | PLoS genetics 20090101 |
| Phase II trial of erlotinib and capecitabine for patients with previously untreated metastatic colorectal cancer. | Clinical colorectal cancer 20090101 |
| Oxaliplatin-mediated autoimmune thrombocytopenia. | Clinical colorectal cancer 20090101 |
| Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase inhibition with sunitinib. | Clinical genitourinary cancer 20090101 |
| Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions. | Scandinavian journal of gastroenterology 20090101 |
| Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients. | World journal of surgical oncology 20090101 |
| Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus. | BMC genetics 20090101 |
| Adjuvant chemoradiotherapy for high-risk pancreatic cancer. | Singapore medical journal 20090101 |
| Updates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology. | Journal of hematology & oncology 20090101 |
| Dramatic response with capecitabine after cranial radiation to the brain parenchymal and leptomeningeal metastases from lung cancer. | European journal of internal medicine 20090101 |
| Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers. | Oncology 20090101 |
| Chemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumors. | PloS one 20090101 |
| A second case of secondary acute myeloblastic leukemia associated with the MLL-KIAA0284 fusion gene. | Blood cells, molecules & diseases 20090101 |
| Phase II study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancer. | Oncology 20090101 |
| Pharmacokinetics of gemcitabine at fixed-dose rate infusion in patients with normal and impaired hepatic function. | Clinical pharmacokinetics 20090101 |
| Chemotherapy and quality of life in NSCLC PS 2 patients. | Acta oncologica (Stockholm, Sweden) 20090101 |
| Lapatinib plus capecitabine resolved human epidermal growth factor receptor 2-positive brain metastases. | American journal of therapeutics 20090101 |
| Cisplatin plus gemcitabine as adjuvant chemotherapy for radically resected non-small-cell lung cancer: a pilot study. | Clinical lung cancer 20090101 |
| Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis. | Journal of hematology & oncology 20090101 |
| Tolerability of gemcitabine and carboplatin doublet therapy in cats with carcinomas. | Journal of veterinary internal medicine 20090101 |
| Cardiac toxicity with capecitabine, vinorelbine and trastuzumab therapy: case report and review of fluoropyrimidine-related cardiotoxicity. | Oncology 20090101 |
| Fixed-dose-rate gemcitabine in combination with oxaliplatin in patients with metastatic pancreatic cancer refractory to standard-dose-rate gemcitabine: a single-institute study. | Oncology 20090101 |
| Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. | Oncology 20090101 |
| Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma. | Journal of translational medicine 20090101 |
| Novel regimens of capecitabine alone and combined with irinotecan and bevacizumab in colorectal cancer xenografts. | Anticancer research 20090101 |
| The effect of adjuvant and neoadjuvant chemo(radio)therapy on survival in 1,679 resected pancreatic carcinoma cases in Japan: report of the national survey in the 34th annual meeting of Japanese Society of Pancreatic Surgery. | Journal of hepato-biliary-pancreatic surgery 20090101 |
| Long-term disease stabilization during second-line gemcitabine in a refractory metastatic haemangioendothelioma. | Anti-cancer drugs 20090101 |
| Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin. | Anti-cancer drugs 20090101 |
| Microsatellite instability: a predictive marker in metastatic colorectal cancer? | Targeted oncology 20090101 |
| 'Hand-foot' syndrome-an unusual case of plantar pathology presenting to a burns unit. | Journal of burn care & research : official publication of the American Burn Association 20090101 |
| Efficacy and safety of capecitabine and oxaliplatin combination as second-line treatment in advanced colorectal cancer. | American journal of therapeutics 20090101 |
| Gemcitabine and carboplatin treatment in advanced NSCLC: a retrospective evaluation including elderly patients. | Tumori 20090101 |
| Feasibility study of biweekly capecitabine, oxaliplatin, and irinotecan in patients with untreated advanced gastric cancer. | Tumori 20090101 |
| Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues. | Antiviral chemistry & chemotherapy 20090101 |
| Assessing software impact on clinical workflow and resource utilization. | Studies in health technology and informatics 20090101 |
| Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial. | BMC cancer 20090101 |
| Cisplatin plus gemcitabine chemotherapy in taxane/anthracycline-resistant metastatic breast cancer. | Chemotherapy 20090101 |
| Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy. | BMC cancer 20090101 |
| [Gallbladder cancer staging with 18F-FDG PET-CT]. | Revista espanola de medicina nuclear 20090101 |
| Identification of genomic alterations associated with the aggressiveness of pancreatic cancer using an ultra-high-resolution CGH array. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20090101 |
| Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression. | PloS one 20090101 |
| The 'win-win' initiative: a global, scientifically based approach to resource sparing treatment for systemic breast cancer therapy. | World journal of surgical oncology 20090101 |
| Medical management of pancreatic adenocarcinoma. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20090101 |
| Use of probiotics in the management of chemotherapy-induced diarrhea: a case study. | JPEN. Journal of parenteral and enteral nutrition 20090101 |
| Fludarabine in the treatment of chronic lymphocytic leukemia: a review. | Therapeutics and clinical risk management 20090101 |
| The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study. | Retrovirology 20090101 |
| Emtricitabine/tenofovir disoproxil fumarate: in combination with a protease inhibitor in HIV-1 infection. | Drugs 20090101 |
| Best cases from the AFIP: urachal carcinoma. | Radiographics : a review publication of the Radiological Society of North America, Inc 20090101 |
| Effect of combined treatment methods on quality of life in patients with pancreatic cancer. | American journal of therapeutics 20090101 |
| Lack of in vitro interactions using human liver microsomes between rabeprazole and anticancer drugs. | European journal of drug metabolism and pharmacokinetics 20090101 |
| Efficacy and toxicity of gemcitabine and pegylated liposomal Doxorubicin in recurrent platinum-resistant/refractory epithelial ovarian cancer. | Asian Pacific journal of cancer prevention : APJCP 20090101 |
| Gemcitabine and carboplatin treatment in patients with relapsing ovarian cancer. | Neoplasma 20090101 |
| Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy. | Neoplasma 20090101 |
| High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer. | PloS one 20090101 |
| Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine. | American journal of clinical dermatology 20090101 |
| Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines. | Journal of experimental & clinical cancer research : CR 20090101 |
| Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer. | BMC cancer 20090101 |
| Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor. | Molecular cancer 20090101 |
| Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial. | World journal of surgical oncology 20090101 |
| Clinical pharmacology and pharmacogenetics of gemcitabine. | Drug metabolism reviews 20090101 |
| [Coronary artery disease attack caused by cytotoxic chemotherapy]. | Duodecim; laaketieteellinen aikakauskirja 20090101 |
| Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer. | Journal of translational medicine 20090101 |
| A feasibility study of weekly docetaxel with capecitabine in ovarian cancer: a promising combination of two active drugs with a potential for synergism. | Chemotherapy 20090101 |
| [Bevacizumab in combination with capecitabine and irinotecan (XELIRI) in treatment of metastatic colorectal cancer]. | Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20090101 |
| Recurrent cutaneous toxic erythema induced by gemcitabine in a patient with pancreatic cancer. | Cutaneous and ocular toxicology 20090101 |
| Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer. | Journal of experimental & clinical cancer research : CR 20090101 |
| Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. | Journal of translational medicine 20090101 |
| Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT). | European journal of medical research 20090101 |
| Current oncological treatment of patients with pancreatic cancer in germany: results from a national survey on behalf of the Arbeitsgemeinschaft Internistische Onkologie and the Chirurgische Arbeitsgemeinschaft Onkologie of the Germany Cancer Society. | Oncology 20090101 |
| Phase I study of prolonged-infusion gemcitabine combined with cyclophosphamide in patients with metastatic carcinoma of the breast: tolerability of an optimal dose schedule. | Oncology 20090101 |
| Usefulness of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) in patients for unresectable biliary carcinoma. | Hepato-gastroenterology 20090101 |
| Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer. | Radiation oncology (London, England) 20090101 |
| Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells. | Molecular cancer 20090101 |
| Budget impact analysis of ixabepilone used according to FDA approved labeling in treatment-resistant metastatic breast cancer. | Journal of managed care pharmacy : JMCP 20090101 |
| Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. | BMC cancer 20090101 |
| Evolving treatment of advanced colon cancer. | Annual review of medicine 20090101 |
| Steady-state amprenavir, tenofovir, and emtricitabine pharmacokinetics before and after reducing ritonavir boosting of a fosamprenavir/tenofovir/emtricitabine regimen from 200 mg to 100 mg once daily (TELEX II). | HIV clinical trials 20090101 |
| Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor. | Molecular pharmaceutics 20090101 |
| Effects of mixtures of polychlorinated biphenyls, methylmercury, and organochlorine pesticides on hepatic DNA methylation in prepubertal female Sprague-Dawley rats. | International journal of toxicology 20090101 |
| Coordinated posttranscriptional mRNA population dynamics during T-cell activation. | Molecular systems biology 20090101 |
| Clinical presentation and outcomes of patients with biliary malignancies: the Aga Khan University experience. | Asian Pacific journal of cancer prevention : APJCP 20090101 |
| [Efficiency of the capecitabine in patients with breast cancer with liver metastasis]. | Georgian medical news 20090101 |
| Early and late results of adjuvant treatment in colorectal cancer. The experience of the Emergency County hospital Alba Iulia-Romania. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20090101 |
| Hypoxia-induced transcription of dopamine D3 and D4 receptors in human neuroblastoma and astrocytoma cells. | BMC neuroscience 20090101 |
| A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck. | BMC cancer 20090101 |
| Cost-effectiveness analysis of capecitabine compared with bolus 5-fluorouracil/l-leucovorin for the adjuvant treatment of colon cancer in Japan. | PharmacoEconomics 20090101 |
| Randomized double-blind phase II trial comparing gemcitabine plus LY293111 versus gemcitabine plus placebo in advanced adenocarcinoma of the pancreas. | Cancer journal (Sudbury, Mass.) 20090101 |
| Phase I trial of metastatic renal cell carcinoma with oral capecitabine and thalidomide. | German medical science : GMS e-journal 20090101 |
| Clinical impact of radiotherapy for locally advanced pancreatic cancer. | Journal of gastroenterology 20090101 |
| Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID). | Biologics : targets & therapy 20090101 |
| Comparative 454 pyrosequencing of transcripts from two olive genotypes during fruit development. | BMC genomics 20090101 |
| Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC). | BMC cancer 20090101 |
| Emerging role of microRNAs in diagnosis and treatment of various diseases including ovarian cancer. | Journal of ovarian research 20090101 |
| Transitions at CpG dinucleotides, geographic clustering of TP53 mutations and food availability patterns in colorectal cancer. | PloS one 20090101 |
| Primary HIV-1 drug resistance and polymorphic patterns among injecting drug users (IDUs) in Chennai, Southern India. | Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20090101 |
| Phase II study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer. | Oncology 20090101 |
| Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group. | Oncology 20090101 |
| Do recurrent and metastatic pancreatic cancer patients have the same outcomes with gemcitabine treatment? | Oncology 20090101 |
| Costs associated with capecitabine or 5-fluorouracil monotherapy after surgical resection in patients with colorectal cancer. | Oncology 20090101 |
| AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma. | PloS one 20090101 |
| Synthesis and hybridization properties of oligonucleotides having 4-N-(pyrrol-2-ylcarbonyl)deoxycytidine. | Nucleic acids symposium series (2004) 20090101 |
| Evaluation of base recognition abilities of 2'-deoxynucleoside N-oxide derivatives by polymerase reactions. | Nucleic acids symposium series (2004) 20090101 |
| Development of new DNA triplex triads by using 5-substituted deoxycytidine. | Nucleic acids symposium series (2004) 20090101 |
| Tenofovir-emtricitabine-efavirenz in HIV-I-infected adults in Senegal: a 96-week pilot trial in treatment-naive patients. | Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20090101 |
| Cancer of unknown primary site in which tumor marker-oriented chemotherapy was effective and pancreatic cancer was finally confirmed at autopsy. | Internal medicine (Tokyo, Japan) 20090101 |
| Comparison of 3-drug versus 4-drug and PI versus non-PI combinations as initial HAART: experience from 1998 to 2007. | Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20090101 |
| [Budget impact of a set-dose combination of efavirenz-emtricitabine-tenofovir in the treatment of patients infected with HIV-1]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101 |
| Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity. | In vivo (Athens, Greece) 20090101 |
| Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model. | Clinical & experimental metastasis 20090101 |
| Gemcitabine plus irinotecan as first-line weekly therapy in locally advanced and/or metastatic pancreatic cancer. | Oncology research 20090101 |
| Lower limb high arterial flow induced by tenofovir and emtricitabine treatment. | Antiviral therapy 20090101 |
| Comparison of the pharmacokinetics of apricitabine in the presence and absence of ritonavir-boosted tipranavir: a phase I, open-label, controlled, single-centre study. | Clinical drug investigation 20090101 |
| A case of progressive hypertension preceding gemcitabine-associated thrombotic microangiopathy complicated by acute kidney injury and stroke. | Renal failure 20090101 |
| IL-18 paradox in pancreatic carcinoma: elevated serum levels of free IL-18 are correlated with poor survival. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20090101 |
| Is therapeutic plasma exchange indicated for patients with gemcitabine-induced hemolytic uremic syndrome? | Journal of clinical apheresis 20090101 |
| Management of elderly patients with advanced non-small cell lung cancer in Turkey. | Asian Pacific journal of cancer prevention : APJCP 20090101 |
| The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target. | PloS one 20090101 |
| [Inflammation of multiple seborrheic keratoses induced by chemotherapy with gemcitabine]. | Anais brasileiros de dermatologia 20090101 |
| Docetaxel and gemcitabine in the treatment of metastatic breast carcinoma: a dose finding study. | Tumori 20090101 |
| Gemcitabine-induced supraventricular tachycardia. | Tumori 20090101 |
| Important role of gemcitabine in the treatment of classic Kaposi's sarcoma. | Tumori 20090101 |
| RAD51 paralogs promote homology-directed repair at diversifying immunoglobulin V regions. | BMC molecular biology 20090101 |
| The role of UPF0157 in the folding of M. tuberculosis dephosphocoenzyme A kinase and the regulation of the latter by CTP. | PloS one 20090101 |
| Splenic artery used for replaced common hepatic artery reconstruction during pancreatoduodenectomy--a case report. | Chirurgia (Bucharest, Romania : 1990) 20090101 |
| Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers. | PloS one 20090101 |
| [Serious cutaneous toxicity following ifosfamide, gemcitabine and vinorelbine therapy in a patient with relapsed Hodgkin lymphoma and ichthyosis]. | Casopis lekaru ceskych 20090101 |
| Viral load decay in antiretroviral-naïve patients receiving once-daily tenofovir and emtricitabine plus twice-daily nevirapine. | HIV clinical trials 20090101 |
| Role of TGF-beta1 (-509C>T) promoter polymorphism in susceptibility to cervical cancer. | Oncology research 20090101 |
| A pilot study for combination chemotherapy using gemcitabine and S-1 for advanced pancreatic cancer. | Oncology 20090101 |
| First-line capecitabine monotherapy for slowly progressing metastatic breast cancer: do we need aggressive treatment? | Oncology 20090101 |
| Mutations in the human naked cuticle homolog NKD1 found in colorectal cancer alter Wnt/Dvl/beta-catenin signaling. | PloS one 20090101 |
| Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. | Retrovirology 20090101 |
| Automated mass action model space generation and analysis methods for two-reactant combinatorially complex equilibriums: an analysis of ATP-induced ribonucleotide reductase R1 hexamerization data. | Biology direct 20090101 |
| The protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesis. | Molecular cancer 20090101 |
| Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2'-deoxycytidine results in increased tumorigenicity. | PloS one 20090101 |
| [Final results of cooperative studies of dicarbamine used as a hemoprotector in combination chemotherapy for cancer]. | Voprosy onkologii 20090101 |
| Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines. | Molecular cancer 20090101 |
| Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA gene. | Drug metabolism and pharmacokinetics 20090101 |
| Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia. | Drug design, development and therapy 20090101 |
| Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in advanced Hodgkin lymphoma. | Hematology/oncology and stem cell therapy 20090101 |
| The effects of intravesical chemoimmunotherapy with gemcitabine and Bacillus Calmette-Guérin in superficial bladder cancer: a preliminary study. | The Journal of international medical research 20090101 |
| Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20090101 |
| Cure of gemcitabine-induced systemic capillary leak syndrome without corticosteroids. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20090101 |
| Long-term efficacy and safety of once-daily nevirapine in combination with tenofovir and emtricitabine in the treatment of HIV-infected patients: a 72-week prospective multicenter study (TENOR-trial). | European journal of medical research 20090101 |
| Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview. | Nutrition and cancer 20090101 |
| Microdetermination of emtricitabine in human plasma by liquid chromatography/tandem mass spectrometry. | Journal of AOAC International 20090101 |
| Promising treatments of tomorrow for multiple sclerosis. | Annals of Indian Academy of Neurology 20090101 |
| Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter survey. | Tumori 20090101 |
| Enhancing apoptosis and overcoming resistance of gemcitabine in pancreatic cancer with bortezomib: a role of death-associated protein kinase-related apoptosis-inducing protein kinase 1. | Tumori 20090101 |
| Metronomic chemotherapy against cancer: from paradigm to clinical practice? | Tumori 20090101 |
| [Economic evaluation of capecitabine use as first line treatment in patients with advanced gastric carcinoma in Portugal]. | Acta medica portuguesa 20090101 |
| The ubiquitin-proteasome system as a molecular target in solid tumors: an update on bortezomib. | OncoTargets and therapy 20090101 |
| Gemcitabine for the treatment of advanced nonsmall cell lung cancer. | OncoTargets and therapy 20090101 |
| Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia. | OncoTargets and therapy 20090101 |
| Usefulness of contrast-enhanced ultrasonography in determining treatment efficacy and outcome after pancreatic cancer chemotherapy. | World journal of gastroenterology 20081221 |
| Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081220 |
| Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer. | Journal of the National Cancer Institute 20081217 |
| Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells. | Clinical cancer research : an official journal of the American Association for Cancer Research 20081215 |
| Methyl-CpG targeted transcriptional activation allows re-expression of tumor suppressor genes in human cancer cells. | Biochemical and biophysical research communications 20081212 |
| Adjuvant chemoradiation for pancreatic cancer: few good data, much debate. | Journal of the National Cancer Institute 20081203 |
| A heavily pretreated patient with recurrent clear cell adenocarcinoma of the ovary in whom carcinomatous peritonitis was controlled successfully by salvage therapy with gemcitabine. | Archives of gynecology and obstetrics 20081201 |
| A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses. | Breast cancer research and treatment 20081201 |
| RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells. | Journal of cellular and molecular medicine 20081201 |
| A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer. | Cancer chemotherapy and pharmacology 20081201 |
| Does saturable formation of gemcitabine triphosphate occur in patients? | Cancer chemotherapy and pharmacology 20081201 |
| Gemcitabine at fixed dose-rate in patients with advanced soft-tissue sarcomas: a mono-institutional phase II study. | Cancer chemotherapy and pharmacology 20081201 |
| Renal excretion of emtricitabine I: effects of organic anion, organic cation, and nucleoside transport inhibitors on emtricitabine excretion. | Journal of pharmaceutical sciences 20081201 |
| Renal excretion of emtricitabine II. effect of trimethoprim on emtricitabine excretion: In vitro and in vivo studies. | Journal of pharmaceutical sciences 20081201 |
| Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors. | Cancer chemotherapy and pharmacology 20081201 |
| Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trial. | Lung cancer (Amsterdam, Netherlands) 20081201 |
| Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20081201 |
| Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel-gemcitabine chemotherapy. | Lung cancer (Amsterdam, Netherlands) 20081201 |
| Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol. | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20081201 |
| Low copy number and low oxidative damage of mitochondrial DNA are associated with tumor progression in lung cancer tissues after neoadjuvant chemotherapy. | Interactive cardiovascular and thoracic surgery 20081201 |
| Severe skin toxicity observed with the combination of capecitabine and weekly paclitaxel in metastatic breast cancer patients. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20081201 |
| Differential allelic expression in leukoblast from patients with acute myeloid leukemia suggests genetic regulation of CDA, DCK, NT5C2, NT5C3, and TP53. | Drug metabolism and disposition: the biological fate of chemicals 20081201 |
| Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). | Journal of surgical oncology 20081201 |
| Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer. | Gynecologic oncology 20081201 |
| Phase I/II trial of induction chemotherapy followed by concurrent chemoradiotherapy and surgery for locoregionally advanced pancreatic cancer. | Annals of surgical oncology 20081201 |
| Results of surgical treatment after neoadjuvant chemotherapy for stage III non-small cell lung cancer. | World journal of surgery 20081201 |
| Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone. | The Journal of antimicrobial chemotherapy 20081201 |
| Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the bladder. | The Journal of urology 20081201 |
| A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma. | Cancer 20081201 |
| Personalized medicine in advanced non-small-cell lung cancer: reality or wishful thinking? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081201 |
| Study on disulfur-backboned nucleic acids: part 3. Efficient synthesis of 3',5'-dithio-2'-deoxyuridine and deoxycytidine. | Nucleosides, nucleotides & nucleic acids 20081201 |
| Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study. | The Lancet. Oncology 20081201 |
| Restoration of adenosine deaminase-deficient human thymocyte development in vitro by inhibition of deoxynucleoside kinases. | Journal of immunology (Baltimore, Md. : 1950) 20081201 |
| Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma. | Cancer science 20081201 |
| Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. | Cancer research 20081201 |
| Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate and tacrolimus at steady state when administered alone or in combination. | International journal of clinical pharmacology and therapeutics 20081201 |
| Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II Consortium. | American journal of clinical oncology 20081201 |
| A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20081201 |
| Activity of ixabepilone in patients with metastatic breast cancer with primary resistance to taxanes. | Clinical breast cancer 20081201 |
| A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338. | Clinical breast cancer 20081201 |
| A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors. | Molecular cancer therapeutics 20081201 |
| Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: results of a prospective phase II trial. | Annals of surgery 20081201 |
| Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy. | International journal of clinical oncology 20081201 |
| [Gemcitabine treatment in patients with stage IV pancreatic cancer and prognostic factors for survival of patients with stage IVb(a retrospective survey at 15 hospitals in Niigata Prefecture)]. | Gan to kagaku ryoho. Cancer & chemotherapy 20081201 |
| [A long survival case of unresectable pancreatic cancer by chemoradiotherapy with gemcitabine as key drug]. | Gan to kagaku ryoho. Cancer & chemotherapy 20081201 |
| Gilead AIDS pill effective in study with weekends off. | The AIDS reader 20081201 |
| Concurrent chemoradiotherapy with gemcitabine plus regional hyperthermia for locally advanced pancreatic carcinoma: initial experience. | Radiation medicine 20081201 |
| [Capecitabine combined with cisplatin as first-line therapy in Chinese patients with advanced gastric carcinoma-a phase II clinical study]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20081201 |
| [Docetaxel and capecitabine combination chemotherapy for patients with anthracycline-resistant metastatic breast cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20081201 |
| Study shows people can safely switch to Atripla. | Project Inform perspective 20081201 |
| Switching Combivir to Truvada keeps HIV undetectable, improves blood fats, fails to improve limb fat. | Project Inform perspective 20081201 |
| New drugs currently available in non-muscle invasive bladder cancer: update on gemcitabine studies. | Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20081201 |
| Gemcitabine and taxanes in metastatic breast cancer: a systematic review. | Therapeutics and clinical risk management 20081201 |
| First-line therapeutic strategies in metastatic colorectal cancer. | Oncology (Williston Park, N.Y.) 20081130 |
| Management of a patient with borderline resectable pancreatic cancer. Case report and review. | Oncology (Williston Park, N.Y.) 20081130 |
| A patient with unresectable advanced pancreatic cancer achieving long-term survival with gemcitabine chemotherapy. | World journal of gastroenterology 20081128 |
| Triplex formation on DNA targets: how to choose the oligonucleotide. | Biochemistry 20081125 |
| Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase-inhibition with sunitinib. | European journal of medical research 20081124 |
| Emtricitabine: Inhibitor and substrate of multidrug resistance associated protein. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20081115 |
| The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines. | International journal of cancer 20081115 |
| Phase 2 study of gemcitabine and irinotecan in metastatic breast cancer with correlatives to determine topoisomerase I localization as a predictor of response. | Cancer 20081115 |
| Phase 1 trial of lipoplatin and gemcitabine as a second-line chemotherapy in patients with nonsmall cell lung carcinoma. | Cancer 20081115 |
| Quantitative analysis of vascular endothelial growth factor in liver metastases from pancreatic carcinoma as a predictor of chemotherapeutic effect and prognosis. | Clinical cancer research : an official journal of the American Association for Cancer Research 20081115 |
| Regression of HIV-related diffuse large B-cell lymphoma in response to antiviral therapy alone. | Blood 20081115 |
| p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia. | Cancer research 20081115 |
| Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography-electrospray ionization mass spectrometry. | Mutation research 20081110 |
| Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study. | Journal of pharmaceutical and biomedical analysis 20081104 |
| Safety and pharmacokinetics of motesanib in combination with gemcitabine for the treatment of patients with solid tumours. | British journal of cancer 20081104 |
| Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer. | JOP : Journal of the pancreas 20081103 |
| Interaction between capecitabine and gemcitabine with warfarin in a patient with pancreatic cancer. | JOP : Journal of the pancreas 20081103 |
| Radiation recall phenomenon secondary to bevacizumab in a patient with pancreatic cancer. | JOP : Journal of the pancreas 20081103 |
| Determinants of high-risk sexual behavior during post-exposure prophylaxis to prevent HIV infection. | AIDS and behavior 20081101 |
| Pooled analysis of diarrhea events in patients with cancer treated with lapatinib. | Breast cancer research and treatment 20081101 |
| Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20081101 |
| Tumor resensitization to erlotinib following brief substitution of cetuximab. | Cancer chemotherapy and pharmacology 20081101 |
| Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell. | Cancer chemotherapy and pharmacology 20081101 |
| [Acral necrosis in metastatic ovarian carcinoma. A single episode of Moschowitz syndrome during gemcitabine chemotherapy]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20081101 |
| Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20081101 |
| Treatment outcome in performance status 2 advanced NSCLC patients administered platinum-based combination chemotherapy. | Lung cancer (Amsterdam, Netherlands) 20081101 |
| Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as postoperative treatment for stage II and III rectal cancer. | International journal of radiation oncology, biology, physics 20081101 |
| mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids. | American journal of respiratory cell and molecular biology 20081101 |
| Human immunodeficiency virus-induced uveitis: intraocular and plasma human immunodeficiency virus-1 RNA loads. | Ophthalmology 20081101 |
| Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma. | International journal of radiation oncology, biology, physics 20081101 |
| Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors. | Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20081101 |
| Switch from zidovudine- to non-zidovudine-containing regimens is associated with modest haematological improvement and no obvious clinical benefit: a substudy of the ANRS 099 ALIZE trial. | The Journal of antimicrobial chemotherapy 20081101 |
| Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: an observational study. | Critical reviews in oncology/hematology 20081101 |
| Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy. | Annals of surgical oncology 20081101 |
| Phase-I-study of four different schedules of pemetrexed, gemcitabine and cisplatin in patients with locally advanced or metastatic solid tumours. | European journal of cancer (Oxford, England : 1990) 20081101 |
| The CAP-CR study: direct medical costs in Italian metastatic colorectal cancer patients on first-line infusional 5-fluorouracil or oral capecitabine. | European journal of cancer (Oxford, England : 1990) 20081101 |
| [Molecular targets for colon cancer. VEGF, EGFR - and what else?]. | Der Pathologe 20081101 |
| A case of cardiogenic shock caused by capecitabine treatment. | Nature clinical practice. Cardiovascular medicine 20081101 |
| Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982). | European journal of cancer (Oxford, England : 1990) 20081101 |
| A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer. | Cancer 20081101 |
| Neoadjuvant gemcitabine and cisplatin: another step on the path toward improving the outcomes of patients with high-risk, invasive bladder cancer. | Cancer 20081101 |
| A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience. | Cancer 20081101 |
| Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: study of mechanisms. | Anti-cancer drugs 20081101 |
| Docetaxel plus oxaliplatin (DOCOX) as a second-line treatment after failure of fluoropyrimidine and platinum in Chinese patients with advanced gastric cancer. | Anti-cancer drugs 20081101 |
| Application of epothilones in breast cancer therapy. | Current opinion in oncology 20081101 |
| Prognostic factors in japanese patients with advanced pancreatic cancer treated with single-agent gemcitabine as first-line therapy. | Japanese journal of clinical oncology 20081101 |
| Effect of local sugar and base geometry on 13C and 15N magnetic shielding anisotropy in DNA nucleosides. | Journal of biomolecular NMR 20081101 |
| Capecitabine-associated cerebellar ataxia. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081101 |
| Influence of capecitabine absorption on its metabolites pharmacokinetics: a bioequivalence study. | Annals of oncology : official journal of the European Society for Medical Oncology 20081101 |
| Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine. | Pancreas 20081101 |
| Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: a phase II study. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20081101 |
| Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a review. | Clinical cancer research : an official journal of the American Association for Cancer Research 20081101 |
| Gemcitabine: vascular toxicity and prothrombotic potential. | Expert opinion on drug safety 20081101 |
| [Efficacy of whole body gamma-knife radiotherapy combined with thermochemotherapy on locally advanced pancreatic cancer]. | Ai zheng = Aizheng = Chinese journal of cancer 20081101 |
| [Efficacy of GDP regimen (gemcitabine, dexamethasone, and cisplatin) on relapsed or refractory aggressive non-Hodgkin's Lymphoma: a report of 24 cases]. | Ai zheng = Aizheng = Chinese journal of cancer 20081101 |
| Bortezomib is ineffective in an orthotopic mouse model of pancreatic adenocarcinoma. | Molecular cancer therapeutics 20081101 |
| [A phase I study of combination therapy with capecitabine and paclitaxel for patients with inoperable breast cancer or recurrent breast cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20081101 |
| [Remarkable effect of gemcitabine-oxaliplatin (GEMOX) therapy in a patient with advanced metastatic mucinous cystic neoplasm of the pancreas]. | Gan to kagaku ryoho. Cancer & chemotherapy 20081101 |
| Adrenal metastasis of breast cancer with involvement of the inferior vena cava. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20081101 |
| Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer. | Clinical colorectal cancer 20081101 |
| 96-week CASTLE data show similar efficacy results. | AIDS patient care and STDs 20081101 |
| Trial will evaluate a once-daily dose of raltegravir. | AIDS patient care and STDs 20081101 |
| [Use of diffusion-weighted MRI in monitoring response of lymph node metastatic bladder cancer treated with chemotherary]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20081101 |
| [Metastases from urethelial carcinoma: role of chemotherapy]. | Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20081101 |
| [A case report of intra-operative radiotherapy and gemcitabine for unresectable pancreatic body cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20081101 |
| [S-1+gemcitabine (GEM) therapy was effective in a case of unresectable pancreatic head carcinoma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20081101 |
| [Effective combination chemotherapy with gemcitabine hydrochloride, S-1 and nedaplatin for recurrent pancreatic cancer--a case report]. | Gan to kagaku ryoho. Cancer & chemotherapy 20081101 |
| [A phase I study of combination-therapy with gemcitabine and epitope peptides derived from human vascular endothelial growth factor receptor for unresectable or recurrent pancreas cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20081101 |
| [Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20081101 |
| Capecitabine induced vasospastic angina. | International journal of cardiology 20081030 |
| GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group. | British journal of cancer 20081021 |
| Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081020 |
| Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma--epigenetic downregulation of caspases. | International journal of cancer 20081015 |
| Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer. | Cancer 20081015 |
| Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. | Cancer research 20081015 |
| Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers. | Clinical cancer research : an official journal of the American Association for Cancer Research 20081015 |
| Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. | Nature 20081009 |
| Mechanistic basis of zidovudine hypersusceptibility and lamivudine resistance conferred by the deletion of codon 69 in the HIV-1 reverse transcriptase coding region. | Journal of molecular biology 20081003 |
| A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer. | Cancer chemotherapy and pharmacology 20081001 |
| Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil. | Investigational new drugs 20081001 |
| Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer. | Cancer chemotherapy and pharmacology 20081001 |
| Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20081001 |
| A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable? | Investigational new drugs 20081001 |
| Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC). | Lung cancer (Amsterdam, Netherlands) 20081001 |
| A phase II trial of low-dose gemcitabine and radiation alternated to cisplatin and 5-fluorouracil: an active and manageable regimen for stage IV squamous cell carcinoma of the head and neck. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20081001 |
| Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: final results of a phase II study. | Lung cancer (Amsterdam, Netherlands) 20081001 |
| Phase I/II study of gemcitabine with pegylated liposomal doxorubicin as first-line therapy in Asian women with metastatic breast cancer. | Breast (Edinburgh, Scotland) 20081001 |
| Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20081001 |
| Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies. | Annals of oncology : official journal of the European Society for Medical Oncology 20081001 |
| Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study. | Annals of oncology : official journal of the European Society for Medical Oncology 20081001 |
| Phase II trial of capecitabine and weekly docetaxel in metastatic renal cell carcinoma. | Urology 20081001 |
| Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course. | Journal of acquired immune deficiency syndromes (1999) 20081001 |
| Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology. | Japanese journal of clinical oncology 20081001 |
| Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20081001 |
| Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluation. | Cancer investigation 20081001 |
| HER-2-positive metastatic breast cancer: trastuzumab and beyond. | Expert opinion on pharmacotherapy 20081001 |
| Borderline resectable pancreatic cancer: on the edge of survival. | Cancer control : journal of the Moffitt Cancer Center 20081001 |
| Cancer of the pancreas: are we making progress? A review of studies in the US Oncology Research Network. | Cancer control : journal of the Moffitt Cancer Center 20081001 |
| The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal-regulated and checkpoint kinases. | Oncology reports 20081001 |
| Serum CA19-9 decline compared to radiographic response as a surrogate for clinical outcomes in patients with metastatic pancreatic cancer receiving chemotherapy. | Pancreas 20081001 |
| Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081001 |
| Bevacizumab in advanced colorectal cancer: a challenge to the current paradigm. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081001 |
| Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20081001 |
| A phase II study of oxaliplatin, pemetrexed, and bevacizumab in previously treated advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20081001 |
| A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20081001 |
| Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. | Cancer research 20081001 |
| ATM and the Mre11-Rad50-Nbs1 complex respond to nucleoside analogue-induced stalled replication forks and contribute to drug resistance. | Cancer research 20081001 |
| Time to full publication of studies of anti-cancer medicines for breast cancer and the potential for publication bias: a short systematic review. | Health technology assessment (Winchester, England) 20081001 |
| [Pathogenesis of and therapeutic progress for myelodysplastic syndromes]. | [Rinsho ketsueki] The Japanese journal of clinical hematology 20081001 |
| The combination of thalidomide and capecitabine in metastatic renal cell carcinoma -- is not the answer. | American journal of clinical oncology 20081001 |
| A phase II trial of fixed-dosed rate gemcitabine in platinum-resistant ovarian cancer: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) Trial. | American journal of clinical oncology 20081001 |
| [An autopsy case of pancreatic cancer with poor performance status due to peritonitis carcinomatosa treated successfully with continuous infusion of low-dose 5-FU with octreotide]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20081001 |
| Coronary spasm induced by capecitabine mimicks ST elevation myocardial infarction. | Emergency medicine journal : EMJ 20081001 |
| FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2. | The oncologist 20081001 |
| Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines. | Molecular cancer therapeutics 20081001 |
| An update on biochemotherapy of advanced gastric and gastroesophageal adenocarcinoma. | Journal of the National Comprehensive Cancer Network : JNCCN 20081001 |
| [Two cases of advanced biliary tract cancer successfully treated with gemcitabine combination chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20081001 |
| Prometheus' spirit: quality survival in advanced hepatocellular carcinoma after gemcitabine and cisplatin-based chemotherapy. | Singapore medical journal 20081001 |
| A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancer. | Clinical breast cancer 20081001 |
| Carboplatin plus gemcitabine repeating doublet therapy in recurrent breast cancer. | Clinical breast cancer 20081001 |
| Complete remission of unresectable colon cancer after preoperative chemotherapy selected by adenosine triphosphate-based chemotherapy response assay. | Journal of Korean medical science 20081001 |
| Preoperative chemoradiation for locally advanced rectal cancer with capecitabine 2,000 mg/m2/day. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20081001 |
| Effective chemotherapy based on a chemosensitivity test for malignant pleural mesothelioma. | Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20081001 |
| In vivo chemotherapeutic profile of human gallbladder small cell carcinoma. | Biomedical research (Tokyo, Japan) 20081001 |
| Antiangiogenic effect of capecitabine combined with ginsenoside Rg3 on breast cancer in mice. | Cancer biotherapy & radiopharmaceuticals 20081001 |
| [Two novel fixed formulations of nucleoside analogues (tenofovir-emtricitabine, and abacavir-lamivudine). Prospective, open study on clinical practice and therapeutic perspectives, in patients naïve and in subjects pre-treated with antiretrovirals]. | Recenti progressi in medicina 20081001 |
| [Combination of docetaxel and capecitabine for the treatment of anthracycline-resistant advanced breast carcinoma]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20081001 |
| Patient challenges trust's right to deprive her of NHS treatment for buying drugs privately. | BMJ (Clinical research ed.) 20080930 |
| The high rate of endoreduplication in the repair deficient CHO mutant EM9 parallels a reduced level of methylated deoxycytidine in DNA. | Mutation research 20080926 |
| Breathless beyond obvious. | BMJ (Clinical research ed.) 20080917 |
| Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer. | British journal of cancer 20080916 |
| Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study. | British journal of cancer 20080916 |
| Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer. | British journal of cancer 20080916 |
| Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy. | British journal of cancer 20080916 |
| Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma. | Cancer 20080915 |
| Chemoradiotherapy with twice-weekly administration of low-dose gemcitabine for locally advanced pancreatic cancer. | World journal of gastroenterology 20080914 |
| Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. | Cancer cell 20080909 |
| Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma. | World journal of gastroenterology 20080907 |
| Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer. | British journal of cancer 20080902 |
| Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer. | British journal of cancer 20080902 |
| Trichostatin A and 5 Aza-2' deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR. | Breast cancer research and treatment 20080901 |
| Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas. | Cancer chemotherapy and pharmacology 20080901 |
| A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors. | Cancer chemotherapy and pharmacology 20080901 |
| Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation. | Cancer chemotherapy and pharmacology 20080901 |
| Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients. | Cancer chemotherapy and pharmacology 20080901 |
| A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors. | Cancer chemotherapy and pharmacology 20080901 |
| A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma. | Cancer chemotherapy and pharmacology 20080901 |
| An iatrogenic hepatic subcapsular biloma successfully treated by percutaneous drainage and endoscopic biliary stenting. | Endoscopy 20080901 |
| Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3,3' diindolylmethane (DIM). | Pharmaceutical research 20080901 |
| Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20080901 |
| Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. | Annals of oncology : official journal of the European Society for Medical Oncology 20080901 |
| A spectroscopic study of the interaction of the fluorescent beta-carboline-3-carboxylic acid N-methylamide with DNA constituents: nucleobases, nucleosides and nucleotides. | Journal of fluorescence 20080901 |
| EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. | International journal of radiation oncology, biology, physics 20080901 |
| Overcoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemcitabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carcinoma cell lines. | Molecular pharmacology 20080901 |
| Attenuation of vision loss and delay in apoptosis of photoreceptors induced by proinsulin in a mouse model of retinitis pigmentosa. | Investigative ophthalmology & visual science 20080901 |
| Detection of endogenous DNA adducts, O-carboxymethyl-2'-deoxyguanosine and 3-ethanesulfonic acid-2'-deoxycytidine, in the rat stomach after duodenal reflux. | Cancer science 20080901 |
| Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics. | Drug metabolism and disposition: the biological fate of chemicals 20080901 |
| Drug Insight: intracellular inhibitors of HER2--clinical development of lapatinib in breast cancer. | Nature clinical practice. Oncology 20080901 |
| A modern regimen of pre-operative concurrent chemo-radiation therapy in locally advanced rectal cancer. | Journal of surgical oncology 20080901 |
| Tumor heterogeneity in ovarian cancer as demonstrated by in vitro chemoresistance assays. | Gynecologic oncology 20080901 |
| A phase II trial of gemcitabine plus capecitabine for metastatic renal cell cancer previously treated with immunotherapy and targeted agents. | The Journal of urology 20080901 |
| Systemic therapy for unresectable and metastatic transitional cell carcinoma of the urothelium: first-line and beyond. | Current opinion in supportive and palliative care 20080901 |
| Prediction of the effect of capecitabine in gastric cancer by immunohistochemical staining of thymidine phosphorylase and dihydropyrimidine dehydrogenase. | Anti-cancer drugs 20080901 |
| Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer. | Anti-cancer drugs 20080901 |
| Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer. | International journal of oncology 20080901 |
| Significant antitumor activity of cationic multilamellar liposomes containing human interferon-beta gene in combination with 5-fluorouracil against human renal cell carcinoma. | International journal of oncology 20080901 |
| Long-term effects of multimodal treatment for patients with resectable carcinoma of the pancreas. | Oncology reports 20080901 |
| Novel therapies in peripheral T-cell lymphomas. | Current oncology reports 20080901 |
| Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression. | Cancer research 20080901 |
| Promising survival in patients with recurrent non-small cell lung cancer treated with docetaxel and gemcitabine in combination as second-line therapy. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080901 |
| Docetaxel as second line therapy in advanced non-small cell lung cancer-the dose and combination may matter! | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080901 |
| Matuzumab short-term therapy in experimental pancreatic cancer: prolonged antitumor activity in combination with gemcitabine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080901 |
| A phase I study of EKB-569 in combination with capecitabine in patients with advanced colorectal cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080901 |
| Complete remission in a colon cancer patient with a large, irresectable liver metastasis after XELOX/cetuximab/bevacizumab treatment. | Onkologie 20080901 |
| Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosis. | Molecular cancer therapeutics 20080901 |
| AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies. | Molecular cancer therapeutics 20080901 |
| Bilateral inflammatory metachronic ERBB2 (HER2/neu)-positive breast carcinoma: prolonged survival with combined chemotherapy and trastuzumab. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20080901 |
| [A case of elderly non-small cell lung cancer effectively treated by combined chemotherapy of gemcitabine and S-1]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080901 |
| [A recurrent case of lipid-secreting carcinoma of the breast successfully treated with capecitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080901 |
| Craniocervical paraganglioma with numerous pulmonary metastases--case report. | Neurologia medico-chirurgica 20080901 |
| S-phase cell-specific modification by gemcitabine of PFGE-analyzed radiation-induced DNA fragmentation and rejoining. | International journal of radiation biology 20080901 |
| Prospective study on warfarin and regional chemotherapy in patients with pancreatic carcinoma. | Journal of gastrointestinal and liver diseases : JGLD 20080901 |
| Second-line therapy for gemcitabine-refractory pancreatic cancer: is there a standard? | Oncology (Williston Park, N.Y.) 20080901 |
| [Combination therapy consisting of gemcitabine, docetaxel and carboplatin as a second-line chemotherapy for patients with MVAC-treated metastatic urothelial carcinoma]. | Hinyokika kiyo. Acta urologica Japonica 20080901 |
| Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20080901 |
| Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer? | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20080901 |
| Apricitabine continues to show good results. | Project Inform perspective 20080901 |
| Gay community to test HIV prevention pill. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20080901 |
| Gemcitabine concurrent with radiation therapy for locally advanced head and neck carcinomas. | African health sciences 20080901 |
| Kinetic analysis of translesion synthesis opposite bulky N2- and O6-alkylguanine DNA adducts by human DNA polymerase REV1. | The Journal of biological chemistry 20080829 |
| Efficacy of the oral fluorouracil pro-drug capecitabine in cancer treatment: a review. | Molecules (Basel, Switzerland) 20080827 |
| Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1. | Molecular cell 20080822 |
| Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080820 |
| tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation. | British journal of cancer 20080819 |
| A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer. | British journal of cancer 20080819 |
| A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei. | British journal of cancer 20080819 |
| Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts. | Cancer letters 20080818 |
| Proteasome inhibition activates epidermal growth factor receptor (EGFR) and EGFR-independent mitogenic kinase signaling pathways in pancreatic cancer cells. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080815 |
| The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080815 |
| Mexico conference considers pre-exposure prophylaxis for AIDS. | BMJ (Clinical research ed.) 20080814 |
| The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance. | British journal of cancer 20080805 |
| Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer. | Investigational new drugs 20080801 |
| Preliminary experience with gemcitabine and cisplatin adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20080801 |
| Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma. | Cancer chemotherapy and pharmacology 20080801 |
| A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas. | Investigational new drugs 20080801 |
| Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H. | Leukemia research 20080801 |
| The feasibility of using topotecan, vinorelbine, thiotepa and gemcitabine (TVTG) in adult patients with relapsed/refractory acute lymphoblastic leukaemia/lymphoma. | Leukemia 20080801 |
| Nail and periungual toxicity following capecitabine therapy. | British journal of clinical pharmacology 20080801 |
| [A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)]. | Der Internist 20080801 |
| Squalenoylation favorably modifies the in vivo pharmacokinetics and biodistribution of gemcitabine in mice. | Drug metabolism and disposition: the biological fate of chemicals 20080801 |
| Development of bioluminescent pyrophosphate assay using pyruvate phosphate dikinase and its application to single-nucleotide polymorphism analysis. | Analytical biochemistry 20080801 |
| Extensive metabolism and hepatic accumulation of gemcitabine after multiple oral and intravenous administration in mice. | Drug metabolism and disposition: the biological fate of chemicals 20080801 |
| Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology Consortium. | Gynecologic oncology 20080801 |
| Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer. | Nature clinical practice. Oncology 20080801 |
| Functional characterization of cohesin subunit SCC1 in Trypanosoma brucei and dissection of mutant phenotypes in two life cycle stages. | Molecular microbiology 20080801 |
| Large bowel perforation associated with capecitabine treatment for breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20080801 |
| Synthesis of 3'-deoxy-3'-C-methyl nucleoside derivatives. | Bioorganic & medicinal chemistry 20080801 |
| Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer. | Biochemical pharmacology 20080801 |
| Scheduled administration of low dose irinotecan before gemcitabine in the second line therapy of non-small cell lung cancer: a phase II study. | Anti-cancer drugs 20080801 |
| Pyogenic granuloma-like lesions caused by capecitabine therapy. | Clinical and experimental dermatology 20080801 |
| Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine. | Journal of the American Academy of Dermatology 20080801 |
| Ribonucleotide reductase subunit M1 is a possible chemoresistance marker to gemcitabine in biliary tract carcinoma. | Oncology reports 20080801 |
| Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: a single-institution phase II study. | Annals of surgery 20080801 |
| The combined effect of fludarabine monophosphate and radiation as well as gemcitabine and radiation on squamous carcinoma tumor cell lines in vitro. | International journal of radiation biology 20080801 |
| Cytotoxic effects of haplamine and its major metabolites on human cancer cell lines. | Planta medica 20080801 |
| Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080801 |
| Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080801 |
| Capecitabine-induced coronary vasospasm. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080801 |
| Drug development in the targeted therapy era. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080801 |
| Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080801 |
| Influence of food on the pharmacokinetics of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor. | Expert opinion on pharmacotherapy 20080801 |
| Weekly docetaxel as salvage therapy in patients with gemcitabine-refractory metastatic pancreatic cancer. | Journal of chemotherapy (Florence, Italy) 20080801 |
| Evidence-based guidelines for adjuvant therapy for resected adenocarcinoma of the pancreas. | Clinical journal of oncology nursing 20080801 |
| Enhancement of somatostatin-receptor-targeted (177)Lu-[DOTA(0)-Tyr(3)]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation. | Nuclear medicine and biology 20080801 |
| FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer. | Current cancer drug targets 20080801 |
| [The prevention of diarrhea while under capecitabine therapy]. | Deutsche medizinische Wochenschrift (1946) 20080801 |
| Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine. | Journal of gastroenterology and hepatology 20080801 |
| [Clinical effect and positioning of capecitabine for metastatic breast carcinoma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080801 |
| [Management of hand-foot syndrome in patient treated with capecitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080801 |
| [A case of recurrent gall bladder cancer responding to chemotherapy with gemcitabine after endoscopic metallic biliary stent implantation]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080801 |
| [A case of left urothelial carcinoma with multiple bone metastasis, liver metastasis and right adrenal metastasis successfully treated with combination chemotherapy of gemcitabine and carboplatin]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080801 |
| Phase II study of single-agent gemcitabine in heavily pretreated Japanese patients with recurrent ovarian cancer. | International journal of clinical oncology 20080801 |
| Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1. | Molecular cancer therapeutics 20080801 |
| New insights into the pharmacology and cytotoxicity of gemcitabine and 2',2'-difluorodeoxyuridine. | Molecular cancer therapeutics 20080801 |
| Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia. | Leukemia & lymphoma 20080801 |
| CD4 count improvement following tenofovir to abacavir switch in a patient with persistent lymphopenia despite an undetectable viral load. | The AIDS reader 20080801 |
| Gemcitabine plus UFT combination chemotherapy as second- or third-line therapy in non-small cell lung cancer: a pilot study. | The journal of medical investigation : JMI 20080801 |
| Acinar cell carcinoma--a rare tumour of the pancreas. | South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie 20080801 |
| Alternating XELFOX and XELFIRI in patients with metastatic colorectal cancer. | American journal of clinical oncology 20080801 |
| Capecitabine in gastric cancer. | Drugs of today (Barcelona, Spain : 1998) 20080801 |
| New nucleotide pairs for stable DNA triplexes stabilized by stacking interaction. | Journal of the American Chemical Society 20080730 |
| Altered order of substrate binding by DNA polymerase X from African Swine Fever virus. | Biochemistry 20080729 |
| Elucidation of different binding modes of purine nucleosides to human deoxycytidine kinase. | Journal of medicinal chemistry 20080724 |
| New treatment strategies provide more options for patients with breast cancer. | JAMA 20080723 |
| Clinical trials probe new therapies for some difficult-to-treat cancers. | JAMA 20080723 |
| UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study. | British journal of cancer 20080722 |
| [Investigation into the controlled release behavior of gemcitabine-loaded nanovesicles]. | Zhonghua yi xue za zhi 20080722 |
| Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080720 |
| Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080720 |
| Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080720 |
| Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080720 |
| Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080720 |
| Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer. | Cancer 20080715 |
| Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma. | Cancer 20080715 |
| Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting. | Langmuir : the ACS journal of surfaces and colloids 20080715 |
| Ixabepilone in combination with capecitabine and as monotherapy for treatment of advanced breast cancer refractory to previous chemotherapies. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080715 |
| Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080710 |
| New developments in the treatment of pancreatic cancer. Highlights from the '44th ASCO Annual Meeting'. Chicago, IL, USA. May 30 - June 3, 2008. | JOP : Journal of the pancreas 20080710 |
| Translational research in pancreatic cancer. Highlights from the '44th ASCO Annual Meeting'. Chicago, IL, USA. May 30 - June 3, 2008. | JOP : Journal of the pancreas 20080710 |
| Is there a role for herbal medicine in the treatment of pancreatic cancer?. Highlights from the '44th ASCO Annual Meeting'. Chicago, IL, USA. May 30 - June 3, 2008. | JOP : Journal of the pancreas 20080710 |
| Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses. | British journal of cancer 20080708 |
| Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU). | Cancer chemotherapy and pharmacology 20080701 |
| Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis. | Cancer chemotherapy and pharmacology 20080701 |
| Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancer. | International journal of radiation oncology, biology, physics 20080701 |
| Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests. | Clinical endocrinology 20080701 |
| Phase II trial of gemcitabine/carboplatin followed by paclitaxel in patients with performance status=2,3 or other significant co-morbidity (HIV infection or s/p organ transplantation) in advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20080701 |
| Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target. | Journal of cancer research and clinical oncology 20080701 |
| Complete radiographic response of primary pulmonary angiosarcomas following gemcitabine and taxotere. | Lung cancer (Amsterdam, Netherlands) 20080701 |
| 188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases. | European journal of nuclear medicine and molecular imaging 20080701 |
| Repetitive transarterial chemoembolization (TACE) of liver metastases from renal cell carcinoma: local control and survival results. | European radiology 20080701 |
| Discoid lupus erythematosus (DLE)-like lesions induced by capecitabine. | International journal of colorectal disease 20080701 |
| Candidate mechanisms for capecitabine-related hand-foot syndrome. | British journal of clinical pharmacology 20080701 |
| Inhibition of proliferation to omega-3 fatty acids in chemoresistant pancreatic cancer cells: mechanism of action may be more complex. | Annals of surgical oncology 20080701 |
| Pancreatic cancer--is the wall crumbling? | Annals of oncology : official journal of the European Society for Medical Oncology 20080701 |
| Review article: current antiviral therapy of chronic hepatitis B. | Alimentary pharmacology & therapeutics 20080701 |
| Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma. | British journal of haematology 20080701 |
| Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma. | Laboratory investigation; a journal of technical methods and pathology 20080701 |
| Efficacy of alemtuzumab and gemcitabine in a patient with enteropathy-type T-cell lymphoma. | British journal of haematology 20080701 |
| Galloylated catechins as potent inhibitors of hypochlorous acid-induced DNA damage. | Chemical research in toxicology 20080701 |
| Combined cetuximab, capecitabine, oxaliplatin, and radiotherapy in rectal cancer: Dr. Jekyll or Mr. Hyde? In regard to Rödel et al. (Int J Radiat Oncol Biol Phys 2008;70:1081-1086.). | International journal of radiation oncology, biology, physics 20080701 |
| The effects of sulfur-containing compounds and gemcitabine on the binding of cisplatin to plasma proteins and DNA determined by inductively coupled plasma mass spectrometry and high performance liquid chromatography-inductively coupled plasma mass spectrometry. | Anti-cancer drugs 20080701 |
| Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2'-deoxycytidine analog. | Nature medicine 20080701 |
| Optimized blood sampling with cytidine deaminase inhibitor for improved analysis of capecitabine metabolites. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080701 |
| A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting. | Oncology reports 20080701 |
| Establishment of combined immuno-chemotherapy with systemically administered gemcitabine and intra-portal administration of interleukin-2 in murine models of liver metastases of pancreatic cancer. | International journal of oncology 20080701 |
| Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: results of a phase III study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080701 |
| Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer. | Cancer research 20080701 |
| Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial). | Clinical cancer research : an official journal of the American Association for Cancer Research 20080701 |
| A pharmacodynamic model for the time course of tumor shrinkage by gemcitabine + carboplatin in non-small cell lung cancer patients. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080701 |
| Randomized phase III trial comparing single-agent paclitaxel Poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080701 |
| Synthesis and characterization of DNA adducts from the HIV reverse transcriptase inhibitor nevirapine. | Chemical research in toxicology 20080701 |
| Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents? | The oncologist 20080701 |
| Gemcitabine pulmonary toxicity in ovarian cancer. | The oncologist 20080701 |
| High excretion of etheno adducts in liver fluke-infected patients: protection by praziquantel against DNA damage. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20080701 |
| [Ethnic differences of genetic polymorphisms in cancer chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080701 |
| [Randomized phase II study of carboplatin/paclitaxel followed by gemcitabine versus carboplatin/gemcitabine followed by docetaxel in patients with advanced nonsmall cell lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080701 |
| [Chemotherapy with gemcitabine after non-curative resection of bile duct cancer--a case report]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080701 |
| [Usefulness of S-1/gemcitabine combination therapy for advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080701 |
| [A case of advanced pancreatic cancer successfully treated by combined chemotherapy of S-1 and gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080701 |
| A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients. | Journal of chromatographic science 20080701 |
| An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics of the TORCH trial. | Clinical lung cancer 20080701 |
| Dual biologic therapy in the first-line mCRC setting: implications of the CAIRO2 study. | Clinical colorectal cancer 20080701 |
| Highlights from: The 44th Annual Meeting of the American Society of Clinical Oncology. Chicago, IL; May 30-June 3, 2008. | Clinical colorectal cancer 20080701 |
| Salvage regimens for Hodgkin lymphoma. | Clinical advances in hematology & oncology : H&O 20080701 |
| The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients. | Lung cancer (Amsterdam, Netherlands) 20080701 |
| FDA notifications. Generic emtricitabine approved by FDA. | AIDS alert 20080701 |
| Phase II trial of gemcitabine in combination with cisplatin in inoperable or advanced hepatocellular carcinoma. | Annals of the Academy of Medicine, Singapore 20080701 |
| Antiretroviral rounds. Is that 'one pill' treatment enough? | AIDS clinical care 20080701 |
| Severe psoriasis due to cessation of antiretroviral therapy in a patient with human immunodeficiency virus. | The Israel Medical Association journal : IMAJ 20080701 |
| [Salvage chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer: survival benefit in selected patients]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080701 |
| Survival for patients with pancreatic cancer after addition of gemcitabine to fluorouracil chemoradiation. | JAMA 20080625 |
| Survival for patients with pancreatic cancer after addition of gemcitabine to Fluorouracil chemoradiation. | JAMA 20080625 |
| Targeting angiogenesis in pancreatic cancer. | Lancet (London, England) 20080621 |
| Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study. | Lancet (London, England) 20080621 |
| Experimental treatment of pancreatic cancer with two novel histone deacetylase inhibitors. | World journal of gastroenterology 20080621 |
| Nonmetastatic pancreatic cancer: many trials, little progress. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080620 |
| Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study. | British journal of cancer 20080617 |
| Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study. | Cancer 20080615 |
| Phase 2 trial of pemetrexed disodium and gemcitabine in advanced urothelial cancer (E4802): a trial of the Eastern Cooperative Oncology Group. | Cancer 20080615 |
| Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080615 |
| Metabolic interrelations within guanine deoxynucleotide pools for mitochondrial and nuclear DNA maintenance. | The Journal of biological chemistry 20080613 |
| Solid-state nuclear magnetic resonance spectroscopy studies of furanose ring dynamics in the DNA HhaI binding site. | Journal of the American Chemical Society 20080611 |
| Deamination of the radical cation of the base moiety of 2'-deoxycytidine: a theoretical study. | Chemphyschem : a European journal of chemical physics and physical chemistry 20080602 |
| A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer. | Breast cancer research and treatment 20080601 |
| Sequential vinorelbine-capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial. | Cancer chemotherapy and pharmacology 20080601 |
| A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma. | Cancer chemotherapy and pharmacology 20080601 |
| PK/PD model of indisulam and capecitabine: interaction causes excessive myelosuppression. | Clinical pharmacology and therapeutics 20080601 |
| Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer. | Cancer chemotherapy and pharmacology 20080601 |
| Role of gemcitabine in metastatic breast cancer patients: a short review. | Breast (Edinburgh, Scotland) 20080601 |
| A phase II study of biweekly paclitaxel (P) and gemcitabine (G), followed by maintenance weekly paclitaxel in elderly patients with advanced non-small cell lung cancer (NSCLC). | Lung cancer (Amsterdam, Netherlands) 20080601 |
| Vinorelbine and gemcitabine as salvage treatment in advanced and very poor prognosis non-Hodgkin's lymphoma patients. | Annals of hematology 20080601 |
| Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine. | Annals of hematology 20080601 |
| Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo. | Gut 20080601 |
| A phase I trial of CEP-701 + gemcitabine in patients with advanced adenocarcinoma of the pancreas. | Investigational new drugs 20080601 |
| Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil. | Annals of oncology : official journal of the European Society for Medical Oncology 20080601 |
| A well-tolerated 5-FU-based treatment subsequent to severe capecitabine-induced toxicity in a DPD-deficient patient. | British journal of clinical pharmacology 20080601 |
| A novel humanized anti-human death receptor 5 antibody CS-1008 induces apoptosis in tumor cells without toxicity in hepatocytes. | Annals of oncology : official journal of the European Society for Medical Oncology 20080601 |
| Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine. | The Journal of clinical endocrinology and metabolism 20080601 |
| Inhibition of c-Myc down-regulation by sustained extracellular signal-regulated kinase activation prevents the antimetabolite methotrexate- and gemcitabine-induced differentiation in non-small-cell lung cancer cells. | Molecular pharmacology 20080601 |
| Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma. | American journal of surgery 20080601 |
| Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study. | Gynecologic oncology 20080601 |
| Capecitabine, irinotecan, oxaliplatin (CAPIRINOX) and concomitant irradiation in advanced rectal cancer: the Lyon R-02-01 phase I trial. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20080601 |
| A phase II study of oxaliplatin and gemcitabine in advanced inoperable stage IIIB/IV non-small cell lung cancer. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20080601 |
| Cerebellar toxicity with capecitabine in a patient with metastatic breast cancer. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20080601 |
| New directions in the management of advanced pancreatic cancer: a review. | Anti-cancer drugs 20080601 |
| Capecitabine: an overview of the side effects and their management. | Anti-cancer drugs 20080601 |
| Liposomal delivery improves the growth-inhibitory and apoptotic activity of low doses of gemcitabine in multiple myeloma cancer cells. | Nanomedicine : nanotechnology, biology, and medicine 20080601 |
| Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer. | European journal of cancer (Oxford, England : 1990) 20080601 |
| High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study. | Leukemia & lymphoma 20080601 |
| A liquid chromatography-quadrupole time-of-flight (LC-QTOF)-based metabolomic approach reveals new metabolic effects of catechin in rats fed high-fat diets. | Journal of proteome research 20080601 |
| mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines. | Respirology (Carlton, Vic.) 20080601 |
| Down-regulation of Mcl-1 with antisense technology alters the effect of various cytotoxic agents used in treatment of squamous cell carcinoma of the head and neck. | Oncology reports 20080601 |
| Pancreatic cancer. | Integrative cancer therapies 20080601 |
| Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080601 |
| Update on T-cell lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20080601 |
| Oral administration of gemcitabine in patients with refractory tumors: a clinical and pharmacologic study. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080601 |
| Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080601 |
| Antibodies to vascular endothelial growth factor in non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080601 |
| Addition of single-dose tenofovir and emtricitabine to intrapartum nevirapine to reduce perinatal HIV transmission. | Journal of acquired immune deficiency syndromes (1999) 20080601 |
| Phase I dose escalation study with irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients with solid malignancies. | American journal of clinical oncology 20080601 |
| Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial. | American journal of clinical oncology 20080601 |
| Pulmonary strongyloidiasis mimicking cancer symptoms: a case of hyperinfection in a patient with metastatic lung cancer. | American journal of clinical oncology 20080601 |
| Novel advances in pancreatic cancer treatment. | Expert review of anticancer therapy 20080601 |
| Gemcitabine/docetaxel--welcome to a new standard. | Gynecologic oncology 20080601 |
| Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. | Gynecologic oncology 20080601 |
| Oxaliplatin plus gemcitabine as a salvage schedule for hormone-refractory prostate adenocarcinoma. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20080601 |
| RNAi depletion of deoxycytidine and deoxyguanosine kinase in human leukemic CEM cells. | Nucleosides, nucleotides & nucleic acids 20080601 |
| Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples. | Nucleosides, nucleotides & nucleic acids 20080601 |
| Imatinib-resistant CML cells have low ENT activity but maintain sensitivity to gemcitabine. | Nucleosides, nucleotides & nucleic acids 20080601 |
| Inhibition of deoxynucleoside kinases in human thymocytes prevents dATP accumulation and induction of apoptosis. | Nucleosides, nucleotides & nucleic acids 20080601 |
| 5-Bromovinyl 2'-deoxyuridine phosphorylation by mitochondrial and cytosolic thymidine kinase (TK2 and TK1) and its use in selective measurement of TK2 activity in crude extracts. | Nucleosides, nucleotides & nucleic acids 20080601 |
| [Economic evaluation of gemcitabine-cisplatin chemotherapy for non small-cell lung cancer patient in an outpatient setting]. | Taehan Kanho Hakhoe chi 20080601 |
| Neoadjuvant chemoradiation for rectal cancer: is more better? | Oncology (Williston Park, N.Y.) 20080601 |
| Capecitabine: new indication. Advanced-stage gastric cancer: oral route for some patients. Risk of palmoplantar erythrodysaesthesia. | Prescrire international 20080601 |
| Mesojejunoileac liposarcoma with intrahepatic metastasis in a dog. | The Journal of veterinary medical science 20080601 |
| [Phase II study of combination of gemcitabine and carboplatin in advanced non-small cell lung cancer (an interim report)]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080601 |
| [Feasibility and anti-tumor activity of postoperative adjuvant chemotherapy with gemcitabine for resected pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080601 |
| [A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080601 |
| Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer. | Clinical breast cancer 20080601 |
| Gemcitabine/epirubicin/paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group. | Clinical breast cancer 20080601 |
| Nutritional and pharmacologic support in patients with pancreatic cancer. | Collegium antropologicum 20080601 |
| New drugs. | Journal of HIV therapy 20080601 |
| Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs. | Veterinary and comparative oncology 20080601 |
| [Clinical data II. Clinical experience of tenofovir DF in combination with protease inhibitors]. | Enfermedades infecciosas y microbiologia clinica 20080601 |
| Characterization of intestinal absorption of mizoribine mediated by concentrative nucleoside transporters in rats. | European journal of pharmacology 20080531 |
| Stability of antiretroviral regimens in patients with viral suppression. | AIDS (London, England) 20080531 |
| Kinetic investigation of the inhibitory effect of gemcitabine on DNA polymerization catalyzed by human mitochondrial DNA polymerase. | The Journal of biological chemistry 20080530 |
| [Chemotherapy and renal toxicity]. | Bulletin du cancer 20080528 |
| Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine. | British journal of cancer 20080520 |
| Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080520 |
| Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080520 |
| Gemcitabine and cisplatin treatment over a 3-week versus a 4-week dosing schedule: a randomized trial conducted in Chinese patients with nonsmall cell lung cancer. | Chinese medical journal 20080520 |
| Increased urinary 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine excretion in thalassemia patients: markers for lipid peroxidation-induced DNA damage. | Free radical biology & medicine 20080515 |
| Efficacy of gemcitabine in patients with non-small cell lung cancer according to promoter polymorphisms of the ribonucleotide reductase M1 gene. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080515 |
| Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid. | Journal of controlled release : official journal of the Controlled Release Society 20080508 |
| Capecitabine as salvage therapy for a pancreatic cancer patient with extensive liver metastases and associated impairment of liver function. | JOP : Journal of the pancreas 20080508 |
| Comparison of two column characterisation systems based on pharmaceutical applications. | Journal of chromatography. A 20080502 |
| Structural basis for substrate promiscuity of dCK. | Journal of molecular biology 20080502 |
| Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group. | Cancer chemotherapy and pharmacology 20080501 |
| A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma. | Cancer chemotherapy and pharmacology 20080501 |
| Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients. | Journal of neurology, neurosurgery, and psychiatry 20080501 |
| A phase I clinical trial of low-dose interferon-alpha-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma. | Cancer chemotherapy and pharmacology 20080501 |
| Retrospective case series of gemcitabine plus cisplatin in the treatment of recurrent and metastatic nasopharyngeal carcinoma. | Oral oncology 20080501 |
| Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810). | Lung cancer (Amsterdam, Netherlands) 20080501 |
| Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment. | Lung cancer (Amsterdam, Netherlands) 20080501 |
| Phase II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20080501 |
| Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT. | European journal of nuclear medicine and molecular imaging 20080501 |
| Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015. | Annals of oncology : official journal of the European Society for Medical Oncology 20080501 |
| 96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B. | Journal of hepatology 20080501 |
| A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines. | Annals of oncology : official journal of the European Society for Medical Oncology 20080501 |
| Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine. | The Journal of pharmacology and experimental therapeutics 20080501 |
| The hepatitis C virus replicon presents a higher barrier to resistance to nucleoside analogs than to nonnucleoside polymerase or protease inhibitors. | Antimicrobial agents and chemotherapy 20080501 |
| Systemic therapy for metastatic colorectal cancer: current questions. | Cancer 20080501 |
| Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer. | Gynecologic oncology 20080501 |
| Reaction of 2'-deoxycytidine with peroxynitrite in the presence of ammonium bromide. | Bioorganic & medicinal chemistry 20080501 |
| Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer. | Molecular therapy : the journal of the American Society of Gene Therapy 20080501 |
| Synthesis of gemcitabine triphosphate (dFdCTP) as a tris(triethylammonium) salt. | Bioorganic & medicinal chemistry letters 20080501 |
| Synergy of gemcitabine and lidamycin associated with NF-kappaB downregulation in pancreatic carcinoma cells. | Acta pharmacologica Sinica 20080501 |
| Pulmonary gemcitabine delivery for treating lung cancer: pharmacokinetics and acute lung injury aspects in animals. | Canadian journal of physiology and pharmacology 20080501 |
| Capecitabine-associated coronary vasospasm: a case report. | Emergency medicine journal : EMJ 20080501 |
| Protein kinase C: a target for therapy in pancreatic cancer. | Pancreas 20080501 |
| Predictive value of individualized tumor response testing by ATP-based chemotherapy response assay in ovarian cancer. | Cancer investigation 20080501 |
| Potential regional differences for the tolerability profiles of fluoropyrimidines. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080501 |
| Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080501 |
| Pharmacoeconomic benefits of capecitabine-based chemotherapy in metastatic colorectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080501 |
| Re: Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080501 |
| Pooled analysis of elderly patients with non-small cell lung cancer treated with front line docetaxel/gemcitabine regimen: the Hellenic Oncology Research Group experience. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080501 |
| Efficacy and safety of oxaliplatin and gemcitabine with bevacizumab in advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080501 |
| Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080501 |
| Capecitabine and oxaliplatin for advanced esophagogastric cancer. | The New England journal of medicine 20080501 |
| A phase I study of the safety and pharmacokinetics of the combination of pertuzumab (rhuMab 2C4) and capecitabine in patients with advanced solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080501 |
| Current role of gemcitabine in the treatment of Hodgkin lymphoma. | Leukemia & lymphoma 20080501 |
| [Acute coronary syndrome during oral capecitabine monotherapy]. | Revista espanola de cardiologia 20080501 |
| Use of capecitabine in refractory metastatic medullary thyroid carcinoma. | Thyroid : official journal of the American Thyroid Association 20080501 |
| A carboxylesterase 2 gene polymorphism as predictor of capecitabine on response and time to progression. | Current drug metabolism 20080501 |
| [A case of occult breast cancer successfully treated by capecitabine in combination with weekly paclitaxel followed by FEC (75)]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080501 |
| [A long-term survival case of unresectable malignant pancreatic endocrine tumor successfully treated with systemic chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080501 |
| [Recurrent gallbladder carcinoma treated with combination chemotherapy with gemcitabine, CPT-11 and S-1--a successful case with metastatic tumors replaced by marked calcification]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080501 |
| Metastatic pancreatic cancer 2008: is the glass less empty? | The oncologist 20080501 |
| Optimizing oxaliplatin-based therapy in metastatic colorectal cancer. | Clinical advances in hematology & oncology : H&O 20080501 |
| [Outpatient chemotherapy and oncology network : Onco Pays-de-la-Loire experiment]. | Bulletin du cancer 20080501 |
| Synthesis and antitumor activity of a heterodinucleotide of BVDU and gemcitabine. | Nucleosides, nucleotides & nucleic acids 20080501 |
| [Nonmuscle-invasive bladder cancer (NMIBC): when to perform cystectomy?]. | Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20080501 |
| Colon cancer: update on adjuvant therapy. | Clinical colorectal cancer 20080501 |
| Is XELOX equivalent to FOLFOX or other continuous-infusion 5-fluorouracil chemotherapy in metastatic colorectal cancer? | Clinical colorectal cancer 20080501 |
| [Three-dimensional conformal radiation therapy concurrent with full dose Gemcitabine for locally advanced inoperable pancreatic cancer]. | Harefuah 20080501 |
| [Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B]. | Enfermedades infecciosas y microbiologia clinica 20080501 |
| [Clinical management of patients with chronic hepatitis B virus infection]. | Enfermedades infecciosas y microbiologia clinica 20080501 |
| [Hepatitis B in patients with HIV infection]. | Enfermedades infecciosas y microbiologia clinica 20080501 |
| The effect of HIF-1alpha siRNA on growth and chemosensitivity of MIA-paca cell line. | Yonsei medical journal 20080430 |
| Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: seven cases. | World journal of gastroenterology 20080428 |
| [First line therapy. Tenofovir DF/emtricitabine--the potent backbone]. | MMW Fortschritte der Medizin 20080428 |
| [Complete HAART in a single pill. New milestone for improving compliance]. | MMW Fortschritte der Medizin 20080428 |
| [HIV therapy and adherence]. | MMW Fortschritte der Medizin 20080428 |
| [One pill--all HAART. Complete divergent HAART in a single tablet per day]. | MMW Fortschritte der Medizin 20080428 |
| [Hemolytic uremic syndrome following gemcitabine treatment]. | Revue medicale suisse 20080423 |
| Systematic exploration of active site mutations on human deoxycytidine kinase substrate specificity. | Biochemistry 20080422 |
| A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling. | British journal of cancer 20080422 |
| A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours. | British journal of cancer 20080422 |
| Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080420 |
| Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080420 |
| Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer? | Journal of the National Cancer Institute 20080416 |
| Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial. | Journal of the National Cancer Institute 20080416 |
| A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021. | Cancer 20080415 |
| Nuclear magnetic resonance investigation of primer--template models: formation of a pyrimidine bulge upon misincorporation. | Biochemistry 20080415 |
| HIV study yields unexpected preliminary efficacy results. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080415 |
| Defining the optimal schedule of drug administration: art or science? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410 |
| Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410 |
| Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410 |
| Compassionate approval process for experimental gene-based products. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410 |
| Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410 |
| Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer. | British journal of cancer 20080408 |
| Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells. | British journal of cancer 20080408 |
| Global genomic methylation levels in the liver and gonads of the three-spine stickleback (Gasterosteus aculeatus) after exposure to hexabromocyclododecane and 17-beta oestradiol. | Environment international 20080401 |
| Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer. | Cancer chemotherapy and pharmacology 20080401 |
| Gemcitabine in the management of metastatic breast cancer: a systematic review. | Breast cancer research and treatment 20080401 |
| A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma. | Cancer chemotherapy and pharmacology 20080401 |
| Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study. | Cancer chemotherapy and pharmacology 20080401 |
| Effects of tumor selective replication-competent herpes viruses in combination with gemcitabine on pancreatic cancer. | Cancer chemotherapy and pharmacology 20080401 |
| A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells. | Investigational new drugs 20080401 |
| Topical henna for capecitabine induced hand-foot syndrome. | Investigational new drugs 20080401 |
| Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro. | Cancer chemotherapy and pharmacology 20080401 |
| Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from the EORTC 10001 randomized phase II trial. | Breast (Edinburgh, Scotland) 20080401 |
| Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma. | Lung cancer (Amsterdam, Netherlands) 20080401 |
| Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03. | Annals of oncology : official journal of the European Society for Medical Oncology 20080401 |
| 3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome. | International journal of radiation oncology, biology, physics 20080401 |
| Tenofovir DF plus lamivudine or emtricitabine for nonoccupational postexposure prophylaxis (NPEP) in a Boston Community Health Center. | Journal of acquired immune deficiency syndromes (1999) 20080401 |
| Pharmacokinetics of gemcitabine when delivered by selective pulmonary artery perfusion for the treatment of lung cancer. | Drug metabolism and disposition: the biological fate of chemicals 20080401 |
| Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium. | Investigational new drugs 20080401 |
| Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20080401 |
| Recombinant human endostatin-associated acute left heart failure. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20080401 |
| Kinetic parameters and recognition of thymidine analogues with varying functional groups by thymidine phosphorylase. | Bioorganic & medicinal chemistry 20080401 |
| A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity. | Annals of oncology : official journal of the European Society for Medical Oncology 20080401 |
| Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma. | Cancer 20080401 |
| Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients. | AIDS patient care and STDs 20080401 |
| Independent-model diagnostics for a priori identification and interpretation of outliers from a full pharmacokinetic database: correspondence analysis, Mahalanobis distance and Andrews curves. | Journal of pharmacokinetics and pharmacodynamics 20080401 |
| Polyaspartylhydrazide copolymer-based supramolecular vesicular aggregates as delivery devices for anticancer drugs. | Biomacromolecules 20080401 |
| Localized malignant mesenteric mesothelioma causing small bowel obstruction. | Pathology international 20080401 |
| Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine. | Human mutation 20080401 |
| Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects. | Pediatrics 20080401 |
| Hand-foot syndrome with sclerodactyly-like changes in a patient treated with capecitabine. | The American Journal of dermatopathology 20080401 |
| Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer. | Pancreas 20080401 |
| Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer. | Pancreas 20080401 |
| Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques. | AIDS research and human retroviruses 20080401 |
| A Phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable advanced pancreatic cancer after vascular supply distribution via superselective embolization. | Japanese journal of clinical oncology 20080401 |
| Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080401 |
| Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080401 |
| Long-lasting complete remission with tyrosine kinase inhibitor in bronchioloalveolar carcinoma with a so far unknown EGFR mutation. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080401 |
| Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells. | Cancer research 20080401 |
| Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080401 |
| Lapatinib/gemcitabine and lapatinib/gemcitabine/oxaliplatin: a phase I study for advanced pancreaticobiliary cancer. | American journal of clinical oncology 20080401 |
| PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapy. | American journal of clinical oncology 20080401 |
| Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trial. | American journal of clinical oncology 20080401 |
| Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells. | Leukemia & lymphoma 20080401 |
| Gemcitabine in the treatment of metastatic pancreatic cancer. | Expert review of anticancer therapy 20080401 |
| Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial. | Expert review of anticancer therapy 20080401 |
| Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. | Molecular cancer research : MCR 20080401 |
| Capecitabine in the treatment of advanced gastric cancer. | Future oncology (London, England) 20080401 |
| Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer. | Japanese journal of clinical oncology 20080401 |
| [Phase I/II study of combination chemotherapy with gemcitabine and UFT for advanced pancreatic cancer in a multi-center trial]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080401 |
| [A case of HER2-positive metastatic breast cancer responding to trastuzumab plus gemcitabine combination therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080401 |
| Preclinical investigations with epothilones in breast cancer models. | Seminars in oncology 20080401 |
| Clinical studies with epothilones for the treatment of metastatic breast cancer. | Seminars in oncology 20080401 |
| Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer. | Seminars in oncology 20080401 |
| LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. | Molecular cancer therapeutics 20080401 |
| Beyond the guidelines in the treatment of peripheral T-cell lymphoma: new drug development. | Journal of the National Comprehensive Cancer Network : JNCCN 20080401 |
| Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naive HIV-infected patients. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080401 |
| Chemotherapy in elderly patients with colorectal cancer. | The oncologist 20080401 |
| Systemic therapy for biliary tract cancers. | The oncologist 20080401 |
| Preparation of pH-sensitive, long-circulating and EGFR-targeted immunoliposomes. | Archives of pharmacal research 20080401 |
| Remarkable shrinkage of sarcomatoid renal cell carcinoma with single-agent gemcitabine. | Anti-cancer drugs 20080401 |
| Chemoradiotherapy for unresectable pancreatic cancer. | International journal of clinical oncology 20080401 |
| Current status of chemoradiotherapy for locally advanced pancreatic cancer in Japan. | International journal of clinical oncology 20080401 |
| A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer. | International journal of clinical oncology 20080401 |
| Occurrence of autoimmunity in a long-term survivor with metastatic colon carcinoma treated with a new chemo-immunotherapy regimen. | Journal of chemotherapy (Florence, Italy) 20080401 |
| Budget impact model of adding erlotinib to a regimen of gemcitabine for the treatment of locally advanced, nonresectable or metastatic pancreatic cancer. | Clinical therapeutics 20080401 |
| Improved in vitro anti-tumoral activity, intracellular uptake and apoptotic induction of gemcitabine-loaded pegylated unilamellar liposomes. | Journal of nanoscience and nanotechnology 20080401 |
| A Phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes. | Clinical breast cancer 20080401 |
| A Phase II trial of split, low-dose docetaxel and low-dose capecitabine: a tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-negative metastatic breast cancer. | Clinical breast cancer 20080401 |
| Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer. | Clinical breast cancer 20080401 |
| 'One pill, once daily': what clinicians need to know about Atriplatrade mark. | Therapeutics and clinical risk management 20080401 |
| Treating refractory leukemias in childhood, role of clofarabine. | Therapeutics and clinical risk management 20080401 |
| [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine]. | Zhonghua er ke za zhi = Chinese journal of pediatrics 20080401 |
| Abacavir/3TC vs. tenofovir/FTC: interim results from ACTG 5202. | AIDS clinical care 20080401 |
| Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080320 |
| Treatment of breast cancer with trastuzumab during pregnancy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080320 |
| Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer. | International journal of radiation oncology, biology, physics 20080315 |
| High-performance liquid chromatography determination of 5-methyl-2'-deoxycytidine, 2'-deoxycytidine, and other deoxynucleosides and nucleosides in DNA digests. | Analytical biochemistry 20080315 |
| Increased mitochondrial DNA copy-number in CEM cells resistant to delayed toxicity of 2',3'-dideoxycytidine. | Biochemical pharmacology 20080315 |
| Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. | Cancer research 20080315 |
| Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080315 |
| Crystal structures of Streptococcus mutans 2'-deoxycytidylate deaminase and its complex with substrate analog and allosteric regulator dCTP x Mg2+. | Journal of molecular biology 20080314 |
| Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management. | World journal of gastroenterology 20080314 |
| Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. | British journal of cancer 20080311 |
| Sepsis from liver abscesses in metastatic colorectal carcinoma after chemoimmunotherapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080310 |
| Optimal second line treatment options for gemcitabine refractory advanced pancreatic cancer patients. Can we establish standard of care with available data? | JOP : Journal of the pancreas 20080308 |
| Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008. | JOP : Journal of the pancreas 20080308 |
| [Elevation of CA 19.9 in urothelial bladder cancer]. | Medicina clinica 20080308 |
| Mimicking phosphorylation of Ser-74 on human deoxycytidine kinase selectively increases catalytic activity for dC and dC analogues. | FEBS letters 20080305 |
| Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. | JAMA 20080305 |
| Adjuvant therapy for surgically resected pancreatic adenocarcinoma. | JAMA 20080305 |
| Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma. | Pediatric blood & cancer 20080301 |
| Phase II trial of gemcitabine and irinotecan in previously treated patients with small-cell lung cancer. | Cancer chemotherapy and pharmacology 20080301 |
| A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial. | Cancer chemotherapy and pharmacology 20080301 |
| A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging. | Cancer chemotherapy and pharmacology 20080301 |
| Effects of the proteasome inhibitor bortezomib on gene expression profiles of pancreatic cancer cells. | The Journal of surgical research 20080301 |
| Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer. | Cancer chemotherapy and pharmacology 20080301 |
| Neoadjuvant and adjuvant strategies for pancreatic cancer. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20080301 |
| Palliative hepatic intraarterial chemotherapy (HIC) using a novel combination of gemcitabine and mitomycin C: results in hepatic metastases. | European radiology 20080301 |
| Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate. | British journal of clinical pharmacology 20080301 |
| Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. | International journal of radiation oncology, biology, physics 20080301 |
| Fixed dose-rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma: a dose-finding study. | Journal of neuro-oncology 20080301 |
| Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group. | Annals of oncology : official journal of the European Society for Medical Oncology 20080301 |
| Efficacy of combination chemotherapy with irinotecan (CPT-11) plus capecitabine in patients with metastatic or advanced colorectal carcinoma--a dual-centre phase II study: the MAC-6. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20080301 |
| Stevens-Johnson syndrome after treatment with capecitabine. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20080301 |
| Adenoviral vector transduction of the human deoxycytidine kinase gene enhances the cytotoxic and radiosensitizing effect of gemcitabine on experimental gliomas. | Cancer gene therapy 20080301 |
| Potency of tenofovir in chronic hepatitis B: mono or combination therapy? | Journal of hepatology 20080301 |
| Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations. | Journal of hepatology 20080301 |
| Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer. | The Journal of urology 20080301 |
| CXCR7 transcription in human non-small cell lung cancer and tumor-free lung tissues; possible regulation upon chemotherapy. | Virchows Archiv : an international journal of pathology 20080301 |
| Measurement of plasma concentration of gemcitabine and its metabolite dFdU in hemodialysis patients with advanced urothelial cancer. | Japanese journal of clinical oncology 20080301 |
| Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 in patients with resected pancreatic cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01). | Japanese journal of clinical oncology 20080301 |
| Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20080301 |
| The importance of schedule in whole body thermochemotherapy. | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20080301 |
| Efficacy, toxicity and cost analysis for non-platinum triplet (gemcitabine and vinorelbine, followed by docetaxel) vs. platinum-based chemotherapy in IIIB/IV non-small-cell lung cancer: single-institution experience. | European journal of cancer care 20080301 |
| Oral treatment for gastric cancer: new choices, better choices? | The Lancet. Oncology 20080301 |
| Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinaire en Oncologie phase II study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301 |
| Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301 |
| Gemcitabine resistance in pancreatic cancer: picking the key players. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080301 |
| HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080301 |
| [Unresectable pancreatic cancer in the Hokuriku area]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20080301 |
| Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model. | Molecular cancer therapeutics 20080301 |
| [A case of triple negative recurrent breast cancer successfully treated with capecitabine+docetaxel combination chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080301 |
| [Combination of carboplatin and gemcitabine is a safe and feasible regimen in adjuvant therapy for stage II and IIIA NSCLC]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080301 |
| Syncope as a probable side effect to combination antiretroviral therapy initiated during primary HIV-1 infection. | Sexual health 20080301 |
| [Recent developments in systemic chemotherapy for hepatocellular carcinoma]. | The Korean journal of hepatology 20080301 |
| Real-time high-resolution compound imaging allows percutaneous initiation and surveillance in an orthotopic murine pancreatic cancer model. | Pancreas 20080301 |
| Ixabepilone: a novel antineoplastic agent with low susceptibility to multiple tumor resistance mechanisms. | The oncologist 20080301 |
| Prolonged versus standard gemcitabine infusion: translation of molecular pharmacology to new treatment strategy. | The oncologist 20080301 |
| New therapeutic directions for advanced pancreatic cancer: targeting the epidermal growth factor and vascular endothelial growth factor pathways. | The oncologist 20080301 |
| [Radiochemotherapeutic options for bladder cancer]. | Aktuelle Urologie 20080301 |
| [Pancreatic cancer: ten years of systemic therapy]. | Bulletin du cancer 20080301 |
| Erlotinib-induced acute hepatitis in a patient with pancreatic cancer. | Clinical advances in hematology & oncology : H&O 20080301 |
| Dose enhancement effect of anticaner drugs associated with increased temperature in vitro. | Experimental oncology 20080301 |
| The use of capecitabine in the combined-modality therapy for rectal cancer. | Clinical colorectal cancer 20080301 |
| Current questions in the treatment of advanced colorectal cancer: the CAIRO studies of the Dutch Colorectal Cancer Group. | Clinical colorectal cancer 20080301 |
| Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer. | Clinical colorectal cancer 20080301 |
| Evaluation of quality of life in patients with metastatic colorectal cancer treated with capecitabine. | Clinical colorectal cancer 20080301 |
| Southwest Oncology Group phase II study of irinotecan in patients with advanced transitional cell carcinoma of the urothelium that progressed after platinum-based chemotherapy. | Clinical genitourinary cancer 20080301 |
| Phase I trial of oral S-1 plus gemcitabine in elderly patients with nonsmall cell lung cancer. | Anti-cancer drugs 20080301 |
| A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients. | Anti-cancer drugs 20080301 |
| The epigenetic origin of aneuploidy. | Current genomics 20080301 |
| Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers. | British journal of cancer 20080226 |
| Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080220 |
| Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080220 |
| Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080220 |
| Tumor lysis syndrome after capecitabine plus cisplatin treatment in advanced gastric cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080220 |
| Inhibition of Src reduces gemcitabine-induced cytotoxicity in human pancreatic cancer cell lines. | Cancer letters 20080218 |
| Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma. | Cancer 20080215 |
| Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. | Cancer research 20080215 |
| Persistence of side population cells with high drug efflux capacity in pancreatic cancer. | World journal of gastroenterology 20080214 |
| First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study. | British journal of cancer 20080212 |
| Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines. | Cancer letters 20080208 |
| CXCL14 expression and potential function in pancreatic cancer. | Cancer letters 20080208 |
| Pharmacodynamic characterization of gemcitabine cytotoxicity in an in vitro cell culture bioreactor system. | Cancer chemotherapy and pharmacology 20080201 |
| Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer. | Cancer chemotherapy and pharmacology 20080201 |
| A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer. | Cancer chemotherapy and pharmacology 20080201 |
| Pharmacokinetics of gemcitabine in tumor and non-tumor extracellular fluid of brain: an in vivo assessment in rats employing intracerebral microdialysis. | Cancer chemotherapy and pharmacology 20080201 |
| Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer. | Digestive diseases and sciences 20080201 |
| Docetaxel, gemcitabine, and cisplatin administered for non-small cell lung cancer during the first and second trimester of an unrecognized pregnancy. | Lung cancer (Amsterdam, Netherlands) 20080201 |
| Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancer. | Breast (Edinburgh, Scotland) 20080201 |
| Comparison of the safety and efficacy of paclitaxel plus gemcitabine combination in young and elderly patients with locally advanced or metastatic non-small cell lung cancer. A retrospective analysis of the Southern Italy Cooperative Oncology Group trials. | Critical reviews in oncology/hematology 20080201 |
| Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study. | Investigational new drugs 20080201 |
| Complete remission of a metastatic neuroendocrine tumor of the pancreas with capecitabine (Xeloda) monotherapy. | Cancer chemotherapy and pharmacology 20080201 |
| Application of pressure mapping techniques to measure push and gripping forces with precision. | Ergonomics 20080201 |
| Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review. | International journal of colorectal disease 20080201 |
| High-resolution waveguide THz spectroscopy of biological molecules. | Biophysical journal 20080201 |
| Gemcitabine plus paclitaxel may be a promising chemotherapy regimen for metastatic granular cell tumour. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20080201 |
| Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry. | Journal of mass spectrometry : JMS 20080201 |
| Uracil incorporation into genomic DNA does not predict toxicity caused by chemotherapeutic inhibition of thymidylate synthase. | DNA repair 20080201 |
| Ternary borate-nucleoside complex stabilization by ribonuclease A demonstrates phosphate mimicry. | Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20080201 |
| Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20080201 |
| Telomerase transcriptional targeting of inducible Bax/TRAIL gene therapy improves gemcitabine treatment of pancreatic cancer. | Molecular therapy : the journal of the American Society of Gene Therapy 20080201 |
| A phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20080201 |
| GEMOX-R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large-cell lymphoma: a phase II study. | European journal of haematology 20080201 |
| Pancreatic cancer cell genetics and signaling response to treatment correlate with efficacy of gemcitabine-based molecular targeting strategies. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20080201 |
| Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells. | Biochemical pharmacology 20080201 |
| Minor emtricitabine intolerance in treatment-stable patients switched from tenofovir/lamivudine to a fixed-dose combination of tenofovir/emtricitabine (Truvada). | The Journal of antimicrobial chemotherapy 20080201 |
| Antibody diversification by somatic mutation: from Burnet onwards. | Immunology and cell biology 20080201 |
| Excess toxicity associated with docetaxel and irinotecan in patients with metastatic, gemcitabine-refractory pancreatic cancer: results of a phase II study. | Cancer investigation 20080201 |
| 'One-pot' syntheses of malondialdehyde adducts of nucleosides. | Nucleosides, nucleotides & nucleic acids 20080201 |
| Pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers treated with trimethoprim-sulphamethoxazole. | Journal of clinical pharmacy and therapeutics 20080201 |
| Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080201 |
| The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer. | Future oncology (London, England) 20080201 |
| Setting the stage for tailored chemotherapy in the management of non-small cell lung cancer. | Future oncology (London, England) 20080201 |
| Cancer-associated stromal fibroblasts promote pancreatic tumor progression. | Cancer research 20080201 |
| Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080201 |
| Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue. | Small (Weinheim an der Bergstrasse, Germany) 20080201 |
| CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial. | The Lancet. Oncology 20080201 |
| Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: a dose-escalation study. | European journal of cancer (Oxford, England : 1990) 20080201 |
| Pulmonary complications of novel antineoplastic agents for solid tumors. | Chest 20080201 |
| Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. | PLoS medicine 20080201 |
| Trial methodology in soft tissue sarcomas; the 'one plus one is three or zero' phenomenon. | Onkologie 20080201 |
| Docetaxel and gemcitabine in the treatment of soft tissue sarcoma - a single-center experience. | Onkologie 20080201 |
| Structural insights into DNA lesion bypass. | Structure (London, England : 1993) 20080201 |
| Protein-template-directed synthesis across an acrolein-derived DNA adduct by yeast Rev1 DNA polymerase. | Structure (London, England : 1993) 20080201 |
| Capecitabine plus oxaliplatin for the treatment of colorectal cancer. | Expert review of anticancer therapy 20080201 |
| [A pilot clinical trial of gemcitabine and capecitabine chemotherapy for the treatment of advanced renal cell carcinoma failing immunotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080201 |
| [Two advanced/recurrent breast cancer cases effectively treated by trastuzumab/capecitabine combination therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080201 |
| Preoperative chemoradiation with capecitabine in locally advanced rectal cancer. | The Netherlands journal of medicine 20080201 |
| Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma. | The oncologist 20080201 |
| Thymidine phosphorylase and dihydropyrimidine dehydrogenase are predictive factors of therapeutic efficacy of capecitabine monotherapy for breast cancer-preliminary results. | The journal of medical investigation : JMI 20080201 |
| Cost-effectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in combination with efavirenz, in antiretroviral-naive, HIV-1-infected patients. | Clinical therapeutics 20080201 |
| Biweekly triple combination chemotherapy with gemcitabine, oxaliplatin, levofolinic acid and 5-fluorouracil (GOLF) is a safe and active treatment for patients with inoperable pancreatic cancer. | Journal of chemotherapy (Florence, Italy) 20080201 |
| [Radiation therapy in pancreatic cancer]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080201 |
| [Chemotherapy for pancreatic cancer]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080201 |
| Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors. | American journal of clinical oncology 20080201 |
| Unilateral blindness as a presenting symptom of lung cancer treated with erlotinib. | Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20080201 |
| [Gemcitabine combined with capecitabine in the treatment for 41 patients with relapsed or metastatic biliary tract carcinoma]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080201 |
| [Clinical observation of XELOX (Capecitabine puls Oxaliplatin): an adjuvant chemotherapy regimen used in stage III colorectal cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080201 |
| Clinical study of combined use of tomudex (raltitrexed) and xeloda (capecitabine) as first-line treatment for patients with metastasizing colorectal cancer. | Bulletin of experimental biology and medicine 20080201 |
| Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial. | British journal of cancer 20080129 |
| A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer. | British journal of cancer 20080129 |
| 2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups. | The Journal of biological chemistry 20080125 |
| Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. | Cancer letters 20080118 |
| Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy. | British journal of cancer 20080115 |
| Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080115 |
| [Anti-viral therapy of type B chronic hepatitis. 3. Future of anti-viral agents]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20080110 |
| Pancreatic carcinosarcoma. Case report of multimodal therapy and review of the literature. | JOP : Journal of the pancreas 20080108 |
| Capecitabine and oxaliplatin for advanced esophagogastric cancer. | The New England journal of medicine 20080103 |
| Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection. | AIDS (London, England) 20080102 |
| Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. | Cancer chemotherapy and pharmacology 20080101 |
| The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer. | Cancer chemotherapy and pharmacology 20080101 |
| Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer. | Cancer chemotherapy and pharmacology 20080101 |
| A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer. | Cancer chemotherapy and pharmacology 20080101 |
| The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis. | Cancer chemotherapy and pharmacology 20080101 |
| Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study. | Journal of cancer research and clinical oncology 20080101 |
| Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trial. | Lung cancer (Amsterdam, Netherlands) 20080101 |
| Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20080101 |
| Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy. | Lung cancer (Amsterdam, Netherlands) 20080101 |
| Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20080101 |
| Gemcitabine and cisplatin in locally advanced and metastatic bladder cancer; 3- or 4-week schedule? | Acta oncologica (Stockholm, Sweden) 20080101 |
| Daily low-dose/continuous capecitabine combined with neo-adjuvant irradiation reduces VEGF and PDGF-BB levels in rectal carcinoma patients. | Acta oncologica (Stockholm, Sweden) 20080101 |
| Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin's lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin's Lymphoma Study Group. | International journal of radiation oncology, biology, physics 20080101 |
| A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20080101 |
| Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma. | Acta oncologica (Stockholm, Sweden) 20080101 |
| Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20080101 |
| Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy. | Cancer chemotherapy and pharmacology 20080101 |
| Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice. | Cancer chemotherapy and pharmacology 20080101 |
| Gemcitabine and pegylated liposomal doxorubicin alternating with cisplatin plus cyclophosphamide in platinum refractory/resistant, paclitaxel-pretreated, ovarian carcinoma. | Gynecologic oncology 20080101 |
| A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102. | BJU international 20080101 |
| Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literature. | Acta oncologica (Stockholm, Sweden) 20080101 |
| Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group. | Annals of oncology : official journal of the European Society for Medical Oncology 20080101 |
| Oncolytic adenovirus Ad5/3-delta24 and chemotherapy for treatment of orthotopic ovarian cancer. | Gynecologic oncology 20080101 |
| The structural modification of DNA nucleosides by nonenzymatic glycation: an in vitro study based on the reactions of glyoxal and methylglyoxal with 2'-deoxyguanosine. | Analytical and bioanalytical chemistry 20080101 |
| Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis. | Journal of acquired immune deficiency syndromes (1999) 20080101 |
| Synthesis and properties of oligodeoxynucleotides containing 5-carboxy-2'-deoxycytidines. | Bioorganic & medicinal chemistry letters 20080101 |
| A phase I safety, tolerability, and pharmacokinetic study of enzastaurin combined with capecitabine in patients with advanced solid tumors. | Anti-cancer drugs 20080101 |
| Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a study of the Multidisciplinary Oncology Group on Gastrointestinal Tumors. | Anti-cancer drugs 20080101 |
| 19F NMR in vivo spectroscopy reflects the effectiveness of perfusion-enhancing vascular modifiers for improving gemcitabine chemotherapy. | Magnetic resonance in medicine 20080101 |
| Fixed dose rate infusion of gemcitabine with oral doxifluridine and leucovorin for advanced unresectable pancreatic cancer: a phase II study. | Chemotherapy 20080101 |
| Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity. | European journal of cancer (Oxford, England : 1990) 20080101 |
| Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial. | The Lancet. Oncology 20080101 |
| Carbon beam therapy in recurrent ovarian cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20080101 |
| Primary advanced unresectable pancreatic cancer. | Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20080101 |
| Re: The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. | BJU international 20080101 |
| Survival and prognostic factors of unresectable pancreatic cancer. | Journal of clinical gastroenterology 20080101 |
| Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling. | International journal of oncology 20080101 |
| Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080101 |
| The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080101 |
| Improving treatment of pancreatic cancer. | The Lancet. Oncology 20080101 |
| Granulomatous septal panniculitis associated with capecitabine (Xeloda). | Journal of the European Academy of Dermatology and Venereology : JEADV 20080101 |
| San Antonio Breast Cancer Symposium. | The Lancet. Oncology 20080101 |
| Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours. | European journal of nuclear medicine and molecular imaging 20080101 |
| [Interdisciplinary diagnosis of and therapy for cholangiocarcinoma]. | Zeitschrift fur Gastroenterologie 20080101 |
| Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients. | Neoplasma 20080101 |
| Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer. | Pancreas 20080101 |
| [Irinotecan plus gemcitabine(IRINOGEM)in the treatment of biliary malignancies]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080101 |
| [Short-term outcome of neoadjuvant gemcitabine-carboplatin therapy for muscle-invasive bladder cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080101 |
| [A case of drug-induced interstitial pneumonitis after adjuvant chemotherapy with gemcitabine for pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080101 |
| [A case of salvage chemotherapy with gemcitabine hydrochloride and nedaplatin for gemcitabine-refractory pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080101 |
| [Fatal liver failure associated with gemcitabine hydrochloride therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20080101 |
| Can the new humanized mouse model give HIV research a boost. | PLoS medicine 20080101 |
| Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. | PLoS medicine 20080101 |
| A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer. | Medical oncology (Northwood, London, England) 20080101 |
| Cardiac toxicity: old and new issues in anti-cancer drugs. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20080101 |
| Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20080101 |
| Multiple-dose pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in patients with HIV-1 infection. | Clinical drug investigation 20080101 |
| Ectopic expression of AID in a non-B cell line triggers A:T and G:C point mutations in non-replicating episomal vectors. | PloS one 20080101 |
| Post-SELEX chemical optimization of a trypanosome-specific RNA aptamer. | Combinatorial chemistry & high throughput screening 20080101 |
| Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein. | PLoS genetics 20080101 |
| Integrating microarray and proteomics data to predict the response on cetuximab in patients with rectal cancer. | Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 20080101 |
| Functional group and substructure searching as a tool in metabolomics. | PloS one 20080101 |
| A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. | The journal of supportive oncology 20080101 |
| Capecitabine-related cardiotoxicity: recognition and management. | The journal of supportive oncology 20080101 |
| Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. | The oncologist 20080101 |
| Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancer. | Clinical colorectal cancer 20080101 |
| The biochemistry of somatic hypermutation. | Annual review of immunology 20080101 |
| Primary chemotherapy with low-dose prolonged infusion gemcitabine and cisplatin in patients with bladder cancer: a Phase II trial. | Urologic oncology 20080101 |
| Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. | Genome biology 20080101 |
| Effectiveness of gemcitabine as second-line chemotherapy in non-small cell lung cancer. | Tuberkuloz ve toraks 20080101 |
| [National study of adjuvant treatments of resected cholangiocarcinoma]. | Gastroenterologie clinique et biologique 20080101 |
| Hemolytic-uremic syndrome associated with gemcitabine treatment for metastatic pancreatic cancer. | Journal of clinical gastroenterology 20080101 |
| Onycholysis associated with capecitabine in patients with breast cancer. | Journal of cutaneous medicine and surgery 20080101 |
| NS-398 enhances the efficacy of gemcitabine against lung adenocarcinoma through up-regulation of p21WAF1 and p27KIP1 protein. | Neoplasma 20080101 |
| New drugs for chronic hepatitis B: a review. | American journal of therapeutics 20080101 |
| Intravesicle gemcitabine in management of BCG refractory superficial TCC of urinary bladder-our experience. | Urologic oncology 20080101 |
| Palliative pancreatectomy with postoperative gemcitabine for patients with advanced pancreatic cancer. | Journal of gastroenterology 20080101 |
| Chronic myeloid leukemia following the treatment of rectal adenocarcinoma. | Medical oncology (Northwood, London, England) 20080101 |
| Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer. | BMC cancer 20080101 |
| The utility of vitamin K3 (menadione) against pancreatic cancer. | Anticancer research 20080101 |
| Pretreatment with S-1, an oral derivative of 5-fluorouracil, enhances gemcitabine effects in pancreatic cancer xenografts. | Anticancer research 20080101 |
| Gemcitabine plus oxaliplatin (GEMOX) in pretreated patients with advanced ovarian cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG). | Anticancer research 20080101 |
| Low-dose capecitabine in breast cancer patients with symptomatic bone marrow infiltration: a case study. | Anticancer research 20080101 |
| Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20080101 |
| Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection. | PloS one 20080101 |
| Inflammation of actinic keratoses with capecitabine therapy for colon cancer. | European journal of dermatology : EJD 20080101 |
| Clinical interpretation of quality-of-life outcomes: an investigation of data from the randomized trial of gemcitabine plus paclitaxel compared with paclitaxel alone for advanced breast cancer. | The breast journal 20080101 |
| RPA repair recognition of DNA containing pyrimidines bearing bulky adducts. | Journal of molecular recognition : JMR 20080101 |
| Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases. | BMC cancer 20080101 |
| European Commission approves Atripla. | AIDS patient care and STDs 20080101 |
| Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer. | BMC cancer 20080101 |
| Capecitabine, alone and in combination, in the management of patients with colorectal cancer: a review of the evidence. | Drugs 20080101 |
| Efficacy of cancer chemotherapy in relation to synchronization of cortisol rhythm, immune status and psychospiritual profile in metastatic non-small cell lung cancer. | In vivo (Athens, Greece) 20080101 |
| Highly elevated serum CA 125 in a lady with ascites and retroperitoneal mass--a diagnostic dilemma. | The Journal of the Association of Physicians of India 20080101 |
| Interferon-alpha plus capecitabine and thalidomide in patients with metastatic renal cell cancer. | Journal of experimental therapeutics & oncology 20080101 |
| Novel approaches to deliver gemcitabine to cancers. | Current pharmaceutical design 20080101 |
| Chemotherapy with gemcitabine in advanced biliary tract carcinoma. | Reviews on recent clinical trials 20080101 |
| Impact of switching virologically suppressed, HIV-1-infected patients from twice-daily fixed-dose zidovudine/lamivudine to once-daily fixed-dose tenofovir disoproxil fumarate/emtricitabine. | HIV clinical trials 20080101 |
| Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20080101 |
| 2'-deoxy-4'-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants. | The international journal of biochemistry & cell biology 20080101 |
| Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimens. | Medical oncology (Northwood, London, England) 20080101 |
| Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule. | Anticancer research 20080101 |
| Present treatment and future expectations in advanced pancreatic cancer. | Anticancer research 20080101 |
| SOCS3 inhibiting migration of A549 cells correlates with PYK2 signaling in vitro. | BMC cancer 20080101 |
| Mouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1). | PloS one 20080101 |
| Uracil within DNA: an actor of antiviral immunity. | Retrovirology 20080101 |
| HPCE quantification of 5-methyl-2'-deoxycytidine in genomic DNA: methodological optimization for chestnut and other woody species. | Plant physiology and biochemistry : PPB 20080101 |
| [Pulmonary metastases from a testicular cancer]. | Pneumologia (Bucharest, Romania) 20080101 |
| Modified CAPOX (capecitabine plus oxaliplatin) regimen every two weeks as second-line treatment in patients with advanced colorectal cancer previously treated with irinotecan-based frontline therapy: a multicenter phase II study. | Oncology 20080101 |
| Schedule-dependent synergistic effect of pemetrexed combined with gemcitabine against malignant pleural mesothelioma and non-small cell lung cancer cell lines. | Chemotherapy 20080101 |
| HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells. | PloS one 20080101 |
| A regulatory role for NBS1 in strand-specific mutagenesis during somatic hypermutation. | PloS one 20080101 |
| HIV-1 Vif, APOBEC, and intrinsic immunity. | Retrovirology 20080101 |
| Treatment of chronic hepatitis B infection: an update of Swedish recommendations. | Scandinavian journal of infectious diseases 20080101 |
| The AID/APOBEC family of nucleic acid mutators. | Genome biology 20080101 |
| Capecitabine-induced oromandibular dystonia: a case report and literature review. | Acta oncologica (Stockholm, Sweden) 20080101 |
| Combinations of 2'-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon system. | Antiviral chemistry & chemotherapy 20080101 |
| Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison. | BMC cancer 20080101 |
| Rectal cancer adjuvant chemotherapy: when is more useful? | Anticancer research 20080101 |
| Palliative treatment for elderly patients with colon cancer in ten Italian medical oncology units. | Anticancer research 20080101 |
| Irinotecan plus capecitabine as first-line chemotherapy in advanced colorectal cancer. | Anticancer research 20080101 |
| Interferon-alpha restitutes the chemosensitivity in pancreatic cancer. | Anticancer research 20080101 |
| Phase II study of neo-adjuvant gemcitabine plus epirubicin in primarily unresectable locally advanced breast cancer. | The breast journal 20080101 |
| Splenic infarct as a diagnostic pitfall in radiology. | Journal of cancer research and therapeutics 20080101 |
| Efficacy of gemcitabine for locally advanced pancreatic cancer: comparison with 5-fluorouracil-based chemoradiotherapy. | Chemotherapy 20080101 |
| [The dilemma of first-line chemotherapy in advanced non-small-cell lung cancer: are third-generation drugs all the same?]. | Tumori 20080101 |
| Interleukin-2 inhalation therapy in renal cell cancer: a case report and review of the literature. | In vivo (Athens, Greece) 20080101 |
| The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia. | The journal of supportive oncology 20080101 |
| Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes. | Chemotherapy 20080101 |
| Down-regulation of deoxycytidine kinase enhances acquired resistance to gemcitabine in pancreatic cancer. | Anticancer research 20080101 |
| Complete response after imatinib mesylate administration in a patient with chemoresistant stage IV seminoma. | Anticancer research 20080101 |
| Comparison of hyper-fractionated accelerated and standard fractionated radiotherapy with concomitant low-dose gemcitabine for unresectable pancreatic cancer. | Anticancer research 20080101 |
| Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naïve patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/emtricitabine given once daily. | HIV clinical trials 20080101 |
| 'White coat compliance' limits the reliability of therapeutic drug monitoring in HIV-1-infected patients. | HIV clinical trials 20080101 |
| Self-Avoiding Molecular Recognition Systems (SAMRS). | Nucleic acids symposium series (2004) 20080101 |
| Site-specific modification by functionality-transfer oligonucleotide with the photo-inducible reactivity. | Nucleic acids symposium series (2004) 20080101 |
| A new linker group for functionalization of nucleic acids. | Nucleic acids symposium series (2004) 20080101 |
| Stereoselective formation of a cyclobutane pyrimidine dimer by using N4-acetyl protection of the cytosine base. | Nucleic acids symposium series (2004) 20080101 |
| Base recognition abilities of 2'-deoxynucleoside N-oxide derivatives and their substrate specificity in enzyme reaction. | Nucleic acids symposium series (2004) 20080101 |
| pH effect on the one-electron photooxidation of 5-methylcytosine with naphthoquinone sensitizer. | Nucleic acids symposium series (2004) 20080101 |
| A multisubstrate deoxyribonucleoside kinase from plants. | Nucleic acids symposium series (2004) 20080101 |
| Suppression of bcr-abl mRNA by chemically modified siRNA. | Nucleic acids symposium series (2004) 20080101 |
| Kinetics of dCTP incorporation opposite to 7,8-dihydro-8-oxoguanine with different 5' nearest neighbors by yeast polymerase eta. | Nucleic acids symposium series (2004) 20080101 |
| Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer. | BMC cancer 20080101 |
| Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer : economic evaluation in an Italian NHS setting. | Clinical drug investigation 20080101 |
| CA 19-9 response as an early indicator of the effectiveness of gemcitabine in patients with advanced pancreatic cancer. | Oncology 20080101 |
| The short chain fatty acid butyrate induces promoter demethylation and reactivation of RARbeta2 in colon cancer cells. | Nutrition and cancer 20080101 |
| Comparison of protracted infusion 5-fluorouracil and capecitabine in adjuvant chemoradiotherapy for rectal cancer. | Hepato-gastroenterology 20080101 |
| Capecitabine cardiotoxicity--case reports and literature review. | Hepato-gastroenterology 20080101 |
| Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials. | Breast cancer research : BCR 20080101 |
| A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma. | Radiation oncology (London, England) 20080101 |
| Gemcitabine and cisplatin treatment of advanced-stage non-small-cell lung cancer in patients given cisplatin on day 8. | Tumori 20080101 |
| Primary mucinous adenocarcinoma of appendix treated with chemotherapy and radiotherapy: a case report. | Tumori 20080101 |
| [Capecitabine in colorectal carcinoma: news from ASCO 2008]]. | Tumori 20080101 |
| [Thymidine and thymidylate kinases from the scallop Mizuhopecten yessoensis gonads]. | Prikladnaia biokhimiia i mikrobiologiia 20080101 |
| Intestinal permeability and toxicity of second-line therapeutic agents in ovarian cancer. | Tumori 20080101 |
| Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR. | BMC cancer 20080101 |
| Postoperative adjuvant treatments for biliary tract cancer. | Journal of hepato-biliary-pancreatic surgery 20080101 |
| -(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro. | Pharmacological research 20080101 |
| Effectiveness and safety of generic fixed-dose combination of tenofovir/emtricitabine/efavirenz in HIV-1-infected patients in Western India. | Medscape journal of medicine 20080101 |
| [Neoadjuvant intra-arterial oil chemoembolization and adjuvant selective intra-arterial chemoinfusion in the combined treatment of pancreatic cancer]. | Voprosy onkologii 20080101 |
| Quality-of-life assessment in phase III clinical trials of gemcitabine in non-small-cell lung cancer. | Drugs & aging 20080101 |
| The role of herpes simplex virus-1 thymidine kinase alanine 168 in substrate specificity. | The open biochemistry journal 20080101 |
| Twenty novel genetic variations and haplotype structures of the DCK gene encoding human deoxycytidine kinase (dCK). | Drug metabolism and pharmacokinetics 20080101 |
| Sequence specificity of BAL 31 nuclease for ssDNA revealed by synthetic oligomer substrates containing homopolymeric guanine tracts. | PloS one 20080101 |
| Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer. | Journal of translational medicine 20080101 |
| Gemcitabine as palliative treatment in patients with unresectable pancreatic cancer previously treated with placement of a covered metal stent. A randomized controlled trial. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20080101 |
| Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine model. | Journal of experimental & clinical cancer research : CR 20080101 |
| Resection of gallbladder cancer with hepatic metastasis after chemotherapy with gemcitabine. | Journal of hepato-biliary-pancreatic surgery 20080101 |
| Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients. | PloS one 20080101 |
| XeNA: capecitabine plus docetaxel, with or without trastuzumab, as preoperative therapy for early breast cancer. | International journal of medical sciences 20080101 |
| Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer. | Journal of gastroenterology 20080101 |
| The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. | BMC molecular biology 20080101 |
| Activated p38-MAPK and gemcitabine sensitivity in recurrent ovarian cancer. | Anticancer research 20080101 |
| Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trial. | Anticancer research 20080101 |
| Hypofractionated accelerated radiotherapy, cytoprotection and capecitabine in the treatment of rectal cancer: a feasibility study. | Anticancer research 20080101 |
| Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients. | Anticancer research 20080101 |
| Bevacizumab added to the irinotecan and capecitabine combination for advanced colorectal cancer: a well-tolerated, active and convenient regimen. | Anticancer research 20080101 |
| [Treatment of advanced pancreatic carcinoma]. | Onkologie 20080101 |
| Atypical hand-and-foot syndrome in an African American patient treated with capecitabine with normal DPD activity: is there an ethnic disparity? | Cutaneous and ocular toxicology 20080101 |
| The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer. | BMC cancer 20080101 |
| Infusion chemotherapy with cisplatinum and fluorouracil in the treatment of locally-advanced and metastatic gallbladder cancer. | Journal of cancer research and therapeutics 20080101 |
| Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy). | BMC cancer 20080101 |
| Capecitabine and docetaxel combination for the treatment of breast cancer. | Women's health (London, England) 20080101 |
| Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo. | PloS one 20080101 |
| Identification of G1-regulated genes in normally cycling human cells. | PloS one 20080101 |
| Upstream stimulatory factors are involved in the P1 promoter directed transcription of the A beta H-J-J locus. | BMC molecular biology 20080101 |
| Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins. | PloS one 20080101 |
| Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study. | BMC cancer 20080101 |
| Sequential or combination chemotherapy for a patient with mCRC? | Cancer treatment reviews 20080101 |
| Evaluation of therapeutic response to gemcitabine in pancreatic cancer. | Hepato-gastroenterology 20080101 |
| Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine. | BMC cancer 20080101 |
| A systematic approach to biomarker discovery; preamble to 'the iSBTc-FDA taskforce on immunotherapy biomarkers'. | Journal of translational medicine 20080101 |
| Paralytic ileus associated with capecitabine. | Tumori 20080101 |
| Tissue microarrays of human tumor xenografts: characterization of proteins involved in migration and angiogenesis for applications in the development of targeted anticancer agents. | Cancer genomics & proteomics 20080101 |
| Capecitabine and mitomycin-C in the therapy of pretreated patients with metastatic colorectal cancer: single center retrospective study with 36 patients. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20080101 |
| Chemotherapy side-effect management using mobile phones. | Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20080101 |
| Psoriasis disappearance after the first phase of an oncologic treatment: a serendipity case report. | La Clinica terapeutica 20080101 |
| Application of confidence intervals to bioanalytical method validation--drug stability in biological matrix testing. | Acta poloniae pharmaceutica 20080101 |
| Role of neoadjuvant treatment in cT3N0M0 rectal cancer. | Anticancer research 20080101 |
| A randomized study of gemcitabine plus cisplatin and vinorelbine plus cisplatin in patients with advanced non-small-cell lung cancer. | Chang Gung medical journal 20080101 |
| [Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorithm of patients with rectal carcinoma]. | Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20080101 |
| Pharmacogenomic approaches to individualizing chemotherapy for non-small-cell lung cancer: current status and new directions. | Clinical lung cancer 20080101 |
| Palmar-plantar hyperpigmentation with capecitabine in adjuvant colon cancer. | Journal of gastrointestinal cancer 20080101 |
| [Assessment of the value of PEF (cisplatin, epirubicin, 5 fluorouracil) in advanced extrahepatic biliary tract and pancreatic cancer]. | Przeglad lekarski 20080101 |
| Management of BCG non-responders with fixed dose intravesical gemcitabine in superficial transitional cell carcinoma of urinary bladder. | Indian journal of urology : IJU : journal of the Urological Society of India 20080101 |
| Gemcitabine/5-flourouracil/leucovorin for the treatment of advanced pancreatic carcinoma. | Hematology/oncology and stem cell therapy 20080101 |
| Dependence of antibody gene diversification on uracil excision. | The Journal of experimental medicine 20071224 |
| Questions about gemcitabine dose rate: answered or unanswered? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071220 |
| Randomized crossover study evaluating the effect of gemcitabine infusion dose rate: evidence of auto-induction of gemcitabine accumulation. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071220 |
| Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071220 |
| Finding clinical meaning in cancer data. | Journal of the National Cancer Institute 20071219 |
| A phase 1 study of fixed dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer. | Cancer 20071215 |
| A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types. | Journal of controlled release : official journal of the Controlled Release Society 20071204 |
| Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational study. | British journal of cancer 20071203 |
| Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial. | British journal of cancer 20071203 |
| A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret hospital Phase II consortium. | Investigational new drugs 20071201 |
| Potential interaction of chemotherapy and gefitinib in the induction of hematologic neoplasia. | Leukemia 20071201 |
| A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer. | International journal of radiation oncology, biology, physics 20071201 |
| Chemotherapy improves low performance status lung cancer patients. | The European respiratory journal 20071201 |
| Enhancement of gemcitabine affinity for biomembranes by conjugation with squalene: differential scanning calorimetry and Langmuir-Blodgett studies using biomembrane models. | Journal of colloid and interface science 20071201 |
| Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants. | The Journal of pharmacology and experimental therapeutics 20071201 |
| Intra-arterial and systemic chemotherapy plus external hyperthermia in unresectable biliary cancer. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20071201 |
| Inhibition of proliferation by omega-3 fatty acids in chemoresistant pancreatic cancer cells. | Annals of surgical oncology 20071201 |
| IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients. | Bone marrow transplantation 20071201 |
| Development and characterization of gemcitabine-resistant pancreatic tumor cells. | Annals of surgical oncology 20071201 |
| Toxicity profile and efficacy of oral capecitabine as adjuvant chemotherapy for Chinese patients with Stage III colon cancer. | Diseases of the colon and rectum 20071201 |
| Gemcitabine resistance in a highly metastatic subpopulation of a pulmonary adenocarcinoma cell line resistant to gefitinib. | International journal of oncology 20071201 |
| Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. | International journal of oncology 20071201 |
| Severe or lethal toxicities upon capecitabine intake: is DPYD genetic polymorphism the ideal culprit? | Trends in pharmacological sciences 20071201 |
| Treatment of advanced colorectal cancer in the elderly. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20071201 |
| FDA approves new breast cancer treatment. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20071201 |
| Gemcitabine in bladder cancer. | Expert opinion on pharmacotherapy 20071201 |
| Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer. | Expert opinion on pharmacotherapy 20071201 |
| Carbohydrate antigen 19-9-positive prostatic ductal adenocarcinoma effectively treated with cisplatin and gemcitabine. | International journal of urology : official journal of the Japanese Urological Association 20071201 |
| Intensified irinotecan-based neoadjuvant chemoradiotherapy in rectal cancer: four consecutive designed studies to minimize acute toxicity and to optimize efficacy measured by pathologic complete response. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20071201 |
| How the new oral antineoplastics affect nursing practice: capecitabine serves to illustrate. | The American journal of nursing 20071201 |
| Anti-mesothelin immunotoxin SS1P in combination with gemcitabine results in increased activity against mesothelin-expressing tumor xenografts. | Clinical cancer research : an official journal of the American Association for Cancer Research 20071201 |
| Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients--results of a phase II study. | Onkologie 20071201 |
| [Single-nucleotide polymorphisms of the cytidine deaminase gene in childhood with acute leukemia and normal Chinese children]. | Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 20071201 |
| [Efficacy and toxicity of gemcitabine combined vinorelbine on metastatic breast cancer: a report of 34 cases]. | Ai zheng = Aizheng = Chinese journal of cancer 20071201 |
| [Efficacy of gemcitabine with concurrent radiotherapy on stage III,inoperable non-small cell lung cancer]. | Ai zheng = Aizheng = Chinese journal of cancer 20071201 |
| [Efficacy of gemcitabine combined oxaliplatin on advanced pancreatic cancer]. | Ai zheng = Aizheng = Chinese journal of cancer 20071201 |
| [A case undergoing repeated anaphylactic shock after systemic administration of vinorelbine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20071201 |
| Structures of human deoxycytidine kinase product complexes. | Acta crystallographica. Section D, Biological crystallography 20071201 |
| Ureterovesical malignancy following renal transplantation: a case report. | Transplantation proceedings 20071201 |
| TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth. | Molecular cancer therapeutics 20071201 |
| Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer. | American journal of clinical oncology 20071201 |
| [A rare primary tumor of the mediastinum: pleomorphic liposarcoma]. | Revue de pneumologie clinique 20071201 |
| [Favorable outcome of gemcitabine-induced acute respiratory distress syndrome]. | Revue de pneumologie clinique 20071201 |
| Combined systemic therapy and radiotherapy for bladder cancer. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20071201 |
| [Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer]. | Gastroenterologie clinique et biologique 20071201 |
| A case of gemcitabine-refractory pancreatic cancer responsive to second-line chemotherapy using S-1. | Japanese journal of clinical oncology 20071201 |
| Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreas. | Oncology (Williston Park, N.Y.) 20071201 |
| The role of adjuvant chemotherapy in colon cancer. | Surgical oncology 20071201 |
| Capecitabine for treatment of advanced hepatocellular carcinoma. | Hepato-gastroenterology 20071201 |
| Clinical efficacy of intra-arterial pharmacokinetic chemotherapy with 5-fluorouracil, CDDP, gemcitabine, and angiotensin-II in patients with advanced pancreatic cancer. | Hepato-gastroenterology 20071201 |
| Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer. | Clinical breast cancer 20071201 |
| [Non-small cell lung neoplasms--weekly taxane combinations are possible]. | Pneumologie (Stuttgart, Germany) 20071201 |
| Update on clinical data combining capecitabine with targeted agents in newly diagnosed colorectal cancer. | Clinical colorectal cancer 20071201 |
| Update on clinical data with regimens inhibiting angiogenesis and epidermal growth factor receptor for patients with newly diagnosed metastatic colorectal cancer. | Clinical colorectal cancer 20071201 |
| Sublethal concentrations of gemcitabine (2',2'-difluorodeoxycytidine) alter mitochondrial ultrastructure and function without reducing mitochondrial DNA content in BxPC-3 human pancreatic carcinoma cells. | Human & experimental toxicology 20071201 |
| Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. | Therapeutics and clinical risk management 20071201 |
| Rates of spontaneous disintegration of DNA and the rate enhancements produced by DNA glycosylases and deaminases. | Biochemistry 20071127 |
| Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071120 |
| Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients. | British journal of cancer 20071119 |
| Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. | British journal of cancer 20071119 |
| Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. | Lancet (London, England) 20071117 |
| [Chemotherapy and radiotherapy for inoperable pancreatic cancer. A survey of a Cochrane review]. | Ugeskrift for laeger 20071112 |
| Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta. | Science (New York, N.Y.) 20071109 |
| Long-term survival on capecitabine in two gemcitabine refractory pancreatic cancer patients. Is there a pharmacogenetic explanation? | JOP : Journal of the pancreas 20071109 |
| A phase I study of bi-weekly administration of 24-h gemcitabine followed by 24-h irinotecan in patients with solid tumors. | Cancer chemotherapy and pharmacology 20071101 |
| Etheno-DNA adduct formation in rats gavaged with linoleic acid, oleic acid and coconut oil is organ- and gender specific. | Mutation research 20071101 |
| Pilot study of an outpatient-based approach for advanced lymphoma using vinorelbine, gemcitabine and filgrastim. | Internal medicine journal 20071101 |
| Capecitabine therapy of central nervous system metastases from breast cancer. | Journal of neuro-oncology 20071101 |
| Histological evaluation of colonic anastomotic healing, during perioperative Capecitabine administration. Experimental study in rats. | Histology and histopathology 20071101 |
| Short versus continuous gemcitabine treatment of non-small cell lung cancer in an in vitro cell culture bioreactor system. | Lung cancer (Amsterdam, Netherlands) 20071101 |
| Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules. | International journal of pharmaceutics 20071101 |
| Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: a phase II study. | Lung cancer (Amsterdam, Netherlands) 20071101 |
| A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study. | Gynecologic oncology 20071101 |
| Economic evaluation of docetaxel/gemcitabine versus docetaxel as frontline treatment of patients with advanced/metastatic non-small cell lung cancer in Greece. | Lung cancer (Amsterdam, Netherlands) 20071101 |
| A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective study. | Annals of surgical oncology 20071101 |
| Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20071101 |
| Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up data. | Annals of oncology : official journal of the European Society for Medical Oncology 20071101 |
| Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer: a randomized phase 3 trial of the Minnie Pearl Cancer Research Network. | Cancer 20071101 |
| Management of platinum-sensitive recurrent ovarian cancer: a cost-effectiveness analysis. | Gynecologic oncology 20071101 |
| Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors. | Journal of medicinal chemistry 20071101 |
| Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer. | International journal of radiation oncology, biology, physics 20071101 |
| Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study. | Anti-cancer drugs 20071101 |
| Medical treatment for advanced gastroesophageal adenocarcinoma. | Current opinion in gastroenterology 20071101 |
| Ammonia elimination from protonated nucleobases and related synthetic substrates. | Journal of the American Society for Mass Spectrometry 20071101 |
| Surgery combined with intra-arterial chemotherapy for stage iv advanced gastric cancer. | ANZ journal of surgery 20071101 |
| A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer. | Japanese journal of clinical oncology 20071101 |
| [Transarterial chemoperfusion with gemcitabine and mitomycin C in pancreatic carcinoma: results in locally recurrent tumors and advanced tumor stages]. | RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 20071101 |
| Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20071101 |
| Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer. | Japanese journal of clinical oncology 20071101 |
| Role of platinum agents in the management of advanced pancreatic cancer. | Expert opinion on pharmacotherapy 20071101 |
| Capecitabine in advanced gastric cancer. | Expert opinion on pharmacotherapy 20071101 |
| Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma. | International journal of urology : official journal of the Japanese Urological Association 20071101 |
| Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient. | Journal of the European Academy of Dermatology and Venereology : JEADV 20071101 |
| Comments on final report of the AIO Colorectal Cancer Group Study: fluorouracil/oxaliplatin versus capecitabine/oxaliplatin. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071101 |
| Capecitabine plus oxaliplatin in metastatic colorectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071101 |
| Rituximab, gemcitabine and oxaliplatin: an effective regimen in patients with refractory and relapsing mantle cell lymphoma. | Leukemia & lymphoma 20071101 |
| Clinical potential of an antitumor drug sensitivity test and diffusion-weighted MRI in a patient with a recurrent solid pseudopapillary tumor of the pancreas. | Journal of gastroenterology 20071101 |
| Identification of adducts formed by reaction of N-acetoxy-3,5-dimethylaniline with DNA. | Chemical research in toxicology 20071101 |
| [Preparation of gemcitabine polybutylcyanoacrylate nanoparticles]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20071101 |
| Weekly gemcitabine and cisplatin concurrent with pelvic irradiation for primary therapy of cervical cancer: report of the first seven cases in Thai women. | Radiation medicine 20071101 |
| [A long-term survivor case with good quality of life due to biliary bypass and gemcitabine for advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20071101 |
| Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology. | Journal of the National Comprehensive Cancer Network : JNCCN 20071101 |
| Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature. | The oncologist 20071101 |
| Inoperable pancreatic cancer: standard of care. | Oncology (Williston Park, N.Y.) 20071101 |
| Bevacizumab: optimal dose, schedule, and duration of therapy. | Clinical lung cancer 20071101 |
| [A case of gemcitabine-based chemo-radiation therapy for unresectable pancreatic cancer with liver metastases]. | Gan to kagaku ryoho. Cancer & chemotherapy 20071101 |
| [Assessment of efficacy of arterial infusion chemotherapy with gemcitabine for four cases of advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20071101 |
| European CHMP issues positive opinion for Atripla. | AIDS patient care and STDs 20071101 |
| [Prediction of adverse drug reactions based on genomic information]. | Nihon rinsho. Japanese journal of clinical medicine 20071028 |
| Electron attachment induced proton transfer in a DNA nucleoside pair: 2'-deoxyguanosine-2'-deoxycytidine. | The Journal of chemical physics 20071021 |
| Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071020 |
| Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071020 |
| Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071020 |
| Genotype-based methods for anticipating gemcitabine-related severe toxicities may lead to false-negative results. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071020 |
| PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: the ghost regimen. | Cancer letters 20071018 |
| The absence of human equilibrative nucleoside transporter 1 expression predicts nonresponse to gemcitabine-containing chemotherapy in non-small cell lung cancer. | Cancer letters 20071018 |
| A truvada hypersensitivity reaction simulating abacavir hypersensitivity. | AIDS (London, England) 20071018 |
| Simultaneous determination of gemcitabine and gemcitabine-squalene by liquid chromatography-tandem mass spectrometry in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071015 |
| Interleukin-4 cytotoxin therapy synergizes with gemcitabine in a mouse model of pancreatic ductal adenocarcinoma. | Cancer research 20071015 |
| Capecitabine induced inflammation of actinic keratoses. | Dermatology online journal 20071013 |
| Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) and identification of a novel active 5'-triphosphate species. | The Journal of biological chemistry 20071012 |
| Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071010 |
| Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071010 |
| Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial. | British journal of cancer 20071008 |
| Paraneoplastic neurological syndromes and breast cancer. Regression of paraneoplastic neurological sensorimotor neuropathy in a patient with metastatic breast cancer treated with capecitabine: a case study and mini-review of the literature. | Breast cancer research and treatment 20071001 |
| Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study. | Cancer chemotherapy and pharmacology 20071001 |
| Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapy. | Cancer chemotherapy and pharmacology 20071001 |
| Clinical significance of high-Km 5'-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome. | Leukemia research 20071001 |
| O(2/3) exposure inhibits cell progression affecting cyclin B1/cdk1 activity in SK-N-SH while induces apoptosis in SK-N-DZ neuroblastoma cells. | Journal of cellular physiology 20071001 |
| Metastatic urothelial carcinoma of upper urinary tract. | American journal of hematology 20071001 |
| Androgen receptor blockade in experimental combination therapy of pancreatic cancer. | The Journal of surgical research 20071001 |
| Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20071001 |
| Effects of apricitabine and other nucleoside reverse transcriptase inhibitors on replication of mitochondrial DNA in HepG2 cells. | Antiviral research 20071001 |
| A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumors. | Investigational new drugs 20071001 |
| Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer Group. | Annals of surgical oncology 20071001 |
| Effects of the minor groove pyrimidine nucleobase functional groups on the stability of duplex DNA: the impact of uncompensated minor groove amino groups. | Biopolymers 20071001 |
| Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study. | Annals of oncology : official journal of the European Society for Medical Oncology 20071001 |
| Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen. | Journal of acquired immune deficiency syndromes (1999) 20071001 |
| An open multicenter phase II trial of docetaxel-gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): the GFPC 02-02a study. | Critical reviews in oncology/hematology 20071001 |
| Severe lung and skin toxicity during treatment with gemcitabine and erlotinib for metastatic pancreatic cancer. | Anti-cancer drugs 20071001 |
| Improving adjuvant chemotherapy in breast cancer -- can we get more for less with TACT2? | Clinical oncology (Royal College of Radiologists (Great Britain)) 20071001 |
| Enhancement of capecitabine efficacy by oxaliplatin in human colorectal and gastric cancer xenografts. | Oncology reports 20071001 |
| Prognosis of small bowel adenocarcinoma treated with Mayo or Xelox regimen: a matched case-control study from a database of 581 patients with colorectal cancer. | Oncology reports 20071001 |
| Chromatin structure regulates gene conversion. | PLoS biology 20071001 |
| Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulation. | Pharmacogenetics and genomics 20071001 |
| Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC). | Journal of immunotherapy (Hagerstown, Md. : 1997) 20071001 |
| Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models. | Pancreas 20071001 |
| Successful management of multiple liver metastases from pancreatic neuroendocrine tumor by hepatic arterial administration of cisplatin powder. | Pancreas 20071001 |
| The characteristics of Hep-2 cell with multiple drug resistance induced by Taxol. | Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20071001 |
| Effects of capecitabine and vinorelbine on cell proliferation, metabolism and COX2 and p16 expression in breast cancer cell lines and solid tumour tissues. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20071001 |
| Evaluation of therapeutic efficacy of capecitabine on human breast carcinoma tissues and cell lines in vitro. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20071001 |
| Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071001 |
| Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20071001 |
| Phase I and pharmacokinetic study of imatinib mesylate (Gleevec) and gemcitabine in patients with refractory solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20071001 |
| Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20071001 |
| Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20071001 |
| Paclitaxel albumin-bound particles (abraxane) in combination with bevacizumab with or without gemcitabine: early experience at the University of Miami/Braman Family Breast Cancer Institute. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20071001 |
| Dose escalating study of biweekly gemcitabine and carboplatin in patients with advanced cancer. | American journal of clinical oncology 20071001 |
| A phase I dose escalation study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA nonsmall cell lung cancer. | American journal of clinical oncology 20071001 |
| COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin. | American journal of clinical oncology 20071001 |
| [Non-small-cell bronchial carcinoma--induction--combined with radiochemotherapy--a more certain alternative]. | Pneumologie (Stuttgart, Germany) 20071001 |
| Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma. | International journal of clinical oncology 20071001 |
| Prognostic relevance of carbohydrate antigen 19-9 levels in patients with advanced biliary tract cancer. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20071001 |
| [A case of recurrent breast cancer with multiple liver metastases responding to combination therapy of capecitabine and MPA]. | Gan to kagaku ryoho. Cancer & chemotherapy 20071001 |
| [A case of elderly metastatic breast cancer with a complete response to treatment with capecitabine and cyclophosphamide]. | Gan to kagaku ryoho. Cancer & chemotherapy 20071001 |
| Effect of dose regimen on the toxicity of 2'-deoxy-2'-methylidenecytidine (DMDC) in monkeys. | The Journal of toxicological sciences 20071001 |
| Gemcitabine combination in advanced NSCLC. | The Lancet. Oncology 20071001 |
| [Strategy for chemical biology using affinity magnetic nanobeads]. | Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme 20071001 |
| Comparative cytotoxicity of C-1311 in colon cancer in vitro and in vivo using the hollow fiber assay. | Journal of chemotherapy (Florence, Italy) 20071001 |
| Gemcitabine combined with oxaliplatin (GEMOX) as salvage treatment in elderly patients with advanced ovarian cancer refractory or resistant to platinum: a single institution experience. | Journal of chemotherapy (Florence, Italy) 20071001 |
| Study supports activity of gemcitabine in treatment of early-stage breast cancer. | Oncology (Williston Park, N.Y.) 20071001 |
| Current options for the management of rectal cancer. | Current treatment options in oncology 20071001 |
| Decitabine in the treatment of myelodysplastic syndromes. | Therapeutics and clinical risk management 20071001 |
| Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma. | Oncogene 20070927 |
| Inhibition of histone deacetylase for the treatment of biliary tract cancer: a new effective pharmacological approach. | World journal of gastroenterology 20070921 |
| Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070920 |
| Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070920 |
| Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070920 |
| Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer. | Cancer 20070915 |
| Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis. | World journal of gastroenterology 20070914 |
| Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis. | AIDS (London, England) 20070912 |
| Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy. | British journal of cancer 20070911 |
| [Myocardial ischaemia as a result of treatment with capecitabine]. | Nederlands tijdschrift voor geneeskunde 20070908 |
| Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells. | World journal of gastroenterology 20070907 |
| Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA-IIIA non-small-cell lung cancer. | Cancer chemotherapy and pharmacology 20070901 |
| Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model. | Gut 20070901 |
| A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma. | Cancer chemotherapy and pharmacology 20070901 |
| Cisplatin cytotoxicity is enhanced with zoledronic acid in A549 lung cancer cell line: preliminary results of an in vitro study. | Cell biology international 20070901 |
| Interaction of lipophilic gemcitabine prodrugs with biomembrane models studied by Langmuir-Blodgett technique. | Journal of colloid and interface science 20070901 |
| Capecitabine-induced diffuse palmoplantar keratoderma: is it a sequential event of hand-foot syndrome? | Clinical and experimental dermatology 20070901 |
| Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer. | Cancer chemotherapy and pharmacology 20070901 |
| The impact of hypoxic treatment on the expression of phosphoglycerate kinase and the cytotoxicity of troxacitabine and gemcitabine. | Molecular pharmacology 20070901 |
| Overexpression of acid sphingomyelinase sensitizes glioma cells to chemotherapy. | Antioxidants & redox signaling 20070901 |
| Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner. | The Journal of antimicrobial chemotherapy 20070901 |
| A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer. | Current medical research and opinion 20070901 |
| [Capecitabine-induced hyperpigmentation]. | Actas dermo-sifiliograficas 20070901 |
| The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells. | International journal of oncology 20070901 |
| Regulation of DR-5 protein and mitochondrial transmembrane potential by gemcitabine, a possible mechanism of gemcitabine-enhanced TRAIL-induced apoptosis. | Oncology reports 20070901 |
| siRNA directed against TrkA sensitizes human pancreatic cancer cells to apoptosis induced by gemcitabine through an inactivation of PI3K/Akt-dependent pathway. | Oncology reports 20070901 |
| Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070901 |
| Gemcitabine-related 'pseudocellulitis': report of 2 cases and review of the literature. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070901 |
| [Laparoscopic ovarian transposition and cryopreservation of ovarian tissue before chemo-radiotherapy for rectal cancer]. | Gynecologie, obstetrique & fertilite 20070901 |
| Enhanced efficacy in anti-tumour activity by combined therapy of recombinant FGFR-1 related angiogenesis and low-dose cytotoxic agent. | European journal of cancer (Oxford, England : 1990) 20070901 |
| Cutaneous metastasis as the first clinical manifestation of pancreatic adenocarcinoma: a case treated with gemcitabine. | The Journal of dermatology 20070901 |
| Causes of thrombotic thrombocytopenic purpura. | The Lancet. Oncology 20070901 |
| Metastatic esophageal adenocarcinoma presenting in the iris. | American journal of ophthalmology 20070901 |
| Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070901 |
| Histopathologic evidence of capecitabine corneal toxicity in dogs. | Veterinary pathology 20070901 |
| [A case of unresectable advanced pancreatic cancer with peritoneal dissemination responding to continuous dose S-1 monotherapy after chemo-radiation therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070901 |
| Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. | Cancer investigation 20070901 |
| Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study. | Cancer investigation 20070901 |
| T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity. | PLoS pathogens 20070901 |
| Forodesine (BCX-1777, Immucillin H)--a new purine nucleoside analogue: mechanism of action and potential clinical application. | Mini reviews in medicinal chemistry 20070901 |
| Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma. | Urology 20070901 |
| Pleomorphic leiomyosarcoma of the adrenal gland: case report and review of the literature. | Urology 20070901 |
| Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network. | Clinical lung cancer 20070901 |
| Tyrosine kinase inhibitors in non-small cell lung and pancreatic cancer: the emerging role of erlotinib. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20070901 |
| Combined-modality therapy for rectal cancer: future prospects. | Clinical colorectal cancer 20070901 |
| Two Doses of oxaliplatin with capecitabine (XELOX) in metastatic colorectal cancer. | Clinical colorectal cancer 20070901 |
| Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrual. | Clinical colorectal cancer 20070901 |
| Phase II trial of 5-fluorouracil/leucovorin/gemcitabine/cisplatin as second-line treatment in patients with metastatic or recurrent colorectal carcinoma: a cancer therapeutics research group study. | Clinical colorectal cancer 20070901 |
| Phase II pharmacogenomics-based adjuvant therapy trial in patients with non-small-cell lung cancer: Southwest Oncology Group Trial 0720. | Clinical lung cancer 20070901 |
| Phase II study of gemcitabine combined with platinum chemotherapy for recurrent epithelial ovarian cancer. | Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20070901 |
| Safety of capecitabine use in patients with liver dysfunction. | Clinical advances in hematology & oncology : H&O 20070901 |
| Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells. | British journal of cancer 20070828 |
| Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial. | British journal of cancer 20070828 |
| Interaction of low-energy electrons with the pyrimidine bases and nucleosides of DNA. | The Journal of chemical physics 20070828 |
| 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity. | Journal of medicinal chemistry 20070823 |
| Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer. | British journal of cancer 20070820 |
| Phase I and pharmacokinetic study of lapatinib in combination with capecitabine in patients with advanced solid malignancies. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070820 |
| Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F. | Virology 20070815 |
| Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase. | Journal of acquired immune deficiency syndromes (1999) 20070815 |
| Column selection for pharmaceutical analyses based on a column classification using four test parameters. | Journal of pharmaceutical and biomedical analysis 20070815 |
| Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site. | Cancer 20070815 |
| NMR investigation of primer-template models: structural effect of sequence downstream of a thymine template on mutagenesis in DNA replication. | Biochemistry 20070814 |
| Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070810 |
| Positive regulation of deoxycytidine kinase activity by phosphorylation of Ser-74 in B-cell chronic lymphocytic leukaemia lymphocytes. | Cancer letters 20070808 |
| Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity. | British journal of cancer 20070806 |
| Quantitative 19F MR spectroscopy at 3 T to detect heterogeneous capecitabine metabolism in human liver. | NMR in biomedicine 20070801 |
| Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer. | Cancer chemotherapy and pharmacology 20070801 |
| Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed. | Thorax 20070801 |
| A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors. | Investigational new drugs 20070801 |
| Clinical efficacy of capecitabine as first-line chemotherapy in metastatic breast cancer--how low can you go? | Breast (Edinburgh, Scotland) 20070801 |
| Long-term survival after gemcitabine and cisplatin in patients with locally advanced transitional cell carcinoma of the bladder: focus on supplementary treatment strategies. | European urology 20070801 |
| Editorial comment on: Long-term survival after gemcitabine and cisplatin in patients with locally advanced transitional cell carcinoma of the bladder: focus on supplementary treatment strategies. | European urology 20070801 |
| Lipid peroxidation-derived etheno-DNA adducts in human atherosclerotic lesions. | Mutation research 20070801 |
| A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge. | Cancer chemotherapy and pharmacology 20070801 |
| The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains. | Virology 20070801 |
| Tissue transglutaminase induces the release of apoptosis inducing factor and results in apoptotic death of pancreatic cancer cells. | Apoptosis : an international journal on programmed cell death 20070801 |
| A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC). | Lung cancer (Amsterdam, Netherlands) 20070801 |
| Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20070801 |
| Chemotherapeutic stress selectively activates NF-kappa B-dependent AKT and VEGF expression in liver cancer-derived endothelial cells. | American journal of physiology. Cell physiology 20070801 |
| Phase II study of capecitabine plus trastuzumab in human epidermal growth factor receptor 2 overexpressing metastatic breast cancer pretreated with anthracyclines or taxanes. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070801 |
| Gemcitabine-based combinations for inoperable pancreatic cancer: have we made real progress? A meta-analysis of 20 phase 3 trials. | Cancer 20070801 |
| Capecitabine as third-line treatment in patients with metastatic renal cell carcinoma after failing immunotherapy. | Anti-cancer drugs 20070801 |
| Medullary thyroid cancer treated by capecitabine. | Anti-cancer drugs 20070801 |
| DPD is a molecular determinant of capecitabine efficacy in colorectal cancer. | International journal of oncology 20070801 |
| Endoscopic ultrasound-guided fine-needle injection of immature dendritic cells into advanced pancreatic cancer refractory to gemcitabine: a pilot study. | Pancreas 20070801 |
| A pure invasive micropapillary carcinoma of the pancreatic head: long disease-free survival after pancreatoduodenectomy and adjuvant chemotherapy with gemcitabine. | Pancreas 20070801 |
| Rapid determination of gemcitabine in plasma and serum using reversed-phase HPLC. | Journal of separation science 20070801 |
| Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021. | Pediatrics 20070801 |
| Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma. | Cancer investigation 20070801 |
| American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 3. | IDrugs : the investigational drugs journal 20070801 |
| Phase I pharmacokinetic and pharmacodynamic study of the oral protein kinase C beta-inhibitor enzastaurin in combination with gemcitabine and cisplatin in patients with advanced cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070801 |
| Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070801 |
| Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. | Cancer research 20070801 |
| A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model. | Cancer research 20070801 |
| Locally advanced pancreatic cancer: a review. | Seminars in oncology 20070801 |
| Future chemoradiation strategies in pancreatic cancer. | Seminars in oncology 20070801 |
| Cytotoxic therapy for advanced pancreatic adenocarcinoma. | Seminars in oncology 20070801 |
| [Consideration of preventive free-flowing IV infusion method for vinorelbine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070801 |
| Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20070801 |
| [Efficacy of transcatheter arterial chemoembolization combined thalidomide on hepatocellular carcinoma: a controlled randomized trial]. | Ai zheng = Aizheng = Chinese journal of cancer 20070801 |
| [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer]. | Ai zheng = Aizheng = Chinese journal of cancer 20070801 |
| [Meta-analysis on gemcitabine of fixed-dose rate infusion plus oxaliplatin as first-line therapy for advanced pancreatic cancer]. | Ai zheng = Aizheng = Chinese journal of cancer 20070801 |
| Superiority of extended neoadjuvant chemotherapy with gemcitabine in pancreatic cancer: a comparative analysis in a clinically adapted orthotopic xenotransplantation model in SCID beige mice. | Cancer biology & therapy 20070801 |
| Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study. | International journal of clinical oncology 20070801 |
| Gemcitabine and cisplatin for advanced urothelial carcinomas: the Ehime University Hospital experience. | International journal of clinical oncology 20070801 |
| Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers. | International journal of clinical oncology 20070801 |
| Baseline genotype as a predictor of virological failure to emtricitabine or stavudine in combination with didanosine and efavirenz. | AIDS research and human retroviruses 20070801 |
| Neoadjuvant chemotherapy enables R0 resection of locally advanced rectal cancer in a patient with a previously irradiated pelvis. | The British journal of radiology 20070801 |
| A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer. | American journal of clinical oncology 20070801 |
| A phase I study of docetaxel, oxaliplatin, and capecitabine in patients with metastatic gastroesophageal cancer. | American journal of clinical oncology 20070801 |
| Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial results. | American journal of clinical oncology 20070801 |
| Gemcitabine and docetaxel in metastatic sarcoma: past, present, and future. | The oncologist 20070801 |
| A novel alkylating agent, glufosfamide, enhances the activity of gemcitabine in vitro and in vivo. | Neoplasia (New York, N.Y.) 20070801 |
| [Chemotherapy in lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070801 |
| Biweekly administration of docetaxel and gemcitabine for elderly patients with advanced non-small cell lung cancer: a phase II study. | Journal of chemotherapy (Florence, Italy) 20070801 |
| 144-week data released on Gilead's study 934. | AIDS patient care and STDs 20070801 |
| [Transhepatic arterial chemoembolization with gemcitabine and carboplatin for the treatment of stage III hepatocellular carcinoma]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070801 |
| Synthesis and biological activity of a gemcitabine phosphoramidate prodrug. | Journal of medicinal chemistry 20070726 |
| Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy? | British journal of cancer 20070716 |
| Depletion of mitochondrial DNA by down-regulation of deoxyguanosine kinase expression in non-proliferating HeLa cells. | Experimental cell research 20070715 |
| Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070715 |
| S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer. | Cancer research 20070715 |
| Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard? | Lancet (London, England) 20070714 |
| Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. | Lancet (London, England) 20070714 |
| Pancreatic cancer: is this bleak landscape finally changing? Highlights from the '43rd ASCO Annual Meeting'. Chicago, IL, USA. June 1-5, 2007. | JOP : Journal of the pancreas 20070709 |
| Gemcitabine-induced liver fibrosis in a patient with pancreatic cancer. | JOP : Journal of the pancreas 20070709 |
| A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours. | British journal of cancer 20070702 |
| [Unilateral acral necrosis as a minor form of hand-foot syndrome. Patient with unilateral acral necrosis secondary to capecitabine therapy for metastatic breast cancer]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20070701 |
| Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy. | Cancer chemotherapy and pharmacology 20070701 |
| The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer. | Cancer chemotherapy and pharmacology 20070701 |
| Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial. | Cancer chemotherapy and pharmacology 20070701 |
| A nurse-/pharmacy-led capecitabine clinic for colorectal cancer: results of a prospective audit and retrospective survey of patient experiences. | European journal of oncology nursing : the official journal of European Oncology Nursing Society 20070701 |
| Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial. | European urology 20070701 |
| Modulation by budesonide of a CpG endonuclease in mouse lung tumors. | Carcinogenesis 20070701 |
| A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20070701 |
| Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: preliminary results. | International journal of radiation oncology, biology, physics 20070701 |
| Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. | International journal of radiation oncology, biology, physics 20070701 |
| Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results. | Lung cancer (Amsterdam, Netherlands) 20070701 |
| Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-9137. | Journal of acquired immune deficiency syndromes (1999) 20070701 |
| Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. | Annals of oncology : official journal of the European Society for Medical Oncology 20070701 |
| A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin. | Annals of surgical oncology 20070701 |
| K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment. | Cancer science 20070701 |
| Successful salvage of a relapsed high risk gestational trophoblastic neoplasia patient using capecitabine. | Gynecologic oncology 20070701 |
| Pharmacokinetic evaluation of emtricitabine in combination with other nucleoside antivirals in healthy volunteers. | Journal of clinical pharmacology 20070701 |
| Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. | Cancer 20070701 |
| Expression of orotate phosphoribosyl transferase in human pancreatic cancer: implication for the efficacy of uracil and tegafur-based adjuvant chemotherapy. | Oncology reports 20070701 |
| Molecular impacts of rapamycin-based drug combinations: combining rapamycin with gemcitabine or imatinib mesylate (Gleevec) in a human leiomyosarcoma model. | International journal of oncology 20070701 |
| Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine. | Biochimica et biophysica acta 20070701 |
| Imatinib in the treatment of follicular dendritic sarcoma: a case report and review of literature. | Onkologie 20070701 |
| Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070701 |
| Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070701 |
| Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070701 |
| Gemcitabine-associated thrombotic thrombocytopenic purpura. | The Lancet. Oncology 20070701 |
| Magnetic poly epsilon-caprolactone nanoparticles containing Fe3O4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model. | Journal of drug targeting 20070701 |
| The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression. | Cancer research 20070701 |
| Radiotherapy for localized rectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20070701 |
| [Treatment of pancreatic cancer--surgical point of view]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070701 |
| [Treatments of pancreatic cancer from the standpoint of medical oncology]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070701 |
| [Evaluation of therapeutic regimens for taxane-resistant recurrent/metastatic breast cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070701 |
| [A case of advanced pancreatic cancer successfully treated by combined chemotherapy of S-1 and gemcitabine as second-line chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070701 |
| [A case of severe hand-foot syndrome caused by capecitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070701 |
| [Evaluation of combination therapy of high-dose toremifene and oral chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070701 |
| Low dose gemcitabine plus cisplatin in a weekly-based regimen as salvage therapy for relapsed breast cancer after taxane-anthracycline-containing regimens. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070701 |
| Capecitabine and irinotecan in advanced gastric cancer. | The Lancet. Oncology 20070701 |
| Phase II study of combination chemotherapy with gemcitabine and cisplatin for patients with metastatic pancreatic cancer. | Japanese journal of clinical oncology 20070701 |
| [Peak concentration of gemcitabine at fixed-dose-rate and its hematological toxicity profile]. | Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20070701 |
| [Lung cancer treatment in elderly patients]. | Bulletin du cancer 20070701 |
| The first once-daily single-tablet regimen for the treatment of HIV-infected patients. | Drugs of today (Barcelona, Spain : 1998) 20070701 |
| Locally advanced leiomyosarcoma of the urinary bladder: near-complete pathologic response to neoadjuvant gemcitabine and docetaxel. | Anti-cancer drugs 20070701 |
| [Comparison of the suppressing capecitabine and 5-fluorouracil effects on the pronounce of inflammatory cells score in the induction of episcleral fibrosis after trabeculectomy]. | Vojnosanitetski pregled 20070701 |
| Neoadjuvant chemotherapy in locally advanced non-small cell lung cancer. | The Gulf journal of oncology 20070701 |
| Expression of deoxynucleoside kinases and 5'-nucleotidases in mouse tissues: implications for mitochondrial toxicity. | Biochemical pharmacology 20070630 |
| [Myocardial ischaemia as a result of treatment with capecitabine]. | Nederlands tijdschrift voor geneeskunde 20070630 |
| Nonenantioselectivity property of human deoxycytidine kinase explained by structures of the enzyme in complex with L- and D-nucleosides. | Journal of medicinal chemistry 20070628 |
| [Current situation and features of chemotherapy for breast neoplasms]. | Nihon rinsho. Japanese journal of clinical medicine 20070628 |
| [Optimal chemotherapy for advanced and recurrent breast cancer patients]. | Nihon rinsho. Japanese journal of clinical medicine 20070628 |
| Oligonucleotides forming an i-motif: the pH-dependent assembly of individual strands and branched structures containing 2'-deoxy-5-propynylcytidine. | Organic & biomolecular chemistry 20070621 |
| Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070620 |
| Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070620 |
| Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070620 |
| Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer. | JAMA 20070620 |
| Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer. | JAMA 20070620 |
| Pharmacokinetics of once-daily tenofovir, emtricitabine, ritonavir and fosamprenavir in HIV-infected subjects. | AIDS (London, England) 20070619 |
| An increase of cytochrome C oxidase mediated disruption of gemcitabine incorporation into DNA in a resistant KB clone. | Biochemical pharmacology 20070615 |
| Cell cycle effect on the activity of deoxynucleoside analogue metabolising enzymes. | Biochemical and biophysical research communications 20070615 |
| Defects in maintenance of mitochondrial DNA are associated with intramitochondrial nucleotide imbalances. | Human molecular genetics 20070615 |
| Surface-enhanced Raman spectroscopy of soft-landed polyatomic ions and molecules. | Analytical chemistry 20070615 |
| A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070615 |
| p53R2-dependent ribonucleotide reduction provides deoxyribonucleotides in quiescent human fibroblasts in the absence of induced DNA damage. | The Journal of biological chemistry 20070608 |
| Ultrafast IR spectroscopy of the short-lived transients formed by UV excitation of cytosine derivatives. | Chemical communications (Cambridge, England) 20070607 |
| Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer. | World journal of gastroenterology 20070607 |
| Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party. | British journal of cancer 20070604 |
| [Hand-foot syndrome with capecitabine therapy]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20070601 |
| A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study. | Cancer chemotherapy and pharmacology 20070601 |
| Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial. | Cancer chemotherapy and pharmacology 20070601 |
| Adjuvant therapy for pancreatic cancer: a time that has not yet come. | Journal of surgical oncology 20070601 |
| Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers. | Investigational new drugs 20070601 |
| Severe pulmonary toxicity in patients with leiomyosarcoma after treatment with gemcitabine and docetaxel. | Investigational new drugs 20070601 |
| Estrogen receptor beta/alpha ratio predicts response of pancreatic cancer cells to estrogens and phytoestrogens. | The Journal of surgical research 20070601 |
| Bi-weekly administration of gemcitabine plus vinorelbine in elderly patients with advanced non-small-cell lung cancer: multicenter phase II trial. | Lung cancer (Amsterdam, Netherlands) 20070601 |
| Chemotherapy induced reversible posterior leukoencephalopathy syndrome. | Lung cancer (Amsterdam, Netherlands) 20070601 |
| Electrolyte abnormalities and progressive renal failure in a cancer patient. | Kidney international 20070601 |
| Liquid chromatography-tandem mass spectrometric assay for the nucleoside reverse transcriptase inhibitor emtricitabine in human plasma. | Biomedical chromatography : BMC 20070601 |
| Patient attitudes towards chemotherapy as assessed by patient versus physician: a prospective observational study in advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20070601 |
| Chemotherapy of advanced gastric cancer. | Cancer treatment reviews 20070601 |
| A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20070601 |
| Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor model. | Anti-cancer drugs 20070601 |
| Chemoimmunotherapy in the treatment of metastatic gastric cancer. | Anti-cancer drugs 20070601 |
| Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. | Annals of oncology : official journal of the European Society for Medical Oncology 20070601 |
| Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE. A randomised phase III trial of control vs. capecitabine plus oxaliplatin. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20070601 |
| Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results. | International journal of radiation oncology, biology, physics 20070601 |
| Acute myeloid leukaemia secondary to treatment with capecitabine for metastatic colorectal cancer. | European journal of haematology 20070601 |
| Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study. | The Lancet. Oncology 20070601 |
| Steady-state pharmacokinetics of emtricitabine and tenofovir disoproxil fumarate administered alone and in combination in healthy volunteers. | Journal of clinical pharmacology 20070601 |
| Concurrent chemoradiotherapy for advanced pancreatic cancer: 1,000 mg/m2 gemcitabine can be administered using limited-field radiotherapy. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20070601 |
| Combination chemotherapy in advanced pancreatic cancer: time to raise the white flag? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601 |
| Moving forward in advanced bladder cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601 |
| Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601 |
| Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601 |
| Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070601 |
| Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study. | American journal of clinical oncology 20070601 |
| Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxane. | American journal of clinical oncology 20070601 |
| Her signaling in pancreatic cancer. | Expert opinion on biological therapy 20070601 |
| Capecitabine in the treatment of colorectal cancer. | Expert review of anticancer therapy 20070601 |
| Shortness of breath and hypoxemia after chemotherapy with carboplatin and gemcitabine. | Chest 20070601 |
| [Biliary tract carcinoma in elderly patients in whom gemcitabine chemotherapy induced complete remission - a report of two cases]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070601 |
| Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: a new paradigm for antimetabolite radiosensitizers. | Molecular cancer therapeutics 20070601 |
| A phase I study of thalidomide, capecitabine and temozolomide in advanced cancer. | Cancer biology & therapy 20070601 |
| Gemcitabine has significant immunomodulatory activity in murine tumor models independent of its cytotoxic effects. | Cancer biology & therapy 20070601 |
| Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20070601 |
| Collecting duct carcinoma producing granulocyte-colony-stimulating factor (G-CSF). | International journal of urology : official journal of the Japanese Urological Association 20070601 |
| HPV oral infection. Case report of an HIV-positive Nigerian sex worker. | Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20070601 |
| [Gemcitabine and radiotherapy for the future]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20070601 |
| An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients. | The oncologist 20070601 |
| Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report. | The Korean journal of internal medicine 20070601 |
| In vitro simulation study of individualized chemotherapy in lung cancer. | Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20070601 |
| Pancreatic cancer: new studies, new treatments. 'Periodontal disease,', 'gemcitabine' and 'adjuvant therapy' are the new buzzwords. | DukeMedicine healthnews 20070601 |
| Lapatinib plus capecitabine in patients with HER2-positive advanced breast cancer. | Clinical advances in hematology & oncology : H&O 20070601 |
| Urinary metabolic fingerprinting for thioacetamide-induced rat acute hepatic injury using fourier transform-ion cyclotron resonance mass spectrometry (FT-ICR MS), with reference to detection of potential biomarkers for hepatotoxicity. | Toxicologic pathology 20070601 |
| [Lung adenocarcinoma feigning an interstitial lung disease in a 30-year-old man]. | Anales de medicina interna (Madrid, Spain : 1984) 20070601 |
| Clinicopathologic and prognostic significance of overexpression of her-2/neu and p53 oncoproteins in gastric carcinoma using tissue microarray. | Journal of the Egyptian National Cancer Institute 20070601 |
| 8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins. | Nature 20070531 |
| Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma. | World journal of gastroenterology 20070528 |
| A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer. | British journal of cancer 20070521 |
| Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070520 |
| Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity. | Oncogene 20070517 |
| The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent. | Biochemical pharmacology 20070515 |
| Oxidation of 2'-deoxycytidine to four interconverting diastereomers of N1-carbamoyl-4,5-dihydroxy-2-oxoimidazolidine nucleosides. | The Journal of organic chemistry 20070511 |
| Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer? | JOP : Journal of the pancreas 20070509 |
| First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study. | British journal of cancer 20070507 |
| The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer. | British journal of cancer 20070507 |
| Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model. | World journal of gastroenterology 20070507 |
| Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models. | Cancer chemotherapy and pharmacology 20070501 |
| Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer. | Journal of surgical oncology 20070501 |
| Cutaneous metastasis resembling acute dermatitis in patient with advanced gastric cancer. | Clinical and experimental dermatology 20070501 |
| A phase II study of days 1 and 8 combination of docetaxel plus gemcitabine for the second-line treatment of patients with advanced non-small-cell lung cancer and good performance status. | Lung cancer (Amsterdam, Netherlands) 20070501 |
| Low-dose radiotherapy as a chemopotentiator of gemcitabine in tumors of the pancreas or small bowel: a phase I study exploring a new treatment paradigm. | International journal of radiation oncology, biology, physics 20070501 |
| Differing conformational pathways before and after chemistry for insertion of dATP versus dCTP opposite 8-oxoG in DNA polymerase beta. | Biophysical journal 20070501 |
| Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients. A Southern Italy Cooperative Oncology Group randomised phase II trial. | Lung cancer (Amsterdam, Netherlands) 20070501 |
| A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC). | Lung cancer (Amsterdam, Netherlands) 20070501 |
| Novel therapeutic approaches in the treatment of advanced pancreatic carcinoma. | Cancer treatment reviews 20070501 |
| Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone. | Annals of oncology : official journal of the European Society for Medical Oncology 20070501 |
| Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trial. | Cancer 20070501 |
| Human equilibrative nucleoside transporter 1 is associated with the chemosensitivity of gemcitabine in human pancreatic adenocarcinoma and biliary tract carcinoma cells. | Oncology reports 20070501 |
| A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer. | European journal of cancer (Oxford, England : 1990) 20070501 |
| Digital ischemic changes after gemcitabine therapy in a patient with metastatic non-small-cell lung cancer. | The Annals of pharmacotherapy 20070501 |
| Pancreatic cancer: an update. | Current oncology reports 20070501 |
| Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study. | The Journal of urology 20070501 |
| Combination therapy of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cells. | Journal of gastroenterology and hepatology 20070501 |
| Role of induction chemotherapy in resectable N2 non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070501 |
| Atrial fibrillation induced by gemcitabine treatment in a 65-year-old man. | Onkologie 20070501 |
| The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation. | Health technology assessment (Winchester, England) 20070501 |
| 3,3',5-Triiodo-L-thyronine inhibits ductal pancreatic adenocarcinoma proliferation improving the cytotoxic effect of chemotherapy. | The Journal of endocrinology 20070501 |
| Elementary, my dear Watson. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070501 |
| EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070501 |
| Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070501 |
| Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel. | Urology 20070501 |
| Bexarotene (LGD1069, Targretin), a selective retinoid X receptor agonist, prevents and reverses gemcitabine resistance in NSCLC cells by modulating gene amplification. | Cancer research 20070501 |
| Treatment options for hepatobiliary and pancreatic cancer. | Mayo Clinic proceedings 20070501 |
| [A resected case of effective treatment with gemcitabine for advanced pancreatic cancer with peritoneal metastasis]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070501 |
| Integration of novel agents into combined-modality treatment for rectal cancer patients. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20070501 |
| Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070501 |
| Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas. | Journal of gastroenterology 20070501 |
| Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice. | Neoplasia (New York, N.Y.) 20070501 |
| Comparison of pharmacokinetics, efficacy and toxicity profile of gemcitabine using two different administration regimens in Chinese patients with non-small-cell lung cancer. | Journal of Zhejiang University. Science. B 20070501 |
| A randomized phase II study of sorafenib/gemcitabine or sorafenib/erlotinib for advanced non-small-cell lung cancer in elderly patients or patients with a performance status of 2: treatment rationale and protocol dynamics. | Clinical lung cancer 20070501 |
| Development and validation of a stability-indicating liquid chromatographic method for determination of emtricitabine and related impurities in drug substance. | Journal of separation science 20070501 |
| Phase I study of irinotecan and gemcitabine in previously untreated patients with advanced non-small cell lung cancer. | Japanese journal of clinical oncology 20070501 |
| Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070420 |
| Design and synthesis of novel prodrugs of 2'-deoxy-2'-methylidenecytidine activated by membrane dipeptidase overexpressed in tumor tissues. | Bioorganic & medicinal chemistry letters 20070415 |
| Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivo. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070415 |
| Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. | Cancer research 20070415 |
| A case of capecitabine-induced coronary microspasm in a patient with rectal cancer. | World journal of gastroenterology 20070414 |
| [Palliative treatment of pancreatic cancer]. | Deutsche medizinische Wochenschrift (1946) 20070413 |
| [Molecular-based treatment concepts in advanced pancreatic cancer]. | Deutsche medizinische Wochenschrift (1946) 20070413 |
| [Diagnosis of and therapy for pancreatic neoplasms]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20070410 |
| Lapatinib plus capecitabine in breast cancer. | The New England journal of medicine 20070405 |
| [Establishment of a multi drug-resistant human lung adenocarcinoma cell line and biological characteristics there of]. | Zhonghua yi xue za zhi 20070403 |
| Capecitabine-induced pancolitis. | International journal of colorectal disease 20070401 |
| Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours? | Cancer chemotherapy and pharmacology 20070401 |
| Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter. | Cancer chemotherapy and pharmacology 20070401 |
| Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study. | Cancer chemotherapy and pharmacology 20070401 |
| Short-schedule intravesical gemcitabine with ablative intent in recurrent Ta-T1, G1-G2, low- or intermediate-risk, transitional cell carcinoma of the bladder. | European urology 20070401 |
| Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance. | Breast cancer research and treatment 20070401 |
| Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine. | Lung cancer (Amsterdam, Netherlands) 20070401 |
| Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts. Evidence linking EGFR signaling to gefitinib antitumor response. | International journal of cancer 20070401 |
| Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20070401 |
| Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20070401 |
| Antitumor effect of gemcitabine on orthotopically inoculated human gallbladder cancer cells in nude mice. | Annals of surgical oncology 20070401 |
| Chemotherapy dose--response relationships in non-small cell lung cancer and implied resistance mechanisms. | Cancer treatment reviews 20070401 |
| Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells. | Pharmacological research 20070401 |
| Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer. | Cancer science 20070401 |
| Operative complications and early mortality after induction therapy for lung cancer. | European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20070401 |
| Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors: preliminary evidence of activity in small cell and neuroendocrine carcinomas. | Cancer 20070401 |
| Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study. | Cancer 20070401 |
| Low concentrations of the histone deacetylase inhibitor, depsipeptide, enhance the effects of gemcitabine and docetaxel in hormone refractory prostate cancer cells. | Oncology reports 20070401 |
| Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II study. | Anti-cancer drugs 20070401 |
| DNA-dependent protein kinase inhibits AID-induced antibody gene conversion. | PLoS biology 20070401 |
| Delayed posterior encephalopathy syndrome following chemotherapy with oxaliplatin and gemcitabine. | Journal of neurology 20070401 |
| Evaluation of the L-stereoisomeric nucleoside analog troxacitabine for the treatment of acute myeloid leukemia. | Expert opinion on investigational drugs 20070401 |
| Gemcitabine radiosensitizes multiple myeloma cells to low let, but not high let, irradiation. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20070401 |
| Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer. | International journal of radiation oncology, biology, physics 20070401 |
| Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070401 |
| H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation. | Molecular cancer therapeutics 20070401 |
| Radiation recall pneumonitis induced by gemcitabine. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20070401 |
| Efficacy of vinorelbine in the second-line setting and beyond in non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070401 |
| Impact of gemcitabine on the survival of patients with stage IV pancreatic cancer. | Pancreas 20070401 |
| Acute tubulointerstitial nephritis associated with long-term gemcitabine therapy. | Pancreas 20070401 |
| A phase I study of gemcitabine and uracil-ftorfar (UFT)/leucovorin. | American journal of clinical oncology 20070401 |
| Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei. | Journal of cardiothoracic and vascular anesthesia 20070401 |
| Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma. | PLoS medicine 20070401 |
| [Efficacy of docetaxel combined capecitabine on metastatic breast cancer]. | Ai zheng = Aizheng = Chinese journal of cancer 20070401 |
| [Clinical comparison of GC regimen (gemcitabine and cisplatin) versus FEC regimen (fluorouracil, epirubicin, and cyclophosphamide) as neoadjuvant chemotherapy for breast cancer]. | Ai zheng = Aizheng = Chinese journal of cancer 20070401 |
| [Non-cisplatin based chemotherapy in advanced non-small cell lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070401 |
| [Outpatient chemotherapy for lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070401 |
| Adjuvant treatment of colon cancer: past, present and future. | Journal of chemotherapy (Florence, Italy) 20070401 |
| Clinical phase I and pharmacology study of gemcitabine (2', 2'-difluorodeoxycytidine) administered in a two-weekly schedule. | Journal of chemotherapy (Florence, Italy) 20070401 |
| Circadian physiology is a toxicity target of the anticancer drug gemcitabine in mice. | Journal of biological rhythms 20070401 |
| Role of thymidine phosphorylase and orotate phosphoribosyltransferase mRNA expression and its ratio to dihydropyrimidine dehydrogenase in the prognosis and clinicopathological features of patients with pancreatic cancer. | International journal of clinical oncology 20070401 |
| Medicines Control Council and registration backlog of antiretrovirals. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20070401 |
| Population stratification of a common APOBEC gene deletion polymorphism. | PLoS genetics 20070401 |
| Treatment of advanced pancreatic cancer. | Seminars in oncology 20070401 |
| Adjuvant therapy for stage II and III colorectal cancer. | Seminars in oncology 20070401 |
| Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL). | Hematology (Amsterdam, Netherlands) 20070401 |
| Parotid gland metastasis of a breast cancer. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070401 |
| Capecitabine in combination with novel targeted agents in the management of metastatic breast cancer: underlying rationale and results of clinical trials. | The oncologist 20070401 |
| [A case of lung adenocarcinoma with Marie-Bamberger syndrome that improved by chemotherapy]. | Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20070401 |
| [Strategy in the treatment of anthracycline-resistant breast cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070401 |
| [Clinical characteristics and chemotherapy of advanced-stage bronchioloalveolar carcinoma of the lung: report of 53 patients]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070401 |
| A glucuronidation pathway of capecitabine occurs in rats but not in mice and humans. | Drug metabolism letters 20070401 |
| Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. | British journal of cancer 20070326 |
| A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer. | British journal of cancer 20070326 |
| The metabolism and molecular toxicology of chloroprene. | Chemico-biological interactions 20070320 |
| Gemcitabine plus cisplatin in advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070320 |
| Weekly gemcitabine as a radiosensitiser for the treatment of brain metastases in patients with non-small cell lung cancer: phase I trial. | Chinese medical journal 20070320 |
| Mutagenesis of non-conserved active site residues improves the activity and narrows the specificity of human thymidine kinase 2. | Biochemical and biophysical research communications 20070316 |
| Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer. | International journal of cancer 20070315 |
| Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancer. | International journal of radiation oncology, biology, physics 20070315 |
| A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma. | International journal of radiation oncology, biology, physics 20070315 |
| Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study. | International journal of radiation oncology, biology, physics 20070315 |
| Potentiation of high-LET radiation by gemcitabine: targeting HER2 with trastuzumab to treat disseminated peritoneal disease. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070315 |
| Structure-function analysis of a bacterial deoxyadenosine kinase reveals the basis for substrate specificity. | Journal of molecular biology 20070309 |
| Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study. | Gynecologic oncology 20070301 |
| A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression. | Cancer chemotherapy and pharmacology 20070301 |
| Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma. | Gynecologic oncology 20070301 |
| The determination of gemcitabine and 2'-deoxycytidine in human plasma and tissue by APCI tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070301 |
| Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study. | Annals of oncology : official journal of the European Society for Medical Oncology 20070301 |
| The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20070301 |
| Gemcitabine in advanced biliary tract cancers. | Critical reviews in oncology/hematology 20070301 |
| A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20070301 |
| Reversible posterior leukoencephalopathy syndrome after carboplatin therapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20070301 |
| The histone deacetylase inhibitors depsipeptide and MS-275, enhance TRAIL gene therapy of LNCaP prostate cancer cells without adverse effects in normal prostate epithelial cells. | Cancer gene therapy 20070301 |
| Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo. | Cancer science 20070301 |
| Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20070301 |
| Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method. | Nucleic acids research 20070301 |
| Pooled efficacy analysis from a phase I-II study of biweekly irinotecan in combination with gemcitabine, 5-fluorouracil, leucovorin and cisplatin in patients with metastatic pancreatic cancer. | Anti-cancer drugs 20070301 |
| An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors. | Anti-cancer drugs 20070301 |
| Functional studies of active-site mutants from Drosophila melanogaster deoxyribonucleoside kinase. Investigations of the putative catalytic glutamate-arginine pair and of residues responsible for substrate specificity. | The FEBS journal 20070301 |
| Treatment options for patients with pretreated metastatic breast cancer. | The Lancet. Oncology 20070301 |
| Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial. | The Lancet. Oncology 20070301 |
| Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. | Cancer research 20070301 |
| Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein. | Molecular cancer therapeutics 20070301 |
| Integrating Chinese and conventional medicine in colorectal cancer treatment. | Integrative cancer therapies 20070301 |
| [A patient with advanced recurrent breast cancer who firmly resisted hair loss and was then treated by combination therapy with high-dose toremifene and capecitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070301 |
| 13-cis-Retinoic acid in combination with gemcitabine in the treatment of locally advanced and metastatic pancreatic cancer--report of a pilot phase II study. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20070301 |
| Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells. | Molecular cancer therapeutics 20070301 |
| Reactions of {4-[bis(2-chloroethyl)amino]phenyl}acetic acid (phenylacetic acid mustard) with 2'-deoxyribonucleosides. | Chemistry & biodiversity 20070301 |
| bcl-2-specific siRNAs restore gemcitabine sensitivity in human pancreatic cancer cells. | Journal of cellular and molecular medicine 20070301 |
| Stress chaperones, mortalin, and pex19p mediate 5-aza-2' deoxycytidine-induced senescence of cancer cells by DNA methylation-independent pathway. | The journals of gerontology. Series A, Biological sciences and medical sciences 20070301 |
| Pancreatic cancer: an update on a 'stealth' cancer. Treatment advances have been slow in coming. What makes this cancer so intractable? | Harvard health letter 20070301 |
| A pharmacogenomic study of docetaxel and gemcitabine for the initial treatment of advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070301 |
| Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070301 |
| A randomized phase II trial of single-agent gemcitabine, vinorelbine, or docetaxel in patients with advanced non-small cell lung cancer who have poor performance status and/or are elderly. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070301 |
| Four-modality therapy in malignant pleural mesothelioma: a phase II study. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070301 |
| Efficacy and safety of gemcitabine monotherapy in patients with transitional cell carcinoma after Cisplatin-containing therapy: a Japanese experience. | Japanese journal of clinical oncology 20070301 |
| Predictive value of MSH2 gene expression in colorectal cancer treated with capecitabine. | Clinical colorectal cancer 20070301 |
| Highlights from: 5-Fluorouracil Drug Management Pharmacokinetics and Pharmacogenomics Workshop; Orlando, Florida; January 2007. | Clinical colorectal cancer 20070301 |
| Phase II study of preoperative irradiation and chemotherapy with capecitabine in patients with locally advanced rectal carcinoma. | Journal of experimental & clinical cancer research : CR 20070301 |
| Mature results of a phase II trial of gemcitabine/paclitaxel given every 2 weeks in patients with advanced non-small-cell lung cancer. | Clinical lung cancer 20070301 |
| [Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070301 |
| Investigating the 'steric gate' of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by targeted insertion of unnatural amino acids. | Biochemistry 20070227 |
| DNA polymerase beta catalytic efficiency mirrors the Asn279-dCTP H-bonding strength. | FEBS letters 20070220 |
| Sequential chemotherapy in nonsmall-cell lung cancer: cisplatin and gemcitabine followed by docetaxel. | Cancer 20070215 |
| Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070215 |
| Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells. | British journal of cancer 20070212 |
| Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070210 |
| Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. | The Journal of biological chemistry 20070209 |
| Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: result of a dose-intensity study. | Investigational new drugs 20070201 |
| Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas. | Cancer chemotherapy and pharmacology 20070201 |
| Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer. | Cancer chemotherapy and pharmacology 20070201 |
| Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma. | Cancer chemotherapy and pharmacology 20070201 |
| Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective study. | American journal of hematology 20070201 |
| Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902. | Annals of oncology : official journal of the European Society for Medical Oncology 20070201 |
| Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways. | Journal of hepatology 20070201 |
| Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC): results of a prospective randomized study. | Lung cancer (Amsterdam, Netherlands) 20070201 |
| Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101). | Annals of oncology : official journal of the European Society for Medical Oncology 20070201 |
| Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20070201 |
| Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20070201 |
| Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan. | Annals of oncology : official journal of the European Society for Medical Oncology 20070201 |
| Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells. | Clinica chimica acta; international journal of clinical chemistry 20070201 |
| Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. | International journal of radiation oncology, biology, physics 20070201 |
| Effective use of multi-arterial infusion chemotherapy for advanced non-small cell lung cancer patients: four clinical specified cases. | Lung cancer (Amsterdam, Netherlands) 20070201 |
| Gemcitabine-induced apoptosis in 5637 cell line: an in-vitro model for high-risk superficial bladder cancer. | Anti-cancer drugs 20070201 |
| Docetaxel and gemcitabine combination therapy in advanced transitional cell carcinoma of the urothelium: results of a phase II and pharmacologic study. | Anti-cancer drugs 20070201 |
| ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma. | Clinical chemistry 20070201 |
| Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function. | Cancer 20070201 |
| Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancer. | Oncology reports 20070201 |
| Transcleral orbital invasion by a radiation and chemotherapy-resistant choroidal metastasis of a pulmonary adenocarcinoma. | American journal of ophthalmology 20070201 |
| Data acquisition for the histoculture drug response assay in lung cancer. | The Journal of thoracic and cardiovascular surgery 20070201 |
| Chemotherapy resistance and oncogene expression in non-small cell lung cancer. | The Journal of thoracic and cardiovascular surgery 20070201 |
| Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070201 |
| Implementing Good Clinical Practice in two noncommercial phase II studies in children with cancer. | Onkologie 20070201 |
| Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: pretreatment levels or kinetics during chemotherapy? | Onkologie 20070201 |
| Oral capecitabine (Xeloda) in cancer treatment. | The Nurse practitioner 20070201 |
| Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all? | Expert opinion on pharmacotherapy 20070201 |
| Prognostic factors in patients with gemcitabine-refractory pancreatic cancer. | Japanese journal of clinical oncology 20070201 |
| A phase II study of second-line neoadjuvant chemotherapy with capecitabine and radiation therapy for anthracycline-resistant locally advanced breast cancer. | American journal of clinical oncology 20070201 |
| Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H. | PLoS pathogens 20070201 |
| Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience. | Haematologica 20070201 |
| Capecitabine. | The oncologist 20070201 |
| [A case of advanced large cell lung carcinoma for whom fourth-line chemotherapy of cisplatin and gemcitabine proved effective for the first time]. | Gan to kagaku ryoho. Cancer & chemotherapy 20070201 |
| Prediction of drug combination chemosensitivity in human bladder cancer. | Molecular cancer therapeutics 20070201 |
| Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. | Molecular cancer therapeutics 20070201 |
| CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients. | European journal of haematology 20070201 |
| Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer. | Urology 20070201 |
| Combined treatment of bladder cancer cell lines with lapatinib and varying chemotherapy regimens--evidence of schedule-dependent synergy. | Urology 20070201 |
| Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabine-resistant leukemic cells. | International journal of hematology 20070201 |
| Induction therapy with enfuvirtide-based highly active antiretroviral therapy in a patient with acute HIV-1 infection. | AIDS patient care and STDs 20070201 |
| Assessment of functional status, symptoms and comorbidity in elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with gemcitabine and vinorelbine. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070201 |
| Thrombotic microangiopathy in a sirolimus-treated renal transplant patient receiving gemcitabine for lung cancer. | Clinical nephrology 20070201 |
| APOBEC3G and HIV-1: strike and counterstrike. | Current HIV/AIDS reports 20070201 |
| [Progress of study on prevention and treatment of xeloda induced hand-foot syndrome by measures of Chinese and Western medicine]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20070201 |
| Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy. | Clinical breast cancer 20070201 |
| Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology Group. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070201 |
| Image-guided convection-enhanced delivery of gemcitabine to the brainstem. | Journal of neurosurgery 20070201 |
| Cloning and characterization of an alternative splicing transcript of the gene coding for human cytidine deaminase. | Biochemistry and cell biology = Biochimie et biologie cellulaire 20070201 |
| Gemcitabine plus bevacizumab no better than gemcitabine alone in clinical study of 600 patients with pancreatic cancer. | Cancer biology & therapy 20070201 |
| Truvada intolerance. | AIDS (London, England) 20070130 |
| Combined effects of a third-generation bisphosphonate, zoledronic acid with other anticancer agents against murine osteosarcoma. | British journal of cancer 20070129 |
| Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. | JAMA 20070117 |
| Adjuvant therapy for pancreatic cancer: one small step forward. | JAMA 20070117 |
| Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells. | British journal of cancer 20070115 |
| The Hollow Fibre Assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells. | British journal of cancer 20070115 |
| Rapid and simultaneous determination of capecitabine and its metabolites in mouse plasma, mouse serum, and in rabbit bile by high-performance liquid chromatography. | Journal of chromatography. A 20070105 |
| Synthesis and fluorescent properties of bi- and tricyclic 4-N-carbamoyldeoxycytidine derivatives. | The Journal of organic chemistry 20070105 |
| Major oxidative products of cytosine are substrates for the nucleotide incision repair pathway. | DNA repair 20070104 |
| Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer. | Cancer chemotherapy and pharmacology 20070101 |
| A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens. | Cancer chemotherapy and pharmacology 20070101 |
| Altered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients. | British journal of clinical pharmacology 20070101 |
| Lichenoid photosensitive eruption due to capecitabine chemotherapy for metastatic breast cancer. | Clinical and experimental dermatology 20070101 |
| Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. | Molecular carcinogenesis 20070101 |
| Concurrent radiotherapy and capecitabine, followed by high-dose methotrexate consolidation, provided effective palliation in a patient with leptomeningeal metastases from breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20070101 |
| Which benefit from adding gemcitabine to vinorelbine in elderly (>or=70 years) women with metastatic breast cancer? Early interruption of a phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20070101 |
| Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO). | Annals of oncology : official journal of the European Society for Medical Oncology 20070101 |
| Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20070101 |
| Tezacitabine enhances the DNA-directed effects of fluoropyrimidines in human colon cancer cells and tumor xenografts. | Biochemical pharmacology 20070101 |
| Phase II analysis of paclitaxel and capecitabine in the treatment of recurrent or disseminated squamous cell carcinoma of the head and neck region. | Head & neck 20070101 |
| The effect of capecitabine on the healing of colonic anastomoses in rats. | Diseases of the colon and rectum 20070101 |
| Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20070101 |
| Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070101 |
| Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070101 |
| Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070101 |
| Case of carcinosarcoma of urinary bladder obtained a pathologically complete response by neoadjuvant chemoradiotherapy. | International journal of urology : official journal of the Japanese Urological Association 20070101 |
| The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070101 |
| 2'-Deoxy-5-propynylcytidine: a nucleoside forming two solid-state conformations. | Acta crystallographica. Section C, Crystal structure communications 20070101 |
| Phase II trial of capecitabine and rHu-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity. | Urologic oncology 20070101 |
| Use of capecitabine to prevent acute renal allograft rejection in dog erythrocyte antigen-mismatched mongrel dogs. | Veterinary surgery : VS 20070101 |
| Evaluation of intrahepatic perfusion on fusion imaging using a combined CT/SPECT system: influence of anatomic variations on hemodynamic modification before installation of implantable port systems for hepatic arterial infusion chemotherapy. | Cardiovascular and interventional radiology 20070101 |
| Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma. | Haematologica 20070101 |
| Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo. | Cell cycle (Georgetown, Tex.) 20070101 |
| Reconstitution of an infectious human endogenous retrovirus. | PLoS pathogens 20070101 |
| Efficacy of lower dose capecitabine in patients with metastatic breast cancer and factors influencing therapeutic response and outcome. | Southern medical journal 20070101 |
| Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes. | Current drug delivery 20070101 |
| Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis. | Japanese journal of clinical oncology 20070101 |
| Open, randomized, phase II study of single-agent gemcitabine and docetaxel as first- and second-line treatment in patients with advanced non-small-cell lung cancer. | Clinical lung cancer 20070101 |
| Toxicities and survival among octogenarians and nonagenarians with colorectal cancer treated with chemotherapy or concurrent chemoradiation therapy. | Clinical colorectal cancer 20070101 |
| Palmar-plantar erythrodysesthesia associated with scrotal and penile involvement with capecitabine. | Clinical colorectal cancer 20070101 |
| Distinct energetics and closing pathways for DNA polymerase beta with 8-oxoG template and different incoming nucleotides. | BMC structural biology 20070101 |
| Gemcitabine-oxaliplatin combination in heavily pretreated metastatic breast cancer: a pilot study on 43 patients. | The breast journal 20070101 |
| Molecular mechanisms of antibody somatic hypermutation. | Annual review of biochemistry 20070101 |
| Synergistic antitumor activity of oxaliplatin in combination with gemcitabine in pancreatic tumor-bearing mice. | Chemotherapy 20070101 |
| Pre-operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer. | Anticancer research 20070101 |
| Antitumor activity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs. | Anticancer research 20070101 |
| Capecitabine: in advanced gastric or oesophagogastric cancer. | Drugs 20070101 |
| Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Yoon-Koo Kang. | Drugs 20070101 |
| Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Sai-Hong Ignatius Ou and Randall F. Holcombe. | Drugs 20070101 |
| Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20070101 |
| Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20070101 |
| Establishment of a novel orthotopic xenograft model of human gallbladder carcinoma. | Clinical & experimental metastasis 20070101 |
| The influence of primary care prescribing rates for new drugs on spontaneous reporting of adverse drug reactions. | Drug safety 20070101 |
| Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. | Cancer nursing 20070101 |
| Treatment of advanced hepatocellular carcinoma with gemcitabine plus oxaliplatin. | Hepato-gastroenterology 20070101 |
| Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20070101 |
| Phase I study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first line therapy in patients with non-resectable gastric cancer. | Acta oncologica (Stockholm, Sweden) 20070101 |
| Efficacy and safety of cisplatin and capecitabine in combination as first line treatment for unselected patients with advanced gastric cancer. | Acta oncologica (Stockholm, Sweden) 20070101 |
| Phase II trial of pegylated liposomal doxorubicin (Caelyx) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer. | Acta oncologica (Stockholm, Sweden) 20070101 |
| Dosage of capecitabine and cyclophosphamide combination therapy in patients with metastatic breast cancer. | Anticancer research 20070101 |
| Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancer. | Anticancer research 20070101 |
| Intracavitary mass as the initial manifestation of primary pericardial mesothelioma: a case report. | Angiology 20070101 |
| The cumulative incidence of gemcitabine-induced thrombotic microangiopathy. | Acta oncologica (Stockholm, Sweden) 20070101 |
| A Phase I dose-finding study using an innovative sequential biweekly schedule of irinotecan followed 24 hours later by capecitabine. | Cancer investigation 20070101 |
| Capecitabine-induced headache responding to diltiazem. | Chemotherapy 20070101 |
| Effective treatment of locally advanced endocrine tumors of the pancreas with chemoradiotherapy. | Neuroendocrinology 20070101 |
| Apricitabine: a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor for the treatment of nucleoside-resistant HIV infection. | Antiviral chemistry & chemotherapy 20070101 |
| Kinetics of inhibition of HIV type 1 reverse transcriptase-bearing NRTI-associated mutations by apricitabine triphosphate. | Antiviral chemistry & chemotherapy 20070101 |
| Intermittent capecitabine monotherapy with lower dose intensity in heavily pretreated patients with metastatic breast cancer. | Tumori 20070101 |
| A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium. | BMC cancer 20070101 |
| Simultaneous alteration of de novo and salvage pathway to the deoxynucleoside triphosphate pool by (E)-2'-deoxy-(fluoromethylene)cytidine (FMdC) and zidovudine (AZT) results in increased radiosensitivity in vitro. | Acta oncologica (Stockholm, Sweden) 20070101 |
| A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy. | Respiratory research 20070101 |
| Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20070101 |
| [Detection of dihydropyrimidine dehydrogenase deficiency before treatment by fluoropyrimidines]. | Therapie 20070101 |
| Five-year follow up of once-daily therapy with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial). | Antiviral therapy 20070101 |
| The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer. | Hepato-gastroenterology 20070101 |
| Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects. | Anticancer research 20070101 |
| Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study. | BMC cancer 20070101 |
| Dose-finding study of capecitabine in combination with weekly paclitaxel for patients with anthracycline-pretreated metastatic breast cancer. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20070101 |
| Capecitabine in pretreated metastatic cholangiocarcinoma. A case report and review of the literature. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20070101 |
| Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses. | BMC nuclear medicine 20070101 |
| Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer. | BMC cancer 20070101 |
| Chemotherapy for pancreatic cancer: from metastatic disease to adjuvant therapy. | Cancer journal (Sudbury, Mass.) 20070101 |
| Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions. | Retrovirology 20070101 |
| Understanding ribonucleotide reductase inactivation by gemcitabine. | Chemistry (Weinheim an der Bergstrasse, Germany) 20070101 |
| Acquired resistance of pulmonary adenocarcinoma to initially successful targeted therapy due to EGFR mutation T790M. | Anticancer research 20070101 |
| Successful treatment with low-dose capecitabine for disseminated esophageal adenocarcinoma. | Acta oncologica (Stockholm, Sweden) 20070101 |
| [Modern chemotherapy of invasive bladder cancer]. | Magyar onkologia 20070101 |
| Primary small cell bladder carcinoma. | Tumori 20070101 |
| Medical treatment of uveal melanoma. | Tumori 20070101 |
| Preoperative radiotherapy and concomitant capecitabine treatment induce thymidylate synthase and thymidine phosphorylase mRNAs in rectal carcinoma. | Neoplasma 20070101 |
| Complete remission of recurrent breast cancer with multiple liver metastases after oral capecitabine and injected trastuzumab. | Breast cancer (Tokyo, Japan) 20070101 |
| [Skin lesions in a female patient with non-Hodgkin lymphoma]. | Enfermedades infecciosas y microbiologia clinica 20070101 |
| Mitomycin C plus capecitabine (mixe) in anthracycline- and taxane-pretreated metastatic breast cancer. A multicenter phase II study. | Anticancer research 20070101 |
| Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: a phase II study. | Anticancer research 20070101 |
| Dummy run for a phase II multi-institute trial of chemoradiotherapy for unresectable pancreatic cancer: inter-observer variance in contour delineation. | Anticancer research 20070101 |
| Gemcitabine and oral vinorelbine as salvage treatment in patients with advanced anthracycline- and taxane-pretreated breast cancer. | Anticancer research 20070101 |
| Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study. | Anticancer research 20070101 |
| Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer. | Anticancer research 20070101 |
| Antitumor activity of capecitabine and bevacizumab combination in a human estrogen receptor-negative breast adenocarcinoma xenograft model. | Anticancer research 20070101 |
| A simple non-destructive test of cellular activity (NTCA) for in vitro assessment of cancer cell chemosensitivity/resistance. | Anticancer research 20070101 |
| Everolimus and mycophenolate mofetil sensitize human pancreatic cancer cells to gemcitabine in vitro: a novel adjunct to standard chemotherapy? | European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20070101 |
| Pancreatic acinar cell carcinoma with excessive alpha-fetoprotein expression. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20070101 |
| [Management of capecitabine-induced hand-foot syndrome by local phytotherapy]. | Wiener medizinische Wochenschrift (1946) 20070101 |
| A phase I study of hypofractionated radiotherapy followed by systemic chemotherapy with full-dose gemcitabine in patients with unresectable locally advanced pancreatic cancer. | Hepato-gastroenterology 20070101 |
| Comparison of intrahepatic and pancreatic perfusion on fusion images using a combined SPECT/CT system and assessment of efficacy of combined continuous arterial infusion and systemic chemotherapy in advanced pancreatic carcinoma. | Cardiovascular and interventional radiology 20070101 |
| Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B. | Antiviral therapy 20070101 |
| A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment. | Antiviral therapy 20070101 |
| Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity. | Retrovirology 20070101 |
| Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase. | Cancer journal (Sudbury, Mass.) 20070101 |
| [Gemcitabine and pemetrexed update]. | Bulletin du cancer 20070101 |
| [Gemcitabine: from preclinic to clinic passing by pharmacokinetics]. | Bulletin du cancer 20070101 |
| [Updates on gemcitabine on metastatic breast cancer]. | Bulletin du cancer 20070101 |
| [Gemcitabine and non small-cell lung cancer]. | Bulletin du cancer 20070101 |
| [Gemcitabine and digestive carcinomas]. | Bulletin du cancer 20070101 |
| [Gemcitabine and pemetrexed in genito-urinary tumors treatment]. | Bulletin du cancer 20070101 |
| [Docetaxel and gemcitabine combination in soft-tissue sarcomas treatment]. | Bulletin du cancer 20070101 |
| [Gemcitabine and radiotherapy in non-small cell lung cancer: dolce vita at last!]. | Bulletin du cancer 20070101 |
| [Gemcitabine and pemetrexed: novel associations and mechanisms of resistance]. | Bulletin du cancer 20070101 |
| Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. | Medical oncology (Northwood, London, England) 20070101 |
| High level glucose increases mutagenesis in human lymphoblastoid cells. | International journal of biological sciences 20070101 |
| Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding study. | Cancer investigation 20070101 |
| [Intestinal pneumatosis and portomesenteric gas: a case review]. | Revista de medicina de la Universidad de Navarra 20070101 |
| Meta-analysis of randomised trials comparing gemcitabine-based doublets versus gemcitabine alone in patients with advanced and metastatic pancreatic cancer. | Drugs & aging 20070101 |
| Trial of adjuvant gemcitabine for pancreatic cancer: the jury is still out. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20070101 |
| Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer. | Medical oncology (Northwood, London, England) 20070101 |
| Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer. | Medical oncology (Northwood, London, England) 20070101 |
| Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma. | Medical oncology (Northwood, London, England) 20070101 |
| Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer. | Acta oncologica (Stockholm, Sweden) 20070101 |
| Feasibility and efficacy of chemotherapy with gemcitabine mono and with paclitaxel/mitoxantron in gynaecological cancers. | European journal of gynaecological oncology 20070101 |
| Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma. | International braz j urol : official journal of the Brazilian Society of Urology 20070101 |
| The effect of combined treatment methods on survival and toxicity in patients with pancreatic cancer. | Medicina (Kaunas, Lithuania) 20070101 |
| Bilateral renal infarction in a patient with lung carcinoma treated with cisplatin and gemcitabine. | Renal failure 20070101 |
| A pilot phase II study of capecitabine plus cisplatin in the treatment of recurrent carcinoma of the uterine cervix. | Oncology 20070101 |
| A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumors. | Oncology 20070101 |
| An open-label, multicenter study of outpatient capecitabine monotherapy in 631 patients with pretreated advanced breast cancer. | Oncology 20070101 |
| Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors. | Antiviral therapy 20070101 |
| Disorder in clotting pattern after antiretroviral treatment with emtricitabine in an HIV-positive haemophiliac patient. | Clinical drug investigation 20070101 |
| Cetuximab plus gemcitabine-oxaliplatin (GEMOX) in patients with refractory advanced intrahepatic cholangiocarcinomas. | Oncology 20070101 |
| Functionalization of DNA by the base pair-mimic nucleosides. | Nucleic acids symposium series (2004) 20070101 |
| Synthesis and properties of oligodeoxynucleotides incorporating 5-carboxydeoxycytidine. | Nucleic acids symposium series (2004) 20070101 |
| Recognition of target chain-length by use of oligonucleotides having bulky substituents at the terminal bases. | Nucleic acids symposium series (2004) 20070101 |
| Identification of DNA basepairing via tunnel-current decay. | Nano letters 20070101 |
| Differential expression of autophagy in Hodgkin lymphoma cells treated with various anti-cancer drugs. | Acta medica Indonesiana 20070101 |
| A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine. | Antiviral chemistry & chemotherapy 20070101 |
| Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides. | Urologic oncology 20070101 |
| Troxacitabine prodrugs for pancreatic cancer. | Nucleosides, nucleotides & nucleic acids 20070101 |
| A pyrimidopyrimidoindole nucleoside (dC PPI): photophysical properties and thermal stability of the modified DNA duplexes. | Nucleosides, nucleotides & nucleic acids 20070101 |
| In vivo and in vitro activity and mechanism of action of the multidrug cytarabine-L-glycerylyl-fluorodeoxyuridine. | Nucleosides, nucleotides & nucleic acids 20070101 |
| Reactions of malonaldehyde and acetaldehyde with calf thymus DNA: formation of conjugate adducts. | Nucleosides, nucleotides & nucleic acids 20070101 |
| Methylation-dependent fragment separation: novel analysis of 5-methyl cytosine by capillary electrophoresis of amplified DNA using PCR incorporation of chemically modified dCTP. | Nucleosides, nucleotides & nucleic acids 20070101 |
| pH-dependent assembly of DNA-gold nanoparticles based on the i-motif. | Nucleosides, nucleotides & nucleic acids 20070101 |
| The multidisciplinary management of gastrointestinal cancer. The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer. | Best practice & research. Clinical gastroenterology 20070101 |
| Synthesis of the 3'-thio-nucleosides and subsequent automated synthesis of oligodeoxynucleotides containing a 3'-S-phosphorothiolate linkage. | Nature protocols 20070101 |
| Cost consequences of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French setting. | Oncology 20070101 |
| Irinotecan plus gemcitabine and 5-fluorouracil in advanced pancreatic cancer: a phase II study. | Oncology 20070101 |
| Dose-finding phase I and pharmacokinetic study of capecitabine (Xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer. | Oncology 20070101 |
| Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes. | Oncology 20070101 |
| Re: Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma. | International braz j urol : official journal of the Brazilian Society of Urology 20070101 |
| Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine. | Oncology 20070101 |
| Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study. | Anticancer research 20070101 |
| Long-term survivors after chemotherapy in advanced non-small cell lung cancer. | Anticancer research 20070101 |
| A phase II study of gemcitabine at fixed infusion rate of 10 mg/m2/min with or without immunotherapy in advanced renal cancer. | Anticancer research 20070101 |
| Rapamycin enhances the anti-tumor effect of gemcitabine in pancreatic cancer cells. | Hepato-gastroenterology 20070101 |
| A phase I study of combination of intravenous gemcitabine, oxaliplatin, and 5-FU with daily oral thalidomide (GOFT) in metastatic/locally advanced pancreatic carcinoma patients. | Hepato-gastroenterology 20070101 |
| Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-gamma agonists in recurrent high-grade gliomas - a phase II study. | Oncology 20070101 |
| Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer. | Oncology 20070101 |
| Treatment of transformed mycosis fungoides with intermittent low-dose gemcitabine. | Oncology 20070101 |
| 18FDG-PET evaluation correlates better than CT with pathological response in a metastatic colon cancer patient treated with bevacizumab-based therapy. | Tumori 20070101 |
| [The choice of treatment in advanced gastric cancer]. | Tumori 20070101 |
| Preoperative treatment combining capecitabine with radiation therapy in rectal cancer: a GERCOR Phase II Study. | Oncology 20070101 |
| Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer. | Oncology 20070101 |
| Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99). | Oncology 20070101 |
| Acral and palmo-plantar hyperpigmentation in a patient with disseminated hepatocellular carcinoma. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20070101 |
| Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessment. | Oncology 20070101 |
| XELOX followed by XELIRI or the reverse sequence in advanced colorectal cancer. | Oncology 20070101 |
| Chemotherapy with gemcitabine and oxaliplatin in patients with advanced biliary tract cancer: a single-institution experience. | Oncology 20070101 |
| Short time to progression under first-line chemotherapy is a negative prognostic factor for time to progression and residual survival under second-line chemotherapy in advanced pancreatic cancer. | Oncology 20070101 |
| Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer. | Oncology 20070101 |
| Response of a patient with pleural and peritoneal mesothelioma after second-line chemotherapy with lipoplatin and gemcitabine. | Oncology 20070101 |
| [Neoadjuvant chemotherapy of invasive cancer of the urinary bladder]. | Urologiia (Moscow, Russia : 1999) 20070101 |
| Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: a North Central Cancer Treatment Group (NCCTG) phase I and II Trial, N9943. | Journal of gastrointestinal cancer 20070101 |
| CA 19-9 and survival in advanced and unresectable pancreatic adenocarcinoma and cholangiocarcinoma. | Journal of gastrointestinal cancer 20070101 |
| Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival. | Cancer informatics 20070101 |
| Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas. | Core evidence 20070101 |
| Lapatinib plus capecitabine for HER2-positive advanced breast cancer. | The New England journal of medicine 20061228 |
| Targeted therapy for metastatic breast cancer. | The New England journal of medicine 20061228 |
| Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. | Journal of the National Cancer Institute 20061220 |
| Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and morphologic changes--a 96-week analysis. | Journal of acquired immune deficiency syndromes (1999) 20061215 |
| Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibility. | Journal of acquired immune deficiency syndromes (1999) 20061215 |
| Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : results of an Italian multicenter, randomized, phase II study. | Cancer 20061215 |
| Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine in mice. | Clinical cancer research : an official journal of the American Association for Cancer Research 20061215 |
| Endoscopic biliary drainage for patients with unresectable pancreatic cancer with obstructive jaundice who are to undergo gemcitabine chemotherapy. | World journal of gastroenterology 20061207 |
| Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells. | Cancer chemotherapy and pharmacology 20061201 |
| Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase. | Cancer chemotherapy and pharmacology 20061201 |
| Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art. | Annals of oncology : official journal of the European Society for Medical Oncology 20061201 |
| Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20061201 |
| A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20061201 |
| Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer. | International journal of radiation oncology, biology, physics 20061201 |
| ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. | Annals of oncology : official journal of the European Society for Medical Oncology 20061201 |
| Pifithrin-alpha enhances chemosensitivity by a p38 mitogen-activated protein kinase-dependent modulation of the eukaryotic initiation factor 4E in malignant cholangiocytes. | The Journal of pharmacology and experimental therapeutics 20061201 |
| In vitro human immunodeficiency virus type 1 resistance selections with combinations of tenofovir and emtricitabine or abacavir and lamivudine. | Antimicrobial agents and chemotherapy 20061201 |
| Gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growth. | Molecular therapy : the journal of the American Society of Gene Therapy 20061201 |
| Induction cisplatin-gemcitabine-paclitaxel plus concurrent radiotherapy and gemcitabine in the multimodality treatment of unresectable stage IIIB non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20061201 |
| A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients. | Lung cancer (Amsterdam, Netherlands) 20061201 |
| Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): a multicenter phase II study. | Lung cancer (Amsterdam, Netherlands) 20061201 |
| A phase II trial of docetaxel plus capecitabine in patients with previously treated non-small cell lung cancer. | Japanese journal of clinical oncology 20061201 |
| Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells. | The Journal of surgical research 20061201 |
| Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. | International journal of radiation oncology, biology, physics 20061201 |
| First-line gemcitabine and carboplatin in advanced ovarian carcinoma: a phase II study. | BJOG : an international journal of obstetrics and gynaecology 20061201 |
| Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. | Cancer 20061201 |
| Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061201 |
| Molecular features linked to the growth-inhibitory effects of gemcitabine on human pancreatic cancer cells. | Oncology reports 20061201 |
| Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium. | Oncology reports 20061201 |
| Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: a GOAM phase II randomised study (FOCA trial). | European journal of cancer (Oxford, England : 1990) 20061201 |
| Effect of switching to tenofovir with emtricitabine in patients with chronic hepatitis B failing to respond to an adefovir-containing regimen. | European journal of gastroenterology & hepatology 20061201 |
| Clinically occult cutaneous metastases. | Journal of the American Academy of Dermatology 20061201 |
| Quantitative analysis of gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry. | Journal of mass spectrometry : JMS 20061201 |
| Mediastinal follicular dendritic cell sarcoma involving bone marrow: a case report and review of the literature. | Annals of diagnostic pathology 20061201 |
| A step in the right direction. | Nature clinical practice. Oncology 20061201 |
| Phase I study of bryostatin 1 and gemcitabine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20061201 |
| Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20061201 |
| Consistent liver metastases in a rat model by portal injection of microencapsulated cancer cells. | Cancer research 20061201 |
| A phase II study of sequential neoadjuvant gemcitabine and paclitaxel, radiation therapy with cisplatin and 5-fluorouracil and surgery in locally advanced esophageal carcinoma. | American journal of clinical oncology 20061201 |
| Radiochemotherapy followed by gemcitabine and capecitabine in extrahepatic bile duct cancer: a phase I/II trial. | American journal of clinical oncology 20061201 |
| An unusual case of gemcitabine-induced radiation recall. | American journal of clinical oncology 20061201 |
| [Routine chemotherapeutic drug treatment effectiveness predictive molecules and chemotherapeutic drug selection]. | Ai zheng = Aizheng = Chinese journal of cancer 20061201 |
| Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domain. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20061201 |
| Conservative treatment with transurethral resection, neoadjuvant chemotherapy followed by radiochemotherapy in stage T2-3 transitional bladder cancer. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20061201 |
| Biomarkers for isocyanate exposure: Synthesis of isocyanate DNA adducts. | Chemical research in toxicology 20061201 |
| Didanosine, lamivudine-emtricitabine and efavirenz as initial therapy in naive patients. | Expert review of anti-infective therapy 20061201 |
| Urachal carcinoma: surgical and chemotherapeutic options. | Expert review of anticancer therapy 20061201 |
| Atripla approval in Europe. | AIDS patient care and STDs 20061201 |
| [Successful treatment of an elderly patient with pretreated recurrent breast cancer using low-dose capecitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20061201 |
| [Two cases of advanced pancreas cancer treated with GTX: combined use of gemcitabine, docetaxel and capecitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20061201 |
| [A case of small cell carcinoma in the urinary bladder responding to gemcitabine/cisplatin combination therapy as neoadjuvant chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20061201 |
| Hepatitis B virus treatment in HIV-infected patients. | Topics in HIV medicine : a publication of the International AIDS Society, USA 20061201 |
| A phase I study of an all-oral combination of vinorelbine/capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and/or taxanes. | Clinical breast cancer 20061201 |
| Capecitabine and oxaliplatin (XELOX) for the treatment of patients with metastatic gastric cancer and severe liver dysfunction. | The Korean journal of internal medicine 20061201 |
| [New therapeutics in the suppression of superficial bladder carcinoma]. | Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20061201 |
| [The not-infrequent story of a superficial bladder carcinoma...Discussion of clinical case no.1]. | Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20061201 |
| [The not-infrequent story of a superficial bladder carcinoma...Discussion of clinical case no.2]. | Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20061201 |
| Azacytidine (Vidaza(R)) in the treatment of myelodysplastic syndromes. | Therapeutics and clinical risk management 20061201 |
| Meta-analysis on inoperable pancreatic cancer: a comparison between gemcitabine-based combination therapy and gemcitabine alone. | World journal of gastroenterology 20061121 |
| Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study. | British journal of cancer 20061120 |
| Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors. | Cancer 20061115 |
| Unexpected immunohistochemical localization of deoxycytidine kinase. | Clinical cancer research : an official journal of the American Association for Cancer Research 20061115 |
| Treatment of Stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: impact of chemotherapy schemes. | International journal of radiation oncology, biology, physics 20061115 |
| Persistence of a sexually transmitted highly resistant HIV-1: pol quasispecies evolution over 33 months in the absence of treatment. | AIDS (London, England) 20061114 |
| [MMW drug award for gemcitabine. Cytostatic drug with growing indications]. | MMW Fortschritte der Medizin 20061109 |
| Novel interpenetrating network chitosan-poly(ethylene oxide-g-acrylamide) hydrogel microspheres for the controlled release of capecitabine. | International journal of pharmaceutics 20061106 |
| Preparation of poly epsilon-caprolactone nanoparticles containing magnetite for magnetic drug carrier. | International journal of pharmaceutics 20061106 |
| Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer. | British journal of cancer 20061106 |
| Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study. | Gynecologic oncology 20061101 |
| Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: a phase II study of the Gynecologic Oncology Group. | Gynecologic oncology 20061101 |
| Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer. | Gynecologic oncology 20061101 |
| Determination of the mechanism of gemcitabine modulation of cisplatin drug resistance in panel of human endometrial cancer cell lines. | Gynecologic oncology 20061101 |
| Surgery is an essential part of salvage treatment in refractory germ cell tumors. | European urology 20061101 |
| Phase II study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin-refractory nonseminomatous germ cell tumor. | European urology 20061101 |
| Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs. | International archives of occupational and environmental health 20061101 |
| Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimen. | Gynecologic oncology 20061101 |
| Gene transfer of cytidine deaminase protects myelopoiesis from cytidine analogs in an in vivo murine transplant model. | Blood 20061101 |
| Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy. | Journal of cancer research and clinical oncology 20061101 |
| Effects of trimethoprim on the clearance of apricitabine, a deoxycytidine analog reverse transcriptase inhibitor, and Lamivudine in the isolated perfused rat kidney. | The Journal of pharmacology and experimental therapeutics 20061101 |
| Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apoptosis, proliferation, and potentiation of chemotherapy. | The Prostate 20061101 |
| A new mechanism of methotrexate action revealed by target screening with affinity beads. | Molecular pharmacology 20061101 |
| Gemcitabine-induced thrombotic microangiopathy: a systematic review. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20061101 |
| Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group. | Annals of oncology : official journal of the European Society for Medical Oncology 20061101 |
| A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumors. | Annals of oncology : official journal of the European Society for Medical Oncology 20061101 |
| Patient preference for oral or intravenous chemotherapy: a randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer. | European journal of cancer (Oxford, England : 1990) 20061101 |
| Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule. | International journal of radiation oncology, biology, physics 20061101 |
| Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. | International journal of radiation oncology, biology, physics 20061101 |
| State-of-the-art management of metastatic disease at initial presentation or recurrence. | World journal of urology 20061101 |
| A new, simple method for quantifying gemcitabine triphosphate in cancer cells using isocratic high-performance liquid chromatography. | Cancer science 20061101 |
| Pancreatic cancer: a review of recent advances. | Expert opinion on investigational drugs 20061101 |
| Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients. | Pharmacogenetics and genomics 20061101 |
| The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation. | Health technology assessment (Winchester, England) 20061101 |
| Large topographic variability of upper abdominal lymphatics and the consequences for radiation treatment planning. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20061101 |
| Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment. | Journal of the American Academy of Dermatology 20061101 |
| Management dilemmas due to a paratracheal follicular dendritic cell tumor. | The Annals of thoracic surgery 20061101 |
| Early detection of Richter's transformation: stable disease with dose-reduced gemcitabine and local radiation. | Onkologie 20061101 |
| Metastatic non-small-cell lung carcinoma successfully treated with pre-operative chemotherapy and bilateral adrenalectomy. | Japanese journal of clinical oncology 20061101 |
| Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabine. | Anti-cancer drugs 20061101 |
| Nongenotoxic p53 activation protects cells against S-phase-specific chemotherapy. | Cancer research 20061101 |
| Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. | Cancer research 20061101 |
| Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB. | Cancer research 20061101 |
| Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer. | Pancreas 20061101 |
| Exatecan and gemcitabine: no better than gemcitabine only. | The Lancet. Oncology 20061101 |
| [A case of gemcitabine-based chemo-radiation therapy for locally advanced unresectable pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20061101 |
| [A case of intrahepatic cholangiocarcinoma effectively treated by hepatic arterial infusion chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20061101 |
| [Pancreatic cancer]. | Praxis 20061101 |
| Site-specific synthesis of oligonucleotides containing malondialdehyde adducts of deoxyguanosine and deoxyadenosine via a postsynthetic modification strategy. | Chemical research in toxicology 20061101 |
| Lentivirus-mediated RNA interference of HMGA1 promotes chemosensitivity to gemcitabine in pancreatic adenocarcinoma. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20061101 |
| Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20061101 |
| Cytosine arabinoside-metabolizing enzyme genes are underexpressed in children with MLL gene-rearranged acute lymphoblastic leukemia. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20061101 |
| Combination therapy with gemcitabine and 5-Fluorouracil: unblocking the pathways to survivin? | Cancer biology & therapy 20061101 |
| Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial). | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20061101 |
| [Low-dose gemcitabine concurrent with radiation therapy for locally advanced pancreatic carcinoma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20061101 |
| A case report--The marked response to gemcitabine combined with irinotecan and low-dose cisplatin chemotherapy for advanced gastric cancer with multiple liver metastases. | Gan to kagaku ryoho. Cancer & chemotherapy 20061101 |
| Gemcitabine/carboplatin in a modified 21-day administration schedule for advanced-stage non-small-cell lung cancer. | Clinical lung cancer 20061101 |
| Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness. | Clinical colorectal cancer 20061101 |
| Profiling dihydropyrimidine dehydrogenase deficiency in patients with cancer undergoing 5-fluorouracil/capecitabine therapy. | Clinical colorectal cancer 20061101 |
| [Phase III randomised trial of adjuvant chemotherapy with cisplatin plus docetaxel versus cisplatin plus gemcitabine in resected non-small cell bronchial carcinoma with quality of life as the primary objective]. | Revue des maladies respiratoires 20061101 |
| Recent advances in structure and function of cytosolic IMP-GMP specific 5'-nucleotidase II (cN-II). | Purinergic signalling 20061101 |
| Basal cell carcinoma metastatic to cervical lymph nodes and lungs. | Dermatology online journal 20061031 |
| Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines. | Biochemical and biophysical research communications 20061027 |
| Highly selective and sensitive template-directed photoligation of DNA via 5-carbamoylvinyl-2'-deoxycytidine. | Organic letters 20061026 |
| Ferrocene-modified pyrimidine nucleosides: synthesis, structure and electrochemistry. | Dalton transactions (Cambridge, England : 2003) 20061021 |
| Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061020 |
| Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis. | Oncogene 20061019 |
| RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061010 |
| Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061010 |
| Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer. | British journal of cancer 20061009 |
| Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas. | Cancer chemotherapy and pharmacology 20061001 |
| Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine. | Cancer chemotherapy and pharmacology 20061001 |
| Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells. | Cancer chemotherapy and pharmacology 20061001 |
| Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancer. | Cancer chemotherapy and pharmacology 20061001 |
| Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer. | Gynecologic oncology 20061001 |
| Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma. | Cancer chemotherapy and pharmacology 20061001 |
| Acute coronary syndrome induced by capecitabine therapy. | Heart, lung & circulation 20061001 |
| Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma. | Head & neck 20061001 |
| Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cells. | Blood 20061001 |
| Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group. | Annals of oncology : official journal of the European Society for Medical Oncology 20061001 |
| Collisionally activated dissociation of protonated 2'-deoxycytidine, 2'-deoxyuridine, and their oxidatively damaged derivatives. | Journal of the American Society for Mass Spectrometry 20061001 |
| Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study. | Annals of oncology : official journal of the European Society for Medical Oncology 20061001 |
| A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium. | Annals of oncology : official journal of the European Society for Medical Oncology 20061001 |
| Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20061001 |
| A phase II study with gemcitabine and split-dose cisplatin in patients with advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20061001 |
| Antagonistic interactions between gemcitabine and 5-fluorouracil in the human pancreatic carcinoma cell line Capan-2. | Cancer biology & therapy 20061001 |
| Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20061001 |
| Vitamins C and K3 sensitize human urothelial tumors to gemcitabine. | The Journal of urology 20061001 |
| A phase II trial with gemcitabine and paclitaxel for the treatment of refractory and relapsed multiple myeloma patients. | Oncology reports 20061001 |
| Time course of enhanced activity of deoxycytidine kinase and thymidine kinase 1 and 2 in cultured human squamous lung carcinoma cells, SW-1573, induced by gamma-irradiation. | Oncology reports 20061001 |
| Inhibition of expression of vascular endothelial growth factor and its receptors in pulmonary adenocarcinoma cell by TNP-470 in combination with gemcitabine. | Journal of Zhejiang University. Science. B 20061001 |
| Purine analogues: rationale for development, mechanisms of action, and pharmacokinetics in hairy cell leukemia. | Hematology/oncology clinics of North America 20061001 |
| RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patients. | Anti-cancer drugs 20061001 |
| Boronate functionalised polymer monoliths for microscale affinity chromatography. | The Analyst 20061001 |
| Are dose-finding studies still necessary when targeted therapy is associated with chemotherapy? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061001 |
| Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20061001 |
| Gemcitabine and oxaliplatin in patients with metastatic breast cancer resistant to or pretreated with both anthracyclines and taxanes: clinical and pharmacokinetic data. | American journal of clinical oncology 20061001 |
| Update on capecitabine in colorectal cancer. | The oncologist 20061001 |
| [Therapeutic efficacy of capecitabine on advanced and recurrent breast cancer with special reference to time to progression]. | Gan to kagaku ryoho. Cancer & chemotherapy 20061001 |
| [Case report of advanced breast cancer responding to capecitabine and trastuzumab combination therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20061001 |
| [A case of adenocarcinoma of unknown primary site successfully treated with gemcitabine monotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20061001 |
| [A case of stage IVA intrahepatic biliary tract cancer successfully treated with gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20061001 |
| [Chemotherapy-naïve advanced pancreatic cancer with multiple liver metastases successfully treated by S-1 monotherapy--a case report]. | Gan to kagaku ryoho. Cancer & chemotherapy 20061001 |
| Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial. | Croatian medical journal 20061001 |
| Metastatic hidradenocarcinoma: efficacy of capecitabine. | Archives of dermatology 20061001 |
| Gemcitabine and epirubicin in patients with metastatic breast cancer: a phase I/II study. | Breast (Edinburgh, Scotland) 20061001 |
| Haematological toxicity in patients treated with cisplatin and gemcitabine for bladder cancer: the Weston Park Hospital, Sheffield, experience. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20061001 |
| [Apoptosis of breast cancer cell line MCF-7 cells induced by gemcitabine and radiation]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20061001 |
| The effects of prolonged treatment with zidovudine, lamivudine, and abacavir on a T-lymphoblastoid cell line. | AIDS research and human retroviruses 20061001 |
| [Onycholysis with hyponychium exudate secondary to chemotherapy with paclitaxel and capecitabine]. | Actas dermo-sifiliograficas 20061001 |
| Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20061001 |
| Feasiblity study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20061001 |
| [Treatment of squamous cell carcinoma of the pancreas with gemcitabine]. | Gastroenterologie clinique et biologique 20061001 |
| DNA hypermethylation of myeloid cells, a novel therapeutic target in MDS and AML. | Current pharmaceutical biotechnology 20061001 |
| Capecitabine/Cyclophosphamide/Methotrexate for patients with metastatic breast cancer: a dose-finding, feasibility, and efficacy study. | Clinical breast cancer 20061001 |
| The M184V mutation: what it does, how to prevent it, and what to do with it when it's there. | The AIDS reader 20061001 |
| Combination therapy using gemcitabine and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin. | Cancer biotherapy & radiopharmaceuticals 20061001 |
| The role of angiogenesis inhibition in the treatment of breast cancer. | Clinical advances in hematology & oncology : H&O 20061001 |
| Assessment of supra-additive effects of cytotoxic drugs and low dose rate irradiation in an in vitro model for hepatocellular carcinoma. | Canadian journal of physiology and pharmacology 20061001 |
| A once-daily combination tablet (Atripla) for HIV. | The Medical letter on drugs and therapeutics 20060925 |
| Hemoglobin induces colon cancer cell proliferation by release of reactive oxygen species. | World journal of gastroenterology 20060921 |
| Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060920 |
| Transfer of surface polymerase reaction products to a secondary platform with conservation of spatial registration. | Journal of the American Chemical Society 20060920 |
| Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060920 |
| Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. | Cancer 20060915 |
| A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008. | Cancer 20060915 |
| In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060915 |
| Pharmacogenetics of capecitabine in advanced breast cancer patients. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060915 |
| A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer. | British journal of cancer 20060904 |
| A phase II trial of oral capecitabine in patients with platinum--and taxane--refractory ovarian, fallopian tube, or peritoneal cancer. | Gynecologic oncology 20060901 |
| Joint use of small-angle X-ray and neutron scattering to study biological macromolecules in solution. | European biophysics journal : EBJ 20060901 |
| In response to: 'On prejudice and facts and choices', an editorial by Kohne and Folprecht. | Annals of oncology : official journal of the European Society for Medical Oncology 20060901 |
| Phase I/II study of gemcitabine and epirubicine in stage IIIB-IV non small cell lung cancer. | Frontiers in bioscience : a journal and virtual library 20060901 |
| Uridine phosphorylase in breast cancer: a new prognostic factor? | Frontiers in bioscience : a journal and virtual library 20060901 |
| Differential roles of phosphoinositide-dependent protein kinase-1 and akt1 expression and phosphorylation in breast cancer cell resistance to Paclitaxel, Doxorubicin, and gemcitabine. | Molecular pharmacology 20060901 |
| Divided dose of cisplatin combined with gemcitabine in malignant mesothelioma. | Lung cancer (Amsterdam, Netherlands) 20060901 |
| Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patients. | Lung cancer (Amsterdam, Netherlands) 20060901 |
| Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy. | International journal of radiation oncology, biology, physics 20060901 |
| Multicapillary electrophoresis analysis of single-nucleotide sequence variations in the deoxycytidine kinase gene. | Clinical chemistry 20060901 |
| Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines. | Oncology reports 20060901 |
| Phase II study of combination chemotherapy with gemcitabine and irinotecan in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. | Japanese journal of clinical oncology 20060901 |
| A phase I/II study of combination chemotherapy with gemcitabine and 5-fluorouracil for advanced pancreatic cancer. | Japanese journal of clinical oncology 20060901 |
| Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancer. | Cancer 20060901 |
| Intravesical gemcitabine: an update of clinical results. | Current opinion in urology 20060901 |
| Modified approach of administering cytostatics to the lung: more efficient isolated lung perfusion. | The Annals of thoracic surgery 20060901 |
| The relationship of premature mitosis to cytotoxicity in response to checkpoint abrogation and antimetabolite treatment. | Cell cycle (Georgetown, Tex.) 20060901 |
| Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma. | Scandinavian journal of gastroenterology 20060901 |
| Thymidine phosphorylase and capecitabine: a predictive marker for therapy selection? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060901 |
| Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060901 |
| Advanced non-small-cell lung cancer: 'triplets' better than 'doublets'? | Nature clinical practice. Oncology 20060901 |
| Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage? | Annals of oncology : official journal of the European Society for Medical Oncology 20060901 |
| [Malignant mesothelioma--diagnosis and treatment strategies]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060901 |
| [Arterial infusion chemotherapy for patients with advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060901 |
| [Tailored-dose chemotherapy using gemcitabine for advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060901 |
| [Gemcitabine versus combined chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060901 |
| [A patient with pancreatic cancer and multiple liver metastases after total pancreatectomy who showed a partial response to combination chemotherapy with gemcitabine and UFT]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060901 |
| [Gemcitabine is an effective single agent for the treatment of advanced biliary tract cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060901 |
| Bilateral avascular necrosis of the hips after chemoradiotherapy for cervical cancer. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20060901 |
| Pharmacy benefit spending on oral chemotherapy drugs. | Journal of managed care pharmacy : JMCP 20060901 |
| Experience of the treatment with gemcitabine, docetaxel, and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate. | International journal of urology : official journal of the Japanese Urological Association 20060901 |
| [Gemcitabine and carboplatin chemotherapy in advanced transitional cell carcinoma in regard to patients with impaired renal function]. | Aktuelle Urologie 20060901 |
| Capecitabine-docetaxel combination treatment. | Expert review of anticancer therapy 20060901 |
| Management of hand-foot syndrome induced by capecitabine. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20060901 |
| Once-daily dosing and the treatment of HIV disease. | The AIDS reader 20060901 |
| [Gemcitabine and cisplatin therapy in advanced or metastatic urothelial cancer: comparison of side effect with MVAC (methotrexate, vinblastine, doxorubicin, and cisplatin)]. | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20060901 |
| Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine. | Clinical colorectal cancer 20060901 |
| Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer. | Clinical genitourinary cancer 20060901 |
| Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer. | Clinical genitourinary cancer 20060901 |
| Randomized, multicenter, open-label phase II study of gemcitabine plus single-dose versus split-dose carboplatin in the treatment of patients with advanced-stage non-small-cell lung cancer. | Clinical lung cancer 20060901 |
| [Second-line chemotherapy with gemcitabine and cisplatin for urothelial cancer previously treated with or resistant to M-VAC therapy]. | Hinyokika kiyo. Acta urologica Japonica 20060901 |
| [A case of leiomyosarcoma of the scrotum: chemotherapy with anti-cancer agents was effective for the lung metastasis]. | Hinyokika kiyo. Acta urologica Japonica 20060901 |
| Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060901 |
| A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (E1501). | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060901 |
| Gemcitabine plus doxorubicin as first-line treatment in advanced or metastatic breast cancer (MBC), a phase II study. | Journal of the Egyptian National Cancer Institute 20060901 |
| [Myositis as a 'radiation-recall phenomenon' following palliative chemotherapy with carboplatin-gemcitabin for non-small-cell pulmonary carcinoma]. | Nederlands tijdschrift voor geneeskunde 20060826 |
| Cytidine is a novel substrate for wild-type concentrative nucleoside transporter 2. | Biochemical and biophysical research communications 20060825 |
| Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). | British journal of cancer 20060821 |
| Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060820 |
| Bayesian sample size calculations in phase II clinical trials using a mixture of informative priors. | Statistics in medicine 20060815 |
| Phase II trial evaluating a docetaxel-capecitabine combination as treatment for hormone-refractory prostate cancer. | Cancer 20060815 |
| [Requirements for the development of molecularly defined targeted therapy in oncology]. | Medizinische Klinik (Munich, Germany : 1983) 20060815 |
| Antitumor effect of trastuzumab for pancreatic cancer with high HER-2 expression and enhancement of effect by combined therapy with gemcitabine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060815 |
| Simultaneous determination of gemcitabine di- and triphosphate in human blood mononuclear and cancer cells by RP-HPLC and UV detection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060807 |
| Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study. | British journal of cancer 20060807 |
| In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients. | British journal of cancer 20060807 |
| Toxic death-case after capecitabine + oxaliplatin (XELOX) administration: probable implication of dihydropyrimidine deshydrogenase deficiency. | Cancer chemotherapy and pharmacology 20060801 |
| Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer. | Cancer chemotherapy and pharmacology 20060801 |
| A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors. | Cancer chemotherapy and pharmacology 20060801 |
| Gemcitabine aerosol: in vitro antitumor activity and deposition imaging for preclinical safety assessment in baboons. | Cancer chemotherapy and pharmacology 20060801 |
| The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro. | Cancer chemotherapy and pharmacology 20060801 |
| Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial. | Cancer chemotherapy and pharmacology 20060801 |
| 5-Fluorouracil can cross brain-blood barrier and cause encephalopathy: should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma. | Cancer chemotherapy and pharmacology 20060801 |
| Bullous dermatosis associated with gemcitabine therapy for non-small-cell lung carcinoma. | Respiratory medicine 20060801 |
| Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum-taxane therapy: a phase II Austrian AGO study. | Gynecologic oncology 20060801 |
| Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning. | Gynecologic oncology 20060801 |
| Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis. | International journal of cancer 20060801 |
| Response to paclitaxel, gemcitabine, and cisplatin in renal medullary carcinoma. | Pediatric blood & cancer 20060801 |
| Aggressive multimodality treatment in transitional cell carcinoma of the parafallopian tube: report of 2 cases and review of the literature. | Gynecologic oncology 20060801 |
| Systemic chemotherapy in the management of malignant peritoneal mesothelioma. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20060801 |
| A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors. | Annals of oncology : official journal of the European Society for Medical Oncology 20060801 |
| A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma. | International journal of radiation oncology, biology, physics 20060801 |
| Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer. | Lung cancer (Amsterdam, Netherlands) 20060801 |
| Common arm analysis: one approach to develop the basis for global standardization in clinical trials of non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20060801 |
| Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20060801 |
| Rational drug sequencing of paclitaxel, gemcitabine and carboplatin in patients with untreated stage IV and select stage IIIB non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20060801 |
| Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers. | European journal of clinical pharmacology 20060801 |
| Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104. | Cancer 20060801 |
| Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian cancer: A cost-effectiveness analysis. | Cancer 20060801 |
| Deficient expression of the DPD gene is caused by epigenetic modification in biliary tract cancer cells, and induces high sensitivity to 5-FU treatment. | International journal of oncology 20060801 |
| Growth inhibition and apoptosis induction in ovarian cancer cells. | International journal of oncology 20060801 |
| Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer. | Oncology reports 20060801 |
| Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: a randomised phase II study. | European journal of cancer (Oxford, England : 1990) 20060801 |
| Combination of gemcitabine antagonizes antitumor activity of paclitaxel through prevention of mitotic arrest and apoptosis. | Cancer biology & therapy 20060801 |
| An update and review of antiretroviral therapy. | Pharmacotherapy 20060801 |
| Pancreatic cancer: from bench to 5-year survival. | Pancreas 20060801 |
| Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model. | Pancreas 20060801 |
| Capecitabine in carcinoma of the pancreas. | Expert opinion on pharmacotherapy 20060801 |
| Antiangiogenic therapy in metastatic prostate carcinoma complicated by cutaneous lupus erythematodes. | The Lancet. Oncology 20060801 |
| Gemcitabine, ifosfamide, and cisplatin combination (GIP) in treatment of patients with locally advanced or metastatic nonsmall cell lung cancer: results of a phase II study. | American journal of clinical oncology 20060801 |
| Surgical adjuvant therapy for colorectal cancer: current approaches and future directions. | Annals of surgical oncology 20060801 |
| An in vivo platform for translational drug development in pancreatic cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060801 |
| Intrapericardial instillation of mitomycin C in recurrent cardiac tamponade due to malignant pericardial effusion. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20060801 |
| Capecitabine therapy for refractory metastatic thyroid carcinoma: a case series. | Thyroid : official journal of the American Thyroid Association 20060801 |
| [A phase-I clinical study of a combination therapy of vinorelbine and capecitabine in patients with advanced/recurrent breast cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060801 |
| Formation of 1,4-dioxo-2-butene-derived adducts of 2'-deoxyadenosine and 2'-deoxycytidine in oxidized DNA. | Chemical research in toxicology 20060801 |
| Translesion DNA Synthesis across the heptanone--etheno-2'-deoxycytidine adduct in cells. | Chemical research in toxicology 20060801 |
| Phase II study of gemcitabine in children with solid tumors of mesenchymal and embryonic origin. | Anti-cancer drugs 20060801 |
| Capecitabine: a new adjuvant option for colorectal cancer. | Clinical journal of oncology nursing 20060801 |
| Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy. | Molecular cancer therapeutics 20060801 |
| A 99mTc-labeled gemcitabine bisphosphonate drug conjugate as a probe to assess the potential for targeted chemotherapy of metastatic bone cancer. | Nuclear medicine and biology 20060801 |
| Usefulness of predictive tests for cancer treatment. | Bulletin du cancer 20060801 |
| Relationship between AUC of 5'-DFUR and toxicity of capecitabine, fluoropyrimidine carbamate analogs, and 5'-DFUR in monkeys, mice, and rats. | The Journal of toxicological sciences 20060801 |
| [A randomized comparative trial of three combined regimens containing cisplatin for treatment of advanced non-small cell lung cancer]. | Ai zheng = Aizheng = Chinese journal of cancer 20060801 |
| [Phase II trial of prolonged infusion of low-dose gemcitabine in advanced non-small cell lung cancer treatment]. | Ai zheng = Aizheng = Chinese journal of cancer 20060801 |
| [Analysis of antineoplastic drugs used in Cancer Center, Sun Yat-sen University, during the period of 1996-2005]. | Ai zheng = Aizheng = Chinese journal of cancer 20060801 |
| Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone. | Expert review of anti-infective therapy 20060801 |
| [Experience with gemcitabine-carboplatin chemotherapy in relapsed ovarian cancer]. | Orvosi hetilap 20060730 |
| Translesion synthesis across bulky N2-alkyl guanine DNA adducts by human DNA polymerase kappa. | The Journal of biological chemistry 20060728 |
| Liquid chromatography-tandem mass spectrometric assay for the analysis of uracil, 5,6-dihydrouracil and beta-ureidopropionic acid in urine for the measurement of the activities of the pyrimidine catabolic enzymes. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060724 |
| Palladium-catalyzed direct N-arylation of nucleosides, nucleotides, and oligonucleotides for efficient preparation of dG-N2 adducts with carcinogenic amino-/nitroarenes. | The Journal of organic chemistry 20060721 |
| Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. | The Cochrane database of systematic reviews 20060719 |
| Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers. | Cancer 20060715 |
| Serum tumor markers for pancreatic cancer: the dawn of new era? | JOP : Journal of the pancreas 20060710 |
| Pancreatic cancer: highlights from the 42nd annual meeting of the American Society of Clinical Oncology, 2006. | JOP : Journal of the pancreas 20060710 |
| Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer. | JOP : Journal of the pancreas 20060710 |
| The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer. | British journal of cancer 20060703 |
| Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme. | Cancer chemotherapy and pharmacology 20060701 |
| CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas. | Cancer chemotherapy and pharmacology 20060701 |
| Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study. | Annals of oncology : official journal of the European Society for Medical Oncology 20060701 |
| A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20060701 |
| Emtricitabine intolerance in treatment-experienced patients switched from lamivudine: a method of assessing toxicity. | The Journal of antimicrobial chemotherapy 20060701 |
| Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients. | Lung cancer (Amsterdam, Netherlands) 20060701 |
| Neurological complications of cancer chemotherapy. | Current opinion in oncology 20060701 |
| Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trial. | Lung cancer (Amsterdam, Netherlands) 20060701 |
| Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis. | Cancer 20060701 |
| Inhibition of PDGFR phosphorylation and Src and Akt activity by GN963 leads to therapy of human pancreatic cancer growing orthotopically in nude mice. | International journal of oncology 20060701 |
| Accumulation of FFA-1, the Xenopus homolog of Werner helicase, and DNA polymerase delta on chromatin in response to replication fork arrest. | Journal of biochemistry 20060701 |
| Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20060701 |
| Clinical monitoring of innate cellular immunity of monocytes/macrophages by tumor necrosis factor alpha productivity in whole blood stimulated by lipopolysaccharide in patients with pancreatic cancer. | Pancreas 20060701 |
| Biological agents versus chemotherapy in the treatment of colorectal cancer. | Expert opinion on pharmacotherapy 20060701 |
| Correlation of hENT1 expression and function with gemcitabine cytotoxicity in mantle cell lymphoma lines and clinical samples. | Haematologica 20060701 |
| Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma. | Haematologica 20060701 |
| Hoogsteen base pair formation promotes synthesis opposite the 1,N6-ethenodeoxyadenosine lesion by human DNA polymerase iota. | Nature structural & molecular biology 20060701 |
| A phase II Study of the global dose and schedule of capecitabine in Japanese patients with metastatic colorectal cancer. | Japanese journal of clinical oncology 20060701 |
| [Capecitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060701 |
| [Interferon-alpha+cisplatin+5-FU therapy for gemcitabine-refractory unresectable and recurrent pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060701 |
| Erysipeloid skin toxicity induced by gemcitabine. | Journal of the European Academy of Dermatology and Venereology : JEADV 20060701 |
| Formation of malonaldehyde-acetaldehyde conjugate adducts in calf thymus DNA. | Chemical research in toxicology 20060701 |
| 2'-deoxyguanosine, 2'-deoxycytidine, and 2'-deoxyadenosine adducts resulting from the reaction of tetrahydrofuran with DNA bases. | Chemical research in toxicology 20060701 |
| Strategy for prevention of local recurrence of pancreatic cancer after pancreatectomy: antitumor effect of gemcitabine mixed with fibrin glue in an orthotopic nude mouse model. | Surgery 20060701 |
| [Adjuvant treatment of colorectal cancer]. | Bulletin du cancer 20060701 |
| Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma. | Clinical lymphoma & myeloma 20060701 |
| Long-term survival under maintenance gemcitabine chemotherapy for metastatic transitional cell carcinoma. | International journal of urology : official journal of the Japanese Urological Association 20060701 |
| Hungarian laboratory scientist use gene therapy to improve gemcitabine chemotherapy in glioma tumours. | European journal of cancer care 20060701 |
| The determinants of sensitivity and acquired resistance to gemcitabine differ in non-small cell lung cancer: a role of ABCC5 in gemcitabine sensitivity. | Molecular cancer therapeutics 20060701 |
| Malignant acanthosis nigricans and tripe palms associated with pancreatic adenocarcinoma. | Cutis 20060701 |
| Sequential therapy with capecitabine followed by vinorelbine/cisplatin in patients with anthracycline/taxane-refractory metastatic breast cancer. | Journal of the Chinese Medical Association : JCMA 20060701 |
| High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice. | Anti-cancer drugs 20060701 |
| Gemcitabine and cisplatin after radical cystectomy for bladder cancer in an adjuvant setting: feasibility study from the Genito-Urinary Group of the French Federation of Cancer Centers. | Anti-cancer drugs 20060701 |
| Combined gemcitabine and alpha-interferon therapy for pancreatic cancer: report of a case. | Digestive diseases and sciences 20060701 |
| Safety and efficacy of regimens containing emtricitabine in HIV-infected patients taking highly active antiretroviral therapy. | The new microbiologica 20060701 |
| [A pilot study on the impact of the drug resistance on the radioresistance in human pancreatic cancer cell lines]. | Zhonghua wai ke za zhi [Chinese journal of surgery] 20060701 |
| A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060701 |
| Salvage therapy for Chinese non-small cell lung cancer patients who failed previous chemotherapy. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060701 |
| The 1.48 A resolution crystal structure of the homotetrameric cytidine deaminase from mouse. | Biochemistry 20060627 |
| Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation. | Journal of the National Cancer Institute 20060621 |
| Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060620 |
| Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study. | British journal of cancer 20060619 |
| Stereoselective synthesis of dinucleoside boranophosphates by an oxazaphospholidine method. | Bioorganic & medicinal chemistry letters 20060615 |
| Chemoradiotherapy in gallbladder cancer. | Journal of surgical oncology 20060615 |
| Ascorbate and H2O2 induced oxidative DNA damage in Jurkat cells. | Free radical biology & medicine 20060615 |
| Efficacy and tolerability of 10-day monotherapy with apricitabine in antiretroviral-naive, HIV-infected patients. | AIDS (London, England) 20060612 |
| Systemic therapy in the palliative management of advanced salivary gland cancers. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060610 |
| Streptokinase increases the sensitivity of colon cancer cells to chemotherapy by gemcitabine and cis-platine in vitro. | Cancer letters 20060608 |
| Tenofovir DF and emtricitabine vs. zidovudine and lamivudine. | The New England journal of medicine 20060608 |
| Tenofovir DF and emtricitabine vs. zidovudine and lamivudine. | The New England journal of medicine 20060608 |
| Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data. | British journal of cancer 20060605 |
| A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma. | British journal of cancer 20060605 |
| Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer. | British journal of cancer 20060605 |
| Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine. | Cancer chemotherapy and pharmacology 20060601 |
| Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction. | Breast (Edinburgh, Scotland) 20060601 |
| Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium. | Gynecologic oncology 20060601 |
| Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first? | Annals of oncology : official journal of the European Society for Medical Oncology 20060601 |
| Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo. | The Journal of pharmacology and experimental therapeutics 20060601 |
| Is thrombotic microangiopathy associated with antitumoral activity? | Gynecologic oncology 20060601 |
| A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy. | Lung cancer (Amsterdam, Netherlands) 20060601 |
| A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract. | Annals of oncology : official journal of the European Society for Medical Oncology 20060601 |
| Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20060601 |
| Mid-infrared study of deoxycytidine at high pressures: evidence of a phase transition. | Journal of biomolecular structure & dynamics 20060601 |
| A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy. | Lung cancer (Amsterdam, Netherlands) 20060601 |
| Characterization of BlsM, a nucleotide hydrolase involved in cytosine production for the biosynthesis of blasticidin S. | Chembiochem : a European journal of chemical biology 20060601 |
| Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma. | Cancer 20060601 |
| Cost-minimization analysis for Portugal of five doublet chemotherapy regimens from two phase III trials in the treatment of advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20060601 |
| Phase II study of gemcitabine plus cisplatin in metastatic breast cancer. | Anti-cancer drugs 20060601 |
| Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil. | Journal of surgical oncology 20060601 |
| Ribonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemosensitivity in cancer cell lines. | Pharmacogenetics and genomics 20060601 |
| Optimal therapy for platinum-resistant recurrent ovarian cancer: doxorubicin, gemcitabine or topotecan? | Expert opinion on pharmacotherapy 20060601 |
| Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. | Journal of gastroenterology and hepatology 20060601 |
| Current therapies and advances in the treatment of pancreatic cancer. | Critical reviews in oncology/hematology 20060601 |
| Gemcitabine-cisplatin chemotherapy before lung resection: a case-matched analysis of early outcome. | The Annals of thoracic surgery 20060601 |
| Neoadjuvant therapy with bevacizumab. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060601 |
| Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitor. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060601 |
| Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival? | American journal of clinical oncology 20060601 |
| Studying health outcomes in farmworker populations exposed to pesticides. | Environmental health perspectives 20060601 |
| Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale). | Annals of oncology : official journal of the European Society for Medical Oncology 20060601 |
| Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers. | Annals of oncology : official journal of the European Society for Medical Oncology 20060601 |
| Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM). | Annals of oncology : official journal of the European Society for Medical Oncology 20060601 |
| Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. | Gastroenterology 20060601 |
| Adjuvant chemotherapy of colon cancer: lymph node involvement without metastases. | Prescrire international 20060601 |
| Adjuvant treatment strategies for pancreatic cancer. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20060601 |
| [Chemotherapy for metastatic breast cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060601 |
| Gemcitabine plus cisplatin (GC): a salvage regimen for advanced breast cancer patients who have failed anthracycline and/or taxane therapy. | Gan to kagaku ryoho. Cancer & chemotherapy 20060601 |
| [Carboplatin plus gemcitabine therapy versus carboplatin plus weekly paclitaxel therapy for advanced non-small cell lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060601 |
| [A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060601 |
| Model-based drug development: the road to quantitative pharmacology. | Journal of pharmacokinetics and pharmacodynamics 20060601 |
| Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome. | Chest 20060601 |
| Intramedullary metastases due to non microcytic lung carcinoma. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060601 |
| Overview of gemcitabine activity in advanced breast cancer. | Seminars in oncology 20060601 |
| Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer. | Clinical breast cancer 20060601 |
| Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report. | Clinical breast cancer 20060601 |
| Response to cetuximab and gemcitabine-oxaliplatin in an advanced case of intrahepatic cholangiocarcinoma. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20060601 |
| Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer. | Japanese journal of clinical oncology 20060601 |
| Chemotherapy and chemosensitization of non-small cell lung cancer with a novel immunomodulatory oligonucleotide targeting Toll-like receptor 9. | Molecular cancer therapeutics 20060601 |
| APOBEC3G and HIV-1: strike and counterstrike. | Current infectious disease reports 20060601 |
| Thirty novel genetic variations in the SLC29A1 gene encoding human equilibrative nucleoside transporter 1 (hENT1). | Drug metabolism and pharmacokinetics 20060601 |
| [Combination chemotherapy with gemcitabine and S-1 for advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060601 |
| A case of Guillain-Barré syndrome in a patient with non small cell lung cancer treated with chemotherapy. | Journal of chemotherapy (Florence, Italy) 20060601 |
| Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060601 |
| Docetaxel in combination with either cisplatin or gemcitabine in unresectable non-small cell lung carcinoma: a randomized phase II study by the Japan Lung Cancer Cooperative Clinical Study Group. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060601 |
| Thymidine phosphorylase (platelet-derived endothelial cell growth factor) as a target for capecitabine: from biology to the bedside. | Recent patents on anti-cancer drug discovery 20060601 |
| An efficiently extended class of unnatural base pairs. | Journal of the American Chemical Society 20060531 |
| Bromovinyl-deoxyuridine: A selective substrate for mitochondrial thymidine kinase in cell extracts. | Biochemical and biophysical research communications 20060526 |
| Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer. | British journal of cancer 20060522 |
| Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice. | International journal of cancer 20060515 |
| Dual-color imaging of nascent blood vessels vascularizing pancreatic cancer in an orthotopic model demonstrates antiangiogenesis efficacy of gemcitabine. | The Journal of surgical research 20060515 |
| Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes. | Cancer 20060515 |
| Gemcitabine-induced rectus abdominus radiation recall. | JOP : Journal of the pancreas 20060509 |
| A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma. | British journal of cancer 20060508 |
| Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer. | British journal of cancer 20060508 |
| Study of the interaction of an anticancer drug with human and bovine serum albumin: spectroscopic approach. | Journal of pharmaceutical and biomedical analysis 20060503 |
| Interferon-alpha plus capecitabine and thalidomide in patients with metastatic renal cell carcinoma: a pilot study. | Investigational new drugs 20060501 |
| Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: results of a prospective randomized phase II study. | Investigational new drugs 20060501 |
| An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma. | Investigational new drugs 20060501 |
| Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. | Cancer chemotherapy and pharmacology 20060501 |
| High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer. | Cancer chemotherapy and pharmacology 20060501 |
| Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patients. | Cancer chemotherapy and pharmacology 20060501 |
| In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer. | International journal of cancer 20060501 |
| Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival. | Cancer gene therapy 20060501 |
| Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models. | Cancer chemotherapy and pharmacology 20060501 |
| Electrophysiological characterization and modeling of the structure activity relationship of the human concentrative nucleoside transporter 3 (hCNT3). | Molecular pharmacology 20060501 |
| Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer. | The European respiratory journal 20060501 |
| Apurinic/apyrimidinic endonuclease-1 protein level is associated with the cytotoxicity of L-configuration deoxycytidine analogs (troxacitabine and beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine) but not D-configuration deoxycytidine analogs (gemcitabine and beta-D-arabinofuranosylcytosine). | Molecular pharmacology 20060501 |
| Selective kinase inhibition with daily imatinib intensifies toxicity of chemotherapy in patients with solid tumours. | European journal of cancer (Oxford, England : 1990) 20060501 |
| Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20060501 |
| Haplotyping of the deoxycytidine kinase gene by multicapillary electrophoresis. | Analytical biochemistry 20060501 |
| With a little help from small friends: Enhanced chemotherapeutic effects with imatinib. | European journal of cancer (Oxford, England : 1990) 20060501 |
| Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1). | Lung cancer (Amsterdam, Netherlands) 20060501 |
| Phase II study of the combination of gemcitabine and nedaplatin for advanced non-small-cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20060501 |
| Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project. | Cancer 20060501 |
| Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial. | Lung cancer (Amsterdam, Netherlands) 20060501 |
| High-performance liquid chromatographic method for the determination of gemcitabine and 2',2'-difluorodeoxyuridine in plasma and tissue culture media. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060501 |
| Liposomal cisplatin combined with gemcitabine in pretreated advanced pancreatic cancer patients: a phase I-II study. | Oncology reports 20060501 |
| Analysis of ribonucleotide reductase M2 mRNA levels in patient samples after GTI-2040 antisense drug treatment. | Oncology reports 20060501 |
| Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer. | Oncology reports 20060501 |
| Functional single nucleotide polymorphism haplotypes in the human equilibrative nucleoside transporter 1. | Pharmacogenetics and genomics 20060501 |
| Does postoperative chemotherapy have a survival benefit for patients with pancreatic cancer? | Journal of surgical oncology 20060501 |
| Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers. | Cancer research 20060501 |
| Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20060501 |
| [Present and future home therapy in advanced stage of pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060501 |
| Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies. | PLoS pathogens 20060501 |
| Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinoma. | The Netherlands journal of medicine 20060501 |
| Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer. | Journal of gastroenterology and hepatology 20060501 |
| Not in the BNF. | British journal of hospital medicine (London, England : 2005) 20060501 |
| FDA makes final approvals. | AIDS patient care and STDs 20060501 |
| Cardiac metastasis from uterine leiomyosarcoma. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060501 |
| [Irinotecan for the treatment of metastatic colorectal cancer]. | Bulletin du cancer 20060501 |
| Capecitabine-induced cerebellar toxicity. | Clinical colorectal cancer 20060501 |
| Pharmacodynamic separation of epidermal growth factor receptor tyrosine kinase inhibitors and chemotherapy in non-small-cell lung cancer. | Clinical lung cancer 20060501 |
| Gemcitabine in the treatment of advanced transitional cell carcinoma of the urothelium. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Actual experience and future development of gemcitabine in superficial bladder cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Pharmacogenomics and gemcitabine. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| A phase II study of gemcitabine and immunotherapy in renal cancer: preliminary results and review of the literature. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Pharmacokinetic evaluation of gemcitabine and 2',2'-difluorodeoxycytidine-5'-triphosphate after prolonged infusion in patients affected by different solid tumors. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Gemcitabine: monochemotherapy of breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| In vitro studies on gemcitabine combinations with other antiblastics. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Gemcitabine and taxanes in metastatic breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Biological agents and gemcitabine in the treatment of breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Role of gemcitabine in ovarian cancer treatment. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Gemcitabine and anthracyclines in platinum-resistant ovarian cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| In vitro basis for schedule-dependent interaction between gemcitabine and topoisomerase-targeted drugs in the treatment of colorectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Topoisomerase I, II alpha and II beta mRNA expression in peripheral blood mononuclear cells of patients with solid tumor: preliminary results. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Clinical studies of pemetrexed and gemcitabine combinations. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Development of gemcitabine in non-small cell lung cancer: the Italian contribution. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Simplified gemcitabine and platin regimen in patients with advanced or metastatic non-small cell lung cancer (NSCLC) to be proposed as neoadjuvant therapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| First line chemotherapy in advanced or metastatic NSCLC. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Cellular pharmacology of gemcitabine. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Non-small-cell lung cancer: which platinum for gemcitabine? | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Non-platinum combination of gemcitabine in NSCLC. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| [Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060501 |
| Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060501 |
| Gemcitabine and carboplatin chemotherapy safely administered to a patient with homocystinuria. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060501 |
| Introduction. Gemcitabine: ten years of clinical experience. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Gemcitabine: ten years of clinical experience. Proceedings of a workshop. September 19-21, 2005. Monastier di Treviso, Italy. | Annals of oncology : official journal of the European Society for Medical Oncology 20060501 |
| Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial. | British journal of cancer 20060424 |
| Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060420 |
| Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060420 |
| Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060420 |
| [Blisters unlike others]. | Revue medicale suisse 20060419 |
| Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. | Proceedings of the National Academy of Sciences of the United States of America 20060418 |
| Targeting oncogenes to improve breast cancer chemotherapy. | Cancer research 20060415 |
| Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo. | Cancer research 20060415 |
| Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survival. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060415 |
| Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060415 |
| Synthesis and properties of a new fluorescent bicyclic 4-N-carbamoyldeoxycytidine derivative. | Organic letters 20060413 |
| Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060410 |
| Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study. | British journal of cancer 20060410 |
| A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer. | British journal of cancer 20060410 |
| XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer. | British journal of cancer 20060410 |
| A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer. | British journal of cancer 20060410 |
| Role of the guanine N1 imino proton in the migration and reaction of radical cations in DNA oligomers. | Journal of the American Chemical Society 20060405 |
| Accrual delayed in adjuvant bevacizumab trial. | Journal of the National Cancer Institute 20060405 |
| Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. | Gut 20060401 |
| Gemcitabine-induced respiratory failure associated with elevated erythrocyte sedimentation rate (ESR). | Respiratory medicine 20060401 |
| Sequential gemcitabine-carboplatin followed by paclitaxel-carboplatin in the first-line treatment of advanced ovarian cancer: A phase II study. | Gynecologic oncology 20060401 |
| Modulation of uridine phosphorylase gene expression by tumor necrosis factor-alpha enhances the antiproliferative activity of the capecitabine intermediate 5'-deoxy-5-fluorouridine in breast cancer cells. | Molecular pharmacology 20060401 |
| Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20060401 |
| Multicenter phase-I/II study using a combination of gemcitabine and docetaxel in metastasized and unresectable, locally advanced pancreatic carcinoma. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20060401 |
| Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter. | Human genetics 20060401 |
| Capecitabine use in geriatric oncology: an analysis of current safety, efficacy, and quality of life data. | Critical reviews in oncology/hematology 20060401 |
| Randomized phase II study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer: Korean Cancer Study Group experience. | Lung cancer (Amsterdam, Netherlands) 20060401 |
| Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. | European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20060401 |
| Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group. | Annals of oncology : official journal of the European Society for Medical Oncology 20060401 |
| Characterization of an in vitro cell culture bioreactor system to evaluate anti-neoplastic drug regimens. | Breast cancer research and treatment 20060401 |
| Pharmacokinetics of gemcitabine and its primary metabolite in dogs after intravenous bolus dosing and its in vitro pharmacodynamics. | Journal of veterinary pharmacology and therapeutics 20060401 |
| Pharmacokinetics of gemcitabine and its primary metabolite in dogs after intravenous infusion. | Journal of veterinary pharmacology and therapeutics 20060401 |
| Synergistic growth suppression induced in esophageal squamous cell carcinoma cells by combined treatment with docetaxel and heavy carbon-ion beam irradiation. | Oncology reports 20060401 |
| Triplet chemotherapy for malignant pericardial mesothelioma: a case report. | Japanese journal of clinical oncology 20060401 |
| [Is there a nonsurgical therapeutic approach to cholangiocellular carcinomas?]. | Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20060401 |
| What's new in pancreatic cancer treatment pipeline? | Best practice & research. Clinical gastroenterology 20060401 |
| Chemotherapy for advanced pancreatic cancer. | Best practice & research. Clinical gastroenterology 20060401 |
| The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer. | Best practice & research. Clinical gastroenterology 20060401 |
| Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients. | Expert opinion on pharmacotherapy 20060401 |
| Erlotinib or capecitabine with gemcitabine in pancreatic cancer? | Future oncology (London, England) 20060401 |
| Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma. | Cancer research 20060401 |
| Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine. | Cancer research 20060401 |
| Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial. | American journal of clinical oncology 20060401 |
| Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma. | American journal of clinical oncology 20060401 |
| A pilot trial of gemcitabine and vinorelbine plus capecitabine in locally advanced or metastatic nonsmall cell lung cancer. | American journal of clinical oncology 20060401 |
| Capecitabine monotherapy: safe and effective treatment for metastatic breast cancer. | The oncologist 20060401 |
| Maintenance chemotherapy after chemoradiation improves survival of patients with locally advanced pancreatic carcinoma: a retrospective analysis of prospectively recruited patients. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20060401 |
| XIAP is related to the chemoresistance and inhibited its expression by RNA interference sensitize pancreatic carcinoma cells to chemotherapeutics. | Pancreas 20060401 |
| [Non-surgical treatment for pancreatic cancer]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20060401 |
| Intraventricular metastases from rectal-sigmoid adenocarcinoma. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060401 |
| Pelvic chemoradiotherapy after chemotherapy for metastatic bladder cancer. | The Canadian journal of urology 20060401 |
| Management of platinum-sensitive recurrent ovarian cancer. | Seminars in oncology 20060401 |
| Optimizing gemcitabine regimens in ovarian cancer. | Seminars in oncology 20060401 |
| The role of gemcitabine in first-line treatment of advanced ovarian carcinoma. | Seminars in oncology 20060401 |
| Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancer. | Journal of chemotherapy (Florence, Italy) 20060401 |
| Capecitabine/Taxane combination therapy: evolving clinical utility in breast cancer. | Clinical breast cancer 20060401 |
| Something old, something new... | Leukemia & lymphoma 20060401 |
| Syntheses of pyridine C-nucleosides as analogues of the natural nucleosides dC and dU. | The Journal of organic chemistry 20060331 |
| Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan. | British journal of cancer 20060327 |
| Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer. | British journal of cancer 20060327 |
| Fluorescence energy transfer studies of human deoxycytidine kinase: role of cysteine 185 in the conformational changes that occur upon substrate binding. | Biochemistry 20060321 |
| Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060320 |
| A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. | Cancer 20060315 |
| Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060315 |
| The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia. | Biochemical pharmacology 20060314 |
| Effect of gemcitabine on the expression of apoptosis-related genes in human pancreatic cancer cells. | World journal of gastroenterology 20060314 |
| Synthesis and anti-HIV activity of D- and L-thietanose nucleosides. | Journal of medicinal chemistry 20060309 |
| A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer. | International journal of radiation oncology, biology, physics 20060301 |
| Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20060301 |
| Monitoring of cell growth and assessment of cytotoxicity using electrochemical impedance spectroscopy. | Biochimica et biophysica acta 20060301 |
| Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi. | Leukemia & lymphoma 20060301 |
| Validation of real-time reverse-transcription-polymerase chain reaction for quantification of capecitabine-metabolizing enzymes. | Analytical biochemistry 20060301 |
| Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: a multicenter phase II study. | Lung cancer (Amsterdam, Netherlands) 20060301 |
| Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials. | Lung cancer (Amsterdam, Netherlands) 20060301 |
| Interferon receptors and the caspase cascade regulate the antitumor effects of interferons on human pancreatic cancer cell lines. | American journal of surgery 20060301 |
| The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been? | Annals of oncology : official journal of the European Society for Medical Oncology 20060301 |
| Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma. | Expert review of anticancer therapy 20060301 |
| Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060301 |
| Gemcitabine and atrial fibrillation: a rare manifestation of chemotherapy toxicity. | Anti-cancer drugs 20060301 |
| Acute coronary syndrome induced by oral capecitabine. | The Canadian journal of cardiology 20060301 |
| Capecitabine as an alternative in a case of fluorouracil-induced photodermatitis. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20060301 |
| Toxicity and efficacy of isolated lung perfusion with gemcitabine in a rat model of pulmonary metastases. | The Thoracic and cardiovascular surgeon 20060301 |
| Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES-10 cells) highly expressing vascular endothelial growth factor and its receptor. | Cancer science 20060301 |
| SUMOylation plays a role in gemcitabine- and bortezomib-induced cytotoxicity in human oropharyngeal carcinoma KB gemcitabine-resistant clone. | Molecular cancer therapeutics 20060301 |
| Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299). | Molecular cancer therapeutics 20060301 |
| [Palliative chemotherapy of head and neck cancer: present status and future development]. | Laryngo- rhino- otologie 20060301 |
| Improvement of quality of life with Shenfu injection in non small cell lung cancer patients treated with gemcitabine plus cisplatin regimen. | Chinese journal of integrative medicine 20060301 |
| Chemotherapy of advanced non-small cell lung cancer in elderly patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20060301 |
| [A case of non-small cell lung cancer accompanied with hemorrhage after chemotherapy including gemcitabine]. | Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20060301 |
| Identification and treatment of aggressive thyroid cancers. Part 1: subtypes. | Oncology (Williston Park, N.Y.) 20060301 |
| Multicenter phase II study of fixed sequences of capecitabine combined with oxaliplatin or irinotecan in patients with previously untreated metastatic colorectal cancer. | Clinical colorectal cancer 20060301 |
| Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver. | Clinical colorectal cancer 20060301 |
| Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer. | Journal of gastroenterology and hepatology 20060301 |
| Tumour regression and mesorectal lymph node changes after intensified neoadjuvant chemoradiation for carcinoma of the rectum. | APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20060301 |
| [Patient with haemolytic anemia and treatment with capecitabine. Review of one case and literature]. | Anales de medicina interna (Madrid, Spain : 1984) 20060301 |
| Multicenter study on the use of gemcitabine to prevent recurrence of multiple-recurring superficial bladder tumors following intravesical antiblastic agents and/or BCG: evaluation of tolerance. | Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20060301 |
| High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients. | Journal of experimental & clinical cancer research : CR 20060301 |
| [Changes and clinical significance of serum soluble Apo-1/Fas in pancreatic cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060301 |
| Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060301 |
| The tyrosine kinase inhibitor imatinib fails to inhibit pancreatic cancer progression. | Cancer letters 20060227 |
| Antagonistic effects of sequential administration of BL1521, a histone deacetylase inhibitor, and gemcitabine to neuroblastoma cells. | Cancer letters 20060227 |
| Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. | British journal of cancer 20060227 |
| Identification of in vivo phosphorylation sites on human deoxycytidine kinase. Role of Ser-74 in the control of enzyme activity. | The Journal of biological chemistry 20060224 |
| Relationship between cisplatin administration and the development of ototoxicity. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060220 |
| Phase II study of gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): a Children's Oncology Group Report. | Pediatric blood & cancer 20060201 |
| Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse. | Breast (Edinburgh, Scotland) 20060201 |
| Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. | International journal of radiation oncology, biology, physics 20060201 |
| Nucleoside ester prodrug substrate specificity of liver carboxylesterase. | The Journal of pharmacology and experimental therapeutics 20060201 |
| Achieving cure for early stage pediatric Hodgkin disease with minimal morbidity: are we there yet? | Pediatric blood & cancer 20060201 |
| Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. | Gynecologic oncology 20060201 |
| Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20060201 |
| Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracil. | Annals of oncology : official journal of the European Society for Medical Oncology 20060201 |
| Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20060201 |
| A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study. | Annals of oncology : official journal of the European Society for Medical Oncology 20060201 |
| Phase II study of gemcitabine in children with relapsed leukemia. | Pediatric blood & cancer 20060201 |
| A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20060201 |
| Re: 'Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival'. | Gynecologic oncology 20060201 |
| Prolonged gemcitabine infusion in advanced non-small-cell lung cancer with stable disease after gemcitabine 30-min infusion. | Lung cancer (Amsterdam, Netherlands) 20060201 |
| Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells. | Cancer 20060201 |
| Capecitabine-induced severe hypertriglyceridemia: report of two cases. | The Annals of pharmacotherapy 20060201 |
| Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas. | International journal of oncology 20060201 |
| Putting the chemo in chemoradiation for pancreatic cancer. | Annals of surgical oncology 20060201 |
| Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen. | Japanese journal of clinical oncology 20060201 |
| A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. | Annals of surgical oncology 20060201 |
| The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation. | Acta crystallographica. Section D, Biological crystallography 20060201 |
| On prejudice and facts and choices. | Annals of oncology : official journal of the European Society for Medical Oncology 20060201 |
| Phase II study of a 4-week capecitabine regimen in advanced or recurrent gastric cancer. | Anti-cancer drugs 20060201 |
| Multimodality treatment of unresectable stage III non-small cell lung cancer: interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy. | The Journal of thoracic and cardiovascular surgery 20060201 |
| In vitro antiretroviral activity and in vitro toxicity profile of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus infection. | Antimicrobial agents and chemotherapy 20060201 |
| Gemcitabine and carboplatin: is this the best combination for non-small cell lung cancer? | Expert review of anticancer therapy 20060201 |
| Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060201 |
| Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060201 |
| Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060201 |
| A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growth. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20060201 |
| A phase I dose finding study of cisplatin, gemcitabine, and weekly docetaxel for patients with advanced transitional cell cancer. | American journal of clinical oncology 20060201 |
| The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer. | American journal of clinical oncology 20060201 |
| Phase II trial of gemcitabine as first line chemotherapy in patients with metastatic or unresectable soft tissue sarcoma. | American journal of clinical oncology 20060201 |
| Capecitabine plus weekly oxaliplatin in gastrointestinal tumors: a phase I study. | American journal of clinical oncology 20060201 |
| An observational study examining the impact of capecitabine on warfarin antithrombotic activity and bleeding complications. | Current medical research and opinion 20060201 |
| The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060201 |
| Use of capecitabine after renal allograft transplantation in dog erythrocyte antigen-matched dogs. | Veterinary surgery : VS 20060201 |
| Role of gemcitabine in breast cancer management: an update. | Seminars in oncology 20060201 |
| Gemcitabine-induced radiation necrosis of the pectoralis major muscle. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20060201 |
| Capecitabine plus rofecoxib show no activity in patients with metastatic neuroendocrine tumours. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20060201 |
| Gemcitabine-induced chronic systemic capillary leak syndrome: a life-threatening disease. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20060201 |
| Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer. | Journal of Korean medical science 20060201 |
| A phase II study of gemcitabine and carboplatin combination chemotherapy in gallbladder carcinoma. | Hepatobiliary & pancreatic diseases international : HBPD INT 20060201 |
| [Recent progress in the treatment for urothelial cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060201 |
| [Progress in therapy for testicular tumors]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060201 |
| [Clinical features of long time survivors with unresectable pancreatic cancer treated by gemcitabine alone]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060201 |
| [A case report of unresectable gallbladder cancer that responded remarkably to the combination of thalidomide, celecoxib, and gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060201 |
| Drug interaction between capecitabine and warfarin: a case report and review of the literature. | International journal of clinical pharmacology and therapeutics 20060201 |
| c-Abl-independent p73 stabilization during gemcitabine- or 4'-thio-beta-D-arabinofuranosylcytosine-induced apoptosis in wild-type and p53-null colorectal cancer cells. | Molecular cancer therapeutics 20060201 |
| Timing of significant adverse events is essential information during early development of new drugs. | International journal of clinical oncology 20060201 |
| Analysis of mannitol in pharmaceutical formulations using hydrophilic interaction liquid chromatography with evaporative light-scattering detection. | Journal of separation science 20060201 |
| [Is the frequency of hemolytic uremic syndrome as a complication of gemcitabine underestimated? The role of systematic screening]. | Gastroenterologie clinique et biologique 20060201 |
| Capecitabine chemoradiation for rectal cancer after curative surgery. | Journal of chemotherapy (Florence, Italy) 20060201 |
| Phase II trial of weekly docetaxel/ gemcitabine as first-line chemotherapy in patients with locally recurrent or metastatic breast cancer. | Clinical breast cancer 20060201 |
| Capecitabine/vinorelbine: an effective and well-tolerated regimen for women with pretreated advanced-stage breast cancer. | Clinical breast cancer 20060201 |
| Guides for adjuvant treatment of colon cancer. TTD Group (Spanish Cooperative Group for Gastrointestinal Tumor Therapy). | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060201 |
| Bronchiolitis obliterans organizing pneumonia simulating progression in bronchioloalveolar carcinoma. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060201 |
| Subcutaneous metastasis as the first manifestation of a solid-pseudopapillary tumor of the pancreas. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060201 |
| [Development of a molecular target therapy on the basis of global gene analyses of gastrointestinal carcinoma]. | Fukuoka igaku zasshi = Hukuoka acta medica 20060201 |
| Coronary artery spasm induced by capecitabine. | Journal of cardiovascular medicine (Hagerstown, Md.) 20060201 |
| [Maintenance chemotherapy in advanced NSCLC]. | Revue de pneumologie clinique 20060201 |
| [From ASCO and WCLC 2005 to clinical practice: 'conventional' treatments]. | Revue de pneumologie clinique 20060201 |
| [Modern possibilities of chemotherapy in patients with ductal pancreatic adenocarcinoma]. | Klinichna khirurhiia 20060201 |
| Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060201 |
| Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: adjuvant 5-FU/cisplatin and chemoradiation with capecitabine. | World journal of gastroenterology 20060128 |
| Efficient and high fidelity incorporation of dCTP opposite 7,8-dihydro-8-oxodeoxyguanosine by Sulfolobus solfataricus DNA polymerase Dpo4. | The Journal of biological chemistry 20060127 |
| Gemcitabine doublets in advanced pancreatic cancer: should we move on? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120 |
| Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120 |
| Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. | The New England journal of medicine 20060119 |
| Structural basis for the preference of UTP over ATP in human deoxycytidine kinase: illuminating the role of main-chain reorganization. | Biochemistry 20060117 |
| Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial. | British journal of cancer 20060116 |
| SCOTROC 2A: carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancer. | British journal of cancer 20060116 |
| Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma. | Cancer 20060115 |
| The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group. | Cancer 20060115 |
| Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma. | Cancer 20060115 |
| Synergistic effects of gemcitabine and gefitinib in the treatment of head and neck carcinoma. | Cancer research 20060115 |
| Folate-mediated targeting of polymeric conjugates of gemcitabine. | International journal of pharmaceutics 20060113 |
| A single amino acid governs enhanced activity of DinB DNA polymerases on damaged templates. | Nature 20060112 |
| Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer. | JOP : Journal of the pancreas 20060111 |
| Squamous cell carcinoma of the pancreas: report of a case and review of the literature. | JOP : Journal of the pancreas 20060111 |
| Radiotherapy and chemotherapy in pancreatic cancer. Topical issues and future perspectives. | JOP : Journal of the pancreas 20060111 |
| A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B. | Archives of internal medicine 20060109 |
| Cyclopentenyl cytosine-induced activation of deoxycytidine kinase increases gemcitabine anabolism and cytotoxicity in neuroblastoma. | Cancer chemotherapy and pharmacology 20060101 |
| A phase I trial of gemcitabine and topotecan in previously treated ovarian or peritoneal cancer: a Gynecologic Oncology Group study. | Gynecologic oncology 20060101 |
| Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial. | Cancer chemotherapy and pharmacology 20060101 |
| Prolonged stabilization of platinum-resistant ovarian cancer in a single patient consuming a fermented soy therapy. | Gynecologic oncology 20060101 |
| Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myeloma. | Bone marrow transplantation 20060101 |
| Weekly paclitaxel plus capecitabine in advanced breast cancer patients: dose-finding trial of GOIRC and GOL. | Annals of oncology : official journal of the European Society for Medical Oncology 20060101 |
| A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20060101 |
| Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial. | Gynecologic oncology 20060101 |
| Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group. | Annals of oncology : official journal of the European Society for Medical Oncology 20060101 |
| Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie). | Lung cancer (Amsterdam, Netherlands) 20060101 |
| In-vitro and in-vivo anti-cancer activity of a novel gemcitabine-cardiolipin conjugate. | Anti-cancer drugs 20060101 |
| Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors. | Anti-cancer drugs 20060101 |
| Gemcitabine-related radiation recall in a patient with pancreatic cancer. | Anti-cancer drugs 20060101 |
| Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060101 |
| Chemoradiotherapy in patients with pancreatic carcinoma: phase-I study with a fixed radiation dose and escalating doses of weekly gemcitabine. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20060101 |
| Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines. | International journal of oncology 20060101 |
| Combined modality therapy of gemcitabine and irradiation on human glioma spheroids derived from cell lines and biopsy tissue. | Oncology reports 20060101 |
| Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma. | Head & neck 20060101 |
| Differences in immune cells engaged in cell-mediated immunity after chemotherapy for far advanced pancreatic cancer. | Pancreas 20060101 |
| Gemcitabine and oxaliplatin in patients with pancreatic adenocarcinoma: clinical and pharmacokinetic data. | Pancreas 20060101 |
| A phase II study of weekly cisplatin and gemcitabine in patients with advanced pancreatic cancer: is this a strategy still worth pursuing? | Pancreas 20060101 |
| 4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells. | Cancer chemotherapy and pharmacology 20060101 |
| Multimodality approach in management of malignant pleural mesothelioma. | European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20060101 |
| Upregulation of thymidine phosphorylase in rectal cancer tissues by mitomycin C. | Journal of surgical oncology 20060101 |
| Stepwise translocation of Dpo4 polymerase during error-free bypass of an oxoG lesion. | PLoS biology 20060101 |
| Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma. | BMC cancer 20060101 |
| Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060101 |
| Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-alpha. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060101 |
| p8 is a new target of gemcitabine in pancreatic cancer cells. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060101 |
| Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99). | International journal of clinical practice 20060101 |
| [Pilot study of primary systemic chemotherapy with docetaxel (DOC), epirubicin (EPI) and capecitabine (Xeloda) in patients with advanced breast cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060101 |
| [A 65-year-old man with liver metastases after lung cancer resection that responded to concomitant use of gemcitabine and carboplatin]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060101 |
| [A case of drug-induced interstitial pneumonitis after gemcitabine treatment for advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20060101 |
| Meta-analysis of inoperable pancreatic cancer: gemcitabine combined with cisplatin versus gemcitabine alone. | Chinese journal of digestive diseases 20060101 |
| Latency: the hidden HIV-1 challenge. | Retrovirology 20060101 |
| A phase II study of single-agent gemcitabine as a second-line treatment in advanced non-small cell lung cancer. | Japanese journal of clinical oncology 20060101 |
| Case study: an active, 24-year-old woman positive for HIV. | JAAPA : official journal of the American Academy of Physician Assistants 20060101 |
| [Geriatric urology -- tumour diseases]. | Aktuelle Urologie 20060101 |
| Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Preclinical in vivo activity of a combination gemcitabine/liposomal doxorubicin against cisplatin-resistant human ovarian cancer (A2780/CDDP). | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101 |
| Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines. | Cancer cell international 20060101 |
| [Management of pancreatic cancer: current therapy and continued development]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [Gemcitabine chemotherapy for patients with advanced or relapsed pancreatic cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [Combination chemotherapy in unresectable pancreatic carcinoma]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [Adjuvant chemotherapy for pancreatic cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [IMRD therapy for patients with metastatic pancreas cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [Therapeutics with replication--selective virus (RSV) for pancreatic cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [Gene therapy of human pancreatic cancer cells by human interferon-beta gene]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [Multimodal therapy for advanced pancreatic cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [Arterial infusion chemotherapy and radiotherapy after vascular supply distribution for pancreatic carcinoma]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [Concurrent chemoradiation therapy with gemcitabine for advanced or relapsed pancreatic tumors]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [Chemoradiation therapy and immunotherapy for pancreatic cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [Significance of thermo-chemotherapy for the patients with unresectable pancreas cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [Prognostic significance of CA19-9 levels in patients with pancreatic cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [Chemotherapy for biliary tract cancers: general remarks]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [5 -fluoropyrimidines for treatment of biliary tract cancers]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| [Systemic chemotherapy with gemcitabine for advanced biliary tract carcinoma]. | Nihon rinsho. Japanese journal of clinical medicine 20060101 |
| Benefits and risks of palliative capecitabine based therapy to elderly patients with advanced colorectal cancer: Danish single centre experiences. | Acta oncologica (Stockholm, Sweden) 20060101 |
| Hepatocellular carcinoma--Pathological complete response to oral capecitabine, megestrol and thalidomide. | Acta oncologica (Stockholm, Sweden) 20060101 |
| Response of pseudomyxoma peritonei to gemcitabine. | Acta oncologica (Stockholm, Sweden) 20060101 |
| Phase II trial of gemcitabine and cisplatin sequentially administered in Asian patients with unresectable or metastatic non-small cell lung cancer. | Annals of the Academy of Medicine, Singapore 20060101 |
| Gemcitabine as a radiosensitizer in undifferentiated tumors. | Anticancer research 20060101 |
| Evaluation of chemosensitivity of human bone marrow stromal cells--differences between common chemotherapeutic drugs. | Anticancer research 20060101 |
| [A case of salvage combination chemotherapy of gemcitabine plus nedaplatin for squamous cell carcinoma of the ureter]. | Hinyokika kiyo. Acta urologica Japonica 20060101 |
| Choroidal metastasis from breast carcinoma. | Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20060101 |
| Intravesical gemcitabine in BCG-refractory T1G3 transitional cell carcinoma of the bladder: a pilot study. | Urologia internationalis 20060101 |
| Comparison of standard-dose and low-dose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial. | Journal of gastroenterology 20060101 |
| Evaluation of the efficacy of combined continuous arterial infusion and systemic chemotherapy for the treatment of advanced pancreatic carcinoma. | Cardiovascular and interventional radiology 20060101 |
| Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer. | BMC cancer 20060101 |
| Hydralazine target: from blood vessels to the epigenome. | Journal of translational medicine 20060101 |
| A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin. | Clinical colorectal cancer 20060101 |
| Is capecitabine safe in patients with gastrointestinal cancer and dihydropyrimidine dehydrogenase deficiency? | Clinical colorectal cancer 20060101 |
| Gemcitabine-carboplatin-paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101 |
| Recurrent ovarian cancer metastatic to the sternum, costae, and thoracic wall after prolonged treatment with platinum-based chemotherapy: a case report and review of the literature. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101 |
| Elevated CA125 level associated with Meigs' syndrome: case report and review of the literature. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101 |
| [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study. | BMC cancer 20060101 |
| A pilot phase II study of capecitabine in advanced or recurrent breast cancer. | Breast cancer (Tokyo, Japan) 20060101 |
| Modest induction of phase 2 enzyme activity in the F-344 rat prostate. | BMC cancer 20060101 |
| Adjuvant treatment of pancreatic carcinoma in a clinically adapted mouse resection model. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20060101 |
| Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience. | BMC cancer 20060101 |
| A phase I study of oral uracil-tegafur prior to weekly intravenous gemcitabine in patients with advanced pancreatic cancer. | Chemotherapy 20060101 |
| The almost-forgotten fifth nucleotide in DNA: an introduction. | Current topics in microbiology and immunology 20060101 |
| Dietary nucleotides and human immune cells. II. Modulation of PBMC growth and cytokine secretion. | Nutrition (Burbank, Los Angeles County, Calif.) 20060101 |
| Combination effect of TZT-1027 (Soblidotin) with other anticancer drugs. | Anticancer research 20060101 |
| Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a phase II study. | Anticancer research 20060101 |
| Planned sequence of gemcitabine followed by vinorelbine in the treatment of elderly patients with advanced non-small cell lung cancer. | Anticancer research 20060101 |
| Influence of altering administration sequence of docetaxel, gemcitabine and cisplatin in patients with advanced non-small cell lung cancer. | Anticancer research 20060101 |
| Salvage treatment with single-agent capecitabine in patients with heavily pretreated advanced colorectal cancer. | Anticancer research 20060101 |
| Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer? | Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20060101 |
| Primary carcinoid tumour of the pancreas. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060101 |
| Gemcitabine combined with 5-fluorouracil for the treatment of advanced carcinoma of the pancreas. | In vivo (Athens, Greece) 20060101 |
| Cerebellar metastasis from pancreatic adenocarcinoma. A case report. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20060101 |
| Multicenter phase II study of gemcitabine and oxaliplatin (GEMOX) as second-line chemotherapy in colorectal cancer patients pretreated with 5-fluorouracil plus irinotecan. | Oncology 20060101 |
| Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents. | Oncology 20060101 |
| Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101 |
| Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study. | Tumori 20060101 |
| [Novel methods of treatment for colorectal carcinoma: from oral chemotherapy to angiogenesis inhibitors]. | Tumori 20060101 |
| Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report. | BMC cancer 20060101 |
| Gemcitabine and acute myocardial infarction--a case report. | Angiology 20060101 |
| [Concomitant treatment with gemcitabine and radiotherapy in patients with advanced stages of epidermoid carcinoma originating in the head and neck. A phase II sutdy]. | Gaceta medica de Mexico 20060101 |
| Radiosensitizers in cervical cancer. Cisplatin and beyond. | Radiation oncology (London, England) 20060101 |
| A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer. | BMC cancer 20060101 |
| The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines. | BMC cancer 20060101 |
| Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments. | BMC cancer 20060101 |
| Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer. | Anticancer research 20060101 |
| Gemcitabine combined with 5-fluorouracil and cisplatin (GFP) in patients with advanced biliary tree cancers: a pilot study. | Anticancer research 20060101 |
| In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabine. | Antiviral therapy 20060101 |
| Heavily pretreated ovarian cancer patients treated by single-agent gemcitabine. A retrospective outcome comparison between platinum-sensitive and platinum-resistant patients. | Acta oncologica (Stockholm, Sweden) 20060101 |
| Formation of N-branched oligonucleotides as by-products in solid-phase oligonucleotide synthesis. | Oligonucleotides 20060101 |
| Dramatic regression of multiple brain metastases from breast cancer with Capecitabine: another arrow at the bow? | Cancer investigation 20060101 |
| Cytotoxic chemotherapy for pancreatic cancer: Advances to date and future directions. | Drugs 20060101 |
| Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database. | BMC cancer 20060101 |
| Capecitabine-induced hypertriglyceridemia: a report of two cases. | Anticancer research 20060101 |
| Gemcitabine plus mitoxantrone and prednisone in the palliative treatment of hormone-resistant prostate cancer (HRPC): A phase II study (GOAM 01.01 study). | Anticancer research 20060101 |
| Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. | Anticancer research 20060101 |
| The role of capecitabine in the treatment of colorectal cancer in the elderly. | Anticancer research 20060101 |
| Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients. | Anticancer research 20060101 |
| Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report. | BMC cancer 20060101 |
| Quality of life assessment in advanced pancreatic adenocarcinoma: results from a phase III randomized trial. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20060101 |
| Vitamin D receptor agonists, cancer and the immune system: an intricate relationship. | Current topics in medicinal chemistry 20060101 |
| Phosphoprotein analysis: from proteins to proteomes. | Proteome science 20060101 |
| Could the hand-foot syndrome after capecitabine treatment be associated with better outcome in metastatic breast cancer patients? | Acta oncologica (Stockholm, Sweden) 20060101 |
| Successful resection of advanced pancreatic tail cancer after neoadjuvant gemcitabine chemotherapy: report of a case. | Surgery today 20060101 |
| Cisplatin, gemcitabine and paclitaxel triplet chemotherapy in 50 patients with advanced or metastatic urothelial cancer. | The West Virginia medical journal 20060101 |
| Gemcitabine treatment of experimental C6 glioma: the effects on cell cycle and apoptotic rate. | Anticancer research 20060101 |
| A phase II study of gemcitabine plus cisplatin in previously untreated advanced ovarian cancer. | Anticancer research 20060101 |
| Efficient large-scale synthesis of 5'-O-dimethoxytrityl-N4-benzoyl-5-methyl-2'-deoxycytidine. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Efavirenz/emtricitabine/tenofovir disoproxil fumarate: triple combination tablet. | Drugs 20060101 |
| New ultrasensitive 32P-postlabelling method for the analysis of 3,N4-etheno-2'-deoxycytidine in human urine. | Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 20060101 |
| Stimulation of erythrocyte phosphatidylserine exposure by paclitaxel. | Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20060101 |
| Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data. | BMC cancer 20060101 |
| New agents for intrathecal administration. | Cancer investigation 20060101 |
| Capecitabine: expanding options for the treatment of patients with early or locally advanced breast cancer. | The oncologist 20060101 |
| HER-2-positive metastatic breast cancer: optimizing trastuzumab-based therapy. | The oncologist 20060101 |
| The role of capecitabine in first-line treatment for patients with metastatic breast cancer. | The oncologist 20060101 |
| Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells. | Neoplasma 20060101 |
| A phase I trial of gemcitabine administered as a 96-h continuous intravenous infusion in patients with advanced carcinoma and lymphoma. | Medical oncology (Northwood, London, England) 20060101 |
| [The use of gemcitabine in the treatment of patients with mesothelioma]. | Voprosy onkologii 20060101 |
| Chemotherapy with mitomycin C and capecitabine in patients with advanced colorectal cancer pretreated with irinotecan and oxaliplatin. | Tumori 20060101 |
| Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication. | Antiviral chemistry & chemotherapy 20060101 |
| Intracellular levels of S-adenosylhomocysteine but not homocysteine are highly correlated to the expression of nm23-H1 and the level of 5-methyldeoxycytidine in human hepatoma cells with different invasion activities. | Nutrition and cancer 20060101 |
| Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: a multicenter phase II study. | Oncology 20060101 |
| Capecitabine and mitomycin C is an effective combination for anthracycline- and taxane-resistant metastatic breast cancer. | Oncology 20060101 |
| Vaccinia virus replication is not affected by APOBEC3 family members. | Virology journal 20060101 |
| Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug design. | BMC structural biology 20060101 |
| Concurrent capecitabine and upper abdominal radiation therapy is well tolerated. | Radiation oncology (London, England) 20060101 |
| Cellular resistance against troxacitabine in human cell lines and pediatric patient acute myeloid leukemia blast cells. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Study of the efficacy of a pronucleotide of 2-chloro-2'-deoxyadenosine in deoxycytidine kinase-deficient lymphoma cells. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Micro-array analysis of resistance for gemcitabine results in increased expression of ribonucleotide reductase subunits. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Identification of phosphorylation sites on human deoxycytidine kinase after overexpression in eucaryotic cells. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Deoxycytidine kinase is reversibly phosphorylated in normal human lymphocytes. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Enhanced activity of deoxycytidine kinase after pulsed low dose rate and single dose gamma irradiation. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Effects of intracellular calcium chelation and pifithrin-alpha on deoxynucleotide metabolism in human lymphocytes. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Cell cycle dependent regulation of deoxycytidine kinase, deoxyguanosine kinase, and cytosolic 5'-nucleotidase I activity in MOLT-4 cells. | Nucleosides, nucleotides & nucleic acids 20060101 |
| Analysis of deoxycytidine accumulation in gemcitabine treated patients. | Nucleosides, nucleotides & nucleic acids 20060101 |
| [Bladder preservation possibilities in the treatment of muscle-invasive bladder cancer]. | Medicina (Kaunas, Lithuania) 20060101 |
| [Effect of combined treatment methods on quality of life in patients with pancreatic cancer]. | Medicina (Kaunas, Lithuania) 20060101 |
| Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer. | Anticancer research 20060101 |
| Dual-color imaging of nascent angiogenesis and its inhibition in liver metastases of pancreatic cancer. | Anticancer research 20060101 |
| Silencing of X-linked inhibitor of apoptosis (XIAP) decreases gemcitabine resistance of pancreatic cancer cells. | Anticancer research 20060101 |
| Comparison of PrASE and Pyrosequencing for SNP Genotyping. | BMC genomics 20060101 |
| Haloperidol treatment induces tissue- and sex-specific changes in DNA methylation: a control study using rats. | Behavioral and brain functions : BBF 20060101 |
| Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma. | Urologic oncology 20060101 |
| Characterization of lipophilic gemcitabine prodrug-liposomal membrane interaction by differential scanning calorimetry. | Molecular pharmaceutics 20060101 |
| Synthesis of deoxycytidine derivatives and their use for the selective photo crosslinking with 5-methylcytosine. | Nucleic acids symposium series (2004) 20060101 |
| Synthesis and properties of DNA oligomers containing 2'-deoxycytidine-N-oxide. | Nucleic acids symposium series (2004) 20060101 |
| Recognition of the base pair-mimic nucleosides by DNA polymerases. | Nucleic acids symposium series (2004) 20060101 |
| A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer. | BMC cancer 20060101 |
| Phase II study of cisplatin combined with weekly gemcitabine in the treatment of patients with metastatic pancreatic carcinoma. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20060101 |
| Methylation patterns and chemosensitivity in NSCLC. | Advances in experimental medicine and biology 20060101 |
| Pharmacokinetics of single oral doses of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor, in healthy volunteers. | Clinical drug investigation 20060101 |
| Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancer. | Tumori 20060101 |
| FOLFOX-4 stop and go and capecitabine maintenance chemotherapy in the treatment of metastatic colorectal cancer. | Oncology 20060101 |
| Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature. | Oncology 20060101 |
| A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer. | PloS one 20060101 |
| Single agent gemcitabine chemotherapy in dogs with spontaneously occurring lymphoma. | Journal of veterinary internal medicine 20060101 |
| [The innate antiretroviral defense of human cells, based on the DNA editing]. | Postepy biochemii 20060101 |
| Drug interactions. Super pills-the treatments of the future? | TreatmentUpdate 20060101 |
| Successful treatment of a patient with gastric and duodenal metastases from large cell carcinoma of the lung with carboplatin and gemcitabine. | Anticancer research 20060101 |
| Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer. | Tumori 20060101 |
| [Metastatic colorectal cancer: adjournments from ESMO 2006]. | Tumori 20060101 |
| [A review of chemotherapy for metastatic colon cancer]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20060101 |
| Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer. | Medical oncology (Northwood, London, England) 20060101 |
| Second line chemotherapy with methotrexate and gemcitabine in patients with relapsing head and neck cancer. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20060101 |
| Gemcitabine-cisplatin given on day 1 every 3 weeks in advanced non-small cell lung cancer. | Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20060101 |
| First of a kind in HIV treatment. | FDA consumer 20060101 |
| Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK. | Oncology 20060101 |
| Improved survival with single-agent paclitaxel consolidation/maintenance therapy in advanced ovarian carcinoma. | Oncology 20060101 |
| Pick the winner designs in phase II cancer clinical trials. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060101 |
| A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer. | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060101 |
| A dose escalation study of docetaxel plus capecitabine in combination with gemcitabine in patients with advanced solid tumors. | Oncology research 20060101 |
| [Intramolecular hygrogen bonds in conformers of 2'-deoxycytidine: results of quantum-chemical analysis of electron density topology]. | Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20060101 |
| Paradigm development: comparative and predictive 3D modeling of HIV-1 Virion Infectivity Factor (Vif). | Bioinformation 20060101 |
| New strategies in the treatment of Ta-T1 transitional cell carcinoma (TCC) of the bladder. | TheScientificWorldJournal 20060101 |
| A dose escalation study of gemcitabine plus pemetrexed administered biweekly in patients with solid tumors. | Oncology 20060101 |
| A multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancer. | Oncology 20060101 |
| A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors. | Oncology 20060101 |
| The analgesic effect of gemcitabine in mice. | Romanian journal of internal medicine = Revue roumaine de medecine interne 20060101 |
| Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220 |
| 14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220 |
| Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220 |
| Symptoms in cancer patients and an unusual tumor: Case 3. Follicular dendritic cell sarcoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220 |
| Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinoma. | Cancer 20051215 |
| Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. | Cancer 20051215 |
| Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects. | Clinical cancer research : an official journal of the American Association for Cancer Research 20051215 |
| Capecitabine-induced multifocal leukoencephalopathy: a report of five cases. | Neurology 20051213 |
| RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer. | British journal of cancer 20051212 |
| The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia. | British journal of cancer 20051212 |
| Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051210 |
| Pre-steady-state kinetic characterization of the DinB homologue DNA polymerase of Sulfolobus solfataricus. | The Journal of biological chemistry 20051209 |
| Procainamide is a specific inhibitor of DNA methyltransferase 1. | The Journal of biological chemistry 20051209 |
| Structure of a halophilic nucleoside diphosphate kinase from Halobacterium salinarum. | FEBS letters 20051205 |
| Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells. | FEBS letters 20051205 |
| Paclitaxel and gemcitabine combination in a biweekly schedule in patients with advanced non small-cell lung cancer: a phase I study. | Cancer chemotherapy and pharmacology 20051201 |
| Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20051201 |
| Activity of carboplatin in patients with advanced non-small cell lung cancer pre-treated with a non-platinum combination. | Investigational new drugs 20051201 |
| A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer. | Investigational new drugs 20051201 |
| Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer. | Cancer chemotherapy and pharmacology 20051201 |
| Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis. | Cancer chemotherapy and pharmacology 20051201 |
| A computational model of mitochondrial AZT metabolism. | The Biochemical journal 20051201 |
| ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation. | Oncogene 20051201 |
| In vitro and in vivo enhancement of ganciclovir-mediated bystander cytotoxicity with gemcitabine. | Molecular therapy : the journal of the American Society of Gene Therapy 20051201 |
| Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival. | Molecular pharmacology 20051201 |
| Decitabine activates specific caspases downstream of p73 in myeloid leukemia. | Annals of hematology 20051201 |
| Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients. | Cancer 20051201 |
| Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study. | Annals of oncology : official journal of the European Society for Medical Oncology 20051201 |
| Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma. | Annals of surgical oncology 20051201 |
| No evidence of gemcitabine accumulation during weekly administration. | European journal of clinical pharmacology 20051201 |
| Pharmacokinetic modelling of 5-FU production from capecitabine--a population study in 40 adult patients with metastatic cancer. | Journal of pharmacokinetics and pharmacodynamics 20051201 |
| Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer. | Cancer treatment reviews 20051201 |
| Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors. | Scandinavian journal of gastroenterology 20051201 |
| Phase I study of fixed dose rate infusion of gemcitabine in patients with unresectable pancreatic cancer. | Japanese journal of clinical oncology 20051201 |
| Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells. | Leukemia 20051201 |
| A case of advanced Hodgkin lymphoma with breast involvement treated with a combination of gemcitabine and pegylated liposomal doxorubicin. | European journal of haematology 20051201 |
| Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051201 |
| Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051201 |
| Pegylated liposomal doxorubicin-based combination chemotherapy as salvage treatment in patients with advanced hepatocellular carcinoma. | American journal of clinical oncology 20051201 |
| Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer: a phase I study. | American journal of clinical oncology 20051201 |
| Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors. | American journal of clinical oncology 20051201 |
| Perspectives in colorectal cancer - Sixth Annual Conference. Metastatic colorectal cancer. | IDrugs : the investigational drugs journal 20051201 |
| The prognostic value of cN-II and cN-III enzymes in adult acute myeloid leukemia. | Haematologica 20051201 |
| Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children. | Haematologica 20051201 |
| The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20051201 |
| [Pharmacokinetic comparison of capecitabine and 5'-deoxy-5-fluorouridine (doxifluridine; 5'-DFUR)]. | Gan to kagaku ryoho. Cancer & chemotherapy 20051201 |
| [An outpatient with unresectable pancreatic cancer treated with gemcitabine showing prolonged NC (22 months)]. | Gan to kagaku ryoho. Cancer & chemotherapy 20051201 |
| [A paclitaxel-resistant case of recurrent breast cancer responded to combination therapy of capecitabine and trastuzumab]. | Gan to kagaku ryoho. Cancer & chemotherapy 20051201 |
| Brief communication: a new combination in the treatment of advanced pancreatic cancer. | Seminars in oncology 20051201 |
| High efficacy of gemcitabine and cisplatin plus trastuzumab in patients with HER2-overexpressing metastatic breast cancer: a phase II study. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20051201 |
| A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD). | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20051201 |
| Docetaxel/gemcitabine administered every other week as first-line treatment for metastatic breast cancer: final results of a phase II trial. | Clinical breast cancer 20051201 |
| Front-line therapy of advanced pancreatic cancer. | Seminars in oncology 20051201 |
| Front-line therapy for advanced colorectal cancer: emphasis on chemotherapy. | Seminars in oncology 20051201 |
| Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience. | Seminars in oncology 20051201 |
| Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin. | Prescrire international 20051201 |
| Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer. | Collegium antropologicum 20051201 |
| What news in urological cancer. | La Tunisie medicale 20051201 |
| Gemcitabine and cisplatin in the treatment of elderly patients with advanced non-small cell lung cancer: impact of comorbidities on safety and efficacy outcome. | Journal of chemotherapy (Florence, Italy) 20051201 |
| [The mechanism of resistance to 2', 2'-difluorodeoxycytidine (gemcitabine) in a pancreatic cancer cell line]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20051201 |
| Optimizing adjuvant chemotherapy in early-stage breast cancer. | Oncology (Williston Park, N.Y.) 20051201 |
| Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxel. | Lung cancer (Amsterdam, Netherlands) 20051201 |
| Actinic keratosis and capecitabine therapy. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20051201 |
| Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours. | British journal of cancer 20051128 |
| Transient state kinetic studies of the MutT-catalyzed nucleoside triphosphate pyrophosphohydrolase reaction. | Biochemistry 20051122 |
| MSX2 overexpression inhibits gemcitabine-induced caspase-3 activity in pancreatic cancer cells. | World journal of gastroenterology 20051121 |
| Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051120 |
| [Pancreatic carcinoma (ductal adenocarcinoma)]. | Praxis 20051116 |
| Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer. | International journal of radiation oncology, biology, physics 20051115 |
| Detection of chlorinated DNA and RNA nucleosides by HPLC coupled to tandem mass spectrometry as potential biomarkers of inflammation. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20051115 |
| Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomal aberrations. | Cancer research 20051115 |
| Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model. | Cancer research 20051115 |
| Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck. | British journal of cancer 20051114 |
| Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer. | British journal of cancer 20051114 |
| [Review of effectiveness of chemotherapy with gemcitabine in ovarian cancer]. | Orvosi hetilap 20051113 |
| What's happening in PHARMAC--where do all the submissions go? On the trail of gemcitabine. | The New Zealand medical journal 20051111 |
| PHARMAC's response on gemcitabine and transparency. | The New Zealand medical journal 20051111 |
| Portal hypertension secondary to 90Yttrium microspheres: an unknown complication. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051110 |
| Simultaneous determination of capecitabine and its metabolites by HPLC and mass spectrometry for preclinical and clinical studies. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20051105 |
| Design and studies of novel 5-substituted alkynylpyrimidine nucleosides as potent inhibitors of mycobacteria. | Journal of medicinal chemistry 20051103 |
| Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study. | Cancer chemotherapy and pharmacology 20051101 |
| Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma. | Cancer chemotherapy and pharmacology 20051101 |
| S-phase modulation by irinotecan: pilot studies in advanced solid tumors. | Cancer chemotherapy and pharmacology 20051101 |
| Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study. | Annals of hematology 20051101 |
| Is adjuvant therapy with three-dimensional conformal irradiation combined with capecitabine (Xeloda) for gastric cancer effective? | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20051101 |
| Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site: a Minnie Pearl Cancer Research Network Phase II trial. | Cancer 20051101 |
| Serum amyloid A as a tumor marker in sera of nude mice with orthotopic human pancreatic cancer and in plasma of patients with pancreatic cancer. | International journal of oncology 20051101 |
| Identifying genes with differential expression in gemcitabine-resistant pancreatic cancer cells using comprehensive transcriptome analysis. | Oncology reports 20051101 |
| Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a Phase II Hoosier Oncology Group Study. | The Journal of urology 20051101 |
| Gemcitabine and paclitaxel in metastatic or recurrent squamous cell carcinoma of the head and neck: a phase I-II study. | Anti-cancer drugs 20051101 |
| Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer. | Anti-cancer drugs 20051101 |
| Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option. | BJU international 20051101 |
| Unraveling the mechanism of radiosensitization by gemcitabine: the role of TP53. | Radiation research 20051101 |
| Safety and efficacy of trastuzumab every 3 weeks combined with cytotoxic chemotherapy in patients with HER2-positive recurrent breast cancer: findings from a case series. | Onkologie 20051101 |
| Gemcitabine in the treatment of relapsed and refractory Hodgkin's disease. | Onkologie 20051101 |
| Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051101 |
| Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies. | Pancreas 20051101 |
| Gemcitabine and carboplatin in the treatment of locally advanced and metastatic non-small cell lung cancer. | Respirology (Carlton, Vic.) 20051101 |
| 5-fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancer. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20051101 |
| Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting. | Nature clinical practice. Oncology 20051101 |
| Determination of the importance of the stereochemistry of psorospermin in topoisomerase II-induced alkylation of DNA and in vitro and in vivo biological activity. | Molecular cancer therapeutics 20051101 |
| [Molecular targeted therapy--non-small-cell lung cancer and gefitinib]. | Gan to kagaku ryoho. Cancer & chemotherapy 20051101 |
| [A case of pancreatic cancer complicated by gemcitabine-induced peripheral edema]. | Gan to kagaku ryoho. Cancer & chemotherapy 20051101 |
| Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of the bladder. | Urology 20051101 |
| Formation of DNA adducts with cholyl adenylate, a putative intermediate for biosynthesis of cholyl-CoA. | Chemical research in toxicology 20051101 |
| Phase II study of neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small cell lung cancer. | Chest 20051101 |
| Gemcitabine/carboplatin in patients with metastatic non-small-cell lung cancer: phase II study of 28-day and 21-day schedules. | Clinical lung cancer 20051101 |
| Randomized multicenter phase II study of gemcitabine versus docetaxel as first-line therapy with second-line crossover in advanced-stage non-small-cell lung cancer. | Clinical lung cancer 20051101 |
| Capecitabine/Oxaliplatin combinations in advanced colorectal cancer: summary of recent randomized studies. | Clinical colorectal cancer 20051101 |
| Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysis. | Clinical colorectal cancer 20051101 |
| Gemcitabine and radiotherapy in the treatment of uterine cervical cancer patients at Phramongkutklao Hospital. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20051101 |
| Hydrothermal deamidation of 4-N-acylcytosine nucleoside derivatives: efficient synthesis of uracil nucleoside esters. | Organic letters 20051027 |
| Sugar pucker modulates the cross-correlated relaxation rates across the glycosidic bond in DNA. | Journal of the American Chemical Society 20051026 |
| Age-dependent increase of etheno-DNA-adducts in liver and brain of ROS overproducing OXYS rats. | Biochemical and biophysical research communications 20051021 |
| Gallbladder cancer, a different disease that needs individual trials. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051020 |
| Nonenzymatic glycation of DNA nucleosides with reducing sugars. | Analytical biochemistry 20051015 |
| In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant. | Cancer research 20051015 |
| In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor. | Clinical cancer research : an official journal of the American Association for Cancer Research 20051015 |
| Rob Ashley of AmpliMed discusses the discovery and development of Imexon. Interview by Steve Carney. | Drug discovery today 20051015 |
| UFT plus gemcitabine combination chemotherapy in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial. | British journal of cancer 20051003 |
| CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials. | British journal of cancer 20051003 |
| Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study. | British journal of cancer 20051003 |
| Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer. | International journal of radiation oncology, biology, physics 20051001 |
| Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20051001 |
| Cisplatin and gemcitabine in malignant mesothelioma. | Annals of oncology : official journal of the European Society for Medical Oncology 20051001 |
| Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20051001 |
| PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20051001 |
| A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20051001 |
| Synergistic interaction of hyperthermia and Gemcitabine in lung cancer. | Cancer biology & therapy 20051001 |
| Combination therapy for advanced pancreatic cancer using Herceptin plus chemotherapy. | International journal of oncology 20051001 |
| Inhibition of phosphatidylinositol-3-kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria. | Anti-cancer drugs 20051001 |
| Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbidities. | Anti-cancer drugs 20051001 |
| Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial. | Anti-cancer drugs 20051001 |
| Phase I clinical and pharmacologic study of a 2-weekly administration of cisplatin and gemcitabine in patients with advanced non-small cell lung cancer. | Anti-cancer drugs 20051001 |
| A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma. | Melanoma research 20051001 |
| Systemic therapy for pancreatic cancer. | Seminars in radiation oncology 20051001 |
| Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051001 |
| Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 3. Photo therapy recall with gemcitabine following ultraviolet B treatment. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051001 |
| A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer. | American journal of clinical oncology 20051001 |
| Induction chemotherapy with cisplatin and gemcitabine followed by reirradiation for locally recurrent nasopharyngeal carcinoma. | American journal of clinical oncology 20051001 |
| Biweekly administration of cisplatin/gemcitabine in advanced nonsmall cell lung cancer. | American journal of clinical oncology 20051001 |
| Effect of capecitabine on mean corpuscular volume of red blood cells. | American journal of clinical oncology 20051001 |
| Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20051001 |
| Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. | Cancer research 20051001 |
| Aerosol delivery of chemotherapy in an orthotopic model of lung cancer. | The European respiratory journal 20051001 |
| Human DNA polymerase iota incorporates dCTP opposite template G via a G.C + Hoogsteen base pair. | Structure (London, England : 1993) 20051001 |
| Reduced dose capecitabine is an effective and well-tolerated treatment in patients with metastatic breast cancer. | Breast (Edinburgh, Scotland) 20051001 |
| Erlotinib in the treatment of non-small cell lung cancer. | Expert review of anticancer therapy 20051001 |
| [A case report of chemotherapy with thalidomide, celecoxib and gemcitabine in the treatment of patients with brain metastases from lung cancer]. | No shinkei geka. Neurological surgery 20051001 |
| Adjuvant systemic chemotherapy with gemcitabine for stage IV pancreatic cancer: a preliminary report of initial experience. | Chemotherapy 20051001 |
| Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine. | Molecular cancer therapeutics 20051001 |
| [Locally advanced pancreatic cancer that enlarged after administration of gemcitabine and responded to oral TS-1--a case report]. | Gan to kagaku ryoho. Cancer & chemotherapy 20051001 |
| [Combined systemic and intraarterial chemotherapy with gemcitabine and concomitant external-beam radiotherapy in patients with liver metastasis from pancreatic cancer--report of two cases]. | Gan to kagaku ryoho. Cancer & chemotherapy 20051001 |
| Intravesical gemcitabine therapy for superficial transitional cell carcinoma: results of a Phase II prospective multicenter study. | Urology 20051001 |
| Advanced colorectal cancer: current treatment and nursing management with economic considerations. | Clinical journal of oncology nursing 20051001 |
| [Successful removal of T4 lung cancer with left atrial invasion after induction chemotherapy]. | Kyobu geka. The Japanese journal of thoracic surgery 20051001 |
| Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models. | Neoplasia (New York, N.Y.) 20051001 |
| Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Cancer mouse models and other techniques for improved prediction of efficacy. | IDrugs : the investigational drugs journal 20051001 |
| [Drug resistance and activity changes of thioredoxin reductase in pancreatic cancer cells strain SW1990 induced by gemcitabine]. | Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20051001 |
| Meeting notes from the 3rd IAS Conference. Old drugs, new data. | AIDS clinical care 20051001 |
| North Central Cancer Treatment Group N0531: Phase II Trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane) in combination with gemcitabine in patients with metastatic breast cancer. | Clinical breast cancer 20051001 |
| Hopes dashed for formulation. | AIDS patient care and STDs 20051001 |
| Improving outcomes in the treatment of locally-advanced NSCLC with gemcitabine. | Lung cancer (Amsterdam, Netherlands) 20051001 |
| Using translational research to tailor the use of chemotherapy in the treatment of NSCLC. | Lung cancer (Amsterdam, Netherlands) 20051001 |
| A ten-year review of progress in the treatment of non-small-cell lung cancer with gemcitabine. | Lung cancer (Amsterdam, Netherlands) 20051001 |
| The development of gemcitabine and carboplatin in the treatment of non-small-cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20051001 |
| Incorporating novel agents with gemcitabine-based treatment of NSCLC. | Lung cancer (Amsterdam, Netherlands) 20051001 |
| [A study of recurrent pancreatic cancer with metastatic liver tumors after pancreatectomy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20051001 |
| [Intraperitoneal and intrapleural gemcitabine in patients with advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20051001 |
| [Gemcitabine concurrent with radiation for locally advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20051001 |
| [A case of advanced pancreatic cancer treated with chemoradiation]. | Gan to kagaku ryoho. Cancer & chemotherapy 20051001 |
| Gemcitabine combined with oxaliplatin is safe and effective in patients with previously untreated advanced pancreatic adenocarcinoma. | Gastroenterologie clinique et biologique 20051001 |
| Rev1 employs a novel mechanism of DNA synthesis using a protein template. | Science (New York, N.Y.) 20050930 |
| Formation of modified cytosine residues in the presence of depurinated DNA. | The Journal of organic chemistry 20050930 |
| Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cells. | Cancer letters 20050928 |
| Phase I/IIa study of cisplatin and gemcitabine as induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine and paclitaxel for locally advanced non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050920 |
| Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree. | Cancer 20050915 |
| Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050915 |
| Base pair stability of 8-chloro- and 8-iodo-2'-deoxyguanosine opposite 2'-deoxycytidine: implications regarding the bioactivity of 8-oxo-2'-deoxyguanosine. | Journal of the American Chemical Society 20050907 |
| Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan. | British journal of cancer 20050905 |
| Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas. | Cancer immunology, immunotherapy : CII 20050901 |
| Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases. | International journal of cancer 20050901 |
| Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Muller S, Schütt P, Bojko P, Nowrousian MR, Hense J, Seeber S, Moritz T. Ann. Hematol. 2005 Feb; 84(2):110-4. | Annals of hematology 20050901 |
| Combination of chemotherapy without platinum compounds in the treatment of advanced non-small cell lung cancer: a systematic review of phase III trials. | Lung cancer (Amsterdam, Netherlands) 20050901 |
| cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20050901 |
| Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors. | European urology 20050901 |
| The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells. | Lung cancer (Amsterdam, Netherlands) 20050901 |
| Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine. | Cancer 20050901 |
| Capecitabine-warfarin interaction. | The Annals of pharmacotherapy 20050901 |
| Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma. | Journal of cancer research and clinical oncology 20050901 |
| Four-color multiplex reverse transcription polymerase chain reaction--overcoming its limitations. | Analytical biochemistry 20050901 |
| Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study. | Journal of cancer research and clinical oncology 20050901 |
| Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cells. | Journal of cancer research and clinical oncology 20050901 |
| Phase I study of vinorelbine plus gemcitabine as third-line chemotherapy for refractory non-small cell lung cancer. | Oncology reports 20050901 |
| Preferential inhibition of bone metastases by 5'-deoxy-5-fluorouridine and capecitabine in the 4T1/luc mouse breast cancer model. | Oncology reports 20050901 |
| Posttreatment exacerbation of hepatitis B virus (HBV) infection in long-term HBV trials of emtricitabine. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050901 |
| APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis. | Cell cycle (Georgetown, Tex.) 20050901 |
| Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancer. | The Journal of urology 20050901 |
| In vitro partition of docetaxel and gemcitabine in human volunteer blood: the influence of concentration and gender. | Anti-cancer drugs 20050901 |
| Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation. | Leukemia & lymphoma 20050901 |
| Treatment cost of pancreatic cancer in Japan: analysis of the difference after the introduction of gemcitabine. | Japanese journal of clinical oncology 20050901 |
| Regulation of 5' template usage and incorporation of noncognate nucleotides by human telomerase. | RNA (New York, N.Y.) 20050901 |
| A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non-small cell lung cancer. | Respirology (Carlton, Vic.) 20050901 |
| Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901 |
| What is the best chemotherapy treatment option for anthracycline and taxane pretreated metastatic breast cancer? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901 |
| Is the tolerance to MIP chemotherapy different between English and other European populations? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901 |
| Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma. | American journal of hematology 20050901 |
| Randomized phase II marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent Stage Ta urothelial cell carcinoma of the bladder. | Urology 20050901 |
| Partial, but not complete, tumor-debulking surgery promotes protective antitumor memory when combined with chemotherapy and adjuvant immunotherapy. | Cancer research 20050901 |
| Gemcitabine in the treatment of advanced head and neck cancer. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20050901 |
| Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine models. | Human gene therapy 20050901 |
| Phase II trial of gemcitabine/irinotecan in refractory or relapsed small-cell lung cancer. | Clinical lung cancer 20050901 |
| [Phase II study of gemcitabine (GEM) and docetaxel (TXT) combination chemotherapy for unresectable non small cell lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050901 |
| [Two cases of advanced gallbadder cancer with para-aortic lymph node metastasis responding to intra-aortic infusion of gemcitabine and low-dose CDDP/5-FU]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050901 |
| [Experience of gemcitabine therapy after non-curative resection for biliary tract cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050901 |
| Treatment of metastatic pancreatic cancer. | Journal of the National Comprehensive Cancer Network : JNCCN 20050901 |
| An adverse interaction between warfarin and fluoropyrimidines revisited. | Clinical colorectal cancer 20050901 |
| [Cost-effectiveness analysis of capecitabine in combination with docetaxel in comparison to docetaxel monotherapy in advanced or metastatic breast cancer in France]. | Bulletin du cancer 20050901 |
| Immunohistochemical expression of thymidylate synthase as predictor of response to capecitabine in patients with advanced colorectal adenocarcinoma. | APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20050901 |
| [First-line non-small-cell lung cancer: role of gemcitabine]. | Revue de pneumologie clinique 20050901 |
| [Experience of gemcitabine plus cisplatin chemotherapy in 52 patients with head and neck cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20050901 |
| Cloning and characterization of the ecto-nucleotidase NTPDase3 from rat brain: Predicted secondary structure and relation to other members of the E-NTPDase family and actin. | Purinergic signalling 20050901 |
| A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma. | Yonsei medical journal 20050831 |
| Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication. | Journal of medicinal chemistry 20050825 |
| Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study. | British journal of cancer 20050822 |
| Phase II trial of the novel retinoid, bexarotene, and gemcitabine plus carboplatin in advanced non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820 |
| Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050815 |
| Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050815 |
| Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide. | The Journal of biological chemistry 20050812 |
| Comparison of functional properties of mammalian DNA polymerase lambda and DNA polymerase beta in reactions of DNA synthesis related to DNA repair. | Biochimica et biophysica acta 20050810 |
| Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells. | British journal of cancer 20050808 |
| Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050805 |
| Motions of the fingers subdomain of klentaq1 are fast and not rate limiting: implications for the molecular basis of fidelity in DNA polymerases. | Molecular cell 20050805 |
| Effect of DNA polymerase beta loop variants on discrimination of O6-methyldeoxyguanosine modification present in the nucleotide versus template substrate. | Biochemistry 20050802 |
| Combination of gemcitabine and Ad5/3-Delta24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer. | Gene therapy 20050801 |
| Proteomic detection of hydrogen peroxide-sensitive thiol proteins in Jurkat cells. | The Biochemical journal 20050801 |
| Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5'-deoxy-5-fluorouridine (5'-DFUR). | Cancer chemotherapy and pharmacology 20050801 |
| Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature. | Annals of oncology : official journal of the European Society for Medical Oncology 20050801 |
| Mismatch repair proficiency is not required for radioenhancement by gemcitabine. | International journal of radiation oncology, biology, physics 20050801 |
| ['Second line' polychemotherapy in metastatic urothelial cancer of the renal pelvis. Persisting partial remission by 18 treatment cycles of gemcitabine/paclitaxel after 24 treatment cycles gemcitabine/cisplatin 'stable disease']. | Der Urologe. Ausg. A 20050801 |
| Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells. | Biochemical pharmacology 20050801 |
| Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival. | Gynecologic oncology 20050801 |
| Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia. | Neuroradiology 20050801 |
| Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group. | European journal of haematology 20050801 |
| Triplet chemotherapy with cisplatin, gemcitabine and vinorelbine for malignant pleural mesothelioma. | Japanese journal of clinical oncology 20050801 |
| The impact of practice guidelines and funding policies on the use of new drugs in advanced non-small cell lung cancer. | Journal of evaluation in clinical practice 20050801 |
| Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer. | Oncology reports 20050801 |
| Gemcitabine and mitoxantrone in metastatic breast cancer: a phase-I-study. | Investigational new drugs 20050801 |
| Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study. | Investigational new drugs 20050801 |
| Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20050801 |
| Combination of vinorelbine plus gemcitabine in previously treated patients with small cell lung cancer: a multicentre phase II study. | Lung cancer (Amsterdam, Netherlands) 20050801 |
| Synergistic effects of imatinib (STI 571) in combination with chemotherapeutic drugs in head and neck cancer. | Anti-cancer drugs 20050801 |
| Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lung. | Anti-cancer drugs 20050801 |
| A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer. | International journal of radiation oncology, biology, physics 20050801 |
| Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian Phase II study. | International journal of radiation oncology, biology, physics 20050801 |
| Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection. | The Annals of thoracic surgery 20050801 |
| Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine. | Cancer research 20050801 |
| Antiangiogenic treatment with three thrombospondin-1 type 1 repeats versus gemcitabine in an orthotopic human pancreatic cancer model. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050801 |
| Phase I study of docetaxel, capecitabine, and carboplatin in metastatic esophagogastric cancer. | American journal of clinical oncology 20050801 |
| Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer. | American journal of clinical oncology 20050801 |
| Cisplatin and gemcitabine for small cell carcinoma of the gall bladder. | American journal of clinical oncology 20050801 |
| [A randomized trial of docetaxol plus cisplatin versus gemzar plus cisplatin in treating advanced non-small cell lung cancer]. | Ai zheng = Aizheng = Chinese journal of cancer 20050801 |
| [Application of adenosine triphosphate tumor chemosensitive assay system to individual chemotherapy for hepatocellular carcinoma]. | Ai zheng = Aizheng = Chinese journal of cancer 20050801 |
| Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells. | Molecular cancer therapeutics 20050801 |
| GRiN: a trial and tribulation in respiratory radiotherapy research. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20050801 |
| A phase I study of moderate-dose radiation therapy and weekly gemcitabine in patients with locally advanced non-small cell lung cancer not suitable for radical chemoradiation therapy. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20050801 |
| Oxidation of 5-hydroxypyrimidine nucleosides to 5-hydroxyhydantoin and its alpha-hydroxy-ketone isomer. | Chemical research in toxicology 20050801 |
| Importance of rational pre-clinical development: gemcitabine comes of age. | Cancer biology & therapy 20050801 |
| [Survey of gemcitabine treatment for advanced pancreatic cancer in 20 hospitals of Nagano Prefecture]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050801 |
| [Experience with capecitabine in patients with anthracycline and/or taxane-resistant recurrent breast cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050801 |
| [A case of recurrent breast cancer successfully treated with capecitabine monotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050801 |
| [An orbital metastasis as the presentation of lung adenocarcinoma]. | Archivos de la Sociedad Espanola de Oftalmologia 20050801 |
| Recent updates on the role of chemotherapy in pancreatic cancer. | Seminars in oncology 20050801 |
| Gemcitabine and carboplatin in second-line ovarian cancer. | Seminars in oncology 20050801 |
| Chemotherapeutic gemcitabine doublets in pancreatic carcinoma. | Seminars in oncology 20050801 |
| Gemcitabine plus paclitaxel in breast cancer. | Seminars in oncology 20050801 |
| A case of diffuse pleural mesothelioma in which contralateral exploratory thoracoscopy assisted the selection of therapy. | Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20050801 |
| Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer. | Surgery 20050801 |
| [Treatment of Bacillus Calmette-Guerin refractory superficial bladder cancer: further intravesical therapy]. | Hinyokika kiyo. Acta urologica Japonica 20050801 |
| Patient with angina secondary to capecitabine. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20050801 |
| Pancreatic cancer combo treatment promising. | Health news (Waltham, Mass.) 20050801 |
| Potentiation of the antitumoral activity of gemcitabine and paclitaxel in combination on human breast cancer cells. | Cancer biology & therapy 20050801 |
| Increased expression of mRNA specific for thymidine kinase, deoxycytidine kinase or thymidine phosphorylase in human papillary thyroid carcinoma. | Cancer letters 20050728 |
| Oral Xeloda plus bi-platinu two-way combined chemotherapy in treatment of advanced gastrointestinal malignancies. | World journal of gastroenterology 20050728 |
| Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. | British journal of cancer 20050725 |
| Release of DNA from dendriplexes encapsulated in PLGA nanoparticles. | International journal of pharmaceutics 20050725 |
| Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC). | British journal of cancer 20050725 |
| Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer. | British journal of cancer 20050725 |
| Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection. | Virology 20050720 |
| Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050720 |
| Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050720 |
| Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108. | Cancer 20050715 |
| Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro. | Journal of immunology (Baltimore, Md. : 1950) 20050715 |
| Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograft. | Cancer research 20050715 |
| Xenopus CENP-A assembly into chromatin requires base excision repair proteins. | DNA repair 20050712 |
| Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer. | British journal of cancer 20050711 |
| Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma. | British journal of cancer 20050711 |
| Gastrointestinal bleeding associated with concurrent capecitabine and radiotherapy in patients with pancreatic cancer. | JOP : Journal of the pancreas 20050708 |
| Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature. | JOP : Journal of the pancreas 20050708 |
| Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study. | Cancer chemotherapy and pharmacology 20050701 |
| A novel phospholipid gemcitabine conjugate is able to bypass three drug-resistance mechanisms. | Cancer chemotherapy and pharmacology 20050701 |
| Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells. | Molecular pharmacology 20050701 |
| Docking simulation with a purine nucleoside specific homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy. | Bioorganic & medicinal chemistry 20050701 |
| A multicenter phase II study of gemcitabine, paclitaxel, and cisplatin in chemonaïve advanced ovarian cancer. | Gynecologic oncology 20050701 |
| CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. | Cancer 20050701 |
| Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: a two-year study. | Journal of hepatology 20050701 |
| A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20050701 |
| Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts. | Oncology reports 20050701 |
| Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer. | Oncology reports 20050701 |
| Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and Cisplatin. | The Journal of urology 20050701 |
| Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities--a multicenter phase II trial. | Lung cancer (Amsterdam, Netherlands) 20050701 |
| Mechanism of action of a novel viral mutagenic covert nucleotide: molecular interactions with HIV-1 reverse transcriptase and host cell DNA polymerases. | Antiviral research 20050701 |
| Neoadjuvant chemotherapy in malignant pleural mesothelioma. | Lung cancer (Amsterdam, Netherlands) 20050701 |
| Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience. | Lung cancer (Amsterdam, Netherlands) 20050701 |
| Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: pharmacoeconomic considerations. | European journal of cancer (Oxford, England : 1990) 20050701 |
| Immunocytochemical detection of deoxycytidine kinase in haematological malignancies and solid tumours. | Journal of clinical pathology 20050701 |
| The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC). | European journal of cancer (Oxford, England : 1990) 20050701 |
| Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients. | International journal of dermatology 20050701 |
| Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system. | Cancer research 20050701 |
| Combination chemotherapy with gemcitabine with isolated lung perfusion for the treatment of pulmonary metastases. | The Journal of thoracic and cardiovascular surgery 20050701 |
| Chemotherapy for non-small cell lung cancer in elderly patients. | Chest 20050701 |
| New drugs. | HIV medicine 20050701 |
| Pharmacology of 5-Aza-2'-deoxycytidine (decitabine). | Seminars in hematology 20050701 |
| Gemcitabine inhibits viability, growth, and metastasis of osteosarcoma cell lines. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20050701 |
| Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice. | Neoplasia (New York, N.Y.) 20050701 |
| Chemotherapy for metastatic colorectal cancer. | Journal of the National Comprehensive Cancer Network : JNCCN 20050701 |
| [Cut-off level of docetaxel, paclitaxel and gemcitabine in histoculture drug response assay for non-small cell lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050701 |
| [Effect of full-length cyclin B1 antisense cDNA on chemosensitivity of lewis lung carcinoma cells to gemicitabine in vitro and in vivo]. | Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20050701 |
| Capecitabine versus continuous-infusion 5-fluorouracil for colorectal cancer: a retrospective efficacy and safety comparison. | Clinical colorectal cancer 20050701 |
| Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study. | Clinical colorectal cancer 20050701 |
| Perspectives on salvage therapy for non-small-cell lung cancer. | Oncology (Williston Park, N.Y.) 20050701 |
| Chemotherapy dosing in the setting of liver dysfunction. | Oncology (Williston Park, N.Y.) 20050701 |
| Capecitabine as adjuvant treatment for stage III colon cancer. | The New England journal of medicine 20050630 |
| Case records of the Massachusetts General Hospital. Case 20-2005. A 58-year-old man with locally advanced pancreatic cancer. | The New England journal of medicine 20050630 |
| Adjuvant therapy for colon cancer--the pace quickens. | The New England journal of medicine 20050630 |
| [Chemotherapy of patients with colorectal carcinoma]. | Nederlands tijdschrift voor geneeskunde 20050625 |
| Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. | Oncogene 20050623 |
| Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial. | British journal of cancer 20050620 |
| Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer. | British journal of cancer 20050620 |
| Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells. | Blood 20050615 |
| Capecitabine plus docetaxel combination therapy. | Cancer 20050615 |
| Deoxyuridine is generated preferentially in the nontranscribed strand of DNA from cells expressing activation-induced cytidine deaminase. | Journal of immunology (Baltimore, Md. : 1950) 20050615 |
| In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: modulation by lower-dose chemotherapy. | Cancer research 20050615 |
| Evaluation of the combined effect of p53 codon 72 polymorphism and hotspot mutations in response to anticancer drugs. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050615 |
| Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients. | British journal of cancer 20050606 |
| Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF. | British journal of cancer 20050606 |
| Rapid quantitation of plasma 2'-deoxyuridine by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry and its application to pharmacodynamic studies in cancer patients. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050605 |
| Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide. | The Journal of pharmacology and experimental therapeutics 20050601 |
| A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancer. | Cancer chemotherapy and pharmacology 20050601 |
| Apoptosis by gemcitabine in non-small cell lung cancer cell line KNS62 is induced downstream of caspase 8 and is profoundly blocked by Bcl-xL over-expression. | Langenbeck's archives of surgery 20050601 |
| A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors. | Cancer chemotherapy and pharmacology 20050601 |
| First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study. | Annals of oncology : official journal of the European Society for Medical Oncology 20050601 |
| Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine. | Anti-cancer drugs 20050601 |
| Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium. | Cancer 20050601 |
| Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer. | Investigational new drugs 20050601 |
| Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix. | Gynecologic oncology 20050601 |
| Cisplatin and gemcitabine induction chemotherapy followed by concurrent chemoradiotherapy or surgery for locally advanced non-small cell lung cancer. | Internal medicine journal 20050601 |
| Cost-minimisation analysis comparing gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of advanced non-small cell lung cancer in Italy. | Lung cancer (Amsterdam, Netherlands) 20050601 |
| Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer. | Gynecologic oncology 20050601 |
| Thymidine phosphorylase expression in tumour cells and tumour response to capecitabine plus docetaxel chemotherapy in non-small cell lung cancer. | Journal of clinical pathology 20050601 |
| Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma. | Melanoma research 20050601 |
| Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study. | American journal of clinical oncology 20050601 |
| A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma. | American journal of clinical oncology 20050601 |
| Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial. | The Lancet. Oncology 20050601 |
| Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. | Cancer research 20050601 |
| Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050601 |
| Pharmacokinetics of gemcitabine combined with trastuzumab in patients with advanced breast cancer. | Onkologie 20050601 |
| Localization of thymidine phosphorylase in breast cancer tissue. | Medical molecular morphology 20050601 |
| Combination chemotherapy for advanced pancreatic cancer--has its time finally come? | The Lancet. Oncology 20050601 |
| A monoclonal antibody as an effective therapeutic agent in breast cancer: trastuzumab. | Expert opinion on biological therapy 20050601 |
| Capecitabine: effective oral fluoropyrimidine chemotherapy. | Expert opinion on pharmacotherapy 20050601 |
| [Chemotherapy for advanced non-small cell lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050601 |
| [New anti-cancer agents--from cytotoxic systemic chemotherapy to target-based agents]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050601 |
| [Changes in tumor marker levels as a predictor of gemcitabine effect on patients with unresectable or recurrent pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050601 |
| [Chemotherapy of pancreatic carcinoma]. | Praxis 20050601 |
| [Comparative proteomics research on removing of large invasive plasmid pINV of Shigella flexneri 2a strain 2457T]. | Wei sheng wu xue bao = Acta microbiologica Sinica 20050601 |
| A randomized phase III study of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin as salvage chemotherapy followed by posttransplantation rituximab maintenance therapy versus observation for treatment of aggressive B-Cell and T-Cell non-Hodgkin's lymphoma. | Clinical lymphoma 20050601 |
| Gemcitabine in metastatic breast cancer. | Expert review of anticancer therapy 20050601 |
| Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer. | Clinical breast cancer 20050601 |
| Gemcitabine/capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes. | Clinical breast cancer 20050601 |
| Adverse interaction between capecitabine and warfarin resulting in altered coagulation parameters and bleeding: case report and review of the literature. | Journal of chemotherapy (Florence, Italy) 20050601 |
| Resistance to 9-beta-D-arabinofuranosyl-2-fluoroadenine due to reduced incorporation into DNA from competition by excess deoxyadenosine triphosphate: implications for different sensitivities to nucleoside analogues. | International journal of hematology 20050601 |
| Structure-activity relationships of dinucleotides: Potent and selective agonists of P2Y receptors. | Purinergic signalling 20050601 |
| Genotoxicity of the benzene metabolites para-benzoquinone and hydroquinone. | Chemico-biological interactions 20050530 |
| Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520 |
| Synthesis and biological evaluation of gemcitabine-lipid conjugate (NEO6002). | Bioorganic & medicinal chemistry letters 20050516 |
| The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog. | Cancer 20050515 |
| Functional epigenomics identifies genes frequently silenced in prostate cancer. | Cancer research 20050515 |
| Anti-tumor efficacy of the nucleoside analog 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl) cytosine (4'-thio-FAC) in human pancreatic and ovarian tumor xenograft models. | International journal of cancer 20050510 |
| Chemoradiation for ductal pancreatic carcinoma: principles of combining chemotherapy with radiation, definition of target volume and radiation dose. | JOP : Journal of the pancreas 20050510 |
| Preclinical relevance of dosing time for the therapeutic index of gemcitabine-cisplatin. | British journal of cancer 20050509 |
| beta-Selective synthesis of 2'-deoxy-5,6-dihydro-4-thiouridine, a precursor of the unstable nucleoside product of ionising radiation damage 2'-deoxy-5,6-dihydrocytidine. | Organic & biomolecular chemistry 20050507 |
| Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. | Nature 20050505 |
| Multiple enzyme activities of Escherichia coli MutT protein for sanitization of DNA and RNA precursor pools. | Biochemistry 20050503 |
| Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin. | Journal of cancer research and clinical oncology 20050501 |
| Combination treatment of CC531-lac-Z rat liver metastases by chemoembolization with pemetrexed disodium and gemcitabine. | Journal of cancer research and clinical oncology 20050501 |
| Treosulfan and gemcitabine. | Journal of cancer research and clinical oncology 20050501 |
| Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050501 |
| Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumors. | Cancer 20050501 |
| The effects of capecitabine in Raynaud's disease: a case report. | Annals of oncology : official journal of the European Society for Medical Oncology 20050501 |
| A mechanistic study of the permeation kinetics through biomembrane models: gemcitabine-phospholipid bilayer interaction. | Journal of colloid and interface science 20050501 |
| Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group. | Annals of oncology : official journal of the European Society for Medical Oncology 20050501 |
| Combination of nucleoside analogues in the treatment of chronic hepatitis B virus infection: lesson from experimental models. | The Journal of antimicrobial chemotherapy 20050501 |
| The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics. | Bulletin of mathematical biology 20050501 |
| Pharmacokinetics of gemcitabine in Chinese patients with non-small-cell lung cancer. | Journal of Zhejiang University. Science. B 20050501 |
| Bis(pivaloyloxymethyl) thymidine 5'-phosphate is a cell membrane-permeable precursor of thymidine 5'-phosphate in thymidine kinase deficient CCRF CEM cells. | Biochemical pharmacology 20050501 |
| Determining patient preferences for improved chemotoxicity during treatment for advanced bladder cancer. | European journal of cancer care 20050501 |
| Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050501 |
| Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2. | Gynecologic oncology 20050501 |
| RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050501 |
| Sensitivity to gemcitabine and its metabolizing enzymes in neuroblastoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050501 |
| Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20050501 |
| Deoxyribonucleoside kinases: two enzyme families catalyze the same reaction. | Trends in biochemical sciences 20050501 |
| Possible antitumor activity of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106) against an established gemcitabine (dFdCyd)-resistant human pancreatic cancer cell line. | Cancer science 20050501 |
| [A phase II study of combination chemotherapy with gemcitabine, 5-fluorouracil, and cisplatin for advanced pancreatic cancer]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20050501 |
| Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers. | European journal of cancer (Oxford, England : 1990) 20050501 |
| [Recent important insights into treatment of pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050501 |
| Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20050501 |
| The development of clinical research in CRC. | Annals of oncology : official journal of the European Society for Medical Oncology 20050501 |
| Adjuvant therapy in colon cancer: which treatment in 2005? | Annals of oncology : official journal of the European Society for Medical Oncology 20050501 |
| Results of a phase II open-label study of capecitabine in combination with irinotecan as first-line treatment for metastatic colorectal cancer. | Clinical colorectal cancer 20050501 |
| [Irinotecan combined with fluoropyrimidine in treatment for advanced/metastatic colorectal carcinoma]. | Zhonghua wai ke za zhi [Chinese journal of surgery] 20050501 |
| Upregulation of BNIP3 by 5-aza-2'-deoxycytidine sensitizes pancreatic cancer cells to hypoxia-mediated cell death. | Journal of gastroenterology 20050501 |
| Salvage, dose intense and high-dose chemotherapy for the treatment of poor prognosis or recurrent germ cell tumours. | Cancer treatment reviews 20050501 |
| On the biological significance of DNA methylation. | Biochemistry. Biokhimiia 20050501 |
| Albumin-bound nanoparticle paclitaxel. | Clinical advances in hematology & oncology : H&O 20050501 |
| Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Con: Pumpin' FU (or, avoiding that oral fixation). | Clinical advances in hematology & oncology : H&O 20050501 |
| In focus: advanced pancreatic cancer. | Clinical advances in hematology & oncology : H&O 20050501 |
| Chemotherapy for metastatic NSCLC: current status and future direction. | Nature clinical practice. Oncology 20050501 |
| De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine. | Oncogene 20050428 |
| Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma. | British journal of cancer 20050425 |
| [Simply convincing. New fixed combination for HIV therapy]. | MMW Fortschritte der Medizin 20050425 |
| Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050415 |
| [Enhancing effects of celecoxib on the growth inhibition of pancreatic carcinoma by gemcitabine treatment]. | Zhonghua yi xue za zhi 20050413 |
| Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases. | Current biology : CB 20050412 |
| In vitro genotoxic effects of the anticancer drug gemcitabine in human lymphocytes. | Mutation research 20050404 |
| Significant responses to platinum-based chemotherapy in renal medullary carcinoma. | Pediatric blood & cancer 20050401 |
| New infusion device for trans-tissue, sustained local delivery of anticancer agent to surgically resected tissue: potential use for suppression of local recurrence of pancreatic cancer. | Journal of biomedical materials research. Part B, Applied biomaterials 20050401 |
| Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050401 |
| Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050401 |
| Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies. | Cancer chemotherapy and pharmacology 20050401 |
| Role of USF1 in the differential expression of the human deoxycytidine kinase gene in acute myeloid leukemia. | Leukemia 20050401 |
| Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin. | Annals of oncology : official journal of the European Society for Medical Oncology 20050401 |
| Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer. | Anti-cancer drugs 20050401 |
| Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity. | Archives of biochemistry and biophysics 20050401 |
| Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study. | The Journal of urology 20050401 |
| Phase I study of combination chemotherapy with gemcitabine and irinotecan for non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20050401 |
| Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the 'polmone toscano group' (POLTO). | Lung cancer (Amsterdam, Netherlands) 20050401 |
| A pilot study of individualized maximum repeatable dose (iMRD), a new dose finding system, of weekly gemcitabine for patients with metastatic pancreas cancer. | Pancreas 20050401 |
| 5-fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer. | Pancreas 20050401 |
| Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin. | Gynecologic oncology 20050401 |
| Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050401 |
| A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancer. | American journal of clinical oncology 20050401 |
| A nonplatinum combination in metastatic transitional cell carcinoma. | American journal of clinical oncology 20050401 |
| A phase II study of gemcitabine in patients with relapsed or refractory low-grade non-Hodgkin lymphoma. | American journal of clinical oncology 20050401 |
| A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas: a Hoosier Oncology Group Study. | American journal of clinical oncology 20050401 |
| Weekly docetaxel in combination with capecitabine in patients with metastatic gastric cancer. | American journal of clinical oncology 20050401 |
| Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial. | American journal of clinical oncology 20050401 |
| Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050401 |
| [Antitumor effects of interferon-gamma-inducible protein 10 combined with gemcitabine]. | Ai zheng = Aizheng = Chinese journal of cancer 20050401 |
| Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer. | Breast cancer research and treatment 20050401 |
| Can cisplatin and infused 5-fluorouracil be replaced by oxaliplatin and capecitabine in the treatment of advanced oesophagogastric cancer? The REAL 2 trial. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20050401 |
| DNA hypermethylation of tumor-related genes in gastric carcinoma. | Journal of Korean medical science 20050401 |
| Reaction of glyoxal with 2'-deoxyguanosine, 2'-deoxyadenosine, 2'-deoxycytidine, cytidine, thymidine, and calf thymus DNA: identification of DNA adducts. | Chemical research in toxicology 20050401 |
| A phase I/II study comparing regimen schedules of gemcitabine and docetaxel in Japanese patients with stage IIIB/IV non-small cell lung cancer. | Japanese journal of clinical oncology 20050401 |
| Clinical experience with single-agent gemcitabine chemotherapy in patients with non-small-cell lung cancer in whom previous chemotherapy has failed. | Journal of the Chinese Medical Association : JCMA 20050401 |
| Benefits and drawbacks of the use of oral fluoropyrimidines as single-agent therapy in advanced colorectal cancer. | Clinical colorectal cancer 20050401 |
| Emtricitabine: new preparation. An antiretroviral very similar to lamivudine. | Prescrire international 20050401 |
| A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane. | Clinical breast cancer 20050401 |
| Current therapies for advanced colorectal cancer. | Oncology (Williston Park, N.Y.) 20050401 |
| LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice. | Neoplasia (New York, N.Y.) 20050401 |
| Docetaxel in the management of advanced pancreatic cancer. | Seminars in oncology 20050401 |
| Experience with docetaxel in the treatment of gastric cancer. | Seminars in oncology 20050401 |
| Docetaxel in the treatment of esophageal cancer. | Seminars in oncology 20050401 |
| Emtricitabine: a novel nucleoside reverse transcriptase inhibitor. | Drugs of today (Barcelona, Spain : 1998) 20050401 |
| Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma. | Clinical advances in hematology & oncology : H&O 20050401 |
| Which should be added to cisplatin for advanced non-small-cell lung cancer--vinorelbine or gemcitabine? | Nature clinical practice. Oncology 20050401 |
| Capecitabine in the treatment of colorectal cancer. | Future oncology (London, England) 20050401 |
| Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo. | British journal of cancer 20050328 |
| Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. | British journal of cancer 20050328 |
| Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients. | AIDS (London, England) 20050325 |
| Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial. | The Journal of infectious diseases 20050315 |
| Activity profiles of deoxynucleoside kinases and 5'-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs. | Biochemical pharmacology 20050315 |
| Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy. | International journal of radiation oncology, biology, physics 20050315 |
| Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study. | International journal of radiation oncology, biology, physics 20050315 |
| Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study. | British journal of cancer 20050314 |
| A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours. | British journal of cancer 20050314 |
| Base selectivity is impaired by mutants that perturb hydrogen bonding networks in the RB69 DNA polymerase active site. | Biochemistry 20050308 |
| Phosphorylation of Cytidine, Deoxycytidine, and Their Analog Monophosphates by Human UMP/CMP Kinase Is Differentially Regulated by ATP and Magnesium. | Molecular pharmacology 20050301 |
| Incorporation of OSI-7836 into DNA of Calu-6 and H460 xenograft tumors. | Cancer chemotherapy and pharmacology 20050301 |
| Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine. | Cancer 20050301 |
| Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma. | Cancer 20050301 |
| Chemotherapy options and new advances in malignant pleural mesothelioma. | Annals of oncology : official journal of the European Society for Medical Oncology 20050301 |
| Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050301 |
| Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient. | The Annals of pharmacotherapy 20050301 |
| Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study. | International journal of radiation oncology, biology, physics 20050301 |
| A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated. | Lung cancer (Amsterdam, Netherlands) 20050301 |
| First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule. | Lung cancer (Amsterdam, Netherlands) 20050301 |
| A phase II trial of weekly paclitaxel and gemctiabine infused at a constant rate in patients with advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20050301 |
| Phase II clinical trial of capecitabine in ovarian carcinoma recurrent 6-12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlates: a Gynecologic Oncology Group study. | Gynecologic oncology 20050301 |
| Sonography and CT of vasculitis during gemcitabine therapy. | AJR. American journal of roentgenology 20050301 |
| Innovations in antineoplastic therapy. | The Nursing clinics of North America 20050301 |
| Automated nanospray using chip-based emitters for the quantitative analysis of pharmaceutical compounds. | Journal of the American Society for Mass Spectrometry 20050301 |
| Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized phase III trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050301 |
| Preoperative gemcitabine for unresectable, solid pseudopapillary tumour of the pancreas. | The Lancet. Oncology 20050301 |
| Prolonged infusion of gemcitabine in advanced solid tumors: a phase-I-study. | Investigational new drugs 20050301 |
| Phase II evaluation of docetaxel-modulated capecitabine in previously treated patients with non-small cell lung cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050301 |
| Advances in colon cancer chemotheapy: nursing implications. | Home healthcare nurse 20050301 |
| Short communication: the efficacy of fixed dose rate infusion of gemcitabine combined with IFN-alpha2a in patients with advanced refractory renal cell carcinoma. | Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20050301 |
| Sequence dependent potentiation of gemcitabine by flavopiridol in human breast cancer cells. | Breast cancer research and treatment 20050301 |
| [Low-dose gemcitabine promotes radiation-induced apoptosis of human hepatoma cell line SMMC-7721]. | Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20050301 |
| [Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature]. | La Revue de medecine interne 20050301 |
| [Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues]. | Bulletin du cancer 20050301 |
| Clinical significance of hypoxia-inducible factor-1a messenger RNA expression in locally advanced non-small-cell lung cancer after platinum agent and gemcitabine chemotherapy followed by surgery. | Clinical lung cancer 20050301 |
| [Active combination immunochemotherapy with interferon-alpha, interleukin-2 and gemcitabine for four patients with metastatic renal cell carcinoma]. | Hinyokika kiyo. Acta urologica Japonica 20050301 |
| Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study. | British journal of cancer 20050227 |
| Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile. | British journal of cancer 20050227 |
| Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver. | World journal of gastroenterology 20050227 |
| Two-once-daily fixed-dose NRTI combinations for HIV. | The Medical letter on drugs and therapeutics 20050227 |
| Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a phase II Hoosier Oncology Group study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050220 |
| Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel. | AIDS (London, England) 20050218 |
| A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma. | Cancer 20050215 |
| Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts. | Cancer research 20050215 |
| A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinoma. | British journal of cancer 20050214 |
| Systemic therapy for colorectal cancer. | The New England journal of medicine 20050203 |
| Long-term disease-free survival effected by gemcitabine in a heavily pretreated patient with recurrent ovarian carcinoma. | Archives of gynecology and obstetrics 20050201 |
| Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma. | Cancer chemotherapy and pharmacology 20050201 |
| Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. | Annals of hematology 20050201 |
| Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter. | Cancer gene therapy 20050201 |
| Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. | Molecular biology and evolution 20050201 |
| Vascular administration of adenoviral vector soaked in absorbable gelatin sponge particles (GSP) prolongs the transgene expression in hepatocytes. | Cancer gene therapy 20050201 |
| Alternating weekly administration of paclitaxel and gemcitabine: a phase II study in patients with advanced non-small-cell lung cancer. | Cancer chemotherapy and pharmacology 20050201 |
| Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: a Phase II trial using a triplet combination. | Cancer 20050201 |
| A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma. | Cancer 20050201 |
| Innovative sequence of docetaxel-gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study. | Lung cancer (Amsterdam, Netherlands) 20050201 |
| Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II study. | Lung cancer (Amsterdam, Netherlands) 20050201 |
| Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium. | Oncology reports 20050201 |
| Induction of apoptosis in non-small lung carcinoma cell line (H1299) by combination of anti-asthma drugs with gemcitabine and cisplatin. | International journal of oncology 20050201 |
| Growth inhibition of human pancreatic cancer cells by human interferon-beta gene combined with gemcitabine. | International journal of molecular medicine 20050201 |
| Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease. | Gynecologic oncology 20050201 |
| A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma. | Gynecologic oncology 20050201 |
| A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC-IV (AGO-OVAR protocol OVAR-8). | Gynecologic oncology 20050201 |
| A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108. | Critical reviews in oncology/hematology 20050201 |
| Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer. | International journal of radiation oncology, biology, physics 20050201 |
| Activation-induced deaminase: controversies and open questions. | Trends in immunology 20050201 |
| Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20050201 |
| A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity. | Annals of oncology : official journal of the European Society for Medical Oncology 20050201 |
| The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20050201 |
| Specific 3'-terminal modification of DNA with a novel nucleoside analogue that allows a covalent linkage of a nuclear localization signal and enhancement of DNA stability. | Chembiochem : a European journal of chemical biology 20050201 |
| Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050201 |
| Phase I and pharmacokinetic study of oral irinotecan given once daily for 5 days every 3 weeks in combination with capecitabine in patients with solid tumors. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050201 |
| Gefitinib and cisplatin-based chemotherapy in non-small-cell lung cancer: simply a bad combination? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050201 |
| Health economic analysis of fluoropyrimidine-based therapies of colorectal cancer from the perspective of statutory sickness funds. | Zeitschrift fur Gastroenterologie 20050201 |
| Unusual liver abscess. | Internal medicine journal 20050201 |
| Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study. | Japanese journal of clinical oncology 20050201 |
| UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan. | Clinical cancer research : an official journal of the American Association for Cancer Research 20050201 |
| [Second-line treatment of malignant pleural mesothelioma with Pemetrexed (Alimta) -- a case report]. | Pneumologie (Stuttgart, Germany) 20050201 |
| Chemotherapy for advanced colorectal cancer: let's not forget how we got here (until we really can). | Seminars in oncology 20050201 |
| Oral capecitabine: bridging the Atlantic divide in colon cancer treatment. | Seminars in oncology 20050201 |
| Combined modality treatment for rectal cancer. | Seminars in oncology 20050201 |
| A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors. | International journal of clinical oncology 20050201 |
| Successful treatment of chemo-refractory pulmonary metastases of renal pelvic cancer by second-line chemotherapy including gemcitabine followed by salvage surgery. | International journal of urology : official journal of the Japanese Urological Association 20050201 |
| [The effect of gemcitabine on proliferation and telomerase activity of Tca8113 cell lines]. | Shanghai kou qiang yi xue = Shanghai journal of stomatology 20050201 |
| Collaboration begins on combined drug. | AIDS patient care and STDs 20050201 |
| Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance. | Prescrire international 20050201 |
| Palmar-plantar erythrodysesthesia. | Clinical journal of oncology nursing 20050201 |
| [A case of recurrence and systemic metastasis of oral cancer successfully treated with combination chemotherapy of cisplatin and gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050201 |
| [Local recurrence of pancreatic cancer successfully treated with gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050201 |
| [A case of unresectable advanced pancreatic tail cancer successfully treated with gemcitabine hydrochloride]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050201 |
| [Two-year survivor in response to gemcitabine-based chemotherapy for advanced pancreatic cancer with multiple lung metastases]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050201 |
| [Acute myocardial infarction induced by lung cancer chemotherapy after radiation of left lung]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050201 |
| [Digital ischaemia and gemcitabine. Two new cases]. | Journal des maladies vasculaires 20050201 |
| Role of gemcitabine in cancer therapy. | Future oncology (London, England) 20050201 |
| Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy. | British journal of cancer 20050131 |
| Glycosidic bond cleavage of pyrimidine nucleosides by low-energy electrons: a theoretical rationale. | Journal of the American Chemical Society 20050126 |
| Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice. | World journal of gastroenterology 20050121 |
| Size-expanded analogues of dG and dC: synthesis and pairing properties in DNA. | The Journal of organic chemistry 20050121 |
| Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma: is it safe? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050120 |
| Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations. | Blood 20050115 |
| Specific method for the determination of genomic DNA methylation by liquid chromatography-electrospray ionization tandem mass spectrometry. | Analytical chemistry 20050115 |
| Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway. | Oncogene 20050106 |
| The photochemistry of thymidylyl-(3'-5')-5-methyl-2'-deoxycytidine in aqueous solution. | Photochemistry and photobiology 20050101 |
| Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial. | Cancer 20050101 |
| Gemcitabine does not prevent acute rejection of the transplanted liver in rats. | Transplant international : official journal of the European Society for Organ Transplantation 20050101 |
| Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. | Gynecologic oncology 20050101 |
| Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer. | Gynecologic oncology 20050101 |
| In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study. | Annals of oncology : official journal of the European Society for Medical Oncology 20050101 |
| Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20050101 |
| Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20050101 |
| Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes. | Lung cancer (Amsterdam, Netherlands) 20050101 |
| Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20050101 |
| Impact of gemcitabine on the treatment of metastatic pancreatic cancer. | Journal of gastroenterology and hepatology 20050101 |
| Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial. | Anti-cancer drugs 20050101 |
| Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study. | Anti-cancer drugs 20050101 |
| In vitro chemosensitivity to gemcitabine, oxaliplatin and zoledronic acid predicts treatment response in metastatic gastric cancer. | Anti-cancer drugs 20050101 |
| Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer. | European journal of cancer (Oxford, England : 1990) 20050101 |
| Rituximab plus gemcitabine: a therapeutic option for elderly or frail patients with aggressive non Hodgkin's lymphoma? | Leukemia & lymphoma 20050101 |
| Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050101 |
| Symptom-free T4 lung cancer with bilateral pulmonary artery infiltration. | The Lancet. Oncology 20050101 |
| Combined modality therapy of gemcitabine and radiation. | The oncologist 20050101 |
| A new highly efficient photoreactive analogue of dCTP. Synthesis, characterization, and application in photoaffinity modification of DNA binding proteins. | Bioconjugate chemistry 20050101 |
| Synergistic antitumor activity of capecitabine in combination with irinotecan. | Clinical colorectal cancer 20050101 |
| Importance of preclinical investigations of the integration of capecitabine into polychemotherapy regimens. | Clinical colorectal cancer 20050101 |
| Biweekly administration of gemcitabine and vinorelbine as first line therapy in elderly advanced breast cancer. | Breast cancer research and treatment 20050101 |
| Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesions. | Urology 20050101 |
| Gemcitabine, ovarian cancer, and the elderly. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101 |
| [Second-line treatment for advanced non-small-cell lung cancers]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050101 |
| [The second-line chemotherapy for urological cancers]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050101 |
| [Cisplatin schedule in combination with gemcitabine in unresectable non-small cell lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050101 |
| [A patient with recurrent gallbladder cancer responding to chemotherapy with CDDP/CPT-11 and gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20050101 |
| Interstitial lung disease in lung cancer: separating disease progression from treatment effects. | Drug safety 20050101 |
| Results of a phase II trial of gemcitabine in patients with non-small-cell lung cancer and a performance status of 2. | Clinical lung cancer 20050101 |
| Clinical evaluation of gemcitabine in dogs with spontaneously occurring malignancies. | Journal of veterinary internal medicine 20050101 |
| Acyclic nucleosides bearing a furanyl scaffold. | Nucleosides, nucleotides & nucleic acids 20050101 |
| Meeting notes from ICAAC. Tenofovir + emtricitabine vs. AZT + 3TC. | AIDS clinical care 20050101 |
| [Experimental study on effect of chemotherapy combined ginsengnoside Rg3 in treating pulmonary carcinoma]. | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20050101 |
| Chemoresistance in non-small cell lung cancer. | Current medicinal chemistry. Anti-cancer agents 20050101 |
| Primary alveolar soft part sarcoma (ASPS) of the breast: report of a deceptive case with xanthomatous features confirmed by TFE3 immunohistochemistry and electron microscopy. | International journal of surgical pathology 20050101 |
| Nucleosomes in pancreatic cancer patients during radiochemotherapy. | Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 20050101 |
| Capecitabine: a review. | Clinical therapeutics 20050101 |
| Investigation of multiple binding sites on ribonuclease A using nano-electrospray ionization mass spectrometry. | Rapid communications in mass spectrometry : RCM 20050101 |
| A comprehensive update of the sequence and structure classification of kinases. | BMC structural biology 20050101 |
| Cloning of the koi herpesvirus (KHV) gene encoding thymidine kinase and its use for a highly sensitive PCR based diagnosis. | BMC microbiology 20050101 |
| Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: a multicenter phase II study. | Cancer investigation 20050101 |
| Low dose docosahexaenoic acid protects normal colonic epithelial cells from araC toxicity. | BMC pharmacology 20050101 |
| Pilot phase II study of gemcitabine and vinorelbine in patients with recurrent or refractory small cell lung cancer. | Lung 20050101 |
| Thymidine phosphorylase profiles in nonmalignant and malignant pancreatic tissue. Potential therapeutic role of capecitabine on tumoral and endothelial cells and tumor-infiltrating macrophages. | Immunopharmacology and immunotoxicology 20050101 |
| Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport. | Molecular pharmaceutics 20050101 |
| Gemcitabine and cisplatin in advanced nasopharyngeal carcinoma: a pilot study. | Cancer investigation 20050101 |
| Paclitaxel plus gemcitabine in advanced non-small cell lung cancer patients with low performance status. | Anticancer research 20050101 |
| Efficacy of gemcitabine--cisplatin treatment in stage IIIA ('bulky'N2), IIIB and IV non-small cell lung cancer. | Anticancer research 20050101 |
| Acute myopathy in a patient with lung adenocarcinoma treated with gemcitabine and docetaxel. | Anticancer research 20050101 |
| Gemcitabine monotherapy in recurrent ovarian cancer: from the bench to the clinic. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101 |
| Gemcitabine reverses platinum resistance in platinum-resistant ovarian and peritoneal carcinoma. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101 |
| Review of gemcitabine-based combinations for platinum-resistant ovarian cancer. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101 |
| Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101 |
| Epirubicin and gemcitabine as first-line treatment in malignant pleural mesothelioma. | Tumori 20050101 |
| A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. | BMC cancer 20050101 |
| Triplet chemotherapy with docetaxel, gemcitabine and liposomal doxorubicin, supported with subcutaneous amifostine and hemopoietic growth factors, in advanced non-small cell lung cancer. | Anticancer research 20050101 |
| Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study. | Neoplasma 20050101 |
| [Yersinia pseudotuberculosis nucleoside-kinase]. | Zhurnal mikrobiologii, epidemiologii, i immunobiologii 20050101 |
| [Gemcitabine plus cisplatin therapy in breast cancer refractory to anthracyclines, docetaxel and capecitabine]. | Voprosy onkologii 20050101 |
| APOBEC3G & HTLV-1: inhibition without deamination. | Retrovirology 20050101 |
| Cytotoxic effects of cladribine and tezacitabine toward HL-60. | Acta biochimica Polonica 20050101 |
| APOBEC3G targets human T-cell leukemia virus type 1. | Retrovirology 20050101 |
| Impact of different treatment methods on survival in advanced pancreatic cancer. | Medicina (Kaunas, Lithuania) 20050101 |
| Expression of human AID in yeast induces mutations in context similar to the context of somatic hypermutation at G-C pairs in immunoglobulin genes. | BMC immunology 20050101 |
| Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma. | BMC cancer 20050101 |
| The role of chemotherapy in cholangiocarcinoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20050101 |
| Safety of pulmonary administration of gemcitabine in rats. | Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 20050101 |
| Gemcitabine radiosensitization for rectal cancer: step forward or dance step? | Cancer journal (Sudbury, Mass.) 20050101 |
| Preoperative concomitant hyperfractionated radiotherapy and gemcitabine for locally advanced rectal cancers: a phase I-II trial. | Cancer journal (Sudbury, Mass.) 20050101 |
| Emtricitabine: a review of its use in the management of HIV infection. | Drugs 20050101 |
| Pseudomyxoma peritonei accompanied by intraductal papillary mucinous neoplasm of the pancreas. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20050101 |
| Major response and clinical benefit following third-line treatment for Bellini duct carcinoma. | Wiener klinische Wochenschrift 20050101 |
| Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer. | BMC cancer 20050101 |
| Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20050101 |
| Enhancement of gemcitabine-induced apoptosis by restoration of p53 function in human pancreatic tumors. | Oncology 20050101 |
| Phase II study of docetaxel and capecitabine in patients with metastatic or recurrent gastric cancer. | Oncology 20050101 |
| Final results of a prospective trial of a PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma. | Oncology 20050101 |
| A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer. | Oncology 20050101 |
| Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer. | Oncology 20050101 |
| Chemoradiotherapy for locally advanced pancreatic carcinoma in elderly patients. | Oncology 20050101 |
| Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study. | Oncology 20050101 |
| Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer. | Oncology 20050101 |
| Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer. | Oncology 20050101 |
| Drugs in development for hepatitis B. | Drugs 20050101 |
| Phase II study of an 'all-oral' regimen of capecitabine, idarubicin and cyclophosphamide for metastatic breast cancer--safety, efficacy and quality of life. | Oncology 20050101 |
| Genetic factors influencing pyrimidine-antagonist chemotherapy. | The pharmacogenomics journal 20050101 |
| The effect of gemcitabine in the treatment of rejection in experimental small intestine transplantation. | Folia biologica 20050101 |
| Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial. | Acta oncologica (Stockholm, Sweden) 20050101 |
| Capecitabine as third line therapy in patients with advanced colorectal cancer. | Acta oncologica (Stockholm, Sweden) 20050101 |
| Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer. | Prostate cancer and prostatic diseases 20050101 |
| Intravesical gemcitabine in recurrent superficial bladder carcinoma: preliminary results on ablative efficacy and tolerability. | Anticancer research 20050101 |
| Intravesical gemcitabine in superficial bladder cancer: a phase II safety, efficacy and pharmacokinetic study. | Anticancer research 20050101 |
| Pharmacokinetics and metabolism of irinotecan combined with capecitabine in patients with advanced colorectal cancer. | Anticancer research 20050101 |
| Phase II study of cisplatin-combined schedules as second-line chemotherapy in patients with non-small cell lung cancer. | Anticancer research 20050101 |
| Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study. | Anticancer research 20050101 |
| Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients. | Oncology 20050101 |
| Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities. | Oncology 20050101 |
| Circulating vascular endothelial growth factor and interferon-gamma-inducible protein-10 levels in pancreatic cancer during chemotherapy. | Anticancer research 20050101 |
| Activation of p38 mitogen-activated protein kinase is necessary for gemcitabine-induced cytotoxicity in human pancreatic cancer cells. | Anticancer research 20050101 |
| Hyperoxia-induced improvement of the in vitro response to gemcitabine in transitional cell carcinoma. | Anticancer research 20050101 |
| Bi-weekly administration of docetaxel and gemcitabine as first-line therapy for non-small cell lung cancer: a phase II study. | Anticancer research 20050101 |
| Bevacizumab as treatment for chemotherapy-resistant pancreatic cancer. | Anticancer research 20050101 |
| Mesothelioma: treatment and survival of a patient population and review of the literature. | Anticancer research 20050101 |
| Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice. | BMC cancer 20050101 |
| The use of capecitabine in cancer: management of the hand foot syndrome. | Acta medica Indonesiana 20050101 |
| Predictive value of heparanase expression in the palliative therapy of pancreatic cancer. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20050101 |
| A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinoma. | Oncology 20050101 |
| Comparative pharmacokinetics and metabolic pathway of gemcitabine during intravenous and intra-arterial delivery in unresectable pancreatic cancer patients. | Clinical pharmacokinetics 20050101 |
| Description of a PCR-based technique for DNA splicing and mutagenesis by producing 5' overhangs with run through stop DNA synthesis utilizing Ara-C. | BMC biotechnology 20050101 |
| The evolution of cancer research and drug discovery at Lilly Research Laboratories. | Advances in enzyme regulation 20050101 |
| Anticancer activity of a lectin-rich mistletoe extract injected intratumorally into human pancreatic cancer xenografts. | Anticancer research 20050101 |
| Phase I trial of an all-oral combination chemotherapy regimen: topotecan and capecitabine in solid tumor patients. | The Journal of oncology management : the official journal of the American College of Oncology Administrators 20050101 |
| Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer. | BMC cancer 20050101 |
| [New fixed combination for HIV therapy]. | Krankenpflege Journal 20050101 |
| [Healing for more patients]. | Krankenpflege Journal 20050101 |
| [Adjuvant therapy of colon cancer soon in tablet form]. | Krankenpflege Journal 20050101 |
| Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer. | BMC cancer 20050101 |
| Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide--AcSDKP. | BMC cancer 20050101 |
| Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure. | Cancer investigation 20050101 |
| Tezacitabine blocks tumor cells in G1 and S phases of the cell cycle and induces apoptotic cell death. | Acta poloniae pharmaceutica 20050101 |
| 518A2 melanoma cells are protected by G3139 and other antineoplastic agents against the cytotoxic effects of DTIC. | Oligonucleotides 20050101 |
| 12th International Conference on Human Retrovirology: HTLV and Related Retroviruses. | Retrovirology 20050101 |
| Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283]. | BMC cancer 20050101 |
| In vitro activity of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor (NRTI), against 215 HIV-1 isolates resistant to other NRTIs. | Antiviral chemistry & chemotherapy 20050101 |
| Synthesis of 2'-C-methyl-4'-thio ribonucleosides. | Nucleosides, nucleotides & nucleic acids 20050101 |
| The synthesis of diene-containing nucleoside phosphoramidites and their use in the labeling of oligonucleotides. | Nucleosides, nucleotides & nucleic acids 20050101 |
| Nm 283, an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine. | Nucleosides, nucleotides & nucleic acids 20050101 |
| Synthesis and in vitro anti-HCV activity of beta-D- and 1-2'-deoxy-2'-fluororibonucleosides. | Nucleosides, nucleotides & nucleic acids 20050101 |
| Epigenetics of cervical cancer. An overview and therapeutic perspectives. | Molecular cancer 20050101 |
| Gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer. | Medical oncology (Northwood, London, England) 20050101 |
| Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non-small cell lung cancer. | Medical oncology (Northwood, London, England) 20050101 |
| [Acute coronary syndrome in a patient previously treated with capecitabine and 5-fluorouracil]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20050101 |
| Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancer. | PharmacoEconomics 20050101 |
| [Thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in soft-tissue sarcoma versus capecitabine potential]. | Voprosy onkologii 20050101 |
| Paclitaxel, carboplatin and gemcitabine combination as induction chemotherapy for stage IIIA N2 bulky non-small cell lung cancer. | Oncology 20050101 |
| Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancer. | Oncology 20050101 |
| Efficacy of immuno-cell therapy in patients with advanced pancreatic cancer. | Anticancer research 20050101 |
| Same-day pegfilgrastim and chemotherapy. | Cancer investigation 20050101 |
| Myelopathy after radiation therapy and chemotherapy with capecitabine and gemcitabine. | Cancer investigation 20050101 |
| Paclitaxel decreases the accumulation of gemcitabine and its metabolites in human leukemia cells and primary cell cultures. | Anticancer research 20050101 |
| The role of taxanes in the management of bladder cancer. | The oncologist 20050101 |
| First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study. | BMC cancer 20050101 |
| Phase II study of gemcitabine and cisplatin in patients with advanced or metastatic bladder cancer: long-term follow-up of a 3-week regimen. | Oncology 20050101 |
| Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes. | Oncology 20050101 |
| A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer. | Oncology 20050101 |
| Pharmacokinetic study of intravesical gemcitabine in carcinoma in situ of the bladder refractory to bacillus Calmette-Guérin therapy. | Urologia internationalis 20050101 |
| Preoperative sequential short-term radiotherapy plus chemotherapy can induce complete remission in T3N2 rectal cancer. | Acta oncologica (Stockholm, Sweden) 20050101 |
| Mitomycin C and capecitabine combination (MiXe) in heavily pretreated metastatic breast cancer patients. A dose-finding study. | Anticancer research 20050101 |
| Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A. | Journal of proteome research 20050101 |
| Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101 |
| A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101 |
| Treatment of recurrent disease: randomized trials of monotherapy versus combination chemotherapy. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101 |
| Gemcitabine-taxane experience in the treatment of metastatic breast cancer. | Cancer treatment reviews 20050101 |
| Gemcitabine plus docetaxel: a new treatment option for anthracycline pretreated metastatic breast cancer patients? | Cancer treatment reviews 20050101 |
| What is the best schedule for administration of gemcitabine-taxane? | Cancer treatment reviews 20050101 |
| Gemcitabine in patients with ovarian cancer. | Cancer treatment reviews 20050101 |
| A dose escalation study of pegylated liposomal Doxorubicin (caelyx) in combination with capecitabine (xeloda) in patients with refractory solid tumors. | Oncology 20050101 |
| Molecular processes during fat cell development revealed by gene expression profiling and functional annotation. | Genome biology 20050101 |
| [Metastatic breast cancer: new chemotherapy regimens with taxanes]. | La Clinica terapeutica 20050101 |
| Chemotherapy for colorectal cancer. | Digestive surgery 20050101 |
| A phase II study of gemcitabine and cisplatin in patients with advanced hepatocellular carcinoma. | Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20050101 |
| SNPs analysis by use of protected oligonucleotide probes. | Nucleic acids symposium series (2004) 20050101 |
| Development of new N-unprotected phosphoramidite building blocks having a silyl-type linker. | Nucleic acids symposium series (2004) 20050101 |
| SNPs typing by base-discriminating fluorescence DNA probe. | Nucleic acids symposium series (2004) 20050101 |
| Comparison study on PCR amplification of modified DNA by using various kinds of polymerase and modified nucleoside triphosphates. | Nucleic acids symposium series (2004) 20050101 |
| Anti-HIV agents. Dueling nukes: AZT + 3TC vs. tenofovir + FTC. | TreatmentUpdate 20050101 |
| Synthesis of classical, three-carbon-bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates. | Journal of medicinal chemistry 20041230 |
| Improved detection limit for a direct determination of 8-hydroxy-2'-deoxyguanosine in untreated urine samples by capillary electrophoresis with optical detection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041225 |
| Polymerization of the triphosphates of AraC, 2',2'-difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase alpha and DNA primase. | Biochemical pharmacology 20041215 |
| Transcriptional regulation of the mouse deoxycytidine kinase: identification and functional analysis of nuclear protein binding sites at the proximal promoter. | Biochemical pharmacology 20041215 |
| Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041215 |
| Relative Bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cells. | Clinical cancer research : an official journal of the American Association for Cancer Research 20041215 |
| Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers. | British journal of cancer 20041213 |
| Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors. | British journal of cancer 20041213 |
| Human deoxycytidine kinase as a deoxyribonucleoside phosphorylase. | Journal of molecular biology 20041210 |
| Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs. | Journal of controlled release : official journal of the Controlled Release Society 20041210 |
| Endogenous formation of novel halogenated 2'-deoxycytidine. Hypohalous acid-mediated DNA modification at the site of inflammation. | The Journal of biological chemistry 20041203 |
| PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain. | Blood 20041201 |
| A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases. | Cancer chemotherapy and pharmacology 20041201 |
| Methylation profile of the promoter CpG islands of 14 'drug-resistance' genes in hepatocellular carcinoma. | World journal of gastroenterology 20041201 |
| Results of a Phase II study of carboplatin plus gemcitabine in patients with untreated extensive small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20041201 |
| Combination chemotherapy of gemcitabine and vinorelbine in patients with advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20041201 |
| Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99). | Annals of oncology : official journal of the European Society for Medical Oncology 20041201 |
| New once-daily HIV combination better tolerated. | Expert review of anti-infective therapy 20041201 |
| Determination of gemcitabine and its metabolite in human plasma using high-pressure liquid chromatography coupled with a diode array detector. | Acta pharmacologica Sinica 20041201 |
| Current chemotherapeutic treatment of malignant pleural mesothelioma. | Expert opinion on pharmacotherapy 20041201 |
| A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma. | American journal of clinical oncology 20041201 |
| Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma. | Gynecologic oncology 20041201 |
| Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20041201 |
| Caspase-3 drives apoptosis in pancreatic cancer cells after treatment with gemcitabine. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20041201 |
| Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice. | Clinical cancer research : an official journal of the American Association for Cancer Research 20041201 |
| Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? | International journal of radiation oncology, biology, physics 20041201 |
| A prospective randomized study of gemcitabine with doxifluridine versus paclitaxel with doxifluridine in concurrent chemoradiotherapy for locally advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20041201 |
| Chemoradiation may prolong survival of patients with non-bulky unresectable extrahepatic biliary carcinoma. A retrospective analysis. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20041201 |
| [Phase II-trial of tirapazamine in combination with cisplatin and gemcitabine in patients with advanced non-small-cell-lung-cancer (NSCLC)]. | Pneumologie (Stuttgart, Germany) 20041201 |
| [Efficacy of selective continuous transarterial infusion chemotherapy on advanced pancreatic cancer]. | Ai zheng = Aizheng = Chinese journal of cancer 20041201 |
| [Short-term efficacy of combined chemotherapy of gemcitabine and cisplatin on advanced hormone refractory prostate cancer]. | Ai zheng = Aizheng = Chinese journal of cancer 20041201 |
| The formation of substituted 1,N6-etheno-2'-deoxyadenosine and 1,N2-etheno-2'-deoxyguanosine adducts by cis-2-butene-1,4-dial, a reactive metabolite of furan. | Chemical research in toxicology 20041201 |
| Capecitabine: the new generation of fluoropyrimidines in colorectal cancer. | Expert review of anticancer therapy 20041201 |
| Phase I trial using weekly administration of gemcitabine and docetaxel in patients with advanced pancreatic carcinoma. | Chemotherapy 20041201 |
| [Significance of tissue thymidine phosphorylase and dihydropyrimidine dehydrogenase activities in ovarian cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20041201 |
| Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20041201 |
| A 3-week gemcitabine-cisplatin regimen for metastatic urothelial cancer. | The Canadian journal of urology 20041201 |
| FOLFOX-4 in pre-treated patients with advanced transitional cell carcinoma of the bladder. | Japanese journal of clinical oncology 20041201 |
| [New horizon of the treatment of pancreatic cancer]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20041201 |
| Gemcitabine and paclitaxel in metastatic breast cancer: a review. | Oncology (Williston Park, N.Y.) 20041201 |
| Gemcitabine and docetaxel in metastatic breast cancer. | Oncology (Williston Park, N.Y.) 20041201 |
| Gemcitabine and platinum-based chemotherapy in metastatic breast cancer. | Oncology (Williston Park, N.Y.) 20041201 |
| Adjuvant chemotherapy for early-stage breast cancer: the tAnGo trial. | Oncology (Williston Park, N.Y.) 20041201 |
| Neoadjuvant therapy with gemcitabine in breast cancer. | Oncology (Williston Park, N.Y.) 20041201 |
| Gemcitabine in combination with trastuzumab and/or platinum salts in breast cancer cells with HER2 overexpression. | Oncology (Williston Park, N.Y.) 20041201 |
| Integrating gemcitabine into breast cancer therapy. | Oncology (Williston Park, N.Y.) 20041201 |
| Gemcitabine/Irinotecan/celecoxib in pancreatic cancer. | Oncology (Williston Park, N.Y.) 20041201 |
| Irinotecan, epirubicin, and capecitabine in metastatic adenocarcinomas: preliminary results of a phase I study. | Oncology (Williston Park, N.Y.) 20041201 |
| Development of docetaxel in advanced non-small-cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20041201 |
| Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in Oncology. | Journal of chemotherapy (Florence, Italy) 20041201 |
| Recent updates in the clinical use of platinum compounds for the treatment of gastrointestinal cancers. | Seminars in oncology 20041201 |
| [Oxaliplatin plus capecitabine as a second line chemotherapy for patients with advanced gastric cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20041201 |
| Modelling and simulation in the development and use of anti-cancer agents: an underused tool? | Journal of pharmacokinetics and pharmacodynamics 20041201 |
| [Emtriva (emtricitabine, FTC)]. | Ugeskrift for laeger 20041129 |
| A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV. | AIDS (London, England) 20041119 |
| Phase I clinical trial of fixed-dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation. | Cancer 20041115 |
| Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma. | British journal of cancer 20041115 |
| Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer. | Cancer research 20041115 |
| Recurrent ovarian cancer: how important is it to treat to disease progression? | Clinical cancer research : an official journal of the American Association for Cancer Research 20041115 |
| Three-dimensional structure of the R115E mutant of T4-bacteriophage 2'-deoxycytidylate deaminase. | Biochemistry 20041102 |
| Pre-steady-state kinetic studies of the fidelity of human DNA polymerase mu. | Biochemistry 20041102 |
| Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine. | International journal of colorectal disease 20041101 |
| Gemcitabine and cisplatin chemotherapy is an active combination in the treatment of platinum-resistant ovarian and peritoneal carcinoma. | Investigational new drugs 20041101 |
| Selenoprotein P, as a predictor for evaluating gemcitabine resistance in human pancreatic cancer cells. | International journal of cancer 20041101 |
| Anabolism of amdoxovir: phosphorylation of dioxolane guanosine and its 5'-phosphates by mammalian phosphotransferases. | Biochemical pharmacology 20041101 |
| Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cells. | Oncology reports 20041101 |
| Targeting metastatic leiomyosarcoma by rapamycin plus gemcitabine: an intriguing clinical observation. | International journal of molecular medicine 20041101 |
| [Hypertrophic myopathy due to muscular metastasis of a signet cell adenocarcinoma of the bladder]. | La Revue de medecine interne 20041101 |
| Delayed-type hypersensitivity reaction with iscador M given in combination with cytotoxic chemotherapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041101 |
| Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma. | Bone marrow transplantation 20041101 |
| Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study. | European journal of cancer (Oxford, England : 1990) 20041101 |
| A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine. | Annals of oncology : official journal of the European Society for Medical Oncology 20041101 |
| Evaluation of gemcitabine in relapsed or refractory multiple myeloma. | Haematologica 20041101 |
| [Do combinations without cisplatin represent an alternative to conventional chemotherapy in non-small cell lung cancers?]. | Revue de pneumologie clinique 20041101 |
| Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines. | Molecular cancer therapeutics 20041101 |
| Activity of bortezomib in advanced non-small-cell lung cancer. | Clinical lung cancer 20041101 |
| Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program. | Breast cancer research and treatment 20041101 |
| Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients. | Pharmacogenetics 20041101 |
| [Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)]. | Ai zheng = Aizheng = Chinese journal of cancer 20041101 |
| [Initial results of intra-arterial chemotherapy for poorly differentiated bladder transitional cell carcinoma]. | Ai zheng = Aizheng = Chinese journal of cancer 20041101 |
| Clinical benefit of gemcitabine plus cisplatin 3-week regimen for patients with advanced non-small cell lung cancer: a prospective observational study. | Chinese medical journal 20041101 |
| [Clinical problems in gemcitabine treatment for unresectable pancreatic cancer in the elderly--a multicentric retrospective study of 53 cases]. | Gan to kagaku ryoho. Cancer & chemotherapy 20041101 |
| Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection. | AIDS research and human retroviruses 20041101 |
| Synthesis of [18F]Xeloda as a novel potential PET radiotracer for imaging enzymes in cancers. | Nuclear medicine and biology 20041101 |
| [Combination of phenylbutyrate and 5-Aza-2'deoxycytidine inhibits human Kasumi-1 xenograft tumor growth in nude mice]. | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20041101 |
| Pemetrexed in pancreatic cancer. | Oncology (Williston Park, N.Y.) 20041101 |
| Pemetrexed in transitional cell carcinoma of the urothelium. | Oncology (Williston Park, N.Y.) 20041101 |
| The promise of pharmacogenomics: gemcitabine and pemetrexed. | Oncology (Williston Park, N.Y.) 20041101 |
| Innovative therapy for patients with brain metastases: oral treatments. | Journal of chemotherapy (Florence, Italy) 20041101 |
| [Chemoradiation for pancreatic adenocarcinoma]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20041101 |
| [Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20041101 |
| [Cardiotoxicity of 5-fluorouracil]. | Bulletin du cancer 20041101 |
| Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum. | International journal of cancer 20041020 |
| Induction of apoptosis and tumor regression by vesicular stomatitis virus in the presence of gemcitabine in lung cancer. | International journal of cancer 20041020 |
| Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway. | European journal of pharmacology 20041019 |
| BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer. | Human molecular genetics 20041015 |
| Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). | Cancer 20041015 |
| A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20041015 |
| The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20041015 |
| A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer. | Cancer chemotherapy and pharmacology 20041001 |
| Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line. | Cancer chemotherapy and pharmacology 20041001 |
| Identification of the cytosolic carboxylesterase catalyzing the 5'-deoxy-5-fluorocytidine formation from capecitabine in human liver. | Drug metabolism and disposition: the biological fate of chemicals 20041001 |
| Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy. | Journal of clinical pharmacology 20041001 |
| Neoadjuvant induction chemotherapy followed by chemoradiation: a phase I trial of gemcitabine, cisplatin, and 5-fluorouracil for advanced pancreatic/gastrointestinal malignancies. | Surgical oncology clinics of North America 20041001 |
| The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX. | Surgical oncology clinics of North America 20041001 |
| New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections. | Current opinion in pharmacology 20041001 |
| Sequential chemotherapy with paclitaxel plus cisplatin, followed by vinorelbine, followed by gemcitabine in advanced non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 001). | Lung cancer (Amsterdam, Netherlands) 20041001 |
| Docetaxel and Gemcitabine administered on days 1 and 8 for metastatic non-small cell lung carcinoma (NSCLC): a phase II multicenter trial. | Lung cancer (Amsterdam, Netherlands) 20041001 |
| Gemcitabine and haemolytic-uraemic syndrome. | Annals of oncology : official journal of the European Society for Medical Oncology 20041001 |
| Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model. | The Journal of urology 20041001 |
| Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma. | Cancer 20041001 |
| Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20041001 |
| Therapeutic effects of gemcitabine on cutaneous manifestations in an Adamantiades-Behçet's disease-like mouse model. | Experimental dermatology 20041001 |
| [Advances in palliative and adjuvant chemotherapy of colon cancer]. | Deutsche medizinische Wochenschrift (1946) 20041001 |
| Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis. | The Annals of thoracic surgery 20041001 |
| Optimizing the management of HER2-negative metastatic breast cancer with capecitabine (Xeloda). | Seminars in oncology 20041001 |
| Future options with capecitabine (Xeloda) in (neo)adjuvant treatment of breast cancer. | Seminars in oncology 20041001 |
| Synchronous solitary metastasis of transitional cell carcinoma of the bladder to the testis. | Urology 20041001 |
| Antineoplastic effect of gemcitabine in an animal model of superficial bladder cancer. | Urology 20041001 |
| Survival benefit with capecitabine/docetaxel versus docetaxel alone: analysis of therapy in a randomized phase III trial. | Clinical breast cancer 20041001 |
| Final results of a phase II clinical trial of weekly docetaxel in combination with capecitabine in anthracycline-pretreated metastatic breast cancer. | Clinical breast cancer 20041001 |
| [Histoculture drug response assay for solitary fibrous tumor--a case report]. | Gan to kagaku ryoho. Cancer & chemotherapy 20041001 |
| [A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with gemcitabine hydrochloride, 5-FU, CDDP and administration of tegafur/uracil]. | Gan to kagaku ryoho. Cancer & chemotherapy 20041001 |
| [Multimodality therapy for diffuse malignant pleural mesothelioma]. | Kyobu geka. The Japanese journal of thoracic surgery 20041001 |
| [Peritoneal dissemination of ovarian cancer and tumor angiogenesis]. | Nihon rinsho. Japanese journal of clinical medicine 20041001 |
| [A case of successful treatment with combined 5-fluorouracil, adriamycin, cisplatin (FAP) therapy followed by Gemcitabine, UFT therapy and intra-arterial FAP therapy for unresectable advanced gallbladder cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20041001 |
| [Intra-arterial cellular immunochemotherapy for unresectable pancreatic cancer with liver metastasis]. | Gan to kagaku ryoho. Cancer & chemotherapy 20041001 |
| [The QOL of the patient with advanced pancreatic carcinoma was changed for the better with combination therapy consisting of arterial chemotherapy and injection of interferon]. | Gan to kagaku ryoho. Cancer & chemotherapy 20041001 |
| [A case of unresectable pancreatic cancer showing tumor dormancy treated with gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20041001 |
| Deoxyribonucleoside kinases in mitochondrial DNA depletion. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenografts. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Selective increase of dATP pools upon activation of deoxycytidine kinase in lymphocytes: implications in apoptosis. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Fluorescence studies of substrate binding to human recombinant deoxycytidine kinase. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR; in relation to enzyme activity. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Immunocytochemical detection of deoxycytidine kinase in pediatric malignancies in relation to in vitro cytarabine sensitivity. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Stimulation of deoxycytidine kinase results in prolonged maintenance of the enzyme activity. | Nucleosides, nucleotides & nucleic acids 20041001 |
| New evidences for a regulation of deoxycytidine kinase activity by reversible phosphorylation. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Effects of 2-chloro-2'-deoxyadenosine on the cell cycle in the human leukemia EHEB cell line. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Increased cytotoxicity of 2',2'-difluoro-2'-deoxycytidine in human leukemic cell-lines after a preincubation with cyclopentenyl cytosine. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell lines. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells. | Nucleosides, nucleotides & nucleic acids 20041001 |
| Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer. | World journal of surgery 20041001 |
| Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experience. | American journal of clinical oncology 20041001 |
| Anthracycline vs nonanthracycline adjuvant therapy for breast cancer. | Oncology (Williston Park, N.Y.) 20041001 |
| Skin discoloration with FTC. | AIDS patient care and STDs 20041001 |
| Costs of treatment of colorectal cancer in different settings in Germany. | The European journal of health economics : HEPAC : health economics in prevention and care 20041001 |
| Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity. | Cancer letters 20040930 |
| Simple determination of capecitabine and its metabolites by liquid chromatography with ultraviolet detection in a single injection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040925 |
| Investigation of the pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in human plasma by liquid chromatography. | Analytical biochemistry 20040915 |
| Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040915 |
| Microregional effects of gemcitabine in HCT-116 xenografts. | Cancer research 20040915 |
| A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040915 |
| Intracellular pharmacology of emtricitabine and tenofovir. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040915 |
| A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer. | British journal of cancer 20040913 |
| Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides. | British journal of cancer 20040913 |
| Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine. | European journal of pharmacology 20040913 |
| O-selectivity and utility of phosphorylation mediated by phosphite triester intermediates in the N-unprotected phosphoramidite method. | Journal of the American Chemical Society 20040908 |
| Translesion synthesis past equine estrogen-derived 2'-deoxycytidine DNA adducts by human DNA polymerases eta and kappa. | Biochemistry 20040907 |
| Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice. | Journal of cancer research and clinical oncology 20040901 |
| A short core promoter drives expression of the ALF transcription factor in reproductive tissues of male and female mice. | Biology of reproduction 20040901 |
| Cytotoxic chemotherapy for metastatic renal cell carcinoma. | Der Urologe. Ausg. A 20040901 |
| HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support. | Bone marrow transplantation 20040901 |
| Structural basis for the dual coding potential of 8-oxoguanosine by a high-fidelity DNA polymerase. | The EMBO journal 20040901 |
| Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC). | Lung cancer (Amsterdam, Netherlands) 20040901 |
| Phase II study to investigate the ablative efficacy of intravesical administration of gemcitabine in intermediate-risk superficial bladder cancer (SBC). | European urology 20040901 |
| New approaches for pancreatic cancer in Japan. | Cancer chemotherapy and pharmacology 20040901 |
| Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. | Annals of oncology : official journal of the European Society for Medical Oncology 20040901 |
| A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20040901 |
| A Phase II trial of gemcitabine for metastatic neuroendocrine tumors. | Cancer 20040901 |
| Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040901 |
| Quantitation of normal and formaldehyde-modified deoxynucleosides by high-performance liquid chromatography/UV detection. | Biomedical chromatography : BMC 20040901 |
| A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours. | European journal of cancer (Oxford, England : 1990) 20040901 |
| Pilot study of outpatient paclitaxel, carboplatin and gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancer. | Gynecologic oncology 20040901 |
| Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group. | Urology 20040901 |
| Analysis of treatment for small cell cancer of the bladder and report of three cases. | Urology 20040901 |
| Thymidylate synthase: a critical target in cancer therapy? | Frontiers in bioscience : a journal and virtual library 20040901 |
| [Adjuvant chemotherapy for unresectable locally advanced pancreatic cancer in light of its characteristics]. | Gan to kagaku ryoho. Cancer & chemotherapy 20040901 |
| [Clinical study of gemcitabine therapy for recurrent or metastatic pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20040901 |
| [Synergistic effects of paclitaxel and gemcitabine on androgen-independent prostate cancer]. | Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20040901 |
| Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphoma. | Clinical lymphoma 20040901 |
| Gemcitabine and cisplatin combination chemotherapy in intrahepatic cholangiocarcinoma as second-line treatment: report of four cases. | Japanese journal of clinical oncology 20040901 |
| Determinants of sensitivity and resistance to gemcitabine: the roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer. | Cancer science 20040901 |
| Gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II California cancer consortium trial. | Clinical lung cancer 20040901 |
| Chemoradiation with gemcitabine for cervical cancer in patients with renal failure. | Anti-cancer drugs 20040901 |
| Peripheral neuropathy associated with capecitabine. | Anti-cancer drugs 20040901 |
| Non-toxic and short treatment with gemcitabine inhibits in vitro migration of HT-1080 cells. | Anti-cancer drugs 20040901 |
| [The synergistic effects of paclitaxel and gemcitabine on prostate cancer cell line PC-3]. | Zhonghua nan ke xue = National journal of andrology 20040901 |
| Treatment of advanced non-small-cell lung cancer in special populations. | Oncology (Williston Park, N.Y.) 20040901 |
| Synthesis, physicochemical and pharmacokinetic studies of potential prodrugs of beta-L-2'-deoxycytidine, a selective and specific anti-HBV agent. | Antiviral chemistry & chemotherapy 20040901 |
| [Evaluation of advanced non-small-cell lung cancer (ANSCLC) chemotherapy in routine practice]. | Revue des maladies respiratoires 20040901 |
| [Capecitabine combined with TACE for advanced liver cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20040901 |
| Optimization of the schedule of gemcitabine-cisplatin combination as induction regimen for patients with biopsy-proven stage IIIa N2 - stage IIIb non-small-cell lung cancer: a prospective phase-II study. | Bulletin du cancer 20040901 |
| Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial. | British journal of cancer 20040831 |
| Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer. | British journal of cancer 20040831 |
| A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer. | British journal of cancer 20040831 |
| Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer. | British journal of cancer 20040816 |
| A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer. | British journal of cancer 20040816 |
| Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulation. | British journal of cancer 20040816 |
| Detection of an alternatively spliced form of deoxycytidine kinase mRNA in the 2'-2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000. | Biochemical pharmacology 20040815 |
| Enantioselectivity of ribonucleotide reductase: a first study using stereoisomers of pyrimidine 2'-azido-2'-deoxynucleosides. | Biochemical pharmacology 20040815 |
| The biological and therapeutic importance of gastrin gene expression in pancreatic adenocarcinomas. | Cancer research 20040815 |
| Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040815 |
| Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040815 |
| FDA approves two combo brand-name AIDS drugs. | Medicine & health (1997) 20040809 |
| Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study. | British journal of cancer 20040802 |
| Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients. | British journal of cancer 20040802 |
| Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid. | Carcinogenesis 20040801 |
| Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC). | Investigational new drugs 20040801 |
| In vitro assessment of nucleoside analogs in multiple myeloma. | Cancer chemotherapy and pharmacology 20040801 |
| Mechanism for induction of hydroxyurea resistance and loss of latent EBV genome in hydroxyurea-treated Burkitt's lymphoma cell line Raji. | Journal of medical virology 20040801 |
| DNA methylation control of tissue polarity and cellular differentiation in the mammary epithelium. | Experimental cell research 20040801 |
| A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20040801 |
| Phase I pharmacokinetic study of a single intravesical instillation of gemcitabine administered immediately after transurethral resection plus multiple random biopsies in patients with superficial bladder cancer. | The Journal of urology 20040801 |
| Synergistic antitumor activity of troxacitabine and camptothecin in selected human cancer cell lines. | Molecular pharmacology 20040801 |
| Severe disabling sensory-motor polyneuropathy during oxaliplatin-based chemotherapy. | Anti-cancer drugs 20040801 |
| Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. | Cancer 20040801 |
| Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site. | Cancer 20040801 |
| Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine. | International journal of radiation oncology, biology, physics 20040801 |
| A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment. | Annals of oncology : official journal of the European Society for Medical Oncology 20040801 |
| Gemcitabine-associated scleroderma-like changes of the lower extremities. | Journal of the American Academy of Dermatology 20040801 |
| Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040801 |
| Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. | Cancer research 20040801 |
| Effect of capecitabine on mean corpuscular volume in patients with metastatic breast cancer. | American journal of clinical oncology 20040801 |
| Gemcitabine combined with epirubicin in the treatment of patients with locally advanced or metastatic breast cancer: a phase II study. | American journal of clinical oncology 20040801 |
| Increased expression of pro-inflammatory cytokines as a cause of lung toxicity after combined treatment with gemcitabine and thoracic irradiation. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20040801 |
| Brain metastases of epithelial ovarian carcinoma responding to cisplatin and gemcitabine combination chemotherapy: a case report and review of the literature. | Gynecologic oncology 20040801 |
| Triplet combination of gemcitabine, carboplatin, and paclitaxel in previously treated, relapsed ovarian and peritoneal carcinoma: an experience in Taiwan. | Gynecologic oncology 20040801 |
| Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040801 |
| Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040801 |
| Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer. | Surgery 20040801 |
| [Predictive value of drug resistance-related genes expression in neoadjuvant chemotherapy in patients with non-small cell lung cancer of stage III]. | Ai zheng = Aizheng = Chinese journal of cancer 20040801 |
| Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane. | Journal of Korean medical science 20040801 |
| Synthesis and liquid chromatography/tandem mass spectrometric characterization of the adducts of bisphenol A o-quinone with glutathione and nucleotide monophosphates. | Chemical research in toxicology 20040801 |
| Retroviral IFN-alpha gene transfer combined with gemcitabine acts synergistically via cell cycle alteration in human pancreatic carcinoma cells implanted orthotopically in nude mice. | Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20040801 |
| Simultaneous determination of capecitabine and its metabolite 5-fluorouracil by column switching and liquid chromatographic/tandem mass spectrometry. | Journal of mass spectrometry : JMS 20040801 |
| [Role of postoperative adjuvant chemotherapy with gemcitabine for pancreatic cancer: feasibility and anti-tumor effect]. | Gan to kagaku ryoho. Cancer & chemotherapy 20040801 |
| Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib. | British journal of cancer 20040801 |
| Gemcitabine plus vinorelbine chemotherapy regimens: a pharmacokinetic study of alternate administration sequences. | Pharmacy world & science : PWS 20040801 |
| [Lamivudine therapy for chronic hepatitis B]. | Nihon rinsho. Japanese journal of clinical medicine 20040801 |
| Coming to grips with hand-foot syndrome. Insights from clinical trials evaluating capecitabine. | Oncology (Williston Park, N.Y.) 20040801 |
| Current and future strategies for treating metastatic pancreatic cancer. | Clinical advances in hematology & oncology : H&O 20040801 |
| Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine. | Journal of computational chemistry 20040730 |
| Mechanisms of cross-resistance between nucleoside analogues and vincristine or daunorubicin in leukemic cells. | Biochemical and biophysical research communications 20040730 |
| Overexpressed decorin in pancreatic cancer: potential tumor growth inhibition and attenuation of chemotherapeutic action. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040715 |
| Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial. | JAMA 20040714 |
| Synthesis of the phosphoramidite derivatives of 2'-deoxy-2'-C-alpha-methylcytidine and 2'-deoxy-2'-C-alpha-hydroxymethylcytidine: analogues for chemical dissection of RNA's 2'-hydroxyl group. | The Journal of organic chemistry 20040709 |
| Effect of LY293111 in combination with gemcitabine in colonic cancer. | Cancer letters 20040708 |
| Regulation of the human secretin gene is controlled by the combined effects of CpG methylation, Sp1/Sp3 ratio, and the E-box element. | Molecular endocrinology (Baltimore, Md.) 20040701 |
| Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma. | Journal of cancer research and clinical oncology 20040701 |
| Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells. | Biochemical pharmacology 20040701 |
| Uracil in DNA, determined by an improved assay, is increased when deoxynucleosides are added to folate-deficient cultured human lymphocytes. | Analytical biochemistry 20040701 |
| Positive interactive radiosensitisation in vitro with the combination of two nucleoside analogues, (E)-2'-deoxy-2'-(fluoromethylene) cytidine and iododeoxyuridine. | European journal of cancer (Oxford, England : 1990) 20040701 |
| Integrating concurrent navelbine and cisplatin to hyperfractionated radiotherapy in locally advanced non-small cell lung cancer patients treated with induction and consolidation chemotherapy: feasibility and activity results. | Lung cancer (Amsterdam, Netherlands) 20040701 |
| Cellular response of X-ray sensitive hamster mutant cell lines to gemcitabine, cisplatin and 5-fluorouracil. | Oncology reports 20040701 |
| Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemia. | International journal of molecular medicine 20040701 |
| Bioactivation of capecitabine in human liver: involvement of the cytosolic enzyme on 5'-deoxy-5-fluorocytidine formation. | Drug metabolism and disposition: the biological fate of chemicals 20040701 |
| Gemcitabine and mitomycin C in advanced pancreatic cancer: a single-institution experience. | Anti-cancer drugs 20040701 |
| Non-allergic nature of docetaxel-induced acute hypersensitivity reactions. | Anti-cancer drugs 20040701 |
| Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer. | The Annals of thoracic surgery 20040701 |
| The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma. | The Annals of thoracic surgery 20040701 |
| Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040701 |
| Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040701 |
| Our experience with 23 consecutive patients on gemcitabine/carboplatin chemotherapy for treatment of metastasized transitional cell carcinoma of the urothelium. | International journal of urology : official journal of the Japanese Urological Association 20040701 |
| Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy. | Urology 20040701 |
| Cisplatin and gemcitabine in patients with metastatic cervical cancer. | Gan to kagaku ryoho. Cancer & chemotherapy 20040701 |
| Efficacy of adjuvant capecitabine compared with bolus 5-fluorouracil/leucovorin regimen in dukes C colon cancer: results from the X-ACT trial. | Clinical colorectal cancer 20040701 |
| New investigative regimens and cytotoxic agents in thoracic cancers: gemcitabine and pemetrexed. | Oncology (Williston Park, N.Y.) 20040701 |
| Carboplatin/gemcitabine combination in advanced NSCLC. | Oncology (Williston Park, N.Y.) 20040701 |
| Gemcitabine-containing regimens vs others in first-line treatment of NSCLC. | Oncology (Williston Park, N.Y.) 20040701 |
| Chemoradiation in NSCLC: focus on the role of gemcitabine. | Oncology (Williston Park, N.Y.) 20040701 |
| Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy. | Japanese journal of clinical oncology 20040701 |
| [Intraoperative 125I brachytherapy combined with chemotherapy for pancreatic cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20040701 |
| Gemcitabine, pemetrexed, and novel agents in the treatment of thoracic cancer. Selected presentations from the 10th World Congress on Lung Cancer. Vancouver, Canada. | Oncology (Williston Park, N.Y.) 20040701 |
| Determination of the deoxycytidine kinase activity in cell homogenates with a non-radiochemical assay using reversed-phase high performance liquid chromatography; Identification of a novel metabolite of 2-chlorodeoxyadenosine. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040615 |
| Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination of gemcitabine and bleomycin: a report of the German Hodgkin's Lymphoma Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615 |
| Capecitabine-induced abnormalities in thyroid function tests. | The American journal of medicine 20040615 |
| Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615 |
| Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615 |
| Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615 |
| Gemcitabine-associated thrombotic microangiopathy. | Cancer 20040615 |
| Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040615 |
| Modulation of the 5'-deoxyribose-5-phosphate lyase and DNA synthesis activities of mammalian DNA polymerase beta by apurinic/apyrimidinic endonuclease 1. | The Journal of biological chemistry 20040611 |
| Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabine. | Cancer chemotherapy and pharmacology 20040601 |
| MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma. | Cancer gene therapy 20040601 |
| Emtricitabine: a once-daily nucleoside reverse transcriptase inhibitor. | The Annals of pharmacotherapy 20040601 |
| Synergistic antitumor activity by combined treatment with gemcitabine and antisense oligodeoxynucleotide targeting clusterin gene in an intravesical administration model against human bladder cancer kotcc-1 cells. | The Journal of urology 20040601 |
| Experimental study on the toxicity and the local and systemic tolerability of gemcitabine after topical treatment of the rabbit bladder. | Oncology reports 20040601 |
| High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study. | Lung cancer (Amsterdam, Netherlands) 20040601 |
| Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. | International journal of radiation oncology, biology, physics 20040601 |
| Systemic chemotherapy for patients with bladder cancer--current controversies and future directions. | Cancer treatment reviews 20040601 |
| Activation induced deaminase: the importance of being specific. | Trends in genetics : TIG 20040601 |
| Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer. | British journal of cancer 20040601 |
| Complete remission of metastatic pancreatic cancer with cardiac involvement after gemcitabine, oxaliplatin and 46-h infusion of 5-fluorouracil/leucovorin. | Journal of gastroenterology and hepatology 20040601 |
| An immediate hemolytic reaction induced by repeated administration of oxaliplatin. | Transfusion 20040601 |
| Weekly combination chemotherapy with docetaxel and gemcitabine as first-line treatment for elderly patients and patients with poor performance status who have extensive-stage small cell lung carcinoma: a Minnie Pearl Cancer Research Network phase II trial. | Cancer 20040601 |
| Gemcitabine (Gemzar) in non-small cell lung cancer. | Expert review of anticancer therapy 20040601 |
| [Bronchiolitis obliterans organizing pneumonia induced by chemotherapy]. | Archivos de bronconeumologia 20040601 |
| Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models. | Anti-cancer drugs 20040601 |
| Phase II study of capecitabine in patients with fluorouracil-resistant metastatic colorectal carcinoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040601 |
| XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040601 |
| Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040601 |
| Gemcitabine in patients with solid tumors and renal impairment: a pharmacokinetic phase I study. | American journal of clinical oncology 20040601 |
| An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines. | Cancer research 20040601 |
| A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. | Cancer research 20040601 |
| Noninvasive measurements of capecitabine metabolism in bladder tumors overexpressing thymidine phosphorylase by fluorine-19 magnetic resonance spectroscopy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040601 |
| 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C-->T and 1298A-->C mutations are associated with DNA hypomethylation. | Journal of medical genetics 20040601 |
| Expression of the pyrG gene determines the pool sizes of CTP and dCTP in Lactococcus lactis. | European journal of biochemistry 20040601 |
| [Development and characterization of a gemcitabine-resistant variant of human lung adenocarcinoma cell line A549]. | Ai zheng = Aizheng = Chinese journal of cancer 20040601 |
| siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity. | Journal of the American College of Surgeons 20040601 |
| Survival following the documentation of platinum and taxane resistance in ovarian cancer: a single institution experience involving multiple phase 2 clinical trials. | Gynecologic oncology 20040601 |
| Surgical resection deteriorates gemcitabine-induced leukopenia in pancreatic cancer. | International journal of clinical oncology 20040601 |
| Advanced pancreatic carcinoma showing a complete response to arterial infusion chemotherapy. | International journal of clinical oncology 20040601 |
| [Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years]. | Gan to kagaku ryoho. Cancer & chemotherapy 20040601 |
| [A case of advanced pancreatic cancer with remarkable response to thalidomide, celecoxib and gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20040601 |
| Pilot study of fixed-infusion rate gemcitabine with Cisplatin and dexamethasone in patients with relapsed or refractory lymphoma. | Clinical lymphoma 20040601 |
| Gemcitabine plus carboplatin combination therapy as second-line treatment in patients with relapsed breast cancer. | Clinical breast cancer 20040601 |
| Phase II study of trastuzumab plus gemcitabine in chemotherapy-pretreated patients with metastatic breast cancer. | Clinical breast cancer 20040601 |
| [New therapy options in colorectal carcinoma]. | Therapeutische Umschau. Revue therapeutique 20040601 |
| Irinotecan in advanced lung cancer: focus on North American trials. | Oncology (Williston Park, N.Y.) 20040601 |
| [Chemotherapy of the elderly patients with advanced non-small cell lung cancer]. | Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20040601 |
| Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas. | Chemotherapy 20040601 |
| [Single-agent Xeloda in the treatment of recurrent and metastatic breast cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20040601 |
| Gemcitabine and oxaliplatinum: an effective regimen in a patient with progressive refractory mantle cell lymphoma. | Leukemia & lymphoma 20040601 |
| Nail changes during docetaxel containing combination chemotherapy. | The Korean journal of internal medicine 20040601 |
| [Recent progress in anti-HIM-1 research]. | Uirusu 20040601 |
| Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK. How important is quality of life? | The European journal of health economics : HEPAC : health economics in prevention and care 20040601 |
| Second-line chemotherapy and beyond for non-small-cell lung cancer. | Clinical advances in hematology & oncology : H&O 20040601 |
| Structural, kinetic, and mutational studies of the zinc ion environment in tetrameric cytidine deaminase. | Biochemistry 20040525 |
| [New approaches in the treatment of hepatitis B]. | Deutsche medizinische Wochenschrift (1946) 20040521 |
| Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer. | Journal of the National Cancer Institute 20040519 |
| Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia. | British journal of cancer 20040517 |
| Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy-resistant advanced renal cell carcinoma: final results of a single-institution Phase II study. | Cancer 20040515 |
| Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. | Oncogene 20040513 |
| Multidisciplinary management of lung cancer. | The New England journal of medicine 20040506 |
| Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract. | British journal of cancer 20040504 |
| Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer. | British journal of cancer 20040504 |
| A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma. | British journal of cancer 20040504 |
| Tumor lysis syndrome following a single dose of capecitabine. | The Annals of pharmacotherapy 20040501 |
| Treatment with alemtuzumab in a case of refractory primary cutaneous CD30-negative CD8-positive cytotoxic large T-cell lymphoma. | European journal of haematology 20040501 |
| Novel therapies for pancreatic adenocarcinoma. | Current oncology reports 20040501 |
| Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines. | Oncology reports 20040501 |
| Chemoembolization of rat liver metastasis with microspheres and gemcitabine followed by evaluation of tumor cell load by chemiluminescence. | Oncology reports 20040501 |
| Phase II study of alternating chemotherapy regimens for advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20040501 |
| Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807). | Lung cancer (Amsterdam, Netherlands) 20040501 |
| A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer. | Gynecologic oncology 20040501 |
| Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer. | Gynecologic oncology 20040501 |
| Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience. | Annals of oncology : official journal of the European Society for Medical Oncology 20040501 |
| Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors. | Annals of oncology : official journal of the European Society for Medical Oncology 20040501 |
| Gemcitabine-related radiation recall preferentially involves internal tissue and organs. | Cancer 20040501 |
| Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040501 |
| Comparison of zero- and second-order derivative spectrophotometric and HPLC methods for the determination of gemcitabine in human plasma. | Farmaco (Societa chimica italiana : 1989) 20040501 |
| A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine. | Cancer chemotherapy and pharmacology 20040501 |
| Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040501 |
| Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: results of a phase I/II Trial. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040501 |
| Enzyme expression profiles suggest the novel tumor-activated fluoropyrimidine carbamate capecitabine (Xeloda) might be effective against papillary thyroid cancers of children and young adults. | Cancer chemotherapy and pharmacology 20040501 |
| 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells. | The journal of gene medicine 20040501 |
| Emerging drugs in pancreatic cancer. | Expert opinion on emerging drugs 20040501 |
| Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. | Annals of human genetics 20040501 |
| [Mechanistic study of radiosensitization by gemcitabine on human squamous carcinoma cell line of the cervix]. | Zhonghua fu chan ke za zhi 20040501 |
| Emtricitabine (FTC) for the treatment of HIV infection. | International journal of clinical practice 20040501 |
| Phase II trial of capecitabine/irinotecan and capecitabine/oxaliplatin in advanced gastrointestinal cancers. | Clinical colorectal cancer 20040501 |
| [Concurrent chemoradiotherapy using full-dose gemcitabine for patients with unresectable pancreatic cancer]. | Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica 20040501 |
| Progress in the development of novel treatments for colorectal cancer. | Oncology (Williston Park, N.Y.) 20040501 |
| Current strategies in previously untreated advanced colorectal cancer. | Oncology (Williston Park, N.Y.) 20040501 |
| Current status of adjuvant therapy for colorectal cancer. | Oncology (Williston Park, N.Y.) 20040501 |
| Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer. | Clinical lung cancer 20040501 |
| Gemcitabine and vinorelbine as second-line therapy for non-small cell lung cancer after treatment with paclitaxel plus platinum. | Japanese journal of clinical oncology 20040501 |
| Hypermethylation of the PTEN gene in ovarian cancer cell lines. | Cancer letters 20040430 |
| [Improved long-term success. New nucleoside for once daily combinations]. | MMW Fortschritte der Medizin 20040426 |
| [Approval of a new nucleoside. Component of complete once daily regimen]. | MMW Fortschritte der Medizin 20040426 |
| Mitochondrial deoxyribonucleotides, pool sizes, synthesis, and regulation. | The Journal of biological chemistry 20040423 |
| Pyrene-labeled base-discriminating fluorescent DNA probes for homogeneous SNP typing. | Journal of the American Chemical Society 20040421 |
| Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft. | International journal of cancer 20040420 |
| A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. | British journal of cancer 20040419 |
| Nuclear factor Y regulation and promoter transactivation of human ribonucleotide reductase subunit M2 gene in a Gemcitabine resistant KB clone. | Biochemical pharmacology 20040415 |
| Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040415 |
| Unusual abdominal tumors, case 1. Pseudomyxoma peritonei: response to capecitabine. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040415 |
| Measurement of the anticancer agent gemcitabine and its deaminated metabolite at low concentrations in human plasma by liquid chromatography-mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040405 |
| Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial. | British journal of cancer 20040405 |
| Dose intense triplet chemotherapy with gemcitabine, carboplatin, paclitaxel with peripheral blood progenitor cell support for six cycles in advanced epithelial ovarian cancer. | British journal of cancer 20040405 |
| A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer. | British journal of cancer 20040405 |
| 2-Chloro-2'-deoxyadenosine synergistically enhances azidothymidine cytotoxicity in azidothymidine resistant T-lymphoid cells. | Biochemical and biophysical research communications 20040402 |
| A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancer. | Investigational new drugs 20040401 |
| Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer. | Investigational new drugs 20040401 |
| Gestational choriocarcinoma: an unusual presentation with response to gemcitabine and surgery. | BJOG : an international journal of obstetrics and gynaecology 20040401 |
| Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease. | Lung cancer (Amsterdam, Netherlands) 20040401 |
| The regulation of somatic hypermutation. | Current opinion in immunology 20040401 |
| Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck. | Annals of oncology : official journal of the European Society for Medical Oncology 20040401 |
| Costs of treatment and outcomes associated with second-line therapy and greater for relapsed ovarian cancer. | Gynecologic oncology 20040401 |
| Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancer. | Journal of the American College of Surgeons 20040401 |
| Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neck. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20040401 |
| Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040401 |
| Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040401 |
| Single ascending dose tolerability, pharmacokinetic-pharmacodynamic study of dihydropyrimidine dehydrogenase inhibitor Ro 09-4889. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040401 |
| [Phase I clinical trial evaluation of capecitabine in concurrent combination of radiotherapy in nasopharyngeal carcinoma]. | Ai zheng = Aizheng = Chinese journal of cancer 20040401 |
| Gemcitabine plus carboplatin; and gemcitabine, docetaxel, and carboplatin combined chemotherapy regimens in patients with metastatic urothelial carcinoma previously treated with a platinum-based regimen: preliminary report. | International journal of clinical oncology 20040401 |
| Novel combinations using pemetrexed in malignant mesothelioma. | Clinical lung cancer 20040401 |
| A pilot phase II study of capecitabine in advanced or recurrent colorectal cancer. | Japanese journal of clinical oncology 20040401 |
| High body mass index correlates with increased risk of venous irritation by vinorelbine infusion. | Japanese journal of clinical oncology 20040401 |
| Gemcitabine in the treatment of soft tissue sarcomas. | Onkologie 20040401 |
| [Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma]. | Hinyokika kiyo. Acta urologica Japonica 20040401 |
| Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands. | Clinical therapeutics 20040401 |
| Novel therapies for pancreatic adenocarcinoma. | Current gastroenterology reports 20040401 |
| Promising combination therapies with gemcitabine. | Seminars in oncology 20040401 |
| Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: results of a multicenter phase II study. | Seminars in oncology 20040401 |
| Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: preliminary results from a phase II trial. | Seminars in oncology 20040401 |
| In vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer: general concepts and future perspectives. | Seminars in oncology 20040401 |
| Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy in stage II and III breast cancer patients: preliminary results of a phase II and pharmacogenomic study. | Seminars in oncology 20040401 |
| Gemcitabine and docetaxel in metastatic and neoadjuvant treatment of breast cancer. | Seminars in oncology 20040401 |
| Gemcitabine (GEM), 5-fluorouracil (5-FU) and folinic acid (FA) in patients with different gastroenteric malignancies. | Journal of chemotherapy (Florence, Italy) 20040401 |
| Phase II study of OK-432 intrapleural administration followed by systemic cisplatin and gemcitabine for non-small cell lung cancer with pleuritis carcinomatosa. | Journal of experimental therapeutics & oncology 20040401 |
| [Phase I study of capecitabine with concurrent radiotherapy in early-stage nasopharyngeal carcinoma]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20040401 |
| Pancreatic cancer. | Lancet (London, England) 20040327 |
| [Severe toxicity after treatment with capecitabine and fluorouracil due to partial dihydropyrimidine dehydrogenase deficiency]. | Nederlands tijdschrift voor geneeskunde 20040327 |
| Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells. | Biochemical and biophysical research communications 20040326 |
| Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. | British journal of cancer 20040322 |
| Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis. | International journal of cancer 20040320 |
| Capecitabine induces severe angina-like chest pain. | Annals of internal medicine 20040316 |
| Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site. | Cancer 20040315 |
| Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040315 |
| A novel cell line and xenograft model of ampulla of Vater adenocarcinoma. | Virchows Archiv : an international journal of pathology 20040301 |
| Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancer. | Pharmacological research 20040301 |
| Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model. | Gut 20040301 |
| Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer. | European journal of cancer (Oxford, England : 1990) 20040301 |
| Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinoma. | International journal of radiation oncology, biology, physics 20040301 |
| In response to Li et al.: Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. IJROBP 2003;57:98-104. | International journal of radiation oncology, biology, physics 20040301 |
| 2'-deoxycytidine in free nucleosides and double-stranded DNA as the major target of lipid peroxidation products. | Free radical biology & medicine 20040301 |
| Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040301 |
| Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC. | Annals of oncology : official journal of the European Society for Medical Oncology 20040301 |
| Phase II study of cisplatin, gemcitabine and 5-fluorouracil in advanced pancreatic cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20040301 |
| Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20040301 |
| Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20040301 |
| Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20040301 |
| Management of primary resistance to gemcitabine and cisplatin (G-C) chemotherapy in metastatic bladder cancer with HER2 over-expression. | Annals of oncology : official journal of the European Society for Medical Oncology 20040301 |
| Enzyme-catalyzed activation of anticancer prodrugs. | Pharmacological reviews 20040301 |
| Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation. | BJU international 20040301 |
| Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: preclinical evaluation. | British journal of haematology 20040301 |
| Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial). | HIV medicine 20040301 |
| Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040301 |
| Phase I dose-finding study of biweekly irinotecan in combination with fixed doses of 5-fluorouracil/leucovorin, gemcitabine and cisplatin (G-FLIP) in patients with advanced pancreatic cancer or other solid tumors. | Anti-cancer drugs 20040301 |
| Combination with liposome-entrapped, ends-modified raf antisense oligonucleotide (LErafAON) improves the anti-tumor efficacies of cisplatin, epirubicin, mitoxantrone, docetaxel and gemcitabine. | Anti-cancer drugs 20040301 |
| Right pneumonectomy for adenocarcinoma stage IIIA-N2 in a heart transplant patient after induction chemotherapy. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20040301 |
| Inflammation of actinic keratoses during capecitabine therapy. | Archives of dermatology 20040301 |
| Reactions of N,N-bis(2-chloroethyl)-p-aminophenylbutyric acid (chlorambucil) with 2'-deoxycytidine, 2'-deoxy-5-methylcytidine, and thymidine. | Chemical research in toxicology 20040301 |
| Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo. | Molecular cancer therapeutics 20040301 |
| The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo. | Molecular cancer therapeutics 20040301 |
| [A case of inoperable advanced gallbladder cancer that has maintained stable disease status for a long period with gemcitabine and cisplatin therapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20040301 |
| Editorial comment: HIV and HBV coinfection--a coming-of-age in treatment strategies. | The AIDS reader 20040301 |
| Activation of deoxycytidine kinase in lymphocytes is calcium dependent and involves a conformational change detectable by native immunostaining. | Biochemical pharmacology 20040301 |
| Effects of gemcitabine on cell survival and chromosome aberrations after pulsed low dose-rate irradiation. | Journal of radiation research 20040301 |
| Gemcitabine and vinorelbine as a salvage regimen for relapse in Hodgkin lymphoma after autologous hematopoietic stem cell transplantation. | Pediatric hematology and oncology 20040301 |
| A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20040301 |
| Phase I study of gemcitabine given weekly as a short infusion for non-small cell lung cancer: results and possible immune system-related mechanisms. | Lung cancer (Amsterdam, Netherlands) 20040301 |
| [Docetaxel and non-small cell lung cancer]. | Bulletin du cancer 20040301 |
| Systemic treatment of pancreatic cancer. | European journal of gastroenterology & hepatology 20040301 |
| RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine. | Oncogene 20040226 |
| Pre-steady-state kinetic studies of the fidelity of Sulfolobus solfataricus P2 DNA polymerase IV. | Biochemistry 20040224 |
| 2'-deoxycytidines carrying amino and thiol functionality: synthesis and incorporation by Vent (exo-) polymerase. | Organic letters 20040219 |
| [Mechanisms of the drug resistance of a 2', 2-difluorodeoxycytide (gemcitabine)-resistant variant of the human lung adenocarcinoma cell line]. | Zhonghua yi xue za zhi 20040217 |
| Alteration in copy numbers of genes as a mechanism for acquired drug resistance. | Cancer research 20040215 |
| Depletion of deoxyribonucleoside triphosphate pools in tumor cells by nitric oxide. | Free radical biology & medicine 20040215 |
| Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040215 |
| Schedule-dependent cytotoxic interaction between epidoxorubicin and gemcitabine in human bladder cancer cells in vitro. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040215 |
| Cilengitide (EMD 121974) arrests the growth of a heavily pretreated highly vascularised head and neck tumour. | Oral oncology 20040201 |
| Rationale for the use of gemcitabine in breast cancer (Review). | International journal of oncology 20040201 |
| Intravesical gemcitabine: a phase 1 and pharmacokinetic study. | European urology 20040201 |
| Phase I study of escalating doses of oxaliplatin in combination with fixed dose gemcitabine in patients with non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20040201 |
| Inhibition of the subgenomic hepatitis C virus replicon in huh-7 cells by 2'-deoxy-2'-fluorocytidine. | Antimicrobial agents and chemotherapy 20040201 |
| Reverse transcriptase activity of hepatitis B virus (HBV) DNA polymerase within core capsid: interaction with deoxynucleoside triphosphates and anti-HBV L-deoxynucleoside analog triphosphates. | Molecular pharmacology 20040201 |
| Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder. | Journal of cancer research and clinical oncology 20040201 |
| New agents in acute myeloid leukemia and other myeloid disorders. | Cancer 20040201 |
| Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine: a phase II trial. | Cancer 20040201 |
| Frequency and voltage dependence of the dielectrophoretic trapping of short lengths of DNA and dCTP in a nanopipette. | Biophysical journal 20040201 |
| Gemcitabine-induced severe pulmonary toxicity. | Fundamental & clinical pharmacology 20040201 |
| Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells. | International journal of radiation oncology, biology, physics 20040201 |
| Newer treatments for HIV in children. | Current opinion in pediatrics 20040201 |
| Phase I study with dose escalation of gemcitabine and cisplatin in combination with ifosfamide (GIP) in patients with non-small-cell lung carcinoma. | American journal of clinical oncology 20040201 |
| Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain. | Annals of oncology : official journal of the European Society for Medical Oncology 20040201 |
| Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20040201 |
| Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20040201 |
| Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck. | Annals of oncology : official journal of the European Society for Medical Oncology 20040201 |
| Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20040201 |
| Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study. | Gynecologic oncology 20040201 |
| Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian/peritoneal cancer. | Gynecologic oncology 20040201 |
| Immunoglobulin gene conversion in chicken DT40 cells largely proceeds through an abasic site intermediate generated by excision of the uracil produced by AID-mediated deoxycytidine deamination. | European journal of immunology 20040201 |
| Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer. | Health technology assessment (Winchester, England) 20040201 |
| Antitumor activity of sugar-modified cytosine nucleosides. | Cancer science 20040201 |
| A novel synthesis of malondialdehyde adducts of deoxyguanosine, deoxyadenosine, and deoxycytidine. | Chemical research in toxicology 20040201 |
| State-of-the-art chemotherapy for advanced non-small cell lung cancer. | Seminars in oncology 20040201 |
| [Effect of inhibitors for demethylation and histone deacetylase on proliferation of cell line K562 and expression of tumor related genes]. | Zhongguo shi yan xue ye xue za zhi 20040201 |
| [Outcomes of treatment with gemcitabine for unresectable pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20040201 |
| Recurrent ovarian cancer. | Onkologie 20040201 |
| Dose finding study for combination treatment with topotecan and gemcitabine of patients with recurrent ovarian cancer after failure of first-line chemotherapy with Paclitaxel and platinum. | Onkologie 20040201 |
| [Chemotherapy in pancreatic cancer]. | Orvosi hetilap 20040201 |
| Serious hand-and-foot syndrome in black patients treated with capecitabine: report of 3 cases and review of the literature. | Cutis 20040201 |
| Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines. | Biochemical pharmacology 20040201 |
| Screening for supra-additive effects of cytotoxic drugs and gamma irradiation in an in vitro model for hepatocellular carcinoma. | Canadian journal of physiology and pharmacology 20040201 |
| [First-line Xeloda (Capecitabine) treatment for advanced and recurrent colorectal cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20040201 |
| Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer. | Japanese journal of clinical oncology 20040201 |
| A phase II Japanese study of a modified capecitabine regimen for advanced or metastatic colorectal cancer. | Anti-cancer drugs 20040201 |
| [The role of meta-analysis in assessing the treatment of advanced non-small cell lung cancer]. | Revue de pneumologie clinique 20040201 |
| An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines. | British journal of cancer 20040126 |
| Expression and regulation of tumor suppressor gene maspin in human bladder cancer. | Cancer letters 20040120 |
| Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040115 |
| Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma. | Cancer 20040115 |
| The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines. | Cancer research 20040115 |
| [Therapy of colorectal carcinoma. To combine saves lives]. | MMW Fortschritte der Medizin 20040115 |
| Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer. | British journal of cancer 20040112 |
| [Conservative therapy for pancreatic cancer]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20040110 |
| Enhancement of effects of irradiation by gemcitabine in a glioblastoma cell line and cell line spheroids. | Journal of cancer research and clinical oncology 20040101 |
| Gemcitabine suppresses malignant ascites of human pancreatic cancer: correlation with VEGF expression in ascites. | Oncology reports 20040101 |
| First clinical experience using a 'pathotropic' injectable retroviral vector (Rexin-G) as intervention for stage IV pancreatic cancer. | International journal of oncology 20040101 |
| Inhibitors of CTP biosynthesis potentiate the anti-human immunodeficiency virus type 1 activity of 3TC in activated peripheral blood mononuclear cells. | Antiviral research 20040101 |
| Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20040101 |
| Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20040101 |
| Emtricitabine: a new nucleoside analogue for once-daily antiretroviral therapy. | Expert opinion on investigational drugs 20040101 |
| Tumor-specific gene expression using regulatory elements of the glucose transporter isoform 1 gene. | Cancer gene therapy 20040101 |
| Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma. | Cancer 20040101 |
| Combination chemotherapy of gemcitabine and vinorelbine for patients in stage IIIB-IV non-small cell lung cancer: a phase II study of the West Japan Thoracic Oncology Group (WJTOG) 9908. | Lung cancer (Amsterdam, Netherlands) 20040101 |
| Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe. | Lung cancer (Amsterdam, Netherlands) 20040101 |
| Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040101 |
| Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study. | Investigational new drugs 20040101 |
| Palliative treatment for advanced or metastatic osteosarcoma. | The Israel Medical Association journal : IMAJ 20040101 |
| [Phase I study of gemcitabine (GEM) and UFT combination chemotherapy for unresectable/recurrent pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20040101 |
| Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study. | Gynecologic oncology 20040101 |
| Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group Study. | Gynecologic oncology 20040101 |
| An in vitro study of the inhibitory activity of gemcitabine and platinum agents in human endometrial carcinoma cell lines. | Gynecologic oncology 20040101 |
| Second line therapy with weekly low-dose docetaxel for pretreated non-small-cell lung carcinoma patients: a multicenter Italian phase II study. | Lung 20040101 |
| New perspectives with antimetabolites in the management of breast cancer. | Clinical breast cancer 20040101 |
| Single-agent gemcitabine in the treatment of advanced breast cancer. | Clinical breast cancer 20040101 |
| Gemcitabine and taxanes as a new standard of care in breast cancer. | Clinical breast cancer 20040101 |
| Gemcitabine and platinum combinations in patients with breast cancer previously treated with anthracyclines and/or taxanes. | Clinical breast cancer 20040101 |
| Gemcitabine and trastuzumab combinations for patients with metastatic breast cancer overexpressing HER2/neu. | Clinical breast cancer 20040101 |
| Rationale and clinical trial design for evaluating gemcitabine as neoadjuvant and adjuvant therapy for breast cancer. | Clinical breast cancer 20040101 |
| Capecitabine-induced coronary vasospasm--a case report. | Angiology 20040101 |
| [A case of primary squamous cell carcinoma of the lung with a metastatic thyroid tumor improved following chemotherapy]. | Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20040101 |
| Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy. | Neuro-oncology 20040101 |
| Treatment of colorectal cancer metastasis: the role of chemotherapy. | Cancer metastasis reviews 20040101 |
| Transcription-coupled mutagenesis by the DNA deaminase AID. | Genome biology 20040101 |
| Labeling changes for tenofovir. | AIDS patient care and STDs 20040101 |
| Activity of irofulven against human pancreatic carcinoma cell lines in vitro and in vivo. | Anticancer research 20040101 |
| Complete response of severe symptomatic bone marrow metastases from heavily pretreated breast cancer with a 3-weekly trastuzumab schedule. A clinical case. | Anticancer research 20040101 |
| [Effectiveness of gemcitabine in combination with cisplatin in a randomized study of untreated patients with advanced non-small-cell lung carcinoma]. | Medicinski arhiv 20040101 |
| The role of new agents in the treatment of colorectal cancer. | Oncology 20040101 |
| Gemcitabine plus paclitaxel as first-line chemotherapy for patients with advanced breast cancer. | Oncology 20040101 |
| Phase II study of gemcitabine combined with uracil-tegafur in metastatic pancreatic cancer. | Oncology 20040101 |
| Role of 2'-2' difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation in radio-enhancement of human head and neck squamous cell carcinomas. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20040101 |
| [Pharmacogenetics in tumors of the lung]. | I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101 |
| [Medical therapy of elderly patients with advanced non-small cell lung carcinoma: significance and possibilities]. | I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101 |
| [Rational and results of a scheduled sequential combination in advanced non-small cell lung carcinoma]. | I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101 |
| Neoadjuvant strategies for non-small cell lung cancer. | I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101 |
| Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine. | Antiviral chemistry & chemotherapy 20040101 |
| [Combined treatment of esophageal cancer: a review]. | Medicina (Kaunas, Lithuania) 20040101 |
| Recent translational research: antiangiogenic therapy for breast cancer - where do we stand? | Breast cancer research : BCR 20040101 |
| Molecules magic ballet. Two Italian contributions. | Bollettino chimico farmaceutico 20040101 |
| Initial therapy for human immunodeficiency virus: broadening the options. | HIV clinical trials 20040101 |
| Familial cutaneous mycosis fungoides: successful treatment with a combination of gemcitabine and alemtuzumab. | Dermatology (Basel, Switzerland) 20040101 |
| A phase I dose escalation trial of gemcitabine with radiotherapy for breast cancer in the treatment of unresectable chest wall recurrences. | The breast journal 20040101 |
| Emtricitabine/tenofovir disoproxil fumarate. | Drugs in R&D 20040101 |
| The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine in node-positive pancreatic cancer. | Hepato-gastroenterology 20040101 |
| Carboplatin and gemcitabine in the palliative treatment of stage IV non-small cell lung cancer: definitive results of a phase II trial. | Tumori 20040101 |
| [Oral capecitabine therapy: experience and developments at the Milano Cancer Institute]. | Tumori 20040101 |
| Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors. | Molecular cancer 20040101 |
| Validated procedure for simultaneous trace level determination of the anti-cancer agent gemcitabine and its metabolite in human urine by high-performance liquid chromatography with tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20040101 |
| Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene. | BMC pharmacology 20040101 |
| Down-regulation of the human tumor antigen mucin by gemcitabine on the pancreatic cancer cell line capan-2. | Anticancer research 20040101 |
| Resistance to gemcitabine in a lymphoma cell line resistant to Fas-mediated apoptosis. | Anticancer research 20040101 |
| Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer. | Acta oncologica (Stockholm, Sweden) 20040101 |
| Bevacizumab in the treatment of breast cancer: rationale and current data. | The oncologist 20040101 |
| New treatment of chronic hepatitis B. | Seminars in liver disease 20040101 |
| Biochemical and mechanistic basis for the activity of nucleoside analogue inhibitors of HIV reverse transcriptase. | Current topics in medicinal chemistry 20040101 |
| [Capecitabine and irinotecan]. | I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101 |
| Dose escalation study on oxaliplatin and capecitabine (Xeloda) in patients with advanced solid tumors. | Oncology 20040101 |
| Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group. | Oncology 20040101 |
| Toxic encephalopathy induced by capecitabine. | Oncology 20040101 |
| Setting the record straight: activity of gemcitabine monotherapy for breast cancer. | Oncology 20040101 |
| A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer. | Oncology 20040101 |
| Gemcitabine and cisplatin in refractory malignant lymphoma. | Oncology 20040101 |
| Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathway. | The pharmacogenomics journal 20040101 |
| Treatment of metastatic pancreatic cancer with a combination of gemcitabine and 5-fluorouracil: a single center phase II study. | Tumori 20040101 |
| Inflammatory metastatic carcinoma of the colon: a case report and review of the literature. | Tumori 20040101 |
| Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation. | Hepato-gastroenterology 20040101 |
| Liver insufficiency due to breast cancer metastases--fast biological response with capecitabine. | Acta oncologica (Stockholm, Sweden) 20040101 |
| Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors. | The International journal of biological markers 20040101 |
| Cardiotoxicity in advanced non-small cell lung cancer patients treated with platinum and non-platinum based combinations as first-line treatment. | Anticancer research 20040101 |
| Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase I-II study. | Anticancer research 20040101 |
| Gemcitabine in heavily pretreated patients with recurrent ovarian, peritoneal and fallopian tube carcinoma. | European journal of gynaecological oncology 20040101 |
| Phase I trial of bi-weekly paclitaxel and gemcitabine as second-line therapy for patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. | Medical oncology (Northwood, London, England) 20040101 |
| Gemcitabine in multi-resistant non-Hodgkin lymphomas. | Tumori 20040101 |
| Palliative treatment of advanced pancreatic carcinoma in community-based oncology group practices. | The journal of supportive oncology 20040101 |
| A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbine. | Anticancer research 20040101 |
| First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer. | Oncology 20040101 |
| Emtricitabine/tenofovir disoproxil fumarate. | Drugs 20040101 |
| Development of and clinical experience with capecitabine (Xeloda) in the treatment of solid tumours. | European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101 |
| Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda). | European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101 |
| Management of hand-foot syndrome in patients treated with capecitabine (Xeloda). | European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101 |
| The vital role of education and information in patients receiving capecitabine (Xeloda). | European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101 |
| Implementation of capecitabine (Xeloda) into a cancer centre: UK experience. | European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101 |
| Implications of capecitabine (Xeloda) for cancer nursing practice. | European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101 |
| [Monomers for oligonucleotide synthesis with linkers carrying reactive residues: I. Synthesis of deoxynucleoside derivatives with methoxyoxalamide groups in heterocyclic bases]. | Bioorganicheskaia khimiia 20040101 |
| [Monomers for oligonucleotide synthesis with linkers carrying reactive residues: II. Synthesis of phosphoamidites based of uridine and cytosine and containing a linker with methoxyoxalamide groups in position 2']. | Bioorganicheskaia khimiia 20040101 |
| Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools. | Clinical pharmacokinetics 20040101 |
| Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells. | BMC cancer 20040101 |
| Severe neurotoxicity caused by gemcitabine treatment. | Acta oncologica (Stockholm, Sweden) 20040101 |
| Capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer. | Medical oncology (Northwood, London, England) 20040101 |
| Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trial. | Medical oncology (Northwood, London, England) 20040101 |
| [Application of principles of evidence-based medicine in cancer of the urinary bladder]. | Urologiia (Moscow, Russia : 1999) 20040101 |
| Single-agent gemcitabine in previously untreated elderly patients with advanced bladder carcinoma: response to treatment and correlation with the comprehensive geriatric assessment. | Oncology 20040101 |
| Combination therapy with capecitabine and interferon alfa-2A in patients with advanced renal cell carcinoma: a phase II study. | Urologic oncology 20040101 |
| A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer. | Urologic oncology 20040101 |
| A vanishing carina: a rare cause of cough. | Respiration; international review of thoracic diseases 20040101 |
| New nucleoside analogs in the treatment of hematological disorders. | Acta poloniae pharmaceutica 20040101 |
| Unexpected toxicity following use of gemcitabine as a radiosensitizer in head and neck carcinomas: a veterinary radiation therapy oncology group pilot study. | Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association 20040101 |
| Phase I trial of topotecan in combination with gemcitabine in refractory solid tumor patients. | Cancer investigation 20040101 |
| Outcome of local application of amifostine (WR-1065) on epirubicin-induced oral mucositis. A phase II study. | Anticancer research 20040101 |
| [Chemotherapy for advanced non-small-cell lung cancer. From the exclusive use of 'P' to a quantitative probabilistic interpretation of meta-analytic data]. | Tumori 20040101 |
| An effective in vitro antitumor response against human pancreatic carcinoma with paclitaxel and daunorubicin by induction of both necrosis and apoptosis. | Anticancer research 20040101 |
| Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro? | Anticancer research 20040101 |
| [Special function of deoxycytidine kinase (dCK) in the activation of chemotherapeutic nucleoside analogs and in the inhibition of cell proliferation]. | Magyar onkologia 20040101 |
| [Adjuvant therapy of colonic carcinoma--soon in tablet form]. | Krankenpflege Journal 20040101 |
| [Pancreatic carcinoma: progress in therapy]. | Krankenpflege Journal 20040101 |
| Capecitabine with weekly paclitaxel for advanced breast cancer: a phase I dose-finding trial. | Oncology 20040101 |
| Antiretrovirals, Part II: focus on non-protease inhibitor antiretrovirals (NRTIs, NNRTIs, and fusion inhibitors). | Psychosomatics 20040101 |
| Evaluation of clinical factors and treatment results in patients with advanced pancreatic cancer. | Medicina (Kaunas, Lithuania) 20040101 |
| Capecitabine plus docetaxel combination chemotherapy for metastatic breast cancer. | Breast cancer (Tokyo, Japan) 20040101 |
| Development of a green fluorescent protein metastatic-cancer chick-embryo drug-screen model. | Clinical & experimental metastasis 20040101 |
| Front-line chemotherapy with docetaxel and gemcitabine administered every two weeks in patients with metastatic breast cancer: a multicenter phase II study. | Oncology 20040101 |
| The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours. | BMC cancer 20040101 |
| Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial. | The oncologist 20040101 |
| Gemcitabine combined with docetaxel for the treatment of unresectable pancreatic carcinoma. | Cancer investigation 20040101 |
| CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin. | Molecular cancer 20040101 |
| New nucleoside analogs in the treatment of solid tumors. | Acta poloniae pharmaceutica 20040101 |
| Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG). | Cancer investigation 20040101 |
| Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu. | Cancer investigation 20040101 |
| Capecitabine: fixed daily dose and continuous (noncyclic) dosing schedule. | Cancer investigation 20040101 |
| Chemotherapeutic response with single agent gemcitabine in metastatic Bellini duct tumor. | Cancer investigation 20040101 |
| Gemcitabine-induced apoptosis in a drug-resistant mouse leukemia L1210 cell line that does not express p53. | Advances in enzyme regulation 20040101 |
| New once-a-day drugs: Truvada and Epzicom. | Positively aware : the monthly journal of the Test Positive Aware Network 20040101 |
| Phosphorylation of isocarbostyril- and difluorophenyl-nucleoside thymidine mimics by the human deoxynucleoside kinases. | Nucleosides, nucleotides & nucleic acids 20040101 |
| Acetaminophen and DMSO modulate growth and gemcitabine cytotoxicity in FM3A breast cancer cells in vitro. | Neoplasma 20040101 |
| Phase II study of leucovorin, 5-fluorouracil and gemcitabine for locally advanced and metastatic pancreatic cancer (FOLFUGEM 2). | Gastroenterologie clinique et biologique 20040101 |
| [Recent results of irinotecan therapy in colorectal cancer]. | Magyar onkologia 20040101 |
| Gemcitabine and cisplatin following surgical treatment of urinary bladder carcinosarcoma. | Tumori 20040101 |
| [ASCO Annual Meeting 2004, New Orleans. Gemcitabine in metastatic breast carcinoma]. | Tumori 20040101 |
| [ASCO Annual Meeting 2004, New Orleans. Capecitabine in adjuvant therapy of colorectal carcinoma: first... the evidence]. | Tumori 20040101 |
| Treatment options for HIV, AIDS. | FDA consumer 20040101 |
| [A new therapy standard in metastatic breast cancer--gemzar/paclitaxel. Longer survival by optimized combination therapy]. | Krankenpflege Journal 20040101 |
| Raltitrexed plus gemcitabine (TOMGEM) in advanced pancreatic cancer. Results of a Belgian multicentre phase II study. | Oncology 20040101 |
| Gemcitabine combined with oxaliplatin (GEMOX) as second-line chemotherapy in patients with advanced ovarian cancer refractory or resistant to platinum and taxane. | Oncology 20040101 |
| Oral fluoropyrimidines in colorectal cancer: a door open to the future? | Acta gastro-enterologica Belgica 20040101 |
| Antisense radiotherapy: targeting full-size mdrl mRNA with 125I-labelled oligonucleotides. | International journal of radiation biology 20040101 |
| Synthesis and alternate-stranded triplex forming ability of novel alpha-beta chimeric oligonucleotides bearing an intercalator-conjugated nucleobase. | Nucleic acids symposium series (2004) 20040101 |
| Tight binding of deoxyribonucleotide triphosphates to human thymidine kinase 2 expressed in Escherichia coli. Purification and partial characterization of its dimeric and tetrameric forms. | Biochemistry 20031230 |
| Hsp90 inhibition depletes Chk1 and sensitizes tumor cells to replication stress. | The Journal of biological chemistry 20031226 |
| Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules. | Cancer 20031215 |
| Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy. | British journal of cancer 20031215 |
| Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: results of a feasibility study. | British journal of cancer 20031215 |
| Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C. | British journal of cancer 20031215 |
| Physical and functional interactions between USF and Sp1 proteins regulate human deoxycytidine kinase promoter activity. | The Journal of biological chemistry 20031212 |
| Rituximab in combination with vinorelbine/gemcitabine chemotherapy in patients with primary refractory or early relapsed T cell rich B cell lymphoma. A pilot study. | Leukemia research 20031201 |
| A phase I and pharmacologic study of weekly gemcitabine in combination with infusional 5-fluorodeoxyuridine and oral calcium leucovorin. | Cancer chemotherapy and pharmacology 20031201 |
| In vitro susceptibility of CD4+ and CD8+ T cell subsets to fludarabine. | Biochemical pharmacology 20031201 |
| Hyper-immunoglobulin-M syndromes caused by an intrinsic B cell defect. | Current opinion in allergy and clinical immunology 20031201 |
| Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer. | International journal of radiation oncology, biology, physics 20031201 |
| Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20031201 |
| Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group. | Annals of oncology : official journal of the European Society for Medical Oncology 20031201 |
| [Pharmacological and clinical properties of Xeloda (Capecitabine), a new oral active derivative of fluoropyrimidine]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20031201 |
| Prospective randomized trial of emtricitabine versus lamivudine short-term monotherapy in human immunodeficiency virus-infected patients. | The Journal of infectious diseases 20031201 |
| Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy. | European urology 20031201 |
| Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20031201 |
| Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20031201 |
| Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy. | American journal of clinical oncology 20031201 |
| Dramatic improvement of psoriasis with gemcitabine monotherapy. | The British journal of dermatology 20031201 |
| A Phase II study of weekly irinotecan and capecitabine in patients with previously treated non-small cell lung cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20031201 |
| Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor. | Clinical cancer research : an official journal of the American Association for Cancer Research 20031201 |
| Capecitabine as salvage therapy for a breast cancer patient with extensive liver metastases and associated impairment of liver function. | Onkologie 20031201 |
| [A case of undifferentiated bladder carcinoma with axilla lymph node metastasis successfully treated with gemcitabine and cisplatin]. | Gan to kagaku ryoho. Cancer & chemotherapy 20031201 |
| Mistletoe and gemcitabine in patients with advanced cancer: a model for the phase I study of botanicals and botanical-drug interactions in cancer therapy. | Integrative cancer therapies 20031201 |
| Radiation sensitizers and targeted therapies. | Oncology (Williston Park, N.Y.) 20031201 |
| Modulation of Toll-like Receptor 9 Responses through Synthetic Immunostimulatory Motifs of DNA. | Annals of the New York Academy of Sciences 20031201 |
| Thermostable DNA polymerase from Thermus thermophilus B35: preparation and study of a modified form of the enzyme with high affinity to ddNTP. | Biochemistry. Biokhimiia 20031201 |
| Introduction. Single-agent or combination chemotherapy in metastatic breast cancer. | Oncology (Williston Park, N.Y.) 20031201 |
| Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience. | Oncology (Williston Park, N.Y.) 20031201 |
| Gemcitabine/paclitaxel as first-line treatment of advanced breast cancer. | Oncology (Williston Park, N.Y.) 20031201 |
| Paclitaxel and gemcitabine as salvage treatment in metastatic breast cancer. | Oncology (Williston Park, N.Y.) 20031201 |
| Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer. | Oncology (Williston Park, N.Y.) 20031201 |
| Gemcitabine, anthracycline, and taxane combinations for advanced breast cancer. | Oncology (Williston Park, N.Y.) 20031201 |
| The continuing evolution of HIV therapy. | The AIDS reader 20031201 |
| Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease. | Clinical advances in hematology & oncology : H&O 20031201 |
| Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer. | Journal of experimental & clinical cancer research : CR 20031201 |
| Polysaccharide-based chiral phase under polar organic mode of elution in the determination of the enantiomeric purity of emtricitabine an anti-HIV analogue nucleoside. | Journal of pharmaceutical and biomedical analysis 20031124 |
| RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. | Biochemical and biophysical research communications 20031121 |
| Oligonucleotide duplexes containing N8-glycosylated 8-aza-7-deazaguanine and self-assembly of 8-aza-7-deazapurines on the nucleoside and the oligomeric level. | Organic & biomolecular chemistry 20031121 |
| A phase II trial of capecitabine (Xeloda) in recurrent ovarian cancer. | British journal of cancer 20031117 |
| Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma. | British journal of cancer 20031117 |
| Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro. | International journal of radiation oncology, biology, physics 20031115 |
| Intensity modulated radiation therapy and chemotherapy for locally advanced pancreatic cancer: results of feasibility study. | World journal of gastroenterology 20031115 |
| In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength. | Cancer research 20031115 |
| Trans-tissue, sustained release of gemcitabine from photocured gelatin gel inhibits the growth of heterotopic human pancreatic tumor in nude mice. | Clinical cancer research : an official journal of the American Association for Cancer Research 20031115 |
| Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers. | International journal of cancer 20031110 |
| Atazanavir (Reyataz) and emtricitabine (Emtriva) for HIV infection. | The Medical letter on drugs and therapeutics 20031110 |
| Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA. | The Journal of biological chemistry 20031107 |
| The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. | Nature medicine 20031101 |
| Pharmacokinetics of intravesical gemcitabine: a preclinical study in pigs. | European urology 20031101 |
| Rapid in vitro chemosensitivity analysis of human colon tumor cell lines. | Toxicology and applied pharmacology 20031101 |
| Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors. | Annals of oncology : official journal of the European Society for Medical Oncology 20031101 |
| High incidence of severe hand-foot syndrome during capecitabine-docetaxel combination chemotherapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20031101 |
| Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031101 |
| A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma. | Cancer 20031101 |
| A phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinoma. | Cancer 20031101 |
| Capecitabine monotherapy and in combination with immunotherapy in the treatment of metastatic renal cell carcinoma. | Anti-cancer drugs 20031101 |
| Thrombotic microangiopathy and digital necrosis: two unrecognized toxicities of gemcitabine. | Anti-cancer drugs 20031101 |
| A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies. | Gynecologic oncology 20031101 |
| Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy. | Gynecologic oncology 20031101 |
| Fanconi's anemia and clinical radiosensitivity report on two adult patients with locally advanced solid tumors treated by radiotherapy. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20031101 |
| Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. | Journal of neurosurgery 20031101 |
| [Chemotherapy of bladder cancer. Systemic therapy with reduced toxicity]. | Der Urologe. Ausg. A 20031101 |
| [Home chemotherapy for lung cancer: a five year retrospective study]. | Revue des maladies respiratoires 20031101 |
| Complete response of brain metastases originating in breast cancer to capecitabine therapy. | The Israel Medical Association journal : IMAJ 20031101 |
| [Chemotherapy for pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20031101 |
| [Non-platinum induction chemotherapy for stage III non-small cell lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20031101 |
| Highlights from the 10th World Conference on Lung Cancer. Vancouver, British Columbia, Canada, August 10-14, 2003. | Clinical lung cancer 20031101 |
| Phase II study of an alternate carboplatin and gemcitabine dosing schedule in advanced non-small-cell lung cancer. | Clinical lung cancer 20031101 |
| Synthesis and biological evaluation of some 5-nitro- and 5-amino derivatives of 2'-deoxycytidine, 2',3'-dideoxyuridine, and 2',3'-dideoxycytidine. | Nucleosides, nucleotides & nucleic acids 20031101 |
| Response of neoplastic meningitis from solid tumors to oral capecitabine. | Journal of neuro-oncology 20031101 |
| [Phase II clinical trial on gemcitabine in the treatment of stage IIIB-IV non-small cell lung cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20031101 |
| [Combined gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20031101 |
| [Combined preoperative xeloda and radiotherapy for lower rectal cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20031101 |
| Integrating oxaliplatin and capecitabine in adjuvant therapy of high-risk colorectal cancer. | Clinical colorectal cancer 20031101 |
| Development of new agents for the treatment of advanced colorectal cancer. | Clinical colorectal cancer 20031101 |
| Impact of Gemcitabine and Cisplatin with radiotherapy in locally advanced or metastatic transitional cell carcinoma of urinary bladder. | JPMA. The Journal of the Pakistan Medical Association 20031101 |
| Sensitization of ara-C-resistant lymphoma cells by a pronucleotide analogue. | International journal of cancer 20031020 |
| Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine. | British journal of cancer 20031020 |
| Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA(N2) nonsmall cell lung carcinoma: a Phase II multicenter study. | Cancer 20031015 |
| Gemcitabine with cyclosporine or with tacrolimus exerts a synergistic effect and induces tolerance in the rat. | Transplantation 20031015 |
| ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine. | Clinical cancer research : an official journal of the American Association for Cancer Research 20031015 |
| A phase I, pharmacokinetic, and biological study of the farnesyltransferase inhibitor tipifarnib in combination with gemcitabine in patients with advanced malignancies. | Clinical cancer research : an official journal of the American Association for Cancer Research 20031015 |
| Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity. | Clinical cancer research : an official journal of the American Association for Cancer Research 20031015 |
| The proline-rich acidic protein is epigenetically regulated and inhibits growth of cancer cell lines. | Cancer research 20031015 |
| Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells. | Cancer research 20031015 |
| Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer. | British journal of cancer 20031006 |
| First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial. | British journal of cancer 20031006 |
| The role of DNA synthesis inhibition in the cytotoxicity of 2',2'-difluoro-2'-deoxycytidine. | Cancer chemotherapy and pharmacology 20031001 |
| Selective targeting of homologous DNA recombination repair by gemcitabine. | International journal of radiation oncology, biology, physics 20031001 |
| Collecting duct carcinoma of the kidney: a clinicopathological study of 9 cases. | The Journal of urology 20031001 |
| Prognostic factors for survival with gemcitabine plus 5-fluorouracil based regimens for metastatic renal cancer. | The Journal of urology 20031001 |
| Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20031001 |
| Establishment of gemcitabine-resistant human pancreatic cancer cells and effect of brefeldin-a on the resistant cell line. | Pancreas 20031001 |
| An expedient assay for determination of gemcitabine and its metabolite in human plasma using isocratic ion-pair reversed-phase high-performance liquid chromatography. | Therapeutic drug monitoring 20031001 |
| Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20031001 |
| A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia. | Leukemia 20031001 |
| Colour junctions as predictors of radiosensitivity: X-irradiation combined with gemcitabine in a lung carcinoma cell line. | Journal of cancer research and clinical oncology 20031001 |
| Recombinant toxin DAB389EGF is cytotoxic to human pancreatic cancer cells. | Expert opinion on biological therapy 20031001 |
| Assessment of the relative potency of emtricitabine and lamivudine. | Journal of acquired immune deficiency syndromes (1999) 20031001 |
| Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study. | Gynecologic oncology 20031001 |
| Pharmacokinetics after pulmonary artery perfusion with gemcitabine. | The Annals of thoracic surgery 20031001 |
| Extensive palliative surgery for advanced mesothelioma of the tunica vaginalis. | Urology 20031001 |
| Adenovirus type 5 E1A sensitizes hepatocellular carcinoma cells to gemcitabine. | Cancer research 20031001 |
| Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B. | Molecular cancer therapeutics 20031001 |
| Gemcitabine: current role and future options in the treatment of ovarian cancer. | Critical reviews in oncology/hematology 20031001 |
| Systemic therapy for colorectal cancer: focus on newer chemotherapy and novel agents. | Seminars in radiation oncology 20031001 |
| Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer. | Seminars in radiation oncology 20031001 |
| Doxorubicin, paclitaxel and gemcitabine: a Phase I study of a new sequential treatment in stage III B - IV breast cancer. | Journal of chemotherapy (Florence, Italy) 20031001 |
| Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder. | Journal of chemotherapy (Florence, Italy) 20031001 |
| Advanced pancreatic cancer: is there a role for combination therapy? | Expert review of anticancer therapy 20031001 |
| Unusual response to second-line single-agent gemcitabine in locally advanced primary leiomyosarcoma of the lung: a case report. | Journal of chemotherapy (Florence, Italy) 20031001 |
| Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin? | Onkologie 20031001 |
| An autopsy case of acute pulmonary toxicity associated with gemcitabine. | Internal medicine (Tokyo, Japan) 20031001 |
| A short, efficient synthesis of 2'-deoxypseudoisocytidine based on Heck-chemistry. | Nucleosides, nucleotides & nucleic acids 20031001 |
| Human MutY: gene structure, protein functions and interactions, and role in carcinogenesis. | Cellular and molecular life sciences : CMLS 20031001 |
| [Chemoradiation therapy for stage IV pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20031001 |
| [Novel chemoradiotherapy for locally advanced pancreatic cancer using arterial infusion chemotherapy following the alteration of peripancreatic blood flow]. | Gan to kagaku ryoho. Cancer & chemotherapy 20031001 |
| [Gemcitabine infusion via splenic artery for advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20031001 |
| A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine. | Breast cancer research and treatment 20031001 |
| Influence of genetic markers on survival in non-small cell lung cancer. | Drugs of today (Barcelona, Spain : 1998) 20031001 |
| FDA notifications. NRTI Emtriva receives FDA approval. | AIDS alert 20031001 |
| Pharmacological basis for cladribine resistance. | Leukemia & lymphoma 20031001 |
| FTC (emtricitabine, Emtriva). | Project Inform perspective 20031001 |
| Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. | Cancer letters 20030925 |
| Changes of mitochondrial respiration, mitochondrial content and cell size after induction of apoptosis in leukemia cells. | Biochimica et biophysica acta 20030923 |
| Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889. | International journal of cancer 20030920 |
| [Tumor specific therapy. Targeted breast cancer therapy]. | MMW Fortschritte der Medizin 20030918 |
| It's what's inside that counts. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030915 |
| Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030915 |
| Supportive care in patients with advanced non-small-cell lung cancer. | British journal of cancer 20030915 |
| Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030915 |
| Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01). | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030915 |
| Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma. | Cancer 20030915 |
| Synthesis and cytotoxic activity of two novel 1-dodecylthio-2-decyloxypropyl-3-phosphatidic acid conjugates with gemcitabine and cytosine arabinoside. | Journal of medicinal chemistry 20030911 |
| Effect of metal-based anticancer drugs on wild type and metallothionein null cell lines. | Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 20030901 |
| Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer. | Cancer chemotherapy and pharmacology 20030901 |
| Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer. | Cancer chemotherapy and pharmacology 20030901 |
| Sensitization of human breast cancer cells to gemcitabine by the protein kinase C modulator bryostatin 1. | Cancer chemotherapy and pharmacology 20030901 |
| Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy. | Cancer chemotherapy and pharmacology 20030901 |
| Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. | International journal of radiation oncology, biology, physics 20030901 |
| Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial. | Lung cancer (Amsterdam, Netherlands) 20030901 |
| Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment. | Lung cancer (Amsterdam, Netherlands) 20030901 |
| Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity. | Cancer 20030901 |
| Mutagenesis by AID, a molecule critical to immunoglobulin hypermutation, is not caused by an alteration of the precursor nucleotide pool. | Molecular immunology 20030901 |
| Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030901 |
| Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030901 |
| Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030901 |
| Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20030901 |
| A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary site. | Annals of oncology : official journal of the European Society for Medical Oncology 20030901 |
| Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study. | Annals of oncology : official journal of the European Society for Medical Oncology 20030901 |
| Cloning, expression, and purification of the His6-tagged hyper-thermostable dUTPase from Pyrococcus woesei in Escherichia coli: application in PCR. | Protein expression and purification 20030901 |
| Phase 2 trial of single-agent gemcitabine in platinum-paclitaxel refractory ovarian cancer. | Gynecologic oncology 20030901 |
| Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine. | Anti-cancer drugs 20030901 |
| Unusual response to gemcitabine in a case of peritoneal malignant fibrous histiocytoma. | Anti-cancer drugs 20030901 |
| Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic-uremic syndrome due to gemcitabine. | Anti-cancer drugs 20030901 |
| Randomized phase I clinical and pharmacologic study of weekly versus twice-weekly dose-intensive cisplatin and gemcitabine in patients with advanced non-small cell lung cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030901 |
| Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030901 |
| Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030901 |
| Localized pleural malignant mesothelioma. | Pathology international 20030901 |
| [A case of advanced pancreatic cancer showing remarkable response to gemcitabine treatment]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030901 |
| Onycholysis with the appearance of a 'sunset' secondary to capecitabine. | Cutis 20030901 |
| Fatal cholestatic liver failure associated with gemcitabine therapy. | Digestive diseases and sciences 20030901 |
| Irinotecan and fixed-dose-rate gemcitabine in advanced pancreatic and biliary cancer: phase I study. | Oncology (Williston Park, N.Y.) 20030901 |
| Gemcitabine and irinotecan in locally advanced or metastatic biliary cancer: preliminary report. | Oncology (Williston Park, N.Y.) 20030901 |
| [Chemotherapy for colon cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Doxifluridine for treatment of colorectal cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Intravenous continuous infusion of fluorouracil for treatment of metastatic colorectal cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Present status of chemotherapy for colorectal cancer in countries outside of Japan]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Adjuvant chemotherapy for colorectal carcinoma after curative resection]. | Nihon rinsho. Japanese journal of clinical medicine 20030901 |
| [Two cases of radiation myositis probably induced by recall phenomenon]. | Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica 20030901 |
| Emtriva gets approval. | AIDS patient care and STDs 20030901 |
| Emtricitabine: a new treatment option for simplified antiretroviral therapy. | The AIDS reader 20030901 |
| Dose-finding with two agents in Phase I oncology trials. | Biometrics 20030901 |
| 5-Chlorouracil, a marker of DNA damage from hypochlorous acid during inflammation. A gas chromatography-mass spectrometry assay. | The Journal of biological chemistry 20030829 |
| Synthesis of the phosphoramidite derivative of 2'-deoxy-2'-C-beta-methylcytidine. | The Journal of organic chemistry 20030822 |
| Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment. | International journal of cancer 20030820 |
| Onycholysis associated with capecitabine in combination with irinotecan in two patients with colorectal cancer. | Journal of the National Cancer Institute 20030820 |
| Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports. | British journal of cancer 20030818 |
| Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030815 |
| Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030815 |
| [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment]. | Ugeskrift for laeger 20030811 |
| Are 5'-O-carbamate-2',3'-dideoxythiacytidine new anti-HIV and anti-HBV nucleoside drugs or prodrugs? | Bioorganic & medicinal chemistry letters 20030804 |
| Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study. | Cancer chemotherapy and pharmacology 20030801 |
| Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study. | Cancer chemotherapy and pharmacology 20030801 |
| Genetic testing for chemotherapy in non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20030801 |
| Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer. | International journal of radiation oncology, biology, physics 20030801 |
| Low-dose gemcitabine plus cisplatin in previously treated, relapsed non-Hodgkin's lymphoma. | American journal of hematology 20030801 |
| Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma. | Cancer 20030801 |
| Multicenter phase II study of oral capecitabine (Xeloda(')) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20030801 |
| A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20030801 |
| Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030801 |
| The systemic treatment of advanced and metastatic bladder cancer. | The Lancet. Oncology 20030801 |
| Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer. | American journal of clinical oncology 20030801 |
| COX-2 inhibitors as radiation sensitizers for upper GI tract cancers: esophagus, stomach, and pancreas. | American journal of clinical oncology 20030801 |
| Triplet chemotherapy combination with gemcitabine, cisplatin and ifosfamide in patients with advanced non-small-cell lung cancer: phase II study. | American journal of clinical oncology 20030801 |
| Capecitabine: new indication. In breast cancer: inadequately assessed. | Prescrire international 20030801 |
| Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors. | Cancer research 20030801 |
| [Chemoradiation in pancreatic carcinoma]. | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20030801 |
| Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer. | Seminars in oncology 20030801 |
| Efficacy of neoadjuvant strategies with gemcitabine and other chemotherapy in resectable non-small cell lung cancer: a combined modality approach. | Seminars in oncology 20030801 |
| Targeted therapy in combination with gemcitabine in non-small cell lung cancer. | Seminars in oncology 20030801 |
| Capecitabine-induced pancreatitis. | Pharmacotherapy 20030801 |
| Oxaliplatin and capecitabine chemotherapy for advanced colorectal cancer: a single institution's experience. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20030801 |
| Capecitabine-induced potentiation of warfarin. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20030801 |
| Lethal toxicity of capecitabine due to abusive folic acid prescription? | Clinical oncology (Royal College of Radiologists (Great Britain)) 20030801 |
| Clinical trials of newer regimens for treating ovarian cancer: the rationale for Gynecologic Oncology Group Protocol GOG 182-ICON5. | Gynecologic oncology 20030801 |
| Gemcitabine in cervical cancer. | Gynecologic oncology 20030801 |
| Gemcitabine combination chemotherapy of ovarian cancer. | Gynecologic oncology 20030801 |
| Gemcitabine as a single-agent treatment for ovarian cancer. | Gynecologic oncology 20030801 |
| [Remission rate of mediastinal lymph nodes after multimodal therapy of lung cancer--is it a prognostic factor?]. | Zentralblatt fur Chirurgie 20030801 |
| [A case of advanced pancreatic cancer treated with gemcitabine hydrochloride]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030801 |
| The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer. | Seminars in oncology 20030801 |
| Capecitabine in combination with irinotecan or oxaliplatin in advanced colorectal cancer. | Clinical colorectal cancer 20030801 |
| Capecitabine-related neurotoxicity presenting as trismus. | Clinical colorectal cancer 20030801 |
| Concomitant gemcitabine (Gemzar) and extended nodes irradiation in the treatment of pancreatic and biliary carcinoma: a phase I study. | Onkologie 20030801 |
| New perspectives in the management of pancreas cancer. | Seminars in oncology 20030801 |
| Current and ongoing trials with irinotecan in the United States. | Seminars in oncology 20030801 |
| SPD-754. Shire. | Current opinion in investigational drugs (London, England : 2000) 20030801 |
| [Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]. | Der Urologe. Ausg. A 20030801 |
| Combination chemotherapy with topotecan for non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20030801 |
| Capecitabine in colorectal, breast, and other solid tumors: novel therapeutic approaches. Selected abstracts from ASCO 2003. | Oncology (Williston Park, N.Y.) 20030801 |
| US FDA approves Emtriva (FTC). | IAPAC monthly 20030801 |
| Isolation of an unknown metabolite of capecitabine, an oral 5-fluorouracil prodrug, and its identification by nuclear magnetic resonance and liquid chromatography-tandem mass spectrometry as a glucuroconjugate of 5'-deoxy-5-fluorocytidine, namely 2'-(beta-D-glucuronic acid)-5'-deoxy-5-fluorocytidine. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030725 |
| Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines. | European journal of pharmacology 20030725 |
| FTC (Emtriva) approved. | AIDS treatment news 20030725 |
| A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid. | British journal of cancer 20030721 |
| Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study. | International journal of radiation oncology, biology, physics 20030715 |
| Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatin. | Cancer 20030715 |
| Proton-block strategy for the synthesis of oligodeoxynucleotides without base protection, capping reaction, and P-N bond cleavage reaction. | The Journal of organic chemistry 20030711 |
| Simultaneous determination of gemcitabine and its metabolite in human plasma by high-performance liquid chromatography. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030705 |
| Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial. | Cancer chemotherapy and pharmacology 20030701 |
| Structure of human dCK suggests strategies to improve anticancer and antiviral therapy. | Nature structural biology 20030701 |
| Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine. | British journal of haematology 20030701 |
| A phase II/III study comparing intravenous ZD9331 with gemcitabine in patients with pancreatic cancer. | European journal of cancer (Oxford, England : 1990) 20030701 |
| Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20030701 |
| Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients. | Lung cancer (Amsterdam, Netherlands) 20030701 |
| Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group. | Lung cancer (Amsterdam, Netherlands) 20030701 |
| Locally advanced acinar cell carcinoma of the pancreas successfully treated by capecitabine and concurrent radiotherapy: report of two cases. | Pancreas 20030701 |
| Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study. | Cancer 20030701 |
| In vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical development. | Leukemia 20030701 |
| Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20030701 |
| Gemcitabine increases systemic 5-fluorouracil exposure in advanced cancer patients. | European journal of cancer (Oxford, England : 1990) 20030701 |
| A Phase I study of gemcitabine with concurrent radiotherapy in stage III, locally advanced non-small cell lung cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030701 |
| A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030701 |
| Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030701 |
| An oxygen-bonded c8-deoxyguanosine nucleoside adduct of pentachlorophenol by peroxidase activation: evidence for ambident c8 reactivity by phenoxyl radicals. | Chemical research in toxicology 20030701 |
| Characterization of 2'-deoxycytidine adducts derived from 4-oxo-2-nonenal, a novel lipid peroxidation product. | Chemical research in toxicology 20030701 |
| The global role of irinotecan in the treatment of lung cancer: 2003 update. | Oncology (Williston Park, N.Y.) 20030701 |
| [Multi-center trial of gemcitabine for 49 patients with advanced pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030701 |
| Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer. | The Journal of surgical research 20030701 |
| A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. | The Journal of surgical research 20030701 |
| Combination treatment with weekly docetaxel and gemcitabine for advanced non-small-cell lung cancer in elderly patients and patients with poor performance status: results of a Minnie Pearl Cancer Research Network phase II trial. | Clinical lung cancer 20030701 |
| Special patients, special treatments. | Clinical lung cancer 20030701 |
| Re: a multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma. | Clinical lung cancer 20030701 |
| Durable local responses with subtherapeutic doses of concurrent radiation and gemcitabine in a patient with refractory Hodgkin's disease. | Clinical advances in hematology & oncology : H&O 20030701 |
| Structure of the large subunit of class Ib ribonucleotide reductase from Salmonella typhimurium and its complexes with allosteric effectors. | Journal of molecular biology 20030627 |
| Thalidomide therapy for renal cell carcinoma. | Critical reviews in oncology/hematology 20030627 |
| Gemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancers. | Critical reviews in oncology/hematology 20030627 |
| The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs. | Mutation research 20030619 |
| Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines. | British journal of cancer 20030616 |
| Identification and quantification of mutagenic halogenated cytosines by gas chromatography, fast atom bombardment, and electrospray ionization tandem mass spectrometry. | Analytical biochemistry 20030615 |
| A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases. | Cancer 20030615 |
| Activation of deoxycytidine kinase by gamma-irradiation and inactivation by hyperosmotic shock in human lymphocytes. | Biochemical pharmacology 20030615 |
| Crystallographic characterization of an exocyclic DNA adduct: 3,N4-etheno-2'-deoxycytidine in the dodecamer 5'-CGCGAATTepsilonCGCG-3'. | Journal of molecular biology 20030613 |
| DNA deamination mediates innate immunity to retroviral infection. | Cell 20030613 |
| [Oral fluoropyrimidines in the treatment of colorectal carcinoma]. | Deutsche medizinische Wochenschrift (1946) 20030613 |
| Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer. | Oncogene 20030605 |
| A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy. | Oral oncology 20030601 |
| Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model. | Antimicrobial agents and chemotherapy 20030601 |
| Expression of genes for certain enzymes of pyrimidine and purine salvage pathway in peripheral blood leukocytes collected from patients with Graves' or Hashimoto's disease. | Journal of cellular biochemistry 20030601 |
| An EORTC phase I study of capecitabine (Xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer. | European journal of cancer (Oxford, England : 1990) 20030601 |
| Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium: a trial of the Eastern Cooperative Oncology Group. | Cancer 20030601 |
| Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study. | Cancer 20030601 |
| Human cytomegalovirus requires cellular deoxycytidylate deaminase for replication in quiescent cells. | The Journal of general virology 20030601 |
| Toll-like receptor 9: modulation of recognition and cytokine induction by novel synthetic CpG DNAs. | Biochemical Society transactions 20030601 |
| Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030601 |
| In vitro effects of combinations of cis-amminedichloro (2-methylpyridine) platinum (II) (ZD0473) with other novel anticancer drugs on the growth of SBC-3, a human small cell lung cancer cell line. | Lung cancer (Amsterdam, Netherlands) 20030601 |
| Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor--BCX-1777. | International immunopharmacology 20030601 |
| Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study. | Anti-cancer drugs 20030601 |
| Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosis. | The Journal of rheumatology 20030601 |
| The recent past and future of adjuvant therapy for pancreatic cancer. | Annals of surgical oncology 20030601 |
| Fatal hepatic failure due to gemcitabine and vinorelbine. | Annals of oncology : official journal of the European Society for Medical Oncology 20030601 |
| Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature. | American journal of clinical oncology 20030601 |
| Gemcitabine, Paclitaxel, and piritrexim: a phase I study. | American journal of clinical oncology 20030601 |
| Phase I trial of docetaxel, carboplatin, and gemcitabine as first-line therapy for patients with high-risk epithelial tumors of müllerian origin. | Gynecologic oncology 20030601 |
| Practical considerations in the use of oral fluoropyrimidines. | Seminars in oncology 20030601 |
| Regioselective synthesis of 1,N(2)-etheno-2'-deoxyguanosine and its generation in oligomeric DNA. | Chemical research in toxicology 20030601 |
| A phase II trial of gemcitabine in the treatment of advanced bile duct and periampullary carcinomas. | Chemotherapy 20030601 |
| Treatment of recurrent platinum resistant ovarian or peritoneal cancer with gemcitabine and doxorubicin: A phase I/II trial of the Puget Sound Oncology Consortium (PSOC 1602). | American journal of obstetrics and gynecology 20030601 |
| Peripheral neuropathy due to therapy with paclitaxel, gemcitabine, and cisplatin in patients with advanced ovarian cancer. | Journal of neuro-oncology 20030601 |
| A new therapeutical approach: topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy with paclitaxel and platinum. | The journal of obstetrics and gynaecology research 20030601 |
| [Combination therapy with vinorelbine and gemcitabine in unresectable non-small cell lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030601 |
| [Effective treatment with the additional administration of UFT for refractory malignant pleural effusion secondary to adenocarcinoma of the lung after the treatment regimen of gemcitabine and vinorelbine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030601 |
| A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer. | Clinical breast cancer 20030601 |
| Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case report. | Journal of chemotherapy (Florence, Italy) 20030601 |
| Protonation of deoxycytidine residues in dC4 tetraloops: UV spectrophotometric study of dC10 and d(A14C4T14). | Biophysical chemistry 20030601 |
| A phase I study of gemcitabine and docetaxel for advanced stage solid tumors. | Cancer investigation 20030601 |
| Pancreatic cancer. | Clinical evidence 20030601 |
| NICE recommends new treatment for breast and bowel cancer. | BMJ (Clinical research ed.) 20030531 |
| Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. | Oncogene 20030522 |
| Structural basis for feedback inhibition of the deoxyribonucleoside salvage pathway: studies of the Drosophila deoxyribonucleoside kinase. | Biochemistry 20030520 |
| Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells. | Journal of immunology (Baltimore, Md. : 1950) 20030515 |
| High-resolution magnetic resonance imaging of the efficacy of the cytosine analogue 1-[2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl]-N(4)-palmitoyl cytosine (CS-682) in a liver-metastasis athymic nude mouse model. | Cancer research 20030515 |
| Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibody. | The Journal of surgical research 20030515 |
| Developmental chemotherapy and management of recurrent ovarian cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030515 |
| A novel cytidine deaminase AIDs in the delivery of error-prone polymerases to immunoglobulin genes. | DNA repair 20030513 |
| Circulating nucleosomes and response to chemotherapy: an in vitro, in vivo and clinical study on cervical cancer patients. | International journal of cancer 20030510 |
| Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivo. | Mutation research 20030509 |
| Inactivation of deoxycytidine kinase and overexpression of P-glycoprotein in AraC and daunorubicin double resistant leukemic cell lines. | Leukemia research 20030501 |
| Chemotherapeutic advances in pancreatic cancer. | Current oncology reports 20030501 |
| The molecular targets of antitumor 2'-deoxycytidine analogues. | Current drug targets 20030501 |
| Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors. | Annals of oncology : official journal of the European Society for Medical Oncology 20030501 |
| Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine. | Lung cancer (Amsterdam, Netherlands) 20030501 |
| Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: a multicentre study of galician-lung-cancer-group. | Lung cancer (Amsterdam, Netherlands) 20030501 |
| A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older. | Lung cancer (Amsterdam, Netherlands) 20030501 |
| Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy. | Cancer 20030501 |
| Weekly paclitaxel and gemcitabine chemotherapy for metastatic non-small cell lung carcinoma (NSCLC): a dose-optimizing phase II trial. | Cancer 20030501 |
| Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia. | Annals of surgical oncology 20030501 |
| Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030501 |
| Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude mice. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030501 |
| [Transarterial chemoperfusion of inoperable pancreas carcinoma and local recurrence]. | RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 20030501 |
| Exudative hyponychial dermatitis associated with capecitabine and docetaxel combination chemotherapy for metastatic breast carcinoma: report of three cases. | The British journal of dermatology 20030501 |
| [Malignant pleural mesothelioma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030501 |
| [Pancreatic cancer--diagnostics and therapy]. | Zentralblatt fur Chirurgie 20030501 |
| [Adjuvant treatment of pancreatic cancer]. | Zentralblatt fur Chirurgie 20030501 |
| New chemotherapy agents in veterinary medicine. | The Veterinary clinics of North America. Small animal practice 20030501 |
| Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: the capecitabine experience. | Investigational new drugs 20030501 |
| Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma. | British journal of cancer 20030422 |
| Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer. | International journal of cancer 20030420 |
| Phase II trial of gemcitabine in patients with advanced sarcomas (E1797): a trial of the Eastern Cooperative Oncology Group. | Cancer 20030415 |
| Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer. | Cancer 20030415 |
| Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030415 |
| Mechanism of DNA strand breakage induced by photosensitized tetracycline-Cu(II) complex. | Mutation research 20030409 |
| Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemia. | Leukemia research 20030401 |
| Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines. | Molecular pharmacology 20030401 |
| Activity of raltitrexed and gemcitabine in advanced pancreatic cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20030401 |
| Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20030401 |
| Sustained partial response of an intra-abdominal desmoid tumor treated with gemcitabine, 5-fluorouracil and leucovorin. | Annals of oncology : official journal of the European Society for Medical Oncology 20030401 |
| The radiosensitising effect of gemcitabine and the influence of the rescue agent amifostine in vitro. | European journal of cancer (Oxford, England : 1990) 20030401 |
| A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20030401 |
| Gemcitabine and carboplatin in patients with locally advanced or metastatic non-small cell lung cancer: a prospective phase II study. | Lung cancer (Amsterdam, Netherlands) 20030401 |
| Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis--a case report. | Lung cancer (Amsterdam, Netherlands) 20030401 |
| Current Canadian experience with capecitabine: partnering with patients to optimize therapy. | Cancer nursing 20030401 |
| Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030401 |
| Gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer: a prospective observational study. | Expert opinion on pharmacotherapy 20030401 |
| Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies. | Anti-cancer drugs 20030401 |
| [Comparison of cisplatin combined with gemcitabine versus cisplatin combined with vinorelbine regimen for treatment of patients with advanced non-small cell lung cancer]. | Ai zheng = Aizheng = Chinese journal of cancer 20030401 |
| Phase II trial of the use of gemcitabine and 5-fluorouracil in the treatment of advanced pancreatic and biliary tract cancer. | American journal of clinical oncology 20030401 |
| Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder. | American journal of clinical oncology 20030401 |
| Active chemotherapy for bone metastasis in sarcomatoid renal cell carcinoma. | International journal of clinical oncology 20030401 |
| Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer. | Cancer chemotherapy and pharmacology 20030401 |
| Monotherapy options in the management of metastatic breast cancer. | Seminars in oncology 20030401 |
| Gemcitabine and anthracyclines in breast cancer. | Seminars in oncology 20030401 |
| Gemcitabine combined with docetaxel in metastatic breast cancer. | Seminars in oncology 20030401 |
| Gemcitabine combined with paclitaxel or paclitaxel/trastuzumab in metastatic breast cancer. | Seminars in oncology 20030401 |
| Gemcitabine and trastuzumab in metastatic breast cancer. | Seminars in oncology 20030401 |
| [Usefulness of gemcitabine in the treatment of advanced pancreatic cancer in terms of its clinical benefits]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030401 |
| [Successful treatment with chemotherapy of vinorelbine and gemcitabine for an elderly patient with advanced non-small cell lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030401 |
| [Gemcitabine improved QOL and survival in a case of diffuse malignant pleural mesothelioma]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030401 |
| Role of capecitabine (Xeloda) in breast cancer. | Expert review of anticancer therapy 20030401 |
| Hydrolytic nucleoside and nucleotide deamination, and genetic instability: a possible link between RNA-editing enzymes and cancer? | Trends in molecular medicine 20030401 |
| Evaluation of (E)-2'-deoxy-2'-(fluoromethylene)cytidine on the 9L rat brain tumor model using MRI. | NMR in biomedicine 20030401 |
| A pilot study of edrecolomab (Panorex, 17-1A antibody) and capecitabine in patients with advanced or metastatic adenocarcinoma. | Cancer investigation 20030401 |
| Combination chemotherapy with gemcitabine and vinorelbine in the treatment of patients with relapsed or refractory small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network. | Cancer investigation 20030401 |
| Synergistic effect of sequential administration of mitoguazone (MGBG) and gemcitabine in treating tissue cultured human breast cancer cells and mammary rat tumors. | Cancer investigation 20030401 |
| Gemcitabine/vinorelbine in metastatic breast cancer patients previously treated with anthracyclines: results of a phase II trial. | Clinical breast cancer 20030401 |
| The evolving role of capecitabine in breast cancer. | Clinical breast cancer 20030401 |
| Treatment of a patient with advanced esophageal cancer with a combination of mitomycin C and capecitabine: activation of the thymidine phosphorylase as active principle? | Onkologie 20030401 |
| [Asbestos--gemcitabin. Combined risk for pulmonary toxicity?]. | Revue des maladies respiratoires 20030401 |
| [Acute pulmonary toxicity due to gemcitabine: a role for asbestos exposure?]. | Revue des maladies respiratoires 20030401 |
| Palliative chemotherapy in patients with salivary gland neoplasms and preliminary reports of 2 recent phase II studies with trastuzumab and gemcitabine. | Clinical advances in hematology & oncology : H&O 20030401 |
| DFT analysis of NMR scalar interactions across the glycosidic bond in DNA. | Journal of the American Chemical Society 20030326 |
| Synthesis of 3'- and 5'-nitrooxy pyrimidine nucleoside nitrate esters: 'nitric oxide donor' agents for evaluation as anticancer and antiviral agents. | Journal of medicinal chemistry 20030313 |
| Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine. | Bioorganic & medicinal chemistry letters 20030310 |
| Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer. | British journal of cancer 20030310 |
| Chemotherapy for elderly patients with advanced non-small-cell lung cancer. | Journal of the National Cancer Institute 20030305 |
| Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. | Journal of the National Cancer Institute 20030305 |
| Effects of base sequence context on translesion synthesis past a bulky (+)-trans-anti-B[a]P-N2-dG lesion catalyzed by the Y-family polymerase pol kappa. | Biochemistry 20030304 |
| Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20030301 |
| Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma. | Cancer 20030301 |
| A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease. | Cancer 20030301 |
| Phosphorylation of 4'-thio-beta-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinase. | The Journal of pharmacology and experimental therapeutics 20030301 |
| Phase I/II trial of gemcitabine plus cisplatin and etoposide in patients with small-cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20030301 |
| The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study. | Breast cancer research and treatment 20030301 |
| Modification by fluoride, bromide, iodide, thiocyanate and nitrite anions of reaction of a myeloperoxidase-H2O2-Cl- system with nucleosides. | Chemical & pharmaceutical bulletin 20030301 |
| Relative anti-HIV-1 efficacy of lamivudine and emtricitabine in vitro is dependent on cell type. | Journal of acquired immune deficiency syndromes (1999) 20030301 |
| Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver. | European journal of cancer (Oxford, England : 1990) 20030301 |
| Population pharmacokinetics and concentration-effect relationships of capecitabine metabolites in colorectal cancer patients. | British journal of clinical pharmacology 20030301 |
| An overview of current results with the gemcitabine and docetaxel combination as initial and salvage chemotherapy regimen in advanced non-small cell lung cancer. | Critical reviews in oncology/hematology 20030301 |
| [Adjuvant and additive therapy for cancer of the pancreas]. | Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20030301 |
| Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma. | British journal of haematology 20030301 |
| Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer. | Gynecologic oncology 20030301 |
| Comparison of cytotoxicity of 2-chloro- 2'-arabino-fluoro-2'-deoxyadenosine (clofarabine) with cladribine in mononuclear cells from patients with acute myeloid and chronic lymphocytic leukemia. | Haematologica 20030301 |
| Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies. | Cancer chemotherapy and pharmacology 20030301 |
| Pharmacokinetics of gemcitabine in a patient with end-stage renal disease: effective clearance of its main metabolite by standard hemodialysis treatment. | Cancer chemotherapy and pharmacology 20030301 |
| [Pancreatic carcinoma--overcome technically but not oncologically]. | Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20030301 |
| [Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis]. | Revue medicale de Liege 20030301 |
| Introduction of the alpha-P-borano-group into deoxynucleoside triphosphates increases their selectivity to HIV-1 reverse transcriptase relative to DNA polymerases. | Nucleosides, nucleotides & nucleic acids 20030301 |
| Effects of intraperitoneal administration of gemcitabine and paclitaxel on hepatic regeneration in rats. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20030301 |
| Kinetic properties of mutant human thymidine kinase 2 suggest a mechanism for mitochondrial DNA depletion myopathy. | The Journal of biological chemistry 20030227 |
| Measurement of the anti-cancer agent gemcitabine in human plasma by high-performance liquid chromatography. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030225 |
| Factors that contribute to efficient catalytic activity of a small Ca2+-dependent deoxyribozyme in relation to its RNA cleavage function. | Biochemistry 20030225 |
| Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer. | British journal of cancer 20030224 |
| Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia. | Blood 20030215 |
| Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes. | Biochemical pharmacology 20030215 |
| Activation of deoxycytidine kinase by UV-C-irradiation in chronic lymphocytic leukemia B-lymphocytes. | Biochemical pharmacology 20030215 |
| Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder: a phase I and pharmacokinetic study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215 |
| Timing is everything, or could be. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215 |
| Gemcitabine and vinorelbine followed by docetaxel in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial of nonplatinum sequential triplet combination chemotherapy (JMTO LC00-02). | British journal of cancer 20030210 |
| High-throughput genotyping by DHPLC of the dihydropyrimidine dehydrogenase gene implicated in (fluoro)pyrimidine catabolism. | International journal of oncology 20030201 |
| (-)-Epigallocatechin-3-gallate enhances anti-tumor effect of cytosine arabinoside on HL-60 cells. | Acta pharmacologica Sinica 20030201 |
| Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). | Annals of oncology : official journal of the European Society for Medical Oncology 20030201 |
| Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20030201 |
| A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors. | Annals of oncology : official journal of the European Society for Medical Oncology 20030201 |
| Increasing-dose gemcitabine plus low-dose cisplatin in metastatic non-small cell lung cancer. | Anti-cancer drugs 20030201 |
| Capecitabine treatment results in increased mean corpuscular volume of red blood cells in patients with advanced solid malignancies. | Anti-cancer drugs 20030201 |
| A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030201 |
| Capecitabine induces rapid, sustained response in two patients with extensive oral verrucous carcinoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030201 |
| Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030201 |
| In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030201 |
| Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma. | American journal of clinical oncology 20030201 |
| Radiation enhancement by gemcitabine-mediated cell cycle modulations. | American journal of clinical oncology 20030201 |
| Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale. | Lung cancer (Amsterdam, Netherlands) 20030201 |
| A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20030201 |
| Extensive cutaneous metastasis of transitional cell carcinoma of the bladder. | International journal of urology : official journal of the Japanese Urological Association 20030201 |
| [Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective]. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20030201 |
| Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabine. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20030201 |
| Novel monoclonal antibody recognition of oxidative DNA damage adduct, deoxycytidine-glyoxal. | Laboratory investigation; a journal of technical methods and pathology 20030201 |
| Gemcitabine in transitional cell carcinoma of the urothelium. | Expert review of anticancer therapy 20030201 |
| Hormone-refractory prostate cancer responding to capecitabine. | Urology 20030201 |
| Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cells. | Urology 20030201 |
| Gemcitabine combined with sequential paclitaxel and carboplatin in patients with urothelial cancers and other advanced malignancies. | Medical science monitor : international medical journal of experimental and clinical research 20030201 |
| Overview of gemcitabine triplets in metastatic bladder cancer. | Critical reviews in oncology/hematology 20030201 |
| [A phase I study of gemcitabine and irinotecan as second line treatment for advanced non-small cell lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030201 |
| [A case of liver metastasis of pancreatic duct carcinoma successfully treated with gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030201 |
| [Cladribine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030201 |
| The combination of capecitabine and oxaliplatin in metastatic colorectal cancer. | Clinical colorectal cancer 20030201 |
| High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study. | Bone marrow transplantation 20030201 |
| Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survival. | The Journal of surgical research 20030201 |
| A balanced deoxyribonucleoside mixture increased the rate of DNA incorporation of 5-[125I]Iodo-2'-deoxyuridine in glioblastoma cells. | Cancer biotherapy & radiopharmaceuticals 20030201 |
| CD4+ CD56+ neoplasia: clinical and biological features with emphasis on cytotoxic drug-induced apoptosis and expression of sialyl Lewis X. | Leukemia & lymphoma 20030201 |
| [Mucinous adenocarcinoma of the urachus]. | Actas urologicas espanolas 20030201 |
| Striking ability of adenosine-2'(3')-deoxy-3'(2')-triphosphates and related analogues to replace ATP as phosphate donor for all four human, and the Drosophila melanogaster, deoxyribonucleoside kinases. | Nucleosides, nucleotides & nucleic acids 20030201 |
| Hydrodynamic and spectroscopic studies of substrate binding to human recombinant deoxycytidine kinase. | Nucleosides, nucleotides & nucleic acids 20030201 |
| Synthesis, conformation, and antiviral activity of 5-methoxymethyl-2'-deoxycytidine analogs. | Nucleosides, nucleotides & nucleic acids 20030201 |
| Zero-mode waveguides for single-molecule analysis at high concentrations. | Science (New York, N.Y.) 20030131 |
| Design and analysis of non-inferiority mortality trials in oncology. | Statistics in medicine 20030130 |
| The reactions of cytidine and 2'-deoxycytidine with SO4.- revisited. Pulse radiolysis and product studies. | Organic & biomolecular chemistry 20030121 |
| Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance. | Biochemical pharmacology 20030115 |
| DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin. | Biochemical pharmacology 20030115 |
| Deoxycytidine glyoxal: lesion induction and evidence of repair following vitamin C supplementation in vivo. | Free radical biology & medicine 20030115 |
| Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: implications for monotherapy and combination treatment. | Cancer letters 20030110 |
| Liquid chromatography-mass spectrometry method for the analysis of the anti-cancer agent capecitabine and its nucleoside metabolites in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030105 |
| Combined intrapleural and intravenous chemotherapy, and pulmonary irradiation, for treatment of patients with lung cancer presenting with malignant pleural effusion. A pilot study. | Oncology 20030101 |
| Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer. | Oncology 20030101 |
| Effect of gemcitabine and cis-platinum combinations on ribonucleotide and deoxyribonucleotide pools in ovarian cancer cell lines. | International journal of oncology 20030101 |
| Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20030101 |
| A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors. | Cancer 20030101 |
| Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies. | Cancer 20030101 |
| Phase I study of the combination of gemcitabine and nedaplatin for treatment of previously untreated advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20030101 |
| Carboplatin and gemcitabine in stage IV non small cell lung cancer: beyond cisplatin in palliative chemotherapy. | Lung cancer (Amsterdam, Netherlands) 20030101 |
| Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20030101 |
| Electron capture dissociation and infrared multiphoton dissociation of oligodeoxynucleotide dications. | Journal of the American Society for Mass Spectrometry 20030101 |
| Gemcitabine reverses cisplatin resistance: demonstration of activity in platinum- and multidrug-resistant ovarian and peritoneal carcinoma. | Gynecologic oncology 20030101 |
| Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients. | Gynecologic oncology 20030101 |
| Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030101 |
| Reproductive toxicology profile of emtricitabine in mice and rabbits. | Reproductive toxicology (Elmsford, N.Y.) 20030101 |
| Capecitabine: a review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer. | Drugs 20030101 |
| Efficacy of camptothecin analog DX-8951f (Exatecan Mesylate) on human pancreatic cancer in an orthotopic metastatic model. | Cancer research 20030101 |
| The mechanism of action of radiosensitization of conventional chemotherapeutic agents. | Seminars in radiation oncology 20030101 |
| Clustering of nucleosides in the presence of alkali metals: Biologically relevant quartets of guanosine, deoxyguanosine and uridine observed by ESI-MS/MS. | Journal of mass spectrometry : JMS 20030101 |
| A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030101 |
| Palliative chemotherapy with gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in metastatic biliary tract and gall bladder adenocarcinomas. | Anti-cancer drugs 20030101 |
| [Two cases of complete response to combination chemotherapy of gemcitabine and docetaxel for recurrent ovarian cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20030101 |
| Capecitabine and PPE syndrome: a case report. | The breast journal 20030101 |
| Restoring apoptosis in pancreatic cancer cells by targeting the nuclear factor-kappaB signaling pathway with the anti-epidermal growth factor antibody IMC-C225. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20030101 |
| Weekly gemcitabine and 24-hour infusional 5-fluorouracil in advanced pancreatic cancer: a phase I-II study. | Oncology 20030101 |
| Emtricitabine: 524W91, BW524W91, Coviracil, FTC. | Drugs in R&D 20030101 |
| [Gemcitabine in advanced bladder cancer]. | Der Urologe. Ausg. A 20030101 |
| Antineoplastic therapy in colorectal cancer through proteasome inhibition. | The American surgeon 20030101 |
| 27th ESMO Congress, Nice, 18-22 October 2002. Iressa disappoints in NSCLC. | European journal of cancer (Oxford, England : 1990) 20030101 |
| [Gemcitabine treatment of pancreatic cancer peritonitis]. | Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20030101 |
| Phase I study of oral CI-994 in combination with gemcitabine in treatment of patients with advanced cancer. | Cancer journal (Sudbury, Mass.) 20030101 |
| [Preclinical studies of concomitant chemoradiation]. | Medicina (Kaunas, Lithuania) 20030101 |
| Cardiotoxicity and capecitabine: a case report. | Clinical journal of oncology nursing 20030101 |
| Phase I trial of gemcitabine and paclitaxel in advanced solid tumors. | Cancer investigation 20030101 |
| Developments in the systemic therapy of pancreatic cancer. | Cancer investigation 20030101 |
| Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments. | Cancer investigation 20030101 |
| Anti-HIV drug updates--three drugs on the near horizon. | Project Inform perspective 20030101 |
| Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20030101 |
| In vitro studies on the immunosuppressive effect of 2',2'-difluorodeoxycytidine (dFdC) and its metabolite 2',2'-difluorodeoxyuridine (dFdU). | Immunobiology 20030101 |
| Synergistic cytotoxic effect of TRAIL and gemcitabine in pancreatic cancer cells. | Anticancer research 20030101 |
| Role of gemcitabine in the treatment of advanced and metastatic breast cancer. | Oncology 20030101 |
| A pilot phase II study of capecitabine in advanced or recurrent gastric cancer. | Oncology 20030101 |
| Efficacy of gemcitabine in heavily pretreated advanced ovarian cancer patients. | European journal of gynaecological oncology 20030101 |
| [Combination chemotherapy with Hemzar (gemcitabine) and cisplatin for relapsing and cisplatin-resistant ovarian cancer]. | Voprosy onkologii 20030101 |
| [Metastatic breast cancer]. | Krankenpflege Journal 20030101 |
| Delayed addition of deoxycytidine protects normal CD34+ cells against cytotoxicity of gemcitabine without compromising its activity against human leukemic cells. | Stem cells (Dayton, Ohio) 20030101 |
| Decitabine: 2'-deoxy-5-azacytidine, Aza dC, DAC, dezocitidine, NSC 127716. | Drugs in R&D 20030101 |
| Gemcitabine plus irinotecan in breast cancer patients pretreated with taxanes and anthracyclines: a multicenter phase II study. | Oncology 20030101 |
| Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study. | Oncology 20030101 |
| Analysis of urinary nucleosides. III. Identification of 5'-deoxycytidine in urine of a patient with head and neck cancer. | Rapid communications in mass spectrometry : RCM 20030101 |
| Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. | Molecular cancer 20030101 |
| Population-based pharmacoeconomic model for adopting capecitabine/docetaxel combination treatment for anthracycline-pretreated metastatic breast cancer. | The oncologist 20030101 |
| [Experience with xeloda (capecitabine) as a component of chemotherapy for relapsing cisplatin-resistant ovarian tumors]. | Voprosy onkologii 20030101 |
| Radiological measurement of breast cancer metastases to lung and liver: comparison between WHO (bidimensional) and RECIST (unidimensional) guidelines. | Journal of computer assisted tomography 20030101 |
| Irinotecan in metastatic colorectal cancer: dose intensification and combination with new agents, including biological response modifiers. | Annals of oncology : official journal of the European Society for Medical Oncology 20030101 |
| DNA damage caused by lipid peroxidation products. | Cellular & molecular biology letters 20030101 |
| Gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the urothelium: a pilot study. | Anticancer research 20030101 |
| Radiation therapy with once-weekly gemcitabine in pancreatic cancer: current status of clinical trials. | International journal of radiation oncology, biology, physics 20030101 |
| Chemotherapy for advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20030101 |
| Newer approaches to gemcitabine-based therapy of pancreatic cancer: fixed-dose-rate infusion and novel agents. | International journal of radiation oncology, biology, physics 20030101 |
| Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials. | International journal of radiation oncology, biology, physics 20030101 |
| [Capecitabine: an oral chemotherapeutic agent against metastatic breast and colorectal cancer]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20030101 |
| Gemcitabine plus cisplatin in adjuvant regimen for bladder cancer. Toxicity evaluation. | Urologia internationalis 20030101 |
| Cardiac toxicity associated with capecitabine therapy. | Acta oncologica (Stockholm, Sweden) 20030101 |
| [Case report: Acro-necrosis of the upper limbs caused by gemcitabine therapy]. | La Clinica terapeutica 20030101 |
| Treatment of advanced disease and new drugs. | I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20030101 |
| Xeloda and Taxotere: a review of the development of the combination for use in metastatic breast cancer. | International journal of clinical practice 20030101 |
| Breast cancer--response rates to chemotherapeutic agents studied in vitro. | Anticancer research 20030101 |
| Gemcitabine and docetaxel after failure of cisplatin-based chemotherapy in patients with carcinoma of unknown primary site. | Anticancer research 20030101 |
| Gemcitabine and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results. | Anticancer research 20030101 |
| Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR products. | Journal of clinical laboratory analysis 20030101 |
| [Effectiveness of Gemzar-Cisplatin therapy in stage IIIA-N2, IIIB and IV non-small cell lung cancer]. | Magyar onkologia 20030101 |
| [Gemcitabine-cisplatin combination in the first line treatment of non-small cell lung cancer. Our experience and analysis of safety]. | Magyar onkologia 20030101 |
| [Experience with the treatment of advanced pancreatic cancer in Hungary]. | Magyar onkologia 20030101 |
| [Role of gemcitabine/cisplatin in the treatment of advanced and metastatic bladder cancer]. | Magyar onkologia 20030101 |
| Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20030101 |
| Simultaneous incorporation of three different modified nucleotides during PCR. | Nucleic acids research. Supplement (2001) 20030101 |
| Highly chemo- and regioselective phosphitylation of 2'-deoxyribonucleosides. | Nucleic acids research. Supplement (2001) 20030101 |
| Chemo-enzymatic syntheses of natural and unnatural 2'-deoxynucleosides. | Nucleic acids research. Supplement (2001) 20030101 |
| Gemcitabine as a radiosensitizer for nonresectable feline oral squamous cell carcinoma. | Journal of the American Animal Hospital Association 20030101 |
| Synergistic activity of gamma-linolenic acid and cytotoxic drugs against pancreatic adenocarcinoma cell lines. | Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20030101 |
| Biweekly low-dose sequential gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (GFP): a highly active novel therapy for metastatic adenocarcinoma of the exocrine pancreas. | Cancer investigation 20030101 |
| Combined therapy with topotecan and gemcitabine in patients with inoperable or metastatic non-small cell lung cancer. | Cancer investigation 20030101 |
| A phase I human trial of mitoguazone and gemcitabine sequential bi-weekly treatment of cancer patients. | Cancer investigation 20030101 |
| Large cell neuroendocrine carcinoma of the urinary bladder with lymphoepithelioma-like features. | Pathology, research and practice 20030101 |
| Pyrazolo[3,4-d]pyrimidine nucleic acids: adjustment of the dA-dT to the dG-dC base pair stability. | Nucleosides, nucleotides & nucleic acids 20030101 |
| Structural basis for topoisomerase I inhibition by nucleoside analogs. | Nucleosides, nucleotides & nucleic acids 20030101 |
| The regiospecific one-pot phosphorylation of either the 5'- or 2'-hydroxyl in 3'-deoxycytidines without protection: critical role of the base. | Nucleosides, nucleotides & nucleic acids 20030101 |
| Monoval-LdC: efficient prodrug of 2'-deoxy-beta-L-cytidine (L-dC), a potent and selective anti-HBV agent. | Nucleosides, nucleotides & nucleic acids 20030101 |
| A new class of Spiegelmers containing 2'-fluoro-nucleotides. | Nucleosides, nucleotides & nucleic acids 20030101 |
| Commercial-scale synthesis of protected 2'-deoxycytidine and cytidine nucleosides. | Nucleosides, nucleotides & nucleic acids 20030101 |
| Incorporation of (alpha-P-borano)-2',3'-dideoxycytidine 5'-triphosphate into DNA by drug-resistant MMLV reverse transcriptase and Taq DNA polymerase. | Nucleosides, nucleotides & nucleic acids 20030101 |
| [The update on pancreatic cancer chemotherapy]. | Medicina (Kaunas, Lithuania) 20030101 |
| Decitabine: 2'-deoxy-5-azacytidine, Aza dC, DAC, dezocitidine, NSC 127716. | Drugs in R&D 20030101 |
| Antiblastic drug combinations with ifosfamide: an update. | Oncology 20030101 |
| Ifosfamide in non-small cell lung cancer. | Oncology 20030101 |
| Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation. | Health technology assessment (Winchester, England) 20030101 |
| Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives. | Tumori 20030101 |
| A phase I study of gemcitabine combined with vinblastine in patients with solid tumors. | Tumori 20030101 |
| Emtricitabine: an antiretroviral agent for HIV infection. | Drugs 20030101 |
| A novel biweekly schedule with cisplatin and gemcitabine in advanced non-small cell lung cancer. | International journal of clinical pharmacology research 20030101 |
| Phase II trial of a 24-hour infusion of gemcitabine in previously untreated patients with advanced pancreatic adenocarcinoma. | Cancer investigation 20030101 |
| Improving first-line therapy of advanced ovarian cancer - the AGO Ovarian Cancer Study Group perspective. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20030101 |
| Elderly patients with advanced non-small cell lung cancer. A pase II study with weekly cisplatin and gemcitabine. | Oncology 20030101 |
| Phase II study of gemcitabine plus docetaxel in advanced pancreatic cancer: a Hoosier Oncology Group study. | Oncology 20030101 |
| Forced expression of cytidine deaminase confers sensitivity to capecitabine. | Oncology 20030101 |
| Irinotecan and gemcitabine in patients with advanced non-small cell lung cancer, previously treated with cisplatin-based chemotherapy. A phase II study. | Anticancer research 20030101 |
| [Use of xeloda (capecitabine) in the treatment of cancer patients (review)]. | Terapevticheskii arkhiv 20030101 |
| Complete and sustained remission of refractory cervical cancer following a single cycle of capecitabine. A case report. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20030101 |
| [Arterial oil chemoembolization: a new method of treatment for pancreatic cancer]. | Voprosy onkologii 20030101 |
| Three new drugs approved by FDA. | Survival news (Atlanta, Ga.) 20030101 |
| Pharmacology of oral chemotherapy agents. | Clinical journal of oncology nursing 20030101 |
| Medication sheets for patients. Oral chemotherapy. | Clinical journal of oncology nursing 20030101 |
| [New: gemzar plus taxan in metastatic breast carcinoma. Optimal combination]. | Krankenpflege Journal 20030101 |
| Taxol plus gemcitabine and vinorelbine given every other week in advanced chemo-naïve non-small cell lung cancer patients. | Oncology 20030101 |
| Entecavir, FTC, L-FMAU, LdT and others. | Journal of hepatology 20030101 |
| Treatment of HBeAg negative chronic hepatitis B with new drugs (adefovir and others). | Journal of hepatology 20030101 |
| The anticancer drug cytarabine does not interact with the human erythrocyte membrane. | Zeitschrift fur Naturforschung. C, Journal of biosciences 20030101 |
| Death receptor 5 and Bcl-2 protein expression as predictors of tumor response to gemcitabine and cisplatin in patients with advanced non-small-cell lung cancer. | Medical oncology (Northwood, London, England) 20030101 |
| Gemcitabine and reactivation of hepatitis B. | Medical oncology (Northwood, London, England) 20030101 |
| Alternating doublets: establishing the optimal multifractionated dosing schedule to administer docetaxel, cisplatin, gemcitabine, and vinorelbine in combination. | Cancer investigation 20030101 |
| A study of the influence of newly synthesized acyclonucleosides and 1,2,3,4-tetrahydroisoquinoline derivatives on deoxythymidine and deoxycytidine kinase activities in human neurofibrosarcoma and ovarian cancer. | Acta biochimica Polonica 20030101 |
| New developments in systemic chemotherapy in advanced colorectal cancer. | Scandinavian journal of gastroenterology. Supplement 20030101 |
| [Systemic treatment of colorectal cancers--factual standards and perspectives]. | Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20030101 |
| DNA double strand breaks occur independent of AID in hypermutating Ig genes. | Clinical & developmental immunology 20030101 |
| Short-time infusion of oxaliplatin (Eloxatin) in combination with capecitabine (Xeloda) in patients with advanced colorectal cancer. | Acta oncologica (Stockholm, Sweden) 20030101 |
| Preclinical evaluation of gemcitabine/paclitaxel-interactions in human bladder cancer lines. | Anticancer research 20030101 |
| Unusual covalent bond-breaking reactions of beta-cyclodextrin inclusion complexes of nucleobases/nucleosides and related guest molecules. | European journal of mass spectrometry (Chichester, England) 20030101 |
| Colon cancer with isolated metastasis to the kidney at the time of initial diagnosis. | International journal of gastrointestinal cancer 20030101 |
| Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas. | International journal of gastrointestinal cancer 20030101 |
| Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome. | International journal of gastrointestinal cancer 20030101 |
| Oxy radicals, lipid peroxidation and DNA damage. | Toxicology 20021227 |
| Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma. | Cancer 20021215 |
| Model of chemotherapy-induced myelosuppression with parameter consistency across drugs. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021215 |
| Unusual radiation response of gemcitabine-treated HeLa cells: reduced and enhanced survival. | Cancer letters 20021210 |
| Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study. | British journal of cancer 20021202 |
| Metastatic pancreatic cancer. | Current treatment options in oncology 20021201 |
| Interactions of enantiomers of 2',3'-didehydro-2',3'-dideoxy-fluorocytidine with wild type and M184V mutant HIV-1 reverse transcriptase. | Antiviral research 20021201 |
| Identification of residues involved in the substrate specificity of human and murine dCK. | Biochemical pharmacology 20021201 |
| Adduction of catechol estrogens to nucleosides. | Steroids 20021201 |
| Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. | Cancer chemotherapy and pharmacology 20021201 |
| Fluorouracil for allergic reactions to capecitabine. | The Annals of pharmacotherapy 20021201 |
| Pyogenic granuloma-like lesions during capecitabine therapy. | The British journal of dermatology 20021201 |
| Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20021201 |
| Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20021201 |
| Developing therapeutic pharmaceuticals for the treatment of soft-tissue sarcomas. | Expert opinion on investigational drugs 20021201 |
| Chemotherapy for advanced non-small cell lung cancer (NSCLC). | Lung cancer (Amsterdam, Netherlands) 20021201 |
| Combined platinum containing treatment in NSCLC. | Lung cancer (Amsterdam, Netherlands) 20021201 |
| Two- versus three-drug combinations in the chemotherapy of advanced non-small-cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20021201 |
| Combination chemotherapy without cisplatin in the treatment of advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20021201 |
| The role of chemotherapy (CT) and supportive care (SC) in advanced non-small cell lung cancer (NSCLC). | Lung cancer (Amsterdam, Netherlands) 20021201 |
| Challenging the platinum combinations in the chemotherapy of NSCLC. | Lung cancer (Amsterdam, Netherlands) 20021201 |
| Meeting the chemotherapy needs of elderly and poor performance status patients with NSCLC. | Lung cancer (Amsterdam, Netherlands) 20021201 |
| Identification of adducts derived from reactions of (1-chloroethenyl)oxirane with nucleosides and calf thymus DNA. | Chemical research in toxicology 20021201 |
| Penetration of capecitabine and its metabolites into malignant and healthy tissue of patients with advanced breast cancer. | International journal of clinical pharmacology and therapeutics 20021201 |
| [Weekly administration of gemcitabine in outpatient clinic for non-small cell lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20021201 |
| [Gemcitabine in elderly patients with unresectable pancreas cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20021201 |
| Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking. | Carcinogenesis 20021201 |
| Capecitabine/irinotecan in colorectal cancer: European early-phase data and planned trials. | Oncology (Williston Park, N.Y.) 20021201 |
| Current status of capecitabine in the treatment of colorectal cancer. | Oncology (Williston Park, N.Y.) 20021201 |
| Can capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer? | Oncology (Williston Park, N.Y.) 20021201 |
| Capecitabine and radiation therapy for advanced gastrointestinal malignancies. | Oncology (Williston Park, N.Y.) 20021201 |
| Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity. | Oncology (Williston Park, N.Y.) 20021201 |
| Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbine. | Cancer biotherapy & radiopharmaceuticals 20021201 |
| Preclinical and clinical studies with combinations of pemetrexed and gemcitabine. | Seminars in oncology 20021201 |
| Emerging insights into the biology and therapy of malignant mesothelioma. | Seminars in oncology 20021201 |
| Pemetrexed in the treatment of non-small cell lung cancer. | Seminars in oncology 20021201 |
| Pemetrexed in pancreatic cancer. | Seminars in oncology 20021201 |
| Past and present treatment of pancreatic adenocarcinoma: chemotherapy as a standard treatment modality. | Seminars in oncology 20021201 |
| Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials. | Seminars in oncology 20021201 |
| Future directions in the treatment of pancreatic cancer. | Seminars in oncology 20021201 |
| Review of gemcitabine in biliary tract carcinoma. | Seminars in oncology 20021201 |
| Chemotherapy in biliary tract carcinomas: results in India. | Seminars in oncology 20021201 |
| Chemotherapy for biliary tract cancer in Japan. | Seminars in oncology 20021201 |
| A phase III randomized evaluation of amifostine in stage IIIA/IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification: preliminary findings. | Seminars in oncology 20021201 |
| Five new drugs enter the homestretch. | GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies 20021201 |
| Gemcitabine therapy in patients with advanced pancreatic cancer. | The Korean journal of internal medicine 20021201 |
| Isocratic ion-exchange chromatographic assay for the nucleotide gemcitabine triphosphate in human white blood cells. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20021125 |
| Chemoradiation protocols offer only incremental gains for pancreatic cancer patients. | Journal of the National Cancer Institute 20021120 |
| Impaired 2',3'-dideoxy-3'-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11. | The Biochemical journal 20021115 |
| Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies. | Cancer 20021115 |
| Analytical and pharmacokinetic studies with 5-chloro-2'-deoxycytidine. | Biochemical pharmacology 20021115 |
| Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation. | International journal of radiation oncology, biology, physics 20021115 |
| [Chemotherapy improves prognosis in colorectal carcinoma. Soon oral therapy at home?]. | MMW Fortschritte der Medizin 20021114 |
| Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice. | International journal of cancer 20021110 |
| Phase I study of weekly gemcitabine as a radiation sensitizer for unresectable pancreatic cancer. | International journal of radiation oncology, biology, physics 20021101 |
| Metabolism of capecitabine, an oral fluorouracil prodrug: (19)F NMR studies in animal models and human urine. | Drug metabolism and disposition: the biological fate of chemicals 20021101 |
| Early changes in [18F]FLT uptake after chemotherapy: an experimental study. | European journal of nuclear medicine and molecular imaging 20021101 |
| Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer. | Journal of surgical oncology 20021101 |
| Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021101 |
| CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. | Radiology 20021101 |
| New drugs for patients with pancreatic cancer. | Current opinion in oncology 20021101 |
| Resistance to mitochondrial- and Fas-mediated apoptosis in human leukemic cells with acquired resistance to 9-beta-D-arabinofuranosylguanosine. | Biochemical and biophysical research communications 20021101 |
| Solid-state NMR determination of sugar ring pucker in (13)C-labeled 2'-deoxynucleosides. | Biophysical journal 20021101 |
| A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy. | Annals of oncology : official journal of the European Society for Medical Oncology 20021101 |
| Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas. | Annals of oncology : official journal of the European Society for Medical Oncology 20021101 |
| Gemcitabine and doxorubicin for the treatment of patients with advanced hepatocellular carcinoma: a phase I-II trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20021101 |
| Phase I study of rubitecan and gemcitabine in patients with advanced malignancies. | Annals of oncology : official journal of the European Society for Medical Oncology 20021101 |
| The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia. | Experimental hematology 20021101 |
| Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice. | Clinical cancer research : an official journal of the American Association for Cancer Research 20021101 |
| Gemzar platinum combinations: phase III trials in non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20021101 |
| Gemcitabine (Gemzar)-based induction chemotherapy in non-small-cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20021101 |
| Healthcare outcomes: gemcitabine cost-effectiveness in the treatment of non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20021101 |
| Gemcitabine/carboplatin in advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20021101 |
| Past, present, and future of gemcitabine and carboplatin regimens in advanced non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20021101 |
| Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer? | Lung cancer (Amsterdam, Netherlands) 20021101 |
| Non-platinum gemcitabine combinations in non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20021101 |
| Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium Trial. | Cancer chemotherapy and pharmacology 20021101 |
| Phase I study of eniluracil, oral 5-fluororacil and gemcitabine in patients with advanced malignancy. | Investigational new drugs 20021101 |
| Phase I escalation of gemcitabine combined with protracted oral etoposide in gynecologic malignancies: A Gynecologic Oncology Group study. | Investigational new drugs 20021101 |
| Neoadjuvant chemotherapy with gemcitabine and cisplatin in stage IIIA/B non-small cell lung cancer. | Investigational new drugs 20021101 |
| Excess dNTPs minimize RNA hydrolysis during reverse transcription. | BioTechniques 20021101 |
| [Phase I study of gemcitabine (GEM) and docetaxel (TXT) combination chemotherapy for unresectable non-small-cell lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20021101 |
| [A case of vulval extramammary Paget's disease associated with pancreatic cancer that was successfully treated with chemotherapy]. | Gan to kagaku ryoho. Cancer & chemotherapy 20021101 |
| [A case of pancreatic tail cancer with peritoneal carcinosis treated with gemcitabine hydrochloride]. | Gan to kagaku ryoho. Cancer & chemotherapy 20021101 |
| Caspase activation is required for gemcitabine activity in multiple myeloma cell lines. | Molecular cancer therapeutics 20021101 |
| Highlights from: 27th congress of the European Society for Medical Oncology. Nice, France. October 18-22, 2002. | Clinical colorectal cancer 20021101 |
| [Intra-arterial chemotherapy with gemcitabine (GEM) for unresectable pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20021101 |
| [New data presented at ASCO 2002 concerning non-small cell bronchial cancers]. | Revue de pneumologie clinique 20021101 |
| [New data presented at ASCO 2002 concerning small cell bronchial cancer]. | Revue de pneumologie clinique 20021101 |
| [New therapeutic options for mesothelioma]. | Revue de pneumologie clinique 20021101 |
| [Therapeutic strategies in advanced non-small cell bronchial cancers: platin-based combinations]. | Revue de pneumologie clinique 20021101 |
| [Gemcitabine in the treatment of relapsed or refractory non-Hodgkin's lymphoma]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20021101 |
| Inhibition of the replication of a hepatitis C virus-like RNA template by interferon and 3'-deoxycytidine. | Antiviral chemistry & chemotherapy 20021101 |
| A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma. | Cancer 20021015 |
| A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma. | Cancer 20021015 |
| Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021015 |
| Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma who are not eligible for platinum-based regimens. | Cancer 20021001 |
| Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. | International journal of radiation oncology, biology, physics 20021001 |
| Gemcitabine-associated hemolytic-uremic syndrome. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20021001 |
| Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021001 |
| Radiation recall dermatitis may represent the Koebner phenomenon. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021001 |
| An in vitro tumor model: analysis of angiogenic factor expression after chemotherapy. | Cancer research 20021001 |
| A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20021001 |
| Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale. | Lung cancer (Amsterdam, Netherlands) 20021001 |
| Improved survival in advanced breast cancer with docetaxel and capecitabine in combination: biological synergy or an artefact of trial design? | European journal of cancer (Oxford, England : 1990) 20021001 |
| Capecitabine named-patient programme for patients with advanced breast cancer. the UK experience. | European journal of cancer (Oxford, England : 1990) 20021001 |
| Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20021001 |
| Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20021001 |
| [Effect of preoperative concurrent chemo-radiotherapy for thymic carcinoma]. | Kyobu geka. The Japanese journal of thoracic surgery 20021001 |
| Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy. | American journal of clinical oncology 20021001 |
| Phase I trial of gemcitabine, administered as a standard and constant dose-rate infusion, in combination with paclitaxel in patients with advanced solid tumors (LOA-2). | American journal of clinical oncology 20021001 |
| Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignancies. | American journal of clinical oncology 20021001 |
| Gemcitabine and interferon-alpha 2b in solid tumors: a phase I study in patients with advanced or metastatic non-small cell lung, ovarian, pancreatic or renal cancer. | Anti-cancer drugs 20021001 |
| In vitro preprogramming of marrow stromal cells for myocardial regeneration. | The Annals of thoracic surgery 20021001 |
| Safety experience with IMC-C225, an anti-epidermal growth factor receptor antibody. | Seminars in oncology 20021001 |
| Single-agent vs combination therapy in advanced breast cancer: potential roles of capecitabine. | Oncology (Williston Park, N.Y.) 20021001 |
| Capecitabine and docetaxel in advanced breast cancer: analyses of a phase III comparative trial. | Oncology (Williston Park, N.Y.) 20021001 |
| New directions with capecitabine combinations in advanced breast cancer. | Oncology (Williston Park, N.Y.) 20021001 |
| Current and planned trials with capecitabine in adjuvant/neoadjuvant therapy of breast cancer. | Oncology (Williston Park, N.Y.) 20021001 |
| [Palliative second-line treatment with oxaliplatin, gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in patients with metastatic pancreatic adenocarcinoma]. | Zeitschrift fur Gastroenterologie 20021001 |
| [Severe interstitial pneumonitis related to Gemcitabine]. | Revue des maladies respiratoires 20021001 |
| Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation. | Molecular cancer therapeutics 20021001 |
| Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer Group. | Leukemia & lymphoma 20021001 |
| Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients. | British journal of cancer 20020923 |
| A Phase II trial of topotecan and gemcitabine in patients with previously treated, advanced nonsmall cell lung carcinoma. | Cancer 20020915 |
| Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial. | Cancer 20020915 |
| Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why? | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020915 |
| Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. | Biochemical and biophysical research communications 20020913 |
| Three-bond sugar-base couplings in purine versus pyrimidine nucleosides: a DFT study of Karplus relationships for (3)J(C2/4-H1') and (3)J(C6/8-H1') in DNA. | Journal of the American Chemical Society 20020911 |
| A77 1726 induces differentiation of human myeloid leukemia K562 cells by depletion of intracellular CTP pools. | Molecular pharmacology 20020901 |
| Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a Phase I trial. | International journal of radiation oncology, biology, physics 20020901 |
| Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines. | International journal of radiation oncology, biology, physics 20020901 |
| Phase II trial of weekly intravenous gemcitabine administration with interferon and interleukin-2 immunotherapy for metastatic renal cell cancer. | The Journal of urology 20020901 |
| Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[(18)F]fluoro-3'-deoxythymidine ([(18)F]FLT) in pancreatic cancer cell lines. | European journal of nuclear medicine and molecular imaging 20020901 |
| A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20020901 |
| Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20020901 |
| Photoeruption in a patient treated with capecitabine (Xeloda) for metastatic breast cancer. | Journal of the American Academy of Dermatology 20020901 |
| Mechanisms of resistance to nucleoside analogue chemotherapy in mantle cell lymphoma: a molecular case study. | Leukemia 20020901 |
| Treatment of advanced non-small-cell lung cancer with two-drug combinations. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020901 |
| Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020901 |
| Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas. | The American journal of pathology 20020901 |
| Phase I clinical trials of tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in patients with refractory solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020901 |
| A method to assess genomic DNA methylation using high-performance liquid chromatography/electrospray ionization mass spectrometry. | Analytical chemistry 20020901 |
| Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: a phase II study. | Journal of neuro-oncology 20020901 |
| Chronomodulated chemotherapy in metastatic gastrointestinal cancer combining 5-FU and sodium folinate with oxaliplatin, irinotecan or gemcitabine: the Jena experience in 79 patients. | Journal of cancer research and clinical oncology 20020901 |
| Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers. | Planta 20020901 |
| [Gemcitabine-based chemotherapy for non-small cell lung cancer (NSCLC)--a review of 30 randomized trials]. | Gan to kagaku ryoho. Cancer & chemotherapy 20020901 |
| Topoisomerase I-based nonplatinum combinations in non-small-cell lung cancer. | Oncology (Williston Park, N.Y.) 20020901 |
| Phase I study of gemcitabine in combination with cisplatin, 5-fluorouracil and folinic acid in patients with advanced esophageal cancer. | Anti-cancer drugs 20020901 |
| Phase II study of gemcitabine and cisplatin in chemonaive patients with advanced epithelial ovarian cancer. | Anti-cancer drugs 20020901 |
| Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia. | European journal of haematology 20020901 |
| Gemcitabine and its combinations in the treatment of malignant lymphoma. | Clinical lymphoma 20020901 |
| Transmission of apoptosis in human colorectal tumor cells exposed to capecitabine, Xeloda, is mediated via Fas. | Molecular cancer therapeutics 20020901 |
| Capecitabine induced cutaneous hyperpigmentation: report of a case. | Journal of drugs in dermatology : JDD 20020901 |
| Combination effects of alkylphosphocholines and gemcitabine in malignant and normal hematopoietic cells. | Cancer letters 20020828 |
| The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE). | British journal of cancer 20020827 |
| A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma. | British journal of cancer 20020827 |
| Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II study. | British journal of cancer 20020827 |
| Gemcitabine and platinum combinations in pancreatic cancer. | Cancer 20020815 |
| Gemcitabine in combination with 5-fluorouracil with or without folinic acid in the treatment of pancreatic cancer. | Cancer 20020815 |
| Gemcitabine-based therapy in pancreas cancer: gemcitabine-docetaxel and other novel combinations. | Cancer 20020815 |
| The pemetrexed/gemcitabine combination in pancreatic cancer. | Cancer 20020815 |
| On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer. | Cancer 20020815 |
| New applications of gemcitabine and future directions in the management of pancreatic cancer. | Cancer 20020815 |
| Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine. | Cancer 20020815 |
| A conserved Tyr residue is required for sugar selectivity in a Pol alpha DNA polymerase. | Biochemistry 20020813 |
| Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancer. | Cancer letters 20020808 |
| Incidental surgical findings of a phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20020801 |
| Gemcitabine and vascular toxicity. | Lung cancer (Amsterdam, Netherlands) 20020801 |
| Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. | European journal of cancer (Oxford, England : 1990) 20020801 |
| Ribonucleotide reductase and thymidine phosphorylation: two potential targets of azodicarbonamide. | Biochemical pharmacology 20020801 |
| Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells. | Biochemical pharmacology 20020801 |
| Gemcitabine and the interaction with anticoagulants. | The Lancet. Oncology 20020801 |
| Intravesical therapy for superficial cancer: need for more options. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020801 |
| Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020801 |
| Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020801 |
| Chemotherapy of non-small cell lung cancer in elderly patients. | Current medicinal chemistry 20020801 |
| Gemcitabine (2',2'-difluoro-2'-deoxycytidine), an antimetabolite that poisons topoisomerase I. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020801 |
| Gemcitabine in models of acute and accelerated rejection. | Transplantation proceedings 20020801 |
| Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies. | Annals of oncology : official journal of the European Society for Medical Oncology 20020801 |
| Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20020801 |
| Saturation of DNA mismatch repair and error catastrophe by a base analogue in Escherichia coli. | Genetics 20020801 |
| New drugs and new approaches for the treatment of metastatic urothelial cancer. | World journal of urology 20020801 |
| A report on serious pulmonary toxicity associated with gemcitabine-based therapy. | Investigational new drugs 20020801 |
| Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancer. | Investigational new drugs 20020801 |
| Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas. | Investigational new drugs 20020801 |
| A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinoma. | Investigational new drugs 20020801 |
| Isolation from Nocardioides sp. strain CT16, purification, and characterization of a deoxycytidine deaminase extremely thermostable in the presence of D,L-dithiothreitol. | Bioscience, biotechnology, and biochemistry 20020801 |
| Cytotoxicity of combinations of IFN-beta and chemotherapeutic drugs. | Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20020801 |
| [Clinical pharmacology of nucleoside analogues]. | Bulletin du cancer 20020801 |
| [New neoadjuvant approaches using gemcitabine in non-small-cell lung cancer]. | Bulletin du cancer 20020801 |
| [Combinations of platinum salts and gemcitabine in the treatment of non-small-cell lung cancer]. | Bulletin du cancer 20020801 |
| [Platinum-free gemcitabine-based combinations: an alternative to conventional chemotherapy of non-small-cell lung cancers?]. | Bulletin du cancer 20020801 |
| [Gemcitabine and pancreatic cancer]. | Bulletin du cancer 20020801 |
| [Gemcitabine-based combinations in inoperable pancreatic cancers]. | Bulletin du cancer 20020801 |
| [Gemcitabine and urogenital tumors]. | Bulletin du cancer 20020801 |
| [Gemcitabine and breast cancer]. | Bulletin du cancer 20020801 |
| [Gemicitabine in the treatment of epithelial ovarian cancer]. | Bulletin du cancer 20020801 |
| [Role of gemcitabine in the treatment of other malignant tumors]. | Bulletin du cancer 20020801 |
| [The role of gemcitabine in hematology]. | Bulletin du cancer 20020801 |
| [Combined gemcitabine and radiotherapy]. | Bulletin du cancer 20020801 |
| [Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002) ]. | Bulletin du cancer 20020801 |
| Purine metabolism in leukocytes and erythrocytes in Graves' or Hashimoto's disease. | Endocrine research 20020801 |
| Effects of the epidermal growth factor receptor inhibitor OSI-774, Tarceva, on downstream signaling pathways and apoptosis in human pancreatic adenocarcinoma. | Molecular cancer therapeutics 20020801 |
| Systemic therapy for advanced pancreatic cancer. | Expert review of anticancer therapy 20020801 |
| Formation of 2'-deoxyuridine hydrates upon exposure of nucleosides to gamma radiation and UVC-irradiation of isolated and cellular DNA. | Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20020801 |
| Bayesian two-stage designs for phase II clinical trials. | Statistics in medicine 20020730 |
| Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer. | British journal of cancer 20020715 |
| A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer. | British journal of cancer 20020715 |
| 3'-Azido-2',3'-dideoxythymidine induced deficiency of thymidine kinases 1, 2 and deoxycytidine kinase in H9 T-lymphoid cells. | Biochemical pharmacology 20020715 |
| The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy. | Cancer 20020715 |
| Potential mechanisms of resistance to cytarabine in AML patients. | Leukemia research 20020701 |
| Current therapy for malignant mesothelioma. | Current oncology reports 20020701 |
| Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial. | Lung cancer (Amsterdam, Netherlands) 20020701 |
| A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies. | International journal of radiation oncology, biology, physics 20020701 |
| Long-term follow-up of patients treated with paclitaxel/carboplatin-based chemotherapy for advanced non-small-cell lung cancer: sequential phase II trials of the Minnie Pearl Cancer Research Network. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020701 |
| Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020701 |
| Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020701 |
| Treatment side effects. Case 1. Radiation recall phenomenon after administration of capecitabine. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020701 |
| Pilot study of gemcitabine (10 mg/m(2) per min) and cisplatin. | Cancer chemotherapy and pharmacology 20020701 |
| Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020701 |
| Pharmacokinetics of intrathecal gemcitabine in nonhuman primates. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020701 |
| A metabolic activation mechanism of 7H-dibenzo[c,g]carbazole via o-quinone. Part 2: covalent adducts of 7H-dibenzo[c,g]carbazole-3,4-dione with nucleic acid bases and nucleosides. | Chemical research in toxicology 20020701 |
| Quantification of 2'-fluoro-2'-deoxyuridine and 2'-fluoro-2'-deoxycytidine in DNA and RNA isolated from rats and woodchucks using LC/MS/MS. | Chemical research in toxicology 20020701 |
| Cost-effectiveness of chemotherapy for nonsmall-cell lung cancer. | Current opinion in oncology 20020701 |
| [The mechanism of synergistic interaction between etoposide and cytarabine]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20020701 |
| [An 80-year-old woman with non-resectable pulmonary adenocarcinoma that responded to concomitant use of gemcitabine and vinorelbine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20020701 |
| [Refractory non-small-cell lung cancer responding to combination chemotherapy with gemcitabine and cisplatin]. | Gan to kagaku ryoho. Cancer & chemotherapy 20020701 |
| Selective cytotoxicity of gemcitabine in bladder cancer cell lines. | Anti-cancer drugs 20020701 |
| The impact of drug administration sequence and pharmacokinetic interaction in a phase I study of the combination of docetaxel and gemcitabine in patients with advanced solid tumors. | Anti-cancer drugs 20020701 |
| Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20020701 |
| [Successful salvage chemotherapy with gemcitabine, etoposide and cisplatin for metastatic ureteral cancer: a case report]. | Hinyokika kiyo. Acta urologica Japonica 20020701 |
| Gemcitabine or gemcitabine plus cisplatin for in 42 patients with locally advanced or metastatic pancreatic cancer. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20020701 |
| Synthesis of methylenecyclobutane analogues of nucleosides with axial chirality and their phosphoralaninates: a new pronucleotide effective against Epstein-Barr virus. | Antiviral chemistry & chemotherapy 20020701 |
| Recovery of cyanine-dye nucleotide triphosphates. | Analytical biochemistry 20020615 |
| Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020615 |
| Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020615 |
| [Oral fluoropyrimidines registered for the treatment of metastatic colorectal carcinoma: a possible gain]. | Nederlands tijdschrift voor geneeskunde 20020615 |
| A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma. | Cancer 20020615 |
| Phase II trial of gemcitabine in advanced sarcomas. | Cancer 20020615 |
| Which endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer? | British journal of cancer 20020605 |
| A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer. | British journal of cancer 20020605 |
| Chemical synthesis and biochemical properties of oligonucleotides that contain the (5'S,5S,6S)-5',6-cyclo-5-hydroxy-5,6-dihydro-2'-deoxyuridine DNA lesion. | Chembiochem : a European journal of chemical biology 20020603 |
| Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection. | Antimicrobial agents and chemotherapy 20020601 |
| Gemcitabine-induced radiation recall. | International journal of radiation oncology, biology, physics 20020601 |
| Capecitabine: fulfilling the promise of oral chemotherapy. | Expert opinion on pharmacotherapy 20020601 |
| Gemcitabine in non-small cell lung cancer. | Expert opinion on pharmacotherapy 20020601 |
| Novel treatments and therapies in development for pancreatic cancer. | Expert opinion on investigational drugs 20020601 |
| Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase. | Cancer research 20020601 |
| Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignancies. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020601 |
| Effect of food on the pharmacokinetics of (-) and (+) dOTC when administered as an oral racemate. | Journal of clinical pharmacology 20020601 |
| Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer. | European journal of cancer (Oxford, England : 1990) 20020601 |
| Enhancement of cytarabine sensitivity in squamous cell carcinoma cell line transfected with deoxycytidine kinase. | Archives of otolaryngology--head & neck surgery 20020601 |
| In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia. | British journal of haematology 20020601 |
| Salvage chemotherapy with the gemcitabine/docetaxel combination in non-small cell lung cancer: an overview of recent phase II studies. | Medical science monitor : international medical journal of experimental and clinical research 20020601 |
| New treatment approaches for lung cancer and impact on survival. | Seminars in oncology 20020601 |
| Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors). | Seminars in oncology 20020601 |
| Present and future treatment of pancreatic cancer. | Seminars in oncology 20020601 |
| The present and future of combination chemotherapy in bladder cancer. | Seminars in oncology 20020601 |
| Gemcitabine and pemetrexed (Alimta) in thoracic cancers: present and future perspectives. Introduction and current controversies. | Seminars in oncology 20020601 |
| Early results of a randomized phase III trial of platinum-containing doublets versus a nonplatinum doublet in the treatment of advanced non-small cell lung cancer: European Organization for Research and Treatment of Cancer 08975. | Seminars in oncology 20020601 |
| Gemcitabine versus gemcitabine/carboplatin in advanced non-small cell lung cancer: preliminary findings in a phase III trial of the Swedish Lung Cancer Study Group. | Seminars in oncology 20020601 |
| Gemcitabine induction chemotherapy in non-small cell lung cancer. | Seminars in oncology 20020601 |
| Overexpression of Bax sensitizes human pancreatic cancer cells to apoptosis induced by chemotherapeutic agents. | Cancer chemotherapy and pharmacology 20020601 |
| Docetaxel in the management of advanced or metastatic urothelial tract cancer. | Oncology (Williston Park, N.Y.) 20020601 |
| The URH1 uridine ribohydrolase of Saccharomyces cerevisiae. | Current genetics 20020601 |
| New studies highlight benefit of Xeloda in new combination treatments for colorectal cancer. | Expert review of anticancer therapy 20020601 |
| A dose finding study of carboplatin and gemcitabine in advanced non-small cell lung cancer. | Journal of chemotherapy (Florence, Italy) 20020601 |
| A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20020601 |
| Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20020601 |
| Potential of capecitabine as first-line therapy for metastatic breast cancer: dosing recommendations in patients with diminished renal function. | Annals of oncology : official journal of the European Society for Medical Oncology 20020601 |
| Gemcitabine and targeted therapy in metastatic breast cancer. | Seminars in oncology 20020601 |
| Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20020601 |
| Salvage chemotherapy for advanced sarcoma patients: a single-institution experience survey. | Journal of experimental & clinical cancer research : CR 20020601 |
| Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple myeloma. | Leukemia & lymphoma 20020601 |
| Perspectives and opportunities: Docetaxel in the current and future treatment of non-small cell lung cancer. | Seminars in oncology 20020601 |
| [Ureteroplasty using the appendix: apropos of a case]. | Archivos espanoles de urologia 20020601 |
| High-performance capillary electrophoretic method for the quantification of 5-methyl 2'-deoxycytidine in genomic DNA: application to plant, animal and human cancer tissues. | Electrophoresis 20020601 |
| Watson-Crick base-pairing properties of tricyclo-DNA. | Journal of the American Chemical Society 20020529 |
| Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene. | Biochemical and biophysical research communications 20020524 |
| Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity. | Biochemical and biophysical research communications 20020524 |
| Detection and characterization of DNA adducts formed from metabolites of the fungicide ortho-phenylphenol. | Journal of agricultural and food chemistry 20020522 |
| The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinase. | Biochemistry 20020521 |
| Thymidine kinase in epithelial ovarian cancer: relationship with the other pyrimidine pathway enzymes. | International journal of cancer 20020520 |
| A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer. | British journal of cancer 20020520 |
| A phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma. | Cancer 20020515 |
| Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma. Carboplatin and gemcitabine followed by paclitaxel. | Cancer 20020515 |
| [Renal toxicity with a gemcitabine-cisplatin combination in lung cancer]. | Presse medicale (Paris, France : 1983) 20020511 |
| [New drugs in bronchial cancer]. | Presse medicale (Paris, France : 1983) 20020511 |
| Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines. | British journal of cancer 20020506 |
| Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study. | Lung cancer (Amsterdam, Netherlands) 20020501 |
| Vasculitis due to gemcitabine. | Lung cancer (Amsterdam, Netherlands) 20020501 |
| Is long term gemcitabine useful in small cell lung cancer? | Lung cancer (Amsterdam, Netherlands) 20020501 |
| Conjugates of nucleoside analogs with lactosaminated human albumin to selectively increase the drug levels in liver blood: requirements for a regional chemotherapy. | The Journal of pharmacology and experimental therapeutics 20020501 |
| Comparative evaluation of L-Fd4C and related nucleoside analogs as promising antiviral agents. | Current medicinal chemistry 20020501 |
| A supramicromolar elevation of intracellular free calcium ([Ca(2+)](i)) is consistently required to induce the execution phase of apoptosis. | Cell death and differentiation 20020501 |
| Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels. | Cancer chemotherapy and pharmacology 20020501 |
| Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020501 |
| Barriers to winning the battle with head-and-neck cancer. | International journal of radiation oncology, biology, physics 20020501 |
| Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. | International journal of radiation oncology, biology, physics 20020501 |
| Concurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: from the laboratory to the clinic. | International journal of radiation oncology, biology, physics 20020501 |
| Effect of gemcitabine on acute and late radiation toxicity of skin and underlying soft tissues to single-dose irradiation in a nude mice model. | International journal of radiation oncology, biology, physics 20020501 |
| Evaluation of a gemcitabine-doxorubicin-paclitaxel combination schedule through flow cytometry assessment of apoptosis extent induced in human breast cancer cell lines. | Japanese journal of cancer research : Gann 20020501 |
| Gemcitabine, ifosfamide and Navelbine (GIN): a platinum-free combination in advanced non-small-cell lung cancer (NSCLC). | Cancer chemotherapy and pharmacology 20020501 |
| Overview: gemcitabine as single-agent therapy for advanced breast cancer. | Clinical breast cancer 20020501 |
| Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines. | Clinical breast cancer 20020501 |
| Phase II trial of gemcitabine plus trastuzumab in metastatic breast cancer patients previously treated with chemotherapy: preliminary results. | Clinical breast cancer 20020501 |
| Pemetrexed (Alimta) and gemcitabine in breast cancer patients previously treated with anthracyclines and taxanes. | Clinical breast cancer 20020501 |
| Gemcitabine plus cisplatin for the treatment of metastatic breast cancer. | Clinical breast cancer 20020501 |
| Gemcitabine/anthracycline combinations in metastatic breast cancer. | Clinical breast cancer 20020501 |
| Gemcitabine in combination with vinorelbine for treatment of advanced breast cancer. | Clinical breast cancer 20020501 |
| Neoadjuvant gemcitabine therapy for breast cancer. | Clinical breast cancer 20020501 |
| Gemcitabine in breast cancer: future directions. | Clinical breast cancer 20020501 |
| Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil. | Annals of oncology : official journal of the European Society for Medical Oncology 20020501 |
| Chemotherapy with gemcitabine in patients with gall-bladder carcinoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20020501 |
| [Docetaxel]. | Nihon rinsho. Japanese journal of clinical medicine 20020501 |
| [Gemcitabine]. | Nihon rinsho. Japanese journal of clinical medicine 20020501 |
| [Carboplatin]. | Nihon rinsho. Japanese journal of clinical medicine 20020501 |
| [Chemotherapy for elderly patients with lung cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20020501 |
| Irinotecan and gemcitabine in patients with solid tumors: phase I trial. | Oncology (Williston Park, N.Y.) 20020501 |
| Irinotecan/gemcitabine followed by twice-weekly gemcitabine/radiation in locally advanced pancreatic cancer. | Oncology (Williston Park, N.Y.) 20020501 |
| Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma. | Journal of the European Academy of Dermatology and Venereology : JEADV 20020501 |
| Viral pharmacodynamic model for (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine (emtricitabine) in chronically infected woodchucks. | Antiviral chemistry & chemotherapy 20020501 |
| Capecitabine (Xeloda): from the laboratory to the patient's home. | Clinical colorectal cancer 20020501 |
| Chemoradiation with novel agents for rectal cancer. | Clinical colorectal cancer 20020501 |
| [Gemcitabine-induced thrombotic microangiopathy]. | Presse medicale (Paris, France : 1983) 20020427 |
| Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy. | Cancer research 20020415 |
| Formation of a fairly stable diazoate intermediate of 5-methyl-2'-deoxycytidine by HNO2 and NO, and its implication to a novel mutation mechanism in CpG site. | Bioorganic & medicinal chemistry 20020401 |
| Low morbidity of bronchoplastic procedures after chemotherapy for lung cancer. | Lung cancer (Amsterdam, Netherlands) 20020401 |
| Activity of gemcitabine and carboplatin in advanced non-small cell lung cancer: a phase II trial. | Lung cancer (Amsterdam, Netherlands) 20020401 |
| Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020401 |
| Acute oxaliplatin-induced peripheral nerve hyperexcitability. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020401 |
| Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020401 |
| Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line. | International journal of cancer 20020401 |
| Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. | Cancer research 20020401 |
| An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes. | European journal of cancer (Oxford, England : 1990) 20020401 |
| Enhancement of DNA ligase I level by gemcitabine in human cancer cells. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020401 |
| Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? | International journal of radiation oncology, biology, physics 20020401 |
| [Antitumor activity of combination treatment combining gemcitabine with topotecin against human lung cancer xenografted in nude mice]. | Gan to kagaku ryoho. Cancer & chemotherapy 20020401 |
| Capecitabine in patients with breast cancer relapsing after high-dose chemotherapy plus autologous peripheral stem cell transplantation--a phase II study. | Anti-cancer drugs 20020401 |
| Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages. | Prescrire international 20020401 |
| Capecitabine as second-line treatment for metastatic cholangiocarcinoma: a report of two cases. | Onkologie 20020401 |
| Capecitabine/irinotecan combination regimens in colorectal cancer. | Oncology (Williston Park, N.Y.) 20020401 |
| [Gemcitabine and ionizing radiations: radiosensitization or radio-chemotherapy combination]. | Bulletin du cancer 20020401 |
| Recurrent ovarian cancer as chronic disease. | Oncology (Williston Park, N.Y.) 20020401 |
| [Acute respiratory failure due to Gemcitabine-induced pulmonary toxicity]. | Revue des maladies respiratoires 20020401 |
| Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20020401 |
| Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study. | Annals of oncology : official journal of the European Society for Medical Oncology 20020401 |
| Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors. | Annals of oncology : official journal of the European Society for Medical Oncology 20020401 |
| First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. | Annals of oncology : official journal of the European Society for Medical Oncology 20020401 |
| Epithelial ovarian cancer. | Current treatment options in oncology 20020401 |
| Gemcitabine and radiotherapy in the treatment of brain metastases from transitional cell carcinoma of the bladder: a case report. | Journal of neuro-oncology 20020401 |
| Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity. | Molecular cancer therapeutics 20020401 |
| [Regional intra-arterial infusion chemotherapy for pancreatic cancer: an experimental study]. | Zhonghua yi xue za zhi 20020325 |
| A Bayesian re-assessment of two Phase II trials of gemcitabine in metastatic nasopharyngeal cancer. | British journal of cancer 20020318 |
| Dear doctor: we really are not sure what dose of capecitabine you should prescribe for your patient. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020315 |
| Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock! | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020315 |
| Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020315 |
| Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020315 |
| Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020315 |
| Characterization of human UMP/CMP kinase and its phosphorylation of D- and L-form deoxycytidine analogue monophosphates. | Cancer research 20020315 |
| Selective sensitization of transformed cells to flavopiridol-induced apoptosis following recruitment to S-phase. | Cancer research 20020315 |
| p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma. | Oncogene 20020314 |
| One-pot two-step enzymatic coupling of pyrimidine bases to 2-deoxy-D-ribose-5-phosphate. A new strategy in the synthesis of stable isotope labeled deoxynucleosides. | The Journal of organic chemistry 20020308 |
| A 3-week schedule of gemcitabine plus cisplatin as induction chemotherapy for Stage III non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20020301 |
| Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020301 |
| Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. | European journal of cancer (Oxford, England : 1990) 20020301 |
| Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020301 |
| Real-time quantitative PCR assays for deoxycytidine kinase, deoxyguanosine kinase and 5'-nucleotidase mRNA measurement in cell lines and in patients with leukemia. | Leukemia 20020301 |
| Characterization of nucleoside adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. | Chemical research in toxicology 20020301 |
| Xeloda. Warning: drug interaction increase bleeding risks. | Nursing 20020301 |
| NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial. | Langenbeck's archives of surgery 20020301 |
| [Radiotherapy and chemotherapy for unresectable pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20020301 |
| [An elderly patient with advanced non-small-cell lung cancer that responded remarkably to combination chemotherapy of vinorelbine and gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20020301 |
| Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial. | European journal of cancer (Oxford, England : 1990) 20020301 |
| Antitumor activity of combinations of anti-HER-2 antibody trastuzumab and oral fluoropyrimidines capecitabine/5'-dFUrd in human breast cancer models. | Cancer chemotherapy and pharmacology 20020301 |
| Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients. | Cancer chemotherapy and pharmacology 20020301 |
| Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil. | Annals of oncology : official journal of the European Society for Medical Oncology 20020301 |
| [How I treat ... An advanced pancreatic cancer]. | Revue medicale de Liege 20020301 |
| Crystal structure of the tetrameric cytidine deaminase from Bacillus subtilis at 2.0 A resolution. | Biochemistry 20020226 |
| Synthesis of novel D-2'-deoxy-2'-C-difluoromethylene-4'-thiocytidine as a potential antitumor agent. | Organic letters 20020221 |
| Somatic recombination: a major genotoxic effect of two pyrimidine antimetabolitic chemotherapeutic drugs in Drosophila melanogaster. | Mutation research 20020215 |
| Functional role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells. | Blood 20020215 |
| An evolving role for oral fluoropyrimidine drugs. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020215 |
| Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale. | Cancer 20020215 |
| Modifications of deoxycytidine kinase and deaminase activities by docosahexaenoic acid in normal and transformed rat fibroblasts. | Biochemical pharmacology 20020215 |
| S-acyl-2-thioethyl (SATE) pronucleotides are potent inhibitors of HIV-1 replication in T-lymphoid cells cross-resistant to deoxycytidine and thymidine analogs. | Antiviral research 20020201 |
| Fragmentation of short single DNA strands by 1-30 eV electrons: dependence on base identity and sequence. | International journal of radiation biology 20020201 |
| Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine. | International journal of cancer 20020201 |
| Prolonged infusion of gemcitabine: clinical and pharmacodynamic studies during a phase I trial in relapsed acute myelogenous leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020201 |
| Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020201 |
| Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020201 |
| Severe pulmonary toxicity in a patient treated with gemcitabine. | American journal of clinical oncology 20020201 |
| Gemcitabine-induced pulmonary toxicity: case report and review of the literature. | American journal of clinical oncology 20020201 |
| Inhibition of nuclear factor kappaB chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation. | The Journal of thoracic and cardiovascular surgery 20020201 |
| The role of gemcitabine in the treatment of malignant mesothelioma. | Seminars in oncology 20020201 |
| The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020201 |
| Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside. | Cell death and differentiation 20020201 |
| Second-line treatment of ovarian cancer with single-agent gemcitabine. | Seminars in oncology 20020201 |
| The role of gemcitabine-based doublets in the management of ovarian carcinoma. | Seminars in oncology 20020201 |
| Gemcitabine, platinum, and paclitaxel regimens in patients with advanced ovarian carcinoma. | Seminars in oncology 20020201 |
| Developmental chemotherapy in advanced ovarian cancer: incorporation of newer cytotoxic agents in a phase III randomized trial of the Gynecologic Oncology Group (GOG-0182). | Seminars in oncology 20020201 |
| Rational development of capecitabine. | European journal of cancer (Oxford, England : 1990) 20020201 |
| Clinical experience of capecitabine in metastatic breast cancer. | European journal of cancer (Oxford, England : 1990) 20020201 |
| Capecitabine as first-line treatment in colorectal cancer. Pooled data from two large, phase III trials. | European journal of cancer (Oxford, England : 1990) 20020201 |
| Future treatment options with capecitabine in solid tumours. | European journal of cancer (Oxford, England : 1990) 20020201 |
| Pancreatic cancer: what the oncologist can offer for palliation. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20020201 |
| Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma. | British journal of cancer 20020201 |
| [Hemolytic-uremic syndrome complicating a long-term treatment with gemcitabine. Report of a case and review of the literature]. | La Revue de medecine interne 20020201 |
| Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20020201 |
| Recent development of anti-cancer drugs for treatment of GI malignancies in Japan. | Gan to kagaku ryoho. Cancer & chemotherapy 20020201 |
| Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma - prognostic factors for response and improvement of quality of life. | Onkologie 20020201 |
| Current and future perspectives in advanced bladder cancer: is there a new standard? | Seminars in oncology 20020201 |
| Gemcitabine doublets in advanced urothelial cancer. | Seminars in oncology 20020201 |
| Novel gemcitabine-containing triplets in the management of urothelial cancer. | Seminars in oncology 20020201 |
| Gemcitabine-based combination treatment of pancreatic cancer. | Seminars in oncology 20020201 |
| Brief communication: use of the multitargeted antifolate pemetrexed (Alimta) in genitourinary cancer. | Seminars in oncology 20020201 |
| Future directions for gemcitabine in the treatment of genitourinary cancer. | Seminars in oncology 20020201 |
| Determinants of response and resistance to cytotoxics. | Seminars in oncology 20020201 |
| Eradication of osteosarcoma lung metastasis using intranasal gemcitabine. | Anti-cancer drugs 20020201 |
| Individualized long-term chemotherapy for recurrent ovarian cancer after failing high-dose treatment. | Anti-cancer drugs 20020201 |
| Prediction of the response of colorectal cancer to systemic therapy. | The Lancet. Oncology 20020201 |
| [Developed new agents for lung cancer]. | Nihon Geka Gakkai zasshi 20020201 |
| [New management strategies for hepatitis B]. | Gastroenterologie clinique et biologique 20020201 |
| [Combined radiotherapy and gemcitabine. Evaluation of clinical data based on experimental knowledge]. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20020201 |
| Phase I/II study of 3-week cycle cisplatin-gemcitabine in advanced non-small cell lung cancer. | Japanese journal of clinical oncology 20020201 |
| Molecular basis of 2',3'-dideoxycytidine-induced drug resistance in human cells. | Molecular and cellular biochemistry 20020201 |
| [Interstitial lung disease in a patient given gemcitabine]. | Revue de pneumologie clinique 20020201 |
| Induction of apoptosis by cladribine (2-CdA), gemcitabine and other chemotherapeutic drugs on CD34+/CD38+ and CD34+/CD38- hematopoietic progenitor cells: selective effects of doxorubicin and 2-CdA with protection of immature cells. | Leukemia & lymphoma 20020201 |
| The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: a Southwest Oncology Group study. | Investigational new drugs 20020201 |
| Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancer. | Investigational new drugs 20020201 |
| Durable control of small cell carcinoma of the urinary bladder by gemcitabine and paclitaxel. | International journal of urology : official journal of the Japanese Urological Association 20020201 |
| A comprehensive update on the use of chemotherapy for metastatic pancreatic adenocarcinoma. | Hematology/oncology clinics of North America 20020201 |
| Management of locally advanced adenocarcinoma of the pancreas. | Hematology/oncology clinics of North America 20020201 |
| Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine). | Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20020201 |
| Population pharmacokinetic analysis of the major metabolites of capecitabine. | Journal of pharmacokinetics and pharmacodynamics 20020201 |
| [The new chemotherapy of colorectal cancers]. | Presse medicale (Paris, France : 1983) 20020126 |
| A new method for the synthesis of oligodeoxyribonucleotides containing 4-N-alkoxycarbonyldeoxycytidine derivatives and their hybridization properties. | The Journal of organic chemistry 20020125 |
| Deoxyribonucleoside kinases belonging to the thymidine kinase 2 (TK2)-like group vary significantly in substrate specificity, kinetics and feed-back regulation. | Journal of molecular biology 20020125 |
| NMR structure of a gemcitabine-substituted model Okazaki fragment. | Biochemistry 20020122 |
| Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer. | British journal of cancer 20020121 |
| Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer. | International journal of cancer 20020120 |
| Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release. | Blood 20020115 |
| Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020115 |
| Gemcitabine-related pulmonary toxicity. | Swiss medical weekly 20020112 |
| Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. | The New England journal of medicine 20020110 |
| Apoptosis induction and DNA interstrand cross-link formation by cytotoxic trans-[PtCl2(NH(CH3)2)(NHCH(CH3)2) : cross-linking between d(G) and complementary d(C) within oligonucleotide duplexes. | Chembiochem : a European journal of chemical biology 20020104 |
| Enhanced levels of deoxycytidine kinase and thymidine kinase 1 and 2 after pulsed low dose rate irradiation as an adaptive response to radiation. | Oncology reports 20020101 |
| A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of life. | Lung cancer (Amsterdam, Netherlands) 20020101 |
| Action of (E)-2'-deoxy-2'-(fluoromethylene)cytidine on DNA metabolism: incorporation, excision, and cellular response. | Molecular pharmacology 20020101 |
| Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurence of peritoneal carcinomatosis. | Journal of surgical oncology 20020101 |
| Gemcitabine (Gemzar) and radiotherapy--is it feasible? | Frontiers of radiation therapy and oncology 20020101 |
| Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020101 |
| Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020101 |
| Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapy. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20020101 |
| Hypochlorite-induced damage to DNA, RNA, and polynucleotides: formation of chloramines and nitrogen-centered radicals. | Chemical research in toxicology 20020101 |
| Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020101 |
| In Vitro schedule-dependent interactions between the multitargeted antifolate LY231514 and gemcitabine in human colon adenocarcinoma cell lines. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020101 |
| Biological basis for chemo-radiotherapy interactions. | European journal of cancer (Oxford, England : 1990) 20020101 |
| Use of 5-[(76)Br]bromo-2'-fluoro-2'-deoxyuridine as a ligand for tumour proliferation: validation in an animal tumour model. | European journal of nuclear medicine and molecular imaging 20020101 |
| Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review. | Thorax 20020101 |
| Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial. | Oncology 20020101 |
| A phase I-II study on a gemcitabine-cyclophosphamide-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients. | Oncology 20020101 |
| Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study. | Oncology 20020101 |
| A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma. | Cancer 20020101 |
| Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literature. | Cancer 20020101 |
| [Successful outpatient treatment with chemotherapy of weekly gemcitabine and vinorelbine for a patient with recurrent lung cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20020101 |
| Simultaneous intra/extravascular administration of antiproliferative agents as a new strategy to inhibit restenosis: the peak of reactive cell proliferation as a hallmark for the duration of the treatment. | BMC cardiovascular disorders 20020101 |
| Prediction of cell kill kinetics of anticancer agents using the collagen gel droplet embedded-culture drug sensitivity test. | Oncology reports 20020101 |
| Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: a single-institution experience. | Cancer investigation 20020101 |
| Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated. | Annals of oncology : official journal of the European Society for Medical Oncology 20020101 |
| A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20020101 |
| Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type. | Annals of oncology : official journal of the European Society for Medical Oncology 20020101 |
| Drug combination approved for advanced breast cancer. | FDA consumer 20020101 |
| Cellular and clinical pharmacology of fludarabine. | Clinical pharmacokinetics 20020101 |
| Taxanes and capecitabine in combination: rationale and clinical results. | Clinical breast cancer 20020101 |
| Phase I/II trial of gemcitabine plus cyclophosphamide in patients with metastatic breast carcinoma previously treated with taxanes. | Clinical breast cancer 20020101 |
| Toxicity of a 24-hour infusion of gemcitabine in biliary tract and pancreatic cancer: a pilot study. | Cancer investigation 20020101 |
| Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer. | Oncology 20020101 |
| [An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years]. | Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20020101 |
| Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy. | Oncology reports 20020101 |
| [Therapy of gallbladder carcinoma. Experience of a central hospital]. | Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20020101 |
| Type III radical hysterectomy induction chemotherapy for patients with locally advanced cervical carcinoma. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20020101 |
| [Capecitabine (xeloda) in the treatment of relapsed and metastatic breast cancer]. | Zhonghua zhong liu za zhi [Chinese journal of oncology] 20020101 |
| Cutaneous drug reaction case reports: from the world literature. | American journal of clinical dermatology 20020101 |
| Breast cancer: single agents chemotherapy. | Tumori 20020101 |
| Novel direct detection method for quantitative determination of intracellular nucleoside triphosphates using weak anion exchange liquid chromatography/tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20020101 |
| Economic evaluation of gemcitabine alone and in combination with cisplatin in the treatment of nonsmall cell lung cancer. | PharmacoEconomics 20020101 |
| [New therapeutic prospects with capecitabin in breast carcinoma]. | Tumori 20020101 |
| Capecitabine in treatment of platinum-resistant recurrent ovarian cancer. | Anticancer research 20020101 |
| Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer. | International journal of colorectal disease 20020101 |
| What's new in pancreatic cancer treatment? | Journal of hepato-biliary-pancreatic surgery 20020101 |
| First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study. | Cancer investigation 20020101 |
| Gemcitabine for patients with relapsed nasopharyngeal carcinoma. | Internal medicine journal 20020101 |
| Gemcitabine and vinorelbine combination in patients with metastatic breast cancer. | The breast journal 20020101 |
| Evolving considerations in the design and interpretation of phase I trials investigating gemcitabine based chemoradiotherapy regimens. | Cancer journal (Sudbury, Mass.) 20020101 |
| Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study. | Cancer journal (Sudbury, Mass.) 20020101 |
| Docetaxel followed by gemcitabine in the treatment of advanced non-small cell lung cancer: a phase I study. | Tumori 20020101 |
| Oral fluoropyrimidines in the treatment of advanced colorectal cancer--results of two consecutive phase II trials. | Acta oncologica (Stockholm, Sweden) 20020101 |
| Fixed erythrodysaesthesia plaque due to gemcitabine and epirubicin treatment. | Acta dermato-venereologica 20020101 |
| A phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer: a Hoosier Oncology Group Study. | Oncology 20020101 |
| Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes. | Oncology 20020101 |
| [Chemotherapy of advanced non-small cell lung cancer with the combination of gemcitabine and cisplatin]. | Pneumonologia i alergologia polska 20020101 |
| The antineoplastic treatment in the elderly. | La Clinica terapeutica 20020101 |
| Time and sequence dependence of hydroxyurea in combination with gemcitabine in human KB cells. | Anticancer research 20020101 |
| A dose-escalation study of irinotecan (CPT-11) in combination with gemcitabine in patients with advanced non-small cell lung cancer previously treated with a cisplatin-based front line chemotherapy. | Anticancer research 20020101 |
| Clinical benefit of gemcitabine-cisplatin in advanced non-small cell lung cancer elderly patients. | Anticancer research 20020101 |
| Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report. | Anticancer research 20020101 |
| Gemcitabine, ifosfamide and vinorelbine in advanced non-small cell lung cancer: a phase II study. | Anticancer research 20020101 |
| A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer. | Anticancer research 20020101 |
| Microwave assisted high yielding preparation of N-protected 2'-deoxyribonucleosides useful for oligonucleotide synthesis. | Nucleosides, nucleotides & nucleic acids 20020101 |
| Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review. | The oncologist 20020101 |
| Eruptive multiple lentigo-maligna-like lesions in a patient undergoing chemotherapy with an oral 5-fluorouracil prodrug for metastasizing colorectal carcinoma: a lesson for the pathogenesis of malignant melanoma? | Dermatology (Basel, Switzerland) 20020101 |
| Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma. | Acta dermato-venereologica 20020101 |
| Granulomatous mycosis fungoides responsive to gemcitabine. | European journal of dermatology : EJD 20020101 |
| Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer. | Drugs & aging 20020101 |
| [Gemcitabine in the treatment of advanced non-small cell lung cancer: report of one case]. | Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20020101 |
| FTC superiority over d4T in phase III trial. | Positively aware : the monthly journal of the Test Positive Aware Network 20020101 |
| [An association of paraneoplastic syndromes in a patient]. | Annales de dermatologie et de venereologie 20020101 |
| Farnesyltransferase inhibitors in breast cancer therapy. | Cancer investigation 20020101 |
| The search for enhanced therapeutic index in breast cancer: targeting the tumor and modulation of enzyme expression. | Cancer investigation 20020101 |
| Cyclophosphamide, doxorubicin, and gemcitabine combination chemotherapy for treatment of metastatic and locally advanced breast cancer. | Cancer investigation 20020101 |
| Early detection and successful treatment of drug-induced pneumonitis with corticosteroids. | Cancer investigation 20020101 |
| Incorporating oral capecitabine into the treatment of breast cancer. Introduction. | The oncologist 20020101 |
| Treatment for anthracycline-pretreated metastatic breast cancer. | The oncologist 20020101 |
| Combination versus sequential single-agent therapy in metastatic breast cancer. | The oncologist 20020101 |
| Single-agent capecitabine: a reference treatment for taxane-pretreated metastatic breast cancer? | The oncologist 20020101 |
| Moving forward with capecitabine: a glimpse of the future. | The oncologist 20020101 |
| Topical 1% cidofovir for the treatment of basal cell carcinoma. | European journal of dermatology : EJD 20020101 |
| Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer. | Urologic oncology 20020101 |
| The role of membrane transporters in cellular resistance to anticancer nucleoside drugs. | Cancer treatment and research 20020101 |
| Syntheses of novel substituted-boranophosphate nucleosides. | Nucleosides, nucleotides & nucleic acids 20020101 |
| [Breast Cancer Conference. Trastuzumab and capecitabine in the treatment of advanced breast cancer. Milano, 6-7 June 2002]. | Tumori 20020101 |
| A dose-escalation study of weekly topotecan, cisplatin, and gemcitabine front-line therapy in patients with inoperable non-small cell lung cancer. | The oncologist 20020101 |
| Characteristic promoter hypermethylation signatures in male germ cell tumors. | Molecular cancer 20020101 |
| Gemcitabine plus Epi-doxorubicin as first-line chemotherapy for bladder cancer in advanced or metastatic stage: a phase II. | Anticancer research 20020101 |
| Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a phase II study. | Anticancer research 20020101 |
| Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase II study. | Anticancer research 20020101 |
| A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II study. | Anticancer research 20020101 |
| Affinity modification of EcoRII DNA methyltransferase by the dialdehyde-substituted DNA duplexes: mapping the enzyme region that interacts with DNA. | Nucleosides, nucleotides & nucleic acids 20020101 |
| The rational development of capecitabine from the laboratory to the clinic. | Anticancer research 20020101 |
| Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine. | International journal of gastrointestinal cancer 20020101 |
| A new strategy for the synthesis of oligodeoxynucleotides in the phosphoramidite method without base protection via phosphite intermediates. | Nucleic acids research. Supplement (2001) 20020101 |
| Development of new amination reaction at 4-position of pyrimidine nucleosides. | Nucleic acids research. Supplement (2001) 20020101 |
| Hybridization ability and base pair geometry of modified deoxycytidine derivatives having a 4-N-carbamoyl group. | Nucleic acids research. Supplement (2001) 20020101 |
| Phase II study of gemcitabine, UFT and leucovorin in patients with advanced pancreatic cancer. | Acta oncologica (Stockholm, Sweden) 20020101 |
| Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage. | Cancer research 20011215 |
| Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy. | Cancer 20011215 |
| [New developments in chemotherapy for metastasized bladder cancer]. | Nederlands tijdschrift voor geneeskunde 20011215 |
| Drug resistance in non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20011201 |
| Combination chemotherapy of the taxanes and antimetabolites: its use and limitations. | European journal of cancer (Oxford, England : 1990) 20011201 |
| Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer. | International journal of radiation oncology, biology, physics 20011201 |
| Treatment of advanced ovarian cancer. | European journal of cancer (Oxford, England : 1990) 20011201 |
| A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis. | Lung cancer (Amsterdam, Netherlands) 20011201 |
| Induction chemotherapy with gemcitabine and cisplatin in stage III non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20011201 |
| Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20011201 |
| Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial. | Lung cancer (Amsterdam, Netherlands) 20011201 |
| Activity of the combination of high-dose epirubicin with gemcitabine in advanced non-small-cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20011201 |
| Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial. | Lung cancer (Amsterdam, Netherlands) 20011201 |
| Radiosensitization with chemotherapeutic agents. | Lung cancer (Amsterdam, Netherlands) 20011201 |
| Gemcitabine and pemetrexed disodium combinations in vitro and in vivo. | Lung cancer (Amsterdam, Netherlands) 20011201 |
| ALIMTA (pemetrexed disodium, LY231514, MTA): clinical experience in non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20011201 |
| Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens. | Cancer 20011201 |
| The role of purine analogue combinations in the management of acute leukemias. | Hematological oncology 20011201 |
| Formation of DNA triple helix containing N(4)-(6-aminopyridin-2-yl)-2'-deoxycytidine. | Journal of biomolecular structure & dynamics 20011201 |
| Gemcitabine activity in cervical cancer cell lines. | Cancer chemotherapy and pharmacology 20011201 |
| Phase I trial of capecitabine in combination with interferon alpha in patients with metastatic renal cancer: toxicity and pharmacokinetics. | Cancer chemotherapy and pharmacology 20011201 |
| Prospective phase II study of single-agent gemcitabine in untreated elderly patients with stage IIIB/IV non-small-cell lung cancer. | American journal of clinical oncology 20011201 |
| Gemcitabine, cisplatin, and radiation in advanced, unresectable squamous cell carcinoma of the head and neck: a feasibility study. | American journal of clinical oncology 20011201 |
| Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer. | Breast cancer research and treatment 20011201 |
| Determination of a non-methylated deoxycytidine residue in the recognition site of DNA-methyltransferases. | Biochemistry. Biokhimiia 20011201 |
| Pancreatic cancer: the evolving role of systemic therapy. | Expert opinion on pharmacotherapy 20011201 |
| Combination chemotherapy of carboplatin and gemcitabine against solid tumors: a phase I trial. | International journal of clinical oncology 20011201 |
| A study of the combination of gemcitabine hydrochloride (LY188011) and cisplatin in non-small-cell lung cancer: 3-week schedule. | International journal of clinical oncology 20011201 |
| Capecitabine and oxaliplatin in advanced colorectal cancer: a dose-finding study. | Annals of oncology : official journal of the European Society for Medical Oncology 20011201 |
| Hand-foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine. | Annals of oncology : official journal of the European Society for Medical Oncology 20011201 |
| Facile synthesis of a fluorescent deoxycytidine analogue suitable for probing the RecA nucleoprotein filament. | Organic letters 20011129 |
| Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer. | International journal of radiation oncology, biology, physics 20011115 |
| Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011115 |
| Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma . | Cancer 20011115 |
| Clinical picture: leopard-like vitiligo with capecitabine. | Lancet (London, England) 20011110 |
| From the Food and Drug Administration. | JAMA 20011107 |
| Mucositis as a treatment-limiting side effect in the use of capecitabine for the treatment of metastatic breast cancer. | Journal of the American Academy of Dermatology 20011101 |
| Drug resistance in hematologic malignancies. | Current opinion in oncology 20011101 |
| Gemcitabine in hematologic malignancies. | Current opinion in oncology 20011101 |
| A feasibility study of carboplatin with fixed dose of gemcitabine in 'unfit' patients with advanced bladder cancer. | European journal of cancer (Oxford, England : 1990) 20011101 |
| Gemcitabine and small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20011101 |
| Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. | Nature genetics 20011101 |
| Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011101 |
| Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011101 |
| Five-chlorodeoxycytidine, a tumor-selective enzyme-driven radiosensitizer, effectively controls five advanced human tumors in nude mice. | International journal of radiation oncology, biology, physics 20011101 |
| Influence of dietary fatty acid, vegetable, and vitamin intake on etheno-DNA adducts in white blood cells of healthy female volunteers: a pilot study. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20011101 |
| Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB. | Clinical cancer research : an official journal of the American Association for Cancer Research 20011101 |
| Durable complete remission of metastatic sarcomatoid carcinoma of the bladder with cisplatin and gemcitabine in an 80-year-old man. | Urology 20011101 |
| Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC). | British journal of cancer 20011101 |
| Novel deoxynucleoside-phosphorylating enzymes in mycoplasmas: evidence for efficient utilization of deoxynucleosides. | Molecular microbiology 20011101 |
| Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network. | Cancer 20011101 |
| A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation. | Bone marrow transplantation 20011101 |
| Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20011101 |
| Gemcitabine-induced systemic capillary leak syndrome. | Annals of oncology : official journal of the European Society for Medical Oncology 20011101 |
| [Does treatment for malignant pleural mesothelioma exist?]. | Revue de pneumologie clinique 20011101 |
| [Phase III clinical trials concerning non-small-cell lung carcinoma (NSCLC) presented at the ASCO 2001]. | Revue de pneumologie clinique 20011101 |
| [New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV]. | Revue de pneumologie clinique 20011101 |
| Capecitabine combinations in the treatment of advanced colorectal cancer. | Clinical colorectal cancer 20011101 |
| An adverse interaction between warfarin and capecitabine: a case report and review of the literature. | Clinical colorectal cancer 20011101 |
| C5-(1-propynyl)-2'-deoxy-pyrimidines enhance mismatch penalties of DNA:RNA duplex formation. | Biochemistry 20011023 |
| Modeling furanose ring dynamics in DNA. | Journal of the American Chemical Society 20011017 |
| Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011015 |
| Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine. | International journal of cancer 20011015 |
| [New therapeutic options in chemotherapy of advanced colorectal cancer]. | Medizinische Klinik (Munich, Germany : 1983) 20011015 |
| Chemotherapy for non-small-cell lung cancer. | Lancet (London, England) 20011013 |
| Bystander effects of nucleoside analogs phosphorylated in the cytosol or mitochondria. | Biochemical and biophysical research communications 20011012 |
| Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial. | Lung cancer (Amsterdam, Netherlands) 20011001 |
| Prototype trial design for rapid dose selection of antiretroviral drugs: an example using emtricitabine (Coviracil). | The Journal of antimicrobial chemotherapy 20011001 |
| Therapeutic efficacy of E2F1 in pancreatic cancer correlates with TP73 induction. | Cancer research 20011001 |
| Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines. | Cancer research 20011001 |
| Retinoic acid enhances the cytotoxic effects of gemcitabine and cisplatin in pancreatic adenocarcinoma cells. | Pancreas 20011001 |
| Phase I trial of weekly gemcitabine at 3-h infusion in refractory, heavily pretreated advanced solid tumors. | Anti-cancer drugs 20011001 |
| Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents. | Clinical cancer research : an official journal of the American Association for Cancer Research 20011001 |
| Tumor uptake and elimination of 2',2'-difluoro-2'-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: correlation with in vivo tumor response. | Clinical cancer research : an official journal of the American Association for Cancer Research 20011001 |
| Wortmannin inhibits pkb/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice. | Clinical cancer research : an official journal of the American Association for Cancer Research 20011001 |
| Recent advances in the use of radiosensitizing nucleosides. | Seminars in radiation oncology 20011001 |
| [Results of gemcitabine hydrochloride in the treatment for pancreatic cancer]. | Gan to kagaku ryoho. Cancer & chemotherapy 20011001 |
| Nonsurgical treatment of hepatocellular carcinoma. | Seminars in oncology 20011001 |
| Gemcitabine-associated CD8+ CD30+ pseudolymphoma. | The British journal of dermatology 20011001 |
| Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients. | Cancer 20011001 |
| Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20011001 |
| A phase II study of gemcitabine in gallbladder carcinoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20011001 |
| Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group. | Annals of oncology : official journal of the European Society for Medical Oncology 20011001 |
| Use of gemcitabine (GEM) in advanced myelodysplastic syndromes. | Annals of oncology : official journal of the European Society for Medical Oncology 20011001 |
| Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. | Cancer biotherapy & radiopharmaceuticals 20011001 |
| Capecitabine in the management of colorectal cancer. | Expert review of anticancer therapy 20011001 |
| Identification and characterization of human deoxyguanosine kinase cDNA fragments. | Cancer letters 20010920 |
| Identification of nucleotides with identical fluorescent labels based on fluorescence polarization in surfactant solutions. | Analytical chemistry 20010915 |
| Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies. | Cancer 20010915 |
| New chemotherapy combinations for advanced bladder cancer. | Current opinion in urology 20010901 |
| Second-line treatment of advanced transitional cell carcinoma of the urothelial tract. | Current opinion in urology 20010901 |
| Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. | The Journal of pharmacology and experimental therapeutics 20010901 |
| Chemosensitization of pancreatic cancer by inhibition of the 26S proteasome. | The Journal of surgical research 20010901 |
| Sustained complete remission in a patient with platinum-resistant ovarian yolk sac tumor. | Gynecologic oncology 20010901 |
| Onychomadesis and onycholysis associated with capecitabine. | The British journal of dermatology 20010901 |
| [Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy]. | Revue des maladies respiratoires 20010901 |
| Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy. | British journal of haematology 20010901 |
| Indications for chemotherapy in stage IV non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20010901 |
| A novel affinity chromatography method for the co-purification of deoxycytidine kinase and cytidine deaminase. | Nucleosides, nucleotides & nucleic acids 20010901 |
| Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene. | Cancer gene therapy 20010901 |
| Capecitabine: a novel agent for the treatment of solid tumors. | Anti-cancer drugs 20010901 |
| Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancer. | Anti-cancer drugs 20010901 |
| Gemcitabine-associated diffuse alveolar hemorrhage. | Intensive care medicine 20010901 |
| Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine. | Annals of oncology : official journal of the European Society for Medical Oncology 20010901 |
| Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20010901 |
| Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: a phase II trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20010901 |
| [Prognosis of pancreatic adenocarcinoma]. | Gastroenterologie clinique et biologique 20010901 |
| Structures of complexes formed by HIV-1 reverse transcriptase at a termination site of DNA synthesis. | The Journal of biological chemistry 20010817 |
| Resistance to topoisomerase poisons due to loss of DNA mismatch repair. | International journal of cancer 20010815 |
| Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2. | Cancer research 20010815 |
| Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma: a phase II multicenter trial. | Cancer 20010815 |
| Ethanol enhances the formation of endogenously and exogenously derived adducts in rat hepatic DNA. | Mutation research 20010808 |
| Ntg2 of Saccharomyces cerevisiae repairs the oxidation products of 8-hydroxyguanine. | Biochemical and biophysical research communications 20010803 |
| Cell cycle effects of gemcitabine. | International journal of cancer 20010801 |
| Sequence-specific damage induced by the impact of 3-30 eV electrons on oligonucleotides. | Radiation research 20010801 |
| Functional p53 mutation as a molecular determinant of paclitaxel and gemcitabine susceptibility in human bladder cancer. | The Journal of urology 20010801 |
| Bladder tumor markers, intravesical therapy and systemic chemotherapy. | The Journal of urology 20010801 |
| Activation of the maternally preset program of apoptosis by microinjection of 5-aza-2'-deoxycytidine and 5-methyl-2'-deoxycytidine-5'-triphosphate in Xenopus laevis embryos. | Development, growth & differentiation 20010801 |
| Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer. | American journal of clinical oncology 20010801 |
| Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010801 |
| Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010801 |
| Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas. | International journal of radiation oncology, biology, physics 20010801 |
| Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010801 |
| Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotide reductase M2 subunit. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010801 |
| Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010801 |
| Radiosensitization by gemcitabine in p53 wild-type and mutant MCF-7 breast carcinoma cell lines. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010801 |
| CaSm/gemcitabine chemo-gene therapy leads to prolonged survival in a murine model of pancreatic cancer. | Surgery 20010801 |
| Nuclear factor-kappa B is upregulated in colorectal cancer. | Surgery 20010801 |
| New cytotoxic agents and schedules for advanced breast cancer. | Seminars in oncology 20010801 |
| Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma. | Cancer 20010801 |
| New options for outpatient chemotherapy--the role of oral fluoropyrimidines. | Cancer treatment reviews 20010801 |
| Synthesis of a new 5'-O-triphosphate analog of 5-methyl 2'-O-deoxycytidine. Preliminary in vitro labelling for non-radioactive detection of DNA. | Nucleosides, nucleotides & nucleic acids 20010801 |
| Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines. | Cancer chemotherapy and pharmacology 20010801 |
| Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial. | Cancer chemotherapy and pharmacology 20010801 |
| Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model. | Cancer chemotherapy and pharmacology 20010801 |
| Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer. | Cancer chemotherapy and pharmacology 20010801 |
| Adjuvant chemotherapy for muscle-invasive bladder cancer. | Seminars in urologic oncology 20010801 |
| [Preclinical studies of oxaliplatin in combination chemotherapy]. | Bulletin du cancer 20010801 |
| Synthesis of the L-enantiomer of 4'-C-ethynyl-2'-deoxycytidine. | Bioscience, biotechnology, and biochemistry 20010801 |
| Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer--a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group. | Annals of oncology : official journal of the European Society for Medical Oncology 20010801 |
| Correlation between c-erbB-4 receptor expression and response to gemcitabine-cisplatin chemotherapy in non-small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20010801 |
| A physiologically based pharmacokinetic analysis of capecitabine, a triple prodrug of 5-FU, in humans: the mechanism for tumor-selective accumulation of 5-FU. | Pharmaceutical research 20010801 |
| [Gemcitabine in the treatment of 4 patients with cholangiocarcinoma]. | Revista medica de Chile 20010801 |
| Oral fluoropyrimidine treatment of colorectal cancer. | Clinical colorectal cancer 20010801 |
| Clinical colorectal cancer: oral chemotherapy comes of age. | Clinical colorectal cancer 20010801 |
| A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors. | Cancer 20010715 |
| Photoaffinity labeling of mouse fibroblast enzymes by a base excision repair intermediate. Evidence for the role of poly(ADP-ribose) polymerase-1 in DNA repair. | The Journal of biological chemistry 20010706 |
| Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine. | Biochemical pharmacology 20010701 |
| Interference of gemcitabine triphosphate with the measurements of deoxynucleotides using an optimized DNA polymerase elongation assay. | International journal of oncology 20010701 |
| Structural basis for substrate specificities of cellular deoxyribonucleoside kinases. | Nature structural biology 20010701 |
| Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer. | European journal of cancer (Oxford, England : 1990) 20010701 |
| Chemotherapy and quality of life in advanced NSCLC. | British journal of cancer 20010701 |
| Evaluating new treatments for advanced cancer. | British journal of cancer 20010701 |
| Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel. | Cancer 20010701 |
| Gemcitabine modulation of alkylator therapy: a phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicin. | Cancer 20010701 |
| Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death. | Pancreas 20010701 |
| Deletion mutants of human deoxycytidine kinase mRNA in cells resistant to antitumor cytosine nucleosides. | Japanese journal of cancer research : Gann 20010701 |
| Rationale for non-platinum chemotherapy in advanced NSCLC. | Oncology (Williston Park, N.Y.) 20010701 |
| Gemcitabine active in patients with metastatic breast cancer. | Oncology (Williston Park, N.Y.) 20010701 |
| Pancreatic cancer in the older patient. | Oncology (Williston Park, N.Y.) 20010701 |
| Recent advances in the chemotherapy of non-small cell lung cancer. | Japanese journal of clinical oncology 20010701 |
| Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features. | Annals of oncology : official journal of the European Society for Medical Oncology 20010701 |
| [Therapeutic strategies in neoadjuvant therapy of non-small cell lung cancer: benefits of gemcitabine]. | Anti-cancer drugs 20010701 |
| [Role of gemcitabine in the treatment of advanced non-small cell lung cancer: review of the main phase II and phase III trials]. | Anti-cancer drugs 20010701 |
| Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study. | Breast cancer research and treatment 20010701 |
| Capecitabine monotherapy in metastatic colorectal cancer. | The Lancet. Oncology 20010701 |
| Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs. | The Journal of biological chemistry 20010629 |
| Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC). | Biochemical pharmacology 20010615 |
| Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010615 |
| Base sequence dependence of in vitro translesional DNA replication past a bulky lesion catalyzed by the exo- Klenow fragment of Pol I. | Biochemistry 20010605 |
| DNA methyltransferase inhibition in normal human fibroblasts induces a p21-dependent cell cycle withdrawal. | The Journal of biological chemistry 20010601 |
| The effect of DNA structure on the catalytic efficiency and fidelity of human DNA polymerase beta on templates with platinum-DNA adducts. | The Journal of biological chemistry 20010601 |
| Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines. | Biochemical pharmacology 20010601 |
| Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemia. | Leukemia research 20010601 |
| Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[Prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug. | Molecular pharmacology 20010601 |
| Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma. | Gynecologic oncology 20010601 |
| Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma. | British journal of haematology 20010601 |
| Oral fluoropyrimidines among the new drugs for patients with metastatic breast cancer. | British journal of cancer 20010601 |
| Phase II trial of the use of paclitaxel and gemcitabine as a salvage treatment in metastatic breast cancer. | American journal of clinical oncology 20010601 |
| Gemcitabine in advanced pancreatic cancer: a phase II trial. | American journal of clinical oncology 20010601 |
| Nucleoside analogues: mechanisms of drug resistance and reversal strategies. | Leukemia 20010601 |
| Neoadjuvant strategies for pancreatic cancer. | Oncology (Williston Park, N.Y.) 20010601 |
| Recent developments in chemotherapy for bladder cancer. | Oncology (Williston Park, N.Y.) 20010601 |
| Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan. | Seminars in oncology 20010601 |
| Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non--small cell lung cancer. | Seminars in oncology 20010601 |
| Neoadjuvant chemotherapy with docetaxel in non--small cell lung cancer. | Seminars in oncology 20010601 |
| An efficient method for the preparation of 1'alpha-branched-chain sugar pyrimidine ribonucleosides from uridine: the first conversion of a natural nucleoside into 1'-substituted ribonucleosides. | Chemistry (Weinheim an der Bergstrasse, Germany) 20010601 |
| Xeloda in colorectal cancer. | International journal of clinical practice 20010601 |
| Treatment of metastatic pancreatic adenocarcinoma: a comprehensive review. | The Surgical clinics of North America 20010601 |
| Therapy for regionally unresectable pancreatic cancer. | The Surgical clinics of North America 20010601 |
| Gemcitabine plus etoposide in chemonaive extensive disease small-cell lung cancer: a multi-centre phase II study. | Annals of oncology : official journal of the European Society for Medical Oncology 20010601 |
| Gemcitabine in pre-treated advanced renal carcinoma: a feasibility study. | Journal of experimental & clinical cancer research : CR 20010601 |
| Antiretroviral activity of emtricitabine, a potent nucleoside reverse transcriptase inhibitor. | Antiviral therapy 20010601 |
| Gemcitabine-containing regimens in bladder cancer: A new standard of care. | Seminars in oncology 20010601 |
| Gemcitabine and carboplatin for patients with advanced non-small cell lung cancer. | Seminars in oncology 20010601 |
| A prospective study of gemcitabine and carboplatin as first-line therapy in advanced non-small cell lung cancer: toxicity of a three- versus a four-week schedule. | Seminars in oncology 20010601 |
| Gemcitabine/carboplatin versus cisplatin/etoposide for patients with poor-prognosis small cell lung cancer: a phase III randomized trial with quality-of-life evaluation. | Seminars in oncology 20010601 |
| Gemcitabine/carboplatin in advanced urothelial cancer. | Seminars in oncology 20010601 |
| Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index. | Seminars in oncology 20010601 |
| Beyond pancreatic cancer: irinotecan and gemcitabine in solid tumors and hematologic malignancies. | Seminars in oncology 20010601 |
| Phase II study of gemcitabine, 5-fluorouracil, and leucovorin in patients with pancreatic cancer. | Seminars in oncology 20010601 |
| Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: a Southern Italy Cooperative Oncology Group phase I/II study. | Seminars in oncology 20010601 |
| A phase II study of neoadjuvant gemcitabine plus doxorubicin in stage IIIB breast cancer: a preliminary report. | Seminars in oncology 20010601 |
| Gemcitabine in ovarian cancer. | Seminars in oncology 20010601 |
| Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples. | Breast cancer research and treatment 20010601 |
| Nucleoside analogues in the treatment of haematological malignancies. | Expert opinion on pharmacotherapy 20010601 |
| Definitive results of a phase II trial of cisplatin, epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinoma. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010515 |
| Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial. | Lancet (London, England) 20010512 |
| [Decline in the need for blood transfusions in cancer patients due to the use of epoietin alfa during cisplatin based chemotherapy]. | Nederlands tijdschrift voor geneeskunde 20010505 |
| High-performance liquid chromatographic determination of deoxycytidine monophosphate and methyldeoxycytidine monophosphate for DNA demethylation monitoring: experimental design and artificial neural networks optimisation. | Journal of chromatography. B, Biomedical sciences and applications 20010505 |
| Akt, MAPK (Erk1/2), and p38 act in concert to promote apoptosis in response to ErbB receptor family inhibition. | The Journal of biological chemistry 20010504 |
| Fluorescence characterization of the transcription bubble in elongation complexes of T7 RNA polymerase. | Journal of molecular biology 20010504 |
| Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA. | International journal of cancer 20010501 |
| Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer. | European journal of cancer (Oxford, England : 1990) 20010501 |
| Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study. | Lung cancer (Amsterdam, Netherlands) 20010501 |
| Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma. | Lung cancer (Amsterdam, Netherlands) 20010501 |
| Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501 |
| Heterogeneous tissue distribution of a mitochondrial DNA polymorphism in heteroplasmic subjects without mitochondrial disorders. | Journal of medical genetics 20010501 |
| Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens. | European journal of cancer (Oxford, England : 1990) 20010501 |
| Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study. | British journal of cancer 20010501 |
| Intestinal permeability in patients with chemotherapy-induced stomatitis. | Journal of cancer research and clinical oncology 20010501 |
| Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML). | Leukemia 20010501 |
| Characterization of nucleoside and DNA adducts formed by S-(1-acetoxymethyl)glutathione and implications for dihalomethane-glutathione conjugates. | Chemical research in toxicology 20010501 |
| The antitumor mechanism of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)-cytosine: effects of its triphosphate on mammalian DNA polymerases. | Japanese journal of cancer research : Gann 20010501 |
| Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide. | British journal of haematology 20010501 |
| [Non-small cell lung cancer with liver metastasis responsive to gemcitabine--a case report]. | Gan to kagaku ryoho. Cancer & chemotherapy 20010501 |
| Hepatitis B infection in China. | Clinics in liver disease 20010501 |
| Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates. | Cancer chemotherapy and pharmacology 20010501 |
| New combinations with epirubicin in advanced breast cancer. | Oncology (Williston Park, N.Y.) 20010501 |
| [Acute respiratory distress syndrome after antineoplastic chemotherapy. Probable role of gemcitabine]. | Presse medicale (Paris, France : 1983) 20010501 |
| A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patients. | Annals of oncology : official journal of the European Society for Medical Oncology 20010501 |
| Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks. | Annals of oncology : official journal of the European Society for Medical Oncology 20010501 |
| Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM). | Annals of oncology : official journal of the European Society for Medical Oncology 20010501 |
| Coronary spasm induced by capecitabine. | Annals of oncology : official journal of the European Society for Medical Oncology 20010501 |
| 25th European Society for Medical Oncology Congress. Hamburg, Germany. October 13-17, 2000. | Clinical colorectal cancer 20010501 |
| First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer. | Clinical colorectal cancer 20010501 |
| Advances in the treatment of metastatic colorectal cancer. | Clinical colorectal cancer 20010501 |
| Deoxynucleoside anabolic enzyme levels in acute myelocytic leukemia and chronic lymphocytic leukemia cells. | Cancer letters 20010426 |
| Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas. | International journal of cancer 20010420 |
| Synthesis and characterization of DNA duplexes containing an N(4)C-ethyl-N(4)C interstrand cross-link. | Journal of the American Chemical Society 20010418 |
| Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010415 |
| Towards an understanding of somatic hypermutation. | Current opinion in immunology 20010401 |
| 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrest. | Molecular pharmacology 20010401 |
| Schedule dependency of antitumor activity in combination therapy with capecitabine/5'-deoxy-5-fluorouridine and docetaxel in breast cancer models. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010401 |
| Alterations in taste sensation: a case presentation of a patient with end-stage pancreatic cancer. | Cancer nursing 20010401 |
| Treatment of refractory T-cell malignancies using gemcitabine. | British journal of haematology 20010401 |
| A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer. | Journal of chemotherapy (Florence, Italy) 20010401 |
| Weekly cisplatin/low-dose gemcitabine combination for advanced and recurrent cervical carcinoma. | American journal of clinical oncology 20010401 |
| Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study. | Anti-cancer drugs 20010401 |
| Incidence of thrombocytopenia with gemcitabine-based therapy and influence of dosing and schedule. | Anti-cancer drugs 20010401 |
| Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine. | European journal of nuclear medicine 20010401 |
| [Gemcitabine and cisplatin as induction therapy for patients with histologically proven stage IIIA-N2 non-small-cell bronchial cancer: a phase-II study of the EORTC Cooperative Group (EORTC 08955)]. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20010401 |
| Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer. | Seminars in oncology 20010401 |
| Gemcitabine in advanced bladder cancer. | Seminars in oncology 20010401 |
| Gemcitabine, epirubicin, and paclitaxel combinations in advanced breast cancer. | Seminars in oncology 20010401 |
| The current role of gemcitabine in ovarian cancer. | Seminars in oncology 20010401 |
| Treatment of metastatic urothelial cancer in the post-MVAC era. | World journal of urology 20010401 |
| A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma. | Annals of oncology : official journal of the European Society for Medical Oncology 20010401 |
| Single-agent gemcitabine in patients with resistant small-cell lung cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20010401 |
| [Capecitabine (Ro09-1978) for therapy of advanced and recurrent gastric cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20010401 |
| Intraoperative saline and gemcitabine irrigation improves tumour control in human squamous cell carcinoma-contaminated surgical wounds. | The Journal of otolaryngology 20010401 |
| Human cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistance. | The Journal of biological chemistry 20010330 |
| [Oral cytostatic drug in colorectal carcinoma. Selective tumor therapy at home]. | MMW Fortschritte der Medizin 20010329 |
| Cotton-wool spots associated with pancreatic carcinoma. | European journal of medical research 20010326 |
| Steroids affect collateral sensitivity to gemcitabine of multidrug-resistant human lung cancer cells. | European journal of pharmacology 20010323 |
| Reaction of cis- and trans-2-Butene-1,4-dial with 2'-deoxycytidine to form stable oxadiazabicyclooctaimine adducts. | Journal of the American Chemical Society 20010321 |
| Production of brominating intermediates by myeloperoxidase. A transhalogenation pathway for generating mutagenic nucleobases during inflammation. | The Journal of biological chemistry 20010316 |
| Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010315 |
| Cytosolic high K(m) 5'-nucleotidase and 5'(3')-deoxyribonucleotidase in substrate cycles involved in nucleotide metabolism. | The Journal of biological chemistry 20010302 |
| Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine. | International journal of radiation oncology, biology, physics 20010301 |
| Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF. | Leukemia 20010301 |
| Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. | Annals of surgical oncology 20010301 |
| [A case of primary malignant hemangiopericytoma of the lung with marked response to combination chemotherapy with cisplatin, ifosfamide and gemcitabine]. | Gan to kagaku ryoho. Cancer & chemotherapy 20010301 |
| Latent hematopoietic stem cell toxicity associated with protracted drug administration. | Experimental hematology 20010301 |
| Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial. | European journal of cancer (Oxford, England : 1990) 20010301 |
| Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma. | European journal of cancer (Oxford, England : 1990) 20010301 |
| Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patients. | Anti-cancer drugs 20010301 |
| Irinotecan/gemcitabine combination chemotherapy in pancreatic cancer. | Oncology (Williston Park, N.Y.) 20010301 |
| Gemcitabine in combination with new platinum compounds: an update. | Oncology (Williston Park, N.Y.) 20010301 |
| Gemcitabine and nonplatinum combinations in non-small-cell lung cancer. | Oncology (Williston Park, N.Y.) 20010301 |
| Gemcitabine for the treatment of non-small-cell lung cancer. | Oncology (Williston Park, N.Y.) 20010301 |
| Gemcitabine and cisplatin combination in early-stage non-small-cell lung cancer. | Oncology (Williston Park, N.Y.) 20010301 |
| Optimizing chemoradiation in locally advanced non-small-cell lung cancer. | Oncology (Williston Park, N.Y.) 20010301 |
| Effect of chemical modifications of cytosine and guanine in a CpG-motif of oligonucleotides: structure-immunostimulatory activity relationships. | Bioorganic & medicinal chemistry 20010301 |
| Gemcitabine as single agent therapy in advanced non small cell lung cancer and quality of life in the elderly. | Panminerva medica 20010301 |
| Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy. | Cancer chemotherapy and pharmacology 20010301 |
| Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane. | Breast cancer research and treatment 20010301 |
| Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20010301 |
| New antiretroviral agents. | The Hopkins HIV report : a bimonthly newsletter for healthcare providers 20010301 |
| Orf135 from Escherichia coli Is a Nudix hydrolase specific for CTP, dCTP, and 5-methyl-dCTP. | The Journal of biological chemistry 20010223 |
| Deoxynucleoside kinases encoded by the yaaG and yaaF genes of Bacillus subtilis. Substrate specificity and kinetic analysis of deoxyguanosine kinase with UTP as the preferred phosphate donor. | The Journal of biological chemistry 20010223 |
| Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010215 |
| Gemcitabine and cisplatin for advanced, metastatic bladder cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010215 |
| End-joining deficiency and radiosensitization induced by gemcitabine. | Cancer research 20010215 |
| DNA structure and aspartate 276 influence nucleotide binding to human DNA polymerase beta. Implication for the identity of the rate-limiting conformational change. | The Journal of biological chemistry 20010202 |
| Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010201 |
| S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine. | Cancer research 20010201 |
| The clinical implications of gemcitabine radiosensitization. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010201 |
| The role of apoptosis in 2',2'-difluoro-2'-deoxycytidine (gemcitabine)-mediated radiosensitization. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010201 |
| Effects of gemcitabine on cisplatin-induced nephrotoxicity in rats: schedule-dependent study. | Pharmacological research 20010201 |
| Gemcitabine as single-agent therapy in the management of advanced breast cancer. | Oncology (Williston Park, N.Y.) 20010201 |
| Treatment of advanced breast cancer with gemcitabine and vinorelbine. | Oncology (Williston Park, N.Y.) 20010201 |
| Docetaxel/gemcitabine: salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer. | Oncology (Williston Park, N.Y.) 20010201 |
| Gemcitabine and paclitaxel as salvage therapy in metastatic breast cancer. | Oncology (Williston Park, N.Y.) 20010201 |
| Gemcitabine plus cisplatin in breast cancer. | Oncology (Williston Park, N.Y.) 20010201 |
| Gemcitabine and Pemetrexed disodium in treating breast cancer. | Oncology (Williston Park, N.Y.) 20010201 |
| Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer. | Oncology (Williston Park, N.Y.) 20010201 |
| The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancer. | Oncology (Williston Park, N.Y.) 20010201 |
| Biweekly gemcitabine, doxorubicin, and paclitaxel as first-line treatment in metastatic breast cancer. Final results from a phase II trial. | Oncology (Williston Park, N.Y.) 20010201 |
| [Palliative therapy of pancreatic adenocarcinoma]. | Zeitschrift fur Gastroenterologie 20010201 |
| 5-fluorouracil/leucovorin versus capecitabine in patients with stage III colon cancer. | Seminars in oncology 20010201 |
| Challenging the platinum combinations: docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer. | Seminars in oncology 20010201 |
| Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20010201 |
| Activation of deoxycytidine kinase by inhibition of DNA synthesis in human lymphocytes. | Biochemical pharmacology 20010115 |
| Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma. A phase II study. | Cancer 20010115 |
| Quantitative analysis of etheno-2'-deoxycytidine DNA adducts using on-line immunoaffinity chromatography coupled with LC/ES-MS/MS detection. | Analytical chemistry 20010115 |
| The significance of thymidine phosphorylase expression in colorectal cancer. | Oncology reports 20010101 |
| Antiviral L-nucleosides specific for hepatitis B virus infection. | Antimicrobial agents and chemotherapy 20010101 |
| The role of laparoscopy in second-look evaluations for ovarian cancer. | Gynecologic oncology 20010101 |
| Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs. | British journal of cancer 20010101 |
| Gemcitabine: progress in the treatment of pancreatic cancer. | Oncology 20010101 |
| Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancer. | Oncology 20010101 |
| Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer. | Oncology 20010101 |
| The role of capecitabine, an oral, enzymatically activated fluoropyrimidine, in the treatment of metastatic breast cancer. | The oncologist 20010101 |
| Fatal pulmonary veno-occlusive disease possibly related to gemcitabine. | Lung cancer (Amsterdam, Netherlands) 20010101 |
| Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine. | Lung cancer (Amsterdam, Netherlands) 20010101 |
| Decreased myelotoxicity of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) with cisplatin infusion on day 15. | Lung cancer (Amsterdam, Netherlands) 20010101 |
| Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial. | Lung cancer (Amsterdam, Netherlands) 20010101 |
| Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B. | Lung cancer (Amsterdam, Netherlands) 20010101 |
| Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer. | Japanese journal of cancer research : Gann 20010101 |
| Options in advanced non-small cell lung cancer: a review and report on a phase II study of vinorelbine plus gemcitabine. | The oncologist 20010101 |
| Induction chemotherapy followed by concomitant chemoradiotherapy for non-small cell lung cancer. | The oncologist 20010101 |
| Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells. | Cancer research 20010101 |
| Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine. | Cancer research 20010101 |
| [Refractory non-small-cell lung cancer responding to combination chemotherapy with docetaxel, gemcitabine and cisplatin]. | Gan to kagaku ryoho. Cancer & chemotherapy 20010101 |
| Capecitabine in colorectal cancer. | Oncology (Williston Park, N.Y.) 20010101 |
| Clinical status of capecitabine in the treatment of breast cancer. | Oncology (Williston Park, N.Y.) 20010101 |
| Docetaxel followed by gemcitabine and irinotecan in solid tumors. | Oncology (Williston Park, N.Y.) 20010101 |
| Chemoradiation in locally advanced non-small cell lung cancer. | Cancer treatment and research 20010101 |
| Lung cancer: therapeutic options for stage IV and recurrent NSCLC. | Cancer treatment and research 20010101 |
| Treatment of extensive stage small cell lung cancer. | Cancer treatment and research 20010101 |
| Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer. | Annals of oncology : official journal of the European Society for Medical Oncology 20010101 |
| High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC). | Annals of oncology : official journal of the European Society for Medical Oncology 20010101 |
| Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: a phase II trial. | Annals of oncology : official journal of the European Society for Medical Oncology 20010101 |
| Phase I trial of gemcitabine in patients with advanced pancreatic cancer. | Japanese journal of clinical oncology 20010101 |
| The Twenty-third Annual San Antonio Breast Cancer Symposium. | Current medical research and opinion 20010101 |
| Clinical pharmacokinetics of capecitabine. | Clinical pharmacokinetics 20010101 |
| Recent advances in bladder cancer chemotherapy. | Cancer investigation 20010101 |
| Achievement of complete remission in refractory Hodgkin's disease with prolonged infusion of gemcitabine. | Investigational new drugs 20010101 |
| The oral fluorinated pyrimidines. | Investigational new drugs 20010101 |
| Excellent response to gemcitabine in a massively pre-treated woman with extensive cutaneous involvement after recurrence of breast cancer. | Investigational new drugs 20010101 |
| Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings. | Magnetic resonance imaging 20010101 |
| Combined use of gemcitabine and radiation in mice. | Anticancer research 20010101 |
| [Capecitabine in the treatment of colorectal cancer]. | Tumori 20010101 |
| Treatment of classical Kaposi's sarcoma with gemcitabine. | Dermatology (Basel, Switzerland) 20010101 |
| [The potential of capecitabine (Xeloda) in the treatment of disseminated solid tumors]. | Voprosy onkologii 20010101 |
| Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20010101 |
| The evolving role of gemcitabine in the management of breast cancer. | Oncology 20010101 |
| The role of duck hepatitis B virus and aflatoxin B1 in the induction of oxidative stress in the liver. | Cancer detection and prevention 20010101 |
| In vivo DNA analysis. | Methods in molecular biology (Clifton, N.J.) 20010101 |
| [Docetaxel (Taxotere) in combination with anthracycline, capecitabin (Xeloda) and new drugs]. | Tumori 20010101 |
| Novel approaches to postoperative chemoradiation therapy in pancreatic cancer. | Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20010101 |
| Preliminary evaluation of influence of gemcitabine (Gemzar) on proliferation and neuroendocrine activity of human TT cell line: immunocytochemical investigations. | Folia histochemica et cytobiologica 20010101 |
| Current options for palliative treatment in patients with pancreatic cancer. | Digestive diseases (Basel, Switzerland) 20010101 |
| Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research Network. | Cancer investigation 20010101 |
| Single-agent gemcitabine is active in previously treated metastatic breast cancer. | Oncology 20010101 |
| Treatment of advanced hepatocellular carcinoma with biweekly high-dose gemcitabine. | Oncology 20010101 |
| Combination gemcitabine and docetaxel therapy in advanced adenocarcinoma of the pancreas. | Oncology 20010101 |
| The clinical pharmacology of the oral fluoropyrimidines. | Current problems in cancer 20010101 |
| Novel clinical strategies for the treatment of pancreatic carcinoma. | Trends in molecular medicine 20010101 |
| Type III radical hysterectomy after induction chemotherapy for patients with locally advanced cervical carcinoma. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20010101 |
| Modulation of human deoxycytidine kinase activity as a response to cellular stress induced by NaF. | Acta biochimica Polonica 20010101 |
| A systematic overview of chemotherapy effects in pancreatic cancer. | Acta oncologica (Stockholm, Sweden) 20010101 |
| [Reagents for modification of protein-nucleic acids complexes. II. Site-specific photomodification of DNA-polymerase beta complexes with primers elongated by the dCTP exo-N-substituted arylazido derivatives]. | Bioorganicheskaia khimiia 20010101 |
| A phase I-II trial of topotecan and gemcitabine in patients with previously treated, advanced non-small cell lung cancer (LOA-3). | Cancer investigation 20010101 |
| Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. | Hepato-gastroenterology 20010101 |
| Linear immunoglobulin A bullous dermatosis induced by gemcitabine. | The Annals of pharmacotherapy 20010101 |
| Gemcitabine in the treatment of ovarian cancer. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20010101 |
| Developmental chemotherapy in advanced ovarian cancer: incorporation of topoisomerase-I inhibitors and perspective of the Gynecologic Oncology Group. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20010101 |
| Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human hepatocellular and gastric cancer xenografts. | In vivo (Athens, Greece) 20010101 |
| A randomized study comparing oral and standard regimens for metastatic breast cancer. | Oncology reports 20010101 |
| Gemcitabine plus epirubicin in advanced pancreatic cancer: a phase II multicenter trial. | Oncology reports 20010101 |
| Acute cardiotoxicity during capecitabine treatment: a case report. | Tumori 20010101 |
| [Xeloda (capecetabine) in the treatment of disseminated breast cancer after failure with anthracyclines and taxanes]. | Voprosy onkologii 20010101 |
| Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling. | Lung cancer (Amsterdam, Netherlands) 20010101 |
| Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20010101 |
| Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer. | Lung cancer (Amsterdam, Netherlands) 20010101 |
| Radiation recall reaction following gemcitabine. | Lung cancer (Amsterdam, Netherlands) 20010101 |
| WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment. | International journal of pancreatology : official journal of the International Association of Pancreatology 20010101 |
| Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. | International journal of pancreatology : official journal of the International Association of Pancreatology 20010101 |
| Combined-modality therapy in pancreatic cancer: current status and future directions. | Cancer journal (Sudbury, Mass.) 20010101 |
| Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II study. | Investigational new drugs 20010101 |
| The NMR conformation study of the complexes of deoxycytidine kinase (dCK) and 2'-deoxycytidine/2'-deoxyadenosine. | Nucleosides, nucleotides & nucleic acids 20010101 |
| Anti-HBV specific beta-L-2'-deoxynucleosides. | Nucleosides, nucleotides & nucleic acids 20010101 |
| Unnatural enantiomers of 5-azacytidine analogues: syntheses and enzymatic properties. | Nucleosides, nucleotides & nucleic acids 20010101 |
| Personal experience in advanced pancreatic cancer: retrospective analysis on the use of 5-fluorouracil or gemcitabine. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20010101 |
| Gemcitabine and vincristine: an effective outpatient regimen with low myelotoxicity for stage IV non-small cell lung cancer. | Neoplasma 20010101 |
| Thymidine phosphorylase (TP) activation: convenience through innovation. | The oncologist 20010101 |
| The evolution of fluoropyrimidine therapy: from intravenous to oral. | The oncologist 20010101 |
| Answering patients' needs: oral alternatives to intravenous therapy. | The oncologist 20010101 |
| Optimizing the use of irinotecan in colorectal cancer. | The oncologist 20010101 |
| Integrating oxaliplatin into the management of colorectal cancer. | The oncologist 20010101 |
| Improving chemoradiotherapy in rectal cancer. | The oncologist 20010101 |
| Vision of the future: capecitabine. | The oncologist 20010101 |
| [Coronary insufficiency after an oral intake of capecitabine]. | Gastroenterologie clinique et biologique 20010101 |
| Dose scheduling--Herceptin. | Oncology 20010101 |
| New combinations with Herceptin in metastatic breast cancer. | Oncology 20010101 |
| A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer. | Health technology assessment (Winchester, England) 20010101 |
| An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group. | Anticancer research 20010101 |
| Long term adaptation of a microbial population to a permanent metabolic constraint: overcoming thymineless death by experimental evolution of Escherichia coli. | BMC biotechnology 20010101 |
| Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer. | The oncologist 20010101 |
| Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model. | Biopharmaceutics & drug disposition 20010101 |
| Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20010101 |
| Exocyclic DNA adducts as secondary markers for oxidative stress: applications in human cancer etiology and risk assessment. | Advances in experimental medicine and biology 20010101 |
| Oral fluoropyrimidines: are they the equivalent of parenteral infusional 5-fluorouracil? | Cancer investigation 20010101 |
| Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer. | Drugs 20010101 |
| Use of capecitabine as first-line therapy in patients with metastatic breast cancer relapsing after high-dose chemotherapy and autologous stem cell support. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101 |
| [Results of phase II clinical trial of cycloplatam in refractory solid tumors]. | Voprosy onkologii 20010101 |
| Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts. | Anticancer research 20010101 |
| Gemcitabine-induced acute lipodermatosclerosis-like reaction. | Acta dermato-venereologica 20010101 |
| Compassionate use of Gemzar in advanced pancreatic cancer: a Belgian experience. | Acta gastro-enterologica Belgica 20010101 |
| Capecitabine in breast cancer: current status. | Clinical breast cancer 20010101 |
| Capecitabine (Xeloda). | Clinical journal of oncology nursing 20010101 |
| Gemcitabine hydrochloride. | Clinical journal of oncology nursing 20010101 |
| Oily chemoembolization of pancreatic head adenocarcinoma. | Cardiovascular and interventional radiology 20010101 |
| Human ribonucleotide reductase M2 subunit gene amplification and transcriptional regulation in a homogeneous staining chromosome region responsible for the mechanism of drug resistance. | Cytogenetics and cell genetics 20010101 |
| Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancer. | Tumori 20010101 |
| Gemcitabine-induced radiation recall dermatitis: case report. | Tumori 20010101 |
| [Colorectal cancer: irinotecan in combination with newer drugs]. | Tumori 20010101 |
| [Second-line and beyond: Docetaxel in the treatment of non-small-cell lung cancer]. | Tumori 20010101 |
| A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer. | Health technology assessment (Winchester, England) 20010101 |
| Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head. | International journal of gastrointestinal cancer 20010101 |
| Development of chemo-enzymatic process and manufacture of deoxynucleosides. | Nucleic acids research. Supplement (2001) 20010101 |
| Synthesis of sugar-modified 4'-thiocytidine derivatives. | Nucleic acids research. Supplement (2001) 20010101 |
| X-ray analyses of d(GCGAAAGC) and d(GXGAAAGCT), where X = 2'-deoxy-5-iodocytidine. | Nucleic acids research. Supplement (2001) 20010101 |
| Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma. | Cancer 20001215 |
| Phosphorylation of the anti-HIV compound (S,S)-isodideoxyadenosine by human recombinant deoxycytidine kinase. | Biochemical pharmacology 20001115 |
| Unnatural enantiomers of 5-azacytidine analogues: syntheses and enzymatic properties. | European journal of medicinal chemistry 20001101 |
| Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC. | Antiviral chemistry & chemotherapy 20001101 |
| Synthesis of 2',3'-dideoxy-3'-fluoro-L-ribonucleosides as potential antiviral agents from D-sorbitol. | Carbohydrate research 20000818 |
| Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies. | American journal of clinical oncology 20000801 |
| Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC]. | Antiviral chemistry & chemotherapy 20000701 |
| [A 42-year-old patient with the hemolytic-uremic syndrome under gemcitabine therapy for an adenocarcinoma of the liver. The hemolytic-uremic syndrome and gemcitabine]. | Zeitschrift fur Gastroenterologie 20000701 |
| Effect of oral administration of emtricitabine on woodchuck hepatitis virus replication in chronically infected woodchucks. | Antimicrobial agents and chemotherapy 20000601 |
| Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine. | Antimicrobial agents and chemotherapy 20000501 |
| Gemcitabine-induced atrial fibrillation: a hitherto unreported manifestation of drug toxicity. | Annals of oncology : official journal of the European Society for Medical Oncology 20000401 |
| Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice. | Antimicrobial agents and chemotherapy 20000301 |
| A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies. | Annals of oncology : official journal of the European Society for Medical Oncology 20000101 |
| Differential transport of cytosine-containing nucleosides by recombinant human concentrative nucleoside transporter protein hCNT1. | Nucleosides, nucleotides & nucleic acids 20000101 |
| Second-line chemotherapy with paclitaxel, cisplatin and gemcitabine in pre-treated sensitive cisplatin-based patients with advanced non-small cell lung cancer. | Anticancer research 20000101 |
| Effects of gemcitabine on cell proliferation and apoptosis in non-small-cell lung cancer (NSCLC) cell lines. | Cancer chemotherapy and pharmacology 20000101 |
| Acute myocardial infarction following gemcitabine therapy--a case report. | Angiology 19991201 |
| Severe non-haematological toxicity after treatment with gemcitabine. | Journal of cancer research and clinical oncology 19991101 |
| Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesothelioma. | Journal of the National Cancer Institute 19991020 |
| Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin. Oncopaz Cooperative Group. | Cancer 19991015 |
| Haemolytic uraemic syndrome after gemcitabine treatment for pancreatic carcinoma. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 19991001 |
| Hemolytic-uremic syndrome caused by gemcitabine. | Annals of oncology : official journal of the European Society for Medical Oncology 19981201 |
| Butylated hydroxytoluene modulates DNA methylation in rats. | European journal of biochemistry 19980915 |
| Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro. | Antimicrobial agents and chemotherapy 19980701 |
| Anti-hepatitis B virus activity and metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine. | Antimicrobial agents and chemotherapy 19980701 |
| Gemcitabine-associated autonomic neuropathy. | Lancet (London, England) 19980227 |
| Gemcitabine induces programmed cell death and activates protein kinase C in BG-1 human ovarian cancer cells. | Cancer chemotherapy and pharmacology 19980101 |
| Synthesis and antiviral activities of 5-substituted 1-(2-deoxy-2-C-methylene-4-thio-beta-D-ertythro-pentofuranosyl)uracils. | Nucleosides & nucleotides 19980101 |
| A purine nucleoside phosphorylase (PNP) inhibitor induces apoptosis via caspase-3-like protease activity in MOLT-4 T cells. | Immunopharmacology 19971001 |
| Nucleoside-mediated mitigation of 5-fluorouracil-induced toxicity in synchronized murine erythroleukemic cells. | Toxicology and applied pharmacology 19970901 |
| Apoptotic death induced in MOLT-4 T-lymphoblasts by purine nucleoside phosphorylase inhibition. | Inflammation research : official journal of the European Histamine Research Society ... [et al.] 19970801 |
| Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19970501 |
| Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model. | Radiation oncology investigations 19970101 |
| Chiral influences of feedback inhibition with dCTP on murine deoxycytidine kinase. | Nucleic acids symposium series 19970101 |
| Anti-human immunodeficiency virus and anti-hepatitis-B virus activities and toxicities of the enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine and their 5-fluoro analogues in vitro. | Journal of medicinal chemistry 19950106 |
| Inhibition of ribonucleotide reductase by 2'-substituted deoxycytidine analogs: possible application in AIDS treatment. | Proceedings of the National Academy of Sciences of the United States of America 19940830 |
| New substrates for old enzymes. 5-Hydroxy-2'-deoxycytidine and 5-hydroxy-2'-deoxyuridine are substrates for Escherichia coli endonuclease III and formamidopyrimidine DNA N-glycosylase, while 5-hydroxy-2'-deoxyuridine is a substrate for uracil DNA N-glycosylase. | The Journal of biological chemistry 19940722 |
| Antiproliferative effects and DNA hypomethylation by 5-aza-2'-deoxycytidine in human neuroblastoma cell lines. | Anti-cancer drugs 19931201 |
| Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. | Proceedings of the National Academy of Sciences of the United States of America 19930615 |
| Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine. | Proceedings of the National Academy of Sciences of the United States of America 19920715 |
| Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs. | Biochemical pharmacology 19920122 |
| The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3'-amino-2',3'-dideoxycytidine and cytosine arabinoside. | Cancer chemotherapy and pharmacology 19920101 |
| Differential alteration of the anti-HIV-1 effect of phosphorothioate oligonucleotide S-dC28 by AZT, interferon-alpha, and dextran sulfate. | AIDS research and human retroviruses 19911101 |
| Synthesis and anticancer and antiviral activities of various 2'- and 3'-methylidene-substituted nucleoside analogues and crystal structure of 2'-deoxy-2'-methylidenecytidine hydrochloride. | Journal of medicinal chemistry 19910801 |
| Site-specific hypomethylation of c-myc protooncogene in liver nodules and inhibition of DNA methylation by N-nitrosomorpholine. | Biochemical pharmacology 19910705 |
| Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro. | Antiviral research 19910701 |
| Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase. | Biochemical pharmacology 19910615 |
| Comparative inhibition of hepatitis B virus DNA polymerase and cellular DNA polymerases by triphosphates of sugar-modified 5-methyldeoxycytidines and of other nucleoside analogs. | Antimicrobial agents and chemotherapy 19910601 |
| Regulatory effects of deoxyribonucleosides on the activity of 5-methoxymethyl-2'-deoxycytidine: modulation of antiherpes activity by deoxyguanosine and tetrahydrodeoxyuridine. | Antiviral research 19910501 |
| Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate. | Cancer research 19910501 |
| Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine. | Molecular pharmacology 19901001 |
| The effect in vitro of 2'-deoxycytidine on the metabolism and cytotoxicity of 2',3'-dideoxycytidine. | AIDS (London, England) 19900501 |
| Synthesis and in vitro evaluation of some modified 4-thiopyrimidine nucleosides for prevention or reversal of AIDS-associated neurological disorders. | Journal of medicinal chemistry 19900101 |
| 2',3'-didehydro-2',3'-dideoxy-5-chlorocytidine is a selective anti-retrovirus agent. | Biochemical and biophysical research communications 19891115 |
| 2'-Deoxycytidine protects normal human bone marrow progenitor cells in vitro against the cytotoxicity of 3'-azido-3'-deoxythymidine with preservation of antiretroviral activity. | Blood 19891101 |
| Evaluation of the effects of erythro-9(2-hydroxy-3-nonyl) adenine (EHNA) on HIV-1 production in vitro. | Biochemical and biophysical research communications 19891016 |
| Effect of phosphorothioate homo-oligodeoxynucleotides on herpes simplex virus type 2-induced DNA polymerase. | The Journal of biological chemistry 19890705 |
| 5-Halogeno-3'-fluoro-2',3'-dideoxyuridines as inhibitors of human immunodeficiency virus (HIV): potent and selective anti-HIV activity of 3'-fluoro-2',3'-dideoxy-5-chlorouridine. | Molecular pharmacology 19890501 |
| Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. | The Journal of biological chemistry 19890415 |
| Synergistic interaction of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1. | The Journal of infectious diseases 19880801 |
| Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues. | Biochemical pharmacology 19880715 |
| The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species. | Biochemical pharmacology 19880301 |
| Synthesis and antiviral evaluation of carbocyclic analogues of 2'-azido- and 2'-amino-2'-deoxycytidine. | Journal of medicinal chemistry 19880201 |
| Synthesis and antiviral properties of (E)-5-(2-bromovinyl)-2'-deoxycytidine-related compounds. | Journal of medicinal chemistry 19880101 |
| 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis. | Molecular pharmacology 19871201 |
| Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus. | Biochemical pharmacology 19870901 |
| 3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents. | Journal of medicinal chemistry 19870801 |
| Potential anti-AIDS drugs. 2',3'-Dideoxycytidine analogues. | Journal of medicinal chemistry 19870501 |
| Antiviral activity of 2',3'-dideoxycytidin-2'-ene (2',3'-dideoxy-2',3'-didehydrocytidine) against human immunodeficiency virus in vitro. | Biochemical pharmacology 19870201 |
| Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides. | Proceedings of the National Academy of Sciences of the United States of America 19860301 |
| Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2'-deoxyuridines and (E)-5-(2-halovinyl)-2'-deoxycytidines. | Journal of medicinal chemistry 19850501 |
| Evaluation of carbodine, the carbocyclic analog of cytidine, and related carbocyclic analogs of pyrimidine nucleosides for antiviral activity against human influenza Type A viruses. | Antimicrobial agents and chemotherapy 19811201 |
| Cellular differentiation, cytidine analogs and DNA methylation. | Cell 19800501 |
| 2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent. | Antimicrobial agents and chemotherapy 19800501 |
| 13-Alkylpyrimidine nucleosides. Preparation and properties of 5-ethyl-2'-deoxycytidine and related nucleosides. | Journal of medicinal chemistry 19740301 |